Clustering O 0 2.1938549252809025e-06
of O 0 9.171259307549917e-10
missense O 0 3.6656247175415047e-06
mutations O 0 8.637243240627868e-07
in O 0 1.766344581710655e-08
the O 0 1.1986154504484148e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 3.7480211176443845e-05
in O 0 6.661561080534284e-09
a O 0 1.8234147525220123e-09
sporadic B-Disease 0 0.04647902771830559
T I-Disease 1 0.9999420642852783
- I-Disease 0 0.09770932048559189
cell I-Disease 1 0.9005162715911865
leukaemia I-Disease 1 0.9999649524688721
. O 0 2.7283164172331453e-08

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9740913510322571
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 3.7461436730445996e-10
is O 0 2.2144836311910332e-11
a O 0 1.882917849416188e-10
recessive B-Disease 0 0.3494817316532135
multi I-Disease 1 0.9940213561058044
- I-Disease 1 0.9999998807907104
system I-Disease 1 0.7255996465682983
disorder I-Disease 1 0.9985295534133911
caused O 0 2.291248746288943e-09
by O 0 2.2851885314589815e-11
mutations O 0 8.033859799638776e-09
in O 0 2.5440285988942435e-10
the O 0 2.1902583913213647e-11
ATM O 0 1.5090540728124324e-07
gene O 0 1.3930146813834199e-08
at O 0 9.427766123337733e-09
11q22 O 0 3.707026792199031e-07
- O 0 6.987746132836037e-07
q23 O 0 9.021761115945992e-07
( O 0 2.2841710745069577e-09
ref O 0 1.7927959561347961e-06
. O 0 5.5666592863046205e-11
3 O 0 1.1021575319070109e-10
) O 0 7.042300770310206e-11
. O 0 5.809194791872585e-10

The O 0 9.041311699320431e-09
risk O 0 5.9434128729662916e-08
of O 0 2.0923844254450152e-11
cancer B-Disease 0 2.3048727371133282e-08
, O 0 5.876379938207776e-11
especially O 0 2.66532218518023e-09
lymphoid B-Disease 0 7.545771495642839e-06
neoplasias I-Disease 0 0.00019886676454916596
, O 0 8.415089736146797e-10
is O 0 1.1221670814798301e-10
substantially O 0 2.6310308953725325e-07
elevated O 0 6.123985762940265e-09
in O 0 2.662214626525383e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9399217367172241
and O 0 7.544421087857245e-09
has O 0 1.892491718891165e-10
long O 0 3.124578720758997e-11
been O 0 5.142488518350419e-11
associated O 0 2.1066856592533156e-10
with O 0 1.3406504795199226e-09
chromosomal O 1 1.0
instability O 1 1.0
. O 0 3.300110762438635e-08

By O 0 1.081542144731884e-08
analysing O 0 4.868613359576557e-06
tumour B-Disease 1 1.0
DNA O 0 2.7124914936393907e-07
from O 0 2.9511812438265395e-10
patients O 0 6.251703044135581e-10
with O 0 3.640800334825389e-12
sporadic B-Disease 0 2.1218771507847123e-05
T I-Disease 1 0.9992210865020752
- I-Disease 0 0.00029372406424954534
cell I-Disease 1 0.6313155889511108
prolymphocytic I-Disease 1 0.876933753490448
leukaemia I-Disease 1 0.9999969005584717
( O 0 1.7663513318666446e-08
T B-Disease 0 7.791053940309212e-05
- I-Disease 0 2.279381988046225e-06
PLL I-Disease 0 5.148295258550206e-06
) O 0 2.075837141068959e-10
, O 0 5.303874527073926e-12
a O 0 1.607076798026963e-11
rare O 0 3.704465623144415e-09
clonal B-Disease 0 2.6711563805292826e-07
malignancy I-Disease 0 8.816690751700662e-06
with O 0 2.319396064098811e-11
similarities O 0 4.189926627873319e-09
to O 0 2.9132779522100805e-11
a O 0 5.578725814636698e-10
mature B-Disease 0 4.765461767419765e-07
T I-Disease 0 0.00010781192395370454
- I-Disease 0 4.031201115139993e-06
cell I-Disease 0 0.003045782446861267
leukaemia I-Disease 1 0.9996116757392883
seen O 0 3.398361059225863e-07
in O 0 2.9041116178518678e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
, O 0 3.1959943025405835e-10
we O 0 2.179573188598738e-11
demonstrate O 0 1.8196607415310595e-11
a O 0 9.673698474210735e-12
high O 0 2.9514513055772795e-10
frequency O 0 4.1191397515127903e-10
of O 0 8.612273220964806e-12
ATM O 0 5.643280474032508e-07
mutations O 0 4.242640461171732e-09
in O 0 4.090158878256034e-09
T B-Disease 0 0.0005576190887950361
- I-Disease 0 7.500128504034365e-06
PLL I-Disease 0 4.5316079194890335e-05
. O 0 3.9842863230887815e-08

In O 0 1.1278738831776991e-08
marked O 0 1.2329326448679012e-09
contrast O 0 2.7163243876415777e-10
to O 0 1.3066388249161065e-11
the O 0 1.518322967353214e-11
ATM O 0 1.935057298396714e-06
mutation O 0 5.546718195859057e-09
pattern O 0 1.1403948008137377e-07
in O 0 6.319637577689718e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 3.2082217438222926e-10
the O 0 1.459602187378617e-12
most O 0 1.1910427071687435e-12
frequent O 0 2.379222339976561e-11
nucleotide O 0 2.642305263478306e-10
changes O 0 4.586849997045839e-11
in O 0 1.368826718639582e-10
this O 0 2.995197978528097e-10
leukaemia B-Disease 0 5.68999930692371e-05
were O 0 9.673897238826612e-09
missense O 0 2.0453699107747525e-06
mutations O 0 5.992632736706582e-07
. O 0 8.995831635161267e-09

These O 0 1.5642313000441277e-09
clustered O 0 1.8401511425736317e-08
in O 0 8.530990497357394e-11
the O 0 1.8479486604133788e-12
region O 0 3.340924412120749e-11
corresponding O 0 1.5232686639832238e-11
to O 0 5.046658403673465e-12
the O 0 9.59021924373804e-12
kinase O 0 8.42175751358809e-09
domain O 0 2.346773331218799e-10
, O 0 6.676523049697902e-12
which O 0 2.0493433339208167e-12
is O 0 1.6244572961093828e-12
highly O 0 5.576699258630358e-12
conserved O 0 2.0765370326025767e-11
in O 0 2.518440733734195e-10
ATM O 0 4.400674811222416e-07
- O 0 2.8098250393071567e-09
related O 0 2.3195385889795972e-10
proteins O 0 4.2408805633886715e-11
in O 0 4.858413671371409e-10
mouse O 0 3.6503132605503197e-07
, O 0 6.495388671368119e-10
yeast O 0 5.34045980771225e-08
and O 0 6.234888716427633e-10
Drosophila O 0 8.788147098925947e-09
. O 0 8.646171001380765e-10

The O 0 2.682299715672798e-09
resulting O 0 1.4831073036347675e-09
amino O 0 1.085810374945595e-08
- O 0 3.641245172048002e-08
acid O 0 3.6247702062119913e-10
substitutions O 0 2.824740441553786e-10
are O 0 7.455050465843271e-12
predicted O 0 1.672473826097587e-10
to O 0 3.2470514992055666e-12
interfere O 0 7.437602755899775e-10
with O 0 8.798934671150338e-12
ATP O 0 1.2725560161186422e-08
binding O 0 9.792519017892687e-10
or O 0 3.408626714218599e-10
substrate O 0 1.9135493189992303e-08
recognition O 0 2.5127657732326725e-09
. O 0 3.052992747498706e-09

Two O 0 1.2862647613687272e-09
of O 0 3.66275655638848e-11
seventeen O 0 3.882276278233121e-09
mutated O 0 2.2244145725380804e-07
T B-Disease 0 4.674344017985277e-05
- I-Disease 0 1.4161198578221956e-06
PLL I-Disease 0 1.4855734207230853e-06
samples O 0 1.2795754678052162e-08
had O 0 3.6970118078016867e-09
a O 0 1.011673904371957e-11
previously O 0 5.651983880916589e-10
reported O 0 9.793189747142605e-06
A B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
T I-Disease 1 1.0
allele O 0 4.856739906244911e-05
. O 0 4.060336067368553e-08

In O 0 1.0082003676359363e-08
contrast O 0 5.260489821523606e-09
, O 0 7.177788224899118e-11
no O 0 5.477910833273647e-11
mutations O 0 7.555592818064838e-10
were O 0 6.313511380362513e-10
detected O 0 3.5544323040426207e-09
in O 0 3.937321649272185e-11
the O 0 2.2414494305761368e-12
p53 O 0 6.121200074593602e-11
gene O 0 2.802822418601636e-10
, O 0 6.8559385599242795e-12
suggesting O 0 2.874493143512069e-10
that O 0 4.1987222726413975e-11
this O 0 3.747553822819327e-09
tumour B-Disease 1 1.0
suppressor O 0 1.0044155942523503e-06
is O 0 4.1468958822399316e-10
not O 0 1.2638709523393743e-10
frequently O 0 4.3478992628465107e-10
altered O 0 4.1808359441120047e-08
in O 0 9.803176048706064e-09
this O 0 1.0298045971524061e-08
leukaemia B-Disease 0 0.004438933916389942
. O 0 1.2749442390713739e-08

Occasional O 0 1.531211455585435e-05
missense O 0 8.483440615236759e-05
mutations O 0 1.1466199794085696e-06
in O 0 1.2418918116097188e-09
ATM O 0 1.0831197272409554e-07
were O 0 2.6239035944009004e-10
also O 0 1.636699283047438e-11
found O 0 7.330128865001839e-11
in O 0 3.140139481772053e-09
tumour B-Disease 1 1.0
DNA O 0 3.1142310064069534e-08
from O 0 2.517603833740445e-11
patients O 0 2.9822291858216943e-10
with O 0 5.8915277170723535e-12
B B-Disease 0 1.0898940672632307e-05
- I-Disease 0 1.6372442246392893e-07
cell I-Disease 0 0.0038868444971740246
non I-Disease 1 0.9997746348381042
- I-Disease 1 0.9999997615814209
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.9999866485595703
( O 0 1.2785362102363251e-08
B B-Disease 0 1.868591243692208e-05
- I-Disease 0 1.9905533577002643e-07
NHL I-Disease 0 3.830333827892218e-09
) O 0 1.0921499815630398e-11
and O 0 1.895365982218511e-11
a O 0 3.2433777885643167e-10
B B-Disease 0 1.776824501575902e-05
- I-Disease 0 3.712424501145506e-08
NHL I-Disease 0 1.1816725375979331e-08
cell O 0 1.4919039870164852e-07
line O 0 6.241057235456537e-07
. O 0 8.679601926075975e-09

The O 0 2.7181640271933816e-10
evidence O 0 9.64488836019406e-11
of O 0 3.7835283950987675e-13
a O 0 5.6166547107716625e-12
significant O 0 5.1606469098075536e-11
proportion O 0 1.07170128327283e-09
of O 0 6.726513443466864e-12
loss O 0 2.463393711238382e-09
- O 0 5.333840036314541e-09
of O 0 2.027610024324389e-11
- O 0 4.909738038350042e-08
function O 0 1.0759384355685242e-10
mutations O 0 1.5210491755013322e-09
and O 0 1.6171754213534228e-10
a O 0 1.6949987247105724e-10
complete O 0 1.3755091510248008e-09
absence O 0 3.1182695314768694e-10
of O 0 5.019354073002025e-13
the O 0 8.058172185076984e-12
normal O 0 3.3960759204809676e-10
copy O 0 6.493236615057185e-09
of O 0 2.9561355533586076e-12
ATM O 0 5.0305231980019016e-08
in O 0 1.716772279891643e-10
the O 0 9.808622664086997e-12
majority O 0 4.9379330485654904e-11
of O 0 2.2826532330988414e-11
mutated O 0 0.0433821976184845
tumours B-Disease 1 1.0
establishes O 0 2.139378096899236e-07
somatic O 0 2.786706545521156e-07
inactivation O 0 1.1878965011646869e-07
of O 0 4.899475356673344e-12
this O 0 1.256732673655947e-12
gene O 0 1.8468089557632794e-10
in O 0 4.604705505784068e-11
the O 0 2.3038760135762892e-11
pathogenesis O 0 2.9031022030778786e-09
of O 0 5.216091447657334e-12
sporadic B-Disease 0 2.8456703148549423e-05
T I-Disease 1 0.9676972031593323
- I-Disease 0 8.432251343037933e-05
PLL I-Disease 0 7.712434126005974e-06
and O 0 8.341421442459307e-10
suggests O 0 1.0390371896207284e-10
that O 0 2.1619795797372943e-12
ATM O 0 5.161341132264852e-09
acts O 0 9.664943151355132e-11
as O 0 2.1085587442737364e-10
a O 0 5.007411818525043e-09
tumour B-Disease 1 1.0
suppressor O 0 6.256866527110105e-06
. O 0 1.0212723111635569e-08

As O 0 5.217869691875876e-09
constitutional O 0 1.1371660280090623e-09
DNA O 0 1.2157879147878248e-08
was O 0 1.3929873921014746e-09
not O 0 2.8613947149203067e-12
available O 0 4.738564141765211e-12
, O 0 7.873302704242136e-13
a O 0 5.627294810683914e-11
putative O 0 4.0470848716722685e-07
hereditary O 0 0.04098419100046158
predisposition O 0 2.0960158053640043e-06
to O 0 2.110905894525672e-09
T B-Disease 0 0.021869391202926636
- I-Disease 0 1.0685436791391112e-05
PLL I-Disease 0 4.6549239414162e-06
will O 0 5.563583482803836e-10
require O 0 1.1881237660382737e-10
further O 0 1.9140877771661735e-10
investigation O 0 1.9701078546319195e-09
. O 0 9.74052297153527e-11
. O 0 4.653427365663987e-10

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 0.00011825114052044228
kinase O 0 1.6010593753890134e-05
is O 0 3.3236696728167203e-10
involved O 0 2.4435637541175836e-11
in O 0 1.6134529476352633e-11
the O 0 2.7059433253123766e-12
modulation O 0 1.6203370589717991e-10
of O 0 1.4382152153241679e-12
the O 0 2.3171230559282385e-11
Ca2 O 0 2.3673345950214753e-08
+ O 0 7.371359345142992e-08
homeostasis O 0 4.97881046612747e-07
in O 0 2.7126652035747156e-09
skeletal O 0 1.0644631402101368e-05
muscle O 0 6.828342975495616e-07
cells O 0 1.289065920673238e-07
. O 0 1.5420589249970362e-08

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999587535858154
DM B-Disease 1 1.0
) O 0 1.745386413176675e-08
, O 0 1.307780793380342e-11
the O 0 1.0619368882511249e-12
most O 0 1.7745274000224853e-11
prevalent O 0 0.00023290657554753125
muscular B-Disease 1 0.9937765598297119
disorder I-Disease 1 0.9404811859130859
in O 0 7.024776493835816e-08
adults O 0 4.439888925844571e-06
, O 0 1.3179529689821834e-10
is O 0 1.3888268313166918e-10
caused O 0 3.442451046442585e-10
by O 0 3.248589244830846e-11
( O 0 4.0685887991998015e-10
CTG O 0 8.271275930837874e-08
) O 0 4.1771468228812836e-11
n O 0 1.522896297956322e-08
- O 0 1.1943372157929844e-07
repeat O 0 3.5222875727214387e-09
expansion O 0 1.6419594850436425e-10
in O 0 2.3604370194552082e-11
a O 0 5.525233048864209e-12
gene O 0 4.502091199842795e-10
encoding O 0 4.227452277127952e-10
a O 0 8.615760188623867e-11
protein O 0 3.199144771315332e-08
kinase O 0 7.029654170764843e-06
( O 0 2.586727099185282e-08
DM B-Disease 1 1.0
protein O 0 3.2952118544926634e-07
kinase O 0 1.983838046726305e-06
; O 0 4.857348412379281e-10
DMPK O 0 3.038042848402256e-07
) O 0 2.8168948076889855e-11
and O 0 6.855206072936548e-12
involves O 0 1.794348523931344e-12
changes O 0 1.9195488948353656e-11
in O 0 2.5533328229521146e-10
cytoarchitecture O 0 2.0806976408493938e-07
and O 0 4.5508358192947185e-10
ion O 0 2.223798922784681e-08
homeostasis O 0 8.331965659635898e-07
. O 0 6.9673418146010135e-09

To O 0 7.414486247192542e-10
obtain O 0 1.029843321731505e-09
clues O 0 1.4357761202177244e-08
to O 0 1.0559951350852526e-11
the O 0 7.441709574951272e-12
normal O 0 1.021520645849705e-10
biological O 0 6.115248585292221e-11
role O 0 2.71716763672325e-11
of O 0 1.1825269496251734e-12
DMPK O 0 1.3463629322529869e-08
in O 0 1.783323072546139e-10
cellular O 0 3.3687509670699e-08
ion O 0 4.911589801537275e-09
homeostasis O 0 1.7100165905503673e-07
, O 0 4.192040811701325e-11
we O 0 1.555737830227777e-11
have O 0 2.3538627644259513e-12
compared O 0 3.3549597128201825e-11
the O 0 2.495771818378234e-12
resting O 0 6.73894759439797e-11
[ O 0 6.265918339742882e-11
Ca2 O 0 1.556125228674432e-09
+ O 0 9.094062392023261e-09
] O 0 1.199100463367131e-08
i O 0 8.043446086958284e-08
, O 0 1.0847898100629916e-12
the O 0 9.99360858823517e-13
amplitude O 0 1.2287245006181724e-11
and O 0 9.52553834421277e-12
shape O 0 3.433539563779675e-10
of O 0 5.283317620202732e-12
depolarization O 0 1.5116899954037422e-09
- O 0 3.8622555820211346e-08
induced O 0 7.99442645416093e-08
Ca2 O 0 1.020986388766687e-07
+ O 0 7.716135996815865e-08
transients O 0 1.0952431921396055e-06
, O 0 6.417397863112129e-11
and O 0 4.307342243298207e-12
the O 0 6.030294536288339e-13
content O 0 5.7337974646021195e-11
of O 0 1.0700698140075904e-12
ATP O 0 5.034052730223948e-09
- O 0 6.952244890889858e-10
driven O 0 1.0645199166603447e-09
ion O 0 4.661155905694159e-10
pumps O 0 4.093342997890659e-09
in O 0 5.635911737300603e-10
cultured O 0 2.4272596874652663e-06
skeletal O 0 6.67563290335238e-06
muscle O 0 1.9649453619763335e-08
cells O 0 5.980911321756821e-10
of O 0 3.725774463253506e-12
wild O 0 6.105670968814536e-10
- O 0 2.2871526539347542e-07
type O 0 3.6899239148624474e-06
and O 0 3.882024479651136e-09
DMPK O 0 2.949101826743572e-06
[ O 0 8.62132587542419e-09
- O 0 3.307096392290987e-07
/ O 0 5.844592578796437e-06
- O 0 8.587429078943387e-07
] O 0 4.0866208195211584e-08
knockout O 0 4.7109892875596415e-06
mice O 0 1.7688716980046593e-05
. O 0 5.130736724368035e-09

In O 0 3.683288696265663e-08
vitro O 0 5.107148808747297e-06
- O 0 4.77644107377273e-06
differentiated O 0 1.2446145092326333e-06
DMPK O 0 1.141671327786753e-05
[ O 0 2.6653896867401272e-08
- O 0 4.887249360763235e-07
/ O 0 1.0150414482268388e-06
- O 0 1.2381512703996123e-07
] O 0 2.1144317408072766e-09
myotubes O 0 4.967515288001323e-09
exhibit O 0 1.8891664621545345e-10
a O 0 2.3914029090299493e-10
higher O 0 1.004235450352553e-08
resting O 0 2.2081001471718764e-09
[ O 0 7.731537632338359e-10
Ca2 O 0 7.0166592536224925e-09
+ O 0 7.868187168469376e-08
] O 0 6.106014183160369e-08
i O 0 3.1911852715893474e-08
than O 0 7.962863007859866e-12
do O 0 5.693214996660423e-11
wild O 0 8.519786959260145e-11
- O 0 4.639312045640054e-09
type O 0 6.17479756215289e-08
myotubes O 0 3.748066887965251e-07
because O 0 2.0617738072381542e-10
of O 0 9.31204766074778e-13
an O 0 1.528290948654698e-12
altered O 0 1.84573933914578e-09
open O 0 2.476570726273053e-09
probability O 0 3.7400305075152573e-11
of O 0 3.5209320268375643e-12
voltage O 0 8.256834327369234e-09
- O 0 2.879566629587771e-08
dependent O 0 2.0563717839650053e-08
l O 0 7.100482690702847e-08
- O 0 8.094106718203875e-09
type O 0 2.5635930711587207e-08
Ca2 O 0 1.1202926586406647e-08
+ O 0 9.87957271547657e-09
and O 0 5.566300753656606e-10
Na O 0 2.467886162094146e-08
+ O 0 3.810935123027548e-09
channels O 0 3.222268674107909e-08
. O 0 5.397897684389363e-09

The O 0 3.871686971024246e-09
mutant O 0 1.8027435544354375e-07
myotubes O 0 2.0416835866399197e-07
exhibit O 0 1.640344970965657e-09
smaller O 0 2.250165609396504e-09
and O 0 1.0323547572355096e-09
slower O 0 2.838040131791786e-07
Ca2 O 0 2.6128343932896314e-08
+ O 0 4.809596276800221e-09
responses O 0 7.747997798901451e-10
upon O 0 1.2369545492052492e-11
triggering O 0 2.484352168430348e-10
by O 0 1.7004703201095595e-11
acetylcholine O 0 4.338849279861279e-08
or O 0 5.7568265710017386e-09
high O 0 1.0294981755976096e-08
external O 0 1.0297166852524242e-07
K O 0 1.3268306986446987e-07
+ O 0 5.1065271122752165e-08
. O 0 3.6951224302583796e-09

In O 0 4.630162475649513e-09
addition O 0 6.243263545036015e-11
, O 0 1.5660328936406565e-11
we O 0 1.6693105231446737e-12
observed O 0 4.561500374471172e-13
that O 0 1.1612832548878183e-13
these O 0 1.716875448233568e-12
Ca2 O 0 1.9743513490766418e-09
+ O 0 9.717949112086899e-09
transients O 0 4.8316838530126915e-08
partially O 0 3.6218970045354126e-09
result O 0 1.7374596206209958e-10
from O 0 4.852509453284748e-12
an O 0 4.32360446273386e-13
influx O 0 7.632700027571104e-12
of O 0 1.4979366488518386e-12
extracellular O 0 3.5225611316747063e-10
Ca2 O 0 1.7832423315766732e-09
+ O 0 4.963099375920876e-10
through O 0 1.9716471510999867e-11
the O 0 1.9537049061879586e-11
l O 0 1.4308224827175309e-08
- O 0 4.377266105137778e-09
type O 0 3.6064783159872604e-08
Ca2 O 0 2.6045698930943217e-08
+ O 0 2.8978368149523703e-08
channel O 0 2.427754282052774e-07
. O 0 4.955534205208778e-09

Neither O 0 1.027560401212213e-07
the O 0 1.8467596896165617e-10
content O 0 4.175460532884756e-10
nor O 0 1.138948269030493e-09
the O 0 4.0720547593575684e-12
activity O 0 3.250648916708343e-10
of O 0 3.877194138662832e-12
Na O 0 2.3467309873126396e-08
+ O 0 3.0651057247865765e-09
/ O 0 4.845265966224588e-09
K O 0 3.283865401826347e-09
+ O 0 4.410638521079591e-09
ATPase O 0 1.7126801310496376e-07
and O 0 1.6532607505226338e-09
sarcoplasmic O 0 1.6370286175515503e-06
reticulum O 0 2.166476861020783e-06
Ca2 O 0 7.336979024330503e-07
+ O 0 2.9988882488396484e-07
- O 0 8.48040215828405e-08
ATPase O 0 1.2717825370600622e-07
are O 0 1.0644930770187244e-10
affected O 0 2.847068969469291e-10
by O 0 7.249886108118275e-11
DMPK O 0 2.5400297545274952e-06
absence O 0 1.9052858846180243e-08
. O 0 1.3226275630273676e-09

In O 0 1.2242208136115096e-08
conclusion O 0 6.019823528546908e-10
, O 0 6.542269330445105e-12
our O 0 2.1690839228927228e-12
data O 0 1.2046715187896684e-11
suggest O 0 1.759412060486909e-11
that O 0 4.655997375840881e-12
DMPK O 0 2.8368702942316304e-08
is O 0 1.2956442559455827e-12
involved O 0 6.523964094645729e-12
in O 0 2.663515415168849e-11
modulating O 0 9.727662009240134e-10
the O 0 8.485935912294629e-12
initial O 0 2.0067109432475583e-11
events O 0 2.9011656358518545e-12
of O 0 3.248265588798316e-12
excitation O 0 3.515744850801639e-08
- O 0 1.878901275631506e-05
contraction O 0 7.901157346168475e-07
coupling O 0 1.2393037707170151e-08
in O 0 6.746307401606089e-10
skeletal O 0 4.884509507974144e-06
muscle O 0 1.1480419459530822e-07
. O 0 2.6606225556058405e-10
. O 0 9.63353175009729e-10

Constitutional O 0 1.7710831343720201e-06
RB1 O 0 0.0006270419107750058
- O 0 1.0549363651080057e-05
gene O 0 7.231168979160429e-07
mutations O 0 1.955458657221243e-07
in O 0 4.098045902622971e-09
patients O 0 1.3986321434344973e-08
with O 0 3.920116661837447e-11
isolated O 0 2.0535738087801292e-07
unilateral B-Disease 0 2.2775418983655982e-05
retinoblastoma I-Disease 0 0.0015652618603780866
. O 0 1.0992786059205173e-07

In O 0 2.442598301399812e-08
most O 0 1.02199471108122e-09
patients O 0 2.0171240233679555e-09
with O 0 7.35181360234094e-12
isolated O 0 3.463536657477562e-08
unilateral B-Disease 0 1.4763000990569708e-06
retinoblastoma I-Disease 0 0.0005104335723444819
, O 0 6.62982158061709e-09
tumor B-Disease 0 1.7513757555320808e-08
development O 0 1.2159258322430588e-10
is O 0 1.0273271816574336e-11
initiated O 0 1.0104517916831313e-10
by O 0 1.6475489375555874e-11
somatic O 0 9.354719665566336e-09
inactivation O 0 9.383634314019673e-09
of O 0 1.89845882070383e-12
both O 0 6.755210973929948e-12
alleles O 0 2.25111762564012e-10
of O 0 4.482773093700265e-12
the O 0 1.995764803419675e-10
RB1 O 0 8.784243732407049e-07
gene O 0 1.7925567874499393e-07
. O 0 1.3331187709297865e-08

However O 0 7.81126132665122e-08
, O 0 8.23433612961999e-11
some O 0 5.614873258182052e-13
of O 0 1.8601550963621982e-13
these O 0 2.5312477808236977e-12
patients O 0 4.518287480270722e-11
can O 0 2.2602159727158622e-11
transmit O 0 6.641202077162234e-08
retinoblastoma B-Disease 0 2.8490649128798395e-05
predisposition O 0 1.1548160728125367e-05
to O 0 1.258468773635002e-09
their O 0 6.870004010117725e-10
offspring O 0 5.920825607574898e-09
. O 0 1.2558359907544059e-09

To O 0 7.99319832545109e-10
determine O 0 8.634915005245603e-10
the O 0 2.1873319128173918e-11
frequency O 0 4.319195667790154e-09
and O 0 8.437071180589228e-11
nature O 0 1.4317920980777554e-11
of O 0 2.669342394692742e-12
constitutional O 0 7.951609926060144e-10
RB1 O 0 1.7507213669887278e-06
- O 0 2.5703496220330635e-08
gene O 0 3.6563402971978576e-08
mutations O 0 4.497563921290748e-08
in O 0 1.3389459541102156e-09
patients O 0 8.149098285059608e-09
with O 0 6.189312951043746e-12
isolated O 0 4.976498146902486e-08
unilateral B-Disease 0 5.968051368654415e-07
retinoblastoma I-Disease 0 4.2729541746666655e-05
, O 0 6.224147863775897e-10
we O 0 5.0036259857666465e-11
analyzed O 0 1.0667186578494636e-10
DNA O 0 3.9520250960656256e-10
from O 0 1.690851798852311e-11
peripheral O 0 8.471365475770654e-08
blood O 0 1.4075706822325174e-08
and O 0 8.766680159588702e-10
from O 0 1.5884189519255187e-09
tumor B-Disease 0 4.645601450192771e-07
tissue O 0 9.484761562816857e-07
. O 0 1.1641648534066462e-08

The O 0 7.087932463178959e-10
analysis O 0 1.896116597066566e-09
of O 0 5.514097164982523e-11
tumors B-Disease 1 1.0
from O 0 1.3812141430591396e-09
54 O 0 8.783924698718693e-09
( O 0 2.141412464018444e-10
71 O 0 2.0065304084937452e-08
% O 0 5.673659111971041e-11
) O 0 4.832227066403627e-12
of O 0 1.155808088126875e-12
76 O 0 1.0404620276460719e-08
informative O 0 1.4763013211904763e-07
patients O 0 3.5841617318510544e-06
showed O 0 4.6604141061834525e-06
loss O 0 4.202548087306468e-09
of O 0 3.895250441643405e-12
constitutional O 0 3.3355536110946105e-09
heterozygosity O 0 9.607860192772932e-06
( O 0 9.527227717853748e-08
LOH O 1 0.999998927116394
) O 0 8.870966183849305e-10
at O 0 1.917015213237505e-09
intragenic O 0 3.386422804396716e-07
loci O 0 1.651560523896478e-07
. O 0 8.096236570054316e-09

Three O 0 5.929019053496631e-09
of O 0 5.852644063830681e-11
13 O 0 9.057342098550691e-10
uninformative O 0 3.7128613712411607e-06
patients O 0 4.543387603916926e-06
had O 0 9.58946841933539e-08
constitutional O 0 5.139620729011085e-09
deletions O 0 8.395600730182196e-07
. O 0 1.145766415078242e-08

For O 0 5.750318887720596e-09
39 O 0 9.762070263263922e-09
randomly O 0 2.2164381441314163e-09
selected O 0 1.7103355176573132e-08
tumors B-Disease 1 1.0
, O 0 7.136660151729757e-10
SSCP O 0 7.18059084192646e-07
, O 0 2.4185306535251527e-10
hetero O 0 5.842681275680661e-06
- O 0 1.0022780827512179e-07
duplex O 0 1.3880915048503084e-06
analysis O 0 1.3458667513788214e-09
, O 0 7.964047823993958e-12
sequencing O 0 1.7169360377877751e-10
, O 0 8.189301667349547e-12
and O 0 5.990118123744281e-12
Southern O 0 8.284036651096116e-11
blot O 0 9.558513056617812e-07
analysis O 0 4.048902046971392e-10
were O 0 8.64038007808432e-11
used O 0 2.200102079685795e-11
to O 0 7.94458335923176e-12
identify O 0 2.689502398567356e-09
mutations O 0 2.599919213253088e-08
. O 0 1.761572887559737e-09

Mutations O 0 2.2310866825137055e-06
were O 0 2.2352123707491955e-08
detected O 0 5.0672326779022114e-08
in O 0 4.333402803258224e-10
21 O 0 7.855044392712784e-10
( O 0 1.5673686307171586e-11
91 O 0 1.5325083424500008e-09
% O 0 5.464719649017624e-11
) O 0 1.1907705724234496e-11
of O 0 6.872097335630656e-11
23 O 0 3.3527976484037936e-05
tumors B-Disease 1 1.0
with O 0 4.220705136503966e-07
LOH O 1 0.9999996423721313
. O 0 5.461643581838871e-08

In O 0 3.369175161083149e-08
6 O 0 5.104985767445669e-09
( O 0 2.0077456364120394e-10
38 O 0 1.8422432468412353e-09
% O 0 3.284914701362496e-11
) O 0 1.024552404721435e-11
of O 0 2.4038999957287643e-11
16 O 0 6.589016834368522e-07
tumors B-Disease 1 1.0
without O 0 1.657109294228576e-07
LOH O 1 0.9999974966049194
, O 0 6.387052692291562e-11
one O 0 3.0191026761938744e-11
mutation O 0 2.3040453989153775e-09
was O 0 1.6954983195205386e-08
detected O 0 1.7789957951208635e-07
, O 0 7.501296112044642e-11
and O 0 2.946106553158856e-11
in O 0 2.1154998586236928e-10
9 O 0 1.349841238784677e-09
( O 0 5.366284500096796e-11
56 O 0 1.980910990795337e-09
% O 0 1.7765457507867843e-11
) O 0 1.4345468172735631e-12
of O 0 1.795320836439629e-12
the O 0 1.5490249083427443e-08
tumors B-Disease 1 1.0
without O 0 1.0763098998722853e-06
LOH O 1 0.9999998807907104
, O 0 3.462738776272012e-11
both O 0 3.392901584686747e-11
mutations O 0 1.1879270900294614e-09
were O 0 2.451516323276337e-09
found O 0 5.276869607939716e-09
. O 0 1.0958779439462774e-09

Thus O 0 6.279191833158393e-09
, O 0 9.045649645988973e-11
a O 0 9.704208790706215e-12
total O 0 3.5319761438473707e-12
of O 0 1.2761703586244844e-12
45 O 0 6.07086603210405e-11
mutations O 0 6.03808392174443e-10
were O 0 5.093983013182424e-10
identified O 0 1.1360090645951004e-08
in O 0 3.8835963778183213e-08
tumors B-Disease 1 1.0
of O 0 4.950352627819399e-11
36 O 0 5.0693471642659915e-09
patients O 0 4.201724834729248e-08
. O 0 4.265229058830755e-09

Thirty O 0 4.083623935002834e-06
- O 0 2.1525590909732273e-06
nine O 0 6.000450136767199e-10
of O 0 4.0776095607680807e-13
the O 0 2.4513631142336623e-12
mutations O 0 1.0940733874420516e-09
- O 0 2.0687787039008754e-09
including O 0 2.232439753890869e-11
34 O 0 3.5169353540531745e-10
small O 0 2.608594174002832e-10
mutations O 0 2.413409205814787e-08
, O 0 1.5026711819299265e-10
2 O 0 1.198426427539978e-11
large O 0 9.552762053610664e-11
structural O 0 0.02563057839870453
alterations O 0 0.12682586908340454
, O 0 6.392003593091999e-10
and O 0 4.60430388260491e-10
hypermethylation O 0 1.9146045815432444e-06
in O 0 6.745850100742246e-08
3 O 0 2.788748076909542e-07
tumors O 1 1.0
- O 0 1.1316034942865372e-05
were O 0 1.4531438274900665e-08
not O 0 1.4721293628561227e-10
detected O 0 4.554797872202698e-09
in O 0 2.331931696353262e-11
the O 0 3.662209858285026e-12
corresponding O 0 1.8892638842249454e-10
peripheral O 0 8.124347772309193e-08
blood O 0 1.46252840949046e-08
DNA O 0 1.6694913540504785e-07
. O 0 5.340090147853971e-09

In O 0 3.7180441836426326e-08
6 O 0 9.285125557312313e-09
( O 0 3.6980535300656925e-10
17 O 0 2.510565644264773e-10
% O 0 1.1856668424847783e-11
) O 0 5.117044483450572e-13
of O 0 5.5824079083291456e-14
the O 0 7.793283379742277e-12
36 O 0 6.933295604305556e-10
patients O 0 5.218852572319577e-10
, O 0 3.4361829787804554e-12
a O 0 1.3223745709556312e-10
mutation O 0 1.1704679891977321e-08
was O 0 9.852422522271809e-08
detected O 0 1.7408980923505624e-08
in O 0 2.537728360785252e-10
constitutional O 0 1.6156585791460287e-10
DNA O 0 1.2241647695532265e-08
, O 0 1.245417831363671e-11
and O 0 2.4901148851230737e-11
1 O 0 1.157156401948578e-11
of O 0 6.418358140976299e-13
these O 0 2.3700100909573862e-11
mutations O 0 3.4569860862809776e-10
is O 0 4.0229789985413156e-12
known O 0 1.504898983206715e-11
to O 0 4.722648053873124e-12
be O 0 3.421038799467091e-11
associated O 0 5.486108442531723e-11
with O 0 2.603403603806953e-11
reduced O 0 1.1995442861234551e-08
expressivity O 0 1.858090854511829e-06
. O 0 1.0424544782949852e-08

The O 0 6.972151189721387e-10
presence O 0 2.375460106396332e-10
of O 0 2.841630142996765e-12
a O 0 3.3619676487184336e-11
constitutional O 0 4.522436591880563e-10
mutation O 0 3.746917887070822e-09
was O 0 6.805453267588746e-08
not O 0 2.3776073124204267e-11
associated O 0 5.363908102407056e-12
with O 0 3.9791525109633685e-12
an O 0 2.9434329973376805e-11
early O 0 2.422589750494808e-05
age O 0 7.993523176708095e-09
at O 0 4.5971959572455035e-10
treatment O 0 6.503446114969336e-10
. O 0 4.2259365451435826e-10

In O 0 3.6861280250377604e-08
1 O 0 4.603024184035576e-09
patient O 0 2.756194383835009e-08
, O 0 5.5475377763736233e-11
somatic O 0 4.349629278976863e-08
mosaicism O 0 8.90110732143512e-06
was O 0 2.5540661141576493e-08
demonstrated O 0 2.54031434776536e-10
by O 0 2.5874127059649643e-12
molecular O 0 3.9601193851934724e-11
analysis O 0 3.03078014074476e-11
of O 0 1.069261758128437e-12
DNA O 0 3.2644811298609966e-09
and O 0 9.012447038658777e-11
RNA O 0 7.271303115174987e-09
from O 0 2.730718706711599e-10
peripheral O 0 1.338644892712182e-06
blood O 0 1.881601008335565e-07
. O 0 1.105059332928704e-08

In O 0 1.7938765140002033e-08
2 O 0 1.2504247637323829e-09
patients O 0 9.382555843373552e-10
without O 0 9.165374188768727e-12
a O 0 5.151755758103782e-11
detectable O 0 1.2395281601129682e-06
mutation O 0 4.7383391432731514e-08
in O 0 1.948641692450792e-09
peripheral O 0 4.936400000588037e-05
blood O 0 2.6440957867635007e-07
, O 0 6.154357024001911e-10
mosaicism O 0 2.745234951362363e-06
was O 0 4.999712359676778e-07
suggested O 0 2.937647902712115e-09
because O 0 1.0330061805952084e-10
1 O 0 1.5927587374009455e-11
of O 0 6.913318658860468e-13
the O 0 7.669508778063161e-11
patients O 0 5.632543675915258e-08
showed O 0 2.483917705831118e-05
multifocal O 1 0.999998927116394
tumors B-Disease 1 1.0
and O 0 6.365340965430732e-08
the O 0 3.1346310963575874e-11
other O 0 3.068460069366452e-11
later O 0 8.625795633321331e-10
developed O 0 5.545216286151344e-09
bilateral B-Disease 0 8.937497000260919e-07
retinoblastoma I-Disease 0 1.742199128784705e-05
. O 0 2.1952011763914925e-08

In O 0 9.410070944682047e-09
conclusion O 0 8.144292462652913e-10
, O 0 1.4897885008968714e-11
our O 0 1.5442809791349488e-12
results O 0 5.3838131869321515e-12
emphasize O 0 2.5449883520045624e-11
that O 0 4.5048586714245553e-13
the O 0 8.230574967231508e-13
manifestation O 0 1.173616759331253e-10
and O 0 2.7940991534358695e-11
transmissibility O 0 3.852137719917437e-09
of O 0 1.974122471395945e-12
retinoblastoma B-Disease 0 4.19738910295564e-09
depend O 0 7.064165363779296e-10
on O 0 5.096908450852311e-10
the O 0 4.638367381154529e-12
nature O 0 3.656647033778437e-12
of O 0 1.91371969811803e-13
the O 0 1.1278802327860382e-12
first O 0 4.2637116060006974e-11
mutation O 0 3.9216123404184344e-11
, O 0 1.411401486135777e-12
its O 0 9.128837009236834e-13
time O 0 6.14861633829733e-11
in O 0 8.044585136923743e-11
development O 0 2.481154344480263e-11
, O 0 3.416116348131659e-11
and O 0 1.592461058852468e-11
the O 0 4.0030378642939846e-13
number O 0 4.455886614546101e-12
and O 0 1.015447535085423e-11
types O 0 1.94104992495836e-11
of O 0 1.6490059101190169e-13
cells O 0 3.6241044887308504e-11
that O 0 2.1895108989755663e-11
are O 0 1.011673904371957e-11
affected O 0 7.238238480811177e-11
. O 0 1.442823638342361e-11
. O 0 2.1591631260697852e-10

Hereditary B-Disease 1 0.9999996423721313
deficiency I-Disease 1 0.9999983310699463
of I-Disease 0 1.4911423484864628e-10
the I-Disease 0 4.8918018941135344e-11
fifth I-Disease 0 1.4342808052347777e-09
component I-Disease 0 3.315520913371728e-10
of I-Disease 0 1.2893971914479385e-12
complement I-Disease 0 1.0614584766699409e-09
in O 0 2.0937369171747378e-08
man O 0 2.7305918592901435e-06
. O 0 2.9881863650160767e-09

I O 0 0.14261798560619354
. O 0 9.43870901437549e-08

Clinical O 0 1.3048327673459426e-05
, O 0 1.5482893189755487e-08
immunochemical O 0 6.2951771724328864e-06
, O 0 1.9539414530811428e-09
and O 0 4.01798316840285e-10
family O 0 2.4664534303830976e-10
studies O 0 2.412772648341388e-09
. O 0 1.99674810019701e-09

The O 0 1.1382467191012324e-09
first O 0 1.947109973254868e-10
recognized O 0 1.0132464312029299e-10
human O 0 4.228256286764598e-11
kindred O 0 7.7193217293825e-06
with O 0 2.3565313256312947e-08
hereditary B-Disease 1 1.0
deficiency I-Disease 1 0.9999004602432251
of I-Disease 0 6.737697639397355e-12
the I-Disease 0 8.953199293060266e-11
fifth I-Disease 0 1.973944563360419e-09
component I-Disease 0 4.442076428912145e-10
of I-Disease 0 3.7603717882583876e-12
complement I-Disease 0 9.70553770685001e-09
( O 0 8.682416563488005e-09
C5 O 0 6.504153020614467e-07
) O 0 6.140869063253618e-11
is O 0 3.65379740352445e-11
described O 0 5.36189093125472e-09
. O 0 3.000310888623403e-09

The O 0 5.29350341338386e-09
proband O 0 1.1154418189107673e-06
, O 0 5.729620944361358e-11
a O 0 6.595709395318394e-11
20 O 0 6.878499991813669e-10
- O 0 4.930646824163887e-08
year O 0 2.842584478912613e-08
- O 0 5.660091346726404e-07
old O 0 2.003438339670538e-06
black O 0 3.0199462930369236e-09
female O 0 2.1438288921871163e-09
with O 0 2.044193037065156e-09
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 0 1.084384712157771e-05
age O 0 7.249301603451386e-08
11 O 0 1.6708158467881873e-10
, O 0 1.7278947370136244e-11
lacked O 0 1.180692521529636e-08
serum O 0 2.401914755978396e-08
hemolytic O 0 9.677146408648696e-07
complement O 0 1.1385274056863182e-08
activity O 0 3.576447511477454e-07
, O 0 2.154374734164577e-10
even O 0 6.696183052490312e-10
during O 0 2.4706778845029476e-09
remission O 0 1.2272161598048115e-07
. O 0 1.6663610491463032e-09

C5 O 0 0.00020578005933202803
was O 0 1.0965626273673479e-07
undetectable O 0 1.1050428838643711e-07
in O 0 7.191701123510086e-10
her O 0 1.0594494725957304e-10
serum O 0 1.1592778126345848e-10
by O 0 4.966579231213686e-12
both O 0 1.8751049324361446e-10
immunodiffusion O 0 5.735643640036869e-07
and O 0 2.0967290126350235e-09
hemolytic O 0 1.3348128049983643e-05
assays O 0 3.537637894623913e-06
. O 0 2.3613862865090596e-08

Other O 0 7.839687232724657e-10
complement O 0 1.5861634228286903e-09
components O 0 3.982422835946409e-09
were O 0 5.254450208269645e-10
normal O 0 1.653929548872668e-09
during O 0 9.690660496275427e-10
remission O 0 3.6430840566481493e-09
of O 0 6.6436600144881286e-12
lupus O 0 3.131540609047079e-07
, O 0 4.355334148886669e-11
but O 0 3.423764827203968e-09
C1 O 0 2.821728003254975e-06
, O 0 2.616212801953566e-10
C4 O 0 2.1721912162320223e-06
, O 0 5.219629173325302e-10
C2 O 0 1.312731399139011e-07
, O 0 3.8950891123601394e-11
and O 0 3.3433736335020114e-10
C3 O 0 5.061889623902971e-06
levels O 0 1.126418851526978e-07
fell O 0 8.811290172161534e-05
during O 0 4.534704611813822e-09
exacerbations O 0 2.2432261630456196e-06
. O 0 4.7550496873327575e-09

A O 0 1.3588154388344265e-06
younger O 0 2.958726099677733e-07
half O 0 3.3648130948193966e-09
- O 0 2.7542611746866896e-07
sister O 0 4.4417507183425187e-07
, O 0 9.636761527653803e-11
who O 0 2.444702495996154e-10
had O 0 4.796074648538706e-09
no O 0 1.640598434882179e-09
underlying O 0 5.092166475151316e-07
disease O 0 2.944207722066494e-07
, O 0 6.839566690786114e-10
was O 0 2.755632806383801e-07
also O 0 1.8953308367208876e-10
found O 0 1.5184946355883966e-10
to O 0 2.8652517858329674e-11
lack O 0 2.6178463841119992e-09
immunochemically O 0 2.878501618397422e-06
detectable O 0 7.905620441306382e-05
C5 O 0 1.3076378309051506e-05
. O 0 1.2918467184874771e-08

By O 0 1.2901673507315081e-08
hemolytic O 0 0.000643337843939662
assay O 0 1.3335263247427065e-05
, O 0 7.460395856639934e-09
she O 0 9.71631752832991e-09
exhibited O 0 5.415687009957537e-09
1 O 0 2.45905962259485e-10
- O 0 1.2036420748984256e-08
2 O 0 3.449067767502534e-11
% O 0 3.2929490297733954e-12
of O 0 1.8852652186769625e-13
the O 0 7.035906579577755e-12
normal O 0 3.4775946566867333e-09
serum O 0 1.168732399747796e-08
C5 O 0 6.89860968350331e-08
level O 0 1.062327448231315e-09
and O 0 1.3575703061707856e-11
normal O 0 9.951960783238789e-11
concentrations O 0 5.185986015621147e-11
of O 0 3.437702054444325e-13
other O 0 1.3594482527537477e-12
complement O 0 1.2078241184987348e-10
components O 0 5.758133525546327e-09
. O 0 9.086498220511885e-10

C5 O 0 0.0001310035731876269
levels O 0 2.3159602235978127e-08
of O 0 1.6316117294051802e-12
other O 0 4.768875398741823e-12
family O 0 5.873978820708503e-12
members O 0 2.1649083350658294e-13
were O 0 4.461553002044205e-11
either O 0 7.196070562348611e-12
normal O 0 3.813696303200942e-10
or O 0 6.225557569461415e-11
approximately O 0 4.00287962498691e-12
half O 0 1.4748645638107405e-09
- O 0 9.719324367551962e-08
normal O 0 7.193995621435079e-09
, O 0 1.8107834676150958e-11
consistent O 0 5.982508377577744e-10
with O 0 4.472373513197958e-11
autosomal O 0 8.506323865731247e-06
codominant O 0 1.5039622667245567e-06
inheritance O 0 3.3683910771742376e-08
of O 0 9.010585680369054e-12
the O 0 4.203345657649571e-11
gene O 0 6.879949410176778e-07
determining O 0 1.6083284208434634e-05
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 6.776478045367185e-08

Normal O 0 4.527654891717248e-05
hemolytic O 0 0.12636367976665497
titers O 0 0.0017004323890432715
were O 0 3.611937415826105e-08
restored O 0 4.8859507550957915e-09
to O 0 1.6873627495250787e-11
both O 0 4.1402967165815596e-10
homozygous O 1 0.9842575788497925
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 2.2571707631868776e-06
C5D B-Disease 1 1.0
) O 0 3.8220562825763693e-10
sera O 0 3.988527286225008e-09
by O 0 6.435421314766876e-13
addition O 0 1.0982322906985531e-12
of O 0 3.533794079840086e-13
highly O 0 4.970410194538033e-11
purified O 0 7.810821989195915e-10
human O 0 5.143236392335382e-10
C5 O 0 6.435499244616949e-07
. O 0 2.255046371857361e-09

In O 0 2.7976232885862373e-08
specific O 0 1.5916800322202107e-08
C5 O 0 1.5183998129941756e-06
titrations O 0 1.3609839015771286e-06
, O 0 3.222609401554166e-10
however O 0 1.0308214698495632e-10
, O 0 5.4045344588526945e-12
it O 0 3.052198077613255e-11
was O 0 3.615921428945512e-08
noted O 0 2.2800522581079008e-10
that O 0 1.4754251423040876e-12
when O 0 9.689390132253117e-13
limited O 0 8.649572486203738e-13
amounts O 0 1.5251953346118174e-12
of O 0 1.873365828783391e-12
C5 O 0 4.864768143875153e-09
were O 0 2.8053668763017292e-11
assayed O 0 2.2311381908668437e-10
in O 0 4.717714500307446e-12
the O 0 5.182737377283642e-13
presence O 0 1.36198457026393e-11
of O 0 1.6836486631949255e-12
low O 0 5.676782155461524e-09
dilutions O 0 1.1670220345649795e-07
of O 0 7.033638862313785e-12
either O 0 8.980796550872583e-09
C5D B-Disease 1 1.0
serum O 0 5.391850166347467e-08
, O 0 2.001909402138402e-11
curving O 0 3.849447427484165e-10
rather O 0 3.982760996001922e-11
than O 0 2.8594416331267913e-12
linear O 0 4.4487580286300954e-10
dose O 0 1.9288616215362708e-07
- O 0 1.113565417654172e-07
response O 0 1.658648357549808e-10
plots O 0 2.175293722928018e-09
were O 0 4.605518189038094e-09
consistently O 0 2.4817708998980947e-10
obtained O 0 1.4521746652396139e-11
, O 0 1.1876353850012733e-12
suggesting O 0 1.2283174477545344e-10
some O 0 1.1515046728638456e-11
inhibitory O 0 5.627343480085756e-09
effect O 0 5.036213668319078e-09
. O 0 1.2842472640883784e-09

Further O 0 8.075478064029085e-09
studies O 0 1.6491823462416733e-09
suggested O 0 1.1973583236013496e-09
that O 0 3.913557325430084e-11
low O 0 8.362979642129176e-09
dilutions O 0 2.570142214608495e-06
of O 0 1.1388020387803621e-10
C5D B-Disease 1 1.0
serum O 0 3.5060332415071116e-09
contain O 0 5.663344099238188e-11
a O 0 6.713110622946772e-11
factor O 0 4.4957843003956555e-10
( O 0 2.498173543030724e-11
or O 0 2.558529776930385e-10
factors O 0 1.3854006830626986e-10
) O 0 6.329565344076471e-12
interfering O 0 5.513342560270473e-10
at O 0 1.4527323788371405e-10
some O 0 2.0574189053823577e-12
step O 0 1.9788165897538512e-11
in O 0 6.2560030940350675e-12
the O 0 1.7610000263568182e-11
hemolytic O 0 2.159097789444786e-07
assay O 0 5.1240697018783976e-08
of O 0 7.565682802468388e-11
C5 O 0 7.450188377333689e-07
, O 0 5.410475019396177e-12
rather O 0 7.858064025867417e-12
than O 0 3.408525415041219e-12
a O 0 4.716025486795061e-11
true O 0 4.039685919110525e-09
C5 O 0 5.778280183221796e-07
inhibitor O 0 1.6964210658443335e-07
or O 0 4.913820017549142e-09
inactivator O 0 7.31176271528966e-07
. O 0 3.5802745212976106e-09

Of O 0 7.580723271338741e-10
clinical O 0 7.950343672291638e-08
interest O 0 4.302734168959432e-09
are O 0 1.4876311293932076e-10
( O 0 2.753174251080015e-11
a O 0 4.106272960546775e-11
) O 0 5.6313074862923695e-12
the O 0 5.360124236825081e-12
documentation O 0 6.7295395922428725e-09
of O 0 8.567386383662168e-11
membranous O 0 0.14203275740146637
glomerulonephritis B-Disease 1 1.0
, O 0 4.251267910149181e-06
vasculitis B-Disease 1 1.0
, O 0 1.9388630789762828e-07
and O 0 5.5405856983270496e-05
arthritis B-Disease 1 1.0
in O 0 6.172982125463022e-09
an O 0 4.678825382686824e-11
individual O 0 4.024671707014704e-10
lacking O 0 2.661210783116985e-05
C5 O 0 1.841435005189851e-05
( O 0 1.8048570971096467e-10
and O 0 1.9533060932608315e-11
its O 0 3.774455574478974e-12
biologic O 0 1.1793219734101967e-08
functions O 0 2.7086813694787715e-11
) O 0 2.1369314304187093e-11
, O 0 2.6064293084937518e-11
and O 0 9.40654359959936e-11
( O 0 5.46484489605259e-11
b O 0 9.872905160079881e-09
) O 0 1.705071630761501e-12
a O 0 1.3902785173103283e-11
remarkable O 0 9.477884033159967e-10
propensity O 0 1.1328859983450457e-07
to O 0 8.913915827690744e-09
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 2.4905088480409177e-07
the O 0 1.7540519037240188e-10
proband O 0 2.6579476752885967e-07
, O 0 2.970046084072031e-11
even O 0 4.430076097627911e-11
during O 0 2.6487980211986617e-11
periods O 0 1.3319254033028471e-10
of O 0 9.061319945248558e-13
low O 0 7.680759139816473e-09
- O 0 1.2420268147295133e-09
dose O 0 3.614567978260652e-09
or O 0 1.3849647817476551e-10
alternate O 0 1.3667221798741025e-09
- O 0 3.70393067328223e-08
day O 0 1.877969335595253e-09
corticosteroid O 0 9.88573788163194e-07
therapy O 0 8.366770885004371e-07
. O 0 2.9054949557405507e-09

Other O 0 2.1688348894599585e-09
observations O 0 1.850088637844749e-09
indicate O 0 2.733523851716768e-09
that O 0 2.3679766480988462e-11
the O 0 6.329713836406015e-11
C5D B-Disease 1 1.0
state O 0 9.542559450959054e-12
is O 0 5.964261636653978e-12
compatible O 0 5.160274985094304e-10
with O 0 4.661684233076002e-12
normal O 0 5.739993480524674e-10
coagulation O 0 3.0394420313939463e-10
function O 0 6.803899110785494e-11
and O 0 4.3310455916101276e-11
the O 0 1.4217821798362396e-12
capacity O 0 3.8229783921872595e-12
to O 0 3.832315541296705e-12
mount O 0 6.2870775252577005e-09
a O 0 7.97535459895471e-09
neutrophilic O 0 7.205260772025213e-05
leukocytosis O 0 7.189255120465532e-05
during O 0 6.271079655562062e-08
pyogenic B-Disease 0 0.0006015649996697903
infection I-Disease 0 0.005446037743240595
. O 0 1.338767208203251e-09
. O 0 3.5442975221400275e-09

Susceptibility O 0 0.000507037213537842
to O 0 1.6511288777110167e-05
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 5.84742083447054e-05
twins O 0 5.921968977418146e-07
: O 0 1.4200727399549251e-11
the O 0 4.553121117981118e-13
role O 0 1.4228626957213386e-11
of O 0 5.830531912311143e-13
genes O 0 9.583134286117456e-10
, O 0 2.9588123617863005e-10
HLA O 0 2.748373333361087e-07
, O 0 8.720247440807682e-11
and O 0 1.1256634513401309e-10
the O 0 6.159802529159819e-11
environment O 0 6.4798006960131715e-09
. O 0 7.199977281047154e-10

OBJECTIVE O 0 1.1114371289977498e-07
To O 0 1.57439242198798e-10
determine O 0 1.1924417009367971e-10
the O 0 4.2575500416863754e-12
relative O 0 1.2486103817543892e-10
effects O 0 6.425717735680792e-10
of O 0 2.3253259127248294e-12
genetic O 0 2.4334454451491183e-09
and O 0 1.2185957798394043e-10
environmental O 0 2.9231967541010206e-11
factors O 0 4.09622093189288e-11
in O 0 2.5816970783409943e-10
susceptibility O 0 6.425809715437936e-07
to O 0 5.404707280831644e-06
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 4.592991899698973e-05
AS B-Disease 1 0.9999998807907104
) O 0 7.739520135885414e-10
. O 0 4.861175906256676e-10

METHODS O 0 1.2100410458515398e-05
Twins O 0 5.2745258471986745e-06
with O 0 8.385256378140582e-10
AS B-Disease 1 1.0
were O 0 7.264617241098392e-10
identified O 0 1.766002483138962e-10
from O 0 3.1239457635307e-12
the O 0 4.35936269721493e-12
Royal O 0 1.8501452592190049e-09
National O 0 2.0827844657289596e-11
Hospital O 0 2.5325570973677713e-08
for O 0 4.701693478992297e-10
Rheumatic B-Disease 1 0.9946979284286499
Diseases I-Disease 0 0.00027789422892965376
database O 0 5.927573738517822e-07
. O 0 3.599145870225584e-08

Clinical O 0 2.8247972295503132e-05
and O 0 1.8463740758534186e-08
radiographic O 0 1.0134580406884197e-05
examinations O 0 5.4426003771368414e-05
were O 0 6.951979547586973e-10
performed O 0 3.8424621123800407e-11
to O 0 6.248736879495287e-13
establish O 0 2.467333004574357e-10
diagnoses O 0 0.0003446444752626121
, O 0 2.0013263268836567e-10
and O 0 1.3952428545849216e-08
disease O 0 4.9902323553396855e-06
severity O 0 1.7024613043759018e-06
was O 0 5.537440017633344e-08
assessed O 0 4.332708636312077e-10
using O 0 4.716367227319829e-11
a O 0 1.467173327274196e-10
combination O 0 1.947825012393878e-08
of O 0 3.534404019456261e-11
validated O 0 2.313664282382888e-08
scoring O 0 1.3435897727731572e-08
systems O 0 2.2181484382599592e-07
. O 0 6.095190574484377e-09

HLA O 0 0.000889805203769356
typing O 0 1.974380029423628e-05
for O 0 1.5410791531778045e-09
HLA O 0 1.5294465356419096e-06
- O 0 1.1536678812262835e-07
B27 O 0 9.81388126319871e-08
, O 0 5.281942661028438e-10
HLA O 0 2.6828647037291375e-07
- O 0 7.1249806055107e-09
B60 O 0 3.0584029531155466e-08
, O 0 2.3532533560688407e-11
and O 0 1.226224677353116e-10
HLA O 0 1.1808702993221232e-06
- O 0 6.588238079530129e-07
DR1 O 1 0.7618172764778137
was O 0 2.1630482294199282e-08
performed O 0 1.1858393433872294e-10
by O 0 2.3403254161002973e-12
polymerase O 0 9.860178229459393e-10
chain O 0 3.1644223352778056e-10
reaction O 0 8.010757855669848e-12
with O 0 4.941932822168094e-13
sequence O 0 3.326705924622253e-11
- O 0 3.652328717240749e-10
specific O 0 6.669182567309306e-11
primers O 0 4.023870303626609e-07
, O 0 6.050855649863962e-11
and O 0 1.0605918226991307e-10
zygosity O 0 6.54636309604939e-08
was O 0 1.6304382288723218e-09
assessed O 0 2.581529434664276e-10
using O 0 3.4149516547898884e-10
microsatellite O 0 2.96087137030554e-07
markers O 0 1.0706332886911696e-06
. O 0 3.241464341385836e-08

Genetic O 0 2.219308726125746e-06
and O 0 1.2669923998842592e-09
environmental O 0 6.605478664045705e-11
variance O 0 5.0345855956424046e-11
components O 0 4.2294221458405445e-09
were O 0 1.064810906115099e-08
assessed O 0 1.7096789539650104e-09
with O 0 5.431213204870611e-13
the O 0 6.488596552417514e-12
program O 0 5.486404108800969e-10
Mx O 0 8.780155269505485e-09
, O 0 7.331673245944414e-13
using O 0 1.2078949819527285e-11
data O 0 2.295421630549299e-09
from O 0 2.0363459182770605e-11
this O 0 1.9502684189820485e-11
and O 0 3.0216603524868546e-11
previous O 0 7.020881792607625e-11
studies O 0 5.957363768960278e-11
of O 0 9.155690528644955e-13
twins O 0 3.2886418033228892e-09
with O 0 1.1601316435294606e-10
AS B-Disease 1 1.0
. O 0 1.0944747330654536e-08

RESULTS O 0 6.864796887384728e-06
Six O 0 1.1165675051216795e-09
of O 0 2.0211424547889045e-11
8 O 0 1.6774680533515607e-09
monozygotic O 0 1.0433163879497442e-05
( O 0 7.141868252347194e-08
MZ O 1 0.9999933242797852
) O 0 3.1146925039138296e-09
twin O 0 1.831419069731055e-07
pairs O 0 1.3368617324260867e-08
were O 0 2.348683949549013e-07
disease O 0 5.309867674441193e-07
concordant O 0 9.807836676145598e-08
, O 0 2.9003774382196923e-10
compared O 0 2.559131351276278e-09
with O 0 2.027022300010728e-11
4 O 0 3.705714346491362e-10
of O 0 8.07811630088029e-12
15 O 0 1.8012434876979455e-09
B27 O 0 2.975806694394123e-07
- O 0 2.1197878652401414e-07
positive O 0 3.128292647147646e-08
dizygotic O 0 1.3018865274716518e-06
( O 0 2.690477174382977e-09
DZ O 0 6.406196189345792e-05
) O 0 1.9746966561928758e-10
twin O 0 2.6172287448389397e-08
pairs O 0 3.5936837949890332e-09
( O 0 9.866273353864585e-10
27 O 0 1.6079560793968994e-08
% O 0 1.8415116653791586e-10
) O 0 2.439288875055734e-11
and O 0 2.3323865061541937e-10
4 O 0 1.8284741776231073e-10
of O 0 3.136413351256806e-11
32 O 0 1.772677080680296e-07
DZ O 1 0.997912585735321
twin O 0 8.931625643526786e-07
pairs O 0 3.688223770836885e-08
overall O 0 2.6036962026410038e-06
( O 0 2.34935404463954e-09
12 O 0 1.6853670681271637e-09
. O 0 6.392073675920429e-11
5 O 0 1.3623853434285849e-10
% O 0 1.7000885421669665e-10
) O 0 1.7810182495470173e-10
. O 0 1.2702517926399537e-09

Nonsignificant O 0 2.0692292309831828e-05
increases O 0 8.731107392634385e-09
in O 0 1.241325237044677e-10
similarity O 0 1.979976599342237e-10
with O 0 1.0123992573093932e-12
regard O 0 5.260343896584807e-11
to O 0 3.051045527335816e-11
age O 0 9.281495572110998e-09
at O 0 3.010905302858191e-09
disease O 0 3.987000596339385e-08
onset O 0 2.746559424338102e-08
and O 0 7.557663522783642e-11
all O 0 2.4854350348657572e-12
of O 0 3.564078557023037e-13
the O 0 1.410049438321792e-10
disease O 0 3.3145951761071046e-07
severity O 0 1.9728865652268723e-07
scores O 0 1.4259402547622813e-08
assessed O 0 1.6291700211112925e-09
were O 0 4.018197996558115e-10
noted O 0 6.028555987747097e-10
in O 0 1.843783015154088e-09
disease O 0 6.509112608910073e-06
- O 0 0.00015051271475385875
concordant O 0 0.008319794200360775
MZ O 1 0.9999929666519165
twins O 0 1.2717410754703451e-05
compared O 0 3.788036551100049e-08
with O 0 6.868693946948667e-10
concordant O 0 4.398058445076458e-05
DZ O 1 0.997962236404419
twins O 0 1.2481669728003908e-05
. O 0 5.601901520435604e-08

HLA O 0 0.020212266594171524
- O 0 0.0002857540384866297
B27 O 0 1.0199659072895884e-06
and O 0 4.3068204558238676e-10
B60 O 0 6.210252756488899e-09
were O 0 2.6419812518274632e-11
associated O 0 1.1162086879790145e-11
with O 0 3.3316554268018883e-13
the O 0 1.4685837615435737e-11
disease O 0 7.835327053840047e-09
in O 0 8.998813361138502e-10
probands O 0 1.2545423260235111e-06
, O 0 4.044492518673337e-11
and O 0 2.2609790775729444e-11
the O 0 4.291473860301709e-12
rate O 0 4.118104524053479e-09
of O 0 1.221694512047733e-12
disease O 0 3.584093688502321e-09
concordance O 0 2.1304842334757268e-08
was O 0 2.4354712024887704e-08
significantly O 0 4.716363299905879e-09
increased O 0 4.904491812673939e-10
among O 0 5.512574841048945e-10
DZ O 0 0.03458058834075928
twin O 0 5.683502024567133e-08
pairs O 0 2.272203120101679e-10
in O 0 8.1397687201612e-11
which O 0 3.799043718499817e-11
the O 0 7.172477889394457e-11
co O 0 5.082912593934452e-06
- O 0 1.73069020092953e-05
twin O 0 3.694730366987642e-06
was O 0 2.1163013741443137e-07
positive O 0 1.2471418342485663e-10
for O 0 3.0544327917630953e-12
both O 0 1.1850026515602963e-10
B27 O 0 3.240227997025613e-08
and O 0 2.675330401658016e-09
DR1 O 0 0.005251497961580753
. O 0 6.4305512026408e-09

Additive O 0 6.446371685342456e-07
genetic O 0 3.5880356108464184e-07
effects O 0 4.695129618426108e-08
were O 0 1.1286049872438753e-09
estimated O 0 5.896789133374991e-12
to O 0 6.81051352466322e-13
contribute O 0 8.677982811511331e-12
97 O 0 8.122155725764912e-10
% O 0 1.6608032657461358e-11
of O 0 7.754150511789237e-13
the O 0 4.047469390894287e-12
population O 0 3.5867348587709236e-12
variance O 0 2.544164323659004e-10
. O 0 1.9309083221230594e-09

CONCLUSION O 0 7.750961117380939e-08
Susceptibility O 0 1.380014680307795e-07
to O 0 2.8268762886085597e-09
AS B-Disease 1 1.0
is O 0 1.5576441178555278e-11
largely O 0 2.112659873432232e-11
genetically O 0 1.0238268011164564e-09
determined O 0 9.561397718016451e-08
, O 0 1.3246516383791374e-10
and O 0 4.0952363028479155e-11
the O 0 3.0559944765723435e-12
environmental O 0 5.442273021127875e-11
trigger O 0 2.8377562522052813e-09
for O 0 1.4532859290983247e-11
the O 0 2.929857190192564e-10
disease O 0 1.3274724608436372e-07
is O 0 4.650508034220735e-10
probably O 0 8.297822517988607e-08
ubiquitous O 0 7.214981678771437e-08
. O 0 7.786224109906925e-09

HLA O 0 0.0023545767180621624
- O 0 7.063719294819748e-06
B27 O 0 2.4269579057545343e-07
accounts O 0 7.048418515509525e-10
for O 0 3.4540100814217656e-12
a O 0 1.0143190107281264e-11
minority O 0 1.2437875729354175e-10
of O 0 1.80300078252843e-12
the O 0 1.674426396147677e-11
overall O 0 3.43378370182279e-09
genetic O 0 1.238146118964778e-08
susceptibility O 0 7.55257403284304e-08
to O 0 1.3407150056821138e-08
AS B-Disease 1 1.0
. O 0 1.2913047520157761e-08

Cell O 0 3.209455098840408e-05
cycle O 0 2.903984295699047e-06
- O 0 5.838013521497487e-07
dependent O 0 5.34187591938462e-08
colocalization O 0 2.455765297781909e-07
of O 0 2.6415480913755118e-11
BARD1 O 0 4.192318669993256e-07
and O 0 5.7785259216514007e-11
BRCA1 O 0 5.559332993954058e-09
proteins O 0 8.124661360353613e-11
in O 0 4.6961073918438956e-11
discrete O 0 3.0496871694651873e-09
nuclear O 0 1.5811266962373338e-07
domains O 0 1.2829582374251913e-07
. O 0 2.956455968927685e-09

Germ O 0 0.004307745024561882
- O 0 0.011274638585746288
line O 0 2.597845139007404e-07
mutations O 0 2.411697330728657e-08
of O 0 2.990217231810255e-12
the O 0 1.0366137635775541e-11
BRCA1 O 0 1.284471409235266e-07
gene O 0 2.699721157739532e-08
predispose O 0 2.8871120605344913e-08
women O 0 1.203434296659367e-10
to O 0 6.490973123579602e-12
early O 0 2.717879760893993e-05
- O 1 0.9794066548347473
onset O 1 0.9905621409416199
breast B-Disease 1 0.9999997615814209
and I-Disease 1 0.999984860420227
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999978542327881
by O 0 5.1737548273367295e-11
compromising O 0 8.854105004729718e-08
the O 0 2.2770871993538222e-11
genes O 0 4.265554576221575e-09
presumptive O 0 1.671512350753801e-08
function O 0 9.99896165865266e-10
as O 0 5.151346016418756e-10
a O 0 3.302080164857557e-09
tumor B-Disease 0 4.946660283167148e-06
suppressor O 0 1.976938801817596e-05
. O 0 1.395714690488603e-07

Although O 0 5.53430101746244e-09
the O 0 8.110184746001892e-11
biochemical O 0 1.740478872136464e-09
properties O 0 1.0533126593159636e-09
of O 0 8.908701901177984e-12
BRCA1 O 0 1.358274914764479e-07
polypeptides O 0 4.98627272804697e-09
are O 0 5.6036460194253124e-11
not O 0 5.5465222692507865e-11
understood O 0 1.8644631671893563e-10
, O 0 9.354843288900128e-13
their O 0 5.537425986495981e-13
expression O 0 3.101623818890786e-11
pattern O 0 7.81923237269666e-09
and O 0 6.661656642981129e-11
subcellular O 0 1.6761287469080344e-08
localization O 0 1.2770422053165476e-08
suggest O 0 2.0729566674315691e-10
a O 0 2.231383827711042e-11
role O 0 1.393183346465321e-10
in O 0 3.3666666676701595e-10
cell O 0 6.698515790048987e-05
- O 0 0.0001562042598379776
cycle O 0 2.997687431616214e-07
regulation O 0 3.9333122003881726e-07
. O 0 4.7367101352335794e-09

When O 0 6.112155404025543e-08
resting O 0 1.833669394102344e-08
cells O 0 1.2429796081292466e-09
are O 0 1.4986631727276212e-11
induced O 0 3.988297192503154e-10
to O 0 1.2212896492724834e-11
proliferate O 0 5.210205245020916e-08
, O 0 1.8967511589140784e-11
the O 0 3.169469027508587e-12
steady O 0 2.940440957388546e-08
- O 0 1.6447553041754048e-10
state O 0 1.5455864669708386e-12
levels O 0 2.4678448520831786e-11
of O 0 3.3046062089016337e-13
BRCA1 O 0 2.53313547915468e-09
increase O 0 2.2360106821661674e-11
in O 0 1.3406753485156742e-10
late O 0 1.0309527453955525e-07
G1 O 0 3.580275986792003e-08
and O 0 7.266688986651282e-12
reach O 0 2.6244980147471786e-11
a O 0 3.120719307969644e-11
maximum O 0 1.69144614980965e-10
during O 0 1.875327892975065e-09
S O 0 1.1603047056496507e-07
phase O 0 1.2615648969926951e-08
. O 0 1.0417046114596928e-09

Moreover O 0 1.022537716721672e-07
, O 0 2.4433410850122073e-10
in O 0 1.6815995818042495e-10
S O 0 3.848218099733458e-08
phase O 0 6.839344646181189e-10
cells O 0 4.918637164230688e-10
, O 0 3.762662403872241e-11
BRCA1 O 0 3.562490391573192e-08
polypeptides O 0 1.1951959422162872e-08
are O 0 2.2979043667881172e-10
hyperphosphorylated O 0 2.8589082035068714e-07
and O 0 9.54555434695692e-10
accumulate O 0 1.8996966222317724e-09
into O 0 4.251919996645093e-11
discrete O 0 7.641335564301244e-09
subnuclear O 0 2.7117876015836373e-06
foci O 0 1.9559115571610164e-06
termed O 0 1.3693144751414366e-07
" O 0 1.485109457632916e-08
BRCA1 O 0 1.245279463546467e-06
nuclear O 0 3.6344317777547985e-07
dots O 0 1.0476155694050249e-05
. O 0 4.328731506575423e-08

" O 0 4.983471058039868e-07
BRCA1 O 0 2.528792538214475e-05
associates O 0 2.1326295041035337e-07
in O 0 3.3489006012743516e-10
vivo O 0 1.1396532784146984e-07
with O 0 1.6162248622775266e-11
a O 0 4.1221889790499233e-10
structurally O 0 8.735824849281926e-06
related O 0 1.0578492748436474e-08
protein O 0 8.263786099860226e-08
termed O 0 8.172486900548392e-07
BARD1 O 0 8.572317165089771e-05
. O 0 2.315796798768588e-08

Here O 0 8.777965376793873e-08
we O 0 1.5202596126417944e-10
show O 0 4.231080416583488e-11
that O 0 5.88693048302058e-13
the O 0 1.2635996849558184e-12
steady O 0 5.817702763977195e-09
- O 0 7.664858331368762e-11
state O 0 1.63657358064756e-12
levels O 0 5.298103622486394e-11
of O 0 4.513330085099271e-13
BARD1 O 0 2.1395326399442638e-08
, O 0 6.84825026547875e-13
unlike O 0 2.5660192286974803e-12
those O 0 1.1134226136563785e-12
of O 0 7.668023117510248e-13
BRCA1 O 0 5.2178826592808036e-08
, O 0 7.372951554840412e-11
remain O 0 4.291224597885446e-10
relatively O 0 7.143206859350215e-11
constant O 0 1.630720419809606e-10
during O 0 4.616236559673581e-10
cell O 0 7.623395390510268e-07
cycle O 0 4.634697603478344e-08
progression O 0 1.112472105546658e-07
. O 0 3.4144713723094355e-09

However O 0 3.403582127248228e-08
, O 0 7.076950137019367e-10
immunostaining O 0 2.0539695810839476e-07
revealed O 0 4.265019981630758e-08
that O 0 9.049618693302008e-11
BARD1 O 0 2.1753804446689173e-07
resides O 0 1.2328714715792444e-09
within O 0 8.837253151483537e-11
BRCA1 O 0 1.7377340100210859e-07
nuclear O 0 2.3049958386422986e-08
dots O 0 1.9080339086485765e-07
during O 0 5.12811482167308e-09
S O 0 2.3729899822910738e-08
phase O 0 6.32363189589924e-11
of O 0 2.3364928156306697e-13
the O 0 4.445682537379536e-12
cell O 0 3.1939990208229574e-08
cycle O 0 3.5403855402904583e-09
, O 0 2.4469122908432617e-11
but O 0 6.461244039801528e-11
not O 0 7.940765232861136e-12
during O 0 4.9230085286122716e-11
the O 0 2.294648845935221e-11
G1 O 0 7.573807891958495e-08
phase O 0 5.319251261681757e-09
. O 0 1.0237877212659896e-09

Nevertheless O 0 1.892365503408655e-06
, O 0 1.4351455579486583e-09
BARD1 O 0 1.3349003324947262e-07
polypeptides O 0 4.506767403711365e-09
are O 0 1.4174424654844753e-11
found O 0 6.234263973114995e-12
exclusively O 0 5.27183201606829e-12
in O 0 3.1745588796594504e-11
the O 0 1.5853443774763165e-12
nuclear O 0 4.033940126380031e-10
fractions O 0 1.2920424452556034e-10
of O 0 1.7909968213353222e-13
both O 0 1.2603340246442052e-11
G1 O 0 4.028454370086365e-08
- O 0 3.0523874539056806e-09
and O 0 2.3288926342956984e-10
S O 0 1.760783447934955e-07
- O 0 3.4086609090877573e-09
phase O 0 1.1267509147927512e-09
cells O 0 4.115513707603213e-09
. O 0 1.914198355379426e-09

Therefore O 0 9.071838746876892e-08
, O 0 1.425341289440496e-09
progression O 0 3.2959386331299356e-09
to O 0 5.8022822657655126e-11
S O 0 3.6082263932257774e-07
phase O 0 1.2566698792682018e-09
is O 0 3.48517464887621e-11
accompanied O 0 2.4151137686945212e-11
by O 0 1.4501617138021339e-12
the O 0 5.05490484539739e-12
aggregation O 0 4.596396180334139e-11
of O 0 9.026302925582708e-13
nuclear O 0 6.026961152372223e-09
BARD1 O 0 2.0400504752160487e-07
polypeptides O 0 3.194486097868321e-08
into O 0 9.949802093345284e-10
BRCA1 O 0 5.520892614185868e-07
nuclear O 0 2.403925236649229e-07
dots O 0 6.803883024986135e-06
. O 0 2.265878151774814e-08

This O 0 4.545771759012496e-09
cell O 0 4.1299614395029494e-07
cycle O 0 1.155400966013076e-07
- O 0 1.1414109479801482e-07
dependent O 0 4.762041072581269e-08
colocalization O 0 1.7449977463002142e-07
of O 0 1.4071551215910638e-11
BARD1 O 0 1.191924411614309e-06
and O 0 5.363064436991749e-10
BRCA1 O 0 8.883284152716442e-08
indicates O 0 8.480443014491357e-10
a O 0 1.5664868707743196e-11
role O 0 7.213912106562859e-11
for O 0 7.706457000322686e-12
BARD1 O 0 7.377590094392872e-08
in O 0 1.378987146694044e-09
BRCA1 O 0 0.00014843228564132005
- O 0 9.039777978614438e-06
mediated O 0 4.3376581743359566e-05
tumor B-Disease 0 3.4622102248249575e-05
suppression O 0 2.6804809749592096e-07
. O 0 2.5583128504536035e-08

Ethnic O 0 1.3380331154166925e-07
differences O 0 3.5968304246125626e-07
in O 0 5.112956724673268e-09
the O 0 1.144656147644696e-09
HFE O 0 3.657698107417673e-05
codon O 0 1.627911615287303e-06
282 O 0 4.544213823010068e-07
( O 0 1.2513702074556932e-08
Cys O 0 0.49501118063926697
/ O 0 8.617023013357539e-06
Tyr O 0 3.970070793002378e-06
) O 0 4.087382432516051e-09
polymorphism O 0 2.2171466298459563e-06
. O 0 7.462758411236337e-09

Recent O 0 2.9851630500843385e-08
studies O 0 2.3245356750578594e-09
have O 0 6.33048613529752e-11
shown O 0 3.432164830119433e-10
that O 0 3.900195224559866e-07
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 1.2248757229826879e-05
HH B-Disease 1 0.9996401071548462
) O 0 6.934984531081767e-11
is O 0 1.508468350230885e-11
likely O 0 1.2344950617304562e-09
to O 0 1.8340443747044688e-11
be O 0 2.460410764015819e-10
caused O 0 6.058639007155975e-11
by O 0 4.629414039614144e-12
homozygosity O 0 6.619410353181365e-09
for O 0 2.486003807325443e-12
a O 0 1.1517952563933065e-10
Cys282Tyr O 0 2.3346326827322628e-07
mutation O 0 4.5956198846397456e-09
in O 0 2.2953242084788883e-10
the O 0 1.1042575187580894e-10
HFE O 0 5.476753131006262e-07
gene O 0 2.329503523412768e-08
located O 0 1.3298528500627071e-08
4 O 0 2.156917844331474e-08
. O 0 5.6040998508422035e-09

5 O 0 2.3988325210666517e-06
Mb O 0 3.897215356118977e-05
telomeric O 0 7.212240689113969e-06
to O 0 1.3768328699370613e-08
HLA O 0 2.370711627008859e-05
- O 0 3.7090848081788863e-07
A O 0 1.1360176799257715e-08
. O 0 3.971386330903215e-09

Population O 0 1.1011558331830429e-09
studies O 0 6.762359006096119e-10
of O 0 7.724023243921296e-13
this O 0 1.7669508434528525e-12
polymorphism O 0 3.5598057834818064e-09
are O 0 3.2634053879349034e-12
facilitated O 0 2.964143167027977e-11
by O 0 6.123459486868932e-13
the O 0 1.8154373403883595e-12
fact O 0 1.0889695395421839e-11
that O 0 2.5811330069819283e-12
the O 0 4.528578033402564e-12
Cys282Tyr O 0 1.4098813672092092e-08
mutation O 0 1.3895800066165975e-09
creates O 0 3.486140265351878e-10
a O 0 1.033428564944927e-09
Rsal O 0 5.250408889878599e-07
restriction O 0 2.1931965576982293e-08
site O 0 2.5218945154392713e-08
. O 0 4.649064688777571e-09

We O 0 2.7424031046052733e-08
have O 0 1.2673107008254192e-10
studied O 0 1.4350635124671385e-09
the O 0 6.072765207365549e-11
codon O 0 4.9867509233081364e-08
282 O 0 2.6873809844119023e-08
( O 0 1.7470476176839611e-09
Cys O 0 0.002113346941769123
/ O 0 2.7156827400176553e-06
Tyr O 0 9.405477499058179e-07
) O 0 5.020338589289963e-10
polymorphism O 0 7.03169362736844e-08
in O 0 2.4182955637996884e-10
different O 0 6.449006606512597e-11
ethnic O 0 2.317588482236843e-10
groups O 0 3.144129678833707e-10
. O 0 9.0877116942778e-10

In O 0 6.361163595869357e-09
agreement O 0 1.2278634775597652e-09
with O 0 9.080078702816685e-12
previous O 0 4.726095070850533e-10
observations O 0 1.0709345216186605e-10
the O 0 1.8938989265748774e-11
Tyr O 0 4.3242255998166e-08
allele O 0 1.6796491308923578e-08
appeared O 0 1.104311735389274e-07
to O 0 2.781688247799341e-11
be O 0 5.4935219567786575e-11
rare O 0 1.913266489683707e-10
or O 0 5.292715599125586e-09
absent O 0 9.977154213913764e-09
in O 0 3.7902586624838364e-10
Asiatic O 0 6.374973882117274e-09
( O 0 2.8847407101961764e-11
Indian O 0 5.252884585638107e-11
, O 0 3.866168669930392e-12
Chinese O 0 5.031386331871834e-12
) O 0 6.2374515275021025e-12
populations O 0 8.748802377001041e-11
. O 0 4.126924912917218e-10

The O 0 1.9002657225541952e-09
highest O 0 3.4756717504080825e-09
allele O 0 3.701670436839777e-08
frequency O 0 2.4229889206139887e-08
( O 0 1.534186999663234e-09
7 O 0 2.902463824838719e-10
. O 0 6.659086476679121e-12
5 O 0 1.2607211281878694e-11
% O 0 1.003054583836871e-11
) O 0 3.449368611921355e-12
was O 0 1.9049950950034145e-08
found O 0 3.1181404125391055e-09
in O 0 3.9599044043825415e-09
Swedes O 0 3.3722856187523575e-06
. O 0 1.7279162545236204e-09

Saamis O 0 6.496185233118013e-05
( O 0 1.904087021387113e-08
2 O 0 8.166007314791557e-10
% O 0 7.295940934737288e-11
) O 0 8.202620006836359e-12
and O 0 6.153955123266996e-11
Mordvinians O 0 3.636518641769726e-08
( O 0 3.7313804823746466e-11
1 O 0 2.369182801331693e-11
. O 0 8.247251839788028e-12
8 O 0 4.723551411123239e-11
% O 0 4.455062620895012e-12
) O 0 2.5416396418065368e-12
had O 0 5.701903393884322e-09
significantly O 0 8.733505474367576e-09
lower O 0 8.963734643430143e-09
frequencies O 0 1.0835258246189028e-09
of O 0 9.721641894278044e-12
the O 0 1.9424584163374448e-10
Tyr O 0 1.9854532240515255e-07
allele O 0 4.798735631084128e-07
. O 0 7.304121307782907e-09

Comparisons O 0 5.483072484935292e-08
with O 0 1.7196430390775674e-10
allele O 0 3.320992547628521e-08
frequencies O 0 5.8611511200012956e-09
based O 0 5.353529286544756e-10
on O 0 5.6353561816990805e-09
prevalence O 0 1.7142259878255572e-07
estimates O 0 1.4382695034953485e-09
of O 0 3.926447361690677e-11
HH B-Disease 1 0.9999203681945801
showed O 0 3.779131702685845e-06
some O 0 4.131018443986889e-11
disagreements O 0 2.686549205321853e-09
with O 0 9.849187437849238e-13
the O 0 1.0120637834731827e-11
RFLP O 0 3.259660985577284e-08
data O 0 2.9973867832211454e-10
, O 0 2.4633713038152427e-12
particularly O 0 1.8760207276535823e-10
in O 0 9.998981642667104e-10
Finns O 0 5.008832886232994e-07
. O 0 2.3157602502266172e-09

The O 0 6.060367319093984e-09
newly O 0 1.2677206839839528e-08
described O 0 8.49539016911649e-09
HFE O 0 9.863964578471496e-07
marker O 0 7.8911490675182e-09
provides O 0 8.912275084593801e-11
a O 0 1.5756332349958768e-10
new O 0 3.6845707040988884e-10
approach O 0 6.336073443691248e-09
to O 0 6.640682795322483e-12
the O 0 5.588742142681458e-12
screening O 0 2.3661178571998676e-10
of O 0 3.155847978775217e-12
HH B-Disease 0 0.00029348974931053817
as O 0 7.385957123684506e-11
well O 0 3.414226887321625e-11
as O 0 7.514222750970578e-12
studies O 0 4.805471558871899e-12
of O 0 5.5674150863495656e-14
the O 0 2.1181745593623624e-12
relationship O 0 3.0433866538004395e-10
between O 0 3.6342109877018913e-11
the O 0 1.518601910888151e-10
HFE O 0 3.0102232813078444e-06
Tyr O 0 3.2859040288713004e-07
allele O 0 1.3571872159445775e-07
and O 0 1.1365631769066908e-09
different O 0 5.422415849665185e-09
disorders O 0 0.00010989144357154146
including O 0 8.498761694397672e-09
cancer B-Disease 0 0.00013035460142418742

Autosomal B-Disease 1 0.9999983310699463
dominant I-Disease 1 0.999995231628418
neurohypophyseal I-Disease 1 0.9999992847442627
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9996008276939392
associated O 0 2.2132482513370633e-07
with O 0 2.549536970430921e-10
a O 0 3.048651775472422e-09
missense O 0 2.6365183657617308e-05
mutation O 0 3.1791964261174144e-07
encoding O 0 1.7642308591803157e-07
Gly23 O 0 1.2760928257193882e-05
- O 0 0.00026189873460680246
- O 0 0.0002503919822629541
> O 0 2.0242249831881054e-07
Val O 0 2.876413191188476e-06
in O 0 1.2937577231753039e-08
neurophysin O 0 1.1177461601619143e-05
II O 0 2.3272220914805075e-06
. O 0 3.4431688611391564e-09

Autosomal B-Disease 1 0.9999995231628418
dominant I-Disease 1 0.9999983310699463
neurohypophyseal I-Disease 1 0.9999998807907104
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999973773956299
( O 0 1.0436431239213562e-06
ADNDI B-Disease 0 0.00023666459310334176
) O 0 3.138294069060521e-10
is O 0 1.651829090176804e-10
an O 0 6.118101580909752e-09
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 1.4641467487308546e-06
by O 0 1.3315323288409786e-09
progressive O 0 3.190637016814435e-06
degeneration O 0 0.0007435064762830734
of O 0 1.0556043886222888e-11
the O 0 3.354934385857433e-11
magnocellular O 0 4.56889601707644e-08
neurons O 0 2.882059702002948e-09
of O 0 3.7721241061272615e-12
the O 0 1.5386105584047627e-11
hypothalamus O 0 1.038197638969507e-09
leading O 0 3.453190233759784e-10
to O 0 1.458431465872767e-11
decreased O 0 6.254449402831597e-09
ability O 0 1.1486842727004287e-10
to O 0 4.637606271229444e-12
produce O 0 4.1982497339665414e-11
the O 0 7.493188014517926e-11
hormone O 0 2.1174264563939005e-09
arginine O 0 4.801237185603213e-09
vasopressin O 0 5.471316733007825e-09
( O 0 3.9516784289261864e-10
AVP O 0 1.66612267094024e-07
) O 0 1.3816298105595592e-10
. O 0 2.8453264744321416e-10

Affected O 0 1.0784629012050573e-07
individuals O 0 1.6987207474006283e-10
are O 0 2.3588617170666737e-11
not O 0 1.2103032465127228e-10
symptomatic O 0 3.3487250306052374e-08
at O 0 3.853350083460327e-09
birth O 0 5.7317368629128396e-09
, O 0 2.7550652731411773e-11
but O 0 5.325582752568891e-10
usually O 0 2.5744304466002177e-09
develop O 0 3.5269960108053056e-07
diabetes B-Disease 1 0.9768418669700623
insipidus I-Disease 0 0.004683271516114473
at O 0 9.509471965429839e-08
1 O 0 1.9690570951524933e-08
- O 0 0.00044424374937079847
6 O 0 2.6061829316859075e-07
yr O 0 2.520079942769371e-05
of O 0 1.0420081464346254e-10
age O 0 1.8377379618073064e-08
. O 0 8.520408822931813e-10

The O 0 1.2733567533729229e-09
genetic O 0 1.732398402509716e-08
locus O 0 5.087683607740701e-09
of O 0 2.6838626807079713e-11
the O 0 9.949271406739513e-10
disease O 0 5.889404519621166e-07
is O 0 1.913660618857449e-10
the O 0 2.342087079831856e-10
AVP O 0 0.00023271409736480564
- O 0 1.5059831639518961e-06
neurophysin O 0 2.043461790890433e-05
II O 0 8.52680386742577e-07
( O 0 1.5372149386738698e-10
NPII O 0 1.5277693776738488e-08
) O 0 4.840169064157518e-12
gene O 0 3.0092270342230165e-10
, O 0 1.4999043673746826e-11
and O 0 2.6481867046457275e-11
mutations O 0 6.242123484767603e-10
that O 0 1.3404035693886929e-11
cause O 0 2.8910876470611413e-10
ADNDI B-Disease 0 1.4996298887126613e-06
have O 0 9.847059834200422e-10
been O 0 3.6416650250892246e-10
found O 0 7.747491537202222e-11
in O 0 4.604246671424672e-12
both O 0 1.2966479018966526e-12
the O 0 1.0816926781370695e-12
signal O 0 4.1546704965256254e-10
peptide O 0 9.746632320672965e-12
of O 0 2.5766357363704584e-13
the O 0 1.1557491942648657e-11
prepro O 0 9.073878004528524e-07
- O 0 3.9044155641931866e-07
AVP O 0 1.557942414365243e-05
- O 0 5.6059633379845764e-08
NPII O 0 1.5483151116768568e-07
precursor O 0 7.314926442347769e-09
and O 0 1.09167987150105e-10
within O 0 5.898299210160829e-11
NPII O 0 3.3112178243754897e-07
itself O 0 4.420340538047185e-09
. O 0 1.7584106393186971e-09

An O 0 7.901359566631072e-09
affected O 0 1.0111703829807084e-07
girl O 0 0.0005153833189979196
who O 0 3.505790935331987e-10
presented O 0 4.599263678239929e-11
at O 0 1.1353196160968082e-09
9 O 0 7.454218908797827e-10
months O 0 6.325130419426728e-10
of O 0 1.2495907086851332e-12
age O 0 1.4904548706340393e-09
and O 0 6.120079443228121e-11
her O 0 6.615238218321551e-11
similarly O 0 6.814838138247126e-10
affected O 0 7.2111951965325716e-09
younger O 0 4.956122978683197e-08
brother O 0 3.433999973267987e-09
and O 0 1.0756080748297592e-10
father O 0 3.752587129923768e-10
were O 0 3.9054015577022483e-10
all O 0 4.5212569582328554e-13
found O 0 8.727631464755525e-12
to O 0 1.3207525351166538e-12
have O 0 1.9331139120004615e-11
a O 0 1.95930615481954e-11
novel O 0 1.5914606299460843e-09
missense O 0 2.176400130338152e-06
mutation O 0 2.980452151746249e-08
( O 0 2.927974807054312e-10
G1758 O 0 5.781809164773222e-08
- O 0 1.5663256647258095e-07
- O 0 3.333409210881655e-07
> O 0 1.0067170208571952e-08
T O 0 2.700334000849125e-08
) O 0 9.223421505721863e-12
encoding O 0 1.4959167238259852e-10
the O 0 1.0948322110015951e-11
amino O 0 2.0496891683929874e-10
acid O 0 8.576132859428043e-11
substitution O 0 1.9100250547854358e-10
Gly23 O 0 9.397196265581442e-08
- O 0 1.5702397604400176e-06
- O 0 6.479447165474994e-06
> O 0 3.151216887431474e-08
Val O 0 2.7960047077613126e-07
within O 0 2.9385949229521202e-09
NPII O 0 1.4717942576680798e-05
. O 0 7.53015960697212e-09

The O 0 4.493754701684338e-09
mutation O 0 5.739320840802975e-08
was O 0 3.060106834595899e-08
confirmed O 0 6.202270919075659e-10
by O 0 1.1264124182008839e-11
restriction O 0 1.0406346895308616e-08
endonuclease O 0 1.3521400887839263e-06
analysis O 0 1.618590417251653e-08
. O 0 2.3665702730824023e-09

A O 0 5.314811915013706e-07
T1 O 0 0.0028568776324391365
- O 0 2.8008327035422553e-07
weighted O 0 2.142517807612876e-08
magnetic O 0 2.519547015467083e-09
resonance O 0 5.596679386599135e-08
imaging O 0 1.1744880794140045e-05
of O 0 5.390885654543709e-11
the O 0 1.4261755665323506e-10
fathers O 0 9.297317582479536e-09
pituitary O 0 5.3676005862257625e-09
gland O 0 1.1805596500380489e-08
demonstrates O 0 6.3643428305226735e-09
an O 0 1.9993996736022979e-10
attenuated O 0 1.128902567870682e-06
posterior O 0 1.007304854283575e-05
pituitary O 0 2.4517930796719156e-05
bright O 0 0.0003146550734527409
spot O 0 5.476844307850115e-05
. O 0 6.917569095321596e-08

This O 0 9.468366535259065e-09
mutation O 0 4.905254513687396e-08
may O 0 4.133276387818796e-09
be O 0 2.5727185139212683e-12
valuable O 0 1.2093841553206808e-11
for O 0 2.368909376385814e-13
developing O 0 3.365573444935599e-11
models O 0 3.0073237233807504e-09
of O 0 3.2235301233862756e-11
dominantly B-Disease 0 1.7340424165013246e-05
inherited I-Disease 1 0.9995965361595154
neurodegeneration I-Disease 1 1.0
, O 0 8.263888462423097e-10
as O 0 2.441895817495432e-11
the O 0 3.5486823982827653e-12
early O 0 2.546191346652904e-08
age O 0 1.8032776660792393e-10
of O 0 7.216436649637448e-13
onset O 0 1.8546711944011918e-09
of O 0 9.961717215012378e-12
symptoms O 0 2.5472647990909536e-08
suggests O 0 2.872454218927345e-10
that O 0 2.2091417237191102e-12
this O 0 5.019232425518272e-12
mutation O 0 2.5016233529129295e-09
may O 0 7.66071472924068e-09
be O 0 5.829382115907222e-11
particularly O 0 5.367905009379115e-10
deleterious O 0 4.043370971373861e-09
to O 0 1.101022953364783e-10
the O 0 1.5866891134308503e-10
magnocellular O 0 2.3579482899549475e-07
neuron O 0 3.4278176741509014e-08
. O 0 4.993551128151807e-10
. O 0 1.4653618318760664e-09

Frequent O 0 5.86697569815442e-06
inactivation O 0 1.0644651410984807e-05
of O 0 1.7183128253606128e-09
PTEN O 0 0.0011272308183833957
/ O 0 0.0001107657008105889
MMAC1 O 0 3.4424661862431094e-05
in O 0 6.224830428891437e-08
primary O 1 0.6722639203071594
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 7.879962282686392e-08

Sporadic B-Disease 1 0.9999986886978149
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 2.1039731734617817e-08
the O 0 2.2488334111558927e-11
most O 0 1.587923716128703e-11
common O 0 1.9348644908490087e-09
male B-Disease 0 5.062708918757153e-09
cancer I-Disease 0 3.728936714963993e-09
in O 0 2.7058016938141805e-10
the O 0 1.552770412249771e-11
Western O 0 2.280070798832412e-09
world O 0 2.342545180056277e-08
, O 0 1.5897965235933675e-11
yet O 0 4.52498871705842e-11
many O 0 2.227516131617091e-13
of O 0 5.6312481668810074e-14
the O 0 2.216408209309434e-13
major O 0 1.0040040847314469e-11
genetic O 0 2.208465632591583e-10
events O 0 6.627788595725548e-12
involved O 0 5.823936471971436e-11
in O 0 1.8532417267458356e-10
the O 0 5.969614386147626e-11
progression O 0 7.709052285420626e-10
of O 0 8.056861384650449e-13
this O 0 2.4708027290820667e-11
often O 0 1.3365813344989874e-08
fatal O 0 7.92783157521626e-06
cancer B-Disease 0 5.5873529163363855e-06
remain O 0 6.328588142423541e-08
to O 0 7.217985931173843e-11
be O 0 8.740433932175051e-10
elucidated O 0 2.617888128497725e-07
. O 0 2.1090584834126958e-09

Numerous O 0 5.977495476372496e-08
cytogenetic O 0 4.4491098378784955e-05
and O 0 2.4110763163776028e-08
allelotype O 0 8.171980425686343e-07
studies O 0 4.275752640836572e-09
have O 0 2.190255476985925e-10
reported O 0 3.937956183364122e-09
frequent O 0 1.3294919609663225e-09
loss O 0 5.294048310844346e-09
of O 0 2.0623391883134445e-11
heterozygosity O 0 3.6789253954339074e-07
on O 0 3.8175500094439485e-08
chromosomal O 0 0.013011790812015533
arm O 0 0.22596041858196259
10q O 0 9.515470992482733e-06
in O 0 4.1815457052507554e-07
sporadic B-Disease 1 0.9999995231628418
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.672955000728507e-08

Deletion O 0 3.616470621636836e-06
mapping O 0 3.31658384311595e-07
studies O 0 4.538462050618364e-08
have O 0 7.033820192958729e-10
unambiguously O 0 1.968009577524299e-08
identified O 0 1.2225027656853626e-09
a O 0 2.4504433204786125e-11
region O 0 3.684268445880434e-10
of O 0 1.2926383921585405e-11
chromosome O 0 1.901887998201346e-07
10q23 O 0 2.3842048335609434e-08
to O 0 1.887803975642033e-11
be O 0 3.138387813517163e-11
the O 0 2.8410771998887974e-12
minimal O 0 3.0586450039393753e-10
area O 0 3.053730879276628e-10
of O 0 5.613658496383955e-11
loss O 0 4.579819545824648e-08
. O 0 3.8388399126176864e-09

A O 0 8.456126465716807e-08
new O 0 2.564492973533561e-08
tumor B-Disease 0 4.837438041249698e-07
suppressor O 0 7.280798399733612e-07
gene O 0 3.1350251106232463e-07
, O 0 2.4326474168390178e-09
PTEN O 0 0.0003376937238499522
/ O 0 0.004895778372883797
MMAC1 O 0 0.0032673263922333717
, O 0 1.2198125842743934e-09
was O 0 1.5840662115351734e-08
isolated O 0 4.253335461612551e-09
recently O 0 9.049372096114894e-08
at O 0 2.380821650938003e-10
this O 0 6.953122973218928e-13
region O 0 2.3885253150335295e-11
of O 0 2.647670277466929e-12
chromosome O 0 1.0964663488266524e-07
10q23 O 0 1.7492391535256502e-08
and O 0 9.477554158143775e-11
found O 0 9.342442791604455e-11
to O 0 2.2447096265088007e-12
be O 0 1.46996251976228e-11
inactivated O 0 4.288129920593242e-11
by O 0 2.235378332091087e-12
mutation O 0 1.214934153281888e-09
in O 0 7.047870731469175e-09
three O 0 1.5598828895235783e-06
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
cell O 0 1.3990509614814073e-05
lines O 0 1.860328438851866e-06
. O 0 1.9068274070832558e-08

We O 0 6.908445726594437e-08
screened O 0 2.0080597096239217e-06
80 O 0 9.2393385386913e-08
prostate B-Disease 0 0.01484489906579256
tumors I-Disease 1 0.9999998807907104
by O 0 1.7087154607908772e-11
microsatellite O 0 1.6681489967140806e-08
analysis O 0 1.5632679595256604e-09
and O 0 1.2622689005148402e-10
found O 0 8.248361438312202e-10
chromosome O 0 1.6309435579842102e-07
10q23 O 0 2.9017970248901293e-08
to O 0 3.074124982349602e-11
be O 0 9.896084646188186e-11
deleted O 0 6.966704102495669e-09
in O 0 1.4981645923839437e-09
23 O 0 1.9028478792648684e-09
cases O 0 6.860366719152466e-10
. O 0 7.25419169178565e-10

We O 0 3.5578185730855694e-08
then O 0 4.67665073333734e-10
proceeded O 0 8.212522328854277e-10
with O 0 8.321227279277366e-13
sequence O 0 8.794623015950798e-12
analysis O 0 2.503195914438372e-11
of O 0 9.155707875879715e-13
the O 0 1.391015948259966e-11
entire O 0 1.976382169033286e-09
PTEN O 0 5.532908835448325e-05
/ O 0 3.1187121294351527e-06
MMAC1 O 0 5.722864443669096e-06
coding O 0 5.520987542695366e-07
region O 0 6.9279320058512894e-09
and O 0 2.963895795460303e-10
tested O 0 6.425349696748128e-10
for O 0 1.739109073764511e-12
homozygous O 0 5.456244345225514e-10
deletion O 0 1.8726469264152e-09
with O 0 6.049051884393641e-12
new O 0 4.009133858229319e-10
intragenic O 0 2.0416523227595462e-07
markers O 0 4.478167170418601e-08
in O 0 4.5518946945044547e-10
these O 0 4.859847593796651e-11
23 O 0 2.9161534298438596e-10
cases O 0 2.0885126961189826e-11
with O 0 1.0374642117616517e-11
10q23 O 0 2.2131617072318477e-07
loss O 0 1.7479051095392606e-08
of O 0 8.243906252092259e-11
heterozygosity O 0 4.354113116278313e-06
. O 0 1.4252496072231224e-08

The O 0 4.96525820459226e-10
identification O 0 1.386265657821184e-09
of O 0 4.488394031443299e-12
the O 0 1.4155215194433524e-11
second O 0 3.1810232226092694e-09
mutational O 0 1.4082868915465951e-07
event O 0 1.0086038670920061e-09
in O 0 3.066339626656145e-09
10 O 0 3.7447722700534314e-10
( O 0 7.131989443465159e-11
43 O 0 3.570638229533074e-09
% O 0 2.3729433973329606e-09
) O 0 1.7454031109309653e-08
tumors B-Disease 1 1.0
establishes O 0 5.421712558018044e-06
PTEN O 0 0.025952545925974846
/ O 0 0.0004385063948575407
MMAC1 O 0 1.2095048077753745e-05
as O 0 1.8176220251131525e-10
a O 0 4.0783917909514855e-11
main O 0 4.632244865465651e-10
inactivation O 0 1.4297802941598547e-08
target O 0 1.1658974896633367e-09
of O 0 1.166933043250662e-11
10q O 0 7.011939828771574e-08
loss O 0 2.582192060174293e-08
in O 0 7.005990454445055e-08
sporadic B-Disease 1 0.9999998807907104
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.055682456538534e-09
. O 0 4.791192331765615e-09

Risk O 0 2.8906110856041778e-06
reversals O 0 3.549428129190346e-07
in O 0 6.498387383757631e-10
predictive O 0 8.419142716320493e-08
testing O 0 5.1124626310183885e-08
for O 0 3.056896957787103e-09
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 3.846222185188708e-08

The O 0 1.6564550842090853e-09
first O 0 4.920532870045236e-10
predictive O 0 5.2766310432161845e-08
testing O 0 2.164699175466467e-08
for O 0 2.284537226060479e-09
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 5.106972622570538e-09
HD B-Disease 0 0.0005000202218070626
) O 0 9.886915591783563e-11
was O 0 1.0175037479243088e-09
based O 0 1.636558770445884e-11
on O 0 8.671054846365323e-11
analysis O 0 1.038660216862164e-11
of O 0 4.0134350920775774e-13
linked O 0 1.8833139492357986e-09
polymorphic O 0 3.2609093203461725e-09
DNA O 0 3.627801392624974e-09
markers O 0 6.06389050084033e-10
to O 0 5.975956274967276e-12
estimate O 0 2.6622365423278893e-10
the O 0 4.407679950191312e-12
likelihood O 0 2.6073704306739387e-10
of O 0 1.8099469405868929e-12
inheriting O 0 1.2019346629088545e-09
the O 0 2.2413395792120205e-11
mutation O 0 8.076183055649722e-10
for O 0 4.4214659711272475e-11
HD B-Disease 0 3.2536125218030065e-05
. O 0 6.191447798897798e-09

Limits O 0 8.226714420800363e-09
to O 0 1.1941897470890694e-10
accuracy O 0 6.824268372618292e-10
included O 0 4.971905699646673e-12
recombination O 0 7.810147667486333e-11
between O 0 1.068200389253704e-11
the O 0 4.317970026673779e-12
DNA O 0 7.038598037745203e-10
markers O 0 5.241178047121764e-10
and O 0 1.8426595319032124e-11
the O 0 7.955303082951559e-12
mutation O 0 5.636041078282972e-10
, O 0 4.6839684908484e-11
pedigree O 0 3.992586172785195e-08
structure O 0 2.058756720657584e-09
, O 0 1.497234801417502e-11
and O 0 3.880471464989821e-12
whether O 0 6.542456246899642e-12
DNA O 0 2.0633394992586318e-10
samples O 0 2.992466691109641e-11
were O 0 2.953674110850457e-11
available O 0 1.5694476968031168e-11
from O 0 4.7567297323247715e-12
family O 0 4.1514919973950626e-11
members O 0 1.9478666943295586e-11
. O 0 2.1693923046850472e-10

With O 0 5.443012707218031e-10
direct O 0 2.62712984699931e-09
tests O 0 4.7239976375124115e-09
for O 0 1.0531745831335315e-12
the O 0 7.236398546356382e-12
HD B-Disease 0 1.7721065887599252e-05
mutation O 0 5.632677102518358e-10
, O 0 6.800353682945293e-12
we O 0 8.171155592429091e-12
have O 0 2.499110944229055e-12
assessed O 0 2.624017496344333e-11
the O 0 4.4781642586852466e-13
accuracy O 0 9.341490248004902e-09
of O 0 7.980192028023136e-13
results O 0 6.652210032820349e-11
obtained O 0 1.0073493254825205e-11
by O 0 1.434355238749685e-12
linkage O 0 4.713530010747036e-09
approaches O 0 6.231666849210171e-10
when O 0 2.8391773307379076e-11
requested O 0 6.360158927298798e-12
to O 0 8.96153203727712e-12
do O 0 1.7146321862338e-10
so O 0 8.358198681779339e-12
by O 0 1.648710329501743e-13
the O 0 5.638852666051131e-12
test O 0 2.5072638409895376e-10
individuals O 0 7.254904142717233e-12
. O 0 2.0961203606173484e-10

For O 0 4.259389785321588e-10
six O 0 2.7537205155026e-11
such O 0 1.3075557346933775e-12
individuals O 0 4.749458638875215e-12
, O 0 1.1566511637361998e-11
there O 0 1.0316909132557228e-10
was O 0 4.244388840390911e-09
significant O 0 5.933572383431951e-11
disparity O 0 5.161593930047559e-10
between O 0 8.081262742321016e-11
the O 0 1.6670723135270293e-10
tests O 0 1.09072981757663e-08
. O 0 1.9916615578985386e-10

Three O 0 5.644585687747394e-09
went O 0 3.1352800355932686e-09
from O 0 9.687102682509607e-12
a O 0 2.8806608140530265e-11
decreased O 0 3.5470314685426274e-08
risk O 0 1.7867514412461816e-10
to O 0 6.806890663103859e-13
an O 0 1.4218526529774511e-12
increased O 0 1.7038030986071817e-09
risk O 0 9.254220501020427e-09
, O 0 1.309183404046843e-11
while O 0 2.296838413906599e-11
in O 0 7.92436810614916e-11
another O 0 7.569998794476618e-11
three O 0 1.458662184095072e-11
the O 0 4.944464629397238e-11
risk O 0 2.12041015856812e-08
was O 0 5.1798647149325916e-08
decreased O 0 7.281423819449628e-08
. O 0 9.642023846012648e-10

Knowledge O 0 4.3025885076986015e-08
of O 0 2.8032328194815825e-11
the O 0 2.4829283594429707e-12
potential O 0 6.457889778488379e-12
reasons O 0 6.920327158543849e-12
for O 0 1.3391577343563332e-13
these O 0 6.736832771324364e-13
changes O 0 1.1558175423698192e-11
in O 0 5.505818578832589e-10
results O 0 1.3455415448504482e-08
and O 0 3.32423220894551e-11
impact O 0 1.951090504437314e-11
of O 0 1.691643515804725e-13
these O 0 4.387800452837487e-12
risk O 0 8.695549835735505e-11
reversals O 0 2.078134747618421e-10
on O 0 5.3819469714166956e-11
both O 0 5.421552096152027e-11
patients O 0 2.474260796248018e-10
and O 0 1.0281661806665898e-11
the O 0 5.618090194448033e-12
counseling O 0 2.905404805630951e-10
team O 0 3.836250327821089e-12
can O 0 9.839084842006018e-13
assist O 0 1.0341485697298869e-12
in O 0 1.4628052241727474e-11
the O 0 2.2205139203063107e-12
development O 0 2.833884819516963e-12
of O 0 2.142365196919696e-13
strategies O 0 4.072856982229034e-11
for O 0 6.632894103755782e-13
the O 0 1.4576192683413147e-11
prevention O 0 1.0823092422285185e-09
and O 0 3.4280298044642166e-10
, O 0 3.0587819603578037e-12
where O 0 4.769102647517176e-12
necessary O 0 4.456163216204345e-10
, O 0 3.602780573874753e-11
management O 0 8.576051674369367e-11
of O 0 1.088526174037284e-13
a O 0 1.189740528317884e-10
risk O 0 4.7170019001896435e-09
reversal O 0 3.5053380198490913e-09
in O 0 3.0844264642393426e-11
any O 0 1.997107861029246e-11
predictive O 0 7.62674545740083e-09
testing O 0 3.80512465980587e-09
program O 0 1.4627675737344248e-09
. O 0 9.979066184495622e-11
. O 0 5.603370545337327e-10

A O 0 4.007081599866069e-08
novel O 0 1.7191496226587333e-08
common O 0 1.114464183160635e-07
missense O 0 9.407598554389551e-05
mutation O 0 2.3946886358316988e-06
G301C O 0 5.175840556148614e-07
in O 0 6.559556231522379e-10
the O 0 1.6042905892632575e-10
N O 0 1.1811998490429687e-07
- O 0 8.712247279163421e-08
acetylgalactosamine O 0 5.5074408010113984e-05
- O 0 4.41569142139997e-07
6 O 0 4.737957137734838e-09
- O 0 2.1052857235304145e-08
sulfate O 0 1.9876901902193822e-08
sulfatase O 0 3.5468295322971244e-07
gene O 0 3.2745106182119343e-08
in O 0 2.5237600898009305e-09
mucopolysaccharidosis B-Disease 0 3.956376986025134e-06
IVA I-Disease 0 0.00011378151248209178
. O 0 2.1698248531265563e-08

Mucopolysaccharidosis B-Disease 0 0.16555608808994293
IVA I-Disease 1 0.999808132648468
( O 0 0.0002987571933772415
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 1.5091403682276905e-09
is O 0 1.173540570276188e-10
an O 0 2.7445559713790146e-10
autosomal B-Disease 1 0.9999943971633911
recessive I-Disease 1 1.0
lysosomal I-Disease 1 0.9999990463256836
storage I-Disease 1 0.9999966621398926
disorder I-Disease 1 0.9999998807907104
caused O 0 1.6420698045749305e-07
by O 0 1.3742706972408314e-10
a O 0 4.072190222359495e-06
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 1.16232330427124e-08
N O 0 1.0282863513566554e-05
- O 0 1.5614859876222908e-06
acetylgalactosamine O 0 0.00219785631634295
- O 0 1.0336781087971758e-05
6 O 0 6.159635290714505e-08
- O 0 6.001863539495389e-07
sulfate O 0 2.239706731188562e-07
sulfatase O 0 3.0240314572438365e-06
( O 0 1.5938361741518747e-09
GALNS O 0 3.3321887826787133e-07
) O 0 2.506355123443882e-10
. O 0 6.285012510431898e-10

In O 0 2.581502656084922e-08
previous O 0 3.496210210229833e-09
studies O 0 1.4473620080224237e-09
, O 0 1.6156515361687163e-11
we O 0 6.8870525601893995e-12
have O 0 3.205502703551577e-12
found O 0 6.8766307752266e-12
two O 0 6.045265741987105e-13
common O 0 2.0346491852452075e-11
mutations O 0 1.7552734266068626e-10
in O 0 1.5374759798625348e-10
Caucasians O 0 3.521066460621114e-08
and O 0 1.9602564016452106e-10
Japanese O 0 4.296763389532998e-09
, O 0 1.815812257499605e-11
respectively O 0 1.4000993697749209e-09
. O 0 5.645692247036038e-10

To O 0 3.1956668422594703e-09
characterize O 0 1.8809748780768132e-07
the O 0 3.4790395564421317e-10
mutational O 0 7.596702289447421e-07
spectrum O 0 5.183340423542404e-09
in O 0 9.126616823396105e-11
various O 0 3.3421971787350735e-12
ethnic O 0 8.390688317760908e-12
groups O 0 6.899147919625648e-12
, O 0 1.879364892876101e-11
mutations O 0 1.415403488858047e-10
in O 0 4.213427176602558e-11
the O 0 1.5769703251566902e-11
GALNS O 0 9.185479044049316e-09
gene O 0 6.327133816874664e-10
in O 0 1.8989747274655855e-10
Colombian O 0 7.673850888068046e-08
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 8.418555239586567e-07
were O 0 6.974544275450967e-10
investigated O 0 1.327029486297704e-09
, O 0 1.4823989258339054e-11
and O 0 2.3084419792374078e-11
genetic O 0 2.1339034983469674e-09
backgrounds O 0 3.819580207675699e-09
were O 0 1.2968594254036958e-10
extensively O 0 9.091209035583248e-11
analyzed O 0 1.1952654144220531e-10
to O 0 1.411274959742248e-12
identify O 0 1.0919506271411805e-10
racial O 0 3.2144675810030776e-11
origin O 0 3.201459236601423e-11
, O 0 2.6682987416815074e-12
based O 0 1.057803324100437e-11
on O 0 2.5043672691182906e-10
mitochondrial O 0 3.6352199028755194e-09
DNA O 0 2.833468748519863e-08
( O 0 1.561255846826981e-10
mtDNA O 0 2.5278275472828682e-08
) O 0 2.921336506034322e-10
lineages O 0 2.7673406677308776e-08
. O 0 3.7222289694938127e-09

Three O 0 8.156749053966905e-09
novel O 0 1.7756541126345837e-08
missense O 0 4.381727194413543e-06
mutations O 0 6.721370482409839e-07
never O 0 2.663773379651957e-08
identified O 0 1.3231574724770212e-09
previously O 0 9.62269153248485e-11
in O 0 9.838526694727623e-12
other O 0 2.8602487132239895e-12
populations O 0 1.076978783931537e-11
and O 0 1.0169754621758287e-10
found O 0 3.0277325091532248e-09
in O 0 7.165553039811812e-09
16 O 0 6.896589965776911e-10
out O 0 1.4137569587235888e-11
of O 0 1.6790083863169047e-12
19 O 0 1.5343420978197742e-09
Colombian O 0 1.1509909114693073e-07
MPS B-Disease 1 0.9999998807907104
IVA I-Disease 1 0.9999995231628418
unrelated O 0 8.711399601679659e-08
alleles O 0 7.95716648127609e-09
account O 0 1.6743002539953977e-09
for O 0 8.017258384951376e-11
84 O 0 1.5965083477453845e-08
. O 0 4.793358598931263e-09

2 O 0 1.9022611041918935e-08
% O 0 3.6341293863095814e-10
of O 0 8.779350944149167e-13
the O 0 1.0777719862409274e-11
alleles O 0 4.658400332147039e-10
in O 0 7.723637285295126e-10
this O 0 7.08288774853294e-11
study O 0 1.5171888745335593e-10
. O 0 4.6285003607593467e-10

The O 0 5.141689296550567e-09
G301C O 0 2.6911646955340984e-07
and O 0 4.66519378683472e-10
S162F O 0 1.6768323618521208e-08
mutations O 0 4.3847703246058245e-09
account O 0 2.578350588589018e-10
for O 0 6.335414831637465e-11
68 O 0 1.7965952281429054e-08
. O 0 8.918469296403941e-10

4 O 0 8.349863946932601e-07
% O 0 8.141578078380007e-09
and O 0 1.3215735172877885e-09
10 O 0 1.2435391605336577e-09
. O 0 9.316183380292387e-10

5 O 0 2.243053565109676e-08
% O 0 2.1532409189006785e-10
of O 0 2.4857715712200967e-12
mutations O 0 1.1800435073539006e-09
, O 0 3.384815344675829e-11
respectively O 0 1.2431834450765678e-09
, O 0 1.9127583197886544e-11
whereas O 0 1.6896919974307423e-10
the O 0 1.0405359733567376e-11
remaining O 0 7.494864173729354e-10
F69V O 0 1.7487107015767833e-06
is O 0 2.0459229796432332e-11
limited O 0 4.503274142475533e-11
to O 0 1.0890651228057102e-11
a O 0 4.842593548382013e-10
single O 0 1.145041128580715e-08
allele O 0 1.1468266620795475e-06
. O 0 2.5821229598932405e-08

The O 0 5.011701720292194e-09
skewed O 0 1.6107408384868904e-07
prevalence O 0 1.3569594159434928e-07
of O 0 1.1175209195524172e-11
G301C O 0 6.623741999334243e-09
in O 0 2.6869667948958842e-11
only O 0 1.132593324681963e-11
Colombian O 0 7.411234403953415e-10
patients O 0 2.90219426268834e-09
and O 0 8.491445047109636e-11
haplotype O 0 2.2055294479628174e-08
analysis O 0 1.9380028137838679e-10
by O 0 8.13622606787856e-12
restriction O 0 1.5603337510938786e-09
fragment O 0 6.686970532854275e-09
length O 0 1.0144245443655109e-09
polymorphisms O 0 6.593681689537334e-08
in O 0 5.920912649060028e-10
the O 0 1.660595133623488e-10
GALNS O 0 2.0711156878405745e-07
gene O 0 3.846044371869084e-09
suggest O 0 3.2701708008175956e-09
that O 0 5.929884361322024e-11
G301C O 0 5.6030100559212315e-09
originated O 0 4.059428349023619e-09
from O 0 6.940648056286136e-11
a O 0 1.4358347844023456e-10
common O 0 9.697058711566342e-10
ancestor O 0 2.038385282787658e-08
. O 0 8.385372396446655e-09

Investigation O 0 5.116003265470681e-08
of O 0 2.3921545300176206e-11
the O 0 2.6878381464978673e-11
genetic O 0 4.040579870689953e-09
background O 0 3.0465940881185816e-09
by O 0 7.865501652770668e-12
means O 0 2.2060532567369506e-10
of O 0 1.998086158333523e-12
mtDNA O 0 1.2662899173676578e-08
lineages O 0 2.411185695549989e-09
indicate O 0 2.0562296310089323e-09
that O 0 2.0845648124323546e-11
all O 0 8.036698043167867e-12
our O 0 3.5794242569942014e-11
patients O 0 1.0848819065323312e-10
are O 0 2.1869431179183385e-12
probably O 0 5.307613792915333e-10
of O 0 1.0732052182702012e-12
native O 0 1.3482606697756694e-10
American O 0 3.520628455433439e-09
descent O 0 3.934741016564658e-06

Low O 0 3.212142701158882e-06
frequency O 0 9.24938845514589e-08
of O 0 1.4667143888313916e-10
BRCA1 O 0 3.6761482533620438e-06
germline O 0 8.499071100231959e-07
mutations O 0 5.723873996998918e-08
in O 0 5.426841198641341e-10
45 O 0 6.283601194922994e-09
German O 1 0.9999997615814209
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 7.351855657589113e-08
. O 0 1.1474285521728689e-08

In O 0 2.6383244033922892e-08
this O 0 3.778044543878423e-11
study O 0 3.975891837981749e-11
we O 0 1.5766787181403785e-11
investigated O 0 3.196957698570202e-10
45 O 0 1.3032544488034148e-10
German O 1 0.999976634979248
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 4.535428699270483e-10
for O 0 9.019854307901198e-12
germline O 0 1.6275113523533946e-07
mutations O 0 3.28403011451428e-08
in O 0 4.954823218383808e-10
the O 0 1.2213181854736632e-10
BRCA1 O 0 1.0296827213096549e-06
gene O 0 6.781093020435947e-07
. O 0 1.9111711324626413e-08

We O 0 3.242941915004849e-08
identified O 0 6.2632952158026e-09
four O 0 6.799837776183537e-11
germline O 0 7.053279915680832e-08
mutations O 0 3.908728984924892e-08
in O 0 5.72569458512362e-09
three O 0 1.783732983540176e-08
breast B-Disease 0 0.000992052024230361
cancer I-Disease 0 5.423884886113228e-06
families O 0 8.521367500513577e-10
and O 0 4.510383039280086e-11
in O 0 1.3336929338692016e-09
one O 0 0.0004225705051794648
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 2.2732066895514436e-08
. O 0 1.1367571814413502e-11
among O 0 1.0140535329841716e-12
these O 0 4.943657787824518e-13
were O 0 2.6837465583184894e-10
one O 0 1.405811855814676e-10
frameshift O 0 2.2349238406604854e-06
mutation O 0 1.1093929330741048e-08
, O 0 1.5157572419433052e-10
one O 0 2.929667342055353e-10
nonsense O 0 2.5114331947406754e-05
mutation O 0 1.6454285045597317e-08
, O 0 1.713761597910146e-11
one O 0 9.335776075813929e-12
novel O 0 2.7823368609070087e-10
splice O 0 1.9118986074317945e-06
site O 0 1.8926920475337283e-08
mutation O 0 4.040180812125982e-08
, O 0 4.737900627382885e-10
and O 0 2.4031862611018084e-10
one O 0 3.7906491834327483e-10
missense O 0 6.756873517588247e-06
mutation O 0 7.018883252385422e-07
. O 0 1.769801194484444e-08

The O 0 6.5868532850288375e-09
missense O 0 1.9137648905598326e-06
mutation O 0 2.5557869776093867e-07
was O 0 7.43203543152049e-07
also O 0 6.561345355926562e-10
found O 0 2.4305035761784666e-10
in O 0 3.193386388655739e-10
2 O 0 1.2992863451799508e-09
. O 0 1.865573917569918e-09

8 O 0 9.52315843960605e-08
% O 0 1.559163770314953e-10
of O 0 4.317563830329857e-13
the O 0 8.042382948839077e-13
general O 0 6.364099243254262e-13
population O 0 1.9094829070784997e-13
, O 0 1.7902052453291906e-12
suggesting O 0 1.0868769217964314e-09
that O 0 1.1720344313126407e-11
it O 0 4.9151464148744495e-11
is O 0 3.082191793457589e-11
not O 0 1.3729117842586902e-09
disease O 0 3.75788244966202e-09
associated O 0 1.4938730252822552e-09
. O 0 2.5425794802913515e-09

The O 0 1.769513424676461e-09
average O 0 2.4413033372638893e-08
age O 0 2.208323524044431e-09
of O 0 6.992253564347406e-12
disease O 0 1.1034779134888595e-07
onset O 0 1.294029630116711e-07
in O 0 7.688112924064683e-10
those O 0 6.856046286252138e-11
families O 0 6.45995062997784e-11
harbouring O 0 3.868455777933377e-08
causative O 0 1.1281545084784739e-06
mutations O 0 4.0583856275588914e-07
was O 0 8.032484544173712e-08
between O 0 2.8901296911243435e-09
32 O 0 4.5691574968032e-08
. O 0 3.4502292134419577e-09

3 O 0 3.976270477323851e-07
and O 0 3.601396514341104e-09
37 O 0 2.097634066444698e-08
. O 0 8.703269771537236e-10

4 O 0 9.3725113003984e-08
years O 0 6.487290704626503e-10
, O 0 2.9923969118578198e-12
whereas O 0 1.9870428219492808e-11
the O 0 3.799462047066049e-12
family O 0 3.449172891745178e-11
harbouring O 0 3.9119791850339425e-09
the O 0 9.979327260378756e-12
missense O 0 1.5349509396855865e-07
mutation O 0 1.2910486013595346e-08
had O 0 5.391898483253499e-09
an O 0 1.4736061329512218e-11
average O 0 1.1668523924868168e-08
age O 0 1.8253355493769163e-09
of O 0 2.0975429726455275e-11
onset O 0 1.725727543089306e-07
of O 0 1.355084933152284e-10
51 O 0 1.3175602475712367e-07
. O 0 6.812125530331059e-09

2 O 0 4.5629914779965475e-07
years O 0 1.683703487742605e-08
. O 0 4.003694709098227e-09

These O 0 6.259124329943688e-10
findings O 0 1.2956213879533607e-09
show O 0 1.534924631840795e-09
that O 0 9.372212728120388e-11
BRCA1 O 0 1.0486244264029665e-06
is O 0 9.968412900684953e-11
implicated O 0 6.701370014461361e-10
in O 0 2.996178999348231e-11
a O 0 8.144408758514743e-12
small O 0 2.2877441260837905e-11
fraction O 0 1.9539265760926128e-09
of O 0 9.520324795175839e-08
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.4225357558572682e-09
suggesting O 0 6.1028218034664405e-09
the O 0 1.0248456597250488e-11
involvement O 0 8.773801130068648e-11
of O 0 1.0253181767158615e-12
another O 0 9.241141185611923e-11
susceptibility O 0 8.92497364901601e-09
gene O 0 2.552990281401435e-07
( O 0 1.2362912471530763e-08
s O 0 4.080431608599611e-06
) O 0 5.99721801108899e-08

Paternal O 0 0.0007027949905022979
transmission O 0 0.004663420375436544
of O 0 5.124167614667385e-07
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 2.4026971914281603e-06

We O 0 1.2930526338550408e-07
report O 0 1.894034484806184e-09
a O 0 1.717210228180388e-11
rare O 0 5.441320727328502e-10
case O 0 5.912091260995567e-09
of O 0 1.7639928406865124e-10
paternally O 0 0.10170046985149384
transmitted O 1 0.9999991655349731
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.08078364282846451
DM B-Disease 1 1.0
) O 0 5.169570371776899e-08
. O 0 8.073198998204134e-09

The O 0 5.062737784555793e-09
proband O 0 7.151894010348769e-07
is O 0 7.203228985508403e-11
a O 0 7.115684430569758e-11
23 O 0 3.6013003690271717e-09
year O 0 6.921984652130675e-10
old O 0 0.0001286009355681017
, O 0 5.2106823744679787e-08
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 3.3515692621222115e-07
who O 0 4.4624616890587276e-08
suffers O 0 0.00028247461887076497
severe O 0 0.009835602715611458
muscular B-Disease 1 0.9898068308830261
weakness I-Disease 1 0.9998114705085754
. O 0 8.385408278854811e-08

He O 0 2.15257841773564e-07
presented O 0 6.687735698562847e-09
with O 0 9.891149232998941e-09
respiratory O 1 0.9925143122673035
and O 0 2.748173244526697e-08
feeding O 0 2.0804131750651322e-08
difficulties O 0 1.3736479331782903e-06
at O 0 7.653062183976544e-09
birth O 0 1.2412837868680526e-08
. O 0 2.708245183669078e-09

His O 0 1.7833681908996368e-07
two O 0 2.088858508386693e-08
sibs O 0 0.03167249634861946
suffer O 0 3.870186264975928e-05
from O 0 9.710166892773486e-09
childhood O 0 6.267731805564836e-05
onset O 1 0.8930350542068481
DM B-Disease 1 1.0
. O 0 3.1019717994240636e-07

Their O 0 3.3894771434006543e-09
late O 0 4.4315200398159504e-07
father O 0 8.453799438257192e-09
had O 0 5.311746043012988e-10
the O 0 2.8192797488918453e-12
adult O 0 9.690434565889916e-11
type O 0 6.75689832974058e-08
of O 0 1.801394811096202e-09
DM B-Disease 1 1.0
, O 0 1.3198152570836896e-09
with O 0 1.0303811276424213e-10
onset O 0 2.8150333264420624e-07
around O 0 4.272769249524799e-09
30 O 0 1.8140383639675406e-09
years O 0 6.661101115135182e-10
. O 0 3.5795555408668633e-10

Only O 0 7.837927640252929e-09
six O 0 1.381824793478259e-10
other O 0 5.4772393218160964e-12
cases O 0 6.3714875389586645e-12
of O 0 2.1340871778074977e-12
paternal O 0 7.058810069793253e-07
transmission O 0 0.0006754877394996583
of O 0 1.1106530450888386e-07
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 1.1541862221520205e-07
been O 0 7.452431560750483e-09
reported O 0 3.570401574393145e-08
recently O 0 3.616024812913565e-08
. O 0 1.264016113999844e-09

We O 0 8.652790484120487e-09
review O 0 3.477897969617061e-10
the O 0 5.076915884222322e-12
sex O 0 3.009020532740436e-10
related O 0 2.3243749980306205e-10
effects O 0 4.005008769070173e-09
on O 0 8.073198998204134e-09
transmission O 0 8.885118586476892e-05
of O 0 5.669859604040539e-08
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 2.5952130044970545e-07

Decreased O 0 8.79971503309207e-06
fertility O 0 1.4727942243553116e-07
of O 0 1.8206814528243243e-11
males O 0 2.42361519742218e-10
with O 0 1.3860369449392174e-11
adult O 0 1.5551549381598306e-07
onset O 1 0.5057860016822815
DM B-Disease 1 1.0
and O 0 4.533807285156399e-08
contraction O 0 3.713947549499608e-08
of O 0 6.178482205021485e-13
the O 0 1.5588559089396714e-12
repeat O 0 2.6324153967749453e-10
upon O 0 4.9081927758209964e-12
male O 0 6.009266001472113e-11
transmission O 0 1.045646125241717e-09
contribute O 0 1.5819260831828608e-11
to O 0 1.505648383748337e-11
the O 0 2.659474376831561e-11
almost O 0 3.1334609906785715e-10
absent O 0 2.948862820595366e-10
occurrence O 0 1.6205099762078845e-10
of O 0 3.903595328924592e-12
paternal O 0 2.286260780692828e-07
transmission O 0 2.636007957335096e-05
of O 0 5.6342518206520253e-08
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 8.317636002175277e-07

Also O 0 8.630144598953393e-09
the O 0 1.791388044847242e-11
fathers O 0 5.0301509485484175e-11
of O 0 1.0430067589771094e-13
the O 0 1.0430157605656465e-11
reported O 0 1.6292830196107388e-06
congenitally O 0 4.2810948798432946e-05
affected O 0 1.6083056664228934e-08
children O 0 5.2271240669199415e-09
showed O 0 1.1153530721230709e-07
, O 0 1.6205712119465865e-11
on O 0 1.320348941291627e-09
average O 0 3.983526752904254e-08
, O 0 9.78465364287473e-11
shorter O 0 1.2267286138012423e-06
CTG O 0 2.9294467367435573e-06
repeat O 0 1.5042074608118128e-07
lengths O 0 2.8961966336282785e-07
and O 0 1.4727415120763254e-10
hence O 0 1.7830643905814014e-10
less O 0 2.3973456553250116e-09
severe O 0 2.733056589931948e-06
clinical O 0 1.6490107555000577e-06
symptoms O 0 1.8732142734734225e-06
than O 0 3.11533125685326e-11
the O 0 1.429167287986255e-11
mothers O 0 3.7386063689304194e-10
of O 0 8.711045665181494e-13
children O 0 7.884344843667179e-10
with O 0 3.1338466044417146e-08
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 1.8337188976147445e-06

We O 0 1.6141077807674264e-08
conclude O 0 7.54093942845202e-09
that O 0 1.1545858019657018e-11
paternal O 0 8.981313470712848e-08
transmission O 0 1.0634778845997062e-05
of O 0 1.6024939597514276e-08
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 4.0883357144139154e-08
rare O 0 7.760751152829926e-09
and O 0 3.6456054841593755e-10
preferentially O 0 1.8144327151858874e-09
occurs O 0 8.536231443923015e-11
with O 0 1.4197992607989374e-11
onset O 0 2.132598950765896e-07
of O 0 5.312535966695009e-10
DM B-Disease 1 1.0
past O 0 1.2055812348421568e-08
30 O 0 6.091572801736334e-10
years O 0 2.5066646675009352e-11
in O 0 6.447981905355338e-12
the O 0 1.070098870625813e-11
father O 0 5.786469636781533e-10
. O 0 1.7606239383072264e-11
. O 0 1.9417212282490937e-10

The O 0 3.001560600068842e-08
RB1 O 0 7.808645023033023e-06
gene O 0 3.3269651567024994e-07
mutation O 0 3.5525495434285403e-08
in O 0 3.2721862996965e-09
a O 0 4.097732819730027e-09
child O 0 6.171934728627093e-06
with O 0 1.243730025635159e-07
ectopic B-Disease 1 0.9999997615814209
intracranial I-Disease 1 0.9999897480010986
retinoblastoma I-Disease 1 0.9952000379562378
. O 0 2.1945875232631806e-06

The O 0 2.074762228687632e-08
RB1 O 0 7.151510544645134e-06
gene O 0 1.5145919007863995e-07
mutation O 0 4.517070806286938e-08
was O 0 1.0954228635284835e-08
investigated O 0 1.8004535640159247e-09
in O 0 7.502655441360417e-11
a O 0 4.764434402559914e-10
child O 0 9.378105687574134e-07
with O 0 5.772913258539347e-09
ectopic B-Disease 1 0.9999938011169434
intracranial I-Disease 0 0.10063450038433075
retinoblastoma I-Disease 0 1.5479903368031955e-06
using O 0 2.413670152634495e-09
DNA O 0 1.1847779646245726e-08
obtained O 0 1.0126827154621765e-09
from O 0 2.930895456887406e-11
both O 0 8.589241297374262e-12
the O 0 2.2060143642366192e-11
pineal B-Disease 0 3.3090617534980993e-07
and I-Disease 0 1.6395910051869578e-06
retinal I-Disease 1 0.999373733997345
tumours I-Disease 1 1.0
of O 0 6.059658885781971e-10
the O 0 1.1894122353695025e-09
patient O 0 4.7002100700410665e-07
. O 0 2.864697368210045e-09

A O 0 3.659941114619869e-07
nonsense O 0 1.1906601685041096e-05
mutation O 0 8.842139465059518e-08
in O 0 9.70834745928073e-10
exon O 0 1.0427989849404184e-07
17 O 0 7.417701564094159e-09
( O 0 3.551326732686988e-10
codon O 0 7.995901718516052e-09
556 O 0 2.680693667045375e-09
) O 0 9.40845925473388e-12
of O 0 5.488551778863593e-13
the O 0 1.9033252404709877e-11
RB1 O 0 5.782382217489612e-08
gene O 0 2.5155375560359516e-09
was O 0 4.9499795373719735e-09
found O 0 5.795612254000382e-11
to O 0 1.4123385620734563e-12
be O 0 9.508874590502536e-12
present O 0 4.846755809195802e-12
homozygously O 0 3.161982320420975e-08
in O 0 2.794207365486301e-10
both O 0 1.1903171504012988e-10
the O 0 1.7149330566734733e-10
retinal B-Disease 0 1.7068994111468783e-06
and I-Disease 0 1.1153164614086108e-08
the I-Disease 0 2.675534460649942e-09
pineal I-Disease 0 0.0004019361804239452
tumours I-Disease 1 1.0
. O 0 3.9297500364909865e-08

The O 0 3.737144482762744e-10
same O 0 2.0055258842521795e-10
mutation O 0 5.332739250185625e-10
was O 0 8.490412817252491e-10
present O 0 5.177068843065236e-12
heterozygously O 0 9.314588211850605e-09
in O 0 5.930483187865931e-11
the O 0 3.696216076265468e-12
DNA O 0 1.1156600643325021e-10
from O 0 7.483353671976223e-13
the O 0 4.0473437860726047e-13
constitutional O 0 1.718257806003487e-12
cells O 0 1.2500942989102093e-11
of O 0 2.3827212989116497e-13
the O 0 7.863401770002998e-12
patient O 0 1.1908178443320594e-08
, O 0 1.0725877651329707e-11
proving O 0 5.541071601555814e-09
it O 0 9.025172102716805e-12
to O 0 3.022604085425873e-12
be O 0 1.4232915193646e-11
of O 0 1.4931159607323163e-12
germline O 0 1.4254507796351845e-08
origin O 0 3.283734173464836e-09
. O 0 1.940407834410962e-09

The O 0 1.1673684241486626e-09
initial O 0 1.7435489718664599e-09
mutation O 0 4.67990091124193e-09
was O 0 3.098421741398738e-09
shown O 0 4.96006846706365e-11
to O 0 6.3891205694111e-12
have O 0 2.0490638352743673e-10
occurred O 0 2.127652720673723e-09
in O 0 3.231261438974009e-11
the O 0 1.3507980324567459e-11
paternally O 0 4.7723883511707754e-08
derived O 0 2.0456763394349764e-08
RB1 O 0 1.1357703442627098e-05
allele O 0 2.902248297687038e-06
. O 0 3.0961430752540764e-08

The O 0 1.9892139047072988e-09
mutation O 0 7.156141901276669e-09
is O 0 2.3049572667188656e-11
in O 0 3.4023502765156977e-11
an O 0 1.1255592811953985e-12
area O 0 3.2421825640893687e-11
of O 0 5.023894711700394e-13
the O 0 1.863966880150114e-12
gene O 0 1.200234217568763e-10
that O 0 8.032173016980781e-13
encodes O 0 1.3809177759616098e-11
the O 0 1.0746227041905088e-12
protein O 0 9.075274420844437e-10
- O 0 3.9877665614085345e-09
binding O 0 5.881832798593223e-10
region O 0 9.803433620447777e-10
known O 0 1.7067823820937633e-09
as O 0 3.942223214536966e-10
the O 0 1.1571806880772417e-11
pocket O 0 1.2236964721523691e-05
region O 0 3.14906571929896e-08
and O 0 7.289525427722765e-08
has O 0 3.316026897515201e-10
been O 0 2.342328275783956e-10
detected O 0 3.037467166677743e-09
in O 0 3.0888892138536406e-11
other O 0 2.9280330330477833e-12
cases O 0 5.676015647076982e-12
of O 0 6.845167878702374e-13
retinoblastoma B-Disease 0 3.3105319374726605e-08
. O 0 7.946848734619039e-10
. O 0 1.8588111050377165e-09

Low O 0 1.9332188458065502e-05
levels O 0 6.963170484652892e-09
of O 0 3.710428232023277e-12
beta O 0 3.1776620224022167e-10
hexosaminidase O 0 6.4456804338419715e-09
A O 0 5.39599087634457e-10
in O 0 3.6169936490360044e-10
healthy O 0 6.600268664946896e-10
individuals O 0 6.46541685207086e-13
with O 0 7.238151918109725e-12
apparent O 0 1.088553744921228e-06
deficiency O 0 0.0018407037714496255
of O 0 6.641987741057287e-12
this O 0 2.4790258387752395e-11
enzyme O 0 1.1127729848681156e-08
. O 0 6.848992484265182e-10

Appreciable O 0 5.642653923132457e-05
beta O 0 2.541422873036936e-06
hexosaminidase O 0 2.2552454538526945e-05
A O 0 2.2528592324988495e-08
( O 0 2.1597161836695022e-09
hex O 0 6.160563259527407e-08
A O 0 8.212068247637205e-10
) O 0 1.6970648844538694e-11
activity O 0 2.2512689490383764e-09
has O 0 1.2052621053970647e-11
been O 0 2.4371681756063523e-11
detected O 0 1.5784081597303157e-08
in O 0 6.061531276913001e-10
cultured O 0 0.0006559187895618379
skin O 1 0.7545248866081238
fibroblasts O 0 3.1776946798345307e-06
and O 0 3.7805307329108473e-07
melanoma B-Disease 0 0.011576075106859207
tissue O 0 4.0233868503491976e-07
from O 0 2.909375518278523e-10
healthy O 0 9.112758325713344e-10
individuals O 0 1.3997821998734672e-12
previously O 0 6.898626114804074e-11
reported O 0 2.951846767018651e-09
as O 0 1.741228411455964e-10
having O 0 3.621912725293441e-08
deficiency B-Disease 0 1.6522724308742909e-06
of I-Disease 0 1.884259675372091e-12
hex I-Disease 0 1.9451816157811663e-08
A I-Disease 0 2.659110709402057e-10
activity O 0 3.085683264458794e-09
indistinguishable O 0 8.03166477769679e-10
from O 0 6.2047732403425204e-12
that O 0 7.385343421886792e-13
of O 0 3.0088437167133386e-13
patients O 0 5.407860270700837e-10
with O 0 5.006096515103309e-08
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 0.8761799335479736
( O 0 1.1710419300925423e-08
TSD B-Disease 0 2.6830695787793957e-05
) O 0 8.15609191295863e-10
. O 0 2.266875576140137e-09

Identification O 0 3.5172246271031327e-07
and O 0 2.4460236058843066e-09
quantitation O 0 2.7427833515503153e-07
of O 0 2.0516047194441e-11
hex O 0 6.221767279157575e-08
A O 0 2.1550745632481494e-09
, O 0 2.1114231890662083e-11
amounting O 0 3.878817544933355e-10
to O 0 4.4899719359170476e-11
3 O 0 8.907283244319331e-10
. O 0 9.56520196382371e-10

5 O 0 3.985092860148143e-07
% O 0 6.93643684712697e-08
- O 0 5.7075808399531525e-06
6 O 0 1.108669422933417e-08
. O 0 2.3764854528707247e-09

9 O 0 1.3093682582621113e-07
% O 0 1.9595985945031202e-10
of O 0 4.102284104860049e-13
total O 0 2.9261348118841957e-12
beta O 0 5.888927123720578e-10
hexosaminidase O 0 4.638491546415935e-08
activity O 0 2.5824579807931514e-08
, O 0 9.72683478900338e-12
has O 0 3.9514034405607745e-12
been O 0 5.2369159356246975e-12
obtained O 0 1.5202703679273455e-11
by O 0 1.3906552125131366e-11
cellulose O 0 1.3348306993066217e-06
acetate O 0 7.90317145060726e-08
gel O 0 1.91475848509981e-07
electrophoresis O 0 3.056653596900105e-08
, O 0 2.0996974992026907e-10
DEAE O 0 6.168547770357691e-07
- O 0 2.7647343969761096e-08
cellulose O 0 3.3414872291359643e-07
ion O 0 4.579764567580469e-09
- O 0 1.4527587133272846e-08
exchange O 0 6.5648912972449125e-09
chromatography O 0 3.486235078398181e-09
, O 0 1.9260915778973597e-11
radial O 0 4.389724139741702e-09
immunodiffusion O 0 4.603737977504352e-07
, O 0 1.1226980456413571e-10
and O 0 3.6642255896168763e-10
radioimmunoassay O 0 5.820740511808253e-07
. O 0 4.0605740991850325e-09

Previous O 0 1.665403033257462e-07
family O 0 4.12953315986897e-09
studies O 0 6.29842900057298e-10
suggested O 0 3.8753567022098423e-10
that O 0 1.3500915880051978e-12
these O 0 3.509505240670979e-13
individuals O 0 5.066649682271274e-13
may O 0 4.927125929476972e-10
be O 0 3.5539928205235993e-12
compound O 0 5.0436585463664585e-11
heterozygotes O 0 4.2005587896909446e-10
for O 0 8.360187542244546e-13
the O 0 4.525728750093272e-12
common O 0 8.432844422756602e-10
mutant O 0 1.880457745073727e-08
TSD B-Disease 0 1.0423320873087505e-06
gene O 0 3.0156193986385915e-08
and O 0 1.0404298533828182e-09
a O 0 5.101119526784714e-10
rare O 0 4.536350317607685e-08
( O 0 4.441671919153123e-09
allelic O 0 5.5368275297951186e-08
) O 0 2.217350331124024e-10
mutant O 0 4.48497132765624e-08
gene O 0 5.402998226600175e-07
. O 0 1.7691364817551403e-08

Thus O 0 1.0085754453825757e-08
, O 0 1.0531835820115631e-10
the O 0 8.387295198641898e-12
postulated O 0 4.355961369384431e-09
rate O 0 5.967411453866589e-09
mutant O 0 1.7412591368781705e-09
gene O 0 2.9095599263229133e-09
appears O 0 1.0759164670304244e-09
to O 0 8.021919066514283e-12
code O 0 3.5725623848126276e-11
for O 0 4.48810910311237e-13
the O 0 8.817074132437541e-13
expression O 0 3.8138252972386155e-11
of O 0 1.6923091617285224e-12
low O 0 1.4055094865739193e-09
amounts O 0 2.5055223520920045e-11
of O 0 3.8747265812544285e-11
hex O 0 2.0526026389688923e-07
A O 0 1.622429302017281e-08
. O 0 6.898158932955312e-09

Heterozygotes O 0 2.0680142824858194e-06
for O 0 2.2724111481409182e-10
the O 0 3.0889776847509154e-11
rare O 0 4.835993827612128e-10
mutant O 0 1.0020353613526822e-07
may O 0 1.3152616418210528e-07
be O 0 1.1683539552498345e-11
indistinguishable O 0 1.71164554751968e-10
from O 0 2.4037076148952785e-11
heterozygotes O 0 1.7021335452227504e-09
for O 0 2.2247702811950543e-12
the O 0 9.370777591388713e-12
common O 0 3.527686365245586e-09
TSD B-Disease 0 2.7151440917805303e-06
mutant O 0 2.299115209325464e-07
. O 0 1.483756051356977e-08

However O 0 8.214202651402047e-09
, O 0 3.103931695003226e-11
direct O 0 1.178248193456355e-10
visualization O 0 3.0397526273873154e-08
and O 0 5.575715444905427e-10
quantitation O 0 1.4260849923175556e-07
of O 0 2.883112325269277e-11
hex O 0 3.26016440510557e-08
A O 0 1.1718809256322515e-10
by O 0 1.5911000815493903e-12
the O 0 3.1242077067755725e-12
methods O 0 1.1818568346200209e-09
described O 0 5.222221322043197e-09
may O 0 1.505790714340094e-09
prevent O 0 1.0704954284124213e-10
false O 0 6.203540348082015e-09
- O 0 2.6467466440749376e-08
positive O 0 3.932507208759262e-09
prenatal O 0 3.6707319850393105e-06
diagnosis O 0 9.506304650130915e-07
of O 0 1.4099545316004214e-11
TSD B-Disease 0 1.1293633406239678e-06
in O 0 1.3016377975461069e-09
fetuses O 0 5.901771515937071e-09
having O 0 1.0607800055018046e-10
the O 0 1.0304553217654888e-11
incomplete O 0 1.0341900669175175e-08
hex B-Disease 0 9.46833097259514e-07
A I-Disease 0 9.444289048587962e-07
deficiency I-Disease 0 0.0007498954655602574
of O 0 3.8824403761350545e-12
the O 0 3.450653651704272e-11
type O 0 7.950477993290406e-06
described O 0 5.623891397021907e-08
in O 0 7.570064575190827e-09
the O 0 4.075485227073017e-10
four O 0 1.616954237171342e-09
healthy O 0 1.1949702560798414e-08
individuals O 0 3.1226440877496486e-10

The O 0 2.2034061686326822e-08
tumor B-Disease 0 1.7945767467608675e-06
suppressor O 0 3.92608262700378e-06
gene O 0 4.93116385769099e-06
Smad4 O 0 0.0003744588466361165
/ O 0 7.575096242362633e-05
Dpc4 O 0 5.760420549449918e-07
is O 0 8.30544313878967e-11
required O 0 4.3092671792033244e-11
for O 0 7.548728135631233e-12
gastrulation O 0 4.4075436633761456e-09
and O 0 7.20896051187303e-11
later O 0 2.0649143506190626e-10
for O 0 3.3560970842672067e-12
anterior O 0 4.667293773685799e-10
development O 0 1.8003007071221155e-11
of O 0 1.3172078445339297e-12
the O 0 6.884534609064019e-11
mouse O 0 3.2231358204626304e-07
embryo O 0 1.3508443430509942e-07
. O 0 1.2331590859560038e-08

Mutations O 0 3.177603502990678e-06
in O 0 5.907684119677015e-09
the O 0 1.3276877375290042e-09
SMAD4 O 0 0.00021747700520791113
/ O 0 2.5230950996046886e-05
DPC4 O 0 1.9755478206207044e-05
tumor B-Disease 0 1.6104472706501838e-06
suppressor O 0 2.407841748208739e-07
gene O 0 5.462508312348291e-08
, O 0 9.341908496773854e-11
a O 0 7.947814628650463e-11
key O 0 2.255622462143947e-07
signal O 0 1.6718555571060278e-06
transducer O 0 5.261104547571449e-07
in O 0 2.100311480290884e-09
most O 0 2.1101682901036867e-10
TGFbeta O 0 4.314629677537596e-06
- O 0 4.010182408364926e-07
related O 0 8.310902188668479e-09
pathways O 0 3.82239129237405e-10
, O 0 1.1715266343831354e-12
are O 0 1.2946061052603736e-13
involved O 0 7.731157836317337e-13
in O 0 7.863191001100667e-12
50 O 0 6.582363126783619e-11
% O 0 1.3229901896227858e-10
of O 0 3.635252654454746e-10
pancreatic B-Disease 0 0.0001325453195022419
cancers I-Disease 0 8.111654460662976e-05
. O 0 1.2351410560995646e-08

Homozygous O 0 9.164382936432958e-05
Smad4 O 0 0.00015016824181657284
mutant O 0 2.8663485863944516e-05
mice O 0 0.350270539522171
die O 0 0.006771319080144167
before O 0 1.0727612576033607e-08
day O 0 4.648709861498901e-09
7 O 0 1.1198306726356577e-09
. O 0 5.870086638992689e-10

5 O 0 2.0117502685934596e-07
of O 0 5.520498502775695e-10
embryogenesis O 0 5.059564500697888e-07
. O 0 1.2409121730172501e-08

Mutant O 0 1.8817230795775686e-07
embryos O 0 6.284621889562914e-08
have O 0 3.803477532926536e-09
reduced O 0 3.9274677954281856e-10
size O 0 7.014273606387178e-10
, O 0 1.921641457069967e-10
fail O 0 5.17665512234089e-07
to O 0 1.1118871795501306e-10
gastrulate O 0 7.356372293543245e-07
or O 0 3.4524391678836253e-10
express O 0 8.543072499422877e-11
a O 0 6.766458920948182e-11
mesodermal O 0 2.5398421144018357e-08
marker O 0 2.3681520744389672e-08
, O 0 8.827583802828443e-11
and O 0 2.2543990979562167e-11
show O 0 5.813742376403752e-09
abnormal O 0 1.398043139033689e-07
visceral O 0 2.8546846664312397e-08
endoderm O 0 8.462820346721855e-07
development O 0 3.6365581657094026e-09
. O 0 5.531821223314637e-09

Growth B-Disease 1 1.0
retardation I-Disease 1 1.0
of O 0 1.137208799351086e-10
the O 0 7.519330991190287e-11
Smad4 O 0 8.043573870963883e-06
- O 0 5.4160449508344755e-05
deficient O 0 7.986003765836358e-06
embryos O 0 4.1823171592625386e-09
results O 0 2.5773929657191275e-09
from O 0 5.032780442393303e-11
reduced O 0 5.036316919060368e-10
cell O 0 8.49317061124566e-09
proliferation O 0 7.917305921978368e-09
rather O 0 1.8415256819448445e-10
than O 0 2.832162282473405e-11
increased O 0 2.4446558666291196e-10
apoptosis O 0 8.544124519005436e-09
. O 0 1.505368496523829e-09

Aggregation O 0 2.2985078373949364e-07
of O 0 1.5343705472847802e-10
mutant O 0 9.032300596345522e-08
Smad4 O 0 8.476067137053178e-07
ES O 0 1.4799128678077977e-07
cells O 0 3.291666716975783e-09
with O 0 1.018400225261118e-10
wild O 0 8.415286245622156e-09
- O 0 4.125401119381422e-06
type O 0 2.9471279958670493e-06
tetraploid O 0 8.827831152302679e-06
morulae O 0 0.00010688418842619285
rescues O 0 6.987278993619839e-06
the O 0 1.6332332153368156e-09
gastrulation B-Disease 0 2.3398847588396166e-06
defect I-Disease 0 6.260303052840754e-06
. O 0 7.678708335845386e-09

These O 0 4.630639427460892e-09
results O 0 6.853425382757905e-09
indicate O 0 1.4200741693670693e-09
that O 0 2.080592642617063e-11
Smad4 O 0 1.4461788211406201e-08
is O 0 6.120508180135209e-12
initially O 0 2.9891238789714336e-11
required O 0 8.592890938727282e-13
for O 0 5.5402121150287253e-14
the O 0 2.7298814792887927e-13
differentiation O 0 1.065695188345872e-11
of O 0 1.4514228035590604e-13
the O 0 1.3587872146891833e-12
visceral O 0 2.94511914855633e-10
endoderm O 0 1.3414798161193175e-08
and O 0 6.426842391604737e-11
that O 0 4.369968362866183e-12
the O 0 7.54341727970953e-12
gastrulation B-Disease 0 1.7545788821848873e-08
defect I-Disease 0 2.3772029678070794e-08
in O 0 6.32363189589924e-11
the O 0 4.955851007348855e-11
epiblast O 0 2.3191567777303135e-07
is O 0 1.292434353983296e-10
secondary O 0 2.6933835162168407e-09
and O 0 1.3474636684218666e-10
non O 0 5.536130842642706e-08
- O 0 6.923693831595301e-07
cell O 0 8.869958037394099e-06
autonomous O 0 1.465782588638831e-07
. O 0 2.9243663490774452e-08

Rescued O 0 1.698281630524434e-05
embryos O 0 3.138872273211746e-07
show O 0 6.757039727744996e-07
severe O 0 0.00023467132996302098
anterior O 0 2.5009338060044684e-05
truncations O 0 2.5948368147510337e-06
, O 0 3.311477758671799e-09
indicating O 0 5.6258222969063354e-08
a O 0 4.2877720818346177e-10
second O 0 6.157985232846386e-10
important O 0 2.506287018200215e-11
role O 0 4.4262163378938624e-11
for O 0 6.218018287762472e-12
Smad4 O 0 1.794345116934437e-08
in O 0 4.847040546707149e-09
anterior O 0 5.203417572374747e-07
patterning O 0 2.0772608877450693e-06
during O 0 1.965432439021697e-08
embryogenesis O 0 8.169899388121848e-07
. O 0 6.41559294578542e-09

Prevalence O 0 7.022687350399792e-05
of O 0 5.914908007831343e-10
p16 O 0 1.094786853172991e-06
and O 0 3.168555195998124e-09
CDK4 O 0 5.777460501121823e-06
germline O 0 1.1127218613182777e-06
mutations O 0 1.4177994955844042e-07
in O 0 1.765599333403145e-09
48 O 0 4.299397744489397e-07
melanoma B-Disease 1 0.9999922513961792
- O 1 0.9991000890731812
prone O 0 0.17584288120269775
families O 0 9.54082679527346e-09
in O 0 9.491203378786395e-09
France O 0 1.3274448974698316e-05
. O 0 1.04714352744395e-08

The O 0 1.3760793393657877e-08
French O 0 5.546812190004857e-06
Familial B-Disease 0 0.03019505925476551
Melanoma I-Disease 1 0.9634956121444702
Study O 0 3.376374024810502e-08
Group O 0 1.65495261938986e-08
. O 0 4.664644226437531e-09

Germline O 0 8.979237463790923e-05
mutations O 0 3.3007834190357244e-06
in O 0 3.740676657315589e-09
the O 0 5.3804901506415703e-11
p16 O 0 3.6399466551984005e-08
and O 0 1.2092371548533265e-10
CDK4 O 0 9.114730659121051e-08
genes O 0 1.5275005704751266e-09
have O 0 8.812174601136036e-11
been O 0 1.339714172932105e-10
reported O 0 4.908207174025847e-10
in O 0 6.27580626355595e-12
a O 0 4.2728763235966305e-12
subset O 0 2.2295897073032478e-10
of O 0 4.1538522621564766e-11
melanoma B-Disease 0 0.00024171028053388
pedigrees O 0 7.384850505331997e-06
, O 0 6.290694354316173e-11
but O 0 9.516535476317145e-11
their O 0 1.7884587907857075e-11
prevalence O 0 1.382150482953648e-08
is O 0 2.1094870641946706e-11
not O 0 5.404166003586397e-11
well O 0 1.3329953807428296e-10
known O 0 8.295741871222617e-10
. O 0 1.4091816602501694e-09

We O 0 8.881976043539908e-09
searched O 0 3.903854572939736e-09
for O 0 1.378390782590111e-12
such O 0 4.924367771191873e-12
germline O 0 6.143994113472218e-08
mutations O 0 1.0552033913313608e-08
in O 0 4.290929833672408e-10
48 O 0 1.1663428445274349e-08
French O 0 0.11688405275344849
melanoma B-Disease 1 1.0
- O 1 0.9999740123748779
prone O 0 0.0004821251495741308
families O 0 2.773615503937066e-10
selected O 0 9.78677729135402e-12
according O 0 7.690525299919315e-12
to O 0 2.6200003538229266e-12
two O 0 9.63565338629735e-12
major O 0 2.2993291992623455e-10
criteria O 0 1.728469922746001e-09
families O 0 4.279270514329081e-12
with O 0 2.0743626000935267e-12
at O 0 5.239231271048084e-09
least O 0 2.1459346799534984e-10
three O 0 3.345694207790295e-11
affected O 0 1.5001712372342269e-10
members O 0 5.4094641092905515e-12
( O 0 8.9374983108792e-12
n O 0 2.5338988685064123e-09
= O 0 2.0977690695644924e-09
20 O 0 3.179323193602812e-10
) O 0 1.1703591221157161e-11
or O 0 5.012607551257986e-10
families O 0 7.680132571574738e-12
with O 0 3.9996185616925084e-13
two O 0 2.4595369144120305e-11
affected O 0 6.250889389436409e-11
members O 0 3.245163252701966e-12
, O 0 7.403851837173292e-12
one O 0 2.8980080054447077e-12
of O 0 8.210203621562134e-14
them O 0 2.3252862309253164e-12
affected O 0 1.354022362981544e-11
before O 0 3.571710982530618e-11
the O 0 4.4847740972298045e-12
age O 0 5.1805386369618844e-11
of O 0 4.375185042276679e-14
50 O 0 3.5327712977206716e-12
( O 0 6.636681655625143e-12
n O 0 3.5870137971016902e-09
= O 0 8.209582347262767e-09
28 O 0 2.7697275584159797e-08
) O 0 5.390258378534796e-11
, O 0 4.950569815198591e-11
and O 0 7.94857374364355e-11
one O 0 8.946230908857267e-12
additional O 0 1.9375879373173532e-11
minor O 0 3.786893021384685e-09
criterion O 0 1.970811780438453e-08
. O 0 4.1402121730982344e-09

Sixteen O 0 1.5661942143196939e-07
different O 0 3.649642810188425e-09
p16 O 0 4.676124660818459e-07
germline O 0 4.283076862066082e-07
mutations O 0 4.22493329210738e-08
were O 0 9.196273187406234e-10
found O 0 1.2482079259079626e-10
in O 0 3.274642709771847e-11
21 O 0 1.188561193909976e-10
families O 0 2.5871362344109805e-12
, O 0 9.894337953120225e-13
while O 0 1.7422939826983175e-11
one O 0 6.083628045772116e-11
germline O 0 1.337283066504824e-07
mutation O 0 2.3555923434059878e-08
, O 0 1.856096387697903e-10
Arg24His O 0 1.042031527731524e-07
, O 0 2.027054357700564e-10
was O 0 1.2007346228415372e-08
detected O 0 4.190224345279603e-08
in O 0 5.504432465386344e-10
the O 0 1.7174796307362072e-10
CDK4 O 0 4.781728080160974e-07
gene O 0 4.196959224600505e-08
. O 0 2.20776352755081e-09

The O 0 1.3918347585573088e-09
frequency O 0 8.9300993266761e-09
of O 0 1.4353959860990972e-11
p16 O 0 3.233449064055094e-08
gene O 0 1.7701658805435727e-08
mutation O 0 3.073242771378659e-09
in O 0 1.2667283888490033e-10
our O 0 3.2717585585206876e-11
sample O 0 2.896406899044468e-11
( O 0 3.961169586785829e-11
44 O 0 4.3519979286976707e-10
% O 0 1.8477309959852306e-11
) O 0 3.108586738714836e-12
is O 0 2.9699140282474223e-12
among O 0 3.3538447626740853e-12
the O 0 6.270828474541634e-12
highest O 0 1.0846822995347338e-08
rates O 0 1.0685706683943863e-06
yet O 0 5.169584760267298e-10
reported O 0 3.0531908112862993e-09
and O 0 1.3128492216962773e-11
the O 0 4.1590424680604254e-12
CDK4 O 0 1.1538175925807082e-07
mutation O 0 1.2868923982001235e-10
is O 0 8.306056363538428e-12
the O 0 3.359965951299504e-12
second O 0 1.0716931786447503e-09
mutation O 0 1.0454028753770217e-09
detected O 0 3.585155283758468e-08
in O 0 4.536163944468541e-10
this O 0 1.704646493405626e-11
gene O 0 2.3796424830635488e-09
worldwide O 0 2.865320425371465e-09
. O 0 5.151466364594626e-09

In O 0 8.062399814434684e-08
summary O 0 4.362890422271448e-07
, O 0 5.4056301102001214e-11
our O 0 1.702716093121559e-11
results O 0 5.875012282219316e-11
show O 0 6.500888022342721e-11
frequent O 0 1.0666494770772417e-10
involvement O 0 1.6613428688305731e-10
of O 0 3.309336854030731e-13
the O 0 4.3961440390760664e-12
p16 O 0 4.447775481253302e-09
gene O 0 5.281179493721311e-09
in O 0 2.145407851372738e-09
familial B-Disease 0 7.442339847330004e-05
melanoma I-Disease 0 0.3126983940601349
and O 0 1.9925936456388627e-09
confirm O 0 9.258545929924367e-09
the O 0 7.534387176655333e-12
role O 0 5.820438228609781e-11
of O 0 7.436669010631169e-13
the O 0 1.0646753444143453e-11
CDK4 O 0 4.067242542760141e-08
gene O 0 2.14058881731205e-09
as O 0 3.01619146325649e-10
a O 0 5.848677098185817e-09
melanoma B-Disease 1 0.5821898579597473
- O 0 3.2880275284696836e-06
predisposing O 0 6.381460480042733e-07
gene O 0 2.3347664068751328e-07
. O 0 1.5127109564971875e-09
. O 0 1.6200659702647613e-09

Progression O 0 4.160755906923441e-06
of O 0 6.410880160068189e-10
somatic O 0 6.366507250277209e-07
CTG O 0 7.5945745265926234e-06
repeat O 0 2.0254105947969947e-07
length O 0 7.480086772204686e-09
heterogeneity O 0 9.714724136244968e-09
in O 0 3.277050020233929e-10
the O 0 2.0801244407508968e-11
blood O 0 2.865998105505696e-09
cells O 0 3.805663340017418e-08
of O 0 4.0027710035417385e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 0.023937176913022995
. O 0 3.010860538665838e-08

The O 0 2.9139641810616013e-09
genetic O 0 3.2329555921251085e-08
basis O 0 7.797042123058873e-09
of O 0 3.914307988850396e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.7397114038467407
DM B-Disease 1 1.0
) O 0 1.725380394113074e-09
is O 0 6.643761495811473e-12
the O 0 3.780693477468261e-13
expansion O 0 2.7699979462947333e-11
of O 0 2.0326739423592866e-12
an O 0 3.624097896781642e-11
unstable O 0 6.06468756814138e-06
CTG O 0 2.392856970345747e-07
repeat O 0 1.333362931177362e-08
in O 0 1.7325751944241574e-10
the O 0 1.2132262208752742e-11
34 O 0 1.3189135894542403e-10
UTR O 0 6.909430805279726e-09
of O 0 5.273209386508215e-12
the O 0 8.099445558684693e-10
DM B-Disease 1 1.0
protein O 0 9.249670540611987e-08
kinase O 0 3.5110883800371084e-07
gene O 0 9.479591511762919e-08
on O 0 2.243361585385628e-08
chromosome O 0 2.1682833903469145e-05
19 O 0 1.144133392472213e-07
. O 0 6.424667020610286e-09

One O 0 6.812229447206164e-09
of O 0 4.084788930713845e-12
the O 0 5.31749817789251e-12
principal O 0 1.8530781076275815e-11
features O 0 3.917993707247547e-11
of O 0 3.282921243880077e-12
the O 0 5.0425697395439784e-08
DM B-Disease 1 1.0
mutation O 0 3.5849364365958536e-08
is O 0 9.505687209587776e-11
an O 0 1.103410592062648e-11
extraordinarily O 0 2.087461012934e-07
high O 0 2.790098641014538e-08
level O 0 1.2547586303313096e-09
of O 0 1.475700963336768e-12
somatic O 0 3.6810747783277975e-09
mosaicism O 0 1.2660176196277462e-07
, O 0 3.370069848185331e-11
due O 0 5.472563721631296e-11
to O 0 1.103145439579345e-11
an O 0 1.8026887274591452e-11
extremely O 0 4.333812455570296e-07
high O 0 6.94767834374943e-08
degree O 0 1.6298116634061444e-07
of O 0 5.4675351052191346e-11
somatic O 0 1.1632530316774137e-07
instability O 0 3.9520291039707445e-08
both O 0 1.1880647854400905e-10
within O 0 3.4080592514751373e-11
and O 0 8.303922133245933e-11
between O 0 4.031845690644076e-11
different O 0 2.1836732422286786e-10
tissues O 0 6.851895939519181e-09
. O 0 2.692541078985755e-09

This O 0 6.331797308689602e-09
instability O 0 2.0785966725611615e-08
appears O 0 2.43914244357768e-09
to O 0 2.2840816044089607e-11
be O 0 7.259041891888307e-12
biased O 0 1.0952801998698192e-09
towards O 0 2.5524148766775667e-12
further O 0 5.391849293434614e-12
expansion O 0 1.9474470647207198e-11
and O 0 1.4422616746723183e-12
continuous O 0 4.564479436780511e-12
throughout O 0 1.422610293455584e-11
the O 0 2.5290954226708795e-12
life O 0 3.0098326175148626e-12
of O 0 2.227298376387011e-14
an O 0 7.708154318823712e-14
individual O 0 1.9553690535235174e-13
, O 0 5.980434246780075e-13
features O 0 1.6913775935378794e-11
that O 0 2.341082050438814e-10
could O 0 5.3028433200097425e-08
be O 0 6.152475751086683e-11
associated O 0 7.529808027095797e-11
with O 0 6.395314833262944e-12
the O 0 3.8014934949925916e-11
progressive O 0 1.3643200458268723e-10
nature O 0 7.486459369099308e-11
of O 0 1.0193635865962669e-11
the O 0 1.0300673647378744e-09
disease O 0 4.7074323106244265e-07
. O 0 3.448051844046063e-09

Although O 0 8.10526046279847e-09
increasing O 0 1.0004761463733303e-09
measured O 0 3.4841545204500335e-09
allele O 0 1.3204252802268002e-08
size O 0 2.3815946992300496e-09
between O 0 1.721100928442354e-09
patients O 0 4.329945113568101e-08
clearly O 0 2.1076673739628404e-09
correlates O 0 1.2131089188738287e-10
with O 0 1.2998421783372294e-12
an O 0 1.2982390770049923e-12
increased O 0 7.851868599750844e-10
severity O 0 6.691809062431275e-08
of O 0 2.3786144928705788e-11
symptoms O 0 1.781364034059152e-07
and O 0 4.1261990352259303e-11
an O 0 1.6756011725696518e-12
earlier O 0 1.4834220962711697e-08
age O 0 1.2355362288829497e-09
of O 0 1.4674348975535212e-12
onset O 0 1.700452667563468e-09
, O 0 1.4740496150078553e-12
this O 0 1.541894108052222e-12
correlation O 0 6.45867248572074e-10
is O 0 2.2465097490598218e-11
not O 0 6.157054727173872e-11
precise O 0 2.8328473788974406e-08
and O 0 6.3962235508086e-10
measured O 0 4.393024166660098e-09
allele O 0 3.4988718589090695e-09
length O 0 5.687563198186751e-10
cannot O 0 1.3498052675586791e-09
be O 0 5.202419224581423e-12
used O 0 2.0540168524374458e-11
as O 0 1.6844751288269677e-11
an O 0 1.1435067302778545e-12
accurate O 0 2.2644393027348997e-08
predictor O 0 8.68921290475555e-08
of O 0 4.0057838990303907e-11
age O 0 6.59096288657679e-09
of O 0 2.304473799286111e-11
onset O 0 3.1089939511730336e-07
. O 0 3.5066889392254552e-09

In O 0 6.767601590240702e-09
order O 0 7.565105486495582e-11
to O 0 8.933236962660462e-12
further O 0 1.220949643471192e-11
characterize O 0 1.5887673399106461e-09
the O 0 4.4650946134927594e-11
dynamics O 0 8.271761942069134e-09
of O 0 5.472002850837043e-10
DM B-Disease 1 1.0
CTG O 0 2.308672628714703e-05
repeat O 0 3.155132617393974e-07
somatic O 0 1.6648772316329996e-07
instability O 0 1.6400039726249815e-07
, O 0 6.050393519529962e-11
we O 0 3.805178741544957e-11
have O 0 6.334565684495974e-12
studied O 0 1.1941562183537258e-09
repeat O 0 1.0474906497748293e-09
length O 0 2.9326191475220753e-10
changes O 0 8.419259733827289e-11
over O 0 1.0145337694944523e-11
time O 0 1.2321303699547315e-10
in O 0 8.336744627968073e-10
111 O 0 3.725232318174676e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 1.3477780157700181e-05
with O 0 3.7551847048566955e-11
varying O 0 1.5646550721726271e-09
clinical O 0 6.819810778324609e-07
severity O 0 2.2594447273149854e-06
and O 0 5.5332352033587995e-09
CTG O 0 1.7383055137543124e-06
repeat O 0 9.028735803440213e-08
size O 0 1.8064870710432501e-09
over O 0 7.054897638303359e-11
time O 0 2.222278749908213e-10
intervals O 0 3.724542063654468e-10
of O 0 9.063291024798137e-13
1 O 0 3.088007072271637e-10
- O 0 2.2012476108557166e-07
7 O 0 5.687468274118146e-09
years O 0 3.928711522771522e-10
. O 0 3.1475794193269735e-10

We O 0 4.539948861292942e-09
have O 0 1.8255079739515345e-11
found O 0 1.945838238801012e-12
a O 0 8.840650108678239e-13
direct O 0 6.157735432665845e-11
progression O 0 5.3041757652749766e-09
of O 0 8.400355064330789e-13
the O 0 3.482368690285731e-12
size O 0 5.581439754820394e-10
heterogeneity O 0 1.3770736773111025e-09
over O 0 1.559199436229619e-10
time O 0 1.3201316428901322e-10
related O 0 6.45492548301263e-11
to O 0 7.601754295483154e-12
initial O 0 2.722730374493665e-10
CTG O 0 8.707993970347161e-08
repeat O 0 6.436122301778369e-09
size O 0 1.918079473028911e-09
and O 0 2.2615925798774583e-10
the O 0 1.3315106829614454e-11
time O 0 3.133239778740915e-10
interval O 0 2.011747712860057e-10
and O 0 1.2114665173812433e-11
always O 0 8.112428090401025e-11
biased O 0 1.4445654672456953e-09
towards O 0 9.706411889520705e-12
further O 0 2.8081400052504257e-11
expansion O 0 8.811186780199876e-10
. O 0 7.566726134555779e-10

Attempts O 0 5.783937595538191e-08
to O 0 1.022708362441449e-09
mathematically O 0 4.168875378240955e-08
model O 0 3.6861544927546674e-09
the O 0 6.507934469102139e-11
dynamics O 0 1.3423833600256785e-08
have O 0 9.877534346003358e-10
proved O 0 7.239477639586767e-08
only O 0 1.1474529659771804e-11
partially O 0 6.045943745647264e-10
successful O 0 3.799653924829727e-10
suggesting O 0 9.122914645942615e-10
that O 0 1.953774598703606e-12
individual O 0 1.9622586162285766e-13
specific O 0 2.363526475229749e-12
genetic O 0 7.392066958544774e-09
and O 0 1.054865261806981e-08
/ O 0 7.11116172169568e-07
or O 0 5.924641333088232e-10
environmental O 0 1.0915549714107797e-10
factors O 0 2.1548103579238642e-10
also O 0 1.7406438790334988e-10
play O 0 1.4443808371567002e-09
a O 0 6.798035745436692e-11
role O 0 4.0494196884566236e-10
in O 0 5.028666927309189e-10
somatic O 0 4.365978512055335e-08
mosaicism O 0 2.042590267592459e-06
. O 0 1.961712570164309e-09
. O 0 3.382656821315777e-09

Aspartylglucosaminuria B-Disease 1 0.9999998807907104
among O 0 3.5077807325478716e-08
Palestinian O 0 4.039542602640722e-07
Arabs O 0 3.0044876098145323e-07
. O 0 6.291696053040141e-09

Aspartylglucosaminuria B-Disease 1 1.0
( O 0 0.22041910886764526
AGU B-Disease 1 1.0
) O 0 2.6918736129033505e-09
is O 0 2.588509788459259e-11
a O 0 2.6735931177301886e-11
rare O 0 5.380169554314307e-08
disorder B-Disease 0 0.00024050821957644075
of I-Disease 0 1.4201920021938985e-11
glycoprotein I-Disease 0 1.5657088852094603e-06
metabolism I-Disease 0 4.0668819565325975e-05
caused O 0 8.547885177456749e-10
by O 0 1.2009160159365262e-11
the O 0 3.032899709154435e-09
deficiency B-Disease 0 8.179154974641278e-05
of I-Disease 0 3.1014917196980907e-12
the I-Disease 0 7.858637351976228e-11
lysosomal I-Disease 0 2.9733773772022687e-06
enzyme I-Disease 0 9.934259423971525e-07
aspartylglucosaminidase I-Disease 0 1.7463609083279152e-06
( O 0 1.6915696621211396e-09
AGA O 0 7.64318883739179e-07
) O 0 1.7228285464909732e-09
. O 0 5.285351267758642e-09

AGU B-Disease 1 1.0
is O 0 1.060528518337378e-07
inherited O 0 2.61593686445849e-06
as O 0 2.9241251642275756e-09
an O 0 6.338729541255361e-10
autosomal O 1 0.9163333177566528
recessive O 1 0.9998365640640259
trait O 0 0.0003867867053486407
and O 0 8.151432950853632e-08
occurs O 0 6.924995576973458e-10
with O 0 8.446470085854418e-12
a O 0 1.2849896702249453e-09
high O 0 2.9530870051530655e-06
frequency O 0 2.1811522401549155e-06
in O 0 3.892673248628853e-06
Finland O 0 7.078116141201463e-06
because O 0 3.70077024580695e-10
of O 0 1.0866057402816875e-12
a O 0 6.094591498140289e-11
founder O 0 6.942363572903787e-09
effect O 0 1.0724953369845025e-08
. O 0 2.9155651226631107e-09

While O 0 1.1078750361548373e-07
very O 0 1.2471097932120756e-08
few O 0 1.8070038798612131e-09
patients O 0 2.3835762252844006e-09
with O 0 1.3838398482679537e-10
AGU B-Disease 1 1.0
have O 0 1.1365459684498092e-09
been O 0 1.1047020936905128e-10
reported O 0 9.232565267858206e-10
from O 0 4.6643522377820545e-12
non O 0 1.9516619431669824e-09
- O 0 4.7569272965120035e-09
Finnish O 0 1.4046198648642871e-09
origin O 0 1.1027105617511523e-10
, O 0 1.4219680988247774e-10
we O 0 1.0307400266640343e-08
diagnosed O 0 1.0251950470774318e-06
the O 0 8.612244251082757e-11
disorder O 0 3.3500546692266653e-07
in O 0 1.0250807147560437e-10
8 O 0 3.378786139762724e-10
patients O 0 3.624728850404324e-10
originating O 0 9.59227808294827e-10
from O 0 2.6474508696416876e-10
3 O 0 1.5491680160906185e-10
unrelated O 0 2.621594052953924e-09
families O 0 1.0380902387696622e-10
, O 0 4.407847784687613e-12
all O 0 2.4154348226418376e-12
Palestinian O 0 3.813392712714858e-09
Arabs O 0 2.901303197688776e-09
from O 0 4.0014005997512925e-11
the O 0 4.245920455503427e-12
region O 0 3.4060335107888307e-10
of O 0 2.0787045695858097e-11
Jerusalem O 0 8.21515982352139e-07
. O 0 2.7782340872306577e-09

The O 0 9.696378810986062e-09
clinical O 0 1.1167297770953155e-06
diagnosis O 0 0.10888645052909851
of O 0 5.7406315256969265e-09
AGU B-Disease 1 1.0
is O 0 2.7418576298288144e-09
often O 0 1.5108310158495897e-09
difficult O 0 6.681388953211354e-08
, O 0 9.565647753062567e-12
in O 0 1.0592206799164838e-11
particular O 0 6.318302825381039e-11
early O 0 2.480702221419051e-07
in O 0 3.954543636996988e-10
the O 0 1.4355383201603011e-11
course O 0 1.0723235632781325e-08
of O 0 5.382527106315149e-13
the O 0 6.126409102247266e-11
disease O 0 1.3305293578014243e-07
, O 0 4.584584448186213e-11
and O 0 4.1150697432934535e-11
most O 0 4.8576949754353116e-12
of O 0 1.3758789843120595e-13
the O 0 2.2074578276409795e-11
patients O 0 1.9151549235374432e-09
are O 0 4.0032885340046676e-10
diagnosed O 0 7.505442454203148e-07
after O 0 3.4827440931195497e-10
the O 0 4.291820371316035e-11
age O 0 2.081984140644977e-09
of O 0 1.2761800080238195e-12
5 O 0 1.202436206160229e-10
years O 0 4.2244052700368684e-10
. O 0 7.490419395850267e-10

However O 0 2.6404942232716166e-08
, O 0 1.4330359121572656e-10
since O 0 4.5004836662920766e-11
these O 0 2.4398833647909512e-12
patients O 0 5.329970145795393e-11
excrete O 0 1.1323129933682452e-10
early O 0 1.3907512641520015e-10
large O 0 1.295871613141153e-12
amounts O 0 1.9708049428524e-11
of O 0 3.083783879295754e-12
aspartylglucosamine O 0 4.472030212809841e-08
in O 0 4.2561087987280644e-10
urine O 0 6.307637190339221e-10
, O 0 2.9173965760548315e-12
biochemical O 0 6.934908758360336e-10
screening O 0 4.475201986764432e-09
is O 0 9.48402814615612e-11
easy O 0 3.893057876069861e-09
by O 0 5.937919600462749e-11
urine O 0 5.480089715348413e-09
chromatography O 0 9.34747923508894e-09
. O 0 1.8885143449054453e-10
. O 0 1.1666226873430219e-09

Detection O 0 4.600200895765738e-07
of O 0 1.671319471707733e-10
heterozygous O 0 2.7367596189264987e-08
carriers O 0 9.990579030727531e-09
of O 0 8.029424347633096e-11
the O 0 3.0477150403385167e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.3159403522422508e-07
ATM O 0 5.109518497192767e-07
) O 0 3.3437801139069023e-11
gene O 0 6.281440922961679e-10
by O 0 7.784730499116321e-11
G2 O 0 4.344905391917564e-06
phase O 0 2.5106446699396656e-08
chromosomal O 0 4.842233011004282e-06
radiosensitivity O 0 1.0126022971235216e-06
of O 0 2.3332719090163323e-10
peripheral O 0 1.4647383068222553e-05
blood O 0 1.470038341722102e-06
lymphocytes O 0 8.225953934015706e-06
. O 0 5.859734386604032e-08

In O 0 0.0003797386307269335
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.053606513887643814
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.1772671726362205e-09
patients O 0 1.6452872841909993e-08
, O 0 1.1814904957163641e-11
mutations O 0 4.4841630408853916e-10
in O 0 1.6084422682638433e-10
a O 0 4.680155221703508e-11
single O 0 1.5518918095036582e-10
gene O 0 1.2805171367702428e-09
, O 0 3.2692883122908967e-11
ATM O 0 2.9748409957619515e-08
, O 0 7.2779525461808e-12
result O 0 8.941253987204689e-11
in O 0 7.934342960425056e-09
an O 0 7.952350642881356e-06
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 5.595953567194556e-08
embraces O 0 7.600547746733355e-09
a O 0 1.2983865371740677e-10
variety O 0 3.377471913257324e-10
of O 0 9.75485317522562e-12
clinical O 0 4.667866093654993e-09
features O 0 7.802309021087694e-09
and O 0 5.327454921655317e-09
manifests O 0 5.066469199732637e-08
extreme O 0 9.350423368914562e-08
radiosensitivity O 0 8.509148756274953e-05
and O 0 1.4131867898115047e-09
a O 0 5.216404530550278e-10
strong O 0 3.857219965652803e-08
pre O 0 0.00015510316006839275
- O 0 2.365066211496014e-05
disposition O 0 3.070614127409499e-07
to O 0 9.664118394425714e-10
malignancy B-Disease 0 1.8881544292526087e-06
. O 0 2.7202244901047834e-09

Heterozygotes O 0 3.6281815027905395e-06
for O 0 3.315242802504059e-10
the O 0 3.409463683601288e-11
ATM O 0 3.2892959467289984e-08
gene O 0 1.5130140473829101e-09
have O 0 5.775704914334767e-11
no O 0 4.100543862795014e-11
clinical O 0 2.5720536811491e-10
expression O 0 1.4714049423325548e-10
of O 0 5.7251751950371244e-11
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 2.5578942768333945e-06
may O 0 6.212399625837861e-07
be O 0 1.7355660242301951e-09
cancer B-Disease 0 2.3023684292411417e-08
prone O 0 4.047120860661835e-09
with O 0 5.3500021253427565e-12
a O 0 7.819676017817301e-10
moderate O 0 1.7225917190444306e-06
increase O 0 5.594349872239945e-09
in O 0 4.187473479078108e-09
in O 0 3.2028613095036462e-09
vitro O 0 2.938137981800537e-07
radiosensitivity O 0 1.3439969279716024e-06
. O 0 9.42386435553999e-09

We O 0 5.839762096115919e-08
performed O 0 3.898764866505644e-09
a O 0 2.922579123154634e-10
blind O 0 5.838381511580337e-08
chromosomal O 0 2.871992137443158e-06
analysis O 0 1.1307516700753695e-08
on O 0 2.1035196695606828e-08
G2 O 0 4.335176708991639e-05
- O 0 1.3848293178853055e-07
phase O 0 9.582151072606848e-09
lymphocytes O 0 9.895187780273318e-09
from O 0 2.581076463670229e-10
7 O 0 6.819727005336063e-10
unrelated O 0 2.8853394340444538e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 0.0005187270580790937
, O 0 8.365667880649852e-11
13 O 0 1.3645334862033565e-10
obligate O 0 8.217811142685605e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
heterozygotes O 0 7.85849078965839e-06
( O 0 1.4748161025757156e-10
parents O 0 4.67060452813417e-11
of O 0 1.4082008129023826e-13
the O 0 2.7592604850273927e-12
patients O 0 3.5792074859486434e-10
) O 0 1.589474211971531e-12
, O 0 1.6152757950638197e-11
and O 0 6.172060640352584e-10
14 O 0 3.6148559146020887e-10
normal O 0 3.5580338675345047e-09
controls O 0 1.8645899046987324e-07
following O 0 2.1883346523754454e-10
X O 0 1.4416875160350173e-07
- O 0 3.263908476824895e-09
irradiation O 0 1.6601336971788783e-09
with O 0 1.4118706204158116e-11
1 O 0 1.3256121200733162e-10
Gy O 0 1.7397162821453094e-08
in O 0 1.0785328359574908e-11
order O 0 3.4918463519967302e-12
to O 0 7.018009762736754e-13
evaluate O 0 2.1487063864289446e-11
this O 0 1.24474996282542e-12
cytogenetic O 0 3.070793619386336e-09
method O 0 1.5000052588920454e-10
as O 0 3.164004475086912e-11
a O 0 1.9954782617959133e-11
tool O 0 1.0004341799429994e-09
for O 0 1.6460215352190333e-12
detection O 0 4.3536585447867537e-10
of O 0 1.015279006699732e-11
ATM O 0 1.4679692412755685e-06
carriers O 0 1.6124116086757567e-07
. O 0 5.978770367676134e-09

Both O 0 2.934284850653057e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
homozygotes O 0 4.7902140067890286e-05
and O 0 2.237411089733854e-10
heterozygotes O 0 3.5345443905043794e-08
showed O 0 1.2175863872698756e-08
significantly O 0 6.276937858373799e-10
increased O 0 6.033176735975587e-11
levels O 0 5.1740015050150134e-11
of O 0 8.181880737159752e-13
radiation O 0 2.187815795196002e-07
- O 0 1.4697351616632659e-05
induced O 0 2.0014759627429157e-07
chromatid O 0 1.031674946716521e-05
damage O 0 1.8124586276258015e-08
relative O 0 4.665825503735732e-10
to O 0 8.283195310210267e-12
that O 0 5.711701944743908e-12
of O 0 1.7231282590027264e-12
normal O 0 1.2739743482370613e-08
controls O 0 5.660216629621573e-06
. O 0 1.6352039722278278e-08

These O 0 1.6952936832126397e-09
results O 0 1.0583048881684931e-09
show O 0 3.888172839250359e-10
that O 0 6.766506625843771e-12
the O 0 3.302857640163914e-11
G2 O 0 8.221649636652728e-07
- O 0 3.1526599997278026e-08
phase O 0 8.637488946305893e-09
chromosomal O 0 1.7331375374851632e-06
radiosensitivity O 0 1.8576217541976803e-07
assay O 0 2.4314608992881404e-08
can O 0 3.1811532574810286e-11
be O 0 1.0273737156146767e-12
used O 0 3.6319363315440167e-12
for O 0 4.637188528132385e-13
the O 0 1.4491718372186546e-12
detection O 0 5.219867871275596e-10
of O 0 6.012051967374532e-11
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
heterozygotes O 0 3.892854874720797e-05
. O 0 1.359578050141863e-08

In O 0 1.1841025049363907e-08
combination O 0 1.0997479371610552e-08
with O 0 3.250064453674817e-11
molecular O 0 1.2592612508299794e-09
genetic O 0 1.094328627715413e-08
analyses O 0 1.6313599360273656e-08
, O 0 1.6131297686516888e-11
this O 0 5.347196643801233e-12
test O 0 9.613088991500263e-09
may O 0 2.413637956166781e-09
be O 0 2.2470829450643715e-12
of O 0 4.8347112581838617e-14
value O 0 4.070602362127307e-12
in O 0 7.466333974692763e-12
studies O 0 6.003812724753033e-11
of O 0 1.100988224200794e-12
familial B-Disease 0 1.9344186696912402e-08
and I-Disease 0 1.6980608030792155e-09
sporadic I-Disease 0 2.231094185844995e-05
cancers I-Disease 0 4.154001362621784e-05
aimed O 0 2.3130731108267355e-08
at O 0 2.1501311842087034e-09
determination O 0 2.6282212517436676e-10
of O 0 3.116278936288186e-13
the O 0 3.9659586920960666e-13
potential O 0 8.177641723505769e-12
involvement O 0 1.6169655892017687e-10
of O 0 4.754462015060801e-12
ATM O 0 1.1628841320998617e-06
mutations O 0 2.310171964836627e-08
in O 0 2.2146211531293147e-09
tumor B-Disease 0 6.356284529829281e-07
risk O 0 2.437376522834711e-08
or O 0 9.740583895023747e-10
development O 0 5.744407172159072e-10
. O 0 4.925528318544536e-10
. O 0 9.329091943399703e-10

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 1.874048471961487e-08
identification O 0 2.894360973115795e-09
and O 0 3.3645849994989874e-11
detection O 0 2.695335066249527e-10
of O 0 1.0960058815373541e-12
founder O 0 1.7446999400760888e-09
- O 0 6.878269687149441e-07
effect O 0 5.415377479778272e-09
mutations O 0 3.0279174723091273e-09
in O 0 6.424954318573484e-11
the O 0 6.9995389692656396e-12
ATM O 0 2.4101385776020834e-08
gene O 0 3.0430749031751247e-09
in O 0 2.2623174167346605e-10
ethnic O 0 1.9628455805165146e-10
populations O 0 6.583348977073911e-09
. O 0 9.015395541212001e-09

To O 0 1.459270260184553e-09
facilitate O 0 1.6195716989741982e-09
the O 0 6.46829742545485e-11
evaluation O 0 1.7013990216696584e-10
of O 0 1.777856724685667e-12
ATM O 0 5.4627584233912785e-08
heterozygotes O 0 8.063087975074268e-09
for O 0 4.57472037682094e-12
susceptibility O 0 6.679140573950804e-10
to O 0 3.940326537277272e-11
other O 0 1.2703776919309462e-09
diseases O 0 3.3166106732096523e-06
, O 0 2.4346301884248245e-12
such O 0 2.5229106997981532e-11
as O 0 1.5391640772577375e-05
breast B-Disease 0 0.004671434871852398
cancer I-Disease 0 3.1824165489524603e-06
, O 0 1.84468954000927e-10
we O 0 1.8433249371341276e-10
have O 0 7.878744531786275e-12
attempted O 0 1.1758842510811718e-10
to O 0 2.736378398177086e-12
define O 0 4.0583557348039534e-11
the O 0 3.757919756625094e-12
most O 0 3.8038287797359516e-11
common O 0 3.522917235709855e-10
mutations O 0 1.1431116053728374e-09
and O 0 3.729537859098464e-11
their O 0 1.4655840777089146e-11
frequencies O 0 3.9681324892626435e-08
in O 0 7.295836439880077e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.003709648735821247
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.1750507233898588e-09
homozygotes O 0 4.150034271788172e-07
from O 0 2.5113891521932885e-10
10 O 0 4.926634447621758e-11
ethnic O 0 8.721478400586236e-11
populations O 0 6.791727735766528e-10
. O 0 2.4047923652403824e-09

Both O 0 2.4092638994943627e-09
genomic O 0 4.663178643227184e-08
mutations O 0 2.6530441843419794e-08
and O 0 1.3885355365506058e-10
their O 0 1.7621355763441926e-11
effects O 0 6.529995988380222e-10
on O 0 3.076801313728339e-10
cDNA O 0 6.0509424137933365e-09
were O 0 5.966466876117238e-09
characterized O 0 7.765652121349831e-09
. O 0 1.471388899609849e-09

Protein O 0 2.434246425764286e-06
- O 0 1.09247662294365e-06
truncation O 0 5.985721429624391e-08
testing O 0 7.401787627259182e-09
of O 0 1.12902959550909e-12
the O 0 1.3779176367620383e-12
entire O 0 1.3457319460175032e-11
ATM O 0 9.553756008529035e-09
cDNA O 0 2.921811459444257e-09
detected O 0 1.4599928022107633e-07
92 O 0 2.401310084110264e-08
( O 0 3.0889671376321814e-10
66 O 0 5.551227033606665e-09
% O 0 8.667912915205633e-11
) O 0 4.221181390540174e-11
truncating O 0 2.251394626284764e-08
mutations O 0 2.120466824351297e-08
in O 0 6.365189486601253e-10
140 O 0 1.8294065151636119e-09
mutant O 0 1.4470113285369735e-07
alleles O 0 4.3311848685334553e-07
screened O 0 3.176867494403268e-06
. O 0 6.186846235323173e-08

The O 0 1.959779005744622e-09
haplotyping O 0 1.3670467069459846e-07
of O 0 1.3935227971551e-11
patients O 0 1.3084358041481892e-09
with O 0 5.1822456915984194e-12
identical O 0 3.633038048178605e-08
mutations O 0 1.4218372257346346e-07
indicates O 0 3.43536157743074e-07
that O 0 4.909861753277234e-11
almost O 0 4.265340858289335e-10
all O 0 2.024648677878549e-12
of O 0 4.522755122347323e-14
these O 0 7.999282930926804e-14
represent O 0 7.700311200307952e-13
common O 0 6.192790724668384e-10
ancestry O 0 2.148136069024531e-08
and O 0 1.1377258024580783e-09
that O 0 9.435240783117749e-11
very O 0 3.4106835133940194e-09
few O 0 9.037204318218528e-10
spontaneously O 0 1.8650332389569257e-09
recurring O 0 2.8321290201915872e-08
ATM O 0 1.083624511011294e-06
mutations O 0 1.0063104127766564e-07
exist O 0 3.307918916561903e-08
. O 0 8.538682649827933e-09

Assays O 0 1.904027271848463e-06
requiring O 0 5.243720568870458e-09
minimal O 0 2.7318873829784707e-09
amounts O 0 2.9236370269192236e-11
of O 0 1.6220392000040884e-12
genomic O 0 5.378851253290406e-10
DNA O 0 2.2040534730649597e-08
were O 0 1.787249237494848e-10
designed O 0 8.645160975984112e-11
to O 0 4.1380267268298354e-12
allow O 0 5.652140214196244e-12
rapid O 0 2.1546787964954461e-10
screening O 0 8.788947347682097e-10
for O 0 3.732204215817214e-12
common O 0 2.1182697262922545e-10
ethnic O 0 4.830315036841171e-10
mutations O 0 1.0838823527592467e-07
. O 0 2.319354042157329e-09

These O 0 3.873356302364073e-09
rapid O 0 1.538348648466581e-08
assays O 0 2.5164848693748354e-07
detected O 0 7.828025161416008e-08
mutations O 0 1.3333019133199286e-08
in O 0 1.5826027988108393e-10
76 O 0 4.118104524053479e-09
% O 0 1.7363921064883492e-11
of O 0 6.055605778106099e-13
Costa O 0 1.2806368188122974e-09
Rican O 0 1.3509642293740853e-09
patients O 0 4.524667218674949e-08
( O 0 6.459728585372915e-11
3 O 0 3.763186290361986e-11
) O 0 6.397754288151036e-12
, O 0 2.9181145347334514e-12
50 O 0 1.463433194071051e-11
% O 0 1.3831109001161135e-11
of O 0 4.81451727443738e-12
Norwegian O 1 0.8158879280090332
patients O 0 1.8945179363072384e-06
( O 0 5.892721727240868e-11
1 O 0 4.090138991386105e-11
) O 0 9.592396321700392e-12
, O 0 2.9424226943852716e-11
25 O 0 2.649591310244226e-11
% O 0 1.6840188965527858e-11
of O 0 9.06329525318661e-12
Polish O 0 3.2318016565113794e-06
patients O 0 6.868214654787153e-07
( O 0 9.332148942498009e-11
4 O 0 2.3670929105712446e-10
) O 0 2.6183031437421178e-11
, O 0 4.792741203907269e-11
and O 0 3.9848754851412593e-10
14 O 0 4.3182377118533566e-10
% O 0 1.3314573402145591e-11
of O 0 3.633426025329012e-12
Italian O 0 4.619263108907035e-06
patients O 0 8.660901329449189e-08
( O 0 7.838039245422479e-11
1 O 0 2.508287189062486e-10
) O 0 6.762755633271667e-11
, O 0 2.8227788162471512e-11
as O 0 7.143533681253089e-11
well O 0 1.3897358264181037e-10
as O 0 4.477904158584067e-11
in O 0 8.754227204255116e-11
patients O 0 1.8434972992587007e-10
of O 0 3.36455754749998e-12
Amish O 0 0.0004281426954548806
/ O 0 2.456211586832069e-05
Mennonite O 0 1.3223000678408425e-05
and O 0 2.5123117808334428e-08
Irish O 0 5.9442065492021356e-08
English O 0 1.5526445906743902e-07
backgrounds O 0 6.776942740316372e-08
. O 0 1.6167476246664592e-09

Additional O 0 1.0351847379297396e-08
mutations O 0 2.988108249724064e-08
were O 0 3.6382075130347857e-10
observed O 0 4.0789049221556795e-11
in O 0 3.0731049649457276e-11
Japanese O 0 4.605252290623696e-10
, O 0 4.52576940767474e-13
Utah O 0 8.373629047098152e-12
Mormon O 0 1.3827897160645364e-10
, O 0 1.0185258886297177e-11
and O 0 5.291132983142877e-12
African O 0 2.211360261572537e-11
American O 0 9.339454765111554e-10
patients O 0 5.239661149403219e-09
. O 0 5.458763996379901e-10

These O 0 9.918009746812118e-10
assays O 0 2.4755330230163963e-08
should O 0 4.204107201255525e-11
facilitate O 0 2.7870894828141424e-11
screening O 0 2.3420065886625707e-10
for O 0 1.5927830235296092e-11
A B-Disease 1 1.0
- I-Disease 1 0.9999953508377075
T I-Disease 1 1.0
heterozygotes O 0 4.407865503708308e-07
in O 0 5.6514343205194e-10
the O 0 1.0384581215772126e-11
populations O 0 7.628701836903673e-11
studied O 0 1.277828509671508e-09
. O 0 5.602448713282193e-11
. O 0 3.226631739572383e-10

The O 0 1.4268046300003334e-07
von B-Disease 1 0.999037504196167
Hippel I-Disease 1 0.9998062252998352
- I-Disease 1 0.9999701976776123
Lindau I-Disease 1 0.9991416931152344
tumor I-Disease 0 0.0003261744568590075
suppressor O 0 2.14835904444044e-06
gene O 0 1.7330089008282812e-07
is O 0 4.116830210065814e-10
required O 0 7.898322967880844e-11
for O 0 1.0076568052186374e-11
cell O 0 4.625804308489023e-07
cycle O 0 3.150940486307263e-08
exit O 0 1.225297729945396e-08
upon O 0 2.9741117901771474e-10
serum O 0 2.9085573061138348e-08
withdrawal O 0 4.8504649186043025e-08
. O 0 4.976562273384388e-09

The O 0 6.861128998281174e-09
inactivation O 0 6.222894910479226e-08
of O 0 1.4085380431461125e-11
the O 0 2.2195463522667325e-10
von B-Disease 1 0.9998337030410767
Hippel I-Disease 1 0.9995653033256531
- I-Disease 1 0.9999679327011108
Lindau I-Disease 1 0.9999489784240723
( I-Disease 0 5.105738409838523e-07
VHL I-Disease 0 0.000447440572315827
) I-Disease 0 9.466903705401819e-09
tumor I-Disease 0 3.0592486837122124e-06
suppressor O 0 3.258373226344702e-06
gene O 0 2.6547456855041673e-06
predisposes O 0 3.0663463803648483e-06
affected O 0 4.289584509820088e-08
individuals O 0 1.2140255467585348e-10
to O 0 2.4502750523014427e-11
the O 0 7.649960526157074e-11
human O 0 1.4286577254551958e-07
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 2.278275568201593e-09
is O 0 8.680520191539642e-11
associated O 0 6.840871202840049e-10
with O 0 1.1151669587761148e-09
sporadic B-Disease 1 0.9999996423721313
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 0 1.4551135791407432e-05
RCC B-Disease 0 0.03475049510598183
) O 0 2.2627932860785904e-09
and O 0 3.830531003501392e-09
brain B-Disease 0 1.7477339497418143e-05
hemangioblastomas I-Disease 0 1.3373535693972372e-05
. O 0 1.4387257607495485e-08

VHL O 0 0.43166685104370117
- O 0 0.0006594662554562092
negative O 0 7.117504082998494e-06
786 O 0 4.717517367680557e-05
- O 0 4.975613046553917e-05
0 O 0 8.564389197829314e-09
RCC B-Disease 0 3.8705820770701393e-07
cells O 0 1.7720669376330989e-09
are O 0 3.5762986322351864e-11
tumorigenic O 0 5.004416081533236e-08
in O 0 1.5116410345683562e-09
nude O 0 1.3780257177131716e-05
mice O 0 2.460867108311504e-06
which O 0 8.831271824938369e-11
is O 0 6.061062676060436e-12
suppressed O 0 1.5629771782377233e-11
by O 0 2.315359275834039e-12
the O 0 9.499448103134078e-12
reintroduction O 0 1.2000517246590903e-09
of O 0 6.512603650810078e-11
VHL B-Disease 0 2.6373088530817768e-06
. O 0 5.349816589728107e-09

Remarkably O 0 0.022154105827212334
, O 0 1.3796791487052928e-09
this O 0 7.241645651190343e-12
occurs O 0 5.6075990205461945e-12
without O 0 4.637933700285535e-12
affecting O 0 2.5906731621061496e-11
the O 0 1.0068690672881964e-11
growth O 0 3.252007729770412e-07
rate O 0 1.498008295186537e-08
and O 0 1.3117678818175271e-11
cell O 0 1.0708845366025344e-08
cycle O 0 3.5925307173556575e-10
profile O 0 1.2314772812604957e-10
of O 0 7.383569125031519e-13
these O 0 1.5638112549690164e-12
cells O 0 1.0076572909412107e-10
in O 0 2.360276141200046e-10
culture O 0 1.0271093309199841e-08
. O 0 1.0178240472669131e-09

The O 0 2.556581080170872e-08
786 O 0 1.5867307183725643e-06
- O 0 2.156069029979335e-07
0 O 0 1.1054571702473481e-09
cell O 0 5.289246374218237e-08
line O 0 9.828454494709149e-08
, O 0 2.702256994557839e-11
like O 0 5.128588873026807e-11
many O 0 1.307351796264733e-11
cancer B-Disease 0 3.7437173361354326e-09
cells O 0 8.519547844976216e-10
, O 0 1.7263078466722703e-10
fails O 0 1.5242874740195589e-09
to O 0 1.0007251104171555e-11
exit O 0 4.958938149002279e-09
the O 0 9.504671355520244e-11
cell O 0 7.920163369590227e-08
cycle O 0 9.014308188781683e-10
upon O 0 4.2193706861759495e-11
serum O 0 6.122525597618278e-09
withdrawal O 0 2.5467594255701442e-08
. O 0 1.8062492612713754e-09

Here O 0 2.0467503247800778e-07
, O 0 4.1599095695898924e-11
it O 0 1.6623141665256247e-12
is O 0 4.139848186479611e-13
shown O 0 3.672926546238742e-12
that O 0 2.3150986336317736e-12
reintroduction O 0 5.177071618622797e-11
of O 0 5.415717787421448e-13
the O 0 3.729329779017521e-12
wild O 0 4.661164232366843e-10
- O 0 1.2417081052262802e-07
type O 0 1.2219717291372945e-06
VHL B-Disease 0 2.0406509975146037e-06
gene O 0 1.718645563641985e-07
restores O 0 4.897196390629688e-07
the O 0 1.5487219839904753e-10
ability O 0 2.3138131410860296e-09
of O 0 3.7836930810719593e-10
VHL O 0 0.0005365366232581437
- O 0 0.00024836621014401317
negative O 0 4.183610872132704e-05
RCC B-Disease 0 0.010485919192433357
cancer I-Disease 0 5.222796630732773e-07
cells O 0 7.728887752023184e-09
to O 0 9.403655631956553e-11
exit O 0 3.386220193135614e-09
the O 0 3.786744875999837e-11
cell O 0 1.6374394817830762e-07
cycle O 0 1.1370711483493778e-08
and O 0 2.211445748745433e-10
enter O 0 3.4492703804289704e-08
G0 O 0 3.302506956970319e-05
/ O 0 3.906389451913128e-07
quiescence O 0 3.127607044461911e-07
in O 0 6.330034274526497e-09
low O 0 3.427439310144109e-07
serum O 0 1.1768236873876958e-07
. O 0 7.1042998150971925e-09

Both O 0 1.1443178493664163e-07
VHL O 0 0.001956949010491371
- O 0 2.3779937691870145e-05
positive O 0 1.4788737345838854e-08
and O 0 1.3956468203346617e-09
VHL O 0 3.62465507350862e-05
- O 0 1.4099803138378775e-06
negative O 0 1.2201138588352478e-07
RCC B-Disease 0 2.670527237569331e-06
cells O 0 5.740193653736014e-09
exit O 0 1.50375090157695e-08
the O 0 4.2138934702729e-11
cell O 0 1.9673302986689123e-08
cycle O 0 8.312769361751293e-10
by O 0 2.301881948940654e-11
contact O 0 3.419661354087111e-08
inhibition O 0 5.389536639199832e-08
. O 0 1.754323686320447e-09

The O 0 1.1461905202736489e-08
cyclin O 0 2.7308471999276662e-06
- O 0 1.5385518281618715e-07
dependent O 0 1.318316833476274e-07
kinase O 0 1.3608696463052183e-06
inhibitor O 0 4.081114184373291e-07
, O 0 8.713197524601313e-11
p27 O 0 1.0119650006856773e-08
, O 0 1.2851845455907895e-11
accumulates O 0 2.3019433581517035e-11
upon O 0 8.097394282868819e-13
serum O 0 1.0714554937729659e-10
withdrawal O 0 1.30103650075597e-10
, O 0 7.571535629372073e-13
only O 0 3.6338052250388386e-13
in O 0 1.8475468550882557e-12
the O 0 7.176493557400909e-13
presence O 0 8.58491749911039e-12
of O 0 2.7665118459974103e-12
VHL B-Disease 0 3.1447083159719114e-08
, O 0 1.1077799268177646e-11
as O 0 2.4363873765698152e-11
a O 0 1.323807383157849e-11
result O 0 1.8918049418670257e-11
of O 0 3.621316300213978e-13
the O 0 1.525065317087293e-11
stabilization O 0 2.0763202268625491e-10
of O 0 6.740226324124243e-13
the O 0 1.3878622209806402e-11
protein O 0 3.658598757283471e-09
. O 0 1.0742369216387715e-09

We O 0 9.257274058427356e-09
propose O 0 2.9431610482077986e-09
that O 0 2.921892242047086e-11
the O 0 1.914488359511246e-11
loss O 0 3.428265449301193e-10
of O 0 1.1041301336764398e-12
wild O 0 3.2331390897866186e-09
- O 0 6.971349648665637e-05
type O 0 0.0002860465319827199
VHL B-Disease 0 6.739047421433497e-06
gene O 0 8.055344125068586e-08
results O 0 1.0116329995923934e-08
in O 0 4.176414422629726e-11
a O 0 1.9911858620269562e-11
specific O 0 1.6624174259405322e-10
cellular O 0 7.853485840314534e-06
defect O 0 8.302460940967649e-08
in O 0 2.8798163853593906e-10
serum O 0 1.7133915619638174e-08
- O 0 1.9838388709558785e-07
dependent O 0 5.9393556739451014e-08
growth O 0 1.21194844382444e-07
control O 0 5.484544818301629e-09
, O 0 3.63037308548364e-11
which O 0 5.457033089295571e-11
may O 0 2.922569519725471e-09
initiate O 0 1.533830062960817e-09
tumor B-Disease 0 4.7798671687360184e-08
formation O 0 1.7090497905769553e-09
. O 0 1.979856945055758e-09

This O 0 6.599718105348984e-09
is O 0 8.238518756087387e-10
corrected O 0 1.5421472099319544e-08
by O 0 6.13073090557914e-12
the O 0 1.3303226575889227e-11
reintroduction O 0 4.076395054841697e-10
of O 0 2.548343480679449e-12
wild O 0 5.420479620710239e-10
- O 0 1.6811973182484508e-05
type O 0 0.0005901718395762146
VHL B-Disease 0 9.387748286826536e-05
, O 0 6.312114719797535e-10
implicating O 0 5.0791921779591576e-08
VHL B-Disease 0 7.758865194773534e-07
as O 0 3.101039425246199e-10
the O 0 9.414598441115363e-12
first O 0 1.1688672252319066e-10
tumor B-Disease 0 5.171391759262178e-09
suppressor O 0 4.555015475915525e-09
involved O 0 6.313234379717869e-10
in O 0 7.816127189919087e-10
the O 0 8.406646906378157e-11
regulation O 0 5.063307551012031e-09
of O 0 6.0733527582068625e-12
cell O 0 7.962423609342295e-08
cycle O 0 4.7297494809583895e-09
exit O 0 4.000956366212449e-08
, O 0 1.0587182519561367e-10
which O 0 2.3019783995659182e-11
is O 0 1.0342201921254013e-11
consistent O 0 3.901797773764315e-10
with O 0 6.104381323340791e-13
its O 0 4.881379155052823e-12
gatekeeper O 0 3.6957708005047607e-09
function O 0 2.4247420044032353e-11
in O 0 3.403656523293108e-10
the O 0 5.207020925546146e-10
kidney O 0 3.010286420135344e-08
. O 0 2.8399207985252417e-10
. O 0 1.5551578913530761e-09

Piebaldism B-Disease 1 1.0
with O 0 0.023107489570975304
deafness B-Disease 1 1.0
: O 0 5.305731409777081e-10
molecular O 0 2.749271366120354e-10
evidence O 0 1.1648966513622128e-10
for O 0 4.560006452297705e-12
an O 0 4.144861537325184e-11
expanded O 0 2.7239306291448884e-05
syndrome O 1 0.9999638795852661
. O 0 5.88548321189819e-09

In O 0 3.3798321918965257e-09
a O 0 2.4645580021243063e-10
South O 0 3.1186264681792863e-10
African O 0 1.3833443279764879e-09
girl O 0 1.2194291230116505e-06
of O 0 3.2706854585784484e-11
Xhosa O 0 2.1235080112091964e-06
stock O 0 3.077664700867899e-07
with O 0 9.891819308105454e-11
severe O 0 2.3015793431113707e-06
piebaldism B-Disease 0 7.079856004565954e-05
and O 0 5.421815885142678e-09
profound O 0 4.720145807368681e-05
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 4.030115121622657e-07
identified O 0 4.2521839382914095e-09
a O 0 4.7882822706846184e-11
novel O 0 5.015438064859268e-10
missense O 0 7.644982957799584e-08
substitution O 0 2.829271261717281e-09
at O 0 9.889976615440332e-10
a O 0 1.7532714863266463e-11
highly O 0 2.5774066214623303e-10
conserved O 0 8.617638269647898e-10
residue O 0 1.9369920778444794e-08
in O 0 1.6867288815669568e-11
the O 0 7.212092468372733e-12
intracellular O 0 1.4896819333642952e-09
kinase O 0 3.221322231183876e-08
domain O 0 1.2952655614739683e-09
of O 0 6.947002435114813e-12
the O 0 3.5464531311646397e-10
KIT O 0 1.4831111002422404e-05
proto O 0 0.0010434635914862156
- O 0 4.968539997207699e-06
oncogene O 0 3.166809619870037e-06
, O 0 1.4841119444497508e-09
R796G O 0 3.7490002569029457e-07
. O 0 6.421824405578036e-09

Though O 0 3.7482709558389615e-07
auditory B-Disease 0 1.1767684554797597e-05
anomalies I-Disease 0 5.595531183644198e-05
have O 0 5.05261610328489e-10
been O 0 1.2291001549868952e-10
observed O 0 3.491135505684362e-11
in O 0 9.994304689397993e-11
mice O 0 1.7423238318770018e-07
with O 0 6.039751337949539e-11
dominant O 0 2.151471926481463e-05
white O 0 5.081712401988625e-07
spotting O 0 0.004904967732727528
( O 0 2.4379019691878057e-08
W O 0 0.016601942479610443
) O 0 1.1372652819474638e-10
due O 0 4.27126750635054e-10
to O 0 3.1619182272457635e-10
KIT O 0 0.002834356389939785
mutations O 0 0.0005578274722211063
, O 0 0.000819753622636199
deafness B-Disease 1 1.0
is O 0 9.588948524097418e-10
not O 0 1.5504628136930876e-10
typical O 0 4.4885442584963187e-10
in O 0 2.346979277589867e-10
human O 0 2.5209059839603754e-10
piebaldism B-Disease 0 1.0437794344397844e-06
. O 0 2.118808017925744e-09

Thus O 0 5.262366098435223e-09
, O 0 3.8685679659700156e-11
the O 0 4.802145660287582e-12
occurrence O 0 2.902781126579157e-09
of O 0 1.9225552261303847e-09
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 6.79385777857533e-07
this O 0 1.2145866534751804e-09
patient O 0 4.2796550303592085e-08
extends O 0 4.1182046661703e-10
considerably O 0 1.7340447300284723e-08
the O 0 1.1133551545972065e-11
phenotypic O 0 3.736327247594318e-09
range O 0 1.4409329285314243e-09
of O 0 1.5709810188835327e-11
piebaldism B-Disease 0 6.84675214301933e-08
due O 0 5.258039559308259e-10
to O 0 1.1117175235941801e-10
KIT O 0 3.408809448046668e-07
gene O 0 1.2194386833641602e-08
mutation O 0 3.1346103490648147e-09
in O 0 6.772630373186317e-11
humans O 0 1.0998942867601613e-09
and O 0 1.4604230047510214e-09
tightens O 0 1.0635097851263708e-06
the O 0 9.840215448031486e-12
clinical O 0 5.679844372608045e-10
similarity O 0 1.7341332814169164e-09
between O 0 8.762885417290533e-10
piebaldism B-Disease 0 4.926970632368466e-06
and O 0 7.343086555477996e-11
the O 0 6.875577581236247e-13
various O 0 1.8894926855778094e-12
forms O 0 5.071975062165279e-10
of O 0 8.579250199147737e-09
Waardenburg B-Disease 1 0.9999890327453613
syndrome I-Disease 1 0.9999932050704956
. O 0 1.018579443012868e-09
. O 0 1.9225296910008183e-09

Cycloheximide O 0 2.5598978936614003e-06
facilitates O 0 1.7792173068187367e-08
the O 0 5.568889099860641e-11
identification O 0 6.171377853192439e-10
of O 0 3.424210134189698e-12
aberrant O 0 3.770045964301971e-08
transcripts O 0 2.6425649224393055e-08
resulting O 0 1.4782293444870476e-10
from O 0 6.000264174410574e-11
a O 0 7.346742658675964e-11
novel O 0 1.0061482758061402e-09
splice O 0 2.3121099729905836e-05
- O 0 4.841240865971486e-07
site O 0 7.40807237775698e-09
mutation O 0 1.5312556556068557e-08
in O 0 1.0674621186979039e-09
COL17A1 O 0 4.683457973442273e-06
in O 0 8.579720267576363e-10
a O 0 2.302332102743776e-09
patient O 0 9.844964665717271e-08
with O 0 4.5822787231308837e-10
generalized O 0 2.03037907340331e-05
atrophic B-Disease 1 0.9995517134666443
benign I-Disease 1 0.9995284080505371
epidermolysis I-Disease 1 0.9858841300010681
bullosa I-Disease 1 0.9656742811203003
. O 0 1.0769685104605742e-05

Patients O 0 0.0002449440653435886
with O 0 2.33094361590247e-08
generalized O 0 2.5178049327223562e-05
atrophic B-Disease 1 0.9998863935470581
benign I-Disease 1 0.9998610019683838
epidermolysis I-Disease 1 0.991605281829834
bullosa I-Disease 1 0.5775635242462158
often O 0 1.6914160596570582e-06
show O 0 1.0954316564948385e-07
decreased O 0 4.661889008161779e-08
expression O 0 4.974395895196437e-10
of O 0 7.36360191572194e-12
type O 0 7.05683874002716e-07
XVII O 0 1.2378577594063245e-06
collagen O 0 1.4886549593029486e-07
, O 0 6.446706363183452e-11
a O 0 7.701787818614747e-11
transmembrane O 0 4.806413933522435e-09
hemidesmosomal O 0 4.230683003925151e-08
protein O 0 3.919118807260702e-09
encoded O 0 2.8714257638284835e-09
by O 0 5.387763568620585e-10
COL17A1 O 0 3.5896073313779198e-06
. O 0 5.354450660632892e-09

This O 0 6.752489678518714e-09
report O 0 1.8502122056673898e-09
documents O 0 4.2011033540845233e-10
a O 0 3.8665910750967925e-11
novel O 0 1.0093390567789129e-09
splice O 0 5.135756146046333e-05
- O 0 4.2820965973078273e-07
site O 0 6.868094537537672e-09
mutation O 0 8.459380751446588e-09
in O 0 2.614772398601417e-09
COL17A1 O 0 3.932374056603294e-06
in O 0 3.8407055313882665e-10
a O 0 1.4994825381364763e-09
patient O 0 1.1838183411327918e-07
with O 0 2.4416968447127374e-10
generalized O 0 2.1134467260708334e-06
atrophic B-Disease 1 0.9997637867927551
benign I-Disease 1 0.9997541308403015
epidermolysis I-Disease 1 0.9800584316253662
bullosa I-Disease 1 0.7931736707687378
, O 0 6.926190820877309e-08
and O 0 2.3425247852593145e-10
applies O 0 2.64039068387234e-10
a O 0 3.8421762299511997e-11
new O 0 4.0508102427949666e-10
methodology O 0 2.563073531192117e-09
to O 0 4.570673266951486e-12
define O 0 3.74555081394945e-10
and O 0 1.3328352310715275e-10
characterize O 0 2.4680919530339906e-09
the O 0 1.572078231482088e-11
resulting O 0 2.5627591715426945e-10
mRNA O 0 8.429583253644068e-09
splice O 0 1.3349834944165195e-06
variants O 0 3.6277208437240915e-07
. O 0 3.3487637551843363e-08

Mutational O 0 8.871658064890653e-05
analysis O 0 1.32574285771625e-07
of O 0 1.3696860312606418e-10
COL17A1 O 0 8.829471767057839e-07
identified O 0 1.2809648453071532e-08
a O 0 5.655046431130017e-10
maternally O 0 3.273034599260427e-05
inherited O 0 0.00011442771210568026
G O 0 5.6366825447184965e-06
- O 0 6.339509184272174e-08
to O 0 6.995781731689021e-10
- O 0 1.4205727438820759e-06
T O 0 3.3860849271150073e-06
transversion O 0 9.372046605449214e-08
at O 0 4.0543657320313287e-10
the O 0 8.768042715490143e-12
- O 0 1.247147274341387e-09
1 O 0 4.831823829931636e-11
position O 0 2.4106966423076415e-10
of O 0 3.421128831615494e-12
exon O 0 1.41851561608064e-08
32 O 0 7.50830331242014e-09
. O 0 1.777666125413191e-09

This O 0 7.998830930944223e-09
acceptor O 0 1.1042148884143899e-07
splice O 0 1.0987522728100885e-05
- O 0 1.0786558277686709e-06
site O 0 2.4905733031488353e-09
mutation O 0 2.5258213298684495e-09
led O 0 4.1005282502837304e-11
to O 0 2.180133677753826e-12
the O 0 1.1955719617443017e-12
formation O 0 1.8717978556015424e-12
of O 0 2.149708633759212e-13
aberrant O 0 2.3574012186777793e-10
transcripts O 0 1.6336726416099623e-09
present O 0 4.9548490310691307e-11
at O 0 3.0506761561355233e-09
extremely O 0 4.0112951182891265e-08
low O 0 4.7567439764861774e-07
levels O 0 8.5904341418086e-09
. O 0 4.707714773566352e-10

Based O 0 2.8044293998163994e-08
on O 0 5.517995393944375e-09
our O 0 5.3082288564709756e-11
recent O 0 6.135168068022168e-11
finding O 0 1.9257730132782314e-10
that O 0 6.630244964167531e-11
cycloheximide O 0 1.7985689737542998e-07
stabilized O 0 6.672234121651854e-06
mutant O 0 2.8459535172942196e-08
COL17A1 O 0 3.4738317822302633e-07
transcripts O 0 1.9079806179433945e-08
in O 0 1.5309239986827095e-10
keratinocytes O 0 2.1280028406067686e-08
homozygous O 0 5.973640249123946e-09
for O 0 7.625890370566157e-12
a O 0 2.934286424949306e-10
frameshift O 0 4.691541471402161e-05
mutation O 0 5.804172431567167e-08
, O 0 1.610231670223783e-10
the O 0 9.020765905087824e-12
effects O 0 7.642439459054629e-10
of O 0 3.143850414374927e-12
the O 0 1.0912343945124192e-10
splice O 0 7.48349521018099e-06
- O 0 1.344269691117006e-07
site O 0 5.981735551330303e-09
mutation O 0 6.340087121969873e-09
on O 0 6.622942749778815e-10
splicing O 0 6.421652987143034e-09
of O 0 2.663687846682361e-11
COL17A1 O 0 6.993653300924052e-08
transcripts O 0 5.561315852276039e-09
were O 0 8.169881438035986e-11
determined O 0 3.2345421480117764e-11
using O 0 4.590499508294599e-11
reverse O 0 1.5614054493795493e-09
transcriptase O 0 1.2038900543132058e-08
polymerase O 0 4.176976098335672e-09
chain O 0 2.7166573435266628e-09
reaction O 0 9.814129370289137e-11
of O 0 5.330392160649011e-13
total O 0 2.919222372513297e-12
RNA O 0 1.5883037107755626e-09
from O 0 5.5523863284889785e-11
keratinocytes O 0 1.547719463701469e-08
incubated O 0 2.9594067196825335e-09
for O 0 1.658255303904621e-11
2 O 0 2.1893825641328135e-10
. O 0 5.24447762995095e-10

5 O 0 6.58425562960474e-08
h O 0 1.4227553890577838e-07
in O 0 1.3630482853521642e-10
the O 0 8.35010446204043e-12
presence O 0 1.4302152517853273e-10
or O 0 5.839823069564432e-10
absence O 0 4.773494377552367e-10
of O 0 5.0576244581268526e-12
10 O 0 8.722742667055527e-11
microg O 0 3.791846125977827e-08
cycloheximide O 0 8.07226285814977e-08
per O 0 6.6441261381555705e-09
ml O 0 1.3710042594539118e-06
. O 0 2.2540402877524457e-09

Using O 0 3.2689175810673987e-09
this O 0 1.1819373257893062e-10
approach O 0 1.0479647372108047e-08
, O 0 4.9842137361810757e-11
an O 0 3.152534830408449e-11
abnormally O 0 8.089170933089918e-08
spliced O 0 7.5838920565729495e-06
transcript O 0 2.5262565031880513e-05
was O 0 8.509178428539599e-08
identified O 0 1.5062819880284906e-09
that O 0 1.3817601576815441e-12
contains O 0 5.653991814666415e-13
an O 0 8.296409891549172e-13
extra O 0 1.7888897307916096e-10
264 O 0 5.746851328147784e-10
bases O 0 4.825009142228609e-11
upstream O 0 4.028127553734606e-10
from O 0 9.306902470918033e-12
exon O 0 2.8089570669465047e-09
32 O 0 9.188190208675451e-10
, O 0 8.690488433049648e-12
resulting O 0 6.096149973711107e-11
in O 0 8.656962924291633e-10
a O 0 2.5049526897191754e-08
premature O 0 2.649666726028954e-07
termination O 0 3.974146522978117e-08
codon O 0 1.1165705871007958e-07
27 O 0 6.530161300588588e-09
bp O 0 6.988053513623527e-08
downstream O 0 7.770289300879085e-09
from O 0 1.748296785120118e-10
the O 0 1.670293209299345e-10
cryptic O 0 1.4475882892384107e-07
splice O 0 4.512693067226792e-06
site O 0 1.663572675170144e-07
. O 0 2.2840328739448523e-08

Three O 0 3.931172276594452e-09
other O 0 8.614282204222334e-11
splice O 0 2.0970865932667948e-07
variants O 0 4.837484368636069e-08
, O 0 2.602271696738878e-11
including O 0 4.682838318503801e-13
one O 0 4.8196351423723804e-12
derived O 0 1.5436428177362238e-11
from O 0 3.1390764987371256e-11
the O 0 1.0290981608540584e-11
skipping O 0 7.401063650824824e-10
of O 0 1.5032946675680448e-12
exon O 0 2.9282161140287144e-09
32 O 0 2.5698285721631464e-09
, O 0 6.351228570844469e-11
were O 0 1.9894035307999047e-09
also O 0 3.236228229841487e-10
identified O 0 1.2861330667135462e-08
. O 0 8.499583259435894e-10

These O 0 2.5321160723734693e-09
results O 0 2.8416236030892605e-09
indicate O 0 1.7852083700198307e-10
the O 0 1.2815903937049566e-12
usefulness O 0 1.2378803537771432e-10
of O 0 8.465626745619848e-13
cycloheximide O 0 3.608182863601428e-09
treatment O 0 2.140702060060562e-10
in O 0 3.645381219108401e-11
evaluating O 0 2.499223328289446e-10
the O 0 8.994565509068408e-12
abnormal O 0 2.464921156075661e-09
processing O 0 1.1489648121809637e-10
of O 0 3.536707060027011e-13
mRNA O 0 1.2187724440781977e-10
due O 0 2.747718545748068e-11
to O 0 1.6619093254344186e-11
splice O 0 6.6185302785015665e-06
- O 0 6.853023393205149e-08
site O 0 4.492837657465998e-09
mutations O 0 4.130362185605918e-08
, O 0 2.8479257146996062e-11
because O 0 1.5680780285354246e-10
( O 0 1.8341048124703718e-10
i O 0 2.7235390120949887e-07
) O 0 3.742305076936958e-12
aberrant O 0 3.6354261268023436e-10
splicing O 0 2.7775768352000796e-09
often O 0 8.723508027053128e-11
generates O 0 3.943020077112891e-10
a O 0 1.9013823848723632e-09
premature O 0 2.7247131129115587e-07
termination O 0 1.4650495039347788e-08
codon O 0 1.0189685539785387e-08
, O 0 2.0449399118493972e-11
( O 0 9.255477460834438e-12
ii O 0 1.1097562868656041e-09
) O 0 6.235143911598184e-12
transcripts O 0 4.121153640568309e-09
with O 0 3.595874292772194e-11
premature O 0 2.6911303407928244e-08
termination O 0 8.643549209708112e-10
codons O 0 1.3508766327774424e-09
can O 0 4.351240548428059e-11
occur O 0 5.53483404941435e-11
at O 0 1.8134320434182172e-10
low O 0 2.633417572894814e-08
or O 0 1.7126325912997231e-09
undetectable O 0 1.9838049070131092e-07
levels O 0 1.3909643437060026e-09
due O 0 3.643831070210268e-11
to O 0 1.2408676516861838e-11
nonsense O 0 4.9318504835582644e-08
- O 0 1.420380368877261e-09
mediated O 0 1.63304090250449e-08
mRNA O 0 5.614903542117133e-10
decay O 0 3.1114608112225994e-10
, O 0 3.3336909621706212e-12
and O 0 3.506977911196807e-12
( O 0 3.051777363802244e-12
iii O 0 3.6657496482739305e-10
) O 0 1.3345483572402284e-12
the O 0 3.88684917584925e-12
levels O 0 9.581337806485735e-11
of O 0 5.528041268016218e-14
these O 0 5.633603392812825e-13
transcripts O 0 4.1866091149422857e-10
can O 0 4.637102334059673e-12
be O 0 1.4409253954947299e-12
increased O 0 8.364769814306339e-12
by O 0 1.5092309346709243e-11
cycloheximide O 0 1.919393071148079e-07
. O 0 1.2569527640948763e-09

A O 0 1.7353922032725677e-07
deletion O 0 1.0956442793030874e-06
mutation O 0 5.6494247502314465e-08
in O 0 2.0235904063525822e-09
COL17A1 O 0 1.4217046555131674e-05
in O 0 2.6490987181659875e-09
five O 0 7.995222539580737e-11
Austrian O 0 1.3888367789149925e-07
families O 0 4.058479247115443e-11
with O 0 2.7316395673215865e-11
generalized O 0 1.248203034265316e-06
atrophic B-Disease 1 0.9996707439422607
benign I-Disease 1 0.9993661046028137
epidermolysis I-Disease 1 0.8457167148590088
bullosa I-Disease 0 0.02147027663886547
represents O 0 3.763056213301752e-07
propagation O 0 5.6963845196378315e-08
of O 0 8.516359145671615e-11
an O 0 8.588803279696577e-11
ancestral O 0 6.478073544258223e-08
allele O 0 1.4718390957568772e-05
. O 0 1.0592609811510556e-07

Patients O 0 7.99791669123806e-05
with O 0 1.6595235408090048e-08
generalized O 0 3.0489838536595926e-05
atrophic B-Disease 1 0.9999535083770752
benign I-Disease 1 0.999987006187439
epidermolysis I-Disease 1 0.999809205532074
bullosa I-Disease 1 0.9995025396347046
, O 0 1.2186765729893523e-07
a O 0 9.799395739307215e-10
usually O 0 6.142676922671342e-10
nonlethal O 0 1.6610363218205748e-07
form O 0 2.3988839359390113e-08
of O 0 3.2426621388026433e-09
junctional B-Disease 0 0.0036907868925482035
epidermolysis I-Disease 1 0.8959161639213562
bullosa I-Disease 1 0.8137151598930359
, O 0 2.3360662737559323e-08
have O 0 7.816932656723452e-10
generalized O 0 2.294503609334697e-08
blistering B-Disease 0 3.5787743399851024e-05
, O 0 5.9510018246555774e-08
nail B-Disease 1 1.0
dystrophy I-Disease 1 0.9999815225601196
, O 0 3.925509872715338e-08
patchy B-Disease 1 0.9999880790710449
alopecia I-Disease 1 0.9999994039535522
, O 0 5.44712079886267e-08
and O 0 1.770492445984928e-07
dental B-Disease 1 0.9999921321868896
abnormalities I-Disease 1 0.9999924898147583
. O 0 4.9951562886008105e-08

Skin B-Disease 1 1.0
fragility I-Disease 1 0.7367147207260132
in O 0 4.0669303480456165e-09
most O 0 4.8898433913091566e-11
cases O 0 5.877478365112765e-11
is O 0 5.381205463866889e-12
due O 0 3.7343281245050264e-11
to O 0 2.4378934634916583e-11
mutations O 0 4.5983186702791556e-10
in O 0 3.760144279274513e-11
the O 0 1.1952670624093553e-11
gene O 0 8.246257898747444e-09
encoding O 0 3.1478769813020335e-08
type O 0 9.970601240638644e-06
XVII O 0 8.16547435533721e-06
collagen O 0 8.095874363789335e-06
( O 0 2.5546704307544132e-08
COL17A1 O 0 1.3014076102990657e-05
) O 0 4.965762467890045e-09
. O 0 4.23663237825167e-09

Recently O 0 6.912293429195415e-06
, O 0 9.65661883789437e-10
we O 0 1.8381428323888116e-10
reported O 0 6.371846383856905e-10
five O 0 5.718351573508196e-12
Austrian O 0 1.8510425192630464e-08
families O 0 1.2697466342248553e-11
with O 0 1.1636924930613635e-11
generalized O 0 9.002612273434352e-07
atrophic B-Disease 1 0.9991816878318787
benign I-Disease 1 0.9982280135154724
epidermolysis I-Disease 1 0.8898804783821106
bullosa I-Disease 1 0.9593586325645447
who O 0 2.7261789909971412e-06
share O 0 3.936426651307556e-08
the O 0 1.924506248807134e-10
same O 0 1.30544941523425e-09
COL17A1 O 0 8.383939530176576e-06
mutation O 0 2.0025355240704812e-07
. O 0 5.458526963764143e-09

Affected O 0 2.823629188242194e-07
individuals O 0 9.06883734774766e-10
in O 0 4.2821654555602606e-10
three O 0 2.7031384075559828e-11
families O 0 3.780969461131267e-12
are O 0 3.598752426701296e-13
homozygous O 0 1.1878585615132664e-10
for O 0 2.7844261184933883e-12
4003delTC O 0 3.3925362519227065e-09
, O 0 1.2269445875956464e-11
whereas O 0 9.921258259382171e-11
those O 0 1.6069050604028412e-11
in O 0 7.274486568675798e-11
two O 0 2.1447878195690606e-11
others O 0 2.788764358330198e-11
are O 0 1.5653034424190082e-12
compound O 0 7.652386502243758e-10
heterozygotes O 0 9.629626873675079e-08
. O 0 1.972694896323901e-09

To O 0 2.694935163916057e-09
determine O 0 1.1641354547009541e-09
if O 0 4.465349964788423e-11
the O 0 2.0695411530324836e-12
occurrence O 0 1.6310035266808853e-10
of O 0 2.8734048560657977e-12
4003delTC O 0 4.998442104664491e-09
in O 0 7.493888842802221e-11
these O 0 4.370602404296653e-12
unrelated O 0 1.7289933373909605e-10
families O 0 1.3108399782302271e-11
signifies O 0 8.906735071700922e-11
propagation O 0 1.7907296478991697e-10
of O 0 2.123182055516204e-12
an O 0 4.332819693309009e-12
ancestral O 0 5.604313901841351e-09
allele O 0 3.5516222851583734e-07
or O 0 1.6002733360664934e-08
a O 0 2.6065078984061074e-08
mutational O 0 0.00012615372543223202
hot O 0 0.00016444789071101695
spot O 0 2.3834514649934135e-05
, O 0 1.6987474760199461e-09
haplotypes O 0 6.57521965763408e-08
were O 0 9.534387501730635e-09
determined O 0 1.4235400636053441e-09
for O 0 5.831669782491167e-12
polymorphisms O 0 5.359948040961626e-09
both O 0 4.308790477192126e-11
within O 0 1.6093412713580335e-10
and O 0 2.1430399677058176e-09
flanking O 0 7.622981001986773e-07
COL17A1 O 0 8.293824066640809e-05
. O 0 5.825564031169961e-09

Five O 0 6.862649826189227e-08
intragenic O 0 1.6396363662352087e-06
polymorphisms O 0 3.670640751352039e-07
were O 0 2.0390529265057467e-09
chosen O 0 6.820855685818472e-11
based O 0 1.8809867552427306e-10
on O 0 1.4072155662958608e-09
their O 0 1.6352896814453288e-10
informativeness O 0 2.3642891733288707e-07
. O 0 1.7315453515465151e-09

One O 0 8.055448752486427e-09
of O 0 3.5580353767439288e-12
these O 0 3.9799036462284665e-12
, O 0 1.3756278017737489e-12
not O 0 9.218602443905599e-12
previously O 0 1.6869099173089097e-10
reported O 0 1.8889564046276064e-07
, O 0 1.3179649212269329e-11
was O 0 3.2257905235866247e-09
2988 O 0 1.2287303396973925e-09
A O 0 2.4808433085610204e-10
or O 0 9.879588258598915e-10
C O 0 2.9282969649102597e-07
that O 0 9.103697830303847e-12
introduces O 0 5.867822894245478e-11
a O 0 3.201605647262795e-11
new O 0 3.167085205202369e-10
restriction O 0 7.792221867752858e-10
site O 0 2.2891769035915388e-10
for O 0 2.4960207511970367e-11
Eco0109 O 0 1.254691426311183e-07
I O 0 1.101705856854096e-05
. O 0 8.576300780660517e-10

All O 0 1.2672944915692597e-09
the O 0 6.715134004409151e-11
4003delTC O 0 1.0675726080933146e-08
alleles O 0 5.1343298501649315e-09
showed O 0 8.765882242300904e-09
the O 0 3.307565376101107e-12
same O 0 6.609385955202995e-11
haplotype O 0 3.273455106977963e-08
for O 0 2.8142953245602342e-11
these O 0 3.086139330199522e-11
five O 0 5.865070928923188e-11
polymorphic O 0 8.634840753529716e-08
markers O 0 3.729052764356311e-07
. O 0 1.5157009869426474e-08

Fourteen O 0 2.5153332217087154e-07
microsatellite O 0 2.4437574666080764e-06
polymorphisms O 0 4.239384907123167e-06
were O 0 3.877288268228085e-09
selected O 0 3.9447632660394305e-11
based O 0 9.995945043916876e-11
on O 0 8.984492594343862e-10
their O 0 5.462822902368991e-11
high O 0 1.0217574342163971e-08
heterozygosity O 0 1.3259118247788138e-08
and O 0 5.378889347817939e-11
their O 0 1.967078626721741e-12
location O 0 1.966435347888762e-10
within O 0 3.801546022419444e-10
10q23 O 0 3.9960988829079724e-07
- O 0 1.641504638882907e-07
q25 O 0 2.3066942844707228e-07
near O 0 2.898611910495674e-07
COL17A1 O 0 2.0314499124651775e-05
. O 0 1.1654534226579472e-08

Three O 0 1.0363108593480774e-08
families O 0 3.1241514930613334e-10
shared O 0 6.012915165776178e-10
microsatellite O 0 5.534630531656148e-07
polymorphisms O 0 4.174599325779127e-06
covering O 0 2.839355772721319e-07
at O 0 1.424011060180419e-07
most O 0 2.224362027902771e-09
19 O 0 8.276480834013e-09
cM O 0 3.7631416205385904e-08
, O 0 6.849380784768044e-11
whereas O 0 4.5873504994631276e-10
the O 0 1.1849772899030775e-11
others O 0 2.352671113481364e-10
shared O 0 1.698071891431674e-11
smaller O 0 2.1151810858377473e-10
regions O 0 1.5937875463833961e-09
consistent O 0 1.0417288649477996e-06
with O 0 6.595281959453914e-11
cross O 0 4.128558828142559e-08
- O 0 5.693103162229818e-07
over O 0 6.918364492403128e-11
events O 0 1.819126273228111e-11
during O 0 4.280064844208731e-11
passage O 0 3.4897178896597936e-11
of O 0 2.7195707166284555e-13
this O 0 1.26641785166276e-12
mutation O 0 5.0829451758716004e-11
through O 0 2.5454640131816753e-11
several O 0 1.6727354223977642e-10
generations O 0 1.3978632695810234e-09
. O 0 6.659461870839323e-10

These O 0 4.087655103290899e-09
results O 0 2.760607076268684e-09
indicate O 0 6.063797797217774e-10
that O 0 1.69812705563821e-11
4003delTC O 0 8.267991624677506e-09
occurs O 0 3.215963953473455e-11
on O 0 7.117176986648488e-11
a O 0 4.0746905849431414e-11
single O 0 4.725914659609032e-10
ancestral O 0 7.089166587093132e-09
allele O 0 1.6226110233219515e-07
. O 0 1.7149109909908589e-09
. O 0 2.3197435083943674e-09

The O 0 1.674365002202194e-08
haptoglobin O 0 2.1562163965427317e-05
- O 0 2.5027040919667343e-06
gene O 0 1.4800144754190114e-07
deletion O 0 1.1771412999905806e-07
responsible O 0 3.2390397031178964e-09
for O 0 9.192725747286801e-11
anhaptoglobinemia B-Disease 0 2.729779851051717e-07
. O 0 2.9329227935193103e-09

We O 0 1.5698992328339045e-08
have O 0 7.574490340500617e-11
found O 0 2.0765488287222134e-11
an O 0 1.03850109935133e-12
allelic O 0 1.1477868655518364e-09
deletion O 0 6.474932590094795e-09
of O 0 4.672420002987954e-12
the O 0 6.131061630609835e-11
haptoglobin O 0 3.3491218687231594e-07
( O 0 4.494069560934122e-10
Hp O 0 4.057199021190172e-09
) O 0 9.993499083815749e-12
gene O 0 6.926329509937545e-10
from O 0 1.8631583775796656e-10
an O 0 1.6795986476636493e-11
individual O 0 2.256550155066428e-11
with O 0 2.0140782097666232e-10
anhaptoglobinemia B-Disease 0 1.5058888493513223e-05
. O 0 1.8453460981504577e-08

The O 0 2.588344427678635e-09
Hp O 0 2.632528506296694e-08
gene O 0 4.404198783447555e-09
cluster O 0 1.1706080549345188e-09
consists O 0 2.81347965758183e-11
of O 0 4.702854859012229e-12
coding O 0 1.5422480714732956e-07
regions O 0 2.363079065759166e-09
of O 0 1.63460286972672e-11
the O 0 4.900169506272256e-11
alpha O 0 2.0754252483268232e-10
chain O 0 8.412329721707579e-10
and O 0 2.1134540298395343e-11
beta O 0 3.552266814033089e-11
chain O 0 1.4767752298805448e-10
of O 0 7.043032064675547e-13
the O 0 1.3688234573594471e-11
haptoglobin O 0 1.6070668351630957e-08
gene O 0 2.6405029274201297e-09
( O 0 7.199355694931242e-11
Hp O 0 4.216743842988535e-09
) O 0 6.156839794935198e-12
and O 0 1.366048420214927e-11
of O 0 2.268415083593947e-13
the O 0 5.364419845832469e-12
alpha O 0 3.261129907783378e-11
chain O 0 3.66173841248596e-10
and O 0 1.7566925344936202e-11
beta O 0 6.023437998381453e-11
chain O 0 1.1778639175119565e-10
of O 0 7.032695823264157e-13
the O 0 1.8885134775437074e-11
haptoglobin O 0 2.5019832605721604e-07
- O 0 7.575134297610475e-09
related O 0 1.6780408174099648e-09
gene O 0 3.808277426742279e-08
( O 0 3.972505657756642e-10
Hpr O 0 1.654020849173321e-07
) O 0 9.657185467970564e-11
, O 0 5.692476351404352e-11
in O 0 5.929604030008306e-10
tandem O 0 1.2733505627693376e-07
from O 0 9.199571104900883e-10
the O 0 8.993699673887079e-10
5 O 0 1.4490249000687072e-09
side O 0 1.766782631307251e-08
. O 0 2.523808273480199e-09

Southern O 0 1.2745815638481872e-06
blot O 0 0.00014840396761428565
and O 0 3.229995604314695e-09
PCR O 0 7.248500111245448e-08
analyses O 0 7.373546218047977e-10
have O 0 4.3985197428764167e-11
indicated O 0 2.6174556966296336e-10
that O 0 1.2335846320127297e-12
the O 0 3.272179619276394e-13
individual O 0 2.6252313040445174e-13
with O 0 1.2645206062811276e-12
anhaptoglobinemia B-Disease 0 5.529587809860459e-08
was O 0 2.1706889619110825e-09
homozygous O 0 1.4897351408027504e-10
for O 0 7.086908100292777e-13
the O 0 2.107358558489647e-12
gene O 0 8.562293651870334e-10
deletion O 0 1.1256210408205902e-09
and O 0 2.0536327846598645e-11
that O 0 1.553945774140919e-12
the O 0 9.242259735309233e-13
gene O 0 2.0736181660652164e-09
deletion O 0 3.0455018507069553e-09
was O 0 1.510125136050533e-09
included O 0 6.3939240187160795e-12
at O 0 6.290309939593897e-11
least O 0 3.213656771250406e-12
from O 0 2.4225680055750543e-12
the O 0 2.7285242207991667e-12
promoter O 0 1.6399007707335045e-09
region O 0 2.8628879822356623e-10
of O 0 1.2587699979582645e-11
Hp O 0 1.424276696582183e-08
to O 0 7.485702335774391e-11
Hpr O 0 8.367721449076271e-08
alpha O 0 8.430544595761091e-10
but O 0 1.2693354700665793e-10
not O 0 1.9548640484146063e-11
to O 0 1.3080002359000531e-11
Hpr O 0 4.877703574379666e-08
beta O 0 4.183115187572639e-09
( O 0 1.8632435871968056e-10
Hpdel O 0 2.2016795497847852e-08
) O 0 1.8678801561033964e-10
. O 0 1.2156620154968323e-09

In O 0 3.868276809981808e-09
addition O 0 4.324334987315659e-11
, O 0 2.2569763766244755e-11
we O 0 1.5478529916124195e-11
found O 0 6.08743177393789e-12
seven O 0 3.8803286755637045e-13
individuals O 0 1.4806193516245583e-14
with O 0 3.509585471631743e-13
hypohaptoglobinemia B-Disease 0 1.2480883526677644e-07
in O 0 1.9787620431088726e-09
three O 0 5.346832004926583e-11
families O 0 1.1561438438556504e-11
, O 0 2.091661045755533e-12
and O 0 1.6143086867259626e-11
the O 0 6.919601176769152e-12
genotypes O 0 7.107088251245841e-10
of O 0 2.4512742096555185e-12
six O 0 1.7097954996270204e-10
of O 0 5.926553193515149e-13
the O 0 5.898341277205121e-12
seven O 0 1.0118552697113703e-11
individuals O 0 1.5202194971614125e-13
were O 0 7.082671948932528e-11
found O 0 5.97974447735794e-11
to O 0 5.177503391295968e-12
be O 0 4.3104611546773697e-10
Hp2 O 0 8.56861390730046e-07
/ O 0 2.2952053768676706e-06
Hpdel O 0 1.5250725482474081e-06
. O 0 4.828014876778752e-09

The O 0 7.048274408560928e-09
phenotypes O 0 1.9576286547362542e-07
and O 0 2.508336427453628e-09
genotypes O 0 8.56561754858376e-08
in O 0 1.6016619142078525e-09
one O 0 3.236035397979897e-11
of O 0 1.8596939038630772e-13
these O 0 2.6649418349150578e-12
three O 0 4.477457900969872e-12
families O 0 4.240393192828096e-12
showed O 0 1.149945916267825e-08
the O 0 9.889776497740144e-12
father O 0 7.706876803403873e-10
to O 0 6.539786073789244e-12
be O 0 2.4348650873307065e-10
hypohaptoglobinemic B-Disease 0 4.311616663699169e-08
( O 0 5.21120091523386e-11
Hp2 O 0 1.295093454700691e-08
) O 0 9.920912182048713e-12
and O 0 7.17401069105783e-11
Hp2 O 0 2.5551045723659627e-07
/ O 0 2.5235576117665914e-07
Hpdel O 0 1.182423829959589e-07
, O 0 3.24099531934241e-11
the O 0 1.2650424111027014e-11
mother O 0 1.670663718478238e-09
to O 0 4.001734273811897e-12
be O 0 5.231367769531481e-11
Hp2 O 0 1.8509297206037445e-08
- O 0 4.510327222817523e-09
1 O 0 5.210813378009327e-11
and O 0 2.7404656322005394e-10
Hp1 O 0 2.149157012354408e-07
/ O 0 1.1095329455201863e-07
Hp2 O 0 6.842769550985395e-08
, O 0 1.755145161153049e-11
one O 0 1.614855926930503e-12
of O 0 4.3325345616901725e-14
the O 0 1.3738709605734534e-12
two O 0 5.532087374998662e-12
children O 0 4.092048748460808e-12
to O 0 1.2440901173832453e-12
be O 0 2.71726224854163e-10
hypohaptoglobinemic B-Disease 0 8.374843218916794e-08
( O 0 9.294595648690063e-11
Hp2 O 0 1.1869719429569159e-08
) O 0 1.9931768041603348e-11
and O 0 1.4487698540843752e-10
Hp2 O 0 4.915950739814434e-07
/ O 0 1.7537544181323028e-06
Hpdel O 0 5.414728434516292e-07
, O 0 1.2708133156902335e-10
and O 0 1.0630073210560198e-11
the O 0 1.0419574274569965e-12
other O 0 1.6652536988237543e-11
child O 0 4.101531336786479e-10
to O 0 1.435797769740177e-12
be O 0 5.982368767032398e-11
Hp1 O 0 1.0439367592596227e-08
and O 0 1.1847496594885598e-10
Hp1 O 0 1.7034163590778917e-07
/ O 0 6.940711472225303e-08
Hpdel O 0 2.292001610726402e-08
, O 0 1.6219811951878604e-11
showing O 0 1.3924933428555164e-09
an O 0 3.66049204836294e-12
anomalous O 0 3.036279894175209e-09
inheritance O 0 4.803856867852119e-09
of O 0 6.9583275773277276e-12
Hp O 0 1.1578978664772421e-08
phenotypes O 0 1.7503596350110229e-09
in O 0 7.088081233064258e-10
the O 0 2.490258554921354e-10
child O 0 2.514411434617614e-08
with O 0 7.131336493548801e-11
Hp1 O 0 1.3435562777885934e-06
. O 0 6.41876285456533e-09

The O 0 9.563747127572242e-09
Hp2 O 0 8.879116649040952e-06
/ O 0 4.082977739017224e-06
Hpdel O 0 9.852121962694582e-08
individuals O 0 1.321779491414432e-10
had O 0 2.9085796882100112e-08
an O 0 2.006366600637577e-11
extremely O 0 2.2650533537671436e-07
low O 0 2.2420349523599725e-06
level O 0 3.1898694796694826e-09
of O 0 1.0695105825270224e-12
Hp O 0 2.902393436698958e-09
( O 0 3.647725177469141e-11
mean O 0 3.453646257867149e-09
+ O 0 1.2900418511208045e-08
/ O 0 1.2914358649140922e-07
- O 0 1.1834256241627372e-07
SD O 0 3.914185981557239e-06
= O 0 5.478877795894732e-09
0 O 0 4.087856164680659e-10
. O 0 7.693507636519215e-11
049 O 0 3.8002673363735084e-07
+ O 0 6.46156195216463e-08
/ O 0 2.5093336830650514e-07
- O 0 3.506710655187817e-08
0 O 0 4.5302067652741584e-10
. O 0 1.265100940672781e-10
043 O 0 4.2638328068278497e-07
mg O 0 9.922215394908562e-05
/ O 0 9.65198410085577e-07
ml O 0 2.3006131755209935e-07
; O 0 2.1131960764586566e-11
n O 0 2.33771446644937e-09
= O 0 2.0903880848521794e-09
6 O 0 2.433750700969739e-10
) O 0 1.0960649055036242e-11
, O 0 6.76150108125384e-12
compared O 0 1.6373402633718115e-10
with O 0 3.5805828788038063e-12
the O 0 6.360929560855766e-10
level O 0 2.533652150304988e-07
( O 0 1.4143879643879753e-11
1 O 0 1.8741780696829302e-11
. O 0 6.555022150078749e-12
64 O 0 3.7683883791217454e-10
+ O 0 7.341931507198751e-09
/ O 0 2.0909597253648826e-07
- O 0 6.7315191643047e-08
1 O 0 3.215560873126577e-10
. O 0 1.7374664207370216e-10
07 O 0 2.2715424208286095e-08
mg O 0 2.902417236327892e-06
/ O 0 1.0742810019337412e-07
ml O 0 1.4770639822359044e-08
) O 0 2.325206216804987e-12
obtained O 0 1.8255567196812095e-11
from O 0 2.0666666294966163e-11
52 O 0 1.3329095605030261e-09
healthy O 0 5.922471957298114e-10
volunteers O 0 4.280015925006708e-11
having O 0 6.231631322073383e-10
phenotype O 0 7.220006636998733e-08
Hp2 O 0 3.261526515530022e-08
, O 0 9.614395217460991e-12
whereas O 0 3.82310398616692e-11
the O 0 3.823700037153266e-12
serum O 0 1.9534420747646664e-09
Hp O 0 8.631148240567654e-09
level O 0 7.105407373586559e-10
of O 0 4.0526430952411707e-13
an O 0 1.3053255308245748e-12
individual O 0 1.0989615250797669e-12
with O 0 5.401713104591366e-11
Hp1 O 0 0.00015769799938425422
/ O 0 5.3360596211859956e-05
Hpdel O 0 5.369392511056503e-06
was O 0 4.795821268999134e-07
0 O 0 2.8476245805819644e-09
. O 0 1.264633509023838e-09

50 O 0 3.0674118534079753e-07
mg O 0 0.000619866419583559
/ O 0 4.829090175917372e-05
ml O 0 2.319035957043525e-06
, O 0 4.508293044436229e-11
which O 0 8.375785308378791e-12
was O 0 8.275907736887689e-10
approximately O 0 8.054602449424075e-13
half O 0 1.1214069603471266e-11
the O 0 6.275267631916659e-12
level O 0 1.5721719759387298e-10
of O 0 4.255420343358962e-13
Hp O 0 7.503946908293813e-10
in O 0 5.2683062773395406e-11
control O 0 9.392659094942246e-09
sera O 0 1.7293604059887002e-07
from O 0 5.477200290537887e-11
the O 0 1.9489082569990046e-10
Hp1 O 0 2.9225820981082506e-06
phenotype O 0 4.229594026128325e-07
( O 0 1.0232933250753362e-10
1 O 0 9.113587662312739e-11
. O 0 8.917614563452858e-11
26 O 0 2.221178130312751e-09
+ O 0 2.0168595682434898e-08
/ O 0 1.107258214005924e-07
- O 0 1.318361597668627e-08
0 O 0 1.5124708430125366e-10
. O 0 2.0911475676066438e-11
33 O 0 4.361564887034319e-09
mg O 0 7.512840238632634e-05
/ O 0 1.0832287671291851e-06
ml O 0 1.2218347933412588e-07
; O 0 2.3349938302330564e-11
n O 0 6.125504103948742e-09
= O 0 9.284824464828034e-09
9 O 0 2.3465058784921666e-09
) O 0 7.578171597188987e-12
, O 0 2.1663055464055114e-12
showing O 0 6.016012688014882e-10
a O 0 1.5451753765383103e-10
gene O 0 1.3533407638988137e-07
- O 0 3.3321984460599197e-07
dosage O 0 1.554618165755528e-06
effect O 0 6.198433766257949e-08
. O 0 4.096748718040999e-09

The O 0 1.6834971194867876e-09
other O 0 3.538966064642324e-10
allele O 0 1.0782962789335215e-07
( O 0 4.088245852962302e-10
Hp2 O 0 5.2150571860920536e-08
) O 0 8.08115119960151e-12
of O 0 2.566835361882819e-13
individuals O 0 4.5244835438981723e-13
with O 0 5.002229967049354e-12
Hp2 O 0 2.6368259113951353e-06
/ O 0 4.429535238159588e-06
Hpdel O 0 2.1526810201066837e-07
was O 0 4.10971878750388e-08
found O 0 7.604541996109049e-11
to O 0 1.6176859114411246e-12
have O 0 6.856438333757708e-11
, O 0 1.052947551198613e-12
in O 0 7.1883336956457544e-12
all O 0 1.358152414317193e-12
exons O 0 1.3499616702272732e-10
, O 0 9.0238979483237e-12
no O 0 8.344600010978809e-11
mutation O 0 1.1075565464757631e-10
, O 0 3.4189370085035975e-12
by O 0 2.2579525055244076e-12
DNA O 0 1.9308459275890755e-09
sequencing O 0 1.4164500683477854e-08
. O 0 2.2066815041910104e-09

On O 0 1.1000039101816128e-08
the O 0 7.65439447936167e-12
basis O 0 1.6036595662516362e-11
of O 0 1.69913277783644e-13
the O 0 1.223408418841998e-12
present O 0 2.9107935679839603e-12
study O 0 1.7265407853406245e-11
, O 0 1.1995418764190746e-12
the O 0 5.818578583359491e-13
mechanism O 0 6.257617340965638e-11
of O 0 1.6736846283893492e-12
anhaptoglobinemia B-Disease 0 6.6525231545711e-08
and O 0 3.9504406690316074e-11
the O 0 3.4433473867362396e-12
mechanism O 0 8.276093005354923e-11
of O 0 1.1021143849973547e-12
anomalous O 0 2.646058705479959e-09
inheritance O 0 7.831173043371109e-09
of O 0 5.221558255219527e-11
Hp O 0 7.844062821504849e-08
phenotypes O 0 2.213802829942324e-08
were O 0 5.4556885231704655e-08
well O 0 7.129344226086687e-09
explained O 0 2.5272106185525445e-08
. O 0 1.0702592145861445e-09

However O 0 3.218693578332932e-08
, O 0 5.8126389118617894e-11
the O 0 4.8906057155406746e-12
mechanism O 0 4.887421578558815e-10
of O 0 7.909641691616898e-12
hypohaptoglobinemia B-Disease 0 1.0731192787716282e-06
remains O 0 5.999998364814019e-08
unknown O 0 1.7809936991852737e-07

ATM O 0 9.738062362885103e-05
mutations O 0 2.485194499968202e-06
and O 0 1.5749368476036807e-09
phenotypes O 0 2.906511724631855e-07
in O 0 6.179821411933517e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 0.00031907885568216443
in O 0 4.053432256512224e-09
the O 0 5.828425242437874e-11
British O 0 1.6426916715772677e-07
Isles O 0 5.435745720205887e-08
: O 0 2.0150482844816242e-12
expression O 0 3.1027994843585427e-12
of O 0 9.012295711140553e-14
mutant O 0 3.2816976913707663e-10
ATM O 0 2.2363595419960802e-08
and O 0 1.9208233961731658e-11
the O 0 6.833783539050842e-12
risk O 0 1.428618334742282e-09
of O 0 5.245855486113449e-11
leukemia B-Disease 1 0.9999033212661743
, O 0 0.00022429721138905734
lymphoma B-Disease 1 1.0
, O 0 7.128625725272286e-07
and O 0 6.070149538572878e-06
breast B-Disease 0 0.08087694644927979
cancer I-Disease 0 4.6647965064039454e-05
. O 0 5.729630458972679e-08

We O 0 2.91466069057833e-08
report O 0 4.027159716812889e-10
the O 0 9.827344016680173e-13
spectrum O 0 1.2323865539176637e-10
of O 0 3.520817968769019e-12
59 O 0 8.425111164278576e-10
ATM O 0 2.9812628099534777e-07
mutations O 0 1.4380892920939914e-08
observed O 0 3.874154330674173e-09
in O 0 1.4130996532912832e-05
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.01878966949880123
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 3.30636562573261e-09
patients O 0 2.8915922101191427e-08
in O 0 1.3460740855286701e-10
the O 0 8.555106623120423e-11
British O 0 3.15504848913406e-07
Isles O 0 9.333226671515149e-07
. O 0 3.2247877701507832e-09

Of O 0 9.668432721099407e-10
51 O 0 1.4519138780144658e-08
ATM O 0 2.9092379350004194e-07
mutations O 0 1.2265206628114811e-08
identified O 0 4.432210598537267e-09
in O 0 8.46586134528593e-11
families O 0 3.684939506309881e-12
native O 0 1.5419155535711937e-11
to O 0 5.1590494029585265e-12
the O 0 2.502031221096601e-11
British O 0 2.684113269424415e-06
Isles O 0 1.5717168935225345e-06
, O 0 3.629202494082051e-11
11 O 0 2.517296440740502e-11
were O 0 1.0047209592078943e-10
founder O 0 3.156790384650776e-10
mutations O 0 2.8837974230810914e-09
, O 0 1.0631619890011379e-10
and O 0 1.3377940422110157e-10
2 O 0 1.6581477510491105e-11
of O 0 1.2360316763160295e-12
these O 0 5.589800497474151e-11
11 O 0 7.078512775926527e-11
conferred O 0 8.170411569530245e-11
a O 0 1.4497952838254946e-10
milder O 0 9.987381781684235e-05
clinical O 0 9.712625796964858e-06
phenotype O 0 1.9189245392681187e-07
with O 0 1.901851766350493e-11
respect O 0 3.2771233643424935e-11
to O 0 3.3668831611599614e-11
both O 0 1.8775179189134406e-09
cerebellar B-Disease 0 1.7783724615583196e-05
degeneration I-Disease 1 0.9612186551094055
and O 0 7.233277532492366e-09
cellular O 0 3.917477044979023e-07
features O 0 5.579316919579469e-08
. O 0 1.975663188602539e-08

We O 0 6.006249719803236e-08
report O 0 1.6591111817731985e-09
, O 0 2.229323713479059e-12
in O 0 1.0090799723583288e-11
two O 0 1.406715716134599e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 1.5171636169597491e-09
, O 0 2.796369039104185e-12
an O 0 1.776599158585801e-12
ATM O 0 1.0217476074103615e-06
mutation O 0 4.62063454165218e-09
( O 0 1.1186943732477417e-10
7271T O 0 6.700966537209752e-08
- O 0 5.39019367806759e-07
- O 0 2.0546447103697574e-06
> O 0 6.522580697776448e-09
G O 0 4.483198701166202e-09
) O 0 1.5634593229438276e-12
that O 0 1.9239538347898266e-12
may O 0 4.648931462014616e-09
be O 0 1.5719094862559624e-12
associated O 0 2.119103937464617e-12
with O 0 3.1056575497054317e-13
an O 0 1.2415015846964361e-12
increased O 0 4.728495817118983e-09
risk O 0 6.665783303105854e-08
of O 0 1.258801812786814e-10
breast B-Disease 0 6.28330308245495e-05
cancer I-Disease 0 3.100770982200629e-07
in O 0 1.217281497822853e-09
both O 0 1.7503763993786947e-09
homozygotes O 0 7.095405294421653e-07
and O 0 1.5767695482615807e-10
heterozygotes O 0 5.1124626310183885e-08
( O 0 2.1430346386352994e-10
relative O 0 2.4670061549159072e-08
risk O 0 1.1227697314097895e-06
12 O 0 1.2223395629007427e-09
. O 0 1.6121546805858422e-11
7 O 0 2.2060279991631404e-10
; O 0 1.2846802788235578e-10
P O 0 0.003007797058671713
= O 0 1.3637074580685749e-08
. O 0 3.202621501330327e-10
0025 O 0 3.5279813914712577e-07
) O 0 4.1949999030066465e-11
, O 0 5.878192464031651e-12
although O 0 6.277604824855842e-11
there O 0 4.63370938841301e-11
is O 0 2.5878667698348012e-12
a O 0 1.8505526971912545e-11
less O 0 2.642741314673458e-08
severe O 0 0.12212085723876953
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 1.0953289347526152e-05
in O 0 4.5012152338763656e-10
terms O 0 1.520459591564105e-10
of O 0 3.466766262082144e-13
the O 0 8.268609755224254e-12
degree O 0 8.976429377582917e-09
of O 0 2.2442495084540326e-10
cerebellar B-Disease 0 6.0805621615145355e-05
degeneration I-Disease 1 0.8325786590576172
. O 0 5.296495331208462e-08

This O 0 9.665303224437594e-09
mutation O 0 5.267761693517059e-08
( O 0 1.0197166444569916e-09
7271T O 0 1.4994067498719232e-07
- O 0 9.177293236461992e-07
- O 0 6.415867574105505e-06
> O 0 1.649582692664353e-08
G O 0 1.8384742617172378e-08
) O 0 5.371381724822433e-12
also O 0 2.485013063380226e-12
allows O 0 1.6466746586077385e-12
expression O 0 1.6644947573030144e-11
of O 0 8.806788848528257e-13
full O 0 1.037342156617882e-10
- O 0 5.219131238298758e-10
length O 0 4.6419895705085423e-11
ATM O 0 1.1313168180038247e-08
protein O 0 1.3360421102781572e-10
at O 0 1.607399352510086e-10
a O 0 4.668749328112787e-12
level O 0 7.005178381813693e-11
comparable O 0 6.254968071273126e-11
with O 0 9.745344722172922e-13
that O 0 1.5703461100913252e-11
in O 0 3.418249294728781e-10
unaffected O 0 9.568749703703361e-08
individuals O 0 2.208476977683116e-11
. O 0 3.520385094546441e-10

In O 0 6.050123069201163e-09
addition O 0 1.3428889944488986e-10
, O 0 2.1139135580883206e-11
we O 0 4.882049625676288e-12
have O 0 2.79628924182429e-12
studied O 0 4.335992898063523e-09
18 O 0 4.1917567195071115e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 6.110113463364542e-05
, O 0 1.991535235335018e-11
in O 0 5.6993427338669633e-11
15 O 0 1.0697973062967492e-10
families O 0 6.789260126316421e-12
, O 0 4.428046471161018e-12
who O 0 4.0040595838952697e-10
developed O 0 6.39257559669204e-05
leukemia B-Disease 1 0.9999998807907104
, O 0 0.0022434282582253218
lymphoma B-Disease 1 1.0
, O 0 4.563789790523742e-09
preleukemic O 0 1.614536995475646e-05
T O 0 8.054777572397143e-05
- O 0 4.936207460559672e-07
cell O 0 3.294317593827145e-06
proliferation O 0 2.6803614673553966e-05
, O 0 8.273197238395369e-09
or O 0 0.3015214502811432
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 6.790034312587068e-09
mostly O 0 9.457045146987753e-10
in O 0 3.420298710921088e-09
childhood O 0 1.5686383392221614e-07
. O 0 3.7679157571801625e-09

A O 0 1.1346777029075383e-07
wide O 0 3.794803582479744e-09
variety O 0 1.056344678396215e-09
of O 0 1.2206563017314043e-11
ATM O 0 5.993277682136977e-06
mutation O 0 5.460807805945933e-09
types O 0 4.052489011030502e-09
, O 0 2.223379813592885e-11
including O 0 1.4409232487744283e-11
missense O 0 7.202797405625461e-06
mutations O 0 1.174337512566126e-06
and O 0 6.7800565162201565e-09
in O 0 9.741855677702915e-08
- O 0 0.00022757153783459216
frame O 0 9.962180229194928e-06
deletions O 0 4.872403565059358e-07
, O 0 3.20991094815426e-10
were O 0 6.280482800491427e-10
seen O 0 1.581263897598717e-09
in O 0 7.504057791818397e-11
these O 0 1.6100374505834125e-11
patients O 0 5.189194629551253e-10
. O 0 2.0638747655343792e-10

We O 0 8.713539223492717e-09
also O 0 4.916346149630435e-11
show O 0 6.327975643483086e-11
that O 0 4.575776389736941e-12
25 O 0 1.0078719976658324e-11
% O 0 1.1487116596473057e-12
of O 0 3.072650369816826e-13
all O 0 3.2940264405034725e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 4.781390543939779e-06
carried O 0 4.872754200135887e-09
in O 0 3.692712802205733e-09
- O 0 4.953014354214247e-07
frame O 0 1.4152961114177742e-07
deletions O 0 1.2265655868759495e-07
or O 0 7.620521991213991e-09
missense O 0 1.3155580518287024e-06
mutations O 0 2.9296758796704125e-08
, O 0 3.3128135651372403e-11
many O 0 1.8652046053502236e-12
of O 0 1.0017114633435742e-13
which O 0 1.7194716137036714e-11
were O 0 1.333993715491033e-08
also O 0 1.5825717472606193e-11
associated O 0 3.911152218066816e-12
with O 0 6.951266276998547e-13
expression O 0 2.6957346077605138e-11
of O 0 2.1543027778347934e-12
mutant O 0 1.5873740100147415e-09
ATM O 0 1.552980819496952e-07
protein O 0 4.2031274460896384e-08
. O 0 3.890222366464968e-09

The O 0 1.0320344578929053e-08
DMPK O 0 2.1266248495521722e-06
gene O 0 2.0498953290370991e-07
of O 0 6.243052186327702e-10
severely O 0 0.00825937557965517
affected O 0 3.069318336201832e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9618314504623413
is O 0 6.669163887806917e-09
hypermethylated O 0 1.2650415328607778e-06
proximal O 0 8.401287345805031e-07
to O 0 6.693858245476747e-10
the O 0 1.2539493055019335e-10
largely O 0 1.3318269820317141e-09
expanded O 0 1.9363493919399843e-08
CTG O 0 4.256204647390405e-06
repeat O 0 5.339003905646678e-07
. O 0 8.778195947911627e-09

Using O 0 5.9437187616140363e-08
methylation O 0 7.724653187324293e-06
- O 0 1.154193978436524e-05
sensitive O 0 4.211690054489736e-07
restriction O 0 7.603476959161526e-09
enzymes O 0 4.336100367652307e-09
, O 0 5.360134645165937e-12
we O 0 4.103154881834881e-12
characterized O 0 5.344525169648229e-12
the O 0 1.2826131649823491e-11
methylation O 0 5.915241274578875e-08
pattern O 0 1.7115664263656072e-07
on O 0 5.776305656013392e-09
the O 0 2.0640864017984484e-11
5 O 0 2.4879121332532783e-11
side O 0 1.2240304603228225e-10
of O 0 1.151157186067564e-12
the O 0 5.0366506104682074e-11
CTG O 0 1.5708268108483026e-07
repeat O 0 2.6582651635465027e-09
in O 0 3.385235147757015e-11
the O 0 1.1708569010171477e-11
DMPK O 0 7.755630804240354e-09
gene O 0 3.740646126182412e-10
of O 0 1.3829703441464725e-12
normal O 0 2.141535143662665e-10
individuals O 0 1.785986397835615e-12
and O 0 1.2351179974612325e-11
of O 0 2.0174480575702036e-12
patients O 0 7.963539272459741e-10
affected O 0 7.077003982836061e-10
with O 0 8.92577389777216e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 2.1010926332110103e-09
showing O 0 9.784757004638323e-09
expansions O 0 1.5091814020706806e-08
of O 0 2.8455149694850412e-11
the O 0 1.6838173910738163e-10
repetitive O 0 1.6417614290276106e-07
sequence O 0 8.038442800284429e-09
. O 0 3.5137521781081205e-09

The O 0 2.284925137985283e-09
gene O 0 1.994944653915809e-08
segment O 0 1.848911423962818e-08
analyzed O 0 1.3672540877252004e-09
corresponds O 0 1.7369693183777457e-10
to O 0 1.693110755762728e-11
the O 0 2.1819941686818112e-11
genomic O 0 7.184973060958555e-09
SacI O 0 4.513265594141558e-06
- O 0 2.1028682795076747e-07
HindIII O 0 9.263689548788534e-08
fragment O 0 3.8113803668693436e-08
carrying O 0 4.0259946487708476e-09
exons O 0 7.295019344155662e-08
11 O 0 1.7234340177196827e-08
- O 0 2.604207907097589e-07
15 O 0 2.979723356943964e-09
. O 0 1.5049895774055244e-09

There O 0 2.7672548696955346e-09
is O 0 1.0043683940086368e-10
constitutive O 0 4.563894595577267e-09
methylation O 0 6.418459719270686e-08
in O 0 8.022815189967503e-10
intron O 0 3.6953574067410955e-07
12 O 0 5.728334473431573e-10
at O 0 6.542472119619447e-11
restriction O 0 6.076183306502614e-11
sites O 0 1.808567531846883e-11
of O 0 1.7964647781518184e-12
SacII O 0 6.023251586384504e-08
and O 0 3.1202923578277364e-10
HhaI O 0 4.833803757264832e-08
, O 0 1.7088002887688525e-11
localized O 0 9.37915634047215e-10
1 O 0 2.4935284392846313e-10
, O 0 4.472970258073694e-11
159 O 0 1.1716071668388395e-08
- O 0 1.7319294443041144e-08
1 O 0 2.2227110429984265e-10
, O 0 3.0977866105619256e-11
232 O 0 1.7731749402116748e-10
bp O 0 5.499209088100088e-09
upstream O 0 1.1547295758473908e-10
of O 0 7.514935397058553e-13
the O 0 7.718976499648811e-12
CTG O 0 2.2632086427165632e-08
repeat O 0 2.3721289377220955e-09
, O 0 4.5445335862537295e-12
whereas O 0 7.562331837129843e-12
most O 0 8.525553527038987e-12
, O 0 2.9631863369267153e-12
if O 0 4.791459329994696e-12
not O 0 1.3644730310902187e-11
all O 0 5.664634885292619e-13
, O 0 1.4422993778028664e-13
of O 0 1.4191906588171925e-14
the O 0 1.0664118378503687e-13
other O 0 2.3021867615394265e-13
sites O 0 6.24711957511459e-12
of O 0 4.772576106017168e-13
SacII O 0 2.6627562377257163e-09
, O 0 2.4907513551664096e-11
HhaI O 0 8.613961988146457e-09
, O 0 1.9788431310230337e-11
and O 0 2.7098287155857825e-11
HpaII O 0 8.662500050604649e-09
in O 0 6.095963317465092e-11
this O 0 4.324627136433057e-13
region O 0 2.1819983320181535e-11
are O 0 1.6057041113404225e-11
unmethylated O 0 7.756074893450204e-09
, O 0 2.8014728124109434e-12
in O 0 5.352706992922673e-12
normal O 0 1.2227213685989113e-10
individuals O 0 6.415102823953411e-13
and O 0 4.076927163920718e-12
most O 0 1.8629397070119014e-12
of O 0 2.2118050934608752e-13
the O 0 3.9055335354643006e-11
patients O 0 3.756864597193044e-09
. O 0 6.764926951952077e-10

In O 0 1.52557966259792e-08
a O 0 1.3796969122736868e-10
number O 0 1.833785553961853e-11
of O 0 3.168792051672087e-12
young O 0 3.570549633735709e-09
and O 0 4.1307049447603106e-10
severely O 0 1.1309680303384084e-05
affected O 0 1.0096817826266147e-09
patients O 0 5.168433681035367e-09
, O 0 1.0876037050133736e-11
however O 0 1.6988827011843455e-10
, O 0 7.527979975496812e-12
complete O 0 2.4648340660182733e-11
methylation O 0 9.312417503792858e-10
of O 0 2.8870276395226435e-13
these O 0 8.759246041163682e-13
restriction O 0 1.4297344558267255e-11
sites O 0 5.4012187084007124e-11
was O 0 1.7112252725937083e-09
found O 0 1.1457389897939763e-10
in O 0 4.30595593903238e-11
the O 0 6.445181888192764e-11
mutated O 0 2.5459880248490663e-07
allele O 0 9.338194786323584e-07
. O 0 1.5688215171394404e-08

In O 0 1.0188364818475293e-08
most O 0 7.331009410638245e-11
of O 0 2.4038152653289846e-13
these O 0 1.795704318748037e-12
patients O 0 6.550650993863982e-11
, O 0 5.616416077873498e-13
the O 0 4.84868829114804e-12
onset O 0 1.1613194850212949e-08
of O 0 3.0190663337370527e-12
the O 0 5.138490744016622e-10
disease O 0 3.270470187999308e-05
was O 0 7.830097456462681e-05
congenital O 1 0.9999549388885498
. O 0 3.1453563309469246e-08

Preliminary O 0 5.99512475218944e-07
in O 0 8.19076628744142e-09
vivo O 0 7.783826276863692e-07
footprinting O 0 1.052885295393935e-06
data O 0 1.6751754428057097e-09
gave O 0 8.434496850950879e-11
evidence O 0 1.3966360186412619e-11
for O 0 4.903212167881033e-13
protein O 0 1.2898954127038564e-10
- O 0 1.5666260511082442e-09
DNA O 0 4.659415520080756e-09
contact O 0 3.875780141271434e-09
in O 0 7.830959769528079e-10
normal O 0 2.1686488160810313e-09
genes O 0 6.859346424192836e-10
at O 0 1.7523631157256858e-10
an O 0 2.5152744470569033e-12
Sp1 O 0 6.42086606106318e-10
consensus O 0 6.568191129874279e-11
binding O 0 1.429189960822086e-10
site O 0 2.1642511394137642e-10
upstream O 0 3.559627315130598e-10
of O 0 1.6668925354595965e-12
the O 0 3.248409527478735e-11
CTG O 0 9.15983449090163e-08
repeat O 0 2.656759701125111e-09
and O 0 3.711589195709575e-12
for O 0 8.152031431623782e-14
a O 0 6.353971710761075e-13
significant O 0 1.584891592965043e-11
reduction O 0 6.096405325006771e-11
of O 0 1.582908202299796e-13
this O 0 9.980046303259549e-13
interaction O 0 5.536985366733083e-12
in O 0 1.0360839790279908e-11
cells O 0 2.268988469333877e-11
with O 0 3.858190676664375e-12
a O 0 1.1300589353169244e-09
hypermethylated O 0 1.560955865897995e-06
DMPK O 0 8.447386790066957e-07
gene O 0 4.006309595183666e-08
. O 0 5.152191451252008e-10
. O 0 1.081574607653124e-09

The O 0 9.364077158124928e-08
hemochromatosis B-Disease 1 0.9999997615814209
gene O 0 1.433802054862099e-07
product O 0 2.0240225051537664e-09
complexes O 0 1.2754033384965169e-09
with O 0 4.287244170786408e-12
the O 0 5.816928102392316e-12
transferrin O 0 4.1189847088674014e-09
receptor O 0 1.356937562313476e-09
and O 0 4.297597278046794e-10
lowers O 0 4.3820778117265036e-09
its O 0 2.7576612868229766e-12
affinity O 0 1.0017607576795484e-10
for O 0 2.8797914573830408e-12
ligand O 0 5.120517898582477e-10
binding O 0 6.842166833109786e-09
. O 0 3.931329928263949e-09

We O 0 1.6739754471473134e-08
recently O 0 4.232294958939065e-09
reported O 0 1.3762702089081813e-09
the O 0 4.450832497698842e-12
positional O 0 1.6281636039394698e-09
cloning O 0 9.282836721524745e-10
of O 0 9.750978236661156e-13
a O 0 3.2701615720887034e-11
candidate O 0 1.9064589906747642e-09
gene O 0 2.4309081254614284e-06
for O 0 1.04611638107599e-06
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 0 2.186777965107467e-05
HFE O 0 0.00927978940308094
. O 0 2.0614579909761233e-07

The O 0 1.585965941908185e-10
gene O 0 2.7719140316406765e-09
product O 0 1.1939536026517317e-09
, O 0 1.5695434535389907e-11
a O 0 8.269781387459929e-11
member O 0 2.071691845850765e-10
of O 0 1.1378932735298108e-12
the O 0 1.1919386484759986e-11
major O 0 1.694559076392821e-10
histocompatibility O 0 7.2282850815952315e-09
complex O 0 6.780354055990756e-09
class O 0 6.439256594603648e-07
I O 0 0.0014957422390580177
- O 0 5.399689584351108e-09
like O 0 2.0777306264374573e-10
family O 0 7.351396574817315e-11
, O 0 3.5889930350557764e-12
was O 0 1.036318142411119e-09
found O 0 1.9334900000500532e-11
to O 0 1.3361350871196609e-12
have O 0 1.1608687622288727e-10
a O 0 1.6187554074953425e-10
mutation O 0 3.973462447959264e-09
, O 0 3.0194668987348905e-10
Cys O 0 0.0001355276326648891
- O 0 2.6969453870151483e-07
282 O 0 2.279773298141663e-06
- O 0 2.485332061041845e-06
- O 0 1.03029969977797e-06
> O 0 1.2284497863390698e-08
Tyr O 0 8.381970673099204e-08
( O 0 8.604100765197131e-11
C282Y O 0 3.2839406749474165e-09
) O 0 6.719306534785918e-12
, O 0 7.510006613982434e-13
in O 0 3.886063346114632e-12
85 O 0 8.510497168101594e-11
% O 0 1.7834648688430654e-11
of O 0 1.2227417862942236e-11
patient O 0 4.056798630358571e-08
chromosomes O 0 7.264984702715083e-08
. O 0 7.974365168195163e-09

This O 0 5.1421014113373076e-09
mutation O 0 4.775284168090366e-08
eliminates O 0 2.4100465623178025e-08
the O 0 9.780156545735608e-11
ability O 0 1.0718669285481042e-09
of O 0 4.96530984731014e-12
HFE O 0 4.6042384838074213e-07
to O 0 6.925243017930072e-11
associate O 0 5.595947594194683e-10
with O 0 2.220536254871064e-11
beta2 O 0 0.00047361134784296155
- O 0 9.011095244204625e-05
microglobulin O 0 2.6050969609059393e-05
( O 0 4.308529644170278e-10
beta2m O 0 1.429036586841903e-07
) O 0 8.986899766028067e-12
and O 0 6.725307376970191e-12
prevents O 0 4.3347395117798726e-11
cell O 0 3.1723911320113984e-07
- O 0 4.170276213244506e-07
surface O 0 8.703373133300829e-09
expression O 0 7.936976409439467e-09
. O 0 2.286477007729104e-09

A O 0 3.392677854208159e-07
second O 0 1.253293024916502e-08
mutation O 0 5.1785380428270855e-09
that O 0 6.233839139335728e-11
has O 0 7.275666180639462e-11
no O 0 7.549998820577386e-11
effect O 0 1.0092158220231795e-09
on O 0 2.27504148853086e-08
beta2m O 0 2.2809861377481866e-07
association O 0 2.3267790472125682e-10
, O 0 1.2307227285901501e-11
H63D O 0 2.1503132074940368e-07
, O 0 7.41683103822055e-11
was O 0 1.4777684853584105e-08
found O 0 4.332162961695474e-10
in O 0 2.039588775648582e-10
eight O 0 2.0661751476414025e-10
out O 0 3.1825611590541314e-11
of O 0 1.1519543999249926e-12
nine O 0 3.6680297688107544e-10
patients O 0 3.189526975866386e-10
heterozygous O 0 8.025876074846394e-10
for O 0 1.1432149497891952e-11
the O 0 1.0300589547984629e-10
C282Y O 0 1.3404240917225252e-07
mutant O 0 2.903273355059355e-07
. O 0 1.3794719144755163e-08

In O 0 2.030895274174327e-08
this O 0 1.5940845865536346e-10
report O 0 3.3035524316105125e-10
, O 0 2.1058398080864293e-12
we O 0 9.473875677012966e-13
demonstrate O 0 3.855557366427842e-12
in O 0 3.75637368432713e-11
cultured O 0 5.009611214745746e-08
293 O 0 2.3093382761629755e-09
cells O 0 1.7827661569214115e-09
overexpressing O 0 1.6668869307068235e-07
wild O 0 5.538472347410561e-09
- O 0 1.3489879790995474e-07
type O 0 1.0086912283213678e-07
or O 0 1.1120362408689743e-09
mutant O 0 8.705365317496216e-09
HFE O 0 4.3731631649279734e-07
proteins O 0 2.6479052284145155e-10
that O 0 9.128318760598386e-12
both O 0 2.3015909924456457e-12
the O 0 5.9548724458402535e-12
wild O 0 6.277009467758887e-10
- O 0 4.4018963762937346e-07
type O 0 3.082148850808153e-06
and O 0 4.937494857415459e-09
H63D O 0 1.1427772506067413e-06
HFE O 0 1.0037969104814692e-06
proteins O 0 1.1871502669791312e-09
form O 0 3.846408747065766e-10
stable O 0 2.3192667342186724e-08
complexes O 0 3.1564711955311964e-10
with O 0 3.9561166842450035e-12
the O 0 2.3589562594961144e-11
transferrin O 0 1.623980416809445e-08
receptor O 0 9.170249448686718e-09
( O 0 6.33269936489711e-10
TfR O 0 1.6808883174235234e-06
) O 0 6.699593657621961e-10
. O 0 1.255500703400969e-09

The O 0 6.723984036227648e-09
C282Y O 0 4.835159188587568e-07
mutation O 0 3.617066113292822e-08
nearly O 0 1.5531333996676722e-09
completely O 0 3.09991143865318e-09
prevents O 0 1.7123247264549946e-10
the O 0 3.840144782024657e-12
association O 0 1.34395689022071e-11
of O 0 5.635427766255939e-14
the O 0 3.689257666722456e-12
mutant O 0 2.43305553482287e-09
HFE O 0 1.7005726249408326e-07
protein O 0 2.2005952615700153e-09
with O 0 3.0322720029341e-11
the O 0 3.7024153187736886e-10
TfR O 0 1.2259391041880008e-05
. O 0 3.4845397678395784e-09

Studies O 0 2.9375550525401195e-07
on O 0 4.265001241066102e-09
cell O 0 1.014218469208572e-07
- O 0 6.249431550031659e-08
associated O 0 8.029306108880974e-10
transferrin O 0 2.03445846835848e-08
at O 0 2.0776045328574355e-09
37 O 0 6.855971346197975e-10
degrees O 0 1.8244803001721266e-08
C O 0 9.237625818059314e-06
suggest O 0 1.5264811636939157e-09
that O 0 2.0147187737573624e-11
the O 0 2.068851513714609e-11
overexpressed O 0 8.343847923697467e-08
wild O 0 2.238137897236925e-09
- O 0 2.7973884542120686e-08
type O 0 3.8927627343809945e-08
HFE O 0 4.39573369703794e-07
protein O 0 2.2390986842424354e-09
decreases O 0 4.779324713766187e-10
the O 0 6.000524296195797e-12
affinity O 0 3.932932590711147e-10
of O 0 3.7992738295689055e-12
the O 0 6.483057146677851e-11
TfR O 0 1.0176792386573652e-07
for O 0 1.1857127779624221e-10
transferrin O 0 1.4259734371080413e-07
. O 0 5.063037100683232e-09

The O 0 5.35845590121653e-09
overexpressed O 0 5.62219247512985e-06
H63D O 0 1.3045909099673736e-06
protein O 0 5.719440032692091e-09
does O 0 3.702069484301518e-10
not O 0 1.8998216194665574e-11
have O 0 2.2995550776061524e-12
this O 0 2.0708116482432565e-13
effect O 0 4.9703435811565555e-11
, O 0 1.8630888932308354e-12
providing O 0 1.2967220613252506e-12
the O 0 7.229111515134889e-13
first O 0 2.8707643900949265e-12
direct O 0 7.914500652073109e-12
evidence O 0 2.5895285915567e-10
for O 0 2.506892913742287e-12
a O 0 1.7285936571020954e-11
functional O 0 1.3557700795363559e-10
consequence O 0 6.218285886205877e-10
of O 0 2.4279339389671195e-12
the O 0 1.1661059617917857e-10
H63D O 0 1.4067298934605788e-06
mutation O 0 5.7139690312624225e-08
. O 0 3.0313498378120585e-09

Addition O 0 3.0025435471259243e-09
of O 0 9.2818405739159e-11
soluble O 0 7.1647761501481e-08
wild O 0 1.4662180802815783e-08
- O 0 0.0001120936794904992
type O 0 0.006218344904482365
HFE O 1 0.7542414665222168
/ O 0 1.1573408301046584e-05
beta2m O 0 2.4844808876878233e-07
heterodimers O 0 1.85717468070834e-08
to O 0 5.659737956076327e-11
cultured O 0 3.962127337331367e-08
cells O 0 1.4678513959864858e-09
also O 0 5.1002216339135487e-11
decreased O 0 3.872896170431517e-10
the O 0 4.765354235346242e-13
apparent O 0 1.7735731286383505e-11
affinity O 0 1.284494038911177e-10
of O 0 6.903936515360865e-13
the O 0 1.481649698764631e-11
TfR O 0 5.087819499038915e-09
for O 0 2.1510291920052993e-13
its O 0 3.55553667020711e-13
ligand O 0 8.19887074898773e-11
under O 0 1.5369158723466114e-10
steady O 0 2.3099441932572518e-06
- O 0 6.6779208829359504e-09
state O 0 3.269051349064078e-11
conditions O 0 3.034776625554514e-07
, O 0 2.3291655062984695e-12
both O 0 2.388414769780023e-12
in O 0 2.6013685996972846e-11
293 O 0 6.434176108571776e-11
cells O 0 5.027618946162882e-11
and O 0 6.005118624585748e-11
in O 0 2.0112335408217774e-10
HeLa O 0 1.9189373290373624e-07
cells O 0 2.2633166452123987e-08
. O 0 1.0242452219699771e-08

Furthermore O 0 6.33658387982905e-08
, O 0 7.709184957072068e-10
at O 0 2.590160586013468e-10
4 O 0 4.4680589089685085e-11
degrees O 0 1.1347051440679934e-06
C O 0 0.24218875169754028
, O 0 3.236759194003014e-10
the O 0 1.7489770742784572e-10
added O 0 1.356939947072533e-07
soluble O 0 2.1439230390996045e-09
complex O 0 6.563060095388096e-10
of O 0 4.25375290546981e-11
HFE O 0 5.14892308274284e-05
/ O 0 1.27608734601381e-06
beta2m O 0 4.1921828142221784e-07
inhibited O 0 2.378264163382937e-08
binding O 0 1.6291762383602304e-09
of O 0 9.973733644530469e-12
transferrin O 0 7.773580890102494e-09
to O 0 1.5229062455546227e-10
HeLa O 0 1.6909775979456754e-07
cell O 0 5.290780791256111e-07
TfR O 0 2.124148068105569e-06
in O 0 3.009405225018469e-10
a O 0 4.701630751391406e-10
concentration O 0 1.1342881833797946e-07
- O 0 3.475328824720236e-08
dependent O 0 3.359427935833992e-08
manner O 0 3.1564871960654273e-07
. O 0 8.600402168212895e-09

Scatchard O 0 2.1165154976188205e-05
plots O 0 8.406338736222096e-08
of O 0 2.7018188034078072e-11
these O 0 3.484448190052558e-12
data O 0 5.6951807853034e-11
indicate O 0 1.1740868000043037e-10
that O 0 4.290909641491147e-12
the O 0 1.8188488909443024e-11
added O 0 3.5054317226723697e-09
heterodimer O 0 7.867639317815645e-10
substantially O 0 1.3270175180934984e-08
reduced O 0 1.2017094264127337e-10
the O 0 4.440598062871448e-12
affinity O 0 3.725067754256628e-10
of O 0 4.047376583188322e-12
TfR O 0 5.100161359905542e-08
for O 0 2.8830628856502116e-11
transferrin O 0 7.520087308421353e-08
. O 0 5.998965768583275e-09

These O 0 2.017785938335237e-09
results O 0 3.7004879716029393e-10
establish O 0 4.473636044943774e-11
a O 0 1.5211724241348534e-11
molecular O 0 2.692673306547988e-10
link O 0 1.2309969932289277e-08
between O 0 4.587755508822511e-09
HFE O 0 0.00010555490734986961
and O 0 1.696201790135632e-10
a O 0 2.476577797005941e-11
key O 0 1.465909726938719e-09
protein O 0 1.5368983863339736e-10
involved O 0 6.487237830254955e-11
in O 0 5.2321359050866434e-11
iron O 0 4.5631825429381934e-08
transport O 0 8.365288461931186e-10
, O 0 1.2951408175088108e-11
the O 0 1.1516672164535446e-11
TfR O 0 3.5525505381883704e-07
, O 0 2.9703347420584336e-11
and O 0 3.100423043300715e-11
raise O 0 1.8418199257408396e-11
the O 0 1.6645414430485617e-12
possibility O 0 5.846931272479594e-11
that O 0 1.9800739173292392e-11
alterations O 0 1.3952908162195854e-08
in O 0 7.425351999934549e-11
this O 0 3.952279475916143e-11
regulatory O 0 8.407621976402879e-08
mechanism O 0 7.0352328407352616e-09
may O 0 4.1025526087423714e-08
play O 0 3.586232144581203e-10
a O 0 4.676574232032049e-12
role O 0 2.1251360046714574e-11
in O 0 2.51594769323793e-11
the O 0 2.3562716014446927e-11
pathogenesis O 0 5.760762178397272e-08
of O 0 1.7693523091111274e-08
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 6.930869034249554e-08
. O 0 5.692482041297353e-09

Genomic O 0 7.378046689154871e-07
organization O 0 1.155312379097495e-08
of O 0 7.912179939006947e-11
the O 0 4.791144703197858e-10
UBE3A O 0 3.4724838769761845e-05
/ O 0 2.152439947167295e-06
E6 O 0 8.050580504459504e-07
- O 0 1.3296469205670292e-06
AP O 0 5.781009349448141e-06
gene O 0 3.491533817623349e-08
and O 0 4.714966195251691e-10
related O 0 6.5678471550256745e-09
pseudogenes O 0 2.0922104226883675e-07
. O 0 8.041478594122964e-09

The O 0 1.4075921761502741e-08
UBE3A O 0 3.0907851851225132e-06
gene O 0 5.500932687141358e-08
encodes O 0 1.262631332821229e-08
the O 0 3.8575251326555815e-10
E6 O 0 7.528439738280213e-08
- O 0 1.3783494523522677e-07
AP O 0 1.2722450719593326e-06
ubiquitin O 0 1.6745502762205433e-08
- O 0 6.298479959809811e-09
protein O 0 7.519047606763252e-10
ligase O 0 6.908004168693083e-10
and O 0 3.1450755194617486e-11
has O 0 1.0961192890845961e-11
recently O 0 2.0761539709646115e-10
been O 0 1.644892555496824e-11
shown O 0 3.2226552156011667e-12
to O 0 6.970597601733963e-13
be O 0 2.477210797602325e-11
mutated O 0 3.62244520601962e-07
in O 0 0.05531952157616615
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 0.0001463436201447621
who O 0 4.191692770660893e-09
lack O 0 5.671359826209255e-09
15q11 O 0 2.7297433007333893e-06
- O 0 4.957086730428273e-06
q13 O 0 1.0090950581798097e-06
deletions O 0 5.769712174696906e-07
or O 0 1.8481287611393782e-08
chromosome O 0 2.596193371573463e-05
15 O 0 2.7943967140231507e-08
paternal O 0 4.3103773350594565e-06
uniparental B-Disease 0 0.0029417492914944887
disomy I-Disease 0 0.0009572834242135286
. O 0 2.1747705147845409e-07

Previous O 0 3.250110012231744e-07
UBE3A O 0 3.736803364517982e-06
cDNA O 0 8.692295949686013e-08
analysis O 0 9.156022606759961e-09
has O 0 9.152242852472625e-11
shown O 0 4.40456421335611e-11
a O 0 1.7480367153765997e-10
coding O 0 8.548317254053472e-08
region O 0 1.2172514107788857e-09
of O 0 8.564669806698788e-12
approximately O 0 8.721478400586236e-11
2 O 0 3.5038455470370877e-10
. O 0 8.328258083167839e-10

6 O 0 2.1181015199545072e-06
kb O 0 2.0974916878913064e-06
and O 0 1.0981543452359688e-09
a O 0 1.4292451666619854e-09
3 O 0 5.715898510061379e-08
- O 0 0.0014710613759234548
untranslated O 0 0.0067649115808308125
region O 0 1.7786898069971357e-06
( O 0 4.508486473042694e-09
UTR O 0 1.703668175423445e-07
) O 0 2.021971479138074e-11
of O 0 2.2486864800774775e-12
< O 0 3.1254878685160747e-09
50 O 0 9.422363583810878e-11
bp O 0 7.085492370606516e-08
, O 0 4.749948264576309e-12
whereas O 0 3.886732602431664e-11
Northern O 0 7.08599637300189e-11
analysis O 0 1.4436557504993175e-10
has O 0 6.448846318063417e-11
indicated O 0 4.1516998172674846e-10
mRNA O 0 7.201237522957982e-11
sizes O 0 4.433781120027902e-10
of O 0 3.04487576645307e-12
5 O 0 1.826826356854383e-09
- O 0 2.895417310355697e-06
8 O 0 1.9238623139017363e-08
kb O 0 2.1465732515935088e-06
. O 0 4.8469108726578725e-09

We O 0 1.1722486092935469e-08
have O 0 4.193935823626482e-11
analyzed O 0 1.484484896119298e-10
additional O 0 2.647599587485283e-12
cDNA O 0 6.10307471227145e-10
clones O 0 3.751744692692682e-09
and O 0 1.513918851392404e-11
provide O 0 4.745022083585404e-12
evidence O 0 2.071066582121084e-11
for O 0 1.7151798644560179e-12
an O 0 1.846775336822315e-12
additional O 0 1.734452338697512e-11
0 O 0 1.6920149725763167e-09
. O 0 3.0521662974791752e-09

5 O 0 2.8220247827448475e-07
kb O 0 4.955405188411532e-07
of O 0 6.044568318097632e-11
5 O 0 3.307967899601749e-09
- O 0 9.717559805721976e-07
UTR O 0 2.3872823931014864e-06
and O 0 1.89791116156357e-09
> O 0 2.21659024468579e-09
2 O 0 1.4746388832254098e-10
kb O 0 7.198019602583372e-08
of O 0 5.375668313267745e-11
3 O 0 1.3991685143821542e-08
- O 0 5.251617949397769e-06
UTR O 0 1.927067023643758e-05
. O 0 3.9842333876549674e-08

We O 0 8.440974141876723e-09
have O 0 3.9103265764284245e-11
established O 0 7.526042289374146e-12
the O 0 6.436698504926064e-13
genomic O 0 1.0680460682532811e-10
organization O 0 4.0472087486920216e-11
of O 0 3.292678846592012e-12
UBE3A O 0 6.28345944164721e-08
and O 0 5.510417122600586e-11
the O 0 2.043835370044156e-12
sequence O 0 4.3792827003619195e-11
of O 0 6.723306807121521e-12
intron O 0 5.432055445453443e-07
- O 0 3.1604872674506623e-07
exon O 0 6.67820415856113e-07
borders O 0 1.9239674031723553e-07
. O 0 2.2705851421278567e-08

We O 0 4.3387082371282304e-08
have O 0 3.3991995329607505e-10
also O 0 3.8743570851540454e-11
mapped O 0 6.8548994258677e-10
two O 0 1.321214231769785e-11
highly O 0 8.469479284567427e-11
homologous O 0 5.186997498185519e-10
processed O 0 8.739233781085431e-10
pseudogenes O 0 2.763220097179442e-09
, O 0 6.089235365935863e-11
UBE3AP1 O 0 1.3448864422116458e-07
and O 0 9.28180518555699e-11
UBE3AP2 O 0 3.838190210103676e-08
, O 0 1.637497862999604e-12
to O 0 1.0659020324363389e-12
chromosomes O 0 2.719429681441454e-10
2 O 0 6.325368701043388e-11
and O 0 5.589493867752537e-10
21 O 0 2.3321118369779015e-09
, O 0 1.718724121357873e-11
respectively O 0 7.552480307815301e-10
, O 0 1.878465438753807e-11
and O 0 3.3631607915252104e-11
determined O 0 4.781494644667816e-10
their O 0 5.090820993924883e-12
genomic O 0 2.8243865024535353e-09
organization O 0 2.547778654715671e-09
. O 0 2.6014603804469516e-09

These O 0 1.9869992318177765e-09
results O 0 5.3894413376553985e-09
will O 0 1.0231892590140124e-11
form O 0 2.5858833303804563e-12
the O 0 1.1268438439293593e-12
basis O 0 8.720226797598318e-12
for O 0 2.5156040987274475e-13
studies O 0 2.095851270311755e-11
of O 0 9.628593495430993e-13
mutation O 0 7.388341605185644e-10
and O 0 3.2243432923628745e-10
imprinting O 0 7.405349577993547e-08
of O 0 1.2592317466531e-10
UBE3A O 0 7.8392076829914e-06
. O 0 2.58208867620624e-08

Mutation O 0 1.5496238120249473e-05
spectrum O 0 1.0128088661076617e-06
and O 0 5.6762978317692614e-08
genotype O 0 0.08009688556194305
- O 0 0.16381868720054626
phenotype O 0 8.798851013125386e-06
analyses O 0 1.5142019549330143e-07
in O 0 1.0410496464885455e-08
Cowden B-Disease 0 0.22456827759742737
disease I-Disease 0 0.00011378248746041209
and O 0 2.0628064589800488e-08
Bannayan B-Disease 1 0.9999258518218994
- I-Disease 1 1.0
Zonana I-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
, O 0 2.8491020653831356e-09
two O 0 1.6133683278241051e-09
hamartoma B-Disease 0 0.0028723531868308783
syndromes I-Disease 0 0.2831691801548004
with O 0 1.704388985501737e-08
germline O 0 0.0004487947153393179
PTEN O 0 0.003914447966963053
mutation O 0 1.791549402696546e-05
. O 0 1.1386777032384998e-07

The O 0 3.154835042096238e-07
tumour B-Disease 1 1.0
suppressor O 0 7.786301284795627e-05
gene O 0 6.179449883347843e-06
PTEN O 0 3.860845390590839e-05
, O 0 7.728810369478367e-10
which O 0 3.4983880375927257e-11
maps O 0 5.0620521108157845e-09
to O 0 6.161697818640732e-10
10q23 O 0 1.0680673767637927e-06
. O 0 5.038836903281663e-09

3 O 0 2.0004696565933955e-08
and O 0 1.2962041162634108e-10
encodes O 0 3.5137437404131333e-10
a O 0 2.918127198214826e-11
403 O 0 4.54183468612257e-10
amino O 0 1.0663815386280362e-09
acid O 0 2.0262667099757437e-09
dual O 0 2.2506434049773816e-08
specificity O 0 1.0666936844927477e-07
phosphatase O 0 0.00013120622315909714
( O 0 1.920773984309676e-09
protein O 0 8.786660288251369e-08
tyrosine O 0 2.195031356677646e-06
phosphatase O 0 3.6288714909460396e-05
; O 0 8.495045777934251e-10
PTPase O 0 1.2692308359874005e-07
) O 0 6.996992568675253e-11
, O 0 2.40789714556211e-11
was O 0 1.3718279845420511e-09
shown O 0 1.344290928573244e-10
recently O 0 2.3118381875519844e-08
to O 0 1.2187533100782577e-11
play O 0 1.2952903194474175e-09
a O 0 2.4563160533341843e-11
broad O 0 6.739246938280985e-10
role O 0 6.631665216971783e-10
in O 0 5.891848120498366e-10
human O 0 7.467937379601608e-10
malignancy B-Disease 0 2.166063950426178e-06
. O 0 3.735300957430354e-09

Somatic O 0 0.0003512547118589282
PTEN O 0 0.001201913459226489
deletions O 0 1.7548052710480988e-05
and O 0 1.3530331521849348e-08
mutations O 0 1.2364657742125473e-08
were O 0 6.1468724554814e-10
observed O 0 1.502304530776044e-10
in O 0 2.2515211917095712e-10
sporadic B-Disease 0 0.004108385648578405
breast I-Disease 1 0.5986749529838562
, I-Disease 0 1.0234332847858241e-07
brain I-Disease 1 0.907362699508667
, I-Disease 0 9.941862799678347e-08
prostate I-Disease 0 0.0068284738808870316
and I-Disease 0 2.431624182008818e-07
kidney I-Disease 0 1.5758558220113628e-05
cancer I-Disease 0 1.9506492208165582e-06
cell O 0 6.671225855825469e-05
lines O 0 0.00011311846901662648
and O 0 9.837719261440725e-08
in O 0 2.7462228047170356e-09
several O 0 7.747672503555236e-10
primary O 0 2.1113153252372285e-06
tumours B-Disease 1 1.0
such O 0 1.102784752404773e-09
as O 0 1.6826750197651563e-06
endometrial B-Disease 1 0.999819815158844
carcinomas I-Disease 1 1.0
, O 1 0.941118597984314
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9532968401908875
thyroid B-Disease 1 0.9999991655349731
tumours I-Disease 1 1.0
. O 0 1.0193810595637842e-07

In O 0 3.3842639801662244e-09
addition O 0 9.642607545767845e-11
, O 0 3.750109944800073e-11
PTEN O 0 8.329391789629881e-07
was O 0 2.0769004294152182e-08
identified O 0 2.224077588763862e-09
as O 0 1.0502924051303264e-11
the O 0 2.836058428032362e-12
susceptibility O 0 3.0586685961786486e-10
gene O 0 4.4172052682256435e-09
for O 0 1.4776062318144767e-10
two O 0 2.1220404988753216e-08
hamartoma B-Disease 1 0.9997345805168152
syndromes I-Disease 1 0.9999997615814209
Cowden B-Disease 1 0.9999984502792358
disease I-Disease 1 0.9999889135360718
( O 0 9.430827674350439e-08
CD B-Disease 0 3.652120994956931e-06
; O 0 4.252037832941369e-09
MIM O 0 0.021923566237092018
158350 O 0 8.023235409382323e-08
) O 0 2.2394434917583084e-10
and O 0 4.030263900389741e-10
Bannayan B-Disease 0 0.00011802494555013254
- I-Disease 0 0.00013082753866910934
Zonana I-Disease 0 5.105242598801851e-05
( I-Disease 0 1.0126383065411915e-09
BZS I-Disease 0 7.17237810476945e-07
) I-Disease 0 6.450248668521397e-11
or I-Disease 0 3.0485866608920276e-10
Ruvalcaba I-Disease 0 1.6564375755478977e-06
- I-Disease 0 3.2635784009471536e-05
Riley I-Disease 0 0.014998727478086948
- I-Disease 1 0.9999970197677612
Smith I-Disease 1 0.9973975419998169
syndrome I-Disease 1 0.9999878406524658
( O 0 4.2689891621705556e-09
MIM O 0 0.0002524359442759305
153480 O 0 3.258930973970564e-07
) O 0 1.6189972695812571e-09
. O 0 3.523503711022613e-09

Constitutive O 0 2.954534920718288e-06
DNA O 0 5.059357590653235e-07
from O 0 2.4247908125829554e-09
37 O 0 3.6418335014332115e-09
CD B-Disease 0 2.2042973668590093e-08
families O 0 7.690690445594228e-11
and O 0 7.417141900667445e-11
seven O 0 9.28191135063372e-11
BZS B-Disease 0 3.827385626209434e-07
families O 0 8.106829096909962e-11
was O 0 2.810054133828288e-10
screened O 0 2.9548155033864987e-09
for O 0 4.118304655631455e-11
germline O 0 2.136891680493136e-06
PTEN O 0 4.090007860213518e-05
mutations O 0 1.26105805975385e-06
. O 0 2.6638751648988546e-08

PTEN O 0 0.0001526985870441422
mutations O 0 4.082647819814156e-07
were O 0 3.762343325774964e-09
identified O 0 1.3013424782215566e-09
in O 0 3.9323457684536933e-11
30 O 0 3.352337157869201e-11
of O 0 9.630320629491762e-13
37 O 0 1.0893549395873947e-09
( O 0 1.2625554768330716e-10
81 O 0 1.90083220275028e-08
% O 0 3.6118785740058e-10
) O 0 4.012053883561961e-11
CD B-Disease 0 2.0404746692292974e-07
families O 0 3.4901900813899545e-11
, O 0 1.1863313066282077e-12
including O 0 6.5140414763631416e-12
missense O 0 5.13720124217798e-06
and O 0 3.069319376436397e-08
nonsense O 0 2.2693466235068627e-05
point O 0 1.0691334928480956e-08
mutations O 0 2.1204171751776357e-09
, O 0 2.7102214569807437e-11
deletions O 0 3.4754994437946607e-09
, O 0 2.0280742363265603e-11
insertions O 0 1.2762216172745866e-08
, O 0 5.3837032054637746e-11
a O 0 4.905408856892279e-10
deletion O 0 1.9485462416923838e-06
/ O 0 1.6855756257427856e-06
insertion O 0 5.8694887172805466e-08
and O 0 2.41170061698881e-09
splice O 0 6.832923645561095e-06
site O 0 1.5605495207182685e-07
mutations O 0 2.778977886919165e-06
. O 0 1.2537186400152223e-08

These O 0 1.8596693074357518e-09
mutations O 0 2.6353971449566416e-08
were O 0 1.48376655406679e-09
scattered O 0 3.474424081773009e-10
over O 0 5.43283473763978e-11
the O 0 1.3301450219049826e-11
entire O 0 1.8683315311518456e-11
length O 0 9.11023340099959e-11
of O 0 2.566498879738588e-12
PTEN O 0 7.433723681060656e-08
, O 0 4.729841518447131e-12
with O 0 4.051004865758545e-13
the O 0 7.821767322377382e-13
exception O 0 2.7846610434201224e-11
of O 0 3.3011663064588803e-13
the O 0 1.803923677101693e-11
first O 0 1.4484176524831582e-08
, O 0 7.306750759994429e-10
fourth O 0 3.1881501172392746e-07
and O 0 2.3490762668387788e-09
last O 0 2.9597973849604386e-08
exons O 0 4.7281918824637614e-08
. O 0 2.393991893612224e-09

A O 0 6.40443317934114e-07
hot O 0 6.385051847246359e-07
spot O 0 3.613080679087943e-08
for O 0 8.685355906701275e-11
PTEN O 0 3.0154551495797932e-06
mutation O 0 6.538948049694682e-09
in O 0 1.0177948484013655e-09
CD B-Disease 0 1.458311800206502e-07
was O 0 1.0409026529600851e-08
identified O 0 5.648320144935326e-10
in O 0 4.262004291155641e-11
exon O 0 1.204018107436866e-09
5 O 0 1.092571380589824e-10
that O 0 4.524968941210794e-12
contains O 0 1.5586596683464515e-12
the O 0 6.181411632555367e-11
PTPase O 0 4.5410335047790795e-08
core O 0 3.6089951027662437e-09
motif O 0 2.0850123849669444e-09
, O 0 1.8330057957594015e-11
with O 0 8.756840738644023e-13
13 O 0 4.139489445664779e-11
of O 0 2.9782965915541026e-13
30 O 0 1.0851115839205505e-10
( O 0 3.492361261292487e-11
43 O 0 2.9511486587807667e-09
% O 0 8.360849512722979e-11
) O 0 1.2331666070231062e-11
CD B-Disease 0 4.3292267548622476e-08
mutations O 0 7.901812537625119e-09
identified O 0 1.5537239050900098e-08
in O 0 4.785846718924347e-10
this O 0 1.7850244893313771e-10
exon O 0 1.3982698021663964e-07
. O 0 5.183508733352937e-09

Seven O 0 6.177245825966793e-09
of O 0 1.525990618589379e-11
30 O 0 1.5068730985223766e-10
( O 0 6.614985642583449e-11
23 O 0 4.207566794978135e-10
% O 0 9.408872118921163e-12
) O 0 7.234545536423387e-13
were O 0 6.574006616855144e-11
within O 0 2.2488577840207302e-12
the O 0 7.30820785832531e-12
core O 0 1.3103389484570016e-09
motif O 0 6.955733766744743e-10
, O 0 7.824412992518681e-12
the O 0 4.041205738103404e-12
majority O 0 1.4106008028313965e-10
( O 0 1.1684303524717166e-10
five O 0 8.856186617389739e-11
of O 0 9.385405863940322e-13
seven O 0 4.358267219339851e-11
) O 0 8.717976969670194e-13
of O 0 2.0088841885552294e-13
which O 0 2.3573776611329755e-11
were O 0 3.097464729151511e-09
missense O 0 1.1202290295386774e-07
mutations O 0 3.932102199399878e-09
, O 0 8.218609820476175e-12
possibly O 0 1.637968094492237e-10
pointing O 0 7.630251985801806e-09
to O 0 1.203493294604785e-11
the O 0 5.32982555659367e-12
functional O 0 6.011902781155598e-11
significance O 0 2.1877838429773533e-10
of O 0 5.457551077725498e-12
this O 0 5.5140548377297094e-11
region O 0 9.69416014129365e-09
. O 0 5.3424544788072126e-09

Germline O 0 0.0008146659238263965
PTEN O 0 0.0002176170382881537
mutations O 0 7.570181992377911e-07
were O 0 7.899958909263205e-09
identified O 0 2.9678517421416473e-09
in O 0 7.35202801416257e-11
four O 0 8.707013408881803e-12
of O 0 8.983913331143956e-13
seven O 0 1.3364576112451232e-10
( O 0 1.33967337223595e-10
57 O 0 1.0345255319066382e-08
% O 0 1.6419281212431969e-10
) O 0 1.2966096252231551e-10
BZS B-Disease 0 1.76335743162781e-06
families O 0 1.458872245230225e-09
studied O 0 5.42588445284764e-08
. O 0 6.977715294453901e-09

Interestingly O 0 7.630380423506722e-06
, O 0 6.663121165928487e-10
none O 0 2.0736644346097677e-10
of O 0 1.964711623643825e-13
these O 0 3.339762928017409e-12
mutations O 0 1.3251147956694354e-09
was O 0 1.727571152798646e-08
observed O 0 9.651918847497498e-11
in O 0 1.770687485525002e-10
the O 0 1.409479338798647e-10
PTPase O 0 1.2006228189420654e-07
core O 0 2.496367201842986e-08
motif O 0 1.3919554930907907e-07
. O 0 1.0010301920715392e-08

It O 0 1.4763203992629315e-08
is O 0 9.245301746396706e-11
also O 0 2.06064835334141e-11
worthy O 0 4.420605548283163e-11
of O 0 1.3461008566487132e-12
note O 0 9.50312273317877e-09
that O 0 8.63441262932696e-12
a O 0 4.659357621950022e-11
single O 0 1.5192602731417537e-09
nonsense O 0 2.597674438220565e-06
point O 0 4.780730922249177e-09
mutation O 0 1.0390911464597252e-09
, O 0 5.062916058617972e-11
R233X O 0 8.118627548014956e-09
, O 0 7.226471504528931e-11
was O 0 8.582961008585244e-10
observed O 0 3.180370550248668e-11
in O 0 2.5934615566214347e-11
the O 0 6.9760547165287345e-12
germline O 0 2.218536021558748e-09
DNA O 0 2.5524187208247895e-09
from O 0 2.7140184197249617e-11
two O 0 1.459756100719023e-11
unrelated O 0 7.499053600312777e-10
CD B-Disease 0 3.763594520478364e-07
families O 0 3.313611884880885e-10
and O 0 6.230653493144445e-11
one O 0 5.313833262299283e-10
BZS B-Disease 0 5.895703907299321e-06
family O 0 1.8043701643932764e-08
. O 0 5.775281142206268e-09

Genotype O 1 0.9994207620620728
- O 1 0.9999542236328125
phenotype O 0 3.739445310202427e-05
studies O 0 8.106454174594546e-08
were O 0 6.729603541089091e-09
not O 0 1.0217895973774205e-10
performed O 0 4.5622905453512885e-10
on O 0 8.545256169334436e-11
this O 0 1.4056951132615514e-12
small O 0 3.5046458790599644e-11
group O 0 3.512631296942459e-10
of O 0 9.65998028096271e-12
BZS B-Disease 0 1.092168304239749e-06
families O 0 6.901313409635179e-10
. O 0 1.1663155996544106e-09

However O 0 4.0573869597437806e-08
, O 0 2.506547858160957e-09
genotype O 0 0.00018834363436326385
- O 0 0.0007465641829185188
phenotype O 0 2.4592179670435144e-06
analysis O 0 1.0746699530272963e-08
inthe O 0 1.5732646261312766e-06
group O 0 3.665499681559936e-09
of O 0 6.63640279882638e-12
CD B-Disease 0 7.313227001759515e-07
families O 0 9.798081790357571e-11
revealed O 0 2.334092252809228e-09
two O 0 2.2286094410878254e-12
possible O 0 8.831790333785339e-12
associations O 0 2.115074955455487e-11
worthy O 0 1.2002319971227138e-10
of O 0 1.86456796183454e-12
follow O 0 2.2172836899869708e-09
- O 0 1.005670242193446e-06
up O 0 5.591533458471076e-09
in O 0 4.172753531594964e-10
independent O 0 1.5529288965865362e-09
analyses O 0 1.1062656568583407e-08
. O 0 1.1672236510662515e-09

The O 0 1.2962764195378895e-09
first O 0 2.2282558020947363e-09
was O 0 1.833438645348906e-08
an O 0 1.850883595694297e-12
association O 0 4.565769984310464e-11
noted O 0 4.2082409779098384e-10
in O 0 2.8121827089222506e-10
the O 0 3.0836090625374624e-11
group O 0 6.032348232043461e-11
of O 0 1.213707086222815e-12
CD B-Disease 0 3.199810407750192e-07
families O 0 2.0806414924301464e-10
with O 0 1.0427542163071735e-09
breast B-Disease 0 0.08909846097230911
disease I-Disease 0 0.0003582854405976832
. O 0 4.7363872823780184e-08

A O 0 9.733813755019582e-08
correlation O 0 2.709122952637699e-07
was O 0 3.314487173611269e-08
observed O 0 3.608131154964056e-11
between O 0 5.859856436890576e-12
the O 0 3.1132269071726393e-12
presence O 0 3.1390481880499976e-10
/ O 0 1.1221023044072354e-07
absence O 0 1.2093732959517212e-10
of O 0 8.630422765332213e-13
a O 0 2.5327767660954237e-10
PTEN O 0 5.139563199918484e-06
mutation O 0 7.583721206572136e-09
and O 0 2.2498385099378737e-10
the O 0 2.4020440150818168e-11
type O 0 1.950385012605693e-06
of O 0 3.5977007484255807e-10
breast O 0 1.1187315976712853e-05
involvement O 0 1.5055049118473107e-07
( O 0 5.384396928320712e-09
unaffected O 0 1.7980946722673252e-05
versus O 0 2.4407725504715927e-05
benign O 0 0.17576882243156433
versus O 0 6.42303639324382e-05
malignant O 0 0.18398016691207886
) O 0 1.0981633380424682e-08
. O 0 6.508338756816556e-09

Specifically O 0 1.2525211090519406e-08
and O 0 2.620033079381301e-10
more O 0 5.88640247656258e-13
directly O 0 2.9209267383284443e-12
, O 0 3.3506478841482945e-12
an O 0 3.2429664422600757e-12
association O 0 7.05892622132609e-10
was O 0 1.1045203507364931e-07
also O 0 2.3065669166322245e-11
observed O 0 1.7345870833435084e-12
between O 0 1.9176780389346115e-12
the O 0 5.164915261972325e-13
presence O 0 5.406142547514925e-12
of O 0 6.030466924433764e-13
a O 0 5.11968800687157e-10
PTEN O 0 0.0002835033228620887
mutation O 0 2.3631628209841438e-06
and O 0 2.97934661830368e-06
malignant B-Disease 1 0.9999849796295166
breast I-Disease 1 0.9997548460960388
disease I-Disease 0 0.07751196622848511
. O 0 1.3656367059411423e-07

Secondly O 0 0.0002234949788544327
, O 0 1.9426225073004844e-09
there O 0 7.760032200154754e-11
appeared O 0 6.655084483497831e-09
to O 0 3.659298124930599e-12
be O 0 1.4110521778798457e-11
an O 0 2.0407267455752054e-12
interdependent O 0 5.499062538660837e-09
association O 0 3.330997977446515e-11
between O 0 5.176242073856585e-11
mutations O 0 2.861890502359188e-09
upstream O 0 5.172582917545299e-10
and O 0 2.042449022410242e-11
within O 0 1.2476283027529345e-12
the O 0 8.50033671923045e-12
PTPase O 0 2.228393114478422e-08
core O 0 6.98376023677838e-09
motif O 0 5.23684384745593e-09
, O 0 2.8611123886745915e-11
the O 0 4.32139740658144e-12
core O 0 3.6973343831014915e-10
motif O 0 2.440872504116953e-10
containing O 0 2.2334235155740956e-11
the O 0 1.3450595671982146e-11
majority O 0 4.679396453655116e-11
of O 0 6.968753699099217e-12
missense O 0 1.988697022170527e-06
mutations O 0 2.816754829382262e-07
, O 0 4.722733870643481e-10
and O 0 8.8221638328001e-11
the O 0 5.669177367134681e-12
involvement O 0 3.8945710545412737e-10
of O 0 9.309614711072722e-13
all O 0 1.6455851438446079e-12
major O 0 3.663525038888338e-11
organ O 0 2.94298843073193e-08
systems O 0 5.971962764306227e-07
( O 0 1.3603503878911738e-09
central O 0 2.0237327191807708e-07
nervous O 1 0.9999281167984009
system O 0 8.352525782129305e-08
, O 0 2.871195947662386e-09
thyroid O 0 4.182956399745308e-05
, O 0 3.331884768087434e-09
breast O 0 0.11546777188777924
, O 0 1.5275474652298726e-05
skin O 1 1.0
and O 0 0.003414373379200697
gastrointestinal O 1 0.9752756357192993
tract O 0 0.3193928301334381
) O 0 1.5565536415351744e-08
. O 0 1.0387627646935016e-08

However O 0 1.6829842408583318e-08
, O 0 4.731468342122902e-11
these O 0 7.330862262719395e-13
observations O 0 3.8306659927433984e-11
would O 0 1.1475149302997423e-10
need O 0 9.392286427767349e-12
to O 0 7.22255100778918e-13
be O 0 3.334697795676078e-11
confirmed O 0 6.366570465266008e-11
by O 0 3.6040417069997666e-13
studying O 0 1.2058600645792339e-11
a O 0 1.3353631351728512e-12
larger O 0 6.468910910412129e-12
number O 0 3.180279650738527e-11
of O 0 1.6350145196075694e-11
CD B-Disease 0 7.121925591491163e-07
families O 0 9.036549286633999e-10
. O 0 6.759289794544543e-10

Molecular O 0 0.00019519412308000028
defects O 0 0.03943299502134323
leading O 0 8.948731200497662e-10
to O 0 8.329298188669565e-12
human O 0 2.7394085264087487e-11
complement B-Disease 0 2.4445938606731943e-07
component I-Disease 1 0.9999967813491821
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 2.369334284324509e-09
an O 0 9.375497773966845e-12
African O 0 2.2411097977403927e-10
- O 0 2.0439291148477423e-08
American O 0 3.291553474227271e-09
family O 0 2.090587258862797e-09
. O 0 8.286806241208922e-10

Complement B-Disease 0 3.8380559999495745e-05
component I-Disease 1 0.9999920129776001
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 3.07065448623689e-08
C6D B-Disease 0 8.150237408699468e-05
) O 0 1.3354491956718562e-09
was O 0 2.4460854547214694e-05
diagnosed O 0 5.268939275993034e-05
in O 0 3.799045245056476e-10
a O 0 1.9320098854080925e-09
16 O 0 1.934525784008656e-08
- O 0 3.813772764260648e-08
year O 0 1.710686814426765e-09
- O 0 2.9995097516888336e-09
old O 0 1.94232701034025e-08
African O 0 9.560380959117154e-11
- O 0 3.466401332641311e-10
American O 0 7.486444797422109e-11
male O 0 8.132836626373319e-10
with O 0 4.942242171068756e-10
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 4.823691313049494e-08

The O 0 1.2048503528205856e-08
patients O 0 1.4390133173947106e-06
father O 0 6.832713950188918e-08
and O 0 3.104572710022069e-10
two O 0 1.3736391191176978e-10
brothers O 0 3.4210296817605013e-09
also O 0 9.165378872522112e-11
had O 0 8.391436878696368e-09
C6D B-Disease 0 2.243076551167178e-06
, O 0 2.966196038789448e-11
but O 0 7.803372531478558e-11
gave O 0 1.3453835268073533e-10
no O 0 1.1602090815854282e-10
history O 0 1.332720739322113e-10
of O 0 8.512737043053775e-11
meningitis B-Disease 1 1.0
or O 0 9.343948725870632e-09
other O 0 2.2038548763703147e-09
neisserial B-Disease 0 4.498878843151033e-05
infection I-Disease 0 0.0009665502002462745
. O 0 1.965826079697308e-08

By O 0 7.758838016513891e-10
using O 0 3.580848284556737e-09
exon O 0 1.472823640824572e-07
- O 0 1.825562812030057e-08
specific O 0 3.5901193129461717e-10
polymerase O 0 3.4136920845639906e-08
chain O 0 1.511543601395715e-08
reaction O 0 6.700909827017654e-10
( O 0 3.2676365085970716e-11
PCR O 0 1.713470076936119e-08
) O 0 3.07752191786026e-11
/ O 0 1.38350808587262e-09
single O 0 5.0181941935179e-10
- O 0 7.74877406684027e-08
strand O 0 3.152582337406784e-07
conformation O 0 3.025078854079766e-08
polymorphism O 0 3.8807677071872604e-08
as O 0 6.39541544722455e-11
a O 0 2.5714637016949204e-11
screening O 0 5.765273813906902e-10
step O 0 7.574288418688013e-11
and O 0 1.6632021281048903e-12
nucleotide O 0 3.2575862146666523e-11
sequencing O 0 4.611112880414936e-11
of O 0 4.812339220693074e-13
target O 0 1.3171194135352948e-09
exons O 0 1.906684587993368e-09
, O 0 4.9167964838447986e-11
we O 0 3.183860466937638e-11
determined O 0 5.47865294797667e-11
that O 0 5.1837284464895106e-12
the O 0 1.9690091571100687e-11
proband O 0 1.0333013023000603e-07
was O 0 4.262398878296381e-09
a O 0 1.0737750098799292e-11
compound O 0 3.1287192281403975e-10
heterozygote O 0 5.787598400530669e-09
for O 0 4.2993168053451214e-11
two O 0 8.538417750614258e-10
C6 O 0 2.0401139408932067e-06
gene O 0 3.045414018743031e-07
mutations O 0 7.283075547093176e-07
. O 0 1.8480054819747238e-08

The O 0 1.161365337232212e-09
first O 0 2.2159087065265481e-10
, O 0 5.488282137783296e-12
1195delC O 0 1.3334734705328088e-10
located O 0 3.9520230837863934e-11
in O 0 2.0394409772084288e-10
exon O 0 1.4596885478113109e-08
7 O 0 5.22766230304228e-09
, O 0 4.552135404733981e-11
is O 0 2.2446924961144754e-12
a O 0 1.6880483122427847e-11
novel O 0 3.178589613739291e-10
mutation O 0 5.210994968862792e-10
, O 0 2.2489276066406383e-11
while O 0 9.691390051580484e-12
the O 0 5.445260561898202e-12
second O 0 9.195887384905177e-10
, O 0 2.019462375102421e-11
1936delG O 0 1.3450917046853306e-09
in O 0 4.710472012448008e-10
exon O 0 2.5152509408599144e-08
12 O 0 4.395487973596346e-09
, O 0 1.0864203980887055e-10
has O 0 2.3404693114126296e-11
been O 0 8.49837908378781e-11
described O 0 1.1557210743973201e-10
before O 0 1.4066292401693214e-11
to O 0 4.1527571312260925e-12
cause O 0 2.4419063993086354e-10
C6D B-Disease 0 2.7919361400563503e-07
in O 0 1.4757840782753107e-10
an O 0 4.161216943937562e-12
unrelated O 0 4.839481593243988e-10
African O 0 3.749067167824194e-10
- O 0 1.909116242870823e-08
American O 0 3.0852928545321845e-10
individual O 0 8.153380054443105e-11
. O 0 9.137386403068604e-10

Both O 0 1.2597278775672294e-08
mutations O 0 3.440820819378132e-07
result O 0 7.724215933535561e-09
in O 0 1.4057998320993192e-08
premature O 0 3.32695265115035e-07
termination O 0 5.5482871630374575e-08
codons O 0 1.2876873256573163e-07
and O 0 2.3494974854543216e-09
C6 O 0 6.5464469116705e-06
null O 0 4.0552545215177815e-06
alleles O 0 2.0423274236236466e-06
. O 0 1.0105072334454235e-07

Allele O 0 1.1782968613260891e-05
- O 0 1.0514775112824282e-06
specific O 0 2.4018400601732992e-09
PCR O 0 3.0451730026470614e-07
indicated O 0 7.83741871401844e-09
that O 0 5.25328261793967e-12
the O 0 2.5953705330705734e-12
probands O 0 5.533301461468909e-08
two O 0 1.0436650849099394e-10
brothers O 0 1.846056196797008e-09
also O 0 2.283201926134293e-11
inherited O 0 1.8308342619732798e-09
the O 0 2.2079296724264452e-11
1195delC O 0 9.145428414569778e-09
mutation O 0 3.355985489505997e-10
from O 0 7.750961331098871e-12
their O 0 1.9384971058911127e-11
heterozygous O 0 8.983434440779092e-09
mother O 0 5.866329200188147e-09
and O 0 1.7088589224223405e-11
the O 0 1.0553870277707489e-11
1936delG O 0 1.2043700259312118e-08
mutation O 0 1.0137727324277535e-09
from O 0 3.835637363280853e-11
their O 0 2.6817544712676167e-11
homozygous O 0 7.147670899598779e-09
father O 0 3.6235003886275763e-09
. O 0 9.216883506413254e-11
. O 0 8.169309118066792e-10

PAX6 O 0 0.002832858357578516
mutations O 0 0.00012669099669437855
reviewed O 0 3.0365997645276366e-06
. O 0 3.835548056940752e-08

Mutations O 0 8.144522325892467e-06
in O 0 1.098469137872371e-08
PAX6 O 0 2.3216516638058238e-06
are O 0 1.532127480441403e-10
responsible O 0 3.6238418515965876e-11
for O 0 1.7044114600586746e-12
human O 0 1.6535312008514325e-10
aniridia B-Disease 1 1.0
and O 0 1.4086879218666581e-08
have O 0 2.757584993684503e-10
also O 0 4.3999604307232154e-12
been O 0 4.364237703863294e-12
found O 0 4.783946155884067e-11
in O 0 3.5573585743797764e-11
patients O 0 1.889955830725043e-10
with O 0 8.874888324239549e-11
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 1.4349328836260611e-08
with O 0 3.3109211017290363e-07
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 8.072260193614511e-09
with O 0 3.5027583056290723e-09
autosomal B-Disease 1 0.9999046325683594
dominant I-Disease 1 0.9997510313987732
keratitis I-Disease 1 0.9999998807907104
, O 0 6.677796022813709e-07
and O 0 3.4155527295354204e-09
with O 0 4.4075748606431375e-10
isolated B-Disease 1 0.5584992170333862
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 4.0648930621500767e-07

No O 0 3.63951606630053e-08
locus O 0 1.6161534333036798e-08
other O 0 6.202623137330221e-11
than O 0 9.793448690897932e-11
chromosome O 0 5.187151259633538e-07
11p13 O 0 2.427009064831509e-07
has O 0 1.755554590587849e-10
been O 0 1.8757488617904272e-10
implicated O 0 2.6093867067089604e-09
in O 0 2.189956838094531e-08
aniridia B-Disease 1 1.0
, O 0 1.6992326989928586e-10
and O 0 2.8445381466957187e-11
PAX6 O 0 1.5906367423212942e-07
is O 0 1.48731901794541e-10
clearly O 0 9.331566630521593e-10
the O 0 2.0758191172920437e-12
major O 0 6.414693082268386e-11
, O 0 1.5721351304121e-11
if O 0 5.174886994613326e-12
not O 0 1.8824825379071264e-11
only O 0 8.32605772521644e-12
, O 0 2.8028517007339104e-12
gene O 0 7.623687237057197e-10
responsible O 0 1.2914813662945335e-09
. O 0 2.3444837182751144e-09

Twenty O 0 1.953029823198449e-06
- O 0 4.746235390484799e-06
eight O 0 2.6672697384100275e-09
percent O 0 2.976190183190397e-09
of O 0 1.3761105970011567e-12
identified O 0 2.348305772059689e-09
PAX6 O 0 3.986137926403899e-07
mutations O 0 1.2717602082545909e-08
are O 0 2.188447340012445e-10
C O 0 2.9618549888255075e-05
- O 0 2.132368081220193e-06
T O 0 1.1746544714696938e-06
changes O 0 4.69955074855477e-10
at O 0 3.485255972712764e-10
CpG O 0 2.8947708230475655e-08
dinucleotides O 0 1.19854533409125e-07
, O 0 4.0270502210670855e-11
20 O 0 1.0422203898519111e-11
% O 0 2.0451574461732847e-12
are O 0 3.247621355867425e-12
splicing O 0 1.5549037613027394e-08
errors O 0 3.137515477646957e-06
, O 0 4.8245397260560097e-11
and O 0 1.4077672187695622e-11
more O 0 1.7985836344575068e-12
than O 0 8.675483942344187e-12
30 O 0 2.153761370637941e-11
% O 0 9.004710171955921e-12
are O 0 2.1217904169756885e-11
deletion O 0 2.3156321304895755e-09
or O 0 1.5410135667526248e-10
insertion O 0 2.456365555403295e-09
events O 0 1.0533628413966767e-09
. O 0 4.900445382816088e-09

There O 0 8.266320072891631e-09
is O 0 1.3769128892615612e-10
a O 0 1.061018703452099e-10
noticeably O 0 8.31311263027601e-06
elevated O 0 4.6421266830520835e-09
level O 0 1.2833927254263244e-09
of O 0 4.1755097643370043e-13
mutation O 0 5.682149542551862e-11
in O 0 2.60461045092919e-11
the O 0 3.4938718584953676e-12
paired O 0 9.369125475444662e-10
domain O 0 5.678674752651602e-10
compared O 0 7.080541708504029e-10
with O 0 7.466333974692763e-12
the O 0 2.9217808727999284e-11
rest O 0 1.8168282156505455e-10
of O 0 3.2769576982505377e-13
the O 0 1.8785478381189158e-11
gene O 0 2.0172635117887694e-08
. O 0 1.3228244055696337e-09

Increased O 0 9.476229934080038e-08
mutation O 0 2.4403954412832718e-08
in O 0 3.5013270061057256e-10
the O 0 1.7272783897626098e-11
homeodomain O 0 2.0804687750342055e-08
is O 0 7.222310249854758e-11
accounted O 0 2.04592898178646e-09
for O 0 9.328972056660279e-13
by O 0 3.747540906068325e-12
the O 0 1.5828925670202665e-10
hypermutable O 0 4.0601898376735335e-07
CpG O 0 3.7967029697938415e-07
dinucleotide O 0 3.2843814778971137e-07
in O 0 4.068140491142458e-09
codon O 0 2.037060369275423e-07
240 O 0 1.0614205514514197e-08
. O 0 1.4670005210604131e-09

Very O 0 1.99246017018595e-07
nearly O 0 1.083517497946218e-09
all O 0 1.1578033670689436e-11
mutations O 0 5.407571612714435e-10
appear O 0 8.715429489214443e-10
to O 0 6.227469234731942e-11
cause O 0 5.773262978792104e-10
loss O 0 6.998904789057292e-10
of O 0 2.8775387021090504e-13
function O 0 6.148906037117818e-12
of O 0 2.0242076244347817e-13
the O 0 7.473343992259185e-12
mutant O 0 8.807512053010669e-09
allele O 0 5.212173448398971e-08
, O 0 1.0187348742363156e-09
and O 0 6.048778145029132e-11
more O 0 8.305339380641763e-13
than O 0 3.5546708805622718e-12
80 O 0 1.5728701327488714e-11
% O 0 6.3741008998752235e-12
of O 0 2.9784401941318484e-12
exonic O 0 3.140692328429395e-08
substitutions O 0 2.2021824364060194e-09
result O 0 5.891735987972879e-10
in O 0 1.887704881298191e-09
nonsense O 0 1.7610365148357232e-06
codons O 0 1.8246826982704079e-07
. O 0 8.036414866907649e-10

In O 0 6.464468516043098e-09
a O 0 1.6642510980435787e-10
gene O 0 8.51322845552005e-10
with O 0 9.78291406217302e-12
such O 0 2.420898481680922e-10
extraordinarily O 0 6.402483268175274e-05
high O 0 4.565411515500273e-08
sequence O 0 1.5670016673130505e-10
conservation O 0 1.1828997850682477e-11
throughout O 0 1.8052451894456922e-11
evolution O 0 5.931603125342022e-11
, O 0 2.2734754617087516e-12
there O 0 3.380813424352924e-12
are O 0 5.457207168796385e-12
presumed O 0 5.6348938848316266e-09
undiscovered O 0 1.0668646410749716e-07
missense O 0 6.44587998976931e-07
mutations O 0 3.186830355161874e-08
, O 0 1.9140028104103202e-11
these O 0 8.633765360629986e-13
are O 0 1.2387270029168285e-12
hypothesized O 0 2.3576923399715177e-11
to O 0 8.054663706846821e-13
exist O 0 8.881729379739411e-11
in O 0 5.331294850030588e-10
as O 0 1.0930686578092264e-08
- O 0 2.100444795871681e-08
yet O 0 7.692781522905534e-09
unidentified O 0 7.287231085228996e-08
phenotypes O 0 4.746079085293786e-09
. O 0 7.832703929899765e-11
. O 0 4.552763166465468e-10

Genetic O 0 1.621641422389075e-05
heterogeneity O 0 3.320402129247668e-06
and O 0 2.0657594745898678e-08
penetrance O 0 9.155500038104947e-07
analysis O 0 6.418404696617586e-10
of O 0 2.5216872860667205e-12
the O 0 7.693581188794596e-11
BRCA1 O 0 2.0854447484452976e-06
and O 0 1.5381894646893102e-09
BRCA2 O 0 3.6861674743704498e-06
genes O 0 3.4850674524022907e-07
in O 0 5.022891969019838e-07
breast B-Disease 1 0.6255096793174744
cancer I-Disease 0 9.756614599609748e-05
families O 0 3.250553248790311e-08
. O 0 9.180118887286426e-09

The O 0 6.9184006861178204e-06
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 6.825668242527172e-05
Consortium O 0 1.9365322714293143e-06
. O 0 4.72374779292295e-08

The O 0 3.2544453243410487e-10
contribution O 0 1.3264669918022776e-10
of O 0 5.638476231056844e-12
BRCA1 O 0 5.45219791092677e-07
and O 0 1.5572475531300256e-09
BRCA2 O 0 0.0002442770346533507
to O 0 4.149149845034117e-06
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 7.344159530475736e-05
assessed O 0 8.477957003094616e-09
by O 0 1.5566253147580866e-11
linkage O 0 2.0858135485468665e-07
and O 0 6.673206986995694e-10
mutation O 0 4.2468728533862077e-10
analysis O 0 1.0041079079314841e-10
in O 0 2.2883737960111006e-10
237 O 0 2.1865582677804696e-09
families O 0 2.956261277442529e-11
, O 0 5.148845759472831e-12
each O 0 3.187965299730755e-13
with O 0 1.24298297349279e-11
at O 0 2.7025185644902194e-08
least O 0 1.0052845361707696e-10
four O 0 3.234486636860545e-11
cases O 0 8.210532809194149e-10
of O 0 4.673565423551906e-10
breast B-Disease 0 0.037300389260053635
cancer I-Disease 0 5.131090347276768e-06
, O 0 5.822681226064219e-11
collected O 0 2.508974972226241e-11
by O 0 1.4581984231210043e-10
the O 0 1.3680030406248989e-06
Breast B-Disease 1 1.0
Cancer I-Disease 1 0.9999998807907104
Linkage O 0 1.5115490896278061e-05
Consortium O 0 1.6267740647890605e-06
. O 0 4.019137378463711e-08

Families O 0 3.825181238426012e-08
were O 0 2.485323613576895e-10
included O 0 7.377646236983448e-12
without O 0 4.563887462394334e-12
regard O 0 1.3127990881878215e-11
to O 0 8.94561172099656e-13
the O 0 2.439906783557877e-12
occurrence O 0 3.2478986167205903e-09
of O 0 3.349814314823618e-10
ovarian B-Disease 0 2.6792798735186807e-07
or I-Disease 0 1.7750639846880745e-09
other I-Disease 0 3.591738018116075e-09
cancers I-Disease 0 1.125679409597069e-05
. O 0 5.060246888177744e-09

Overall O 0 5.2576360758394e-05
, O 0 1.2430133367047347e-08
disease O 0 1.8963152115247794e-07
was O 0 2.221110184663644e-09
linked O 0 8.211634039412274e-09
to O 0 2.1823228987805088e-11
BRCA1 O 0 1.9894539349252227e-08
in O 0 3.773795512196365e-11
an O 0 1.3919706316409264e-12
estimated O 0 9.432356805338937e-12
52 O 0 3.0650224025485784e-10
% O 0 1.1777915448485388e-11
of O 0 5.771800138526517e-13
families O 0 8.120335133476875e-12
, O 0 1.3253731879353525e-12
to O 0 4.330192888285511e-12
BRCA2 O 0 4.365095662706153e-08
in O 0 1.7621029635428442e-10
32 O 0 3.944419235679675e-10
% O 0 1.028733088298539e-11
of O 0 3.387376100102979e-13
families O 0 2.4659062985987745e-11
, O 0 4.984391805545885e-12
and O 0 2.0848153065022856e-11
to O 0 4.717210129456806e-12
neither O 0 3.9810843510679206e-10
gene O 0 9.726437433243973e-10
in O 0 7.076059183042105e-10
16 O 0 3.8454700534984454e-10
% O 0 1.9164246578551314e-11
( O 0 1.643876354484597e-11
95 O 0 6.49846487732475e-09
% O 0 8.611038104788804e-09
confidence O 0 8.388380956603214e-05
interval O 0 1.7823692743945685e-08
[ O 0 5.516185286325026e-09
CI O 0 9.310946552432142e-06
] O 0 2.975656610004762e-09
6 O 0 1.809389721385557e-10
% O 0 3.693971795115658e-10
- O 0 1.1703339168889215e-06
28 O 0 1.6123600232731405e-08
% O 0 1.3343995353132243e-10
) O 0 5.2930910522663854e-12
, O 0 6.5637044410760126e-12
suggesting O 0 1.1190364190838409e-09
other O 0 1.0406794176409662e-10
predisposition O 0 3.014400462575395e-08
genes O 0 4.8387484241629863e-08
. O 0 1.4604237819071386e-08

The O 0 2.9355642361394985e-09
majority O 0 2.195685633310518e-09
( O 0 3.7618030912511813e-10
81 O 0 2.5687800775386904e-09
% O 0 1.3114276158077143e-11
) O 0 1.131992286365624e-12
of O 0 6.875026806532625e-13
the O 0 1.3993451375426957e-07
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.807001546287438e-10
were O 0 1.713742758813197e-10
due O 0 2.573524553184381e-11
to O 0 8.333334022836425e-12
BRCA1 O 0 1.3361038497805566e-07
, O 0 1.3582540474288418e-11
with O 0 1.095017414416699e-12
most O 0 5.672252251232024e-11
others O 0 2.0996264726846903e-09
( O 0 7.204836033336548e-11
14 O 0 3.045267926715667e-10
% O 0 5.6684885951785446e-11
) O 0 1.0509335589270474e-11
due O 0 3.307953633235883e-10
to O 0 1.3844451141054037e-09
BRCA2 O 0 1.2274716027604882e-05
. O 0 1.021363882358628e-08

Conversely O 0 2.821066971137043e-07
, O 0 2.3758814360341773e-10
the O 0 2.0433559358434827e-12
majority O 0 6.112586565382161e-12
of O 0 5.063200835160597e-13
families O 0 5.890763137700317e-12
with O 0 3.204616259855353e-12
male B-Disease 0 2.9805548251715663e-08
and I-Disease 0 7.389729717033333e-07
female I-Disease 0 5.3986182138032746e-06
breast I-Disease 0 0.00016335997497662902
cancer I-Disease 0 2.354883690713905e-06
were O 0 4.975558809405811e-08
due O 0 1.4504184520092167e-09
to O 0 4.589889024408933e-10
BRCA2 O 0 9.351721018902026e-06
( O 0 8.278433494268711e-10
76 O 0 4.76224037981865e-08
% O 0 1.5956277410467123e-09
) O 0 5.08190101111694e-10
. O 0 4.628732064304586e-09

The O 0 4.0161138303851374e-10
largest O 0 1.6816861792001703e-10
proportion O 0 7.706038585020281e-10
( O 0 3.0772534520551176e-10
67 O 0 2.0092802088811368e-08
% O 0 3.7520344470243217e-11
) O 0 1.9202436949555812e-12
of O 0 4.04048674943272e-13
families O 0 4.4303952867474905e-12
due O 0 1.3386764786960104e-11
to O 0 2.996531842103245e-12
other O 0 8.674474333281168e-12
genes O 0 5.206027831050619e-10
was O 0 2.3319002195876237e-07
found O 0 3.413670679464076e-09
in O 0 2.9848185034708763e-10
families O 0 1.0465748927213081e-11
with O 0 1.4271562447445985e-12
four O 0 3.502914971975635e-11
or O 0 1.462870102830749e-10
five O 0 2.7715729017385726e-11
cases O 0 7.399112572636923e-11
of O 0 6.685778319859281e-11
female O 0 7.433038263116032e-06
breast B-Disease 0 0.0002223470073658973
cancer I-Disease 0 2.0753284388774773e-06
only O 0 1.686271211553958e-08
. O 0 1.51649324209302e-08

These O 0 1.175218811155787e-09
estimates O 0 1.2008050109812984e-09
were O 0 1.8493609421632584e-10
not O 0 2.953860073207082e-11
substantially O 0 1.1530508770007941e-09
affected O 0 1.2662011196484801e-11
either O 0 3.4677601502136612e-12
by O 0 3.33218457167217e-12
changing O 0 4.671195097394332e-10
the O 0 1.8032837376114053e-11
assumed O 0 7.425567938312838e-10
penetrance O 0 6.452962608705093e-09
model O 0 3.00936470187807e-10
for O 0 5.905838752068293e-12
BRCA1 O 0 2.0301323289118045e-08
or O 0 6.311871164621508e-11
by O 0 1.9059508745561393e-12
including O 0 6.240426578263403e-12
or O 0 5.002054326297412e-10
excluding O 0 1.6477375197609945e-07
BRCA1 O 0 4.642984549718676e-06
mutation O 0 8.057957501250712e-08
data O 0 6.716756928426548e-08
. O 0 4.1888479351825936e-09

Among O 0 2.407610333321486e-09
those O 0 7.177815286585343e-11
families O 0 2.5938771963662788e-11
with O 0 9.851257830317817e-12
disease O 0 1.6727753404666146e-08
due O 0 5.283171677916698e-10
to O 0 9.083166857548619e-11
BRCA1 O 0 5.904161071157432e-07
that O 0 3.1742802830692085e-11
were O 0 4.4430931156469455e-10
tested O 0 6.485283837731615e-11
by O 0 4.894746717318266e-13
one O 0 3.0919821824432203e-12
of O 0 6.035573245615627e-14
the O 0 1.6867440603973716e-12
standard O 0 1.4306743567615854e-09
screening O 0 4.3068840160920274e-11
methods O 0 1.8680867963638548e-10
, O 0 6.443236569286803e-12
mutations O 0 1.4382853241734495e-10
were O 0 5.93525062431155e-10
detected O 0 8.224048109184423e-09
in O 0 5.653415235951087e-11
the O 0 1.429925275409083e-11
coding O 0 6.965122700819393e-09
sequence O 0 1.5821984000741196e-10
or O 0 1.8187247541323615e-10
splice O 0 2.4837577328185034e-08
sites O 0 3.4635067036603573e-10
in O 0 1.6355766740971944e-10
an O 0 5.7463417704739506e-12
estimated O 0 4.146680221417398e-11
63 O 0 4.1963326147254065e-09
% O 0 1.4308919327188363e-10
( O 0 3.8138252972386155e-11
95 O 0 1.2554774109219125e-08
% O 0 5.803892921818488e-09
CI O 0 0.002839684719219804
51 O 0 2.9627497610817954e-07
% O 0 8.555408825827726e-09
- O 0 1.990313421629253e-06
77 O 0 4.0900204112404026e-08
% O 0 7.332425777661911e-10
) O 0 4.260348740459108e-10
. O 0 1.2959624484665255e-09

The O 0 3.978571916363194e-10
estimated O 0 2.0345920781483784e-10
sensitivity O 0 6.469822011467841e-09
was O 0 6.9246026690450435e-09
identical O 0 6.567088539632948e-11
for O 0 8.221161381868902e-13
direct O 0 2.0891104818288042e-11
sequencing O 0 8.759226122201369e-10
and O 0 6.870432694983108e-11
other O 0 1.2066653232167823e-11
techniques O 0 3.621373778628367e-08
. O 0 2.7246018774462755e-09

The O 0 7.528953460678167e-09
penetrance O 0 1.6340027286787517e-06
of O 0 5.3566311108976805e-11
BRCA2 O 0 1.8000857835431816e-06
was O 0 2.4265118803157293e-09
estimated O 0 1.8964536972060353e-12
by O 0 9.60540783197239e-13
maximizing O 0 1.2990479525409881e-10
the O 0 3.764873482414721e-11
LOD O 0 6.198898518050555e-06
score O 0 7.882028918437811e-10
in O 0 8.690928532395503e-10
BRCA2 O 0 7.506909605581313e-05
- O 0 1.5972544133546762e-05
mutation O 0 3.967663175785674e-08
families O 0 1.2110634717288349e-09
, O 0 2.814799955619396e-11
over O 0 1.818543406140183e-11
all O 0 1.228019248789014e-11
possible O 0 5.172158812349892e-10
penetrance O 0 1.0023335761388807e-07
functions O 0 3.845000429159029e-10
. O 0 1.3757190941987574e-09

The O 0 9.319488514236696e-10
estimated O 0 7.242164090648373e-10
cumulative O 0 3.723620523032878e-09
risk O 0 4.127574726453531e-08
of O 0 1.646399960808509e-10
breast B-Disease 0 0.009816518053412437
cancer I-Disease 0 1.369448727928102e-05
reached O 0 2.618237715523719e-07
28 O 0 3.0676206019819574e-09
% O 0 6.129728669090895e-11
( O 0 2.690074378530749e-11
95 O 0 6.192734769427943e-09
% O 0 4.070375592135633e-09
CI O 0 0.001954440725967288
9 O 0 4.842752865386046e-09
% O 0 1.7434659271842179e-09
- O 0 2.1903187530369905e-07
44 O 0 4.566192757238241e-09
% O 0 1.1713043035488369e-10
) O 0 2.313474281936956e-12
by O 0 8.855708701072107e-12
age O 0 3.8604639485129155e-09
50 O 0 4.0976354254151914e-11
years O 0 1.5060275943001855e-11
and O 0 2.752218765389447e-11
84 O 0 1.7038476185504692e-10
% O 0 1.4770617021153676e-11
( O 0 2.291753418981468e-11
95 O 0 9.64464152986011e-09
% O 0 2.1321173715449504e-09
CI O 0 3.759454921237193e-05
43 O 0 1.216806300163853e-08
% O 0 9.337566275746667e-10
- O 0 3.4587571917654714e-08
95 O 0 1.5564289412850485e-08
% O 0 2.025655060355902e-10
) O 0 3.3836776696521964e-12
by O 0 2.7801925692183538e-11
age O 0 2.303312740536967e-08
70 O 0 3.0596486455536365e-10
years O 0 1.5838166889103888e-10
. O 0 3.2188560150636647e-10

The O 0 8.910281934504383e-08
corresponding O 0 0.20057368278503418
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 6.986465905356454e-06
were O 0 1.3150615707502311e-08
0 O 0 1.8344346042198367e-09
. O 0 1.3218810490656097e-09

4 O 0 1.1446528702663272e-07
% O 0 2.02455918696387e-09
( O 0 1.0245079784532152e-10
95 O 0 1.94848559509353e-09
% O 0 6.863796198075534e-10
CI O 0 1.2530641470220871e-05
0 O 0 1.8651469257946474e-09
% O 0 2.195736037435836e-09
- O 0 7.223615483553658e-08
1 O 0 4.116924579022907e-10
% O 0 4.953413026975717e-11
) O 0 8.926879960062528e-13
by O 0 1.1507313114542117e-12
age O 0 7.780370236964984e-10
50 O 0 2.2533846316674655e-11
years O 0 2.0412222259680313e-11
and O 0 4.458558522379974e-11
27 O 0 1.5035944711527804e-10
% O 0 1.0700662578244646e-11
( O 0 8.09275042812363e-12
95 O 0 2.113544672610601e-09
% O 0 5.076320475083662e-10
CI O 0 4.2179467527603265e-06
0 O 0 5.396433300219883e-10
% O 0 1.2496068624301415e-09
- O 0 1.5656029006549943e-07
47 O 0 2.1811777273228472e-08
% O 0 1.319557657586401e-10
) O 0 3.804175290750278e-12
by O 0 2.290853097497436e-11
age O 0 2.1471979749776438e-08
70 O 0 6.751533221382999e-10
years O 0 4.923274010693035e-10
. O 0 3.964663597422202e-10

The O 0 5.1484607688223605e-09
lifetime O 0 1.6853805462346827e-08
risk O 0 1.2619901212929108e-07
of O 0 1.7129520024639078e-10
breast B-Disease 0 0.0015630667330697179
cancer I-Disease 0 1.9316923953738296e-06
appears O 0 2.996366532670436e-08
similar O 0 3.102909040819668e-10
to O 0 4.126214647737214e-11
the O 0 3.532018774676793e-11
risk O 0 1.791266801554059e-09
in O 0 6.704639621268882e-11
BRCA1 O 0 6.6753514715856e-08
carriers O 0 3.171295759329951e-08
, O 0 1.6872379882126864e-10
but O 0 5.802937574905798e-10
there O 0 5.100835032134654e-11
was O 0 8.403862050698763e-10
some O 0 5.381490066937167e-13
suggestion O 0 1.5798966301883155e-11
of O 0 8.691810292338342e-13
a O 0 7.498910936654113e-10
lower O 0 0.0001629635808058083
risk O 0 4.87289364414778e-09
in O 0 1.6575257832940338e-10
BRCA2 O 0 2.02943610361217e-07
carriers O 0 1.7792274320527213e-08
< O 0 2.9378959709447372e-08
50 O 0 1.563299906193194e-10
years O 0 7.336675017510785e-11
of O 0 1.527024166836366e-11
age O 0 3.2005833539017203e-09
. O 0 5.65822999565313e-10

Eye B-Disease 1 0.9982525706291199
movement I-Disease 0 1.6805657651275396e-05
abnormalities I-Disease 1 0.804141104221344
correlate O 0 1.3618586081065587e-07
with O 0 4.5392106740038685e-10
genotype O 0 0.0001502558880019933
in O 0 1.3213616512075532e-07
autosomal O 1 0.9876844882965088
dominant O 0 0.30496299266815186
cerebellar B-Disease 1 0.5785584449768066
ataxia I-Disease 1 0.9999996423721313
type I-Disease 1 1.0
I I-Disease 1 0.9999982118606567
. O 0 3.7922440299098525e-08

We O 0 7.872090890259642e-08
compared O 0 2.457200665162418e-08
horizontal O 0 8.114821525850857e-07
eye O 1 0.9689818024635315
movements O 0 2.2811369490227662e-05
( O 0 4.320348967468135e-09
visually O 0 6.688118947550947e-09
guided O 0 2.411913513356012e-08
saccades O 0 2.6608288408169756e-06
, O 0 2.349496430742448e-10
antisaccades O 0 3.936059158604621e-07
, O 0 7.77742870106124e-11
and O 0 8.730998563022396e-11
smooth O 0 2.1560777607732007e-09
pursuit O 0 2.7373847633072046e-09
) O 0 5.095270125959894e-12
in O 0 4.9216193620527093e-11
control O 0 4.087553850951053e-09
subjects O 0 1.2068650967478334e-08
( O 0 7.276984570481204e-11
n O 0 6.188425327735558e-09
= O 0 5.405758951582129e-09
14 O 0 1.194611853883032e-09
) O 0 2.115478625608347e-11
and O 0 5.277672188164217e-10
patients O 0 5.596780261463152e-10
with O 0 9.883624951453895e-13
three O 0 4.310448699362812e-12
forms O 0 1.0449915932575493e-10
of O 0 2.2323556891912233e-10
autosomal O 0 0.0009580038022249937
dominant O 0 7.756228296784684e-05
cerebellar B-Disease 0 0.00010740546713350341
ataxias I-Disease 1 0.7448824644088745
type I-Disease 1 0.9999977350234985
I I-Disease 1 0.9999657869338989
spinocerebellar B-Disease 1 0.9822789430618286
ataxias I-Disease 0 0.0013716539833694696
1 I-Disease 0 1.0569639385948904e-08
and I-Disease 0 7.924568778960861e-10
2 I-Disease 0 2.1062394883752944e-10
( O 0 1.30226551764423e-10
SCA1 B-Disease 0 1.823939555833931e-06
, O 0 2.8502840712651967e-11
n O 0 2.7987638873128162e-09
= O 0 5.246481471488096e-09
11 O 0 5.814615455790317e-10
; O 0 3.020911298889928e-11
SCA2 B-Disease 0 2.21725872506795e-06
, O 0 3.965418271523191e-11
n O 0 3.3580744851491318e-09
= O 0 4.434510536555081e-09
10 O 0 1.906974439469522e-10
) O 0 3.147091962030224e-11
and O 0 1.0393493177218716e-08
SCA3 B-Disease 1 1.0
/ O 0 6.584618677152321e-05
Machado B-Disease 0 3.6495336530606437e-07
- I-Disease 0 1.167840991911362e-06
Joseph I-Disease 0 2.1001696950406767e-06
disease I-Disease 0 0.06943455338478088
( O 0 1.5958324439679927e-08
MJD B-Disease 1 1.0
) O 0 1.1797549048786493e-10
( O 0 3.26219988522336e-11
n O 0 6.0362221887544365e-09
= O 0 1.6437784466916128e-08
16 O 0 5.977264905254742e-09
) O 0 4.188334401522553e-10
. O 0 2.5293696026551515e-09

In O 0 5.3313716108505105e-08
SCA1 B-Disease 0 2.378292492721812e-06
, O 0 1.8334508911088676e-10
saccade O 0 4.552715537897711e-08
amplitude O 0 1.7320407330601029e-09
was O 0 2.0073802176057143e-08
significantly O 0 9.626502261994574e-09
increased O 0 3.243563473365185e-10
, O 0 1.854842668347345e-11
resulting O 0 8.484451335943888e-11
in O 0 1.8366437259942359e-09
hypermetria B-Disease 0 4.355334112915443e-06
. O 0 4.050549673451087e-09

The O 0 5.397208013846466e-09
smooth O 0 4.793589525320385e-08
pursuit O 0 1.6742436770300628e-08
gain O 0 2.404335646133404e-07
was O 0 5.1539849721393693e-08
decreased O 0 6.438678923359475e-08
. O 0 6.691471265973803e-10

In O 0 4.094968986123604e-08
SCA2 B-Disease 0 2.608970817163936e-06
, O 0 2.7154073434232373e-10
saccade O 0 1.6306326244830416e-07
velocity O 0 4.3868972454674804e-08
was O 0 4.803749220627651e-08
markedly O 0 1.9564579361031065e-06
decreased O 0 1.525509105704259e-07
. O 0 1.1348000317212836e-09

The O 0 2.4561170874903837e-09
percentage O 0 1.6543594938411843e-08
of O 0 1.1466392071945997e-11
errors O 0 1.164517904328477e-08
in O 0 5.925002710682747e-10
antisaccades O 0 2.7166386189492187e-06
was O 0 7.061286222409535e-09
greatly O 0 2.3031478113555437e-10
increased O 0 3.750605104269056e-10
and O 0 1.197953958254061e-10
was O 0 5.591733187593206e-10
significantly O 0 1.2196514631579447e-10
correlated O 0 3.0644421028513946e-11
with O 0 4.4908261137566186e-12
age O 0 7.16372161591039e-09
at O 0 3.818458438331618e-09
disease O 0 1.6989336870665284e-07
onset O 0 6.190541057549126e-07
. O 0 6.0438254401162794e-09

In O 0 5.713977291321726e-09
addition O 0 2.10949216428169e-10
, O 0 7.580846540788944e-12
a O 0 6.901754341648303e-12
correlation O 0 2.6669342290119857e-09
between O 0 4.729737712594329e-10
smooth O 0 2.7336504615504964e-08
pursuit O 0 1.348640132903256e-08
gain O 0 5.692397735401755e-07
and O 0 1.085043235815597e-10
the O 0 8.881077297184792e-13
number O 0 4.290090852010486e-12
of O 0 3.0240686257204663e-12
trinucleotide O 0 7.841683924425524e-08
repeats O 0 3.5366348072329856e-08
was O 0 4.6083940219432407e-08
found O 0 3.522677261003082e-09
. O 0 4.846575918371343e-10

In O 0 1.4377458228409523e-06
SCA3 B-Disease 1 1.0
, O 0 2.1309595865659503e-08
gaze B-Disease 0 9.029887223732658e-06
- I-Disease 0 1.246458054993127e-06
evoked I-Disease 0 4.8783178385747306e-08
nystagmus I-Disease 0 1.655548430790077e-06
was O 0 1.2642579427790679e-08
often O 0 6.928056739408106e-11
present O 0 6.2222657581934016e-12
as O 0 4.653886304106791e-11
was O 0 2.2011452660564146e-09
saccade O 0 1.0467165623140318e-07
hypometria O 0 3.21544206371982e-07
and O 0 1.7824626497020546e-10
smooth O 0 4.024581556905105e-09
pursuit O 0 2.9090996278569037e-09
gain O 0 7.224014808571155e-08
was O 0 8.942050300220217e-08
markedly O 0 1.3163662515580654e-06
decreased O 0 1.3837863832577568e-07
. O 0 1.1248098008564966e-09

Three O 0 1.0274423978273717e-08
major O 0 2.3526633974313427e-09
criteria O 0 2.092142903364902e-09
, O 0 2.208519131463582e-11
saccade O 0 8.69085354793242e-08
amplitude O 0 1.7223948933775546e-09
, O 0 4.962320832024858e-11
saccade O 0 1.670084692761975e-08
velocity O 0 3.209490229139078e-09
, O 0 4.530230704458127e-11
and O 0 9.085033940425813e-12
presence O 0 7.012397607031318e-11
of O 0 2.4065516940341425e-11
gaze B-Disease 0 1.8684273527469486e-05
- I-Disease 0 2.9089605391163786e-07
evoked I-Disease 0 6.758030135500803e-09
nystagmus I-Disease 0 4.265930897418002e-08
, O 0 6.565607866410028e-12
permitted O 0 2.1031634767076923e-11
the O 0 8.553536351429969e-12
correct O 0 3.634963219312226e-09
assignment O 0 1.95370192246358e-10
of O 0 3.2754390020574287e-13
90 O 0 1.3607902131507199e-11
% O 0 1.8163933898640572e-12
of O 0 2.4930873880092685e-13
the O 0 1.0434813603465987e-11
SCA1 B-Disease 0 2.0800290201350435e-07
, O 0 6.116341808026782e-12
90 O 0 3.1785559427566223e-12
% O 0 1.3930384623606074e-12
of O 0 1.6619836745983968e-13
the O 0 2.2887828785012054e-11
SCA2 B-Disease 0 6.426876097975764e-07
, O 0 1.1874637557973688e-11
and O 0 1.8525762521259814e-11
93 O 0 7.746073227288264e-11
% O 0 4.956538218053863e-12
of O 0 2.262339892245696e-13
the O 0 2.341880335487989e-11
patients O 0 2.3882087418769515e-09
with O 0 2.3218404976432794e-10
SCA3 B-Disease 1 1.0
to O 0 3.487016231318307e-11
their O 0 4.015703568283069e-12
genetically O 0 7.688406022943184e-10
confirmed O 0 2.3250599667790084e-08
patient O 0 1.796540338716568e-08
group O 0 1.0856312376850141e-10
and O 0 1.0273453615594619e-10
, O 0 3.6204203697487447e-12
therefore O 0 6.367518318173282e-11
, O 0 2.5603052664080472e-11
may O 0 1.9386405369914428e-08
help O 0 4.3490938628210074e-10
orient O 0 1.4388252566277515e-05
diagnoses O 0 3.3283638913417235e-05
of O 0 1.3381658628408566e-11
SCA1 B-Disease 0 3.5639288853417384e-06
, O 0 1.466015225881634e-10
SCA2 B-Disease 0 5.682255164174421e-07
, O 0 8.382054772493319e-11
and O 0 1.6886166909202416e-09
SCA3 B-Disease 1 1.0
at O 0 2.7328772578272265e-09
early O 0 8.698063602707862e-09
clinical O 0 1.0740996980729278e-09
stages O 0 1.68392327859479e-10
of O 0 4.8230005059157754e-12
the O 0 2.0660646804504523e-10
diseases O 0 9.027191936183954e-07
. O 0 6.742988389873972e-10
. O 0 2.360106110543825e-09

Genetic O 0 1.9802146198344417e-06
basis O 0 1.5095988459279397e-08
and O 0 2.539011223490206e-10
molecular O 0 1.302684271564658e-08
mechanism O 0 1.3720385538817936e-07
for O 0 2.222294170906025e-07
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 0 2.936052851509885e-06

Ventricular B-Disease 1 0.9999885559082031
fibrillation I-Disease 1 0.9999948740005493
causes O 0 1.7430984655675275e-07
more O 0 1.333544663584263e-10
than O 0 1.4660089114881814e-11
300 O 0 3.3635198792847376e-11
, O 0 1.3382858189692204e-11
000 O 0 1.311383363011842e-10
sudden O 0 3.636204670698362e-09
deaths O 0 5.17312581660434e-10
each O 0 4.406561920911045e-12
year O 0 2.1040753861445438e-10
in O 0 1.9077749102702768e-10
the O 0 6.436164795564636e-11
USA O 0 6.171618593953099e-08
alone O 0 1.4163311412573876e-08
. O 0 1.0083460733056882e-09

In O 0 6.798756224668523e-09
approximately O 0 6.019409970470235e-10
5 O 0 9.051522309455606e-10
- O 0 1.4456473991231178e-06
12 O 0 8.003801510447772e-10
% O 0 4.531999775458928e-12
of O 0 5.332260444280111e-14
these O 0 2.2847125667052604e-12
cases O 0 8.589081529342124e-11
, O 0 2.935671887874247e-12
there O 0 1.0356493440610848e-11
are O 0 2.6718282534338167e-12
no O 0 2.2779397812477953e-10
demonstrable O 0 3.597484464989975e-05
cardiac O 0 1.4534992260450963e-05
or O 0 6.538324548444052e-09
non O 0 0.0029671730007976294
- O 1 0.9958760142326355
cardiac O 0 0.0012080513406544924
causes O 0 1.7590816581147806e-09
to O 0 3.3925910691845473e-11
account O 0 1.898293883195734e-10
for O 0 6.438113497181375e-12
the O 0 5.5139577799512285e-12
episode O 0 1.936001359226225e-09
, O 0 1.873616713166104e-11
which O 0 4.2267305107313025e-12
is O 0 5.123570838427849e-12
therefore O 0 1.1672542099550043e-10
classified O 0 5.541053127444684e-08
as O 0 4.140232704230584e-06
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 0 1.9451023035799153e-05
IVF B-Disease 1 1.0
) O 0 1.1798934274054318e-08
. O 0 3.366064760257359e-09

A O 0 4.862915048420291e-08
distinct O 0 9.238506848419092e-09
group O 0 5.888750376215057e-09
of O 0 1.2460338316699904e-10
IVF B-Disease 1 1.0
patients O 0 1.6993184544844553e-05
has O 0 2.6724220059115567e-10
been O 0 7.266609536316082e-11
found O 0 3.1721618387603456e-11
to O 0 5.849580260279541e-13
present O 0 1.2341258657372345e-12
with O 0 2.3814004154049107e-12
a O 0 6.667392749015733e-10
characteristic O 0 2.0251054877462593e-07
electrocardiographic O 0 5.692940248991363e-05
pattern O 0 8.523766155121848e-06
. O 0 2.1648476788982407e-08

Because O 0 1.659656412300592e-08
of O 0 8.294958470100866e-12
the O 0 2.6672151900303254e-12
small O 0 6.644826182344854e-12
size O 0 8.98220872680433e-11
of O 0 1.1830006375543323e-12
most O 0 5.924604556950541e-11
pedigrees O 0 1.9821325025759506e-08
and O 0 7.508950058965347e-12
the O 0 5.04223225672451e-12
high O 0 1.2369611113172141e-08
incidence O 0 6.842574151733061e-08
of O 0 5.298113683882555e-11
sudden B-Disease 0 7.415158620460716e-08
death I-Disease 0 9.473221096456541e-10
, O 0 1.0852600068611551e-11
however O 0 4.051789459502686e-11
, O 0 1.8424933887623007e-12
molecular O 0 5.735415961605206e-11
genetic O 0 8.351450642152258e-10
studies O 0 9.901451880622858e-10
of O 0 6.241882011259747e-11
IVF B-Disease 1 1.0
have O 0 2.3278289518202655e-08
not O 0 2.886998973217203e-10
yet O 0 1.0110808856822473e-09
been O 0 9.7016283895357e-10
done O 0 1.6250299994524653e-09
. O 0 1.6992326989928586e-10

Because O 0 2.3522575247625355e-06
IVF B-Disease 1 1.0
causes O 0 1.5687439372413792e-05
cardiac O 1 0.8162223696708679
rhythm O 0 0.04174567386507988
disturbance O 0 5.193274432713224e-07
, O 0 1.132040919338273e-10
we O 0 2.6215311171862155e-11
investigated O 0 1.4239112666736276e-10
whether O 0 3.309378118765416e-11
malfunction O 0 1.616194111875302e-07
of O 0 1.1202562315293374e-12
ion O 0 3.2860317245031467e-10
channels O 0 2.8797312978667833e-08
could O 0 7.952934311106219e-07
cause O 0 2.424596301509041e-09
the O 0 5.094828448015676e-10
disorder O 0 1.5598226710267227e-08
by O 0 1.1428699783419538e-12
studying O 0 1.4844961371274223e-10
mutations O 0 7.210503860655137e-10
in O 0 4.1091716834751324e-11
the O 0 1.6873089037083844e-10
cardiac O 0 9.104653031499765e-08
sodium O 0 1.5183223567305504e-08
channel O 0 4.772306283484795e-07
gene O 0 1.4377211527971667e-06
SCN5A O 0 1.6562858945690095e-05
. O 0 2.04357419875123e-08

We O 0 2.2849393488399983e-08
have O 0 1.7768041205012963e-10
now O 0 2.24264808112995e-11
identified O 0 1.0556955309937166e-10
a O 0 2.4938506121285897e-11
missense O 0 7.34672426006e-07
mutation O 0 9.836777614680159e-09
, O 0 2.903968558676251e-11
a O 0 1.5570567057920925e-10
splice O 0 0.0005349599523469806
- O 0 2.1246262349450262e-06
donor O 0 4.8319790835194e-08
mutation O 0 1.7308370559021569e-07
, O 0 2.0231376296475645e-10
and O 0 7.586824224414812e-11
a O 0 9.883337481753074e-10
frameshift O 0 7.467256364179775e-05
mutation O 0 7.48238448977645e-09
in O 0 2.667080445384329e-10
the O 0 1.891072715087816e-11
coding O 0 3.042745788661705e-08
region O 0 1.3814512866971995e-09
of O 0 5.3603108063349225e-11
SCN5A O 0 7.362748419836862e-06
in O 0 2.9657067912580715e-09
three O 0 2.0800035027690456e-09
IVF B-Disease 1 1.0
families O 0 3.480966181967915e-09
. O 0 8.658333494615533e-10

We O 0 5.030770466873946e-09
show O 0 2.674665766644324e-10
that O 0 1.3288611747444556e-12
sodium O 0 7.670763330080987e-12
channels O 0 9.361707936639263e-11
with O 0 1.639516647444772e-12
the O 0 1.8680572713702936e-11
missense O 0 4.600454985848046e-07
mutation O 0 2.0785172694104403e-08
recover O 0 3.254182274758932e-07
from O 0 1.2865979115428416e-10
inactivation O 0 6.624411685862697e-09
more O 0 2.6552865808882053e-12
rapidly O 0 3.466478840086218e-11
than O 0 5.042386647113872e-12
normal O 0 2.3041672736479057e-10
and O 0 3.5927205654928684e-11
that O 0 3.4389498627246384e-12
the O 0 1.2456631559576437e-10
frameshift O 0 4.811241069546668e-06
mutation O 0 4.544297826925003e-09
causes O 0 2.2152366052630157e-10
the O 0 1.990183538802537e-11
sodium O 0 4.000349773658485e-10
channel O 0 7.46591855005363e-09
to O 0 3.875835416500273e-11
be O 0 1.5213995341323283e-10
non O 0 6.4863789894786805e-09
- O 0 1.1453731296739988e-08
functional O 0 3.228209255468073e-09
. O 0 5.447093887056553e-10

Our O 0 1.2338649213461395e-08
results O 0 4.5773456136544155e-09
indicate O 0 9.112063326099928e-10
that O 0 1.89791290322594e-11
mutations O 0 2.8634083992784554e-09
in O 0 4.1176861920178e-10
cardiac O 0 6.355332970997551e-08
ion O 0 3.6459621988171875e-09
- O 0 2.2375882480218934e-08
channel O 0 2.6730363700266935e-08
genes O 0 1.116231107545218e-09
contribute O 0 1.2646853182751716e-11
to O 0 2.54226999694962e-12
the O 0 5.910267067421593e-12
risk O 0 1.1648500219951785e-10
of O 0 1.5443428870789977e-12
developing O 0 8.551558572378326e-09
IVF B-Disease 1 1.0
. O 0 7.447951144712306e-10
. O 0 1.5066956571274659e-09

Molecular O 0 3.0769078307457676e-07
heterogeneity O 0 3.9618561231691274e-07
in O 0 3.746412247096487e-08
mucopolysaccharidosis B-Disease 0 0.00010433463467052206
IVA I-Disease 0 0.0012285478878766298
in O 0 4.539137421488704e-08
Australia O 0 1.2283560835157914e-08
and O 0 9.125398353626579e-11
Northern O 0 4.0648731602921373e-10
Ireland O 0 1.1714488579173121e-07
: O 0 3.1001019893533988e-12
nine O 0 6.834135254235596e-12
novel O 0 2.8779478800089464e-11
mutations O 0 3.652063929049376e-10
including O 0 1.87353830366499e-11
T312S O 0 3.0704907061362974e-08
, O 0 1.5923456997413155e-11
a O 0 3.51023168865261e-11
common O 0 2.832262424590226e-09
allele O 0 5.866354513273109e-08
that O 0 3.0027025310630506e-10
confers O 0 2.4057753122974646e-08
a O 0 5.946224845843062e-08
mild O 1 0.9966026544570923
phenotype O 0 0.00380059820599854
. O 0 9.47052001265547e-08

Mucopolysaccharidosis B-Disease 0 0.2844436466693878
IVA I-Disease 1 0.9999048709869385
( O 0 0.00017878590733744204
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 1.4590977315265263e-09
is O 0 1.9148216345854507e-10
an O 0 3.1842267711468253e-10
autosomal B-Disease 1 0.9999881982803345
recessive I-Disease 1 0.9999997615814209
lysosomal I-Disease 1 0.9999949932098389
storage I-Disease 1 0.9999823570251465
disorder I-Disease 1 0.9999994039535522
caused O 0 9.969529202180638e-08
by O 0 2.1933742322399752e-10
a O 0 1.9657384200399974e-06
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 1.5045140244751565e-08
N O 0 1.664294359216001e-05
- O 0 2.664851308509242e-06
acetylgalactosamine O 0 0.0011825013207271695
- O 0 8.081295163719915e-06
6 O 0 1.067888675265749e-07
- O 0 9.686360726846033e-07
sulfate O 0 2.2385323461548978e-07
sulfatase O 0 2.449943394822185e-06
( O 0 1.214445433106448e-09
GALNS O 0 7.803843686815526e-07
) O 0 2.9610480734021394e-10
. O 0 1.1333334271057538e-09

Previous O 0 9.617127005867587e-08
studies O 0 4.97469265781092e-09
of O 0 9.284491578331888e-12
patients O 0 6.676326158583379e-10
from O 0 1.3278713198450198e-11
a O 0 1.259743420689574e-10
British O 0 8.464922757411841e-06
- O 0 2.2219667243916774e-06
Irish O 0 1.912081604160676e-09
population O 0 3.4574836483419746e-12
showed O 0 2.2139792221764765e-09
that O 0 3.8114672008815464e-12
the O 0 9.711430444536706e-12
I113F O 0 1.6691865667439743e-08
mutation O 0 6.23848139813532e-10
is O 0 1.379822471558878e-11
the O 0 1.3032830023518294e-12
most O 0 6.639935996866075e-12
common O 0 1.9737252110463288e-10
single O 0 3.712161023017302e-09
mutation O 0 4.9815316316426106e-08
among O 0 1.5085892357546982e-07
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 0.0005997633561491966
and O 0 3.5761776873144413e-10
produces O 0 3.9006370355920694e-10
a O 0 7.4697359409015e-09
severe O 0 0.014100846834480762
clinical O 0 5.5205651733558625e-05
phenotype O 0 8.278858149424195e-05
. O 0 2.735319348801113e-08

We O 0 2.755889561001368e-08
studied O 0 1.4357651068053201e-08
mutations O 0 3.957730143611116e-09
in O 0 8.701207115935361e-11
the O 0 2.7391370421847583e-11
GALNS O 0 4.260881070194955e-08
gene O 0 2.5429820471600806e-09
from O 0 2.439625168548787e-10
23 O 0 1.933160076461604e-09
additional O 0 7.268987189945619e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 0.0010107066482305527
( O 0 1.9069454348930037e-10
15 O 0 8.179564664478889e-11
from O 0 2.8757640366250392e-11
Australia O 0 6.795770612910701e-10
, O 0 8.211981442074467e-12
8 O 0 7.382333459815538e-12
from O 0 7.188361017540501e-12
Northern O 0 1.7305713528870115e-09
Ireland O 0 2.44578814090346e-06
) O 0 1.2787878395092989e-11
, O 0 6.307399264340874e-13
with O 0 7.751987935030943e-14
various O 0 1.1267089691791021e-11
clinical O 0 6.008335162732692e-07
phenotypes O 0 1.2422475492712692e-06
( O 0 3.1354488783108536e-08
severe O 0 0.039352577179670334
, O 0 1.5496682825855146e-09
16 O 0 7.463152873476986e-10
cases O 0 6.276147934691778e-10
; O 0 1.1171761432615668e-10
intermediate O 0 1.3683270516651191e-08
, O 0 1.7406738550551637e-10
4 O 0 2.2379362252245016e-10
cases O 0 4.9403592328189916e-09
; O 0 9.989244986741141e-09
mild O 1 0.99972003698349
, O 0 1.724322018503699e-08
3 O 0 2.5662920677405054e-09
cases O 0 4.9385500133780624e-09
) O 0 2.899935014344379e-10
. O 0 3.0373688009177613e-09

We O 0 1.4979111284674218e-08
found O 0 1.7738312207971063e-10
two O 0 2.314586673365926e-12
common O 0 2.7699452107010636e-11
mutations O 0 4.060045633025311e-10
that O 0 7.026894257439187e-12
together O 0 6.5079066267903496e-12
accounted O 0 2.147123145945784e-09
for O 0 3.2110221599712663e-12
32 O 0 2.72582206806149e-10
% O 0 1.1269775911093571e-11
of O 0 7.0371508099909e-13
the O 0 3.2602590765984374e-11
44 O 0 3.221699851341242e-10
unrelated O 0 1.8337175111682313e-09
alleles O 0 3.0017819341310314e-09
in O 0 3.0350291169156662e-09
these O 0 9.753727825412284e-10
patients O 0 4.5540183180037275e-08
. O 0 1.1416255718543766e-09

One O 0 2.091185447028465e-09
is O 0 5.461719271293575e-11
the O 0 1.9896369274352566e-11
T312S O 0 7.754539410598227e-08
mutation O 0 1.0437775976868124e-08
, O 0 2.836216678181458e-11
a O 0 1.1984630302053212e-11
novel O 0 5.284320203635673e-10
mutation O 0 9.418810176242687e-10
found O 0 3.7367026139989434e-10
exclusively O 0 7.312216387944659e-10
in O 0 9.59363610775199e-09
milder O 0 0.0005397133645601571
patients O 0 1.2369216165097896e-05
. O 0 1.97688052594458e-08

The O 0 8.335568346673483e-10
other O 0 3.06464680022156e-11
is O 0 3.338641862971059e-12
the O 0 4.402359011189405e-13
previously O 0 1.5462837954505204e-10
described O 0 3.1147626144978346e-10
I113F O 0 2.1174506592558373e-09
that O 0 5.543241213268324e-12
produces O 0 6.833199978073523e-11
a O 0 3.146134464060424e-09
severe O 0 0.016152948141098022
phenotype O 0 7.91634083725512e-05
. O 0 2.3765682755083617e-08

The O 0 2.4209194648960874e-08
I113F O 0 2.9769876164209563e-07
and O 0 8.337810442071714e-10
T312S O 0 2.8259934836682987e-08
mutations O 0 8.243835836196922e-09
accounted O 0 1.614526645710157e-08
for O 0 6.45034373136788e-12
8 O 0 2.580722024969617e-10
( O 0 2.6294749710942256e-10
18 O 0 7.262470069768767e-10
% O 0 1.6333125824052885e-11
) O 0 8.22423899815572e-12
and O 0 1.3850605107279534e-09
6 O 0 4.950090892741343e-10
( O 0 1.57021506907995e-10
14 O 0 9.679761436842682e-10
% O 0 3.872451317943337e-11
) O 0 2.4887555124392113e-12
of O 0 1.4125433678638388e-12
44 O 0 3.775511014936228e-10
unrelated O 0 2.402811727364451e-09
alleles O 0 9.167485437444611e-09
, O 0 4.3843331742898783e-10
respectively O 0 2.1237370972926328e-08
. O 0 4.917608098509163e-09

The O 0 2.056598225053108e-09
relatively O 0 2.504035379047309e-08
high O 0 1.43417766551579e-08
residual O 0 9.32091879235486e-08
GALNS O 0 2.2971167709329166e-05
activity O 0 1.3530309672660223e-07
seen O 0 5.145839754305825e-09
when O 0 3.0978043047413806e-11
the O 0 3.426222413421831e-12
T312S O 0 4.748231807738534e-10
mutant O 0 4.5311920882085133e-10
cDNA O 0 2.9540940804650972e-09
is O 0 7.380366456866128e-11
overexpressed O 0 2.5137255832419214e-08
in O 0 1.1297243696084536e-10
mutant O 0 8.169200871321891e-10
cells O 0 1.6317565354473373e-10
provides O 0 2.2488334111558927e-11
an O 0 1.481230828097313e-12
explanation O 0 3.1121005078516006e-11
for O 0 2.660711061197585e-12
the O 0 1.68924735310938e-10
mild O 0 0.001234613824635744
phenotype O 0 1.6245585356955417e-06
in O 0 5.966672045332189e-09
patients O 0 1.1596527293988856e-08
with O 0 4.999349458717495e-12
this O 0 1.9424879760254754e-10
mutation O 0 5.07723605380761e-08
. O 0 3.900348932717179e-09

The O 0 4.5510789581371114e-10
distribution O 0 1.35017275137983e-10
and O 0 5.35687379871197e-12
relative O 0 1.6508957395577895e-11
frequencies O 0 3.5042130308582387e-10
of O 0 1.2223564174740353e-12
the O 0 2.915189964425302e-11
I113F O 0 1.0717019272021844e-08
and O 0 4.3859870596518746e-11
T312S O 0 2.1530244254108766e-09
mutations O 0 5.292127847056349e-10
in O 0 9.820832341800312e-11
Australia O 0 3.7933593766137363e-11
corresponded O 0 1.3434827902947255e-11
to O 0 5.477382870183733e-13
those O 0 6.834418556263266e-13
observed O 0 1.9691921704367843e-12
in O 0 2.571233156944963e-11
Northern O 0 1.0021988794406411e-09
Ireland O 0 1.7633360016588995e-07
and O 0 5.20272921966658e-11
are O 0 5.743314352747719e-13
unique O 0 3.0292053045631595e-13
to O 0 7.701633384857298e-13
these O 0 5.644875842800157e-13
two O 0 1.2598815220254966e-12
populations O 0 1.9727860837981392e-12
, O 0 4.712199597536881e-13
suggesting O 0 6.47882997251159e-11
that O 0 2.7313411948837185e-12
both O 0 3.2717008355970245e-12
mutations O 0 5.759204224631276e-11
were O 0 1.0522945848023824e-09
probably O 0 3.1788154331025e-09
introduced O 0 1.1906305108499993e-10
to O 0 8.936578040075194e-12
Australia O 0 2.2858728798702543e-11
by O 0 9.82554532527602e-13
Irish O 0 3.9708919485903493e-10
migrants O 0 1.711567276796444e-10
during O 0 1.0784341301917078e-11
the O 0 5.427032521293507e-12
19th O 0 3.288754601982191e-09
century O 0 3.7991071621945594e-08
. O 0 4.08658751283042e-09

Haplotype O 0 9.85931619652547e-05
analysis O 0 3.768651168911674e-08
using O 0 5.119846768764091e-09
6 O 0 2.84494272584368e-09
RFLPs O 0 1.1324956084024507e-08
provides O 0 3.1889050428057786e-11
additional O 0 1.1482280404262468e-11
data O 0 7.389863720952405e-10
that O 0 4.699859858930955e-12
the O 0 1.2769891047370585e-11
I113F O 0 8.27171486861289e-09
mutation O 0 7.211081731739455e-10
originated O 0 1.1754451856305081e-09
from O 0 4.2835360258841604e-11
a O 0 6.628196602687098e-11
common O 0 4.5183157215689107e-10
ancestor O 0 1.0392641414114223e-08
. O 0 5.243080192229854e-09

The O 0 1.0640632819303164e-09
other O 0 9.656080102171671e-11
9 O 0 9.751956187020738e-11
novel O 0 8.930516742777783e-11
mutations O 0 2.4119122254973036e-09
identified O 0 6.097365279345013e-09
in O 0 2.073949345593462e-10
these O 0 1.7349221018148064e-11
23 O 0 6.145078890185118e-10
patients O 0 3.6686034765587294e-10
were O 0 7.183868777627112e-11
each O 0 2.502778258077487e-13
limited O 0 3.120784880517036e-11
to O 0 1.9467599407518854e-11
a O 0 5.956048987343365e-10
single O 0 1.9109888782509188e-08
family O 0 2.5440685114119788e-09
. O 0 2.095409623592559e-09

These O 0 1.305324848210887e-09
data O 0 8.874282975135372e-10
provide O 0 1.8688342540151837e-11
further O 0 9.038953613371703e-12
evidence O 0 2.1060255969707065e-11
for O 0 7.856965403806038e-13
extensive O 0 1.5069420711277814e-10
allelic O 0 2.6742704051230248e-08
heterogeneity O 0 8.274731300161875e-08
in O 0 1.5286868801922537e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
in O 0 5.117591683756473e-09
British O 0 3.881963039020775e-06
- O 0 6.276468411670066e-06
Irish O 0 1.736421140208222e-08
patients O 0 6.507305250202933e-10
and O 0 3.0669373290992397e-12
provide O 0 4.638391450442758e-13
evidence O 0 7.34868763063723e-12
for O 0 7.257294266406478e-13
their O 0 5.787766533399408e-12
transmission O 0 3.8284495573748245e-09
to O 0 2.4195029660334377e-11
Australia O 0 6.205699842887213e-11
by O 0 1.8799519233003714e-12
British O 0 2.1783385761864338e-07
- O 0 1.635372548491887e-08
Irish O 0 1.4010879123560471e-09
migrants O 0 6.781760153451444e-10
. O 0 1.3322778644186961e-11
. O 0 1.1796985610601496e-10

Identification O 0 1.1899022211991905e-07
of O 0 2.6795216045982784e-10
constitutional O 0 8.527387684864607e-09
WT1 O 0 1.0399459824839141e-05
mutations O 0 5.5639230822635e-07
, O 0 4.262917241426578e-10
in O 0 2.7782962042088855e-10
patients O 0 3.597401043720083e-09
with O 0 6.978479599739629e-11
isolated O 0 0.0003002891899086535
diffuse B-Disease 1 0.9999486207962036
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 4.0878735951821454e-09
and O 0 2.6016463289257885e-11
analysis O 0 8.699398146294612e-11
of O 0 2.239925085689709e-11
genotype O 0 0.005223836749792099
/ O 0 0.0006763245328329504
phenotype O 0 7.274772997334367e-07
correlations O 0 1.0379650206004953e-07
by O 0 2.0223031582666806e-11
use O 0 3.4563663042774806e-10
of O 0 1.3124760826765947e-11
a O 0 5.417264969942437e-10
computerized O 0 1.5672715107939439e-06
mutation O 0 2.3820783212613605e-07
database O 0 2.7938273206018494e-07
. O 0 1.5505856154618414e-08

Constitutional O 0 9.330844363830693e-08
mutations O 0 9.512937282352141e-08
of O 0 1.7231422885788383e-11
the O 0 3.2169270719473175e-11
WT1 O 0 6.11532655625524e-08
gene O 0 3.1933149458041044e-09
, O 0 2.1106219202926546e-11
encoding O 0 4.144594945021396e-10
a O 0 3.316311392165261e-10
zinc O 0 0.0003803960862569511
- O 0 3.0135233828332275e-05
finger O 0 2.1256242689560167e-05
transcription O 0 4.583822033055185e-08
factor O 0 5.588321472238533e-10
involved O 0 5.10194664293806e-10
in O 0 1.4156938732412527e-08
renal O 0 7.748643838567659e-05
and O 0 3.9612344515660425e-09
gonadal O 0 7.031330824247561e-07
development O 0 8.941906659565291e-10
, O 0 1.675812960622025e-11
are O 0 2.1332571126242428e-12
found O 0 6.609007785485232e-11
in O 0 1.3349817779007012e-11
most O 0 3.062379516638458e-11
patients O 0 3.999144071453742e-10
with O 0 1.4608513010383462e-10
Denys B-Disease 1 0.9999988079071045
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.608241857160465e-06
DDS B-Disease 1 1.0
) O 0 4.177828749618584e-09
, O 0 5.009893055962777e-10
or O 0 4.950856009600102e-07
diffuse B-Disease 1 0.9995847344398499
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 7.258831828949042e-06
DMS B-Disease 1 0.9965764880180359
) O 0 9.972787179401976e-11
associated O 0 2.761838258091842e-10
with O 0 4.1146952511894597e-10
pseudohermaphroditism B-Disease 1 1.0
and O 0 2.524712726881262e-05
/ O 0 0.002498998073861003
or O 0 7.414761853397067e-07
Wilms B-Disease 0 0.20507128536701202
tumor I-Disease 0 0.0002984846942126751
( O 0 5.7582244750165046e-08
WT B-Disease 1 0.9999758005142212
) O 0 2.3899358048140584e-09
. O 0 4.102041817333202e-09

Most O 0 2.5589667274061867e-08
mutations O 0 1.673647034294845e-06
in O 0 1.661796659391257e-06
DDS B-Disease 1 1.0
patients O 0 0.00024552183458581567
lie O 0 8.243981142186385e-08
in O 0 7.974848559300085e-10
exon O 0 1.0734493827158076e-07
8 O 0 3.1827223079261557e-09
or O 0 1.77001968637569e-09
exon O 0 5.2511293091583866e-08
9 O 0 7.614071151351709e-09
, O 0 8.01204519396137e-11
encoding O 0 3.9666719686692886e-08
zinc O 0 7.048746920190752e-05
finger O 0 0.1491851657629013
2 O 0 1.6510746547737654e-08
or O 0 2.536995964419475e-07
zinc O 0 0.09952539205551147
finger O 1 0.9582550525665283
3 O 0 8.431191744762145e-09
, O 0 2.4695695488574643e-10
respectively O 0 1.963415652284084e-09
, O 0 1.8100203627580136e-11
with O 0 5.407359456033323e-12
a O 0 1.4990085617228033e-08
hot O 0 0.0052349017933011055
spot O 0 0.000607157708145678
( O 0 1.3722755154432775e-09
R394W O 0 1.473987865097115e-08
) O 0 2.0834479974585207e-11
in O 0 1.9023244091087577e-10
exon O 0 6.65234551888716e-08
9 O 0 1.866948728945772e-08
. O 0 2.5561359695558394e-09

We O 0 1.1971671654009697e-08
analyzed O 0 1.737026411596787e-09
a O 0 1.9110990567838826e-11
series O 0 5.86198381502534e-11
of O 0 4.531325401707642e-12
24 O 0 3.1003488665248824e-09
patients O 0 3.6077216769569986e-09
, O 0 6.383128400844207e-12
10 O 0 5.953270862391058e-12
with O 0 2.6663617494482317e-11
isolated B-Disease 0 0.003928667400032282
DMS I-Disease 1 0.9999994039535522
( O 0 7.788803491060037e-10
IDMS B-Disease 0 8.04642070306727e-07
) O 0 8.280925251069604e-11
, O 0 2.3439717181106268e-11
10 O 0 5.955046178396373e-11
with O 0 3.617678601131047e-09
DDS B-Disease 1 1.0
, O 0 5.0354575620303876e-08
and O 0 8.404423268437711e-10
4 O 0 2.9973923343362685e-10
with O 0 6.211458014604432e-10
urogenital B-Disease 1 0.980652928352356
abnormalities I-Disease 1 1.0
and O 0 2.587033804957173e-06
/ O 0 0.06176897510886192
or O 0 1.9614384655142203e-05
WT B-Disease 1 0.9999994039535522
. O 0 4.55386199860186e-08

We O 0 5.941621950000808e-08
report O 0 6.175101763261637e-09
WT1 O 0 1.1251106570853153e-06
heterozygous O 0 2.2769349072859768e-07
mutations O 0 2.980441138333845e-08
in O 0 8.355370284540697e-10
16 O 0 3.070014686912259e-09
patients O 0 1.4007598636567309e-08
, O 0 4.306785483798592e-11
4 O 0 5.947100450987008e-11
of O 0 3.731186800498554e-12
whom O 0 2.32828090140913e-09
presented O 0 1.893933454510943e-09
with O 0 1.2955323480667857e-09
IDMS B-Disease 0 0.00029495288617908955
. O 0 2.8070999746887537e-08

One O 0 5.703059358097562e-08
male O 0 4.331027270154664e-08
and O 0 1.8323881301185452e-10
two O 0 1.6610988973209118e-10
female O 0 4.649933771361248e-09
IDMS B-Disease 0 2.701014636841137e-05
patients O 0 1.6005412817321485e-07
with O 0 1.3721132008370773e-09
WT1 O 0 0.0023277702275663614
mutations O 0 0.00030417536618188024
underwent O 0 4.1634164517745376e-05
normal O 0 3.6400479075382464e-06
puberty O 0 2.4253797164419666e-05
. O 0 1.0306495212830669e-08

Two O 0 3.341617471619429e-08
mutations O 0 2.075584433214317e-07
associated O 0 3.5980458612527855e-09
with O 0 1.555507112005472e-10
IDMS B-Disease 0 4.581192570185522e-06
are O 0 3.41398610770316e-11
different O 0 1.1138097388840862e-11
from O 0 5.398335251038944e-11
those O 0 7.952909858444102e-11
described O 0 4.446257584334035e-09
in O 0 2.438702324525366e-07
DDS B-Disease 1 1.0
patients O 0 4.458890089154011e-06
. O 0 6.000201668854288e-09

No O 0 8.893133696119548e-08
WT1 O 0 1.0315962754248176e-05
mutations O 0 4.109938629426324e-07
were O 0 6.545237241084578e-09
detected O 0 3.470328024945957e-08
in O 0 1.545558542259684e-10
the O 0 3.964984590654197e-12
six O 0 2.0858455587746683e-11
other O 0 2.246325521426673e-11
IDMS B-Disease 0 6.126469543232815e-06
patients O 0 1.853105580096326e-08
, O 0 1.624606872641099e-11
suggesting O 0 2.889920303061899e-09
genetic O 0 2.2930073839688703e-08
heterogeneity O 0 2.5635733535978034e-08
of O 0 8.346637270228996e-11
this O 0 1.5924384033638717e-09
disease O 0 1.1396286936360411e-06
. O 0 6.2343925577579284e-09

We O 0 3.403004456004055e-08
analyzed O 0 1.696298141951047e-07
genotype O 0 0.000305261870380491
/ O 0 7.325812475755811e-05
phenotype O 0 1.034759293361276e-06
correlations O 0 1.458113160879293e-06
, O 0 2.166150731008898e-10
on O 0 7.590369999199709e-11
the O 0 9.962757615417095e-13
basis O 0 2.430325905800057e-11
of O 0 3.991616607558479e-13
the O 0 5.108133967896e-12
constitution O 0 8.751334726331272e-12
of O 0 2.005966600509071e-13
a O 0 9.332148942498009e-11
WT1 O 0 1.3982392488287587e-07
mutation O 0 1.877170641151338e-09
database O 0 5.223135257637068e-10
of O 0 3.8249329918638164e-12
84 O 0 1.4186934960136455e-09
germ O 0 0.0002651375252753496
- O 0 0.0007275191601365805
line O 0 1.0433356010253192e-06
mutations O 0 2.6491811411233357e-08
, O 0 5.30254919833828e-12
to O 0 7.630018578758113e-13
compare O 0 4.494992919545915e-11
the O 0 7.35712651824677e-13
distribution O 0 1.1774097322114763e-11
and O 0 9.991445865109583e-11
type O 0 2.667993825866688e-08
of O 0 2.2854751945133867e-12
mutations O 0 7.049117400903526e-10
, O 0 1.0930961864830113e-11
according O 0 6.92660035231385e-12
to O 0 2.125280637241267e-12
the O 0 3.4096132167649174e-11
different O 0 3.5912310902830313e-09
symptoms O 0 8.619830964562425e-07
. O 0 1.8408171653661043e-09

This O 0 2.0737092043532357e-09
demonstrated O 0 2.2120627551913685e-09
( O 0 1.3198195314423344e-10
1 O 0 2.7373350114379136e-11
) O 0 2.1702427181746753e-12
the O 0 8.961049133629495e-13
association O 0 6.785945937115567e-12
between O 0 1.3433417572761286e-11
mutations O 0 2.245145402923754e-09
in O 0 6.736625146608333e-10
exons O 0 1.004398253456884e-08
8 O 0 2.0173818171542734e-09
and O 0 2.0534391964588394e-09
9 O 0 2.7446480643789073e-08
and O 0 1.5894387672688026e-07
DMS B-Disease 1 0.9979985356330872
; O 0 3.834657244516926e-11
( O 0 3.396048373072169e-11
2 O 0 8.046702193453825e-11
) O 0 7.665731764638917e-12
among O 0 1.3476789996469396e-11
patients O 0 6.391991380638729e-10
with O 0 8.335818840743414e-11
DMS B-Disease 1 0.9409849643707275
, O 0 2.0423827559734598e-11
a O 0 2.793161535397104e-11
higher O 0 1.4930697789239389e-09
frequency O 0 1.0816901818699876e-09
of O 0 8.367801243580608e-12
exon O 0 4.4174242042061e-09
8 O 0 2.766251117058971e-10
mutations O 0 2.9454128025463433e-09
among O 0 5.473670475208969e-11
46 O 0 9.159126790336813e-10
, O 0 9.59754289930892e-11
XY O 0 8.162880476447754e-06
patients O 0 6.709548472372262e-08
with O 0 2.2917370778863244e-10
female O 0 9.439483505957469e-08
phenotype O 0 3.6111316603637533e-07
than O 0 1.7009123276512383e-10
among O 0 2.6959418031324844e-10
46 O 0 5.327942975696942e-09
, O 0 2.583440683601168e-10
XY O 0 4.057653313793708e-06
patients O 0 1.9612457435869146e-08
with O 0 1.411439715104379e-11
sexual O 0 1.7557296727588323e-09
ambiguity O 0 9.60865342847228e-09
or O 0 1.5174828504882498e-08
male O 0 1.8962186487669896e-08
phenotype O 0 7.34636103061348e-08
; O 0 7.595801071458297e-11
and O 0 1.5861332247624205e-09
( O 0 9.979676113269775e-11
3 O 0 3.961214689596204e-11
) O 0 1.7622188430710395e-12
statistically O 0 9.122300831387875e-11
significant O 0 3.4347299310288903e-11
evidence O 0 7.856212902446202e-10
that O 0 1.0564266822443713e-10
mutations O 0 8.403124307498899e-10
in O 0 2.9685748303975856e-10
exons O 0 8.091327607928633e-09
8 O 0 7.050085515380999e-10
and O 0 7.292365322708605e-11
9 O 0 2.2312234004839837e-10
preferentially O 0 7.566899329347621e-10
affect O 0 7.94039445306538e-10
amino O 0 9.512941823164311e-11
acids O 0 1.7882747366249063e-11
with O 0 5.086431493009358e-13
different O 0 2.489515321321689e-12
functions O 0 4.393086588949657e-11
. O 0 7.20993681424531e-11
. O 0 1.1160053992043117e-09

The O 0 7.87447440586675e-09
185delAG O 0 9.518524848317611e-07
BRCA1 O 0 2.1502548861462856e-06
mutation O 0 1.4256085201225233e-08
originated O 0 6.237984795376406e-09
before O 0 8.608336266036076e-11
the O 0 1.973968081006583e-12
dispersion O 0 2.3784069158594434e-10
of O 0 9.780160893386319e-14
Jews O 0 8.953246130594117e-12
in O 0 9.880086332403337e-12
the O 0 2.3879136515359e-12
diaspora O 0 7.099307253177756e-11
and O 0 3.7904901439844707e-10
is O 0 1.0726941904182219e-11
not O 0 9.913517055870624e-12
limited O 0 3.949310323214661e-11
to O 0 2.5903088007872554e-10
Ashkenazim O 0 1.2756298701788182e-06
. O 0 2.0732502381548557e-09

The O 0 5.159165539225796e-09
185delAG O 0 2.225793878096738e-07
mutation O 0 2.6139160169691422e-08
in O 0 1.082214318159913e-09
BRCA1 O 0 1.3736007531406358e-06
is O 0 1.695134588253211e-10
detected O 0 3.8288966663913016e-08
in O 0 1.484310008237344e-09
Ashkenazi O 0 6.47871587489135e-08
Jews O 0 3.1217434887098605e-11
both O 0 1.5672699249513755e-11
in O 0 7.575650107227716e-10
familial B-Disease 0 0.45696061849594116
breast I-Disease 1 0.9999991655349731
and I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.392706483471784e-08
in O 0 3.0199678868747526e-10
the O 0 3.0401404050445224e-12
general O 0 1.522487344529644e-11
population O 0 2.2759667414606888e-11
. O 0 6.044709732755393e-10

All O 0 3.5765341799276484e-09
tested O 0 9.410810264398606e-08
Ashkenazi O 0 1.7024663634401804e-07
mutation O 0 1.9881365442842025e-09
carriers O 0 2.053321512818229e-09
share O 0 2.2375232777704923e-09
the O 0 2.2330188045871502e-11
same O 0 3.306817875081691e-10
allelic O 0 2.2871804006285856e-08
pattern O 0 3.250178224334377e-07
at O 0 8.586076738481552e-09
the O 0 1.5607971859399328e-10
BRCA1 O 0 9.71343752098619e-07
locus O 0 1.504792948026079e-07
. O 0 1.2172496788309672e-08

Our O 0 5.535621294683324e-09
previous O 0 2.0693066704602359e-10
study O 0 2.267924216481365e-11
showed O 0 2.8462873724599547e-10
that O 0 4.677143004491735e-13
this O 0 7.161288706133973e-13
Ashkenazi O 0 6.761256088338996e-08
mutation O 0 5.201372665908366e-10
also O 0 9.41812391963559e-11
occurs O 0 4.660430895364609e-12
in O 0 1.0594085504689321e-11
Iraqi O 0 7.790537659424501e-11
Jews O 0 1.2182419135975397e-11
with O 0 9.540480384873096e-13
a O 0 3.027567779811946e-11
similar O 0 4.961963617766685e-10
allelic O 0 1.5258582664046116e-07
pattern O 0 5.980762580293231e-06
. O 0 2.7098224109067814e-08

We O 0 1.7949066233313715e-08
extended O 0 1.0453430343559944e-09
our O 0 2.1297781246931713e-11
analysis O 0 8.715320999608256e-12
to O 0 6.788194680841519e-13
other O 0 1.5083437970853097e-12
non O 0 4.690588806255391e-09
- O 0 3.712913354547709e-08
Ashkenazi O 0 1.2237212132504283e-08
subsets O 0 4.76289008233266e-10
354 O 0 1.091921997264933e-09
of O 0 8.78311908879964e-13
Moroccan O 0 2.830545353660341e-09
origin O 0 1.3913191432290972e-10
, O 0 9.713449662662743e-12
200 O 0 3.201911305539262e-11
Yemenites O 0 3.942016491009781e-08
and O 0 2.8117737305155543e-11
150 O 0 3.1369396663594173e-11
Iranian O 0 5.283987691839798e-10
Jews O 0 9.97235516386752e-10
. O 0 7.986569183771053e-10

Heteroduplex O 0 9.797357051866129e-06
analysis O 0 9.712315396370741e-09
complemented O 0 3.093473255333379e-09
by O 0 1.279409998083958e-11
direct O 0 1.8117449207544212e-10
DNA O 0 2.0428212454959294e-09
sequencing O 0 5.486131549048423e-10
of O 0 5.122945470614759e-12
abnormally O 0 4.051437851870787e-09
migrating O 0 6.471891911274952e-10
bands O 0 2.45115172603505e-09
were O 0 9.720131366464102e-10
employed O 0 8.949487373399734e-09
. O 0 8.068576362596502e-10

Four O 0 3.087178512828359e-09
of O 0 1.3013735054856479e-11
Moroccan O 0 1.833323182154345e-08
origin O 0 7.180118721805684e-10
( O 0 6.72195077378035e-11
1 O 0 2.4052025995868753e-11
. O 0 2.3616696705891504e-12
1 O 0 1.4078369546532965e-11
% O 0 1.6819870149453742e-11
) O 0 3.665522312762404e-12
and O 0 4.10165477970903e-11
none O 0 7.120425915552175e-10
of O 0 3.202237737129354e-13
the O 0 8.858783498433276e-12
Yemenites O 0 3.607184995146895e-09
or O 0 8.991636601951569e-11
Iranians O 0 1.0642255965365166e-09
was O 0 3.958784688951056e-10
a O 0 9.585682941848361e-12
carrier O 0 9.688591040557526e-10
of O 0 3.8715189908111736e-12
the O 0 7.659991391184562e-11
185delAG O 0 1.3033854884270113e-07
mutation O 0 7.128422652158406e-08
. O 0 6.432612220663714e-09

BRCA1 O 0 0.0005782490479759872
allelic O 0 7.459348125848919e-06
patterns O 0 7.3457199505355675e-06
were O 0 3.4107696222918094e-08
determined O 0 8.530668949013887e-10
for O 0 2.1396343898028025e-12
four O 0 4.007922032450706e-12
of O 0 5.295186150991969e-14
these O 0 3.332240353873944e-13
individuals O 0 2.0691849384087135e-13
and O 0 2.1470185004868192e-11
for O 0 2.9024332850319245e-12
12 O 0 2.2756196232931458e-11
additional O 0 2.41902331499233e-11
non O 0 1.7755093040250358e-07
- O 0 5.136191703059012e-06
Ashkenazi O 0 3.525405247728486e-07
185delAG O 0 1.497516954884759e-08
mutation O 0 1.0110465353818654e-08
carriers O 0 7.996027306944598e-08
who O 0 2.259163167650513e-08
had O 0 0.0015693972818553448
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.989776059005635e-08

Six O 0 1.3480105565122358e-07
non O 0 1.3766137271886691e-05
- O 0 0.03731426224112511
Ashkenazi O 0 6.312939149211161e-07
individuals O 0 4.868891314430135e-12
shared O 0 1.0422641048835057e-11
the O 0 5.846281358329319e-12
common O 0 7.092060272384515e-09
Ashkenazi O 0 7.967704004840925e-05
haplotype O 0 1.3035114534432068e-06
, O 0 2.584958913587343e-10
four O 0 7.36696328940134e-11
had O 0 5.957187632077421e-09
a O 0 3.964744851869817e-11
closely O 0 6.003933350484658e-09
related O 0 4.963255761936125e-08
pattern O 0 0.00028305043815635145
, O 0 1.2307082464246832e-08
and O 0 2.1392461135860685e-09
the O 0 4.0579685445241154e-11
rest O 0 5.213957599004004e-10
( O 0 4.590236871160336e-11
n O 0 6.641693417464012e-09
= O 0 7.467770402058704e-09
6 O 0 4.5460640807348796e-10
) O 0 1.052343715640669e-11
displayed O 0 1.0465879274335066e-09
a O 0 1.0472269718064808e-09
distinct O 0 3.9715093436143434e-08
BRCA1 O 0 3.329239916638471e-05
allelic O 0 1.976595740416087e-06
pattern O 0 1.6459280232083984e-05
. O 0 9.372332243628989e-08

We O 0 1.4092173650226414e-08
conclude O 0 3.5797689257321963e-09
that O 0 4.033728212560206e-12
the O 0 7.688838281338928e-12
185delAG O 0 4.24327382120282e-08
BRCA1 O 0 3.349228563820361e-06
mutation O 0 1.529492621443751e-08
occurs O 0 1.4360074240826748e-10
in O 0 1.2091903867084142e-11
some O 0 1.0428725591427046e-11
non O 0 3.131552261947945e-08
- O 0 3.489701157377567e-06
Ashkenazi O 0 6.246916939289804e-08
populations O 0 1.0942773770450387e-10
at O 0 5.228417698788235e-10
rates O 0 1.8295183146221916e-09
comparable O 0 1.4442644302725682e-10
with O 0 2.3177939602325726e-12
that O 0 1.7520814660221262e-11
of O 0 3.1568553326977167e-11
Ashkenazim O 0 3.6753172025782987e-06
. O 0 5.1783306531660855e-09

The O 0 1.2417212813531364e-09
majority O 0 2.591870607027147e-10
of O 0 2.1797093210235152e-12
Jewish O 0 7.834799475858745e-10
185delAG O 0 5.2801343741748497e-08
mutation O 0 2.0549082435650234e-09
carriers O 0 5.448240081307176e-09
have O 0 1.1726723758709312e-10
a O 0 7.442693683579193e-11
common O 0 2.6457962487569375e-09
allelic O 0 2.9622938768625318e-08
pattern O 0 8.49555419790704e-07
, O 0 8.836039538939744e-11
supporting O 0 2.1569558639189523e-11
the O 0 1.0487349703935944e-11
founder O 0 2.0993932980939434e-10
effect O 0 1.6520622370119753e-10
notion O 0 4.363401584495108e-10
, O 0 5.1337076950597194e-11
but O 0 6.076902175911059e-11
dating O 0 1.1738857663701197e-09
the O 0 1.2093605197133206e-12
mutations O 0 2.157037916339366e-11
origin O 0 8.002541337925884e-12
to O 0 5.962396375236434e-12
an O 0 7.308082090873302e-12
earlier O 0 1.5949004339432804e-09
date O 0 3.438994422566566e-09
than O 0 2.8503277862967913e-11
currently O 0 2.0505486197919254e-11
estimated O 0 5.066123215380358e-11
. O 0 1.0286183016461337e-09

However O 0 1.8721120653708567e-08
, O 0 4.364639552556504e-11
the O 0 1.0638059443762726e-12
different O 0 5.653433884228454e-12
allelic O 0 2.4727191405560234e-09
pattern O 0 1.001330360850261e-07
at O 0 1.6579407846606387e-09
the O 0 2.067198842659046e-11
BRCA1 O 0 7.03614801977892e-08
locus O 0 1.8398904622074497e-09
even O 0 4.0038303228406846e-10
in O 0 3.013504723536897e-11
some O 0 3.93997898542886e-12
Jewish O 0 9.547589108205301e-11
mutation O 0 2.6969290689571324e-10
carriers O 0 9.768044151314825e-10
, O 0 7.184934071313709e-12
might O 0 3.3007183097844006e-10
suggest O 0 4.4556022760211533e-10
that O 0 2.424575644421889e-11
the O 0 1.840576649425607e-11
mutation O 0 3.977433660207197e-10
arose O 0 3.509939006107743e-10
independently O 0 7.854385475347669e-10
. O 0 1.5608270231837196e-10
. O 0 1.4108489931885515e-09

Crystal O 0 1.0780238881125115e-05
structure O 0 4.504569517393975e-08
of O 0 6.341543956622786e-11
the O 0 1.6037713379546403e-09
hemochromatosis B-Disease 1 1.0
protein O 0 1.4896647826390108e-07
HFE O 0 3.5141879379807506e-06
and O 0 1.960832329839235e-10
characterization O 0 1.0136316230813236e-09
of O 0 6.787547412144546e-13
its O 0 2.004456930299048e-12
interaction O 0 2.1075606537745983e-11
with O 0 3.1072115366792552e-12
transferrin O 0 8.69978844519892e-09
receptor O 0 9.92115456455167e-09
. O 0 2.291816958432946e-09

HFE O 0 0.006274743936955929
is O 0 2.3504041379851515e-08
an O 0 9.402292139304436e-11
MHC O 0 1.4405577530851588e-07
- O 0 3.563231132375222e-08
related O 0 1.7810091179626397e-09
protein O 0 1.7186078116182557e-09
that O 0 2.6510269673929443e-11
is O 0 5.355178106514202e-12
mutated O 0 3.4735243570338525e-09
in O 0 4.0251782462696895e-10
the O 0 1.4429517580794027e-09
iron B-Disease 1 0.9999841451644897
- I-Disease 1 0.9999992847442627
overload I-Disease 1 0.9982905983924866
disease I-Disease 1 0.9999998807907104
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 2.494462250979268e-06

HFE O 0 0.00015563781198579818
binds O 0 1.4304410456134065e-07
to O 0 8.670000273269807e-10
transferrin O 0 3.430100292689531e-08
receptor O 0 9.271445833292091e-09
( O 0 5.676508707530559e-10
TfR O 0 4.20627543462615e-07
) O 0 2.6719924883789048e-11
and O 0 1.9628521030767843e-11
reduces O 0 3.4584616420696435e-11
its O 0 8.51516394288071e-13
affinity O 0 9.673131046161743e-11
for O 0 1.0316628627771163e-11
iron O 0 1.0041043196906685e-06
- O 0 1.4793082314668027e-08
loaded O 0 2.0910180253963517e-09
transferrin O 0 7.871756579902467e-09
, O 0 9.11591704899628e-11
implicating O 0 1.0254180615731912e-08
HFE O 0 3.0051837711653206e-06
in O 0 7.148039049553745e-09
iron O 0 4.442987483344041e-05
metabolism O 0 3.906846814061282e-06
. O 0 3.994435449072853e-09

The O 0 2.2551423839445306e-08
2 O 0 1.58046873366402e-08
. O 0 4.985958756975606e-09

6 O 0 4.501735304529575e-07
A O 0 1.8908375309933945e-08
crystal O 0 6.366595243889606e-06
structure O 0 6.306416366896883e-08
of O 0 1.794281945244336e-10
HFE O 0 1.1602517588471528e-05
reveals O 0 1.862559706466982e-08
the O 0 2.2602029622897923e-11
locations O 0 3.5683234145267306e-09
of O 0 2.3022266315564366e-09
hemochromatosis B-Disease 1 1.0
mutations O 0 3.547604364939616e-06
and O 0 1.5360023253307986e-09
a O 0 9.13696784898832e-10
patch O 0 0.00010661302803782746
of O 0 8.748601842967219e-11
histidines O 0 7.117159270819684e-07
that O 0 4.1071968742700804e-11
could O 0 3.175517071518641e-10
be O 0 7.146201599222968e-12
involved O 0 6.5720853238693255e-12
in O 0 8.103154258698453e-10
pH O 0 1.7484918402033145e-08
- O 0 4.282461940618987e-09
dependent O 0 5.325392571364773e-09
interactions O 0 3.0187257138436507e-09
. O 0 1.1231504615238919e-09

We O 0 1.5318516233264745e-08
also O 0 1.4651654889341614e-10
demonstrate O 0 2.788297648326221e-10
that O 0 5.2960830165815764e-11
soluble O 0 1.4230050737751299e-07
TfR O 0 1.221171442011837e-05
and O 0 3.0133509576479867e-10
HFE O 0 3.328749187403446e-07
bind O 0 4.433478917320599e-09
tightly O 0 2.477950289403452e-09
at O 0 2.0213132556623492e-10
the O 0 1.0990327571624992e-12
basic O 0 1.9365986592134732e-10
pH O 0 6.642953548352537e-11
of O 0 6.611039976090263e-14
the O 0 2.034240614498528e-12
cell O 0 9.81651648856996e-09
surface O 0 1.9693642272500256e-09
, O 0 7.388802764074498e-11
but O 0 3.5347161309040587e-10
not O 0 2.286644831817064e-11
at O 0 5.279471998465013e-11
the O 0 2.513180288876704e-11
acidic O 0 2.6189650448316115e-09
pH O 0 8.315401700542679e-10
of O 0 5.201585689951216e-12
intracellular O 0 7.964485071454419e-09
vesicles O 0 1.1068485150644847e-07
. O 0 1.168649887972606e-08

TfR O 1 0.9194446206092834
HFE O 0 0.00605757674202323
stoichiometry O 0 4.6607028707512654e-06
( O 0 1.1929621734907414e-07
2 O 0 6.347125602879089e-10
1 O 0 1.0086553120514097e-10
) O 0 1.3994892918145485e-11
differs O 0 1.2856026243568408e-09
from O 0 4.207261761202119e-10
TfR O 0 2.351959210500354e-06
transferrin O 0 3.49604505345269e-08
stoichiometry O 0 5.551354043120682e-09
( O 0 2.669889864748143e-10
2 O 0 1.3310084978623848e-10
2 O 0 5.226400909275064e-11
) O 0 8.675119650414231e-12
, O 0 4.512566969400167e-12
implying O 0 3.2432850849417605e-10
a O 0 1.3312211576133048e-11
different O 0 1.0260465220512938e-11
mode O 0 6.71362632154171e-10
of O 0 3.377672761709777e-13
binding O 0 1.0954928630901861e-10
for O 0 1.7882780325995107e-11
HFE O 0 2.2131743548925442e-07
and O 0 1.9702423026402016e-10
transferrin O 0 1.0809357853247548e-08
to O 0 4.4252307374037514e-10
TfR O 0 7.661121344426647e-06
, O 0 5.747900766461811e-11
consistent O 0 5.859862040047403e-10
with O 0 1.790061913801988e-12
our O 0 1.5634601252534353e-11
demonstration O 0 3.35474252544099e-11
that O 0 4.9728164294715604e-12
HFE O 0 3.9880806212977404e-08
, O 0 1.3416364373630696e-11
transferrin O 0 4.715040802238946e-09
, O 0 1.3416423527701227e-10
and O 0 3.2011798767328514e-10
TfR O 0 3.688456331474299e-07
form O 0 1.9538064222057727e-10
a O 0 9.916155674360994e-10
ternary O 0 1.5943113496064143e-08
complex O 0 3.1735769567831085e-08
. O 0 4.082878923838962e-09

Identification O 0 7.965522286212945e-08
of O 0 1.647096348200705e-11
three O 0 1.0782284787236307e-11
novel O 0 4.4925844294718686e-11
mutations O 0 1.2041788677308318e-09
and O 0 1.1361898227812972e-10
a O 0 1.456839093805229e-10
high O 0 1.858025022727361e-08
frequency O 0 3.0412179441441367e-09
of O 0 5.99426671493708e-12
the O 0 7.937422247250581e-11
Arg778Leu O 0 4.256275687453126e-08
mutation O 0 1.8351660191484598e-09
in O 0 2.876182347844036e-10
Korean O 0 1.546781014383214e-08
patients O 0 3.706515316892478e-09
with O 0 7.102612942233577e-11
Wilson B-Disease 0 5.708195658371551e-07
disease I-Disease 0 4.611111307895044e-06
. O 0 9.088756414143973e-09

Four O 0 5.922726131757372e-08
mutations O 0 7.859088668737968e-07
- O 0 1.7947742890100926e-05
- O 0 4.8385545596829616e-06
R778L O 0 2.1573031006028032e-07
, O 0 4.7723811014144246e-11
A874V O 0 1.8204263652066288e-09
, O 0 4.664717397073748e-12
L1083F O 0 6.536824970204691e-10
, O 0 7.749109513788266e-13
and O 0 4.911264103735213e-12
2304delC O 0 4.202243442108511e-09
- O 0 1.773054036924293e-09
- O 0 7.759296538623062e-10
in O 0 2.3913060767655203e-11
the O 0 3.3783577064322445e-12
copper O 0 4.4082160144398586e-09
- O 0 4.447926194028895e-10
transporting O 0 1.901083873656617e-10
enzyme O 0 5.813817205435612e-10
, O 0 5.919665365533566e-12
P O 0 6.887223094054207e-07
- O 0 6.863289048197885e-09
type O 0 2.859399330645829e-07
ATPase O 0 3.4075849271175684e-06
( O 0 1.9798531702974742e-09
ATP7B O 0 5.812852350572939e-07
) O 0 1.688950194977945e-11
, O 0 1.0712664479453626e-12
were O 0 7.565362399042375e-12
identified O 0 7.858187711651254e-11
in O 0 1.215929787412584e-11
Korean O 0 5.98127603002041e-10
Patients O 0 9.113013815786886e-11
with O 0 7.495127782308764e-12
Wilson B-Disease 0 1.7361189463827031e-07
disease I-Disease 0 1.4208939091986394e-06
. O 0 7.565084558791568e-09

Arg778Leu O 0 6.229963037185371e-05
, O 0 6.019226783671172e-10
the O 0 5.5430508273668355e-12
most O 0 2.755962775699561e-12
frequently O 0 2.625133790901124e-11
reported O 0 1.1061552784852324e-09
mutation O 0 3.338223100723958e-11
of O 0 1.9129096635699117e-13
this O 0 2.262669001815154e-12
enzyme O 0 1.9218064639670018e-10
, O 0 5.000665680154892e-12
was O 0 6.998267743085762e-09
found O 0 1.0473147904477287e-09
in O 0 1.9737403378350393e-10
six O 0 4.983139595404751e-11
of O 0 3.8910159274284373e-13
eight O 0 7.252845546368292e-11
unrelated O 0 1.6526175983244684e-09
patients O 0 9.6235819313506e-09
studied O 0 1.4416759341884244e-08
, O 0 2.857523939692186e-11
an O 0 6.7529432566659775e-12
allele O 0 1.8173951232824948e-08
frequency O 0 8.348114022282971e-08
of O 0 9.123053423820693e-10
37 O 0 1.3019767663990933e-07
. O 0 6.072423452962994e-09

5 O 0 1.6750253450936725e-07
% O 0 2.5367035139112204e-09
, O 0 1.992629498903664e-11
which O 0 8.950190415191184e-12
is O 0 1.1623614397382465e-11
considerably O 0 5.25795442740673e-08
higher O 0 2.8877933377913223e-09
than O 0 8.26881445259442e-12
those O 0 1.933083467603458e-12
in O 0 1.3076011627644046e-11
other O 0 8.254191601053673e-12
Asian O 0 8.595473638406403e-11
populations O 0 9.562059477552509e-11
. O 0 5.428860139211622e-10

The O 0 1.1294598589728366e-09
novel O 0 6.258945584036724e-10
single O 0 2.5813817750020007e-10
nucleotide O 0 6.176845257499508e-09
deletion O 0 1.2231285317909624e-08
, O 0 4.195560218689387e-11
2304delC O 0 2.0491595975613563e-08
, O 0 3.006748738876297e-10
was O 0 2.198872017800113e-08
found O 0 2.5519208968205476e-10
in O 0 3.2877872646608353e-10
one O 0 1.6356556109542453e-09
patient O 0 8.503840831508569e-08
. O 0 1.0704551689499908e-09

Since O 0 1.5837036571042518e-08
a O 0 8.56082371658573e-10
mutation O 0 3.898504630228672e-09
at O 0 3.988860075576639e-10
cDNA O 0 3.522390201737835e-08
nucleotide O 0 3.6762565969183925e-07
2302 O 0 2.8326983738224953e-05
( O 0 8.571640064403141e-10
2302insC O 0 1.2497243240261469e-08
) O 0 4.202399539465773e-11
had O 0 1.3331689086015786e-09
been O 0 1.8196338880116514e-10
previously O 0 1.0529244837131913e-10
described O 0 2.2549723199816185e-10
, O 0 2.049288473290889e-12
this O 0 3.1337790435542745e-13
region O 0 5.054868676412916e-11
of O 0 7.41990778714563e-13
the O 0 9.30060368997676e-12
ATP7B O 0 6.5590242570579e-08
gene O 0 1.0457304355782071e-08
may O 0 1.086775913705651e-08
be O 0 6.863033058523982e-11
susceptible O 0 7.27801863220634e-09
to O 0 3.589782290869259e-11
gene O 0 1.599949115416166e-07
rearrangements O 0 3.259855930082267e-06
causing O 0 1.702542533621454e-07
Wilson B-Disease 0 2.0486145331233274e-06
disease I-Disease 0 2.3652151867281646e-05
. O 0 2.2358349838214053e-08

Disruption O 0 2.1343905700632604e-06
of O 0 2.0149734658581053e-10
splicing O 0 4.539639419931518e-08
regulated O 0 4.242494799910901e-09
by O 0 1.6646914749451902e-11
a O 0 3.255823666226121e-10
CUG O 0 4.207830443192506e-06
- O 0 1.3540941701251086e-08
binding O 0 1.3347674077124339e-08
protein O 0 7.889436659525018e-08
in O 0 3.05372907405399e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 1.0250509063780555e-07

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.999984622001648
DM B-Disease 1 1.0
) O 0 1.1614782380320321e-07
is O 0 4.750197457603633e-10
caused O 0 1.422038597986841e-10
by O 0 4.9209781215198145e-12
a O 0 3.087712585614355e-10
CTG O 0 9.717210502913076e-08
expansion O 0 1.3209887628207184e-09
in O 0 6.674823471719549e-10
the O 0 6.522474227388386e-11
3 O 0 2.2181709247171e-10
untranslated O 0 1.3184174463276577e-07
region O 0 5.266151514859985e-09
of O 0 1.9220300351285857e-10
the O 0 7.977229188327328e-08
DM B-Disease 1 1.0
gene O 0 9.160914942185627e-07
. O 0 1.589513765054562e-08

One O 0 6.2527081290397746e-09
model O 0 2.943864174653754e-08
of O 0 8.822908514893868e-10
DM B-Disease 1 1.0
pathogenesis O 0 3.0295311148620385e-07
suggests O 0 3.428031636332207e-09
that O 0 1.0661526349264872e-11
RNAs O 0 7.2633326020365985e-09
from O 0 1.0894785074100355e-11
the O 0 1.7675745849626834e-12
expanded O 0 4.447584661670945e-11
allele O 0 7.283277869696292e-10
create O 0 2.4131568271412718e-11
a O 0 1.5169082656640853e-10
gain O 0 4.313868430472212e-06
- O 0 2.0898546893022285e-08
of O 0 3.057850153642683e-11
- O 0 4.1749867563112275e-08
function O 0 2.0312329943039664e-11
mutation O 0 2.976982202418377e-11
by O 0 1.3578131674574223e-12
the O 0 7.635233591207768e-12
inappropriate O 0 1.5245026352417312e-09
binding O 0 4.770497191719514e-11
of O 0 3.9135085146482784e-13
proteins O 0 6.776244929757036e-12
to O 0 2.2802164670321368e-11
the O 0 3.0324237565437784e-10
CUG O 0 1.2260993571544532e-06
repeats O 0 1.2238699298450229e-07
. O 0 3.2613445277718256e-09

Data O 0 9.243533583003227e-08
presented O 0 2.928596032347741e-09
here O 0 7.268858848163973e-10
indicate O 0 6.539705443842081e-10
that O 0 1.992799371700049e-12
the O 0 1.9086318896882615e-12
conserved O 0 2.9914126731256374e-10
heterogeneous O 0 1.6703641803061942e-09
nuclear O 0 1.814755457019146e-08
ribonucleoprotein O 0 2.540397474604106e-07
, O 0 3.361866895978949e-10
CUG O 0 2.6848661605072266e-07
- O 0 1.0344997747324669e-08
binding O 0 4.599548741879289e-09
protein O 0 1.2339731902955009e-08
( O 0 2.9325966655058266e-10
CUG O 0 4.013440957351122e-06
- O 0 3.8532277812919347e-07
BP O 0 3.8056166431488236e-06
) O 0 2.972647128451911e-11
, O 0 8.940670252755023e-12
may O 0 2.1937172911545844e-10
mediate O 0 2.3575239538331516e-09
the O 0 2.5473241571649652e-11
trans O 0 1.7069851310225204e-08
- O 0 1.1039658964762111e-08
dominant O 0 1.0473392819676519e-08
effect O 0 1.3079591854037176e-09
of O 0 3.5464630364356875e-12
the O 0 3.844558699173106e-11
RNA O 0 1.2517449299309646e-08
. O 0 5.433024585776991e-10

CUG O 0 0.17800670862197876
- O 0 0.2835610508918762
BP O 0 0.0003307938459329307
was O 0 7.137167745696615e-09
found O 0 3.6003627162939367e-11
to O 0 4.2652854989264077e-13
bind O 0 1.8988180819357048e-11
to O 0 8.931035164888579e-13
the O 0 5.449416525665773e-12
human O 0 3.28183535902582e-10
cardiac O 0 3.592534631025046e-05
troponin O 0 1.557337964186445e-05
T O 0 2.4431772089883452e-06
( O 0 3.22634891025686e-10
cTNT O 0 1.3377902341460413e-08
) O 0 4.652271276550657e-11
pre O 0 6.6024654188368e-08
- O 0 1.7018454201433997e-08
messenger O 0 5.1898698671948296e-09
RNA O 0 4.965696298597777e-09
and O 0 1.706748110896772e-11
regulate O 0 9.507174214551384e-11
its O 0 2.3499388199232918e-11
alternative O 0 2.2624737638921033e-09
splicing O 0 3.1021139079712157e-07
. O 0 7.728150563934832e-09

Splicing O 0 2.335386170670972e-06
of O 0 7.731316697956458e-10
cTNT O 0 3.862653841224528e-07
was O 0 3.365803280530599e-08
disrupted O 0 1.650525746299536e-06
in O 0 5.837429171151598e-07
DM B-Disease 1 1.0
striated O 0 2.214158303104341e-05
muscle O 0 5.626606707664905e-06
and O 0 1.088661272241609e-09
in O 0 1.675743571682986e-10
normal O 0 5.011575043845085e-10
cells O 0 1.8516270461343964e-10
expressing O 0 7.852314631850987e-11
transcripts O 0 3.280447469222736e-09
that O 0 7.170093945657596e-12
contain O 0 6.078771375150893e-10
CUG O 0 2.1766368263342883e-06
repeats O 0 2.1034539088304882e-07
. O 0 5.706897621138296e-09

Altered O 0 1.0571997108854703e-06
expression O 0 1.525876491825784e-08
of O 0 7.304783167239037e-11
genes O 0 3.0027955677525142e-09
regulated O 0 1.7685223951957596e-08
posttranscriptionally O 0 7.163792048459072e-08
by O 0 1.019797857271243e-10
CUG O 0 0.00019778702699113637
- O 0 2.3513737232860876e-06
BP O 0 7.227901051010122e-07
therefore O 0 2.640118679231307e-10
may O 0 4.4196299398002736e-10
contribute O 0 8.679394009059038e-11
to O 0 2.6917397200065807e-09
DM B-Disease 1 1.0
pathogenesis O 0 2.11582104725494e-07
. O 0 2.1694254725979079e-10
. O 0 7.421419589981326e-10

Identification O 0 1.9297650055705162e-07
of O 0 4.850596313499267e-11
a O 0 2.651857622382181e-10
novel O 0 1.0872340361345323e-08
nonsense O 0 0.00015469579375348985
mutation O 0 1.1734365479298958e-08
and O 0 5.1937464745632766e-11
a O 0 6.878653896480458e-11
missense O 0 6.542655484054194e-08
substitution O 0 2.217486860800477e-09
in O 0 2.0235582653960194e-10
the O 0 4.966411309981211e-11
vasopressin O 0 2.0561522262596554e-08
- O 0 4.1509130710437603e-07
neurophysin O 0 8.840956979838666e-07
II O 0 2.8834028498181397e-08
gene O 0 3.0651174931506375e-09
in O 0 1.5350234972011378e-10
two O 0 3.8237385480144326e-11
Spanish O 0 4.167632905449636e-09
kindreds O 0 2.850058251624432e-07
with O 0 6.614458980536142e-10
familial B-Disease 0 0.4470198154449463
neurohypophyseal I-Disease 1 0.999504804611206
diabetes I-Disease 1 0.9999966621398926
insipidus I-Disease 1 0.9979315996170044
. O 0 7.178112468864128e-07

Familial B-Disease 1 0.9999969005584717
neurohypophyseal I-Disease 1 0.9999990463256836
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999995231628418
( O 0 0.0034400548320263624
FNDI B-Disease 1 1.0
) O 0 1.1077599948450256e-09
is O 0 6.817760245247939e-11
an O 0 5.0891540981368166e-11
autosomal B-Disease 1 0.999754011631012
dominant I-Disease 1 0.9999984502792358
disease I-Disease 1 0.9999986886978149
caused O 0 1.9153339962940663e-05
by O 0 1.4427874006628372e-08
deficiency O 1 0.5478155612945557
in O 0 2.1502706282205963e-09
the O 0 7.821674974373138e-10
antidiuretic O 0 2.0090865291422233e-06
hormone O 0 1.150739592503669e-07
arginine O 0 1.5486428139865893e-07
vasopressin O 0 6.773092309231288e-08
( O 0 9.538256851016058e-10
AVP O 0 6.267396912562617e-08
) O 0 8.695363006017143e-12
encoded O 0 1.054128104249763e-10
by O 0 9.776310837261715e-12
the O 0 1.319316184078545e-10
AVP O 0 1.8379860193817876e-05
- O 0 1.3765104256435734e-07
neurophysin O 0 1.9419196632952662e-06
II O 0 2.132424015144352e-07
( O 0 2.929091691417085e-10
AVP O 0 5.906886713091808e-07
- O 0 1.9752976143649903e-08
NPII O 0 2.014099891312071e-07
) O 0 3.347194049707625e-11
gene O 0 5.34426858322945e-09
on O 0 5.625433008304981e-09
chromosome O 0 3.5090672554360935e-06
20p13 O 0 1.6906855080378591e-06
. O 0 1.0417369189497094e-08

In O 0 1.6191339824445095e-08
this O 0 3.4179475222329003e-11
study O 0 6.651194872642208e-11
, O 0 1.5039750694834098e-11
we O 0 2.577906638157046e-11
analyzed O 0 8.080246194364094e-11
two O 0 3.405503743586502e-12
families O 0 4.257517081940332e-12
with O 0 4.389801022686157e-12
FNDI B-Disease 1 0.9999932050704956
using O 0 5.359686999772961e-11
direct O 0 6.135159047460093e-10
automated O 0 2.1844464015430276e-07
fluorescent O 0 2.16642561667868e-08
, O 0 1.2117821190926747e-09
solid O 0 1.4608744436372945e-07
phase O 0 1.9194701383895563e-09
, O 0 9.753959792635492e-12
single O 0 1.0197141742107618e-10
- O 0 1.9087511571314053e-09
stranded O 0 4.466169933881048e-10
DNA O 0 3.6828143312739314e-10
sequencing O 0 1.0450155324415178e-10
of O 0 9.867242439787205e-12
PCR O 0 3.470937315341871e-07
- O 0 4.7225675814388524e-08
amplified O 0 4.4016820766046294e-07
AVP O 0 8.463857739116065e-06
- O 0 1.1602084271089552e-07
NPII O 0 7.67430321957363e-07
DNA O 0 8.892607894495086e-08
. O 0 2.269787247044519e-09

In O 0 7.343472496756931e-09
one O 0 4.7823134341484774e-11
of O 0 2.540940277195175e-13
the O 0 1.4309996330258423e-12
families O 0 5.7805956202305886e-12
, O 0 1.1544905656468707e-12
affected O 0 9.667149893088922e-12
individuals O 0 3.9568009784461677e-13
presented O 0 1.1677167913171083e-11
a O 0 7.506376770161083e-11
novel O 0 2.0684709500784493e-09
nonsense O 0 3.7844658891117433e-06
mutation O 0 1.1557746981694095e-09
in O 0 1.3208922844398785e-10
exon O 0 1.2722932707376344e-09
3 O 0 3.693385181025022e-11
of O 0 2.9732564067047607e-13
the O 0 4.903355065727366e-12
gene O 0 4.4508288721267775e-10
, O 0 5.019375973885909e-12
consisting O 0 1.0369335598503504e-12
in O 0 5.833619698414338e-11
a O 0 1.8531188805681609e-09
G O 0 1.7815452793001896e-06
to O 0 3.0165600573006657e-10
T O 0 3.5141474654665217e-06
transition O 0 1.1958246615151324e-09
at O 0 6.320258760794673e-10
nucleotide O 0 1.677013750089884e-09
2101 O 0 1.087640644215071e-08
, O 0 1.0492651886240267e-11
which O 0 2.84088204349775e-12
produces O 0 6.982177856718064e-12
a O 0 1.0291791724403865e-10
stop O 0 9.891847341236826e-09
signal O 0 2.9561526844190666e-06
in O 0 1.223399248573287e-08
codon O 0 1.2221354950270324e-07
82 O 0 1.487262979438242e-09
( O 0 1.5146532639231935e-10
Glu O 0 1.1679239264594798e-07
) O 0 5.720972653944223e-11
of O 0 2.178737919245055e-11
NPII O 0 4.794257620233111e-06
. O 0 5.680930836859943e-09

The O 0 2.1025609697744585e-08
premature O 0 5.643619260808919e-07
termination O 0 3.829970296465035e-08
eliminates O 0 1.1670861610468819e-08
part O 0 1.452092335263444e-10
of O 0 1.8335190136997692e-12
the O 0 1.8805840565350174e-11
C O 0 1.4337927041196963e-06
- O 0 2.7017030834741718e-09
terminal O 0 2.5501705191999235e-09
domain O 0 9.602821871013134e-10
of O 0 3.6762346639074295e-12
NPII O 0 3.428844408404075e-08
, O 0 1.1787258452286564e-12
including O 0 1.6021232463522134e-13
a O 0 1.7106557489987573e-11
cysteine O 0 9.395449973581549e-10
residue O 0 1.2242534985773545e-08
in O 0 1.1409674594009545e-10
position O 0 1.1263470156563926e-09
85 O 0 4.5753418415062086e-11
, O 0 6.04698712977636e-12
which O 0 6.56628397488479e-12
could O 0 1.2316445641147311e-09
be O 0 2.2891484714737675e-12
involved O 0 5.55630324736156e-12
in O 0 3.843018958615829e-11
the O 0 6.868532825832219e-11
correct O 0 1.3113326247093937e-07
folding O 0 1.1579657233085072e-09
of O 0 4.4734715064220776e-12
the O 0 1.5390660967895542e-10
prohormone O 0 1.3113454997437657e-06
. O 0 4.875078118971032e-09

In O 0 4.302637535147369e-08
the O 0 2.162707651853779e-10
second O 0 1.5935017749768576e-09
family O 0 1.5983897538873748e-10
, O 0 3.5276807516804176e-12
a O 0 1.349245281473399e-11
G279A O 0 3.9605088097971475e-09
substitution O 0 1.185264941749864e-10
at O 0 4.5697887141038507e-10
position O 0 1.3952049515708609e-09
- O 0 1.1857087534039579e-09
1 O 0 7.388982654898957e-12
of O 0 1.79893263913683e-13
the O 0 4.393210187997321e-12
signal O 0 4.712901180425888e-09
peptide O 0 7.65039837036241e-11
was O 0 2.6596583269089535e-10
observed O 0 8.746862609210204e-12
in O 0 1.5762035773803085e-11
all O 0 2.0461794151410695e-12
affected O 0 2.0741540429636274e-11
individuals O 0 4.0127406605861005e-12
. O 0 2.451795710900484e-10

This O 0 1.13316103167449e-08
missense O 0 5.671888175129425e-06
mutation O 0 1.1606124417085084e-07
, O 0 3.6436731409850154e-10
which O 0 1.396578741541532e-09
replaces O 0 5.045214038545964e-06
Ala O 0 2.9013410312472843e-05
with O 0 3.8486985820540554e-10
Thr O 0 0.003789431881159544
, O 0 2.0677047574135798e-10
is O 0 5.930898567402254e-12
frequent O 0 1.913401520559077e-10
among O 0 1.9509409199258698e-08
FNDI B-Disease 1 1.0
patients O 0 6.246635166462511e-06
and O 0 6.124738216595205e-11
is O 0 2.7393391374697096e-12
thought O 0 3.740372941929415e-11
to O 0 4.52111926455695e-13
reduce O 0 1.32149152731742e-11
the O 0 5.550350110072877e-12
efficiency O 0 9.72327843240528e-11
of O 0 1.137802200547322e-12
cleavage O 0 1.4056676933549284e-09
by O 0 7.721968897644871e-11
signal O 0 3.0224322244976065e-07
peptidases O 0 2.6966390578309074e-06
. O 0 2.4104589435580692e-09
. O 0 1.8902306386792134e-09

Genetic O 0 4.1571702240617014e-06
heterogeneity O 0 9.99963504000334e-07
of O 0 1.2049737874164634e-09
Saethre B-Disease 1 0.6676656007766724
- I-Disease 1 0.9999996423721313
Chotzen I-Disease 1 0.9999995231628418
syndrome I-Disease 1 1.0
, O 0 2.1240267877864483e-10
due O 0 2.949661626061584e-10
to O 0 6.748775149834074e-11
TWIST O 0 1.3501943385563209e-06
and O 0 4.401763398220737e-09
FGFR O 0 6.042921540938551e-06
mutations O 0 2.156488676519075e-07
. O 0 4.283818189065869e-09

Thirty O 0 1.2185457308078185e-05
- O 0 4.2654461140045896e-05
two O 0 1.5559285804211953e-10
unrelated O 0 2.3719433084323782e-09
patients O 0 1.016781991936e-09
with O 0 4.037829098857415e-13
features O 0 1.7736824509118065e-10
of O 0 4.0276414148276984e-11
Saethre B-Disease 1 0.9978247880935669
- I-Disease 1 0.9999991655349731
Chotzen I-Disease 1 0.9999982118606567
syndrome I-Disease 1 1.0
, O 0 1.419734295404762e-11
a O 0 8.975153259482838e-11
common O 0 1.072229807164149e-07
autosomal B-Disease 1 0.9960015416145325
dominant I-Disease 1 0.997211754322052
condition I-Disease 1 0.9828693270683289
of O 0 1.6618602050044728e-09
craniosynostosis B-Disease 1 0.5686058402061462
and O 0 3.5784205465461127e-06
limb B-Disease 1 0.889569103717804
anomalies I-Disease 0 0.00784502923488617
, O 0 1.2986044184426504e-10
were O 0 2.0510307341403688e-10
screened O 0 1.4108598733741928e-09
for O 0 7.979405330926781e-12
mutations O 0 1.061561727411231e-09
in O 0 2.1084221868417075e-10
TWIST O 0 9.841470500759897e-07
, O 0 4.0313249960455266e-10
FGFR2 O 0 4.735078164230799e-06
, O 0 1.8841034288286096e-10
and O 0 4.6554868293746665e-10
FGFR3 O 0 1.6270053038169863e-06
. O 0 1.4121736002792318e-09

Nine O 0 3.144246818465035e-08
novel O 0 6.198773938592694e-09
and O 0 2.9975752435795755e-10
three O 0 4.928194657916052e-11
recurrent O 0 5.46639640219837e-08
TWIST O 0 7.631617336301133e-06
mutations O 0 2.0617049401039367e-08
were O 0 5.310087480836501e-09
found O 0 8.863270672954116e-10
in O 0 3.0369734504986923e-10
12 O 0 2.622162487142532e-10
families O 0 4.108591591944766e-11
. O 0 1.9734616718558584e-10

Seven O 0 1.2583639019680959e-08
families O 0 3.0271996021014047e-10
were O 0 4.6214938126398764e-11
found O 0 5.02922790218685e-12
to O 0 4.4913289125141087e-13
have O 0 5.203213294252551e-12
the O 0 8.501584852771416e-12
FGFR3 O 0 1.067959487954795e-06
P250R O 0 1.9196981781988143e-08
mutation O 0 1.551605510741183e-09
, O 0 1.9406427853585484e-11
and O 0 8.754005333122539e-12
one O 0 4.993517318391261e-12
individual O 0 1.0840058234720673e-12
was O 0 1.0499193514590388e-08
found O 0 1.577335068114749e-10
to O 0 3.4176459405566018e-12
have O 0 7.65860361240378e-11
an O 0 4.315549220063053e-12
FGFR2 O 0 3.532294101660227e-07
VV269 O 0 1.334864663249391e-07
- O 0 5.5494723483207054e-08
270 O 0 1.5184788537681015e-08
deletion O 0 6.496794071608747e-07
. O 0 1.3403136378542513e-08

To O 0 1.6394628987725923e-09
date O 0 1.3654565478304903e-08
, O 0 8.320183951526783e-12
our O 0 4.824334508268802e-12
detection O 0 7.638558535694173e-11
rate O 0 3.3102637297943716e-10
for O 0 8.001438595896249e-13
TWIST O 0 1.9239392301528824e-08
or O 0 3.798112491182337e-09
FGFR O 0 7.155255843827035e-06
mutations O 0 2.7578666461636203e-08
is O 0 1.0560681495963564e-10
68 O 0 7.499729726134774e-09
% O 0 1.9116604133007087e-11
in O 0 5.118123286296239e-11
our O 0 1.2089426126848934e-09
Saethre B-Disease 0 0.08727079629898071
- I-Disease 1 0.9999983310699463
Chotzen I-Disease 1 0.9999991655349731
syndrome I-Disease 1 1.0
patients O 0 9.329364729637746e-07
, O 0 8.887418578851225e-12
including O 0 5.319953245291886e-12
our O 0 1.3638414009253808e-10
five O 0 2.903619705785232e-11
patients O 0 2.5275551096548554e-10
elsewhere O 0 1.2677223715229502e-09
reported O 0 3.0336011036524724e-08
with O 0 5.418781395816197e-11
TWIST O 0 1.5174303371168207e-05
mutations O 0 2.150035470549483e-06
. O 0 1.667490501233715e-08

More O 0 2.282259492503158e-09
than O 0 1.8932318213149557e-10
35 O 0 1.9965643027752833e-10
different O 0 1.1661165956466935e-11
TWIST O 0 7.965370230067492e-08
mutations O 0 2.9451994176810103e-09
are O 0 4.00803834565977e-11
now O 0 3.946418886124903e-11
known O 0 1.8924292688460298e-11
in O 0 1.0164363795084341e-10
the O 0 9.295903456718602e-12
literature O 0 1.0355712953824536e-09
. O 0 7.788655276286249e-10

The O 0 4.640389184018545e-10
most O 0 1.1849614171832723e-11
common O 0 3.356457473069341e-11
phenotypic O 0 3.6142905335267983e-10
features O 0 5.802583413760942e-10
, O 0 2.164910438418044e-11
present O 0 3.5989054618379424e-12
in O 0 9.83500947349114e-10
more O 0 1.1600359561825258e-11
than O 0 1.2151879329180826e-11
a O 0 5.412005218974336e-11
third O 0 7.36240179932679e-10
of O 0 1.5068400086720724e-12
our O 0 1.3688293554192654e-10
patients O 0 6.971190291693574e-11
with O 0 2.43100158059395e-12
TWIST O 0 1.7166877341878717e-06
mutations O 0 6.81628691268088e-08
, O 0 8.454920097378249e-11
are O 0 3.657088173958378e-11
coronal B-Disease 0 3.129558194814308e-07
synostosis I-Disease 0 8.814708053250797e-06
, O 0 1.9164768383372888e-10
brachycephaly B-Disease 0 2.629172513479716e-06
, O 0 3.0847062681971238e-09
low B-Disease 1 0.6354821920394897
frontal I-Disease 1 0.9999998807907104
hairline I-Disease 1 1.0
, O 0 5.3281080880651643e-08
facial B-Disease 1 0.983180820941925
asymmetry I-Disease 0 0.0017085381550714374
, O 0 1.0378145987033349e-07
ptosis B-Disease 1 0.6231524348258972
, O 0 6.548683817442225e-09
hypertelorism B-Disease 0 0.0006396634271368384
, O 0 2.4754842620211548e-09
broad B-Disease 0 1.11212796127802e-06
great I-Disease 0 6.24624008196406e-05
toes I-Disease 1 0.9783571362495422
, O 0 1.2195450205254588e-09
and O 0 4.421324695247364e-10
clinodactyly B-Disease 0 4.3055479181930423e-07
. O 0 4.579852053154809e-09

Significant O 0 5.174108537175925e-07
intra O 0 0.012063799425959587
- O 0 0.001568454666994512
and O 0 1.8586623351524167e-09
interfamilial O 0 9.525992084036261e-08
phenotypic O 0 7.249771982742459e-08
variability O 0 3.382594115919346e-08
is O 0 1.3671640208823277e-11
present O 0 5.086491991490583e-12
for O 0 8.064936739271555e-12
either O 0 1.0574755515690981e-09
TWIST O 0 2.216349685113528e-06
mutations O 0 2.773693381641351e-07
or O 0 1.1038164160481756e-08
FGFR O 0 7.988288416527212e-06
mutations O 0 7.974305731295317e-07
. O 0 1.608673905195701e-08

The O 0 2.0924342258865636e-09
overlap O 0 2.2307233393803472e-08
in O 0 4.3796274940000046e-10
clinical O 0 1.121480797117158e-09
features O 0 1.4869822040353142e-09
and O 0 4.183096924403884e-10
the O 0 5.022086479317123e-12
presence O 0 4.034030401389721e-11
, O 0 1.3168065596258494e-11
in O 0 4.159907661394069e-12
the O 0 4.949875687283722e-13
same O 0 1.7126636914222004e-11
genes O 0 1.496898577313388e-10
, O 0 4.634750049026248e-12
of O 0 4.1190076523200947e-13
mutations O 0 4.8232057237029835e-11
for O 0 1.21704762153646e-12
more O 0 2.3603458597365456e-12
than O 0 1.912451967622797e-11
one O 0 3.1850649895304173e-10
craniosynostotic B-Disease 0 4.719956450571772e-06
condition I-Disease 0 1.1170471225341316e-05
- O 0 1.3104488605364395e-09
such O 0 5.184984386286118e-12
as O 0 1.5101762895763926e-10
Saethre B-Disease 0 9.9685031784702e-08
- I-Disease 0 4.7662751967436634e-08
Chotzen I-Disease 0 1.0480670198376174e-07
, I-Disease 0 5.874497416291646e-11
Crouzon I-Disease 0 3.2720130604957376e-08
, I-Disease 0 6.574758792954327e-11
and I-Disease 0 1.192776766245629e-09
Pfeiffer I-Disease 0 0.0008557300898246467
syndromes I-Disease 0 1.7102534911828116e-05
- O 0 7.989163997024207e-09
support O 0 4.208616441458979e-11
the O 0 9.907656292607037e-12
hypothesis O 0 2.526282794068635e-10
that O 0 1.1534192871642812e-11
TWIST O 0 2.6003108999361757e-08
and O 0 5.393744825776814e-11
FGFRs O 0 1.3311362012657924e-09
are O 0 1.2693633037047514e-12
components O 0 2.963611647754938e-11
of O 0 7.827240374944089e-14
the O 0 4.773213616894589e-13
same O 0 5.088782260159741e-12
molecular O 0 3.6864459401764194e-11
pathway O 0 2.5912612333645058e-11
involved O 0 1.3275217730646105e-11
in O 0 3.1678267647938796e-11
the O 0 1.410072839741483e-11
modulation O 0 1.9478167967434956e-09
of O 0 1.1174361436161462e-10
craniofacial O 0 0.00018202888895757496
and O 0 2.7580769668134053e-08
limb O 0 1.341497409157455e-06
development O 0 8.845719295935695e-11
in O 0 2.776786300895395e-10
humans O 0 1.5329701952282448e-09
. O 0 3.447359342434453e-10
. O 0 7.425780546022054e-10

Mutation O 0 5.412402970250696e-06
analysis O 0 5.4527649950841806e-08
of O 0 1.2253088543801027e-09
UBE3A O 0 0.07591260969638824
in O 1 0.7633848786354065
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 0.008510627783834934
. O 0 2.3720938102655964e-08

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.6060877442359924
AS B-Disease 1 1.0
) O 0 4.951223875337973e-10
is O 0 2.6224312651978998e-11
caused O 0 5.818251436195965e-11
by O 0 2.2820655087851804e-11
chromosome O 0 1.6491019778186455e-05
15q11 O 0 4.39909035776509e-06
- O 0 1.4976645843489678e-06
q13 O 0 9.542358725411759e-08
deletions O 0 2.9508912646747376e-08
of O 0 3.397065267973787e-11
maternal O 0 4.953304433286121e-09
origin O 0 5.830874671985953e-10
, O 0 2.428194624537472e-11
by O 0 2.0236921513538952e-11
paternal O 0 3.398442686375347e-06
uniparental B-Disease 0 0.004274620674550533
disomy I-Disease 0 0.0048096682876348495
( O 0 3.3581540037630475e-07
UPD B-Disease 1 1.0
) O 0 2.631613593706561e-09
15 O 0 2.2858959169980153e-10
, O 0 2.343684491271092e-12
by O 0 2.7850541317597788e-11
imprinting O 1 0.9322301745414734
defects O 1 0.999974250793457
, O 0 7.6339712329343e-11
and O 0 2.3556066819363508e-11
by O 0 6.83098152695627e-12
mutations O 0 2.629255480002257e-09
in O 0 2.857318270876874e-10
the O 0 1.4870182862836145e-10
UBE3A O 0 1.3212159046815941e-06
gene O 0 2.4362734052374435e-07
. O 0 4.926714591846348e-09

UBE3A O 0 9.747251169756055e-05
encodes O 0 3.855598720292619e-07
a O 0 5.2032307351623786e-09
ubiquitin O 0 1.8351728670040757e-07
- O 0 7.132189949743406e-08
protein O 0 3.780679325160463e-09
ligase O 0 4.1413494855646604e-09
and O 0 1.4171133710938477e-10
shows O 0 1.9052531996521793e-08
brain O 0 9.905244951369241e-06
- O 0 1.1738309524389479e-07
specific O 0 7.665304835313691e-09
imprinting O 0 6.181058779475279e-06
. O 0 3.1854447968271415e-08

Here O 0 5.34045980771225e-08
we O 0 4.409054787934963e-10
describe O 0 2.6022395349656335e-09
UBE3A O 0 3.946721790271113e-06
coding O 0 7.559283858427079e-06
- O 0 4.71000987545267e-07
region O 0 2.2918312581055034e-08
mutations O 0 1.1767956209496333e-07
detected O 0 3.7612402081776963e-08
by O 0 2.4221534500323827e-11
SSCP O 0 7.384108613450735e-08
analysis O 0 3.669856085686263e-10
in O 0 7.482309216655381e-10
13 O 0 2.7889266451808226e-09
AS B-Disease 1 0.9999873638153076
individuals O 0 7.322593052749848e-12
or O 0 2.336189020013535e-10
families O 0 1.3810316779050424e-10
. O 0 3.0475691414899586e-10

Two O 0 5.211235887259136e-09
identical O 0 1.4297230066517841e-08
de O 0 5.8827250626336536e-08
novo O 0 5.450331173051381e-07
5 O 0 7.912037247592707e-09
- O 0 2.7362332843949844e-07
bp O 0 1.8128498879832478e-07
duplications O 0 3.0909859560779296e-08
in O 0 5.337002506600186e-10
exon O 0 2.488755868057524e-08
16 O 0 2.807896359868778e-09
were O 0 6.043568978597591e-10
found O 0 8.927591443885774e-10
. O 0 5.075798115150576e-10

Among O 0 3.797142156258815e-09
the O 0 5.0921055566588436e-11
other O 0 1.2640727874158042e-11
11 O 0 1.0142551729042104e-11
unique O 0 1.1214646399027028e-11
mutations O 0 9.070952877721083e-09
, O 0 3.2604846600392534e-10
8 O 0 1.7392302875673948e-10
were O 0 2.134488419347491e-10
small O 0 4.409035636587788e-11
deletions O 0 5.255555546312962e-09
or O 0 9.2964097531123e-10
insertions O 0 1.078761258099803e-07
predicted O 0 1.7471192848006467e-07
to O 0 5.368383168558033e-11
cause O 0 1.5766531413774487e-09
frameshifts O 0 6.113617473602062e-06
, O 0 1.3229750628340753e-10
1 O 0 4.9392046008733814e-11
was O 0 5.8856959306297085e-09
a O 0 2.2367741339679448e-11
mutation O 0 1.4616791110810823e-10
to O 0 5.5990060678079434e-12
a O 0 5.827147792070164e-11
stop O 0 5.834860594688962e-09
codon O 0 7.536050894429991e-09
, O 0 1.0532152407149997e-11
1 O 0 1.286889258350632e-11
was O 0 1.1971162949819814e-09
a O 0 1.0411161516232781e-10
missense O 0 1.3988903901918093e-06
mutation O 0 2.493911743783883e-08
, O 0 7.978647603712474e-11
and O 0 6.542285463373432e-11
1 O 0 2.375170060631149e-10
was O 0 2.882936200876429e-07
predicted O 0 1.1066032534756687e-08
to O 0 4.305666500420413e-12
cause O 0 3.57592358501968e-11
insertion O 0 3.110861568345058e-10
of O 0 6.247834714867562e-12
an O 0 7.052799316786817e-11
isoleucine O 0 2.5896554234350333e-07
in O 0 1.2774038771201646e-10
the O 0 2.3543758956301453e-11
hect O 0 1.876097677211419e-08
domain O 0 3.3407474009372606e-10
of O 0 7.553837113108419e-13
the O 0 1.557079638836445e-11
UBE3A O 0 3.62426924027659e-08
protein O 0 6.236220984057184e-10
, O 0 5.180486681993779e-12
which O 0 8.700069744488337e-13
functions O 0 3.3161878191384497e-12
in O 0 4.723911886661547e-11
E2 O 0 2.9597973849604386e-08
binding O 0 6.136727237482376e-10
and O 0 9.663855132791e-11
ubiquitin O 0 1.9761483560643e-09
transfer O 0 1.3861758407784919e-09
. O 0 1.7929692175400191e-09

Eight O 0 1.935588755941353e-08
of O 0 5.9124545537248e-12
the O 0 1.1802336885580189e-11
cases O 0 6.907288629953712e-11
were O 0 3.186085562045804e-10
familial O 0 3.1283285295558017e-08
, O 0 3.524805725074742e-10
and O 0 1.5567842570618495e-09
five O 0 8.388836153505608e-11
were O 0 1.999034493493923e-09
sporadic O 0 8.570354452785978e-07
. O 0 8.56102477797549e-09

In O 0 2.6012534348751615e-08
two O 0 4.321401569917782e-10
familial O 0 4.4919531205778185e-07
cases O 0 1.795598336684634e-08
and O 0 6.577948186148319e-10
one O 0 1.352804673837582e-10
sporadic O 0 4.4615768501898856e-07
case O 0 4.052442825752678e-09
, O 0 2.1477557579641093e-11
mosaicism O 0 2.068306237390516e-08
for O 0 1.6650058068390372e-11
UBE3A O 0 5.502726594386331e-07
mutations O 0 4.145595156046511e-08
was O 0 7.655588163402172e-09
detected O 0 1.897340240475387e-08
in O 0 3.390121794399903e-10
the O 0 3.0134644779522546e-11
mother O 0 4.269550935021016e-09
of O 0 4.3507881217035027e-13
three O 0 2.4379040453048617e-10
AS B-Disease 1 1.0
sons O 0 4.731075531339002e-09
, O 0 2.0838998929240127e-12
in O 0 1.7079367434225112e-11
the O 0 4.528960539929017e-11
maternal O 0 1.1108962638672892e-08
grandfather O 0 7.466174345438503e-09
of O 0 1.7837769022283068e-12
two O 0 2.0849316717530542e-10
AS B-Disease 1 1.0
first O 0 9.439187209636657e-10
cousins O 0 1.4078982424337028e-08
, O 0 3.1914956788448023e-12
and O 0 1.0740452797974864e-11
in O 0 1.5155114663212288e-10
the O 0 9.961722419182806e-11
mother O 0 3.37460974719761e-08
of O 0 2.1169144995974998e-12
an O 0 3.64297092492194e-10
AS B-Disease 1 1.0
daughter O 0 0.0007969338330440223
. O 0 1.8862438277977844e-09

The O 0 5.266982405771614e-10
frequencies O 0 2.6909083850057414e-09
with O 0 8.130052187027559e-12
which O 0 2.451911243483984e-11
we O 0 1.1233385055486877e-10
detected O 0 3.1929738852909395e-09
mutations O 0 5.013430226519233e-10
were O 0 1.0609282341533799e-09
5 O 0 8.939868810509122e-12
( O 0 6.718743183337095e-12
14 O 0 2.129014672891394e-11
% O 0 5.37418980844917e-12
) O 0 1.1004886238397127e-12
of O 0 1.0488804920091854e-12
35 O 0 7.298198712035742e-10
in O 0 4.973931266860632e-10
sporadic O 0 0.00022271789202932268
cases O 0 5.689109272566384e-08
and O 0 2.1300077257535577e-09
8 O 0 1.8620073538588855e-10
( O 0 1.1778948476315332e-11
80 O 0 7.413181873916486e-11
% O 0 1.1391816309713754e-11
) O 0 2.635577953796764e-12
of O 0 1.2597685481591236e-12
10 O 0 4.177019494178147e-11
in O 0 1.4217999000365467e-10
familial O 0 1.416237296325562e-07
cases O 0 8.426256137283872e-09
. O 0 5.491135879331921e-10
. O 0 2.9663518308353787e-09

The O 0 2.2506482366679847e-07
hemochromatosis B-Disease 1 1.0
845 O 0 1.6364669136237353e-05
G O 0 2.333997872483451e-05
- O 0 3.2494917832082137e-06
- O 0 1.07640846636059e-06
> O 0 4.319467450386583e-09
A O 0 2.31203861611462e-10
and O 0 1.9044255755717998e-11
187 O 0 3.2194025223475364e-10
C O 0 2.877887368413212e-07
- O 0 8.179591759471805e-08
- O 0 3.6104361811339913e-07
> O 0 9.559879998732868e-09
G O 0 2.9195845741014637e-08
mutations O 0 3.795093128644567e-09
: O 0 2.3978052182682674e-11
prevalence O 0 4.070639825215494e-09
in O 0 2.677187083133248e-10
non O 0 3.1772111697137007e-07
- O 0 3.5184395983378636e-06
Caucasian O 0 3.895273721354897e-07
populations O 0 1.5898413252557475e-08
. O 0 4.219431026797338e-09

Hemochromatosis B-Disease 1 0.9989724159240723
, O 0 5.7009604148561266e-08
the O 0 3.633655154544613e-08
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 0 4.877289128124573e-10
iron I-Disease 0 0.11585351824760437
metabolism I-Disease 0 3.536157964845188e-05
, O 0 5.283128795552372e-11
leads O 0 1.2955961303795505e-10
, O 0 5.039350881030913e-11
if O 0 1.577558639276333e-09
untreated O 0 8.502232731188997e-07
, O 0 5.05507129211491e-11
to O 0 4.8610435121609896e-11
progressive O 0 1.8038132054698508e-07
iron B-Disease 1 0.99941086769104
overload I-Disease 0 0.09003492444753647
and O 0 4.0814296653479687e-07
premature B-Disease 0 1.583947323524626e-06
death I-Disease 0 6.050907774834968e-09
. O 0 1.5490653204608407e-09

The O 0 1.1182948611576649e-07
hemochromatosis B-Disease 1 1.0
gene O 0 6.720652550029627e-07
, O 0 9.924632227154007e-10
HFE O 0 6.140671303001e-06
, O 0 2.2164708957106427e-10
recently O 0 1.66936491297065e-08
has O 0 1.4703473161237213e-10
been O 0 1.2559743522988498e-10
identified O 0 7.174561500455923e-10
, O 0 3.484222242319812e-12
and O 0 3.1113154587425473e-12
characterization O 0 1.1273157407565293e-10
of O 0 4.4838652647587185e-13
this O 0 2.0150942546537376e-12
gene O 0 4.963497390875204e-10
has O 0 3.551609353835694e-11
shown O 0 4.898917035922601e-11
that O 0 8.535510839791094e-12
it O 0 1.6399108633546877e-12
contains O 0 2.7277266274709777e-13
two O 0 4.078008330327121e-12
mutations O 0 1.272865424173375e-10
that O 0 1.1426176844964164e-11
result O 0 3.885768790068411e-11
in O 0 1.3660021724870575e-10
amino O 0 2.2905045915511124e-10
acid O 0 1.2611930944039784e-10
substitutions O 0 5.802495151030485e-10
- O 0 7.715789673845563e-10
cDNA O 0 2.3771020707386015e-09
nucleotides O 0 4.968197409027653e-09
845 O 0 4.0637221587758177e-08
G O 0 2.1801717764446948e-07
- O 0 1.4855774566058244e-07
- O 0 9.10294829736813e-07
> O 0 3.989980790208847e-09
A O 0 1.169541352652459e-09
( O 0 1.8666905521325106e-10
C282Y O 0 6.41849418059337e-09
) O 0 1.2287009951150729e-11
and O 0 4.442351434624792e-12
187 O 0 2.491560291417727e-10
C O 0 7.853274155422696e-07
- O 0 6.580814897461096e-07
- O 0 5.427439191407757e-06
> O 0 3.176538143634389e-08
G O 0 2.211530727436184e-07
( O 0 4.0968950454356445e-10
H63D O 0 8.615853062110546e-07
) O 0 3.178850238594322e-10
. O 0 1.2528812431966685e-09

Although O 0 1.7970831322600134e-05
hemochromatosis B-Disease 1 1.0
is O 0 3.715773688739432e-09
common O 0 9.66846935845922e-10
in O 0 8.703701648293816e-10
Caucasians O 0 2.43698264057457e-06
, O 0 1.5699096189703e-10
affecting O 0 1.333725907493033e-09
> O 0 5.781044976060912e-09
= O 0 4.794977304101167e-09
1 O 0 9.792033850430926e-10
/ O 0 5.114286238949717e-08
300 O 0 1.6167766778152348e-11
individuals O 0 6.004997389098821e-13
of O 0 1.3389612227125702e-13
northern O 0 1.6429180238475283e-10
European O 0 5.532844848943341e-09
origin O 0 2.125388476326151e-10
, O 0 4.100230571735253e-11
it O 0 1.7885748437862503e-11
has O 0 2.6512899514719024e-11
not O 0 5.837245183742956e-12
been O 0 2.910895136043479e-11
recognized O 0 4.109389044326672e-12
in O 0 2.6036716185839914e-11
other O 0 1.0692827699665397e-11
populations O 0 1.0156805257954815e-10
. O 0 9.891296670616612e-10

The O 0 1.2553282857652448e-09
present O 0 3.663636755080191e-11
study O 0 1.4624900249171624e-11
used O 0 4.9433141607879705e-11
PCR O 0 1.9982808296958865e-08
and O 0 1.0009752575423914e-11
restriction O 0 8.719902577780658e-10
- O 0 7.964694459516863e-10
enzyme O 0 3.249117641601629e-10
digestion O 0 2.3545745908570836e-10
to O 0 2.9496303403236945e-12
analyze O 0 2.173592000831448e-10
the O 0 5.675430611584709e-12
frequency O 0 1.5218407090067387e-10
of O 0 6.319670264529065e-13
the O 0 8.654081791459323e-12
845 O 0 2.0057029370690316e-09
G O 0 3.08488417033459e-08
- O 0 3.35862715417079e-08
- O 0 9.058093297653613e-08
> O 0 8.852880095666649e-10
A O 0 2.1677461214952842e-10
and O 0 2.0286931856627888e-11
187 O 0 3.446846696952832e-10
C O 0 1.5792549845627946e-07
- O 0 4.155252852910962e-08
- O 0 1.226721195735081e-07
> O 0 6.930469531596373e-09
G O 0 1.9130638406750222e-08
mutations O 0 6.100413063592214e-09
in O 0 1.091280621423607e-09
HLA O 0 2.324289312127803e-07
- O 0 1.9554140529010056e-09
typed O 0 2.4280626398365257e-09
samples O 0 1.5069594183625412e-10
from O 0 1.1867482690997022e-11
non O 0 6.83285517055765e-09
- O 0 8.867421996683333e-08
Caucasian O 0 2.360161488468293e-08
populations O 0 3.5698466405165163e-10
, O 0 3.2706712772140323e-12
comprising O 0 3.014670327608493e-12
Australian O 0 4.8731955970549024e-11
Aboriginal O 0 8.159883879699237e-11
, O 0 1.607134130637844e-12
Chinese O 0 2.395742241742549e-12
, O 0 3.8545425531943955e-12
and O 0 2.2534533267171142e-11
Pacific O 0 2.847177771325704e-10
Islanders O 0 2.0756489860218608e-08
. O 0 1.3135167398203862e-09

Results O 0 4.513763656177616e-07
showed O 0 2.2006005906405335e-08
that O 0 5.9764120735605886e-12
the O 0 3.3002869100767773e-12
845 O 0 1.8001788948396324e-09
G O 0 6.352824044597583e-08
- O 0 2.482521388458281e-08
- O 0 9.250852883724292e-08
> O 0 1.34667821338752e-09
A O 0 2.957165068373513e-10
mutation O 0 2.328369497206495e-09
was O 0 5.071910003096036e-09
present O 0 4.002330151325895e-12
in O 0 1.0013017325005702e-11
these O 0 8.261622180642803e-13
populations O 0 5.9394004471580164e-12
( O 0 8.141565546737617e-12
allele O 0 1.4262060421543765e-09
frequency O 0 1.281714512302301e-09
0 O 0 9.572332509977244e-11
. O 0 6.705786967375893e-12
32 O 0 7.093758219722801e-11
% O 0 1.7051537265500016e-11
) O 0 7.729982452742146e-12
, O 0 1.9595079031597962e-11
and O 0 3.59339419331306e-10
, O 0 6.288639747831226e-12
furthermore O 0 7.704785420781235e-11
, O 0 1.507605498773934e-11
it O 0 2.1970084085332076e-10
was O 0 3.502851541270502e-06
always O 0 1.778073022151716e-09
seen O 0 1.288095741180939e-10
in O 0 4.5665259768012945e-12
conjunction O 0 5.138449041264259e-11
with O 0 5.930630292416694e-11
HLA O 0 2.128252987176893e-07
haplotypes O 0 4.298028244420493e-08
common O 0 3.00356317595174e-09
in O 0 7.826957415524305e-10
Caucasians O 0 1.6511131661900436e-07
, O 0 2.3046011279892475e-11
suggesting O 0 6.590531453909421e-10
that O 0 3.070169812824375e-11
845 O 0 5.910377520734755e-09
G O 0 1.1560270252175542e-07
- O 0 2.305022945847668e-07
- O 0 1.9534247712726938e-06
> O 0 3.1698124125512095e-09
A O 0 2.9990865346718465e-09
may O 0 1.2911623059608246e-07
have O 0 4.923477944784871e-11
been O 0 3.227812114814377e-11
introduced O 0 2.1482598686062282e-11
into O 0 1.5002297364466455e-12
these O 0 8.435163917179522e-13
populations O 0 2.2994583667723667e-12
by O 0 5.2719126807099226e-12
Caucasian O 0 3.064055320578518e-08
admixture O 0 3.2440345876239007e-07
. O 0 1.270107041762003e-08

187 O 0 1.7888560250867158e-06
C O 0 6.794312412239378e-06
- O 0 1.1157185326737817e-06
- O 0 1.193630623674835e-06
> O 0 6.3915441828044095e-09
G O 0 2.711683855238789e-08
was O 0 4.1059614042104897e-10
present O 0 1.8218894275168207e-12
at O 0 4.041747145300256e-11
an O 0 2.5575611507094864e-12
allele O 0 2.68155275762183e-09
frequency O 0 1.708268371203303e-08
of O 0 1.8667119239257346e-10
2 O 0 4.577660028814989e-09
. O 0 3.294317263424773e-09

68 O 0 8.065276051638648e-05
% O 0 6.436638333440214e-09
in O 0 4.425450561562627e-10
the O 0 1.484716342925463e-11
two O 0 7.948053673545452e-12
populations O 0 2.3808066629271707e-11
analyzed O 0 1.2663811110869005e-09
( O 0 1.0959651935982251e-10
Australian O 0 5.2974824527041164e-09
Aboriginal O 0 1.6221222143286695e-09
and O 0 1.2065691501472742e-10
Chinese O 0 5.5373049895335313e-11
) O 0 4.4315974501163424e-11
. O 0 2.9486155184166307e-10

In O 0 4.01547239903266e-09
the O 0 9.037372239451003e-11
Australian O 0 2.581499736198367e-10
Aboriginal O 0 1.39610142890767e-10
samples O 0 7.92680157624126e-11
, O 0 5.3756660581272264e-12
187 O 0 2.8640731453144497e-10
C O 0 1.8163838433338242e-07
- O 0 1.219842857835829e-07
- O 0 1.3310069562066928e-06
> O 0 1.0058340826901713e-08
G O 0 5.094201682709354e-08
was O 0 5.109193956798208e-09
found O 0 5.055119517427542e-11
to O 0 6.038281853693039e-13
be O 0 2.663849175965627e-12
associated O 0 6.983776404401176e-12
with O 0 5.736091723135273e-12
HLA O 0 9.118016919273941e-08
haplotypes O 0 1.085721379467941e-08
common O 0 1.6676774405866013e-09
in O 0 3.587148911243787e-10
Caucasians O 0 3.71719330871656e-08
, O 0 9.245579128680514e-12
suggesting O 0 8.81735684465923e-10
that O 0 9.163119915611695e-12
it O 0 2.1715438475178317e-11
was O 0 4.118652641160736e-10
introduced O 0 4.795356473019652e-11
by O 0 2.197500861833568e-12
recent O 0 1.2077026045886896e-09
admixture O 0 1.2175949848369783e-07
. O 0 2.041006252895272e-09

In O 0 1.3528214992675203e-08
the O 0 4.1238856079983677e-11
Chinese O 0 1.6479071579533766e-11
samples O 0 6.39358635479148e-11
analyzed O 0 4.913524448424411e-11
, O 0 1.2525807214364137e-12
187 O 0 5.699331631636717e-11
C O 0 5.566518979094326e-08
- O 0 1.8506332466472486e-08
- O 0 1.916227034826079e-07
> O 0 6.392958606937782e-09
G O 0 3.144624471929092e-08
was O 0 1.9958990016277767e-09
present O 0 1.3482857191826625e-11
in O 0 3.78918174614995e-10
association O 0 6.112589601148244e-11
with O 0 6.431519813249187e-13
a O 0 1.3781627748732372e-11
wide O 0 1.3290601952320458e-10
variety O 0 1.1400887178769636e-10
of O 0 1.4207716600433962e-11
HLA O 0 1.035753953715357e-07
haplotypes O 0 1.3644333662909958e-08
, O 0 1.1689513072787872e-11
showing O 0 9.916306664692343e-10
this O 0 2.767704685227579e-12
mutation O 0 2.7472990896115768e-11
to O 0 4.122342224521791e-12
be O 0 1.4951630211701428e-11
widespread O 0 1.342880667776214e-11
and O 0 1.6338627117917781e-09
likely O 0 1.1857065329579086e-09
to O 0 2.6109808759500197e-12
predate O 0 1.0884847467806935e-09
the O 0 1.927380781016619e-12
more O 0 2.9490283912775306e-12
genetically O 0 1.6008609715623123e-10
restricted O 0 5.649667400575709e-10
845 O 0 6.635008098498929e-09
G O 0 1.6305298800034507e-07
- O 0 1.3752651284448802e-07
- O 0 2.9022990588600805e-07
> O 0 9.336948103566556e-09
A O 0 2.163492718310067e-09
mutation O 0 1.8463499884546763e-07
. O 0 2.575098356771832e-09

Genotype O 1 0.996283233165741
- O 1 0.9946306943893433
phenotype O 0 0.0006086722714826465
correlations O 0 0.000244313181610778
in O 0 2.652200009833905e-06
attenuated B-Disease 1 0.9998250603675842
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 0.9999991655349731
coli I-Disease 1 1.0
. O 0 2.0653990304708714e-06

Germ O 0 0.0035174614749848843
- O 0 0.012801005505025387
line O 0 1.2189438791665452e-07
mutations O 0 2.0991310023532606e-08
of O 0 4.147864777342969e-12
the O 0 3.7775543110241117e-11
tumor B-Disease 0 1.426815572358464e-07
suppressor O 0 7.124561420823738e-07
APC O 0 5.3367738672704945e-08
are O 0 1.0525007948514187e-10
implicated O 0 5.5265299891971154e-08
in O 0 6.506058269906134e-08
attenuated B-Disease 1 0.999922513961792
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 0.0031374755781143904
AAPC B-Disease 1 1.0
) O 0 5.52076384607858e-09
, O 0 3.3002885146959926e-11
a O 0 1.1150855933061976e-10
variant O 0 0.004646787885576487
of O 0 7.122516763047315e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 3.5829783882945776e-05
FAP B-Disease 0 4.546666968963109e-05
) O 0 5.739473962762531e-08
. O 0 4.1072972578604094e-08

AAPC B-Disease 1 0.9999998807907104
is O 0 2.1193102384131635e-08
recognized O 0 2.3144124117191467e-10
by O 0 1.109532951626413e-11
the O 0 8.51872652279928e-12
occurrence O 0 5.065198260822967e-10
of O 0 1.328415849544129e-11
< O 0 1.5435391631513085e-08
100 O 0 2.4117730035300156e-10
colonic B-Disease 0 1.1990357506874716e-07
adenomas I-Disease 0 5.370374128688127e-05
and O 0 3.737921916435738e-10
a O 0 1.229011059589169e-10
later O 0 1.9161205955242622e-08
onset O 0 0.00011956140224356204
of O 0 1.638267349335365e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 2.3846370211799695e-08
age O 0 3.413952498476647e-08
> O 0 3.8033687310701225e-09
40 O 0 9.922322963262786e-10
years O 0 5.210358811069682e-10
) O 0 1.1778976405363295e-10
. O 0 7.120194989163053e-10

The O 0 7.09852565616842e-10
aim O 0 1.9204884349477425e-09
of O 0 2.4250738136361027e-12
this O 0 4.5100455488278346e-12
study O 0 1.1152106148271113e-11
was O 0 3.034680562397085e-10
to O 0 6.234620892470177e-12
assess O 0 1.0549779716484409e-08
genotype O 0 0.00014217836724128574
- O 0 4.0536739106755704e-05
phenotype O 0 3.947113327740226e-06
correlations O 0 5.558149496209808e-06
in O 0 4.3205571387261443e-07
AAPC B-Disease 1 0.9999997615814209
families O 0 7.044554450885698e-08
. O 0 6.272847574706475e-09

By O 0 1.8981789473571098e-09
protein O 0 7.079062669390623e-08
- O 0 1.8500513476737979e-07
truncation O 0 1.2445072172795335e-07
test O 0 4.960605792803108e-08
( O 0 1.0388548354889338e-10
PTT O 0 6.256024143169725e-09
) O 0 4.117265989950214e-12
assay O 0 3.8961758819233694e-10
, O 0 1.0671143873056121e-12
the O 0 1.0016011457725238e-12
entire O 0 7.291155179611764e-11
coding O 0 2.465449000510489e-08
region O 0 3.076724985895396e-10
of O 0 2.9543884699778644e-12
the O 0 3.523849614883723e-11
APC B-Disease 0 6.691892595611648e-10
gene O 0 6.610498815007304e-10
was O 0 2.6602078317949918e-09
screened O 0 6.434931698606761e-09
in O 0 2.5089380573106723e-10
affected O 0 2.361730533362305e-10
individuals O 0 4.6508140220946625e-12
from O 0 4.164524280980686e-10
11 O 0 3.3989305592285746e-08
AAPC B-Disease 1 0.9999998807907104
kindreds O 0 4.449493644642644e-06
, O 0 1.5529193209129488e-10
and O 0 7.000339977830672e-12
their O 0 2.0075369318306446e-12
phenotypic O 0 3.1713907056030166e-09
differences O 0 1.0391194571468532e-08
were O 0 3.028773676305718e-08
examined O 0 1.9532126316335052e-07
. O 0 1.5219111526576512e-09

Five O 0 9.369863107622223e-09
novel O 0 1.299180585334625e-08
germ O 0 0.00024015145027078688
- O 0 9.225400572177023e-05
line O 0 3.733682660822524e-07
APC B-Disease 0 9.225356478737012e-08
mutations O 0 7.66977947819214e-09
were O 0 1.5782687379228832e-09
identified O 0 1.6934291746650842e-09
in O 0 2.2676396871368354e-10
seven O 0 5.320029972111229e-10
kindreds O 0 8.384015472984174e-07
. O 0 3.993993136219842e-09

Mutations O 0 1.6170464505194104e-06
were O 0 6.1570841758396e-09
located O 0 3.0441649201407017e-10
in O 0 1.0032598363185485e-10
three O 0 1.6874937861996453e-12
different O 0 1.0019412599940325e-12
regions O 0 8.66883387989903e-12
of O 0 2.431873495981063e-12
the O 0 1.8892339082032805e-11
APC B-Disease 0 1.2233284385487764e-09
gene O 0 8.870560397333804e-10
( O 0 3.4491205030962035e-11
1 O 0 5.9359156479033e-11
) O 0 7.361566217722881e-12
at O 0 5.907129230209307e-10
the O 0 2.431308973593893e-11
5 O 0 3.396451730974803e-10
end O 0 5.657865287389541e-09
spanning O 0 2.1325403665173326e-09
exons O 0 4.387497476443514e-09
4 O 0 4.1336134515290723e-10
and O 0 2.6710667011542455e-10
5 O 0 1.1194627863586604e-10
, O 0 2.7275215072619652e-11
( O 0 7.336908858235347e-12
2 O 0 2.277178272336311e-11
) O 0 1.8619699965888303e-12
within O 0 1.5486266782827052e-11
exon O 0 1.4628938949101666e-08
9 O 0 3.401888193366176e-08
, O 0 4.402198050534878e-10
and O 0 1.3106388196959529e-09
( O 0 3.821572919227023e-11
3 O 0 6.220322867900308e-11
) O 0 8.031748877090905e-12
at O 0 6.544697006560796e-10
the O 0 3.199383813434764e-11
3 O 0 4.1685693785709077e-10
distal O 0 5.5813178079233694e-08
end O 0 3.9855862610238546e-08
of O 0 2.9331979553570697e-12
the O 0 2.0069329878524833e-11
gene O 0 7.811109092870083e-09
. O 0 1.1756043916122394e-09

Variability O 0 4.947084562445525e-06
in O 0 2.5271993386866143e-09
the O 0 2.1614819309401234e-11
number O 0 1.1688049139646495e-10
of O 0 8.922595640115105e-08
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 1.6301706864396692e-06
most O 0 1.2764655651920087e-11
apparent O 0 1.4554668581467922e-10
in O 0 7.256913819864153e-11
individuals O 0 7.604447128418956e-13
with O 0 3.748520591151383e-12
mutations O 0 2.996342063354973e-09
in O 0 1.5747987358594173e-09
region O 0 5.8887050791156526e-09
1 O 0 1.6118304468903943e-09
, O 0 2.1202502253903077e-10
and O 0 3.5378608931324607e-09
upper O 1 0.9902176260948181
- O 1 0.8110402822494507
gastrointestinal O 0 0.0003391430072952062
manifestations O 0 6.532804519565616e-08
were O 0 1.6432581517733524e-08
more O 0 8.308517068789101e-11
severe O 0 1.1391545484684684e-07
in O 0 5.271284519992037e-10
them O 0 2.450650238294827e-10
. O 0 4.088300253890509e-10

In O 0 5.353021581555595e-09
individuals O 0 3.277448798466587e-11
with O 0 2.935079956856157e-11
mutations O 0 6.358446213994284e-09
in O 0 4.6138420861652207e-10
either O 0 9.52111611773887e-10
region O 0 1.701429930278664e-08
2 O 0 9.201501227629194e-10
or O 0 3.6002014702773977e-09
region O 0 1.2622195733058561e-08
3 O 0 2.1650075066048657e-09
, O 0 5.6105543821960424e-11
the O 0 3.3287099205497883e-12
average O 0 1.4105955292720296e-10
number O 0 1.129624063560264e-12
of O 0 6.443761539978721e-13
adenomas B-Disease 0 6.674383712379495e-08
tended O 0 1.3508456575550554e-09
to O 0 1.0077529088992065e-11
be O 0 4.2296782742923256e-10
lower O 0 3.012469207419599e-08
than O 0 7.387431812111434e-12
those O 0 7.497182670686275e-13
in O 0 2.4244818392499257e-12
individuals O 0 3.336055932369464e-13
with O 0 1.0566432711439644e-12
mutations O 0 4.338679138182755e-10
in O 0 2.887384498162504e-10
region O 0 1.9874617507298353e-09
1 O 0 4.148066889975155e-10
, O 0 4.4853152442181354e-11
although O 0 2.975553137218867e-10
age O 0 5.7812439280269246e-09
at O 0 4.333768455211384e-09
diagnosis O 0 9.43247925988544e-07
was O 0 2.560976986032415e-09
similar O 0 5.137648084740931e-10
. O 0 3.4842608798157926e-09

In O 0 1.3599287740362342e-07
all O 0 8.367845971690713e-09
AAPC B-Disease 1 0.9999997615814209
kindreds O 0 4.0041427382675465e-06
, O 0 1.2943339455784297e-10
a O 0 4.911885134739613e-11
predominance O 0 1.1671512112343407e-07
of O 0 3.4616443045365486e-10
right O 1 0.9758470058441162
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 0 4.975200499757193e-05
rectal B-Disease 1 0.9999690055847168
polyp I-Disease 0 9.978767047869042e-05
sparing O 0 2.664239104888111e-07
was O 0 3.5499013506523625e-08
observed O 0 1.1575423286558362e-08
. O 0 2.744086513573052e-09

No O 0 2.061677605524892e-06
desmoid B-Disease 1 0.9650142192840576
tumors I-Disease 1 1.0
were O 0 3.229141611882369e-07
found O 0 1.3690181210890273e-09
in O 0 1.7440934807488873e-10
these O 0 1.0906975322910739e-10
kindreds O 0 4.874690375800128e-07
. O 0 3.803557468984309e-09

Our O 0 3.723024111224049e-09
data O 0 1.1960710200042968e-09
suggest O 0 2.847851121590139e-10
that O 0 9.407633526359316e-12
, O 0 8.683164430534074e-12
in O 0 4.262772801411074e-09
AAPC B-Disease 1 1.0
families O 0 1.9641900605993357e-10
, O 0 5.805873902302305e-13
the O 0 1.5604972012934343e-13
location O 0 3.7930773105765425e-11
of O 0 1.0841010164228115e-12
the O 0 1.4712253637583217e-10
APC B-Disease 0 9.118312505052018e-08
mutation O 0 2.287564448977264e-08
may O 0 2.2378657149602077e-08
partially O 0 8.0485991205137e-09
predict O 0 8.611990232054723e-09
specific O 0 7.127668455453318e-10
phenotypic O 0 1.1209963446390248e-07
expression O 0 3.452482388865974e-08
. O 0 1.0410595940868461e-08

This O 0 1.448765107880945e-09
should O 0 2.340497240460593e-10
help O 0 1.606825436595294e-11
in O 0 3.906383203022834e-11
the O 0 2.061771543424018e-12
design O 0 1.3166320256274844e-09
of O 0 2.38241826440444e-12
tailored O 0 3.413522620121512e-08
clinical O 0 2.7063981633546064e-06
- O 0 1.156186954176519e-05
management O 0 4.438292844355374e-09
protocols O 0 1.2278986716296458e-09
in O 0 1.1030865457173356e-11
this O 0 9.51605439412917e-13
subset O 0 2.7072611513689893e-11
of O 0 2.9287869872385297e-12
FAP B-Disease 0 7.666473678114016e-09
patients O 0 9.688521984685394e-09
. O 0 4.352219973302596e-11
. O 0 5.360129562426152e-10

Wilms B-Disease 1 0.9914647936820984
' I-Disease 0 1.4239191841625143e-05
tumor I-Disease 0 1.985426251849276e-06
1 O 0 5.598373764570397e-09
and O 0 1.5491127269839922e-09
Dax O 1 0.999996542930603
- O 0 8.793852401822733e-08
1 O 0 2.9664862233325096e-10
modulate O 0 1.3639416707178498e-08
the O 0 2.1099187674789022e-10
orphan O 0 8.175224053275087e-08
nuclear O 0 1.5299681521696584e-08
receptor O 0 1.2877531041510792e-08
SF O 0 2.7699827114702202e-05
- O 0 1.2754331812914188e-08
1 O 0 3.6559304195105113e-11
in O 0 3.134702913909493e-11
sex O 0 1.1554484036224721e-09
- O 0 2.7934185520273047e-10
specific O 0 2.468372034547528e-11
gene O 0 5.199242369968715e-09
expression O 0 4.9594870432656535e-09
. O 0 2.548954824987959e-09

Products O 0 7.880455541453557e-07
of O 0 5.408293257680441e-10
steroidogenic O 0 1.7144005823865882e-06
factor O 0 5.851020556946196e-09
1 O 0 9.781654375373705e-10
( O 0 1.911698799261785e-09
SF O 1 0.7614550590515137
- O 0 7.987869139469694e-07
1 O 0 5.076455922292666e-10
) O 0 1.1410762612573677e-10
and O 0 4.93740115459218e-09
Wilms B-Disease 0 0.00015076824638526887
tumor I-Disease 0 6.558360041708511e-07
1 O 0 1.0845865316966297e-09
( O 0 2.0538923339863402e-10
WT1 O 0 4.3038031805053834e-08
) O 0 2.0509944437252514e-11
genes O 0 1.7199645874210745e-10
are O 0 2.944796099677016e-12
essential O 0 3.016736513372642e-11
for O 0 2.739271266413712e-12
mammalian O 0 1.8850532246261764e-09
gonadogenesis O 0 2.0039831127860452e-08
prior O 0 4.1950978801885697e-10
to O 0 3.66400000617606e-11
sexual O 0 4.4504719354243605e-10
differentiation O 0 1.5647334095092447e-08
. O 0 2.838032475693808e-09

In O 0 1.1350430817458346e-08
males O 0 4.078068993607076e-09
, O 0 2.6432225852524027e-10
SF O 0 0.15204742550849915
- O 0 6.436530384235084e-07
1 O 0 1.4900164435616148e-10
participates O 0 1.5801776553914237e-10
in O 0 3.909633033982729e-11
sexual O 0 1.6348179754377412e-11
development O 0 3.7205906758264184e-12
by O 0 7.868633587586327e-13
regulating O 0 1.0209830203500303e-10
expression O 0 2.516096359039821e-11
of O 0 6.714921587519518e-13
the O 0 1.6016665424500864e-11
polypeptide O 0 1.4125999925340693e-08
hormone O 0 1.4445985518918292e-09
Mullerian O 0 8.985666255512115e-08
inhibiting O 0 4.119080898590255e-08
substance O 0 1.3184011038447352e-07
( O 0 4.689908905675111e-09
MIS O 0 3.121083864243701e-05
) O 0 2.953271627248455e-09
. O 0 2.692715606045226e-09

Here O 0 4.2487002360758197e-07
, O 0 1.8782297939168302e-10
we O 0 2.0062672009824034e-11
show O 0 9.978647769193216e-11
that O 0 3.8999657669958054e-11
WT1 O 0 4.8332599362765905e-06
- O 0 5.530061457648117e-07
KTS O 0 3.2800724056869512e-06
isoforms O 0 2.800399379054852e-08
associate O 0 6.702472354902511e-09
and O 0 6.319966772139196e-11
synergize O 0 2.61770800591421e-08
with O 0 2.437959834011849e-10
SF O 0 0.41437798738479614
- O 0 9.823169477840565e-08
1 O 0 9.449143550943617e-11
to O 0 1.0816477921671286e-11
promote O 0 3.521674341033787e-10
MIS O 0 3.3658050142548745e-06
expression O 0 2.0754272966883036e-08
. O 0 5.246641787692852e-09

In O 0 8.178000854286438e-08
contrast O 0 1.4284724159097095e-07
, O 0 4.53660753407803e-09
WT1 O 0 2.2237525627133437e-05
missense O 0 4.389682726468891e-05
mutations O 0 1.4834116655038088e-06
, O 0 2.107228141978723e-10
associated O 0 1.4191285646614205e-10
with O 0 7.563172310653954e-11
male B-Disease 0 3.717378262990678e-07
pseudohermaphroditism I-Disease 1 1.0
in O 0 5.563301783695351e-07
Denys B-Disease 1 0.9999985694885254
- I-Disease 1 1.0
Drash I-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
, O 0 1.05572228736861e-09
fail O 0 1.0175938314205268e-07
to O 0 1.1269136318547979e-10
synergize O 0 2.9562696113316633e-07
with O 0 2.6746058701121456e-09
SF O 1 0.9993364214897156
- O 0 2.478278929629596e-06
1 O 0 4.907432238354659e-09
. O 0 4.4418921874012085e-09

Additionally O 0 3.1419961032952415e-07
, O 0 1.0733829380882298e-09
the O 0 5.283561782531976e-11
X O 0 1.7802745787776075e-05
- O 0 2.662722408786067e-06
linked O 0 2.6089808216056554e-06
, O 0 1.6458787110984474e-10
candidate O 0 1.120450288105701e-09
dosage O 0 2.2337521841109265e-06
- O 0 6.107132577426455e-08
sensitive O 0 1.8243208899093588e-07
sex O 0 1.2696079743079736e-08
- O 0 3.2559808182952565e-09
reversal O 0 5.157502869224118e-09
gene O 0 5.148617976402647e-09
, O 0 2.9371086118779033e-10
Dax O 1 0.9992615580558777
- O 0 1.421649553634552e-08
1 O 0 1.184243675345087e-10
, O 0 2.500051728138164e-11
antagonizes O 0 1.5220599891563324e-08
synergy O 0 8.121292083274056e-09
between O 0 2.73825695451535e-09
SF O 1 0.9702862501144409
- O 0 3.6557133853420964e-07
1 O 0 1.739296484615238e-10
and O 0 6.338871788580391e-11
WT1 O 0 4.949453824565353e-08
, O 0 1.0013934126362756e-11
most O 0 8.290055274196018e-12
likely O 0 1.584493508621776e-10
through O 0 1.6085663617076973e-12
a O 0 3.680472159678372e-12
direct O 0 5.997231877774567e-11
interaction O 0 4.806420261793676e-10
with O 0 2.145042615753212e-10
SF O 1 0.9723182916641235
- O 0 5.127041617924988e-07
1 O 0 2.600016646425729e-09
. O 0 1.3113764518735138e-09

We O 0 1.2686833805730657e-08
propose O 0 3.6918816892494988e-09
that O 0 7.463746981573038e-11
WT1 O 0 5.129526812197582e-07
and O 0 9.120657118444342e-09
Dax O 1 0.9999996423721313
- O 0 2.326600139213042e-07
1 O 0 7.556626158145008e-11
functionally O 0 1.8094319376160684e-09
oppose O 0 5.1810625234516294e-11
each O 0 2.8033807913940834e-12
other O 0 1.55113057814793e-11
in O 0 1.0644200104659163e-10
testis O 0 2.6779238826435403e-09
development O 0 3.2893538587375204e-11
by O 0 3.701304887582246e-11
modulating O 0 3.8159345194799243e-07
SF O 0 0.007742359768599272
- O 0 1.040494268522707e-07
1 O 0 3.786329916266595e-09
- O 0 4.047925372674399e-08
mediated O 0 7.274384756783547e-07
transactivation O 0 4.0777244976197835e-06
. O 0 6.18430417986815e-10
. O 0 4.977148138074483e-10

A O 0 1.0194393951223901e-07
mouse O 0 1.2825682915718062e-06
model O 0 1.259204651660184e-07
for O 0 6.37180335161247e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.791475772857666
- O 0 0.010475578717887402
centre O 0 4.484518285607919e-07
mutations O 0 1.2727449529847945e-06
. O 0 1.5373455397593716e-08

Imprinting O 0 2.4957660571089946e-05
in O 0 1.652769832105605e-08
the O 0 7.18216042194797e-10
15q11 O 0 5.510025857802248e-07
- O 0 4.0993151628754276e-07
q13 O 0 5.0005233731553744e-08
region O 0 1.4728012143194746e-09
involves O 0 7.113285516169299e-10
an O 0 6.056005003030052e-11
imprinting O 0 1.0247575943367337e-07
centre O 0 2.0383268406476418e-08
( O 0 1.7246161443384977e-10
IC O 0 1.4778058243791747e-07
) O 0 7.383403784200215e-12
, O 0 2.1975678655278275e-12
mapping O 0 8.11755107577028e-11
in O 0 4.2850476639211266e-11
part O 0 2.2102975699711536e-11
to O 0 1.5403487513276914e-11
the O 0 2.0423204794006722e-11
promoter O 0 6.423098497521096e-09
and O 0 9.860323668675619e-11
first O 0 8.765037307068013e-11
exon O 0 3.3383669162390106e-09
of O 0 1.107243949305392e-10
SNRPN O 0 7.822912266419735e-06
. O 0 5.3665050181450624e-09

Deletion O 0 2.1749187908426393e-06
of O 0 3.689915872850946e-10
this O 0 1.9247926863474873e-10
IC O 0 3.993952304881532e-06
abolishes O 0 4.758009808369934e-08
local O 0 2.7789320844462395e-10
paternally O 0 5.565860661249644e-08
derived O 0 7.835053716931384e-10
gene O 0 3.320496988479249e-09
expression O 0 9.7620467265358e-10
and O 0 1.9399999662272904e-10
results O 0 7.225279485822966e-09
in O 0 2.4707155716896523e-06
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.3275006267576828e-06
PWS B-Disease 1 1.0
) O 0 2.296885526220649e-08
. O 0 7.38254213317191e-09

We O 0 1.0744608758272989e-08
have O 0 4.9589332640209705e-11
created O 0 5.1185891462857125e-12
two O 0 2.273502393290716e-11
deletion O 0 2.970462320561751e-09
mutations O 0 2.439002777521182e-09
in O 0 1.4515690038852114e-10
mice O 0 1.1203123051473085e-07
to O 0 1.1164008606456832e-10
understand O 0 8.293437758766231e-07
PWS B-Disease 1 1.0
and O 0 2.736349757892498e-10
the O 0 3.592842386448969e-12
mechanism O 0 2.1412695228040235e-10
of O 0 1.7609184509853604e-12
this O 0 9.073834045247864e-11
IC O 0 2.0073091491212836e-06
. O 0 1.5592686031240532e-09

Mice O 0 0.0024393568746745586
harbouring O 0 3.515499338391237e-05
an O 0 4.294829825113311e-09
intragenic O 0 3.648618758234079e-06
deletion O 0 1.87226433467913e-07
in O 0 7.510533861498914e-10
Snrpn O 0 1.6662895063745964e-07
are O 0 9.563372316279128e-11
phenotypically O 0 6.366190774542702e-08
normal O 0 7.76500108656819e-09
, O 0 1.663875807966786e-11
suggesting O 0 9.809119072556882e-10
that O 0 9.134205544714114e-12
mutations O 0 2.9368282805641854e-10
of O 0 1.708538584048458e-12
SNRPN O 0 5.4134591920274033e-08
are O 0 3.562883928859284e-12
not O 0 3.2815939635805202e-12
sufficient O 0 1.5970967603973207e-11
to O 0 4.998942232381509e-11
induce O 0 2.482029799466545e-07
PWS B-Disease 1 1.0
. O 0 3.2175456965433114e-08

Mice O 0 0.000328217662172392
with O 0 1.7369958249524586e-10
a O 0 4.653797486264821e-11
larger O 0 2.71378169935943e-10
deletion O 0 2.818016753280972e-08
involving O 0 5.778330591788006e-10
both O 0 5.279555126413982e-10
Snrpn O 0 3.3788805353651696e-07
and O 0 1.3632484030523528e-10
the O 0 1.768655499834182e-10
putative O 0 7.319527526306047e-07
PWS O 1 1.0
- O 0 0.00022354845714289695
IC O 0 4.218912636133609e-06
lack O 0 1.3956894528988073e-09
expression O 0 1.5534021291507827e-10
of O 0 3.447092871561308e-12
the O 0 3.7713918793480516e-11
imprinted O 0 3.527896907939976e-08
genes O 0 8.831887221560919e-09
Zfp127 O 0 6.307836031282932e-08
( O 0 2.1732023125498046e-10
mouse O 0 7.459402695531026e-08
homologue O 0 2.542115851156268e-07
of O 0 1.5396621477758998e-10
ZNF127 O 0 1.002826707008353e-06
) O 0 8.062326500857253e-11
, O 0 3.7502171507108883e-11
Ndn O 0 5.119244050888483e-08
and O 0 5.055912910556515e-10
Ipw O 0 1.2667702549151727e-06
, O 0 1.4483000909670807e-10
and O 0 8.997572825686362e-11
manifest O 0 1.2495616763530393e-09
several O 0 4.243299808748269e-11
phenotypes O 0 6.770622729135312e-09
common O 0 1.4812282067566684e-08
to O 0 8.949729135565576e-08
PWS B-Disease 1 1.0
infants O 1 0.7022523283958435
. O 0 5.178666828697942e-09

These O 0 9.075032392225069e-10
data O 0 7.127641254989214e-10
demonstrate O 0 3.594077813140473e-11
that O 0 1.1000268621344511e-12
both O 0 1.560881957539395e-12
the O 0 1.5635548411552236e-12
position O 0 7.812948898955341e-11
of O 0 8.756568332848186e-14
the O 0 4.205124096157142e-12
IC O 0 1.1166663682615763e-07
and O 0 1.7236418889399197e-11
its O 0 6.051818659917607e-13
role O 0 9.231112402252606e-12
in O 0 3.5384900304996636e-12
the O 0 3.5735059659633417e-13
coordinate O 0 3.6812441116251815e-12
expression O 0 2.371258051026004e-11
of O 0 4.4720786318910855e-13
genes O 0 7.680941993548629e-11
is O 0 1.950616968296459e-12
conserved O 0 1.5349348528315154e-11
between O 0 6.95718899157427e-11
mouse O 0 9.593291849796515e-08
and O 0 2.7871810415192044e-10
human O 0 1.1815986557250913e-11
, O 0 1.637548777133624e-11
and O 0 5.885754123663434e-12
indicate O 0 5.625537258246993e-10
that O 0 5.982274137866783e-12
the O 0 4.043056254371402e-12
mouse O 0 1.031522778305316e-08
is O 0 8.572907141124464e-12
a O 0 3.858470400824876e-12
suitable O 0 1.8298523807303013e-10
model O 0 1.949853611904473e-09
system O 0 3.870392895066743e-10
in O 0 3.1617977680475917e-10
which O 0 1.3566695510058846e-11
to O 0 1.8421421072584154e-12
investigate O 0 3.723387483750562e-12
the O 0 4.3940708276818397e-13
molecular O 0 1.376880554015969e-11
mechanisms O 0 4.2147375867163106e-11
of O 0 2.312451011926564e-12
imprinting O 0 6.652000728024632e-09
in O 0 2.889698480501579e-10
this O 0 1.2952668451693405e-11
region O 0 2.5360250011097207e-10
of O 0 1.9185011652239625e-12
the O 0 7.469468620013853e-12
genome O 0 1.728633902686738e-10
. O 0 7.547665964446892e-11
. O 0 6.059243107259249e-10

Mutations O 0 5.882421305614116e-07
of O 0 1.188733417256671e-10
the O 0 3.4832605549928175e-11
ATM O 0 5.632447042103195e-08
gene O 0 5.3435447178173945e-09
detected O 0 2.8350958913847535e-08
in O 0 2.366471019144001e-09
Japanese O 0 0.004770687781274319
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9997610449790955
: O 0 1.714795666574176e-10
possible O 0 1.0506955722133782e-10
preponderance O 0 3.209552801308746e-08
of O 0 5.163026690208072e-12
the O 0 2.0643382836471602e-11
two O 0 6.425689841327298e-11
founder O 0 9.388360311390898e-09
mutations O 0 8.160907327692257e-08
4612del165 O 0 1.036892527395139e-07
and O 0 1.947229710808074e-09
7883del5 O 0 4.961599984198983e-07
. O 0 3.902633327612648e-09

The O 0 2.5677706627647012e-09
ATM O 0 2.5171570996462833e-06
( O 0 1.0557368312902327e-08
A O 1 1.0
- O 1 1.0
T O 1 1.0
, O 0 1.3739569482140723e-09
mutated O 0 1.4552546723223259e-08
) O 0 3.16318360393808e-11
gene O 0 1.7139528685206074e-09
on O 0 3.442326423908071e-10
human O 0 4.058280655971913e-10
chromosome O 0 4.818477918888675e-06
11q22 O 0 2.072431016131304e-06
. O 0 9.596308636616868e-09

3 O 0 2.1438673059037683e-07
has O 0 8.799816986204689e-10
recently O 0 1.2803511584280614e-09
been O 0 1.171270719302342e-10
identified O 0 2.075247196309249e-10
as O 0 2.63385927651294e-12
the O 0 2.2784709232184785e-13
gene O 0 4.567755895745762e-11
responsible O 0 5.673450424736881e-12
for O 0 3.28338295137523e-13
the O 0 1.16501600033736e-11
human O 0 1.3626128669841364e-08
recessive B-Disease 1 1.0
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9417601227760315
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 9.735201977889574e-09
. O 0 4.032880696058783e-09

In O 0 3.5028115963342543e-09
order O 0 4.052075341931527e-11
to O 0 1.5747963913806395e-12
define O 0 8.062511075435097e-11
the O 0 4.48053313201191e-12
types O 0 7.79240005854831e-10
of O 0 4.810416995293387e-11
disease O 0 2.9766174520773347e-06
- O 0 8.563916367165803e-07
causing O 0 2.0728558425275878e-08
ATM O 0 1.1147251370857703e-06
mutations O 0 7.630353238141652e-09
in O 0 2.548408983837902e-10
Japanese O 0 3.8599731055910524e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 7.4832234531641e-05
as O 0 2.0236007314267113e-10
well O 0 6.86274509442697e-11
as O 0 1.3147084983178292e-11
to O 0 2.8413590924536436e-12
look O 0 4.914080253826114e-10
for O 0 1.4348971229954932e-12
possible O 0 8.440451115809822e-11
mutational O 0 5.633746980038268e-08
hotspots O 0 2.3378314395472444e-08
, O 0 1.3926040876022228e-10
reverse O 0 4.2403129896229075e-08
- O 0 2.7916211564615878e-08
transcribed O 0 1.462235488247643e-08
RNA O 0 7.131952250993834e-10
derived O 0 6.351143222449451e-11
from O 0 4.004040154992339e-12
ten O 0 2.6467425473519768e-11
patients O 0 3.4669947468479734e-11
belonging O 0 1.3332673853838628e-10
to O 0 1.3330810413880734e-11
eight O 0 6.512292788363183e-11
unrelated O 0 1.77464765105384e-09
Japanese O 0 4.4460355752562464e-07
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
families O 0 5.011462800297295e-09
was O 0 2.960033107513027e-09
analyzed O 0 3.85220910725792e-10
for O 0 1.2794825962614276e-12
mutations O 0 6.050589890227442e-11
by O 0 2.48242637383711e-12
the O 0 1.1702340485530982e-11
restriction O 0 8.118716809946136e-10
endonuclease O 0 1.6708213479432743e-07
fingerprinting O 0 5.111341039309991e-08
method O 0 8.628893155560036e-09
. O 0 1.9349271074275975e-09

As O 0 3.614301036236611e-08
has O 0 1.7332627000321565e-10
been O 0 3.105418006077443e-11
reported O 0 1.8044406246975342e-10
by O 0 5.711807979716377e-13
others O 0 5.483628828795162e-11
, O 0 1.6758952081988299e-12
mutations O 0 1.1207446776184682e-10
that O 0 1.8135279736264387e-11
lead O 0 6.943164099215693e-11
to O 0 3.3695043283321624e-11
exon O 0 2.574657642639977e-08
skipping O 0 1.3623288452890847e-07
or O 0 8.892145686445474e-09
premature O 0 1.9996113209685973e-08
protein O 0 6.251179018867958e-10
truncation O 0 1.845937447342294e-08
were O 0 6.6512524377060345e-09
also O 0 1.895067019974661e-10
predominant O 0 1.0242531267579125e-08
in O 0 8.562995312821897e-10
our O 0 1.6895832510854802e-09
mutants O 0 6.32329104632845e-08
. O 0 1.640238611599898e-09

Six O 0 3.7158023324934675e-09
different O 0 6.079927533653162e-11
mutations O 0 6.09880423940723e-10
were O 0 4.3178752240358165e-10
identified O 0 7.931373335878789e-10
on O 0 3.2737079713740513e-10
12 O 0 2.843366514460044e-11
of O 0 2.2838442291853167e-13
the O 0 1.75829489856838e-11
16 O 0 5.931753421783981e-10
alleles O 0 1.3275643695465078e-08
examined O 0 8.936456765695766e-07
. O 0 1.0539964456768303e-08

Four O 0 5.106660871945223e-09
were O 0 5.961617866034885e-10
deletions O 0 3.9151215602828415e-09
involving O 0 3.1825328483670035e-10
a O 0 4.004808151769623e-10
loss O 0 3.2300324637191125e-09
of O 0 8.142932508836687e-12
a O 0 2.228849743657335e-10
single O 0 2.6803050889867563e-09
exon O 0 9.713875215311418e-08
exon O 0 2.3794262915544095e-07
7 O 0 1.6585298467930443e-08
, O 0 5.768749922197003e-10
exon O 0 8.294958320220758e-08
16 O 0 1.55265134083038e-08
, O 0 3.3440752944535745e-10
exon O 0 8.743260337951142e-08
33 O 0 8.757296399153347e-08
or O 0 1.3345484717319778e-08
exon O 0 7.443568961207347e-07
35 O 0 1.9336705747718952e-07
. O 0 1.747231692661444e-08

The O 0 1.7190930901023194e-09
others O 0 5.92669802124135e-10
were O 0 1.2276474281591732e-10
minute O 0 3.2079891520986337e-10
deletions O 0 5.568278726997278e-09
, O 0 3.117138144825837e-11
4649delA O 0 2.48211784459329e-09
in O 0 6.788304640625853e-11
exon O 0 1.6189053653192786e-08
33 O 0 4.371859319007854e-09
and O 0 1.1434074520533244e-10
7883del5 O 0 1.0082350954121466e-08
in O 0 3.9121111905515704e-10
exon O 0 9.171407100438955e-08
55 O 0 1.83606321257912e-08
. O 0 3.908160461918442e-09

The O 0 1.4445909357618802e-08
mutations O 0 1.9797622030637285e-07
4612del165 O 0 1.2786220793259417e-07
and O 0 2.41671405110111e-10
7883del5 O 0 4.048317236993171e-09
were O 0 2.9285723845973166e-10
found O 0 1.1982030645452113e-10
in O 0 3.522169708669587e-11
more O 0 1.2267661929701856e-12
than O 0 9.047107681070532e-13
two O 0 1.1110295626212685e-12
unrelated O 0 5.105370293190248e-11
families O 0 7.123964178984421e-12
; O 0 1.6392229370762457e-12
44 O 0 3.3941718879937355e-10
% O 0 2.27227237026284e-10
( O 0 1.5631837491092426e-10
7 O 0 5.015208803804683e-10
of O 0 7.908796013922359e-12
16 O 0 3.4360944645150937e-10
) O 0 1.1340755808400549e-12
of O 0 1.3960592393485322e-13
the O 0 4.2895509193285886e-12
mutant O 0 1.79507697595227e-09
alleles O 0 2.7044251282859477e-09
had O 0 3.7825716958650446e-07
one O 0 7.684326785994955e-11
of O 0 1.4744939210581398e-12
the O 0 9.527559990951673e-11
two O 0 4.783337059777182e-10
mutations O 0 2.3361732104376642e-08
. O 0 5.714358763952987e-09

The O 0 6.0303992910348825e-09
4612del165 O 0 8.969364273525571e-08
mutations O 0 1.2676625971153044e-08
in O 0 1.6245549350202282e-10
three O 0 3.4934386113072424e-12
different O 0 2.6128342111436664e-12
families O 0 5.488816432613897e-12
were O 0 3.0730890054897486e-10
all O 0 7.180272544073107e-13
ascribed O 0 2.981630220499909e-11
to O 0 2.8867370733404174e-12
the O 0 3.97647409791646e-12
same O 0 2.250585134921934e-10
T O 0 4.026941269330564e-07
- O 0 1.7184644818257766e-08
- O 0 1.3946628740768574e-08
> O 0 3.7824449128365245e-10
A O 0 1.0312423831537743e-10
substitution O 0 5.862120788791003e-10
at O 0 2.793312248172697e-10
the O 0 4.259872836420708e-12
splice O 0 3.3765541473940175e-08
donor O 0 5.874096764557635e-10
site O 0 2.692458922481933e-09
in O 0 2.563684597944871e-09
intron O 0 9.308567314292304e-06
33 O 0 4.7238467004717677e-07
. O 0 1.9946174489859914e-08

Microsatellite O 0 5.648484147968702e-05
genotyping O 0 1.0695560376916546e-05
around O 0 9.875164685979598e-09
the O 0 1.004324332032347e-10
ATM O 0 2.9778895793697302e-08
locus O 0 1.1466468885501513e-09
also O 0 9.163630965147718e-11
indicated O 0 7.05229152853093e-10
that O 0 1.836087705486822e-12
a O 0 3.6631198074843496e-11
common O 0 3.249697400065088e-08
haplotype O 0 1.3007723282498773e-05
was O 0 4.007119613902432e-08
shared O 0 1.3535369873529657e-11
by O 0 1.4402245672104352e-12
the O 0 4.510010854358315e-12
mutant O 0 1.6076608932991121e-09
alleles O 0 2.238650154140487e-09
in O 0 5.152819837483946e-10
both O 0 9.969768344220142e-10
mutations O 0 1.8230755927106657e-07
. O 0 5.4038418184632064e-09

This O 0 1.1014730239011783e-09
suggests O 0 1.9007115881208847e-09
that O 0 2.7480209947861045e-12
these O 0 6.641021283240733e-13
two O 0 2.2602189217457713e-12
founder O 0 6.091340765124187e-10
mutations O 0 1.4435800999024195e-08
may O 0 1.2840006391456882e-08
be O 0 1.811564266651633e-11
predominant O 0 2.2522395060065037e-09
among O 0 1.2817181344049189e-11
Japanese O 0 9.473618556299357e-10
ATM O 0 5.029093586017552e-08
mutant O 0 3.409247639751811e-08
alleles O 0 1.2365794077595638e-07
. O 0 3.0070328449482986e-08

W474C O 0 6.829744506831048e-06
amino O 0 1.5887506776834925e-07
acid O 0 2.1893848511922442e-08
substitution O 0 1.5216062854150891e-09
affects O 0 6.124099560800289e-10
early O 0 2.6166169231345293e-10
processing O 0 6.390488832552776e-11
of O 0 8.958891977882064e-14
the O 0 7.073619576365708e-13
alpha O 0 2.510923587106806e-11
- O 0 2.615737487721148e-11
subunit O 0 8.392644912369462e-11
of O 0 4.369716394281298e-13
beta O 0 1.0999235966480114e-09
- O 0 5.637240363398632e-08
hexosaminidase O 0 5.394708750827704e-07
A O 0 7.843011573527292e-09
and O 0 1.9157167518990548e-10
is O 0 3.994947168212137e-12
associated O 0 5.907058175935731e-11
with O 0 1.1775001806935137e-10
subacute O 0 4.550563971861266e-06
G B-Disease 0 2.891849544539582e-05
( I-Disease 0 6.953902453865624e-10
M2 I-Disease 0 7.487306902476121e-06
) I-Disease 0 1.915768654825456e-09
gangliosidosis I-Disease 0 4.286127023078734e-06
. O 0 1.2954441963586305e-08

Mutations O 0 3.2194109280681005e-06
in O 0 3.747796739617115e-09
the O 0 1.219367662397275e-10
HEXA O 0 5.94799359987519e-07
gene O 0 4.825234878325091e-09
, O 0 1.9288745947698693e-11
encoding O 0 1.1353189915963569e-10
the O 0 2.69337937369718e-12
alpha O 0 9.967158348667127e-11
- O 0 1.1750703188262435e-10
subunit O 0 2.1400570204832547e-10
of O 0 9.758197938927737e-13
beta O 0 1.966294016497727e-09
- O 0 8.98571741458909e-08
hexosaminidase O 0 3.817143010564905e-07
A O 0 1.2463631016146337e-08
( O 0 1.9153878483280096e-10
Hex O 0 5.8672022795747125e-09
A O 0 2.9890742658800207e-10
) O 0 6.819629496529478e-12
, O 0 1.3576525971156772e-12
that O 0 3.4313235846433754e-12
abolish O 0 1.1791324583398932e-09
Hex O 0 2.2712076663822245e-09
A O 0 1.0255050975072066e-10
enzyme O 0 6.645064054566774e-09
activity O 0 4.786153340319288e-08
cause O 0 2.8930764983670088e-06
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 0.6366434097290039
( O 0 3.325935304943073e-09
TSD B-Disease 0 5.372486157284584e-06
) O 0 7.5771777741096e-11
, O 0 1.361049727782726e-11
the O 0 4.2683009904287417e-11
fatal O 0 8.008365512068849e-06
infantile B-Disease 0 0.00012986701040063053
form I-Disease 0 1.1745404648877411e-08
of I-Disease 0 2.8181321165554607e-10
G I-Disease 0 2.7116661840409506e-06
( I-Disease 0 1.9399111483853204e-10
M2 I-Disease 0 1.840479853854049e-06
) I-Disease 0 4.239823214735594e-10
gangliosidosis I-Disease 0 4.435375728917279e-07
, I-Disease 0 1.6642828781776586e-10
Type I-Disease 0 1.5847224688059214e-07
1 I-Disease 0 5.917529133370181e-09
. O 0 3.824399019691782e-09

Less O 0 2.6193212761427276e-05
severe O 0 0.1753091961145401
, O 0 4.58177407125504e-09
subacute O 0 0.0002637030556797981
( O 0 2.2705272328948922e-07
juvenile O 1 0.6553124785423279
- O 1 0.9862509965896606
onset O 0 0.0409403070807457
) O 0 4.880865489553798e-09
and O 0 5.5334279380758744e-08
chronic O 0 0.040550597012043
( O 0 3.3188254366933734e-09
adult O 0 0.00035852924338541925
- O 1 0.8160812258720398
onset O 0 1.3855329598300159e-05
) O 0 5.286555915251512e-11
variants O 0 5.074929365633807e-09
are O 0 7.323881778820152e-11
characterized O 0 1.0315039794539516e-10
by O 0 2.966511368149294e-12
a O 0 1.9199306033890196e-10
broad O 0 6.252731665767897e-09
spectrum O 0 2.150307487625014e-09
of O 0 1.3699570124148241e-11
clinical O 0 1.7153100051459091e-09
manifestations O 0 5.382442824775069e-10
and O 0 5.890091886451287e-11
are O 0 1.6342902508723056e-12
associated O 0 1.7563641513396178e-11
with O 0 8.587078964561456e-12
residual O 0 1.9179164212346222e-07
levels O 0 4.5158192740757386e-09
of O 0 2.7735283687768675e-12
Hex O 0 5.646136447268191e-09
A O 0 3.42440964473667e-10
enzyme O 0 9.48262623978735e-09
activity O 0 5.386759482917114e-09
. O 0 7.796532863757477e-10

We O 0 1.1422054413401383e-08
identified O 0 4.137125309000567e-09
a O 0 4.205753800778922e-10
1422 O 0 2.9783379886794137e-06
G O 0 1.7714276054903166e-06
- O 0 6.635351610384532e-07
- O 0 9.453092388866935e-07
> O 0 2.069245219615823e-08
C O 0 1.702893257515825e-07
( O 0 8.177427485156485e-11
amino O 0 3.9784503469419974e-10
acid O 0 4.749943771642506e-10
W474C O 0 5.455037532797746e-10
) O 0 8.400067208653994e-13
substitution O 0 3.6276712970378933e-12
in O 0 2.0549180412832158e-11
the O 0 3.804255521711042e-12
first O 0 5.470935510176744e-11
position O 0 1.6649623346687292e-10
of O 0 9.683183074815638e-13
exon O 0 2.006223187578371e-09
13 O 0 1.7766280113740152e-10
of O 0 2.8247755697041743e-12
HEXA O 0 1.0328121788916178e-06
of O 0 1.0498097183231359e-11
a O 0 5.657193602459643e-10
non O 0 8.818431069812505e-07
- O 0 4.940126245855936e-07
Jewish O 0 2.7959588422277193e-08
proband O 0 4.0191964217228815e-05
who O 0 2.061188997259933e-09
manifested O 0 5.556502369330474e-09
a O 0 6.310164613054781e-10
subacute O 0 3.624840701377252e-06
variant O 0 5.399177462095395e-05
of O 0 2.9274511703647477e-09
G B-Disease 0 4.9562488129595295e-05
( I-Disease 0 1.4882902688029276e-09
M2 I-Disease 0 7.7238873927854e-06
) I-Disease 0 5.173779626943542e-09
gangliosidosis I-Disease 0 1.2051524208800402e-05
. O 0 2.0893605068295074e-08

On O 0 1.9294184028240124e-08
the O 0 7.528688089619706e-11
second O 0 1.760256274074834e-09
maternally O 0 6.679466423520353e-06
inherited O 0 3.167016984662041e-05
allele O 0 3.358871367709071e-07
, O 0 3.9624106773494816e-10
we O 0 4.4185658604201095e-11
identified O 0 2.2295940094174682e-10
the O 0 9.603801261193201e-12
common O 0 2.0935097211349785e-07
infantile O 1 0.9825522899627686
disease O 1 0.9011486172676086
- O 0 0.00017369247507303953
causing O 0 3.290074630513118e-07
4 O 0 2.7949457859222093e-08
- O 0 1.794350737327477e-06
bp O 0 1.4554040035363869e-06
insertion O 0 4.672981646081098e-08
, O 0 2.3202909038566588e-10
+ O 0 8.559490005666248e-09
TATC O 0 7.539252351307368e-07
1278 O 0 7.4372542258061e-07
, O 0 2.732130632843166e-10
in O 0 3.267245085591952e-10
exon O 0 9.476392648366527e-08
11 O 0 8.357621261723125e-09
. O 0 1.6106871392196354e-09

Pulse O 0 0.000477942026918754
- O 0 7.106520206434652e-05
chase O 0 1.601188586164426e-07
analysis O 0 3.2486838219547565e-10
using O 0 1.8734748474802387e-10
proband O 0 1.3306474500041077e-07
fibroblasts O 0 4.429593047916569e-08
revealed O 0 6.176823319492541e-08
that O 0 9.638153122826232e-12
the O 0 2.7244107577567567e-12
W474C O 0 8.324462785758158e-10
- O 0 6.443313244064441e-11
containing O 0 4.4897124212850414e-12
alpha O 0 3.316252827900712e-11
- O 0 4.3117502623868376e-11
subunit O 0 1.273909866483791e-10
precursor O 0 1.1225845253370892e-10
was O 0 5.177538398015713e-10
normally O 0 1.7732112653212617e-11
synthesized O 0 2.422505807064823e-10
, O 0 3.4465473010281134e-12
but O 0 7.42642492640444e-12
not O 0 1.3106518908373443e-12
phosphorylated O 0 2.333551234190434e-11
or O 0 2.4024792572019393e-11
secreted O 0 7.014243352809757e-11
, O 0 1.5394911040411685e-11
and O 0 1.0994673921294051e-11
the O 0 1.381107381237534e-11
mature O 0 4.318114199541867e-10
lysosomal O 0 4.325757974044109e-09
alpha O 0 9.958915914154431e-10
- O 0 2.5537336689751555e-09
subunit O 0 6.4906857666358064e-09
was O 0 7.775271093635183e-09
not O 0 1.6527114399256249e-10
detected O 0 7.995813433581134e-08
. O 0 1.248761094529982e-09

When O 0 1.0123664573313818e-08
the O 0 9.35720875783197e-11
W474C O 0 5.74841063638587e-09
- O 0 2.635324181099463e-10
containing O 0 1.453879117790935e-11
alpha O 0 2.9410551771746896e-10
- O 0 5.081261522654756e-10
subunit O 0 1.809984162548517e-09
was O 0 6.855736534028267e-10
transiently O 0 2.9323408146098018e-09
co O 0 2.867129866856999e-09
- O 0 5.319035767392677e-10
expressed O 0 2.0666931707657987e-12
with O 0 2.942116494007718e-13
the O 0 1.5652585564490673e-12
beta O 0 9.804269895941076e-11
- O 0 1.0248812909452454e-10
subunit O 0 1.7973371402302263e-10
to O 0 6.5952031162719305e-12
produce O 0 7.017963293831642e-11
Hex O 0 1.4658601443784391e-08
A O 0 1.2516321312716627e-09
( O 0 9.745781959225042e-11
alphabeta O 0 9.137529843883385e-09
) O 0 5.11101881303655e-12
in O 0 8.399739237496817e-11
COS O 0 7.434387953253463e-05
- O 0 2.0062548955479542e-08
7 O 0 1.1294075397128012e-10
cells O 0 1.8911675003785433e-10
, O 0 3.3788794245176446e-12
the O 0 1.0059548680163566e-12
mature O 0 1.6087145504606326e-11
alpha O 0 1.1376096245574452e-11
- O 0 4.502217695878663e-11
subunit O 0 1.3849171809354743e-10
was O 0 4.751674609337897e-10
present O 0 3.36514822084355e-12
, O 0 3.3457687575316752e-12
but O 0 7.327930796885429e-12
its O 0 3.767980122793696e-13
level O 0 9.227301700498458e-10
was O 0 4.528204478049247e-09
much O 0 4.517124174707732e-11
lower O 0 1.1578574765636063e-09
than O 0 2.1665948115451306e-12
that O 0 5.174035570647273e-13
from O 0 2.0402169537137027e-12
normal O 0 3.9926027761705285e-11
alpha O 0 1.0750255546865262e-10
- O 0 1.9299981057763205e-10
subunit O 0 1.2517371583697923e-09
transfections O 0 7.605304830349269e-09
, O 0 2.1130417294373816e-12
although O 0 1.2515305632121443e-11
higher O 0 1.665102083991954e-10
than O 0 1.3252568530422448e-12
in O 0 4.390470625947884e-12
those O 0 2.2636790445590416e-12
cells O 0 1.0087220989052348e-11
transfected O 0 7.816485236844528e-10
with O 0 2.5779202991044192e-12
an O 0 3.1428791860688143e-12
alpha O 0 3.9777370286486757e-10
- O 0 1.377664760049413e-09
subunit O 0 2.2410939770622917e-09
associated O 0 7.953157021844959e-10
with O 0 6.964335774739538e-10
infantile O 0 0.0008283237693831325
TSD B-Disease 0 0.0002678094315342605
. O 0 2.6033976752160015e-08

Furthermore O 0 6.045995348813449e-08
, O 0 8.480794538856529e-11
the O 0 9.838804033643345e-13
precursor O 0 2.9286950642415377e-10
level O 0 3.442838514278179e-10
of O 0 1.5020700883192767e-13
the O 0 7.36531170254795e-13
W474C O 0 2.037761209772171e-10
alpha O 0 3.2375296887821037e-11
- O 0 3.90304663588914e-11
subunit O 0 1.386576964357289e-10
was O 0 3.624341660124486e-10
found O 0 1.1415111043910908e-11
to O 0 2.39310719678254e-12
accumulate O 0 2.0061149963446212e-10
in O 0 3.733244182541062e-12
comparison O 0 3.317176394679322e-11
to O 0 3.2945634068082263e-12
the O 0 4.627736562012874e-12
normal O 0 1.3512883867417003e-10
alpha O 0 1.3777823326677208e-10
- O 0 1.7166805477142333e-10
subunit O 0 2.4917423679937656e-09
precursor O 0 5.275219372435913e-09
levels O 0 1.8795316414355057e-09
. O 0 4.985128976287001e-10

We O 0 2.701498402757352e-08
conclude O 0 3.923496194602194e-08
that O 0 1.1522670838315374e-11
the O 0 1.3557537904829164e-11
1422 O 0 1.7834004495398403e-07
G O 0 6.987387024537384e-08
- O 0 5.2019039742390305e-08
- O 0 2.3227957512972353e-07
> O 0 6.154559972770812e-09
C O 0 1.5433175803991617e-07
mutation O 0 1.1852384629307267e-09
is O 0 1.922157398526192e-11
the O 0 6.6664824702189485e-12
cause O 0 1.540655103493549e-10
of O 0 1.7088653408992016e-11
Hex B-Disease 0 8.386829790651973e-07
A I-Disease 0 8.876744686858729e-06
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.1354760687254384e-08
the O 0 1.6080381470828797e-09
proband O 0 4.090647962584626e-06
. O 0 9.744993256788348e-09

The O 0 4.0689860369980124e-09
resulting O 0 2.8836102394791396e-09
W474C O 0 1.0007785533616698e-07
substitution O 0 1.0110813519759176e-08
clearly O 0 1.773109126190775e-08
interferes O 0 6.53136966732859e-09
with O 0 3.9483446893917584e-12
alpha O 0 1.93007179682958e-10
- O 0 1.9684318064427941e-10
subunit O 0 4.045204449187878e-10
processing O 0 2.0394097521858612e-10
, O 0 2.9945664004049632e-12
but O 0 6.497909849079164e-12
because O 0 1.0412542139279224e-12
the O 0 2.1595880194801714e-13
base O 0 4.972171112338497e-12
substitution O 0 9.516208654414271e-11
falls O 0 2.361679634077518e-07
at O 0 2.6347915516033993e-10
the O 0 3.093751817229151e-12
first O 0 3.168642431772284e-11
position O 0 2.426797651722268e-10
of O 0 5.783282923735311e-13
exon O 0 1.989832298932015e-09
13 O 0 3.1451130588777687e-10
, O 0 2.1984242551398303e-11
aberrant O 0 4.455502189415483e-09
splicing O 0 1.1489203188830288e-07
may O 0 6.697823096146749e-08
also O 0 2.2046807088282883e-11
contribute O 0 6.301643235007148e-12
to O 0 1.7735190052659e-11
Hex B-Disease 0 4.617474189672066e-07
A I-Disease 0 6.543429549310531e-07
deficiency I-Disease 0 3.882466262439266e-05
in O 0 5.898583288477255e-10
this O 0 2.66170863127968e-10
proband O 0 2.2010733857769083e-07
. O 0 1.7442798594391462e-10
. O 0 1.4925858327075048e-09

Two O 0 8.505360860056044e-09
frequent O 0 9.541230383547372e-08
missense O 0 0.00017533349455334246
mutations O 0 0.0011381253134459257
in O 0 0.0036033308133482933
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.3539707310883387e-07

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 4.344142780610127e-06
an O 0 1.2241563126735855e-05
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 0.007532764691859484
by O 0 7.533722978791957e-09
early O 0 0.12004750221967697
childhood O 1 0.9999872446060181
deafness B-Disease 1 1.0
and O 0 0.0010486145038157701
goiter B-Disease 1 1.0
. O 0 2.2184318027029803e-07

A O 0 8.842712873047276e-08
century O 0 6.607051261653396e-08
after O 0 4.675098641548914e-10
its O 0 1.7737243965254557e-12
recognition O 0 1.4375769671892691e-11
as O 0 5.076882247934122e-10
a O 0 1.3236167717423086e-07
syndrome O 1 0.5271651744842529
by O 0 8.080122682052604e-11
Vaughan O 0 1.8905832348536933e-06
Pendred O 0 5.916392069593712e-07
, O 0 7.067624957501906e-11
the O 0 3.915110249885778e-11
disease O 0 1.214286555750732e-07
gene O 0 1.7592543599675992e-07
( O 0 6.668006591326048e-09
PDS O 0 2.6582254577078857e-05
) O 0 1.8697765558073343e-10
was O 0 6.130460139530669e-09
mapped O 0 2.2034734925568955e-08
to O 0 9.734083539214566e-10
chromosome O 0 1.9830491510219872e-05
7q22 O 0 1.9397006326471455e-05
- O 0 7.03460318618454e-06
q31 O 0 4.790619641426019e-06
. O 0 1.0061794952775927e-08

1 O 0 6.048762912769234e-08
and O 0 6.227377502554532e-10
, O 0 8.275047314043604e-12
recently O 0 7.159579040738606e-10
, O 0 6.168260889040378e-13
found O 0 5.155439443405019e-12
to O 0 6.459771411358728e-13
encode O 0 3.928921354923176e-10
a O 0 5.210378795084125e-10
putative O 0 1.1193874627224432e-07
sulfate O 0 1.7291212373038434e-07
transporter O 0 5.7081251725321636e-06
. O 0 9.583541071833679e-09

We O 0 3.251681590654698e-08
performed O 0 1.7966423904169915e-09
mutation O 0 9.324538918775716e-10
analysis O 0 6.510479655386092e-11
of O 0 1.2213658903692526e-12
the O 0 2.593204470602295e-11
PDS B-Disease 0 9.233929887386694e-08
gene O 0 8.020585084977938e-09
in O 0 1.7297396848192648e-09
patients O 0 3.813000137853351e-09
from O 0 6.419944437174863e-11
14 O 0 8.124665384912078e-10
Pendred B-Disease 0 3.5121257013770446e-08
families O 0 2.6928259969083435e-11
originating O 0 7.640165722300196e-10
from O 0 1.3343665061782417e-10
seven O 0 1.0601407945953767e-10
countries O 0 2.3914292421323147e-11
and O 0 5.464657545917184e-11
identified O 0 2.2664301546626575e-09
all O 0 2.3851155425691495e-11
mutations O 0 9.920511523375808e-09
. O 0 1.3186124414588107e-09

The O 0 4.387028518237912e-09
mutations O 0 1.1680126199564711e-08
include O 0 5.4819662698157856e-11
three O 0 1.8576891760990755e-11
single O 0 1.0223861340863394e-10
base O 0 2.356965178584858e-10
deletions O 0 4.7879428421993e-08
, O 0 3.088460598377196e-10
one O 0 2.1226417845632284e-10
splice O 0 2.932403958766372e-06
site O 0 3.590458774738181e-08
mutation O 0 1.3606057791548665e-07
and O 0 4.577720869036739e-09
10 O 0 8.93808749236058e-10
missense O 0 4.9294712880509906e-06
mutations O 0 3.156091906930669e-06
. O 0 3.3097116158842255e-08

One O 0 1.7858681644611352e-07
missense O 0 3.6706340324599296e-05
mutation O 0 1.875073053270171e-06
( O 0 7.662351642068188e-09
L236P O 0 8.687190700129577e-08
) O 0 1.1065936361687179e-10
was O 0 3.801685632964791e-09
found O 0 1.2848909436424805e-10
in O 0 2.4700581857661774e-11
a O 0 4.494950245348406e-11
homozygous O 0 8.803845985561054e-10
state O 0 2.540468009570862e-11
in O 0 2.7565807969587297e-10
two O 0 3.4999631665089126e-11
consanguineous O 0 5.416309889483273e-08
families O 0 2.1911998604462468e-10
and O 0 5.759995258536321e-11
in O 0 2.1618665191347475e-10
a O 0 2.1619654677618172e-10
heterozygous O 0 4.344693493862906e-09
state O 0 1.9410278939702152e-11
in O 0 4.083094973239554e-10
five O 0 7.843213578606623e-11
additional O 0 1.3115959707210578e-10
non O 0 6.512787535939424e-07
- O 0 2.43297363340389e-05
consanguineous O 0 1.6592170140938833e-05
families O 0 9.09531117088136e-09
. O 0 3.9033629661844316e-09

Another O 0 5.991112317360603e-08
missense O 0 2.5664667191449553e-05
mutation O 0 9.263845299756213e-07
( O 0 4.564050914979134e-09
T416P O 0 2.3111766722649918e-08
) O 0 6.0011794145165e-11
was O 0 1.180478048645739e-09
found O 0 8.633592452067518e-11
in O 0 1.2559329444494782e-11
a O 0 8.410427736194048e-12
homozygous O 0 3.9245476313176653e-10
state O 0 7.495214518482562e-12
in O 0 8.321573430336571e-10
one O 0 7.80738085293109e-10
family O 0 7.861186007707133e-11
and O 0 9.588979610342108e-11
in O 0 3.602368403576861e-11
a O 0 3.3441374669429536e-11
heterozygous O 0 1.026147389282528e-09
state O 0 1.628211454551831e-11
in O 0 2.4441721979684417e-09
four O 0 1.2660188453139654e-09
families O 0 4.3876458022396037e-10
. O 0 7.669366253182375e-10

Pendred B-Disease 0 0.0017996012466028333
patients O 0 5.3649695473723114e-05
in O 0 2.589055414503605e-09
three O 0 1.6950019166017682e-10
non O 0 4.516786233921266e-08
- O 0 1.846932718763128e-06
consanguineous O 0 2.3697300548519706e-06
families O 0 2.2433936652799247e-10
were O 0 2.602653856320636e-11
shown O 0 1.5367452102510448e-11
to O 0 2.104795721394326e-12
be O 0 3.62265165781972e-12
compound O 0 1.4437273598844058e-10
heterozygotes O 0 3.1368949660048884e-09
for O 0 3.120213462604049e-11
L236P O 0 4.445267620667437e-08
and O 0 2.1079404888268982e-09
T416P O 0 3.677631070786447e-07
. O 0 4.612604076470461e-09

In O 0 3.784929258898728e-09
total O 0 5.5268060961122245e-11
, O 0 1.5413599216418383e-11
one O 0 2.7911312584089076e-12
or O 0 1.257234334001156e-11
both O 0 2.6099552206948484e-12
of O 0 8.767230105961865e-14
these O 0 1.5948555410344456e-12
mutations O 0 4.930244060230571e-11
were O 0 5.02630770338186e-10
found O 0 1.7247608896653333e-10
in O 0 4.4373320989832266e-11
nine O 0 7.903492443839255e-11
of O 0 3.1052905472700454e-13
the O 0 2.5226315827908685e-11
14 O 0 3.273520621238646e-10
families O 0 6.74081138130056e-11
analyzed O 0 9.866767847199753e-09
. O 0 5.14653608618687e-09

The O 0 7.412733205036659e-10
identification O 0 1.8372464660743049e-09
of O 0 4.823414671145665e-12
two O 0 2.399264467656259e-11
frequent O 0 5.812400782900795e-09
PDS B-Disease 0 0.00011476733925519511
mutations O 0 2.6660812224577057e-08
will O 0 1.744538541403884e-11
facilitate O 0 2.4648529745041614e-11
the O 0 1.1642074457252072e-11
molecular O 0 7.806729485082542e-09
diagnosis O 0 0.0035482191015034914
of O 0 5.64108013634268e-08
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 5.728854546305229e-08

Insertional O 0 3.82460311811883e-05
mutation O 0 2.675926964457176e-07
by O 0 5.679053893814512e-10
transposable O 0 8.682831662554236e-07
element O 0 7.429981252471407e-08
, O 0 4.116345930782472e-09
L1 O 0 2.2212774638319388e-05
, O 0 8.14745770849612e-11
in O 0 7.609461671886919e-11
the O 0 1.1763692242539037e-09
DMD B-Disease 1 1.0
gene O 0 2.230523961088693e-07
results O 0 8.919459837386512e-09
in O 0 2.631528106533665e-09
X B-Disease 1 0.9999994039535522
- I-Disease 1 0.9999994039535522
linked I-Disease 1 0.9999997615814209
dilated I-Disease 1 0.9999996423721313
cardiomyopathy I-Disease 1 1.0
. O 0 4.499151771142351e-07

X B-Disease 1 0.9999960660934448
- I-Disease 1 0.9999998807907104
linked I-Disease 1 0.9999996423721313
dilated I-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
( O 0 5.726930680793885e-07
XLDCM B-Disease 0 1.0425456821394619e-05
) O 0 6.912349859167222e-11
is O 0 9.711634274545133e-12
a O 0 7.194221607331741e-11
clinical O 0 1.0534421335250954e-07
phenotype O 0 1.2587847777467687e-06
of O 0 9.224709884847471e-11
dystrophinopathy B-Disease 0 8.20816512714373e-06
which O 0 5.075981301949639e-10
is O 0 4.317971674661081e-11
characterized O 0 8.466991691102876e-11
by O 0 3.846950188957088e-11
preferential O 0 1.1248660030105384e-06
myocardial B-Disease 0 1.285100825043628e-05
involvement I-Disease 0 6.93459512035588e-09
without O 0 1.199385174510681e-10
any O 0 3.063571271666454e-11
overt O 0 1.2472645138927874e-08
clinical O 0 1.1359259843857217e-07
signs O 0 2.0202809025704482e-07
of O 0 9.714575810448878e-09
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 9.755929113453021e-07

To O 0 3.217194510796162e-09
date O 0 4.4487453720876147e-08
, O 0 1.727117060479344e-11
several O 0 4.2828232280078815e-12
mutations O 0 5.43598888125274e-10
in O 0 2.0102557118928388e-10
the O 0 1.8630279541298478e-09
Duchenne B-Disease 0 0.09701450914144516
muscular I-Disease 0 0.001032950123772025
dystrophy I-Disease 0 0.04748566448688507
gene O 0 3.904772256646538e-06
, O 0 8.021169861649469e-08
DMD O 1 1.0
, O 0 4.477889725684747e-10
have O 0 2.1358149623895706e-11
been O 0 7.18315615322318e-11
identified O 0 1.7097832039070227e-09
in O 0 2.0322341032219526e-10
patients O 0 1.037178454232901e-09
with O 0 1.3952088616375757e-11
XLDCM B-Disease 0 4.5192478864919394e-05
, O 0 9.191849364986737e-11
but O 0 7.036218135914041e-11
a O 0 4.338081283083994e-11
pathogenic O 0 8.971430709436845e-09
correlation O 0 1.0649322534916905e-09
of O 0 2.8688050199288107e-12
these O 0 1.917400960227411e-11
cardiospecific O 0 8.699693410108011e-08
mutations O 0 8.955962016443664e-08
in O 0 3.7025742471996637e-08
DMD O 1 1.0
with O 0 2.792108211302491e-10
the O 0 7.864743856167422e-10
XLDCM B-Disease 0 0.0021645021624863148
phenotype O 0 5.757067265221849e-05
has O 0 1.0914478210111156e-08
remained O 0 1.1202631355899939e-07
to O 0 4.138462836311696e-11
be O 0 2.4883450855384126e-10
elucidated O 0 4.2143174283637563e-08
. O 0 4.579115975289483e-10

We O 0 3.0689680130535635e-08
report O 0 7.752077868516949e-10
here O 0 1.8306649599009184e-11
the O 0 4.4286013116227874e-13
identification O 0 1.7950477909645102e-11
of O 0 1.202500962303385e-13
a O 0 4.794476447800289e-12
unique O 0 2.555733923104153e-11
de O 0 3.733407893946605e-08
novo O 0 5.152811013431347e-07
L1 O 0 6.702238692923856e-07
insertion O 0 1.0787814197499301e-08
in O 0 4.198572045588378e-10
the O 0 1.1201248956149712e-10
muscle O 0 2.2672095312259444e-08
exon O 0 4.032866840475435e-08
1 O 0 2.664412468433852e-09
in O 0 3.567437829588016e-07
DMD O 1 1.0
in O 0 2.5978819095939798e-08
three O 0 4.061517511200208e-10
XLDCM B-Disease 0 6.683519131911453e-06
patients O 0 1.3736746851122916e-08
from O 0 1.9931997025102177e-11
two O 0 1.3789016803378296e-11
unrelated O 0 1.1430504320841806e-09
Japanese O 0 2.2796196930130463e-08
families O 0 2.2233385965630958e-10
. O 0 5.483349330148712e-10

The O 0 3.770748158160586e-09
insertion O 0 3.374126933408661e-08
was O 0 6.073109659610054e-08
a O 0 1.0425111468537196e-10
5 O 0 2.0814272527758249e-10
- O 0 4.942149356423897e-09
truncated O 0 1.8450001526559845e-09
form O 0 2.258958436973657e-10
of O 0 4.0473614043579076e-12
human O 0 6.612740216516144e-11
L1 O 0 1.029966085752676e-07
inversely O 0 1.7036471122722219e-09
integrated O 0 4.448692081382433e-09
in O 0 7.601878015961461e-10
the O 0 7.594946199729335e-11
5 O 0 1.229281343384514e-09
- O 0 1.3593893299912452e-07
untranslated O 0 1.390383545185614e-06
region O 0 9.001529299723643e-09
in O 0 1.3411107779859321e-09
the O 0 1.1564840751709937e-10
muscle O 0 8.003179452487075e-09
exon O 0 2.676882049357232e-09
1 O 0 1.105201485884777e-10
, O 0 3.788997761378088e-12
which O 0 1.0255608211620637e-12
affected O 0 1.6221544940631105e-11
the O 0 1.882312881951176e-12
transcription O 0 5.576821782149466e-10
or O 0 3.909334661544861e-11
the O 0 9.510506097931692e-12
stability O 0 8.103304138806777e-11
of O 0 1.2335747386679058e-13
the O 0 4.431950032662835e-12
muscle O 0 4.2091882757056e-10
form O 0 5.132062830259798e-11
of O 0 3.294073347426263e-12
dystrophin O 0 1.226274992660592e-08
transcripts O 0 2.1259987548205572e-08
but O 0 3.327684794385277e-10
not O 0 8.442701399102859e-12
that O 0 4.0300962979127053e-13
of O 0 8.608322659298812e-14
the O 0 7.504254162515878e-12
brain O 0 2.339490912106612e-08
or O 0 1.3577056146019117e-10
Purkinje O 0 1.2029558682513652e-08
cell O 0 4.207595338812098e-07
form O 0 3.455631514270863e-08
, O 0 7.824394465671958e-09
probably O 0 3.6071155591343995e-06
due O 0 3.849124352583999e-10
to O 0 5.9014694173131765e-12
its O 0 1.8354014055116386e-12
unique O 0 9.220079560945393e-12
site O 0 2.0540726064499637e-10
of O 0 5.855521796604979e-12
integration O 0 2.8241762262126713e-09
. O 0 5.702237571014734e-10

We O 0 1.524567316835146e-08
speculate O 0 7.833234505483233e-09
that O 0 2.3927966812803403e-12
this O 0 1.667839450531991e-13
insertion O 0 1.3431317689993616e-11
of O 0 7.274895204474607e-13
an O 0 5.953543647657655e-12
L1 O 0 1.6501090271958674e-07
sequence O 0 2.9529714784537475e-10
in O 0 3.951162739213032e-07
DMD O 1 1.0
is O 0 2.0349102958228116e-10
responsible O 0 7.311874196391788e-12
for O 0 7.884843494267157e-13
some O 0 1.3951869173856046e-12
of O 0 6.621742406785411e-14
the O 0 3.7621774727665536e-13
population O 0 7.9450138688094e-14
of O 0 1.0225074096887471e-13
Japanese O 0 9.72016911404694e-10
patients O 0 9.292362712631785e-11
with O 0 6.355017640596872e-12
XLDCM B-Disease 0 4.287885531084612e-06
. O 0 2.9907223919600767e-10
. O 0 1.3478268501287971e-09

Severe O 1 0.9246902465820312
early O 0 0.04861714318394661
- O 1 0.9999970197677612
onset O 1 0.9999884366989136
obesity B-Disease 1 1.0
, O 0 1.5481764421565458e-06
adrenal B-Disease 1 0.9999997615814209
insufficiency I-Disease 1 1.0
and O 0 2.3354523648322356e-07
red O 0 9.419477464689407e-06
hair O 1 1.0
pigmentation O 1 0.9768733978271484
caused O 0 2.1788102344544313e-07
by O 0 8.223039471566551e-10
POMC O 0 6.0836595366708934e-05
mutations O 0 2.5314034246548545e-07
in O 0 1.8480078578519965e-09
humans O 0 1.6565886440389477e-08
. O 0 4.174411483148788e-09

Sequential O 0 5.641897473651625e-07
cleavage O 0 8.432576805716963e-07
of O 0 2.3190067921508017e-11
the O 0 3.724524161308196e-12
precursor O 0 4.235127526452942e-10
protein O 0 1.4659237157488292e-09
pre O 0 3.952173130983283e-07
- O 0 6.171883910610632e-07
pro O 0 4.4245183516977704e-07
- O 0 5.783766482636565e-06
opiomelanocortin O 0 2.310825720996945e-06
( O 0 5.070514563776385e-10
POMC O 0 2.825008209583757e-07
) O 0 5.3626422746866353e-11
generates O 0 2.0932754141167464e-10
the O 0 8.863689643368033e-11
melanocortin O 0 3.511182171678229e-07
peptides O 0 3.391134129060447e-08
adrenocorticotrophin O 0 3.0765701808377344e-07
( O 0 1.1805951771748369e-09
ACTH O 0 7.362254450526962e-08
) O 0 6.001065616656476e-11
, O 0 2.3377209890096395e-11
melanocyte O 0 5.90820491197519e-07
- O 0 2.092983777401969e-06
stimulating O 0 3.363875293871388e-07
hormones O 0 2.756152461813599e-08
( O 0 9.87481624248332e-11
MSH O 0 1.8630257159202301e-07
) O 0 6.2438079879989505e-12
alpha O 0 1.5901056513167866e-11
, O 0 4.733251009018946e-13
beta O 0 4.912875661844396e-12
and O 0 8.448270295141613e-13
gamma O 0 4.513978166947874e-12
as O 0 2.486212624663864e-12
well O 0 1.7088254639432976e-12
as O 0 2.5034558844352905e-13
the O 0 1.0635904049843825e-13
opioid O 0 3.3231799256849825e-11
- O 0 6.69962835209148e-11
receptor O 0 1.2295221785141308e-10
ligand O 0 2.088746064998759e-09
beta O 0 3.5139887444302076e-08
- O 0 4.4414204580789374e-07
endorphin O 0 2.093999501084909e-05
. O 0 1.3383797181631962e-08

While O 0 1.7839916210959927e-08
a O 0 2.964336831556835e-10
few O 0 2.0041875103959939e-10
cases O 0 6.802484270318487e-11
of O 0 1.7324884582503586e-11
isolated O 0 0.0018103368347510695
ACTH B-Disease 1 0.9679644107818604
deficiency I-Disease 0 0.0028073538560420275
have O 0 1.0345758277852113e-10
been O 0 4.1202788403360557e-10
reported O 0 3.727146946630455e-08
( O 0 4.2864720106727816e-10
OMIM O 0 3.3126088965218514e-06
201400 O 0 2.8724683076575275e-08
) O 0 3.724078684319565e-11
, O 0 6.844975974917844e-12
an O 0 3.019908628720813e-11
inherited O 0 0.0013778783613815904
POMC O 1 0.9220313429832458
defect O 0 0.0020469529554247856
has O 0 1.004202765386708e-08
not O 0 5.187561491482029e-10
been O 0 2.4486237482079787e-09
described O 0 3.915726409786657e-09
so O 0 7.040705796157454e-10
far O 0 9.569343095705563e-10
. O 0 6.464193624822201e-10

Recent O 0 4.793187713403313e-08
studies O 0 8.312154520240256e-09
in O 0 1.6775535127688812e-10
animal O 0 3.343845478287477e-10
models O 0 4.27718038764624e-09
elucidated O 0 1.4580468388203371e-08
a O 0 6.398758606307453e-11
central O 0 1.1646744679794097e-10
role O 0 7.082725378415589e-11
of O 0 2.1150496718608247e-12
alpha O 0 8.889598501760076e-10
- O 0 1.193487442208152e-08
MSH O 0 3.0646392588096205e-06
in O 0 3.1206495720859095e-10
the O 0 1.478011463218465e-11
regulation O 0 5.94680860110941e-10
of O 0 3.936161021688561e-13
food O 0 6.882929122487003e-12
intake O 0 1.9421833932775634e-11
by O 0 7.613068161993475e-13
activation O 0 3.235109749533116e-11
of O 0 1.311131975559321e-12
the O 0 1.3458865966153866e-10
brain O 0 1.8060406148379116e-07
melanocortin O 0 4.504410640038259e-07
- O 0 5.1996622119077074e-08
4 O 0 1.2410014127439695e-09
- O 0 7.952554170742587e-09
receptor O 0 2.9265243561837906e-09
( O 0 4.180305268608464e-10
MC4 O 0 2.089473491651006e-05
- O 0 4.6110494622553233e-07
R O 0 1.0957613767459407e-06
; O 0 2.3034553431333649e-10
refs O 0 3.6929193925061554e-07
3 O 0 1.4507919310347006e-09
- O 0 4.550111043499783e-08
5 O 0 8.549690816428424e-11
) O 0 2.8526050879079667e-12
and O 0 1.6928386860695643e-12
the O 0 9.079208738993483e-13
linkage O 0 1.0854018794859144e-09
of O 0 1.3418532777975667e-12
human O 0 4.2133330158122817e-10
obesity B-Disease 1 1.0
to O 0 9.10314670865553e-11
chromosome O 0 9.959855873376e-08
2 O 0 1.3718666480588837e-10
in O 0 3.6299987321575244e-11
close O 0 6.713715694495193e-10
proximity O 0 5.241178047121764e-10
to O 0 3.940890322406965e-11
the O 0 1.0088303109556662e-10
POMC O 0 9.89198412071346e-08
locus O 0 5.118164780881784e-10
, O 0 1.7544557820436957e-11
led O 0 3.0299463025379447e-12
to O 0 4.045323971635373e-12
the O 0 1.0185609300439324e-11
proposal O 0 4.2783201981144714e-10
of O 0 1.3791482062278093e-12
an O 0 5.7226393762599415e-12
association O 0 2.3614726493703664e-11
of O 0 3.2024838510225084e-12
POMC O 0 2.5197269337695616e-07
with O 0 4.810260523235854e-11
human O 0 1.906790991768048e-08
obesity B-Disease 1 1.0
. O 0 2.732055293108715e-08

The O 0 1.9220602887060068e-09
dual O 0 8.481094049272997e-09
role O 0 4.236719031158742e-10
of O 0 2.5541875472295805e-12
alpha O 0 1.812277994339695e-09
- O 0 4.974818779146517e-08
MSH O 0 3.741153477676562e-06
in O 0 1.5982433432260024e-10
regulating O 0 8.913554894185438e-10
food O 0 3.790099900591315e-10
intake O 0 1.0321244969802024e-09
and O 0 6.431452592714493e-11
influencing O 0 3.143520999060456e-08
hair O 1 0.996070384979248
pigmentation O 0 0.0002452607441227883
predicts O 0 1.1352935302966216e-07
that O 0 7.688589348520125e-12
the O 0 9.042436938111464e-12
phenotype O 0 6.633388949239816e-09
associated O 0 2.555189115849288e-10
with O 0 2.6589164897616868e-11
a O 0 8.31080715357757e-09
defect O 0 7.469591764674988e-06
in O 0 2.8399982365812093e-09
POMC O 0 1.4724937500432134e-06
function O 0 4.3259951176821687e-10
would O 0 1.5258021235364794e-10
include O 0 3.5100997108905574e-10
obesity B-Disease 1 1.0
, O 0 7.983919636522785e-10
alteration O 0 7.384135756183241e-07
in O 0 3.275913513789419e-07
pigmentation O 1 0.9772188663482666
and O 0 3.2067564461613074e-05
ACTH B-Disease 0 0.009108586236834526
deficiency I-Disease 0 0.0012902200687676668
. O 0 7.183698524926285e-09

The O 0 1.7425715315155799e-09
observation O 0 7.387979117368104e-09
of O 0 3.761117719353058e-12
these O 0 3.076783827715701e-10
symptoms O 0 1.3443991520034615e-07
in O 0 3.0011107488014943e-10
two O 0 4.0231040721039335e-11
probands O 0 1.9138706619514778e-08
prompted O 0 6.384899831068935e-10
us O 0 2.3204237142859796e-10
to O 0 6.496075812684188e-12
search O 0 7.598220663762589e-11
for O 0 2.175174320176443e-12
mutations O 0 1.825383455500429e-10
within O 0 2.0655475593822636e-11
their O 0 1.1245561426509454e-10
POMC O 0 1.18346565614047e-06
genes O 0 9.383458632328256e-08
. O 0 9.841262915699645e-09

Patient O 0 0.0009224499808624387
1 O 0 1.3841342294540482e-08
was O 0 1.748818867497448e-08
found O 0 7.543046742775061e-11
to O 0 6.348762661423368e-13
be O 0 4.436872744206788e-12
a O 0 4.676788470381332e-12
compound O 0 3.2608701849845545e-10
heterozygote O 0 2.5905670941739345e-09
for O 0 3.592225692253259e-12
two O 0 8.666755507702462e-11
mutations O 0 3.2931108950862154e-09
in O 0 6.058664681063419e-10
exon O 0 3.904228762507955e-08
3 O 0 2.647583485781979e-09
( O 0 7.806978952196175e-10
G7013T O 0 7.445600402888886e-08
, O 0 1.5910227302295965e-10
C7133delta O 0 1.3847205160288922e-08
) O 0 6.944299735939241e-12
which O 0 3.1933832748270996e-12
interfere O 0 5.7703314348955814e-11
with O 0 1.417341721418608e-12
appropriate O 0 6.144899866722398e-11
synthesis O 0 1.6640416822255588e-10
of O 0 7.1165217815916115e-12
ACTH O 0 2.3550891015133857e-08
and O 0 1.4512036017322316e-10
alpha O 0 1.2142328920106138e-08
- O 0 2.903472591242462e-07
MSH O 0 6.0249207308515906e-05
. O 0 9.040794779480166e-09

Patient O 0 0.0016652593621984124
2 O 0 1.0601742594928965e-08
was O 0 1.2536964799636507e-09
homozygous O 0 6.956529796653399e-10
for O 0 2.8742930344854978e-12
a O 0 9.91864645971674e-11
mutation O 0 5.2495243707539885e-09
in O 0 2.5486242005712256e-09
exon O 0 6.34008969768729e-08
2 O 0 9.257274058427356e-09
( O 0 1.158838469628165e-09
C3804A O 0 1.2439151930720982e-07
) O 0 1.5080491022612108e-10
which O 0 4.147979737467722e-10
abolishes O 0 6.493561386378133e-07
POMC O 0 1.7273461708100513e-05
translation O 0 1.2233218740220764e-06
. O 0 2.577841939910286e-08

These O 0 5.648977396965904e-10
findings O 0 2.2820013934055083e-10
represent O 0 9.140235443516609e-12
the O 0 1.926391988635312e-12
first O 0 3.342235342651545e-12
examples O 0 2.3609862329077025e-11
of O 0 1.1364227701232688e-12
a O 0 3.114634949952233e-08
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 2.325315079376722e-10
the O 0 1.588087994441878e-10
POMC O 0 2.596361525775137e-07
gene O 0 4.7969805905268e-09
and O 0 7.849768751677644e-11
define O 0 1.130099902546533e-09
a O 0 7.989677808240003e-10
new O 0 4.932405772706261e-07
monogenic B-Disease 1 0.999946117401123
endocrine I-Disease 1 0.9955065250396729
disorder I-Disease 0 0.006380752194672823
resulting O 0 2.6311919310018084e-09
in O 0 3.4457308117907814e-09
early O 0 0.28419387340545654
- O 1 0.9999986886978149
onset O 1 0.9999969005584717
obesity B-Disease 1 1.0
, O 0 3.48998742083495e-06
adrenal B-Disease 1 0.9999997615814209
insufficiency I-Disease 1 1.0
and O 0 9.530335631779963e-08
red O 0 1.6416249764006352e-06
hair O 1 0.9999946355819702
pigmentation O 0 0.002228964352980256
. O 0 2.8075215485756644e-09
. O 0 2.273418120424253e-09

A O 0 2.465529576056724e-07
European O 0 1.135522040840442e-07
multicenter O 0 3.9082266312107095e-07
study O 0 9.085220575855146e-09
of O 0 1.2668649240765717e-08
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 4.324322677717873e-09
classification O 0 4.989278767908445e-09
of O 0 3.833909318490258e-12
105 O 0 7.927264178420046e-09
mutations O 0 4.2608565564705714e-08
and O 0 2.794527109717393e-10
a O 0 2.320626156515626e-11
general O 0 8.101754510325687e-12
system O 0 1.2151282757777437e-10
for O 0 1.560873999495449e-11
genotype O 0 1.5489162308313098e-07
- O 0 2.0036086567642997e-08
based O 0 3.875536336295227e-09
prediction O 0 2.6205358949482616e-07
of O 0 1.595937410003856e-10
metabolic O 0 8.724685358174611e-06
phenotype O 0 3.986377123510465e-06
. O 0 3.1243153841842286e-08

Phenylketonuria B-Disease 1 0.999897837638855
( O 0 1.7000314983306453e-05
PKU B-Disease 0 0.3867277204990387
) O 0 2.4914013962984427e-08
and O 0 2.808476295967921e-08
mild B-Disease 1 0.9999985694885254
hyperphenylalaninemia I-Disease 1 1.0
( O 0 0.2508697211742401
MHP B-Disease 1 1.0
) O 0 1.5872559933072239e-09
are O 0 7.48128170524609e-10
allelic B-Disease 0 9.447555385122541e-06
disorders I-Disease 1 0.9987154006958008
caused O 0 2.3236934598713788e-09
by O 0 2.9441629689763715e-11
mutations O 0 8.968984666068991e-09
in O 0 1.2700161755585526e-10
the O 0 4.593512376027675e-11
gene O 0 1.4042407769920828e-07
encoding O 0 1.3096195061734761e-06
phenylalanine O 0 0.00012887446791864932
hydroxylase O 0 0.0019952270667999983
( O 0 9.737006934074088e-08
PAH O 0 9.616494935471565e-06
) O 0 3.527558467553149e-09
. O 0 7.4451711462586445e-09

Previous O 0 3.520287705782721e-08
studies O 0 2.1395192284501263e-09
have O 0 4.622022556355354e-11
suggested O 0 1.0729402089015849e-10
that O 0 6.750055158918911e-13
the O 0 1.4526200338080275e-12
highly O 0 7.195145035332473e-10
variable O 0 6.431928056827019e-08
metabolic O 0 2.7660221348924097e-06
phenotypes O 0 1.7425116993763368e-07
of O 0 1.2809477922814949e-08
PAH B-Disease 1 0.9071077108383179
deficiency I-Disease 1 0.9109015464782715
correlate O 0 1.2338138731138315e-05
with O 0 1.4731215003394027e-07
PAH O 0 0.003777420846745372
genotypes O 0 9.528062946628779e-05
. O 0 7.819027558753078e-08

We O 0 1.4036831252894899e-08
identified O 0 3.4441081098179893e-09
both O 0 4.6195106767621397e-11
causative O 0 7.939720347849288e-08
mutations O 0 4.355930371957584e-08
in O 0 7.558348613656563e-09
686 O 0 9.738322432895075e-07
patients O 0 8.327787668349629e-07
from O 0 8.270101270468899e-10
seven O 0 8.386040195595967e-10
European O 0 4.651158125312804e-09
centers O 0 4.025410671459895e-09
. O 0 1.3640606422171686e-09

On O 0 2.9547660318485214e-08
the O 0 2.1046844822514288e-11
basis O 0 2.8694630005432487e-11
of O 0 1.4416228356472355e-13
the O 0 1.5761306105741002e-12
phenotypic O 0 9.382770116417305e-10
characteristics O 0 3.2043995235042644e-10
of O 0 9.752713393818002e-12
297 O 0 1.4481551957601368e-08
functionally O 0 1.333462478214642e-07
hemizygous O 0 9.64741843745287e-07
patients O 0 1.9851447063956584e-07
, O 0 1.2910022009759992e-11
105 O 0 9.282956348055649e-11
of O 0 6.83819971133981e-13
the O 0 1.0356730230365319e-11
mutations O 0 3.6342406861678e-10
were O 0 2.1887363033101792e-09
assigned O 0 7.246374333913508e-11
to O 0 3.1422078480836113e-12
one O 0 1.0598329505673298e-11
of O 0 7.892336957582291e-13
four O 0 1.3986861148451712e-11
arbitrary O 0 8.249840810492515e-10
phenotype O 0 3.124661418496544e-07
categories O 0 6.039863365003839e-08
. O 0 2.9436268977889313e-09

We O 0 5.162148042359149e-09
proposed O 0 6.204445290869387e-11
and O 0 2.767832664452019e-11
tested O 0 2.641624974319967e-10
a O 0 5.217712980426503e-12
simple O 0 2.0552393120709667e-11
model O 0 1.2236126001319292e-10
for O 0 1.864788271715989e-12
correlation O 0 4.234481099096854e-10
between O 0 2.372426421981544e-10
genotype O 0 1.0841842623676712e-07
and O 0 2.020723449680517e-10
phenotypic O 0 2.3802154913710183e-08
outcome O 0 1.5823026444650168e-08
. O 0 3.4501634882389e-09

The O 0 3.2135882843675745e-09
observed O 0 4.8557016185668544e-09
phenotype O 0 2.6908077188636526e-07
matched O 0 3.491700084623517e-08
the O 0 3.802167608535356e-11
predicted O 0 5.726134233441371e-08
phenotype O 0 5.4071435329206e-08
in O 0 1.1138299171875587e-09
79 O 0 3.7832492694178654e-08
% O 0 3.807443943459887e-11
of O 0 3.652330174408469e-13
the O 0 2.1115239765001625e-11
cases O 0 1.3352658978504905e-09
, O 0 9.588065064125573e-11
and O 0 7.276928365440583e-11
in O 0 1.7321521994517752e-10
only O 0 2.394738400635088e-11
5 O 0 1.841674816122074e-12
of O 0 3.8197616185516037e-13
184 O 0 6.562856508240955e-11
patients O 0 9.166576830921258e-09
was O 0 1.8948087543435577e-08
the O 0 1.2308612462597068e-11
observed O 0 8.721299793457149e-10
phenotype O 0 1.6663300073105347e-08
more O 0 4.326562372258813e-11
than O 0 1.3861902944944937e-11
one O 0 1.7397038670763365e-11
category O 0 1.2039238495020754e-09
away O 0 1.7285547992962336e-10
from O 0 8.146665286812294e-11
that O 0 1.293112422695586e-10
expected O 0 3.074028365190884e-09
. O 0 3.3827970979949384e-10

Among O 0 5.994641671946965e-09
the O 0 2.303902381373124e-11
seven O 0 1.4422787616985566e-11
contributing O 0 6.432565851505201e-12
centers O 0 5.2735239786105836e-11
, O 0 3.42750350670884e-12
the O 0 1.021145624655051e-12
proportion O 0 7.512535732390191e-11
of O 0 1.3531077300288352e-12
patients O 0 2.535125442904018e-10
for O 0 6.794749225075281e-13
whom O 0 9.892423685764484e-11
the O 0 5.853846487408054e-12
observed O 0 5.791813695310566e-10
phenotype O 0 1.5788478080480672e-08
did O 0 7.0455725698082006e-09
not O 0 5.399591190835551e-11
match O 0 8.332738943295226e-10
the O 0 1.3698395716355005e-11
predicted O 0 5.974372356831736e-07
phenotype O 0 5.030015017837286e-07
was O 0 1.1944648292683269e-07
4 O 0 3.5316699564802434e-10
% O 0 1.1754743844960558e-09
- O 0 2.2328340492094867e-06
23 O 0 4.220286342615509e-08
% O 0 9.269673362233277e-10
( O 0 1.860982146162371e-09
P O 0 0.442305326461792
< O 0 9.15578226567959e-08
. O 0 5.303766106856678e-11
0001 O 0 3.811547699683615e-08
) O 0 3.84734431813083e-12
, O 0 9.602733105212868e-13
suggesting O 0 2.614631289254987e-10
that O 0 7.089764105655538e-12
differences O 0 5.6844910722997355e-11
in O 0 6.390656667049077e-12
methods O 0 3.24119966976788e-11
used O 0 1.1669954065596233e-11
for O 0 2.1652438956382136e-12
mutation O 0 4.509843609667996e-10
detection O 0 5.359406696214819e-09
or O 0 2.1873729494359395e-08
phenotype O 0 2.7316132218402345e-06
classification O 0 5.085188377051963e-07
may O 0 9.036195081080223e-08
account O 0 3.13359685422121e-11
for O 0 5.814806644001413e-13
a O 0 6.159941046829376e-12
considerable O 0 6.769608484891165e-11
proportion O 0 2.5396857949999685e-09
of O 0 6.402228747148797e-10
genotype O 1 0.8469896912574768
- O 0 0.48796603083610535
phenotype O 0 6.384556763805449e-05
inconsistencies O 0 1.1967528735112865e-05
. O 0 2.2062069504613646e-08

Our O 0 6.287461662424221e-09
data O 0 1.8205791318948172e-09
indicate O 0 2.420561251437192e-10
that O 0 3.3817356467208404e-12
the O 0 6.175542716091442e-11
PAH O 0 1.245967155227845e-06
- O 0 1.8255285283430567e-07
mutation O 0 1.8049380656748326e-08
genotype O 0 4.857112116951612e-07
is O 0 3.521901173475506e-11
the O 0 1.2650078467374426e-12
main O 0 8.626020731039574e-11
determinant O 0 3.789964342360008e-09
of O 0 1.0408422040919518e-10
metabolic O 0 1.1729255675163586e-05
phenotype O 0 4.5729501607638667e-07
in O 0 3.4099938428511223e-09
most O 0 2.5108255474748375e-09
patients O 0 6.130181873231777e-07
with O 0 1.2255716796971683e-07
PAH B-Disease 1 0.9996911287307739
deficiency I-Disease 1 0.9986507296562195
. O 0 6.193552337663277e-08

In O 0 9.566519132420126e-09
the O 0 3.5813088605785026e-11
present O 0 5.806796449930873e-12
study O 0 9.737081800575975e-12
, O 0 2.052731032028965e-12
the O 0 1.8444976448983574e-12
classification O 0 6.127566509750437e-11
of O 0 1.7754168361167055e-12
105 O 0 2.9904175136152844e-08
PAH O 0 4.668549706821068e-07
mutations O 0 2.3455674735828325e-08
may O 0 1.2956831163535298e-09
allow O 0 3.662719433306094e-12
the O 0 3.944505312658553e-12
prediction O 0 1.1660131749025027e-09
of O 0 2.1378099214919982e-13
the O 0 1.4801188052970815e-11
biochemical O 0 1.7413073294392234e-07
phenotype O 0 1.8777021182359022e-07
in O 0 4.504541184502386e-09
> O 0 1.3417971622686764e-08
10 O 0 1.5764267669027276e-10
, O 0 1.7389208128992806e-11
000 O 0 1.702255975066791e-10
genotypes O 0 1.9895944447512193e-08
, O 0 7.311027477863163e-11
which O 0 1.5622923787983467e-10
may O 0 1.249738623698704e-08
be O 0 6.3298311904491644e-12
useful O 0 1.581793203364601e-11
for O 0 9.353950990512172e-13
the O 0 1.172835006196804e-11
management O 0 8.775546955774871e-10
of O 0 1.321935182846401e-11
hyperphenylalaninemia B-Disease 1 1.0
in O 0 8.164254694520423e-08
newborns O 0 1.0248489843434072e-06
. O 0 1.723446385604177e-09

Somatic O 0 3.2362990168621764e-05
instability O 0 1.8831192392099183e-06
of O 0 1.1106493502666126e-10
the O 0 7.010524799566653e-11
CTG O 0 4.897784720014897e-07
repeat O 0 1.6141756375986915e-08
in O 0 2.1603246969092993e-10
mice O 0 1.510903757662163e-08
transgenic O 0 5.47284084717603e-09
for O 0 2.3037793894786773e-11
the O 0 2.620903938321817e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 4.6202930548133736e-07
is O 0 4.855535085113161e-09
age O 0 1.9543364704333044e-09
dependent O 0 3.9714903588006223e-10
but O 0 7.446853550474586e-11
not O 0 5.673980382758792e-12
correlated O 0 1.112896580446332e-11
to O 0 8.000218326351116e-13
the O 0 3.466278696365177e-12
relative O 0 3.491616717976598e-10
intertissue O 0 1.619819656184518e-08
transcription O 0 3.6750360976611773e-08
levels O 0 2.019391320828845e-09
and O 0 3.902765333130276e-10
proliferative O 0 8.996708857011981e-06
capacities O 0 2.6332097036174673e-07
. O 0 6.9429457738579e-09

A O 0 4.046382287015149e-07
( O 0 7.905565979626772e-09
CTG O 0 3.4679959526329185e-07
) O 0 1.3676342003332564e-10
nexpansion O 0 3.231858158869727e-08
in O 0 3.869057019212363e-10
the O 0 1.4794478142565737e-10
3 O 0 1.2209235400462148e-08
- O 0 4.949736194248544e-06
untranslated O 0 5.009865344618447e-05
region O 0 1.025520219855025e-07
( O 0 6.909215977124461e-10
UTR O 0 3.0538213735553654e-08
) O 0 7.630109218059733e-12
of O 0 8.720454913735409e-13
the O 0 4.6258791241982067e-10
DM O 1 1.0
protein O 0 6.859928447511265e-08
kinase O 0 4.536519213615975e-07
gene O 0 1.0735230659975059e-07
( O 0 9.563523306610477e-10
DMPK O 0 3.1874995443104126e-07
) O 0 2.1629706706272067e-11
is O 0 3.6498252337091586e-12
responsible O 0 4.8927258078368396e-11
for O 0 7.153268949400271e-11
causing O 0 2.8272766940062866e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.00256671872921288
DM B-Disease 1 1.0
) O 0 2.5262657743496675e-08
. O 0 5.766794597406033e-09

Major O 0 6.473058533629228e-07
instability O 0 4.1233350202674046e-05
, O 0 1.1542765632199803e-09
with O 0 1.329592078797015e-11
very O 0 1.8855197958522751e-10
large O 0 4.180923402624659e-12
expansions O 0 9.991966143374498e-10
between O 0 4.1971450620570394e-11
generations O 0 7.11307887590884e-11
and O 0 7.002453478177628e-11
high O 0 4.2930747845559836e-10
levels O 0 2.5850856177900283e-11
of O 0 4.039785812728208e-13
somatic O 0 1.4314495144773787e-09
mosaicism O 0 4.642554429779011e-08
, O 0 2.0056548435953836e-11
is O 0 4.534464383837422e-12
observed O 0 2.365872948939529e-11
in O 0 8.808616613897868e-10
patients O 0 1.3420275557507466e-08
. O 0 8.536594209296311e-10

There O 0 1.0231967273455211e-08
is O 0 5.830438215559397e-11
a O 0 3.135970649825737e-11
good O 0 2.791587849770849e-09
correlation O 0 1.1676334343846406e-09
between O 0 4.964254562977999e-10
repeat O 0 3.8946193825495357e-08
size O 0 8.093206660397811e-10
( O 0 6.137204633382964e-11
at O 0 1.2909684432571567e-10
least O 0 1.3471649143448339e-11
in O 0 5.0144218638470406e-11
leucocytes O 0 1.5548502929618735e-08
) O 0 4.179248960789472e-12
, O 0 6.212636741859123e-12
clinical O 0 2.262637854855143e-09
severity O 0 4.587189295079952e-08
and O 0 2.176098634620871e-09
age O 0 2.819687372479507e-09
of O 0 1.9758108343870262e-11
onset O 0 9.749513907308938e-08
. O 0 1.4856810226504535e-09

The O 0 3.149252236767097e-08
trinucleotide O 0 3.3469710615463555e-05
repeat O 0 4.444421847438207e-06
instability O 0 1.0819077544965694e-07
mechanisms O 0 7.437634952367489e-09
involved O 0 2.604965798624903e-09
in O 0 6.249800890145707e-07
DM B-Disease 1 1.0
and O 0 4.158928201825063e-10
other O 0 2.0094073974186166e-11
human O 0 7.788551470433447e-10
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 4.128499764277649e-10
unknown O 0 2.0557365587592358e-08
. O 0 1.1130123489522248e-09

We O 0 2.9824882119555696e-08
studied O 0 3.2398446592196706e-08
somatic O 0 8.829415065747526e-08
instability O 0 6.34421182255096e-09
by O 0 1.1207697096782265e-11
measuring O 0 2.9107201093836466e-09
the O 0 5.645656858677128e-11
CTG O 0 4.799833845936519e-07
repeat O 0 4.4453695835500184e-08
length O 0 2.7028832505493483e-09
at O 0 5.22215881648691e-10
several O 0 9.000107950574154e-12
ages O 0 4.1932099459351946e-10
in O 0 1.9420342070586294e-12
various O 0 2.296342152888209e-12
tissues O 0 8.027617459660519e-11
of O 0 9.969866729062082e-13
transgenic O 0 1.0901869629265093e-08
mice O 0 5.378241141329454e-08
carrying O 0 2.4787907837442447e-10
a O 0 1.675519722965646e-10
( O 0 3.7646238904009977e-10
CTG O 0 2.480210241628811e-07
) O 0 4.0920589833293164e-11
55expansion O 0 1.105118307975772e-08
surrounded O 0 9.187257205001131e-11
by O 0 1.3012642179066614e-11
45 O 0 1.3008578936268833e-10
kb O 0 4.122238106418763e-09
of O 0 1.4980993875979287e-12
the O 0 4.8623327586483356e-11
human O 0 8.30266344564734e-09
DM B-Disease 1 1.0
region O 0 2.4883048510560002e-08
, O 0 1.5434721209461877e-11
using O 0 2.3370923252219455e-11
small O 0 1.3023655487387487e-09
- O 0 1.949477876905803e-07
pool O 0 2.9747729612950025e-08
PCR O 0 1.1270136610619375e-06
. O 0 2.6593556246012895e-09

These O 0 9.270239020864324e-10
mice O 0 6.999378854288807e-08
have O 0 1.1952032245854394e-11
been O 0 4.282765982133174e-12
shown O 0 3.361004183299876e-12
to O 0 4.793946056097509e-12
reproduce O 0 1.6332893926218617e-09
the O 0 1.403204549083048e-11
intergenerational O 0 4.073558157458024e-10
and O 0 1.4750685048414702e-11
somatic O 0 1.9350046009947164e-09
instability O 0 3.521622549129688e-09
of O 0 4.003282080833337e-13
the O 0 3.7715195549958835e-12
55 O 0 1.756227802074406e-10
CTG O 0 7.858873374289033e-08
repeat O 0 5.418228532505509e-09
suggesting O 0 1.7631124338279847e-09
that O 0 2.034000138456671e-12
surrounding O 0 9.656660237070125e-13
sequences O 0 5.097537322806822e-11
and O 0 2.6858189283718303e-11
the O 0 3.4228388352819383e-12
chromatin O 0 6.767623683678892e-10
environment O 0 1.258357862354842e-10
are O 0 1.639269774610097e-12
involved O 0 3.1189995031155604e-11
in O 0 2.9023364267466434e-10
instability O 0 1.105278535362686e-08
mechanisms O 0 1.899585200249021e-08
. O 0 2.438863333509289e-09

As O 0 1.0070780653848033e-08
observed O 0 3.1038621672863087e-10
in O 0 4.22954726797542e-11
some O 0 7.724553960884728e-13
of O 0 5.779244135117531e-14
the O 0 1.8556165718580653e-12
tissues O 0 9.480632945368939e-10
of O 0 5.055064145054189e-10
DM B-Disease 1 1.0
patients O 0 6.967198260099394e-06
, O 0 3.109815877033739e-11
there O 0 3.5688167698832984e-11
is O 0 5.0565051278039785e-12
a O 0 6.123862528184532e-11
tendency O 0 7.44799821816855e-09
for O 0 2.6799954616629762e-11
repeat O 0 2.619034988882163e-09
length O 0 3.8482142472595626e-10
and O 0 8.607548007688592e-11
somatic O 0 3.304600371123456e-09
mosaicism O 0 2.483184502466429e-08
to O 0 6.553621360871897e-12
increase O 0 2.2859819939768933e-11
with O 0 6.744074916575915e-12
the O 0 1.0631092534074682e-10
age O 0 1.419908968181005e-09
of O 0 5.27045204354315e-13
the O 0 4.630440475494879e-11
mouse O 0 3.5028341471843305e-07
. O 0 5.222848376007505e-09

Furthermore O 0 1.3092720507756894e-07
, O 0 8.735467349474391e-10
we O 0 2.3519792016757357e-11
observed O 0 5.2186683793808974e-12
no O 0 6.28953920195352e-12
correlation O 0 7.319859995913447e-11
between O 0 6.5103777403818786e-12
the O 0 4.878605765895605e-12
somatic O 0 1.4923902114105658e-08
mutation O 0 4.646425111332064e-08
rate O 0 3.394558234504075e-07
and O 0 2.2737291216490263e-10
tissue O 0 1.5515619011807757e-08
proliferation O 0 1.748069280438358e-07
capacity O 0 4.978252476917078e-09
. O 0 1.5626030469562124e-09

The O 0 3.554635474856127e-09
somatic O 0 3.2172886221815133e-07
mutation O 0 3.6096511735195236e-07
rates O 0 4.998644840270572e-07
in O 0 1.944110497587026e-11
different O 0 2.1561938432640426e-12
tissues O 0 1.3746849492068947e-10
were O 0 8.750208890795363e-10
also O 0 1.2284244801930022e-11
not O 0 3.222649144069001e-12
correlated O 0 7.022780360715908e-12
to O 0 1.5307706274433897e-12
the O 0 4.860976204890122e-12
relative O 0 3.497862555157383e-10
inter O 0 7.158929804518266e-08
- O 0 6.64680328554823e-08
tissue O 0 1.2819157291232841e-08
difference O 0 6.023774812291549e-10
in O 0 6.213610875827058e-11
transcriptional O 0 3.1226992103228213e-09
levels O 0 1.275903827036018e-10
of O 0 9.85053442352328e-14
the O 0 8.28126358719955e-13
three O 0 2.1229149081009036e-12
genes O 0 6.58969892541883e-11
( O 0 1.8343907989826214e-11
DMAHP O 0 5.618684895125625e-07
, O 0 7.622262820916603e-10
DMPK O 0 1.0182925507251639e-05
and O 0 8.969441855910532e-10
59 O 0 6.836358146244947e-10
) O 0 2.00112951383169e-12
surrounding O 0 1.3290292477652343e-11
the O 0 1.157786228001001e-10
repeat O 0 2.423885625546518e-08
. O 0 1.9783008564644433e-10
. O 0 3.1261779276370305e-10

A O 0 4.778819118200772e-08
novel O 0 1.6184051432333035e-08
missense O 0 1.0156903044844512e-05
mutation O 0 2.4901243023123243e-07
in O 0 5.932808910813492e-09
patients O 0 2.7863761076218907e-08
from O 0 8.951936414369754e-11
a O 0 1.172397845472517e-09
retinoblastoma B-Disease 0 2.41481393459253e-05
pedigree O 0 0.00038617145037278533
showing O 0 1.1208012438146397e-06
only O 0 3.662508518686991e-09
mild O 0 2.298245590282022e-06
expression O 0 1.4103432866008347e-09
of O 0 1.405031039430904e-11
the O 0 5.248280698921803e-10
tumor B-Disease 0 1.219550199493824e-06
phenotype O 0 2.685306299099466e-06
. O 0 2.2917133080113672e-08

We O 0 8.33207547401571e-09
have O 0 1.6352077678027932e-11
used O 0 1.115621223873875e-11
single O 0 4.065064604374946e-11
strand O 0 3.60396796850182e-08
conformation O 0 3.4035869678206154e-09
polymorphism O 0 1.2539027594016261e-08
analysis O 0 2.9710842119889946e-10
to O 0 6.088546767452074e-12
study O 0 3.443171789352384e-11
the O 0 2.5488161928266528e-11
27 O 0 3.159416617215527e-10
exons O 0 3.979300500223104e-10
of O 0 1.7534646694697398e-12
the O 0 2.549273118990225e-11
RB1 O 0 2.9463921080719047e-08
gene O 0 2.7041505146208067e-10
in O 0 3.498080991537478e-11
individuals O 0 2.700122677529171e-12
from O 0 2.0784826984532323e-11
a O 0 1.484785072669581e-10
family O 0 9.06620889473686e-10
showing O 0 4.175106482762203e-07
mild O 0 1.726891605358105e-05
expression O 0 2.9264852763333238e-09
of O 0 3.6272304604345607e-11
the O 0 6.493777737759387e-10
retinoblastoma B-Disease 0 9.509700248599984e-06
phenotype O 0 4.4641466956818476e-05
. O 0 4.056473557056961e-08

In O 0 1.838698793221738e-08
this O 0 4.5281660365770193e-11
family O 0 5.917116796538835e-11
affected O 0 2.1398599905908533e-11
individuals O 0 1.9702403770971433e-12
developed O 0 1.6088948839865225e-08
unilateral B-Disease 0 0.3576533794403076
tumors I-Disease 1 1.0
and O 0 1.892237122547158e-08
, O 0 1.0813094343531393e-11
as O 0 8.486324490353248e-12
a O 0 9.274774524781204e-12
result O 0 3.458501193764896e-11
of O 0 1.511085093858222e-12
linkage O 0 2.17535287561077e-08
analysis O 0 1.2486063294403493e-09
, O 0 7.410538155339097e-11
unaffected O 0 1.8211983032756507e-08
mutation O 0 9.772572751032271e-10
carriers O 0 1.1593425108813449e-09
were O 0 5.919332246584474e-10
also O 0 1.5492057289789862e-11
identified O 0 5.639501018950277e-11
within O 0 6.800950427821029e-12
the O 0 1.6783473222314882e-10
pedigree O 0 1.588780946804036e-06
. O 0 2.045043245857414e-09

A O 0 4.265369852873846e-07
single O 0 7.797592793679087e-09
band O 0 1.6061835195202434e-09
shift O 0 2.481421956801455e-09
using O 0 1.352758904893392e-09
SSCP O 0 1.6247321354967426e-06
was O 0 2.8579847377585565e-09
identified O 0 4.3515913095149017e-10
in O 0 3.514465454768079e-11
exon O 0 4.289213872965547e-09
21 O 0 4.573861012158176e-10
which O 0 8.183149470541995e-12
resulted O 0 2.9269402873621786e-11
in O 0 7.857947625922179e-11
a O 0 3.22906978933446e-10
missense O 0 1.6323921272487496e-06
mutation O 0 1.6485445897274076e-08
converting O 0 1.4118620050851405e-08
a O 0 8.320101052561313e-09
cys O 0 0.3873317837715149
- O 0 1.3211692930781282e-05
- O 0 1.1897437843799707e-06
> O 0 7.2003789597374634e-09
arg O 0 5.855128382137309e-09
at O 0 9.007772305835715e-11
nucleotide O 0 3.9039790844519473e-10
position O 0 1.207292710247998e-09
28 O 0 1.650827391452836e-10
in O 0 3.3482220468394885e-11
the O 0 6.159920490356185e-11
exon O 0 1.2142055538788554e-07
. O 0 5.144779713361913e-09

The O 0 4.505469330950973e-09
mutation O 0 3.9235036553009195e-08
destroyed O 0 1.2695863027545329e-08
an O 0 1.0011055179282025e-10
NdeI O 0 8.983763422065749e-08
restriction O 0 1.4170931983414903e-08
enzyme O 0 2.8694564946363244e-08
site O 0 1.31996946706181e-08
. O 0 5.0936845852334045e-09

Analysis O 0 1.209060851437016e-08
of O 0 2.412287036790417e-11
all O 0 1.1688755865990608e-11
family O 0 8.050045005592033e-12
members O 0 1.578521384784648e-13
demonstrated O 0 6.710047014552023e-12
that O 0 9.566609657229996e-13
the O 0 3.872257549331071e-12
missense O 0 4.107211850623571e-07
mutation O 0 3.177701657364196e-08
co O 0 7.791364851073013e-07
- O 0 1.929481641127495e-07
segregated O 0 9.505261466813408e-09
with O 0 5.116210233246932e-11
patients O 0 3.9417155761611866e-08
with O 0 2.7710789218815535e-09
tumors B-Disease 1 1.0
or O 0 3.3295980301772943e-06
who O 0 1.5738062586478918e-07
, O 0 2.275958067843309e-11
as O 0 4.0531418499245575e-11
a O 0 5.4914475744460844e-11
result O 0 1.7514942274310386e-10
of O 0 1.8978648947537424e-12
linkage O 0 2.4687242472509752e-08
analysis O 0 1.696704221565426e-09
had O 0 2.6880789505412395e-07
been O 0 2.952364797081941e-09
predicted O 0 6.498957483280776e-10
to O 0 1.2148211039550438e-12
carry O 0 9.644705173394996e-11
the O 0 9.607799972277675e-11
predisposing O 0 2.912222214490612e-07
mutation O 0 1.4315162388811586e-07
. O 0 6.115977946308249e-09

These O 0 1.780818825736219e-09
observations O 0 2.146844702011208e-09
point O 0 8.529400519208252e-10
to O 0 4.3466927106272646e-12
another O 0 1.0126662529363895e-11
region O 0 7.332743440224831e-11
of O 0 1.761193946757389e-12
the O 0 2.00591505211678e-11
RB1 O 0 1.1050550696722894e-08
gene O 0 2.6790669682696944e-10
where O 0 1.3940171933457535e-11
mutations O 0 5.620443555010013e-10
only O 0 1.8211607569207366e-11
modify O 0 7.326149131792192e-10
the O 0 7.732430147566749e-12
function O 0 4.783003854091916e-12
of O 0 3.463336117458943e-13
the O 0 5.4301181606764004e-12
gene O 0 2.289278766554048e-09
and O 0 5.006521308636991e-10
raise O 0 6.907315691639937e-11
important O 0 4.448059628958667e-11
questions O 0 8.198792339486616e-11
for O 0 1.0874288665710385e-12
genetic O 0 1.5686292265115753e-09
counseling O 0 7.613577324150356e-09
in O 0 1.4936159253853276e-10
families O 0 3.141400334305544e-11
with O 0 4.055846804240648e-12
these O 0 6.521105877510536e-11
distinctive O 0 2.8235852767011238e-08
phenotypes O 0 2.5403313230754065e-08
. O 0 2.6333996094862755e-10
. O 0 2.182824587748655e-09

Maternal B-Disease 0 0.0002589231007732451
disomy I-Disease 0 0.00233001378364861
and O 0 0.00031579466303810477
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 6.446654197134194e-07
with O 0 1.8025142489719315e-10
gamete O 0 1.396574731415967e-07
complementation O 0 1.0137374374608044e-05
in O 0 8.218993818864817e-10
a O 0 2.6483901183205205e-10
case O 0 1.519622538914689e-09
of O 0 1.1486421189199625e-11
familial O 0 1.7632094113650965e-06
translocation O 0 9.830438330027391e-07
( O 0 9.582005411346017e-09
3 O 0 2.1381121317887164e-09
; O 0 2.943344734607223e-10
15 O 0 7.466228191255198e-10
) O 0 4.9029742071882154e-11
( O 0 7.465626727931607e-11
p25 O 0 4.033898193256391e-08
; O 0 6.557451109889811e-11
q11 O 0 4.169209333326762e-08
. O 0 2.1286583606894283e-10
2 O 0 2.4505567020050023e-10
) O 0 1.2762543799560433e-10
. O 0 7.03108404831454e-10

Maternal B-Disease 0 0.009388974867761135
uniparental I-Disease 1 0.8895854949951172
disomy I-Disease 0 0.4601961076259613
( I-Disease 0 2.1208404632488964e-06
UPD I-Disease 1 0.9999997615814209
) I-Disease 0 2.3135031390619787e-10
for I-Disease 0 1.4574107545795023e-11
chromosome I-Disease 0 8.937633424466185e-07
15 I-Disease 0 2.6061188762582788e-09
is O 0 1.1456948237342779e-11
responsible O 0 8.088444844456255e-12
for O 0 6.567557912437461e-13
an O 0 7.765591555214391e-13
estimated O 0 2.564694290274616e-11
30 O 0 5.6412652327253454e-11
% O 0 6.1691589336998476e-12
of O 0 7.833368285622977e-13
cases O 0 8.723944899813318e-10
of O 0 4.6322583102664794e-07
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.7700450573320268e-06
PWS B-Disease 1 1.0
) O 0 2.856514491611506e-08
. O 0 1.4959296024130708e-08

We O 0 2.731732173799628e-08
report O 0 1.12691000975218e-09
on O 0 2.696737451401976e-11
an O 0 1.1728473552595486e-13
unusual O 0 1.2156375732430558e-11
case O 0 1.625897194657e-10
of O 0 2.4263830961795962e-12
maternal B-Disease 0 1.4236412049228875e-08
disomy I-Disease 0 4.881994755123742e-07
15 I-Disease 0 1.5085849236484705e-09
in O 0 1.3151018052326435e-08
PWS B-Disease 1 1.0
that O 0 9.454916849449546e-10
is O 0 8.215976510239642e-12
most O 0 4.556789841292375e-12
consistent O 0 3.211674814984633e-10
with O 0 2.672398977457413e-12
adjacent O 0 5.609893660718512e-10
- O 0 2.2349593109538546e-07
1 O 0 2.9986849114926883e-10
segregation O 0 1.090535772796386e-09
of O 0 8.687004024107714e-13
a O 0 1.6007724312760985e-10
paternal O 0 1.734162651700899e-06
t O 0 3.128775642835535e-05
( O 0 6.23926632581373e-10
3 O 0 3.248931679245004e-10
; O 0 4.285366506096011e-11
15 O 0 3.933675329914621e-10
) O 0 1.7326536039252716e-11
( O 0 3.3705843671683056e-11
p25 O 0 2.7098224109067814e-08
; O 0 1.1429887591951626e-10
q11 O 0 1.3097498197112145e-08
. O 0 2.1862308838271893e-11
2 O 0 1.2946813759961984e-11
) O 0 9.746330261947711e-13
with O 0 1.122806166618806e-12
simultaneous O 0 2.714885649623966e-09
maternal O 0 2.5723514340825204e-07
meiotic O 0 1.1261755616942537e-06
nondisjunction O 0 4.280047107840801e-07
for O 0 2.6053920132440567e-10
chromosome O 0 2.3216207409859635e-06
15 O 0 2.4843403778618267e-08
. O 0 4.028344768869374e-09

The O 0 1.0399501704227987e-08
patient O 0 1.1517016673678881e-06
( O 0 2.766663786957224e-09
J O 0 5.1792143494822085e-05
. O 0 1.1503110963761998e-10
B O 0 1.3132736853549432e-07
. O 0 5.505182681248e-12
) O 0 1.922435084386609e-12
, O 0 1.6948546515890839e-12
a O 0 3.476994386852894e-11
17 O 0 5.312721818029331e-09
- O 0 3.290651306997461e-08
year O 0 2.7136810132333267e-08
- O 0 3.673705180062825e-07
old O 0 2.4009357275645016e-06
white O 0 1.250114678441605e-09
male O 0 7.605140961430834e-10
with O 0 1.6711951267289749e-10
PWS B-Disease 1 1.0
, O 0 5.443127060189568e-10
was O 0 7.226506504309782e-09
found O 0 3.3043887071038114e-11
to O 0 1.0950446278912285e-12
have O 0 1.3836438939041074e-11
47 O 0 4.55832177559401e-11
chromosomes O 0 9.371676351621616e-11
with O 0 3.111802048677559e-12
a O 0 2.181584468630149e-09
supernumerary O 0 0.04726521298289299
, O 0 2.8072215663144107e-09
paternal O 0 1.4923373782949056e-05
der O 1 0.9930347204208374
( O 0 1.4237925283211439e-09
15 O 0 1.2044905350894197e-10
) O 0 8.326752373548352e-13
consisting O 0 9.047504499065662e-13
of O 0 2.1014262378826754e-12
the O 0 8.063315015682804e-10
short O 0 6.896194463479333e-06
arm O 1 0.9425451755523682
and O 0 3.7097687144438396e-09
the O 0 4.609591180981809e-11
proximal O 0 1.419414701331334e-07
long O 0 1.2915194247398176e-07
arm O 0 8.87725836946629e-05
of O 0 4.600281267030937e-11
chromosome O 0 4.312902092351578e-06
15 O 0 1.1686098311258775e-08
, O 0 3.354232169794358e-10
and O 0 1.084133671724885e-09
distal O 0 1.310866809944855e-05
chromosome O 1 0.5798003673553467
arm O 1 0.9975665807723999
3p O 0 0.006339227315038443
. O 0 1.2742373201035662e-07

The O 0 5.996586338596899e-09
t O 0 1.6966488374237088e-06
( O 0 2.863876635839091e-10
3 O 0 5.8200607527814086e-11
; O 0 6.223785375958357e-12
15 O 0 2.1822398055260095e-11
) O 0 1.6838991138967696e-12
was O 0 1.1672036670518082e-09
present O 0 6.179707353476394e-13
in O 0 4.1791552857217695e-11
the O 0 1.9964173543496333e-12
balanced O 0 1.498503231223136e-11
state O 0 7.693939344140255e-13
in O 0 7.555098213707367e-11
the O 0 6.846402611504487e-11
patients O 0 2.1356625357071835e-09
father O 0 5.911411360415286e-10
and O 0 1.0460605298634462e-10
a O 0 2.3004795846048864e-09
sister O 0 1.1173049642820843e-05
. O 0 6.961443865804995e-09

Fluorescent O 0 1.4585776852982235e-06
in O 0 5.529690483285776e-09
situ O 0 7.629655129903767e-09
hybridization O 0 6.2844490722469e-10
analysis O 0 1.507655111865347e-10
demonstrated O 0 6.440782629457686e-11
that O 0 5.418943939405896e-12
the O 0 9.356459357290348e-11
PWS B-Disease 1 1.0
critical O 0 1.3789029917887774e-09
region O 0 1.3537655441098195e-09
resided O 0 1.1643913389036697e-08
on O 0 2.383165886854499e-10
the O 0 4.709030040905837e-12
derivative O 0 2.775765839402311e-09
chromosome O 0 9.474490525462897e-09
3 O 0 1.3774251184095476e-10
and O 0 4.0781735627382076e-11
that O 0 2.0342883627622044e-11
there O 0 2.1889065560110055e-10
was O 0 1.1031302982189573e-08
no O 0 6.147103659426278e-11
deletion O 0 3.64706598254827e-10
of O 0 2.040909758901921e-12
the O 0 9.260148203793506e-10
PWS B-Disease 1 1.0
region O 0 2.830017464816592e-08
on O 0 1.1687792067505143e-08
the O 0 9.742771867049527e-11
normal O 0 1.5084496984840712e-09
pair O 0 1.4765899614133104e-09
of O 0 3.2619742410672226e-12
15s O 0 2.047623182122038e-09
present O 0 3.1004997180783533e-11
in O 0 2.863714154699437e-09
J O 0 0.0019750932697206736
. O 0 3.4935903059363227e-09

B O 0 0.0017179559217765927
. O 0 3.2680904382687004e-07

Methylation O 0 7.510819273193192e-07
analysis O 0 2.1177708475761392e-08
at O 0 6.638359861810272e-10
exon O 0 4.91652007994503e-09
alpha O 0 1.1820461276457195e-09
of O 0 1.753330878921655e-12
the O 0 3.66738237000952e-12
small O 0 2.928924325296123e-10
nuclear O 0 2.11590986509691e-07
ribonucleoprotein O 0 3.0561575385945616e-06
- O 0 1.8405906132556993e-07
associated O 0 3.7530116792083845e-09
polypeptide O 0 8.42572944748099e-08
N O 0 3.738994891477887e-08
( O 0 8.933446343784013e-11
SNRPN O 0 2.7438208149987986e-08
) O 0 8.66065379134806e-12
gene O 0 8.825954966873439e-10
showed O 0 1.1181258585679643e-08
a O 0 3.2427593943396005e-10
pattern O 0 9.476952556042306e-08
characteristic O 0 3.378981316970453e-09
of O 0 1.2387204977037936e-11
only O 0 1.2833234475095878e-10
the O 0 1.4874013132271102e-10
maternal O 0 3.028842954222455e-08
chromosome O 0 8.786380476522027e-07
15 O 0 4.847946932784453e-09
in O 0 1.362095858326029e-08
J O 0 0.05864300578832626
. O 0 1.7786573991429577e-08

B O 0 0.0035879756323993206
. O 0 2.327922885569933e-07

Maternal B-Disease 0 0.001148350303992629
disomy I-Disease 0 0.0002667063963599503
was O 0 9.646668530649549e-08
confirmed O 0 4.760855043528522e-10
by O 0 1.1994686927724318e-12
polymerase O 0 1.4144839743934767e-09
chain O 0 8.300791165538612e-10
reaction O 0 8.907890397535922e-11
analysis O 0 7.758049064277017e-11
of O 0 1.3712843794505547e-12
microsatellite O 0 1.601397059403098e-08
repeats O 0 6.396605467529071e-09
at O 0 2.2252306941528133e-10
the O 0 5.3081250332709384e-12
gamma O 0 3.653326974273341e-09
- O 0 4.045378076966699e-08
aminobutyric O 0 8.48232772909796e-08
acid O 0 2.4748094684667876e-09
receptor O 0 1.6245775835699305e-09
beta3 O 0 4.073251602676464e-08
subunit O 0 3.250745095328966e-08
( O 0 7.32466753916583e-10
GABRB3 O 0 1.8739632423603325e-07
) O 0 2.1017329543404628e-10
locus O 0 3.07068965810231e-08
. O 0 5.610838460512468e-09

A O 0 2.1149618589788588e-07
niece O 0 2.3717562726233155e-05
( O 0 4.0364205311504975e-09
B O 0 1.7409935537671117e-07
. O 0 2.1463634689022904e-11
B O 0 6.241055228173309e-09
. O 0 6.722713748533171e-13
) O 0 4.3281591960604715e-13
with O 0 3.3586057112539036e-13
45 O 0 1.8734952825227857e-11
chromosomes O 0 1.4159920458389763e-10
and O 0 2.8464430465446888e-11
the O 0 5.14387881248024e-12
derivative O 0 2.447102964708847e-08
3 O 0 1.4588132091208905e-10
but O 0 2.1434802544018083e-10
without O 0 1.4746070683968604e-11
the O 0 1.462512229377655e-11
der O 0 8.340094063896686e-05
( O 0 2.5410109780188428e-11
15 O 0 1.1896356295892918e-11
) O 0 6.133898185385622e-13
demonstrated O 0 1.705732603773935e-11
a O 0 2.5888469146195803e-10
phenotype O 0 6.597404933472717e-08
consistent O 0 2.435466583960988e-08
with O 0 1.8026921969060972e-11
that O 0 2.1637960520570765e-11
reported O 0 9.202524076101781e-09
for O 0 1.0887888680921609e-11
haploinsufficiency O 0 1.1362315888163721e-07
of O 0 6.877565877916325e-11
distal O 0 1.7143678405773244e-06
3 O 0 4.2944879652395684e-08
p O 0 0.00010208001913269982
. O 0 1.52002339603996e-08

Uniparental B-Disease 1 0.9999995231628418
disomy I-Disease 1 0.9999992847442627
associated O 0 1.4012349538461422e-06
with O 0 5.25914556348539e-09
unbalanced O 0 0.0003761550469789654
segregation O 0 6.576625111165413e-08
of O 0 1.2929909747050328e-11
non O 0 2.6937751584910075e-08
- O 0 6.057232440070948e-07
Robertsonian O 0 1.624185586024396e-07
translocations O 0 5.142348072695313e-06
has O 0 1.7060858281681135e-09
been O 0 1.8404230917035136e-10
reported O 0 6.785253470198427e-10
previously O 0 1.3536254062085362e-10
but O 0 2.7062865837201855e-10
has O 0 6.406595306346352e-12
not O 0 4.424095638444481e-12
, O 0 2.1544864416828124e-13
to O 0 2.915615069255112e-13
our O 0 1.9604339852874464e-12
knowledge O 0 5.798993230055061e-12
, O 0 6.895329576414588e-13
been O 0 1.1459089753473872e-11
observed O 0 5.224405109915953e-12
in O 0 2.5357915420243238e-11
a O 0 8.565033404739353e-11
case O 0 1.5415788645611883e-09
of O 0 2.0006125922567009e-10
PWS B-Disease 1 0.9999998807907104
. O 0 2.5420666460718166e-08

Furthermore O 0 4.24431419787652e-07
, O 0 5.918564527362946e-10
our O 0 5.075611805849256e-11
findings O 0 2.683949937298813e-11
are O 0 2.7434751519173073e-12
best O 0 2.2855982731440072e-11
interpreted O 0 1.808775490497183e-10
as O 0 7.428889968463803e-12
true O 0 8.643478988101805e-11
gamete O 0 5.583784989937612e-09
complementation O 0 4.98685551519884e-07
resulting O 0 1.7389260031919207e-09
in O 0 1.953152484190923e-08
maternal B-Disease 0 0.0005369134014472365
UPD I-Disease 1 1.0
15 I-Disease 0 6.601759992008738e-07
and O 0 2.0630511698982446e-07
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9999282360076904
- I-Disease 1 0.9999998807907104
Jampel I-Disease 1 0.999994158744812
syndrome I-Disease 1 0.9999998807907104
type I-Disease 0 5.7246875257987995e-06
2 I-Disease 0 2.4034350065704757e-09
and O 0 1.220149981051577e-09
Stuve B-Disease 1 0.9978610873222351
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 3.955710758951625e-11
a O 0 4.1827600411048493e-11
case O 0 7.789635603216993e-10
for O 0 8.84331930600668e-12
" O 0 8.612512369943204e-10
lumping O 0 8.67440519414231e-09
" O 0 1.5592150903742663e-09
. O 0 4.686857568714231e-10

Recent O 0 4.953644605620866e-09
studies O 0 7.171852001164325e-10
demonstrated O 0 5.969363198188304e-11
the O 0 7.722477171623332e-13
existence O 0 6.6106061596959975e-12
of O 0 1.6132048767571877e-13
a O 0 1.1169008426459293e-11
genetically O 0 1.1140828259925684e-09
distinct O 0 5.854321472043011e-10
, O 0 9.796100736148006e-11
usually O 0 1.945616584508869e-11
lethal O 0 1.0616705431454321e-10
form O 0 3.477750379343725e-11
of O 0 2.938977403457721e-12
the O 0 9.911749199176256e-10
Schwartz B-Disease 1 0.9998455047607422
- I-Disease 1 0.9999997615814209
Jampel I-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
( O 0 6.106701988528584e-08
SJS B-Disease 1 0.9999839067459106
) O 0 1.2327909526543834e-10
of O 0 8.336756979199222e-11
myotonia B-Disease 1 0.851806640625
and O 0 1.1340365517753526e-06
skeletal B-Disease 1 0.9999921321868896
dysplasia I-Disease 1 1.0
, O 0 2.243026875348164e-09
which O 0 1.2774500901535646e-10
we O 0 1.797033077899357e-09
called O 0 1.199201093982083e-08
SJS B-Disease 1 0.999955415725708
type I-Disease 0 1.6137651073222514e-06
2 I-Disease 0 3.489075472984382e-09
. O 0 2.0909542985947382e-09

This O 0 1.9023468667000998e-07
disorder O 0 0.0027291206642985344
is O 0 1.0694158752988514e-10
reminiscent O 0 4.51726656081064e-09
of O 0 3.5012567931730354e-12
another O 0 1.9676960061332238e-10
rare O 0 9.450270788136095e-09
condition O 0 1.1436764907557517e-05
, O 0 1.9793753441854633e-11
the O 0 2.1261993554677616e-10
Stuve B-Disease 1 0.9988908171653748
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 5.966310254734708e-07
SWS B-Disease 1 0.8598303198814392
) O 0 1.8780936528184355e-10
, O 0 1.714677011488419e-11
which O 0 5.955724195066958e-12
comprises O 0 2.6841187258930255e-11
campomelia B-Disease 0 6.376690464549029e-08
at O 0 1.1313076031527203e-09
birth O 0 5.9605294033815426e-09
with O 0 5.318883111726791e-10
skeletal B-Disease 1 0.997866690158844
dysplasia I-Disease 1 1.0
, O 0 1.2021186712729559e-08
contractures B-Disease 0 0.00013984087854623795
, O 0 2.681890487465921e-09
and O 0 1.175633590477787e-09
early B-Disease 0 1.5716990446890122e-06
death I-Disease 0 7.494939779917331e-09
. O 0 8.893736302972854e-10

To O 0 2.6248561102448775e-09
test O 0 1.7744546942921602e-09
for O 0 2.445917383561702e-12
possible O 0 9.433512998535676e-11
nosologic O 0 1.8739632423603325e-07
identity O 0 7.219508102451755e-09
between O 0 1.2802681137458194e-09
these O 0 5.1811563928083615e-09
disorders O 0 0.00011159369751112536
, O 0 1.5339514380929842e-11
we O 0 5.6583990964975683e-11
reviewed O 0 8.911051063709152e-11
the O 0 6.372213412313144e-13
literature O 0 2.8876857502413422e-11
and O 0 2.8952454583092146e-12
obtained O 0 2.7666187049635305e-11
a O 0 3.037672891004206e-11
follow O 0 8.254027461518376e-10
- O 0 3.136232606948397e-08
up O 0 2.6922725160360983e-10
of O 0 2.813911484465109e-13
the O 0 1.2773563673809663e-12
only O 0 6.415252443853214e-12
two O 0 2.4127735399892547e-12
surviving O 0 6.415026843065164e-10
patients O 0 3.4069105869782845e-10
, O 0 1.2195013878932293e-12
one O 0 4.227721905197823e-12
with O 0 6.610747366186942e-11
SJS B-Disease 1 0.999998927116394
type I-Disease 0 6.01797455601627e-06
2 I-Disease 0 7.76520348022558e-10
at O 0 1.0092744417988797e-07
age O 0 1.1985014758408852e-08
10 O 0 2.325784009826748e-11
years O 0 3.3898744922211677e-11
and O 0 7.321671914584105e-12
another O 0 8.860320463432991e-12
with O 0 6.186200857127844e-11
SWS B-Disease 1 0.7244290113449097
at O 0 7.630255538515485e-08
age O 0 6.0307900895395505e-09
7 O 0 6.636751703759103e-10
years O 0 8.300031217878256e-10
. O 0 6.960843013104068e-10

Patients O 0 0.0004988006548956037
reported O 0 2.199552113779646e-07
as O 0 1.1088586299168313e-10
having O 0 3.646293822434643e-10
either O 0 1.295775859944115e-07
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 6.577878934876935e-07
SWS B-Disease 0 0.0024603630881756544
presented O 0 1.0752106982536702e-09
a O 0 1.1443281738854338e-10
combination O 0 3.009848592583353e-09
of O 0 8.784513914894543e-12
a O 0 9.478282603225807e-10
severe O 0 1.0051408935396466e-05
, O 0 3.3399460974692374e-09
prenatal O 1 0.9998815059661865
- O 1 0.9992722868919373
onset O 1 0.9983470439910889
neuromuscular B-Disease 1 0.9999996423721313
disorder I-Disease 1 0.9999984502792358
( O 0 8.359742231789369e-09
with O 0 1.7776127236857064e-08
congenital B-Disease 1 1.0
joint I-Disease 0 0.029628997668623924
contractures I-Disease 1 0.9999994039535522
, O 0 0.003035825677216053
respiratory O 1 0.9999998807907104
and O 0 1.3522540420751739e-08
feeding O 0 7.77140130026055e-09
difficulties O 0 8.51422754521991e-08
, O 0 2.007338913145862e-11
tendency O 0 2.1757167179004e-09
to O 0 2.421221834136844e-10
hyperthermia B-Disease 0 0.00011773763253586367
, O 0 1.1834938584698307e-10
and O 0 1.2676129590438734e-10
frequent O 0 9.742149309488468e-09
death O 0 1.2665937276779005e-07
in O 0 3.21803128144893e-07
infancy O 0 7.476084647350945e-06
) O 0 4.289723090633579e-12
with O 0 2.230812539902316e-12
a O 0 1.1619918915961591e-10
distinct O 0 1.3830074863108166e-08
campomelic B-Disease 1 0.7252968549728394
- I-Disease 1 0.8463993668556213
metaphyseal I-Disease 1 0.8058640360832214
skeletal I-Disease 1 0.9998192191123962
dysplasia I-Disease 1 0.9999963045120239
. O 0 1.9030746045700653e-07

The O 0 3.7603900548965896e-10
similarity O 0 9.122235744563056e-10
of O 0 8.66302797726537e-13
the O 0 3.2982731129616027e-12
clinical O 0 4.5530235137647423e-10
and O 0 1.0950081813509982e-10
radiographic O 0 2.6389491267764242e-06
findings O 0 1.3363778350594657e-07
is O 0 4.262819541800411e-10
so O 0 2.2558800660821277e-10
extensive O 0 7.339572005715667e-11
that O 0 2.405231291913168e-10
these O 0 3.1105590325708476e-10
disorders O 0 2.767410023807315e-06
appear O 0 1.001490002039418e-09
to O 0 1.8590504136106745e-11
be O 0 1.4712646378978178e-10
a O 0 2.6528579680218378e-11
single O 0 7.766995935298837e-10
entity O 0 4.69413556913878e-08
. O 0 1.8311705929363598e-08

The O 0 1.7451259326506374e-09
follow O 0 6.538523944499275e-09
- O 0 1.006170222694891e-07
up O 0 2.57446841622766e-10
observation O 0 9.167341330496015e-10
of O 0 6.908915713838004e-13
an O 0 1.1867885146843449e-12
identical O 0 4.084793059355718e-10
and O 0 8.620823499505548e-11
unique O 0 4.5452988595151567e-11
pattern O 0 2.056581479337183e-06
of O 0 1.1259345678027444e-09
progressive O 0 0.0012086015194654465
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 3.996113662196876e-08
the O 0 1.1225074342258168e-10
two O 0 3.2685790185560393e-10
patients O 0 1.2168458241035296e-08
( O 0 2.3894412490288452e-11
one O 0 8.68475985571493e-11
with O 0 1.857613174394146e-09
SJS B-Disease 1 0.9999998807907104
type I-Disease 0 0.0004779970913659781
2 I-Disease 0 1.7446134537024705e-09
, O 0 4.4564161388871426e-11
one O 0 6.466028407148272e-11
with O 0 2.1426259377843593e-10
SWS B-Disease 0 0.0921240821480751
) O 0 4.331483435815464e-11
surviving O 0 2.4040631707578086e-09
beyond O 0 7.192898276997539e-09
infancy O 0 1.3454589407047024e-06
adds O 0 1.925344328412848e-09
to O 0 2.7321695253434974e-12
the O 0 1.8738981720500814e-12
evidence O 0 3.298262357676052e-11
in O 0 1.673899387155675e-11
favor O 0 7.707578325577558e-11
of O 0 3.5179313889049935e-12
identity O 0 4.90197837876849e-09
. O 0 6.506373773085272e-10

The O 0 1.8343822016930744e-09
hypothesis O 0 3.123236780311345e-08
that O 0 2.424217271368434e-09
SWS B-Disease 1 0.6755170226097107
and O 0 6.067875801818445e-08
SJS B-Disease 1 0.9999897480010986
type I-Disease 0 1.092001639335649e-06
2 I-Disease 0 1.7656354156514453e-10
are O 0 2.5014157412073246e-11
the O 0 4.9220884312806135e-11
same O 0 4.6266780628911874e-08
disorder O 0 1.210680579788459e-06
should O 0 4.344962584168499e-11
be O 0 2.778012412121833e-12
testable O 0 1.553793205211207e-10
by O 0 9.241400179826886e-12
molecular O 0 4.0116657218369767e-10
methods O 0 7.909804367045581e-09
. O 0 4.838743294932613e-10
. O 0 1.1900385121776935e-09

A O 0 1.0718923704189365e-07
mouse O 0 1.284225618292112e-06
model O 0 8.277999796746371e-08
of O 0 1.2902773294243275e-09
severe O 1 0.9999603033065796
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 0.035423990339040756
defects O 1 0.9999330043792725
in O 0 5.950899506501628e-08
hemostasis O 0 0.005495814606547356
and O 0 9.324988354819652e-07
thrombosis B-Disease 0 0.2209916114807129
. O 0 6.125027596226573e-08

von B-Disease 1 0.9965529441833496
Willebrand I-Disease 1 0.9578778743743896
factor I-Disease 0 2.846039569703862e-05
( I-Disease 0 3.4920475400213036e-07
vWf I-Disease 0 0.0005606183549389243
) I-Disease 0 1.4461546925303992e-05
deficiency I-Disease 1 0.9999979734420776
causes O 0 0.002716274233534932
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 1.4641168490925338e-05
humans O 0 8.229777108681446e-07
. O 0 6.271079655562062e-08

We O 0 4.901754113717516e-09
generated O 0 1.6386868251228037e-10
a O 0 1.504948665687067e-10
mouse O 0 3.622375643885789e-08
model O 0 6.867845403490946e-09
for O 0 1.6803258437447788e-11
this O 0 3.246235572018641e-11
disease O 0 4.699273192798614e-10
by O 0 9.719486500359142e-13
using O 0 1.587706355277163e-10
gene O 0 1.8507037680137728e-08
targeting O 0 1.0400894723261445e-07
. O 0 1.0192523269836329e-08

vWf B-Disease 0 0.03893968462944031
- I-Disease 1 0.9999895095825195
deficient I-Disease 1 0.9998651742935181
mice O 0 0.0008216934511438012
appeared O 0 2.6277785991624114e-07
normal O 0 1.1180533832089168e-08
at O 0 1.033132801531167e-09
birth O 0 2.600189230594907e-10
; O 0 9.630394355239491e-13
they O 0 9.721715620025773e-12
were O 0 3.7269440311682445e-10
viable O 0 3.578383367397464e-09
and O 0 3.30163757444879e-10
fertile O 0 1.1017256440482015e-08
. O 0 5.575399253388014e-09

Neither O 0 7.063167231535772e-06
vWf O 0 0.0001795591233531013
nor O 0 2.962775579362642e-05
vWf O 0 0.0004291898512747139
propolypeptide O 0 0.0013959010830149055
( O 0 2.617638585888926e-07
von B-Disease 0 0.005190038122236729
Willebrand I-Disease 0 0.0009480727603659034
antigen O 0 3.1911786209093407e-06
II O 0 1.907269393086608e-06
) O 0 1.61404459242398e-10
were O 0 1.8772450260939877e-10
detectable O 0 6.7136549652957456e-09
in O 0 8.782055638256736e-11
plasma O 0 8.804690310171281e-09
, O 0 2.362199047478697e-10
platelets O 0 5.1499240427688164e-09
, O 0 2.790828852738958e-11
or O 0 1.9133430950724062e-10
endothelial O 0 4.003296028010084e-10
cells O 0 3.7804614994030317e-10
of O 0 4.708904707134698e-12
the O 0 3.061141271021306e-11
homozygous O 0 1.0565047858790422e-07
mutant O 0 4.872385375165322e-07
mice O 0 1.7577767721377313e-05
. O 0 3.545401483506794e-08

The O 0 6.787677975239603e-09
mutant O 0 1.4181687220116146e-06
mice O 0 0.0007848013192415237
exhibited O 0 0.0002592847740743309
defects O 1 0.9487543702125549
in O 0 2.7018010051449437e-09
hemostasis O 0 9.530405691293709e-07
with O 0 1.504739111091169e-10
a O 0 4.990677648919473e-09
highly O 0 9.048403626366053e-06
prolonged O 0 0.01305028609931469
bleeding O 1 0.9999707937240601
time O 0 2.648650543335407e-08
and O 0 5.921737544767325e-10
spontaneous O 0 2.329871184869603e-09
bleeding O 0 2.6731986508821137e-05
events O 0 1.9595417302675777e-11
in O 0 2.3807476823289875e-11
approximately O 0 9.178494769779277e-12
10 O 0 1.5836587249906664e-11
% O 0 8.844567439547646e-12
of O 0 8.76389585902082e-12
neonates O 0 2.808053807257238e-07
. O 0 1.7714449906947038e-09

As O 0 4.1585810350852626e-09
in O 0 8.188556083199572e-11
the O 0 3.1318923149337152e-12
human O 0 2.6217011200868612e-11
disease O 0 1.5457901625381965e-08
, O 0 3.907156282539903e-12
the O 0 3.9696535988897885e-12
factor O 0 5.609102071701955e-10
VIII O 0 6.936409135960275e-07
level O 0 2.269198606796863e-09
in O 0 7.345594271734868e-11
these O 0 1.869903884510471e-11
mice O 0 1.2872379784312216e-07
was O 0 4.0830364866906166e-08
reduced O 0 5.164526098444533e-11
strongly O 0 1.758308255939145e-11
as O 0 4.565750555407533e-12
a O 0 7.125771760846389e-12
result O 0 8.908501714088857e-11
of O 0 7.797561966775557e-13
the O 0 8.875493222315622e-12
lack O 0 1.812920230603865e-10
of O 0 1.2970337694498402e-12
protection O 0 2.3094019752090134e-11
provided O 0 1.2669088868266787e-11
by O 0 3.897697442578618e-11
vWf O 0 5.082604275230551e-07
. O 0 1.7395105800233068e-08

Defective O 0 0.04439692944288254
thrombosis B-Disease 0 0.31920382380485535
in O 0 2.132553689193628e-08
mutant O 0 1.3950997868050763e-07
mice O 0 0.00013668568863067776
was O 0 4.268079862868035e-07
also O 0 2.342502580798822e-10
evident O 0 6.024934995352282e-10
in O 0 3.4570766388464236e-11
an O 0 1.76215498356308e-12
in O 0 2.8281352953962724e-11
vivo O 0 3.940813542158139e-08
model O 0 5.756925602895535e-09
of O 0 1.9235227299851942e-10
vascular B-Disease 1 0.9833430051803589
injury I-Disease 0 0.09921250492334366
. O 0 1.7464387269683357e-08

In O 0 2.649553687561479e-09
this O 0 3.13423662023915e-11
model O 0 9.417301383152221e-10
, O 0 5.044290939809626e-12
the O 0 2.9263132715617868e-12
exteriorized O 0 7.04666405226817e-08
mesentery O 0 1.9848266674671322e-07
was O 0 2.5789042013002472e-08
superfused O 0 1.5413679221865095e-08
with O 0 2.5623865876345242e-11
ferric O 0 2.7692575343962744e-08
chloride O 0 1.4215402188710868e-09
and O 0 1.1800586896537624e-10
the O 0 2.6535006830696872e-11
accumulation O 0 3.6384573132153264e-10
of O 0 6.6595943169767136e-12
fluorescently O 0 5.548604775640342e-08
labeled O 0 1.3308961399616237e-07
platelets O 0 1.248698481504107e-06
was O 0 5.335389730021234e-08
observed O 0 2.47075193637869e-10
by O 0 4.581472701215006e-11
intravital O 0 1.0545780071424815e-07
microscopy O 0 2.0244604570507363e-07
. O 0 9.721582650001892e-09

We O 0 7.775690136213598e-08
conclude O 0 1.6973524807895046e-08
that O 0 6.201010625123127e-12
these O 0 1.8580781444704764e-12
mice O 0 1.2941599791815861e-08
very O 0 3.392974512461677e-10
closely O 0 9.234855102846495e-10
mimic O 0 1.8430706916205963e-07
severe O 0 1.024978882924188e-05
human O 0 5.41318968316773e-07
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 0.026142805814743042
will O 0 6.654097006730808e-08
be O 0 4.490194674411363e-11
very O 0 5.125714089282418e-11
useful O 0 1.722471991427721e-11
for O 0 2.8447741124565384e-13
investigating O 0 9.298084871489642e-12
the O 0 6.572721425283923e-13
role O 0 1.7519411268929197e-11
of O 0 5.027939870005937e-13
vWf O 0 2.0983854653877643e-09
in O 0 4.6517589780137314e-10
normal O 0 6.444465583399506e-08
physiology O 0 1.7708041255559692e-08
and O 0 1.6875341402045052e-10
in O 0 9.65707958044959e-10
disease O 0 2.262388676399496e-08
models O 0 1.4642282941679241e-08
. O 0 1.8854121042188865e-10
. O 0 8.023273712076673e-10

Oral O 0 4.6064747039054055e-06
contraceptives O 0 0.0006174769368954003
and O 0 1.6071888264690415e-09
the O 0 5.220701995711785e-11
risk O 0 2.1668801863938825e-08
of O 0 4.14292111727832e-09
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 5.063928298909559e-08

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 0.9999947547912598
Cancer I-Disease 0 0.00015848546172492206
Clinical O 0 1.0084063433168922e-06
Study O 0 1.224722989690008e-08
Group O 0 1.6587069495699325e-08
. O 0 3.105758539234671e-09

BACKGROUND O 0 6.166801176732406e-05
Women O 0 5.529437352436162e-09
with O 0 1.3091059486436407e-11
mutations O 0 7.85483456056113e-10
in O 0 8.962870029494141e-11
either O 0 1.687675693640145e-10
the O 0 3.264589987228561e-11
BRCA1 O 0 9.171337467250851e-08
or O 0 1.988294945354241e-10
the O 0 1.513607121583771e-11
BRCA2 O 0 4.802869923992148e-08
gene O 0 2.0518573506933535e-09
have O 0 1.9630476411069964e-10
a O 0 1.3191500669584855e-10
high O 0 3.771397771856755e-08
lifetime O 0 4.4824721712188875e-09
risk O 0 1.3565802873927169e-05
of O 0 1.041465679918474e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 7.385403932858026e-08

Oral O 0 5.621098807750968e-06
contraceptives O 0 0.00042795969056896865
protect O 0 5.646634235745296e-07
against O 0 0.06136515736579895
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.6789180046217211e-09
general O 0 3.038124959942046e-11
, O 0 2.923335878923794e-11
but O 0 5.213609544085784e-10
it O 0 2.23503854313023e-11
is O 0 2.27695575068243e-12
not O 0 1.2970641921628001e-11
known O 0 5.993218421540547e-11
whether O 0 6.891340276204971e-11
they O 0 8.069772627905536e-11
also O 0 5.518008359267634e-12
protect O 0 6.613178754610871e-12
against O 0 7.267857149440005e-11
hereditary B-Disease 0 4.1357003510711365e-07
forms I-Disease 0 7.492212716897484e-08
of I-Disease 0 1.5375369912362657e-05
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.871530023820014e-08

METHODS O 0 4.692703043929214e-07
We O 0 4.2824863655255285e-09
enrolled O 0 5.595299334970605e-09
207 O 0 1.9710862275701402e-08
women O 0 8.042073118552651e-10
with O 0 2.2286394951720467e-08
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 2.5300932460226022e-09
161 O 0 1.1456653403740802e-09
of O 0 9.178665856882096e-13
their O 0 2.62243629589598e-11
sisters O 0 1.8343156993338994e-09
as O 0 4.1116492155435225e-11
controls O 0 1.8035100524116388e-08
in O 0 4.368089778772344e-10
a O 0 2.1235417868581408e-09
case O 0 2.204680527029268e-07
- O 0 1.1265004928873168e-07
control O 0 1.051426821163659e-07
study O 0 5.377109868476282e-09
. O 0 2.234443963189392e-09

All O 0 8.230351955518245e-10
the O 0 4.529254055141152e-11
patients O 0 2.2876929517412492e-10
carried O 0 5.3319834658616116e-11
a O 0 1.0405166311899805e-10
pathogenic O 0 5.312622874953377e-07
mutation O 0 9.668953637742561e-09
in O 0 2.877576232851453e-10
either O 0 1.7306471811195934e-09
BRCA1 O 0 8.593551683588885e-06
( O 0 8.851428479061951e-10
179 O 0 7.771772558839984e-09
women O 0 1.3376670882081498e-09
) O 0 2.9692245190338085e-11
or O 0 8.578448174034747e-09
BRCA2 O 0 9.361824777442962e-05
( O 0 5.848632689264832e-09
28 O 0 4.280683540969221e-08
women O 0 6.007873754043658e-09
) O 0 3.1829880398071e-10
. O 0 1.6925023604841272e-09

The O 0 2.4352422300921717e-09
control O 0 1.3070397208991835e-08
women O 0 8.131270101685573e-10
were O 0 2.2070381633376712e-10
enrolled O 0 8.117690547537748e-11
regardless O 0 8.786206137645358e-12
of O 0 1.2265478888627557e-13
whether O 0 1.106588865679159e-11
or O 0 1.403863691962215e-10
not O 0 4.353699900594421e-10
they O 0 1.7093552961977565e-10
had O 0 8.200672918512453e-10
either O 0 6.726633139386706e-11
mutation O 0 2.748093308468924e-09
. O 0 7.607796059794225e-10

Lifetime O 0 3.3577182989574794e-07
histories O 0 3.440072759985924e-07
of O 0 6.879257580250098e-11
oral O 0 1.3204655147092126e-08
- O 0 1.2603111088083097e-07
contraceptive O 0 2.130854568349605e-07
use O 0 2.738166637872297e-10
were O 0 8.471567336520991e-10
obtained O 0 3.0373717430087765e-11
by O 0 6.598059338475126e-12
interview O 0 5.715037687537006e-08
or O 0 2.573004136141588e-11
by O 0 1.0158558022554942e-12
written O 0 5.209601153244314e-11
questionnaire O 0 2.9595333128629164e-11
and O 0 1.9398018347854817e-12
were O 0 2.6277887851811066e-11
compared O 0 2.9303087734078304e-11
between O 0 1.7899671328480693e-11
patients O 0 8.887732771967194e-10
and O 0 2.02143163319235e-11
control O 0 5.855407714250305e-09
women O 0 1.2341513366820323e-09
, O 0 4.566778379067049e-12
after O 0 2.6741286268672226e-11
adjustment O 0 1.1951718781322285e-10
for O 0 5.806494065944967e-13
year O 0 9.629848134184993e-12
of O 0 5.937686865624403e-13
birth O 0 1.8141282920325352e-09
and O 0 2.8785532291131233e-10
parity O 0 7.06025176100411e-08
. O 0 1.355005441183721e-09

RESULTS O 0 4.717562092082517e-07
The O 0 1.917171560394948e-10
adjusted O 0 1.0932441796285275e-07
odds O 0 9.799288136491668e-07
ratio O 0 5.166324626770802e-05
for O 0 4.242632712703198e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 4.905242434460888e-09
with O 0 4.2309995784695076e-11
any O 0 1.4706670603548133e-10
past O 0 1.1719590575776095e-10
use O 0 4.764649785826691e-11
of O 0 4.354144215318323e-12
oral O 0 4.035773937260956e-09
contraceptives O 0 3.013681634911336e-05
was O 0 6.859326617814077e-08
0 O 0 1.4537225867528036e-09
. O 0 9.423751778925293e-10

5 O 0 4.613970006062118e-08
( O 0 1.0424340279868716e-09
95 O 0 2.3366011348002758e-08
percent O 0 1.0271905011904892e-05
confidence O 0 2.629889650052064e-06
interval O 0 9.5523478016446e-10
, O 0 5.721973676126035e-12
0 O 0 8.73714121885083e-12
. O 0 2.8597796873641723e-12
3 O 0 1.4213599915102737e-11
to O 0 1.6861111465371614e-11
0 O 0 1.6164661276185655e-10
. O 0 7.696882714514075e-11
8 O 0 5.448403395114099e-10
) O 0 8.036318832616018e-11
. O 0 7.02946145736405e-10

The O 0 3.3390419318379827e-09
risk O 0 2.549967526022101e-08
decreased O 0 1.1610714167886727e-08
with O 0 3.1060976273672436e-12
increasing O 0 4.801277778132551e-11
duration O 0 2.68178673712427e-10
of O 0 5.214685562700272e-13
use O 0 4.5650039304234724e-11
( O 0 1.8198768880761662e-10
P O 0 1.5627998664058396e-06
for O 0 7.846949652556834e-12
trend O 0 1.7326405554740631e-07
, O 0 5.329451810420771e-11
< O 0 1.3279409794009212e-09
0 O 0 4.950390444791175e-11
. O 0 7.789568469418473e-12
001 O 0 8.658895267465994e-10
) O 0 3.6406386802814716e-13
; O 0 3.838895957304807e-14
use O 0 2.480973326085545e-12
for O 0 3.0405289831031412e-12
six O 0 6.01002303479703e-11
or O 0 1.0021868751541874e-10
more O 0 2.22862769905241e-11
years O 0 1.505405244905944e-10
was O 0 1.0382709136891322e-09
associated O 0 1.8468915632952054e-12
with O 0 2.424832253392073e-13
a O 0 8.701804554700487e-11
60 O 0 9.275156198640389e-10
percent O 0 1.7209350744451513e-07
reduction O 0 1.1368537222722352e-09
in O 0 6.18658413387152e-09
risk O 0 8.7637630485915e-08
. O 0 3.2661628956986988e-09

Oral O 0 1.584597885084804e-05
- O 0 8.456708201265428e-06
contraceptive O 0 4.872901172348065e-06
use O 0 6.07530825647018e-09
protected O 0 1.2675388916250085e-06
against O 0 0.18821947276592255
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999971389770508
both O 0 1.8235938800681417e-11
for O 0 3.102815584760804e-13
carriers O 0 3.739039286521084e-11
of O 0 2.0229724471097776e-13
the O 0 4.445498483218735e-11
BRCA1 O 0 1.9450317267910577e-06
mutation O 0 1.0277755535526012e-08
( O 0 1.9090562464185723e-10
odds O 0 3.284920353507914e-07
ratio O 0 1.5870864444877952e-07
, O 0 2.9188006178682e-11
0 O 0 3.010190013919001e-11
. O 0 3.81631228354995e-12
5 O 0 1.0103433714658827e-11
; O 0 4.936819182621566e-12
95 O 0 7.878699648244947e-08
percent O 0 0.3004731237888336
confidence O 0 0.01011640578508377
interval O 0 4.636169503857701e-10
, O 0 1.653911166007993e-12
0 O 0 2.37938922037495e-12
. O 0 7.6507262981515e-13
3 O 0 4.106991222802003e-12
to O 0 3.1315935088149782e-12
0 O 0 5.984650969237393e-11
. O 0 4.2155171714464146e-11
9 O 0 2.1878504563588308e-10
) O 0 2.0191801789609665e-12
and O 0 2.218702001635653e-12
for O 0 3.30033526549367e-13
carriers O 0 2.8898125212228898e-11
of O 0 3.5786079503365154e-13
the O 0 8.707250892525664e-11
BRCA2 O 0 4.985741725249682e-06
mutation O 0 1.1468115346247032e-08
( O 0 3.193629805053888e-10
odds O 0 3.051184478408686e-07
ratio O 0 1.749583731225357e-07
, O 0 9.992780214407304e-11
0 O 0 7.961257347810502e-11
. O 0 1.3697219573838293e-11
4 O 0 4.472228143370671e-11
; O 0 1.2500896151568242e-11
95 O 0 1.5365986882898142e-07
percent O 1 0.6527035236358643
confidence O 0 0.005158090498298407
interval O 0 1.4329410991109626e-09
, O 0 4.227415726504313e-12
0 O 0 9.623163377270316e-12
. O 0 3.915646019231334e-12
2 O 0 1.5977670575484382e-11
to O 0 1.4202785648953498e-11
1 O 0 2.300658413778578e-10
. O 0 3.479754331903173e-11
1 O 0 1.3108382435067512e-10
) O 0 8.873601853309765e-11
. O 0 2.7674118552312166e-10

CONCLUSIONS O 0 1.5406264992634533e-06
Oral O 0 4.1190111232936033e-07
- O 0 8.566154861000541e-07
contraceptive O 0 1.378487809233775e-06
use O 0 1.886733214107039e-09
may O 0 1.2705480223473842e-08
reduce O 0 5.132121463913286e-11
the O 0 2.4904663400993066e-11
risk O 0 3.6775608691641537e-07
of O 0 2.6613664161345696e-08
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
in O 0 4.453325208597647e-10
women O 0 1.347402051044e-10
with O 0 1.6268758258955462e-12
pathogenic O 0 2.543555588374602e-08
mutations O 0 4.0230005993180384e-09
in O 0 1.1145710743232229e-10
the O 0 2.0194983185728432e-10
BRCA1 O 0 4.165031441516476e-06
or O 0 3.244742785568633e-08
BRCA2 O 0 9.344913269160315e-05
gene O 0 6.295021739788353e-05

A O 0 6.612170011521812e-08
Japanese O 0 5.001009739658002e-08
family O 0 7.976095894868251e-10
with O 0 1.8507936849765372e-10
adrenoleukodystrophy B-Disease 1 1.0
with O 0 1.3072228022270593e-10
a O 0 1.0874700029361861e-09
codon O 0 1.1228537744045752e-07
291 O 0 1.6770497879292634e-08
deletion O 0 8.704204468301668e-09
: O 0 7.54623707271973e-12
a O 0 1.4537294111549581e-11
clinical O 0 2.838849821884537e-09
, O 0 3.113092075790469e-11
biochemical O 0 2.428253864650287e-08
, O 0 3.4445726826426437e-10
pathological O 0 1.447663066755922e-06
, O 0 2.503731943992449e-10
and O 0 2.1121372706378594e-10
genetic O 0 1.413029053765058e-07
report O 0 2.1042986020347598e-07
. O 0 2.8787303651967022e-09

We O 0 2.232468432339374e-08
report O 0 1.2884403544077827e-09
a O 0 2.783301714104347e-11
Japanese O 0 1.3339065407791395e-09
family O 0 3.3313937719547937e-10
with O 0 2.2926300857761817e-09
adrenoleukodystrophy B-Disease 1 1.0
( O 0 0.06362281739711761
ALD B-Disease 1 1.0
) O 0 4.922861007727874e-10
with O 0 1.4210726345664781e-11
a O 0 1.2557395401291416e-10
three O 0 7.968701393190614e-11
base O 0 2.1013803197522662e-10
pair O 0 1.9831837505535077e-08
deletion O 0 1.4198101894180581e-07
( O 0 6.974864019682059e-10
delGAG O 0 5.2844267628415764e-08
291 O 0 2.074904692506152e-08
) O 0 6.47850870172384e-11
in O 0 6.227484639076408e-10
the O 0 1.3535132126207827e-08
ALD B-Disease 1 1.0
gene O 0 2.4403293537034187e-06
. O 0 2.0119339083635168e-08

A O 0 2.4940019827113247e-08
variety O 0 1.0044302056755328e-09
of O 0 1.6810086309049233e-11
phenotypes O 0 2.9176903115768482e-09
were O 0 1.1593380699892464e-09
observed O 0 4.4144635863441195e-11
within O 0 5.243152266520834e-12
this O 0 3.508545190489265e-11
family O 0 7.924417233518e-10
. O 0 1.4037815354583927e-09

While O 0 6.690035547762818e-08
the O 0 8.870949530503935e-10
proband O 0 1.976667363123852e-06
( O 0 2.486832961778873e-09
patient O 0 9.78173844146113e-08
1 O 0 2.0817847445897542e-10
) O 0 2.4894595065938496e-11
was O 0 6.122350626469597e-09
classified O 0 2.9758837616356004e-09
as O 0 7.362285781020717e-11
having O 0 5.710931380575879e-11
a O 0 2.810583363266339e-11
rare O 0 3.8972311489082756e-10
intermediate O 0 1.914358893628787e-09
type O 0 1.493240660010997e-07
of O 0 4.5952300992135875e-11
adult O 0 8.755540648053284e-07
cerebral O 0 0.00012467690976336598
and O 0 1.2282781369776785e-07
cerebello O 1 0.9878750443458557
- O 1 0.6774147152900696
brain O 0 0.00010869710240513086
stem O 0 8.749979407696173e-09
forms O 0 2.669030774171688e-09
, O 0 1.6080350384584108e-09
his O 0 2.1799204663608407e-09
younger O 0 1.6358785615011584e-07
brother O 0 1.8958933978296955e-08
( O 0 4.830186250970314e-10
patient O 0 1.4122691993634362e-07
2 O 0 2.252113912026843e-10
) O 0 5.559995519544003e-11
and O 0 2.3032806772960157e-09
nephew O 0 1.2449168934836052e-05
( O 0 2.399578091782928e-09
patient O 0 1.5767764125484973e-06
3 O 0 7.098499010815829e-10
) O 0 2.1953412698838548e-10
had O 0 5.679091259480629e-07
a O 0 4.964259403550386e-08
childhood O 0 0.0026170387864112854
ALD B-Disease 1 1.0
type O 0 0.0008986471802927554
. O 0 7.770322696387666e-08

Another O 0 3.2341836231353227e-07
nephew O 0 1.4080966138863005e-05
( O 0 1.4866738951013758e-08
patient O 0 9.588718796749163e-08
4 O 0 1.5226130078982436e-10
) O 0 1.6633680544053675e-11
of O 0 4.135194357074434e-12
patient O 0 2.436461556953873e-07
1 O 0 6.733208435250049e-10
was O 0 1.4315327234726283e-07
classified O 0 6.475130653882388e-09
as O 0 1.6590723239673366e-10
having O 0 2.81086348641324e-10
an O 0 1.5506424269617902e-11
adolescent O 0 1.3000506449145632e-08
form O 0 1.1879657257907184e-09
. O 0 5.112605894197486e-09

The O 0 2.5135231673800718e-09
tau O 0 6.78380773777576e-09
level O 0 7.168953208847029e-10
in O 0 3.808635004598493e-11
the O 0 1.7841259025708212e-10
cerebrospinal O 0 3.091113831032999e-05
fluid O 0 6.756820880582382e-07
( O 0 1.1687033563134719e-08
CSF O 1 0.6872369050979614
) O 0 2.8683303995857834e-11
in O 0 3.8597108842353123e-10
patient O 0 7.2454312771697e-08
1 O 0 3.5623032301757007e-10
was O 0 3.015806839812285e-07
as O 0 1.0021836693852038e-09
high O 0 3.4243849977855234e-09
as O 0 1.031566412151852e-11
that O 0 2.2506087705292943e-12
of O 0 2.264922841291317e-12
patients O 0 5.442735151461875e-09
with O 0 2.6744426673275257e-09
Alzheimers B-Disease 1 0.9999873638153076
disease I-Disease 0 0.15114328265190125
( O 0 2.0583015292174878e-09
AD B-Disease 0 6.452204615925439e-06
) O 0 2.9720095273688685e-09
. O 0 4.240908957342526e-09

His O 0 1.973712642211467e-07
brain O 0 2.4131986720021814e-06
magnetic O 0 2.011281630132089e-08
resonance O 0 2.1980737585636234e-07
image O 0 3.6484547649706656e-07
( O 0 3.664842429529358e-09
MRI O 0 0.07328708469867706
) O 0 1.300950347449259e-09
showed O 0 0.0003043079632334411
abnormalities B-Disease 1 0.8107373118400574
in I-Disease 0 3.9134323559508744e-10
the I-Disease 0 5.265684416277949e-11
bilateral I-Disease 0 1.8272827162491012e-07
cerebellar I-Disease 0 6.790075417484331e-07
hemispheres I-Disease 0 5.594240064965561e-05
and O 0 5.881849673983197e-08
brain O 0 1.1692785619743518e-06
stem O 0 8.320418132257146e-09
, O 0 7.008439661948529e-11
but O 0 1.1061758453667636e-10
not O 0 5.2146113815876305e-11
in O 0 1.3361568795833279e-10
the O 0 6.892578729988941e-10
cerebral O 0 0.0006376103847287595
white O 0 7.438239890689147e-07
matter O 0 4.276048670703858e-08
, O 0 9.994185166950498e-12
where O 0 3.2286478178489286e-12
marked O 0 1.340705324537339e-11
reductions O 0 3.0208205381576647e-10
of O 0 8.076971708646796e-13
the O 0 2.3814833785551492e-11
cerebral O 0 4.801679054367014e-08
blood O 0 2.8300539689496418e-09
flow O 0 6.862342916136299e-10
and O 0 2.746453287016948e-09
oxygen O 0 1.3718751690205977e-09
metabolism O 0 1.1574827318838743e-08
were O 0 1.610732519585767e-10
clearly O 0 4.871618108914788e-10
demonstrated O 0 6.640698407833767e-11
by O 0 9.8230572981306e-12
positron O 0 2.1301312358446012e-07
emission O 0 2.899523963151296e-07
tomography O 0 0.0004288199415896088
( O 0 2.6367397154558603e-08
PET O 0 2.0644556570914574e-06
) O 0 3.195289144386493e-09
. O 0 4.194236069565704e-09

In O 0 1.3488079275703058e-07
patients O 0 2.9410392698991927e-07
2 O 0 3.965298922548044e-10
and O 0 1.6262136082190182e-10
3 O 0 6.029392263240396e-11
, O 0 6.352594231900932e-12
the O 0 3.077533367035201e-11
autopsy O 0 2.9485449886124115e-06
findings O 0 8.160230824394432e-10
showed O 0 5.201229313911426e-08
massive O 0 1.412701733372046e-09
demyelination B-Disease 1 0.9999998807907104
of I-Disease 0 1.2295690854369212e-10
the I-Disease 0 1.6801865454496578e-09
cerebral I-Disease 0 0.03767883777618408
white I-Disease 0 3.148063569824444e-07
matter I-Disease 0 3.0013753704594137e-09
with O 0 3.2015922031558564e-12
sparing O 0 1.0052577520403005e-10
of O 0 1.6235900427916117e-12
the O 0 2.282805541820032e-11
U O 0 2.3442178189725382e-06
- O 0 1.618221972421452e-06
fibers O 0 1.4430481769522885e-06
, O 0 2.382928403210638e-11
compatible O 0 5.631721200494155e-10
with O 0 3.429491282971875e-12
the O 0 2.094216987325037e-11
findings O 0 1.2895516876554325e-09
of O 0 1.0655433480000198e-10
childhood O 0 2.419586735413759e-06
ALD B-Disease 1 0.9999996423721313
. O 0 2.0497108010886222e-08

Oleic O 1 0.8168726563453674
and O 0 4.0121372535395494e-07
erucic O 0 5.5889344366732985e-05
acids O 0 4.896644867358191e-08
( O 0 3.062743392234779e-10
Lorenzos O 0 7.011775604581771e-09
Oil O 0 4.979199275112478e-10
) O 0 3.410664979608402e-12
were O 0 4.685056162467838e-12
administered O 0 2.6015359571446295e-12
to O 0 8.931670507361655e-12
patients O 0 5.62006829962769e-10
1 O 0 1.7169383970117025e-11
and O 0 1.4004619686147635e-10
4 O 0 7.20562012834769e-11
, O 0 2.1482830705327194e-12
but O 0 9.994795789614042e-12
sufficient O 0 2.0888077725822463e-11
effectiveness O 0 1.4709202744711547e-09
was O 0 3.554147420814502e-09
not O 0 3.48427710294974e-11
obtained O 0 3.319767238885163e-10
. O 0 3.951391991385833e-10

The O 0 6.690488163485497e-10
findings O 0 7.918645739124486e-10
in O 0 5.488243540185955e-11
this O 0 3.97650445557729e-12
family O 0 1.5202327244279168e-11
suggest O 0 5.985358736415591e-11
that O 0 9.24938858143376e-12
delGAG291 O 0 1.1433121116510847e-09
is O 0 3.2192516881413002e-12
part O 0 5.511213447412233e-12
of O 0 7.033447175369689e-13
the O 0 3.795704375808562e-11
cause O 0 2.8606664259633874e-10
of O 0 2.7329371404816172e-11
Japanese O 0 1.7842182842287002e-06
ALD B-Disease 1 0.9999984502792358
with O 0 6.249101236477372e-11
phenotypic O 0 7.134148916065897e-08
variations O 0 1.9631626457794482e-07
. O 0 3.3332909765704244e-08

Moreover O 0 3.284149840965256e-07
, O 0 6.302225963317198e-10
although O 0 7.168169530169521e-11
the O 0 5.0793952377503615e-12
scale O 0 2.918991715006314e-10
of O 0 1.1788989923156024e-12
the O 0 1.0988615399554202e-11
study O 0 1.0725672953959542e-11
is O 0 2.089189064802266e-12
limited O 0 3.060960512835109e-11
, O 0 1.621220345471297e-11
there O 0 1.616422828920605e-10
is O 0 2.9706616940655683e-12
a O 0 4.865233649981038e-12
possibility O 0 5.539427944123432e-11
that O 0 1.952077041678102e-11
PET O 0 4.02829858359155e-09
can O 0 1.156140044811238e-10
detect O 0 1.2467393162296503e-07
an O 0 3.060640907381895e-10
insidious B-Disease 0 4.792571780853905e-05
lesion I-Disease 0 0.42708101868629456
which O 0 1.4663011915772017e-09
is O 0 1.1912892894372362e-10
undetectable O 0 2.2569914825965043e-09
by O 0 1.781462651007093e-11
computed O 0 1.030358642850615e-08
tomogram O 0 6.150337981125631e-07
( O 0 3.362905787174242e-10
CT O 1 0.9709221124649048
) O 0 5.5856118341690575e-11
or O 0 1.2289572137724747e-10
MRI O 0 2.16386683860037e-06
analysis O 0 3.996002695405565e-10
, O 0 1.321506619411661e-11
and O 0 1.3370330884110437e-11
that O 0 8.999622878522184e-13
the O 0 1.330438688905422e-12
higher O 0 6.692534082475277e-09
level O 0 9.330511363536687e-11
of O 0 1.117751995561439e-13
tau O 0 1.48499962326909e-11
reflects O 0 1.4852941793153107e-11
the O 0 2.0772053781897837e-12
process O 0 3.8018272557893695e-11
of O 0 1.296069935402544e-11
neuronal B-Disease 0 2.76423975265061e-07
degeneration I-Disease 0 0.00020904067787341774
in O 0 7.387417895188264e-07
ALD B-Disease 1 1.0
. O 0 1.232733808365083e-07

Lorenzos O 0 1.8434046069160104e-05
Oil O 0 9.235920117589558e-08
should O 0 1.3370746176910586e-10
be O 0 2.798653019400743e-12
given O 0 4.755393669987618e-13
in O 0 6.353223936522712e-12
the O 0 5.070006480617506e-12
early O 0 1.1650827502762695e-07
stage O 0 5.08102138141453e-09
. O 0 2.2824181780678465e-11
. O 0 1.0224563556926469e-10

Nonsense O 0 0.00027595259598456323
mutation O 0 7.837360271878424e-07
in O 0 5.62792301650461e-09
exon O 0 5.656454860059057e-08
4 O 0 8.098981485460399e-10
of O 0 1.7374181520563026e-12
human O 0 9.186831850804822e-12
complement O 0 1.0539598083170176e-09
C9 O 0 1.5061785063608113e-07
gene O 0 2.4399906095595725e-08
is O 0 1.2842001073654075e-10
the O 0 5.0736342210866425e-12
major O 0 3.2771815816623473e-10
cause O 0 4.643550266525409e-10
of O 0 1.3693144708393223e-11
Japanese O 0 7.130883972195079e-08
complement B-Disease 0 3.700936872519378e-07
C9 I-Disease 0 0.0012090068776160479
deficiency I-Disease 0 0.006687156390398741
. O 0 1.169698027325694e-08

Deficiency B-Disease 1 0.9999891519546509
of I-Disease 0 2.194428666557613e-10
the I-Disease 0 1.3113007901743856e-10
ninth I-Disease 0 1.4450725061010417e-09
component I-Disease 0 1.557941969876353e-10
of I-Disease 0 3.080019963033753e-13
human I-Disease 0 4.6771453897365145e-12
complement I-Disease 0 2.27991425738594e-09
( O 0 4.0382666655069954e-10
C9 O 0 9.109290743936072e-08
) O 0 1.1517639272873303e-11
is O 0 1.3851113181764796e-12
the O 0 6.669939123585267e-13
most O 0 1.5750255266677726e-11
common O 0 1.9582166999043693e-07
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 2.7576877670298927e-08
Japan O 0 1.837250707126259e-08
but O 0 2.327915360478272e-10
is O 0 1.6254304759794058e-12
rare O 0 5.553000420599474e-11
in O 0 2.0156346036692696e-10
other O 0 2.5853520713159384e-11
countries O 0 2.430262380226367e-10
. O 0 3.9173381205515057e-10

We O 0 9.298648073752247e-09
studied O 0 1.4966367034574546e-09
the O 0 2.673673565531387e-12
molecular O 0 5.758786850162956e-11
basis O 0 1.2471561283700083e-10
of O 0 7.219087827525783e-11
C9 B-Disease 0 0.13049127161502838
deficiency I-Disease 0 0.09019380062818527
in O 0 7.127749501734115e-10
four O 0 2.0144125256749135e-10
Japanese O 0 1.8443255811462222e-08
C9 B-Disease 0 6.914385448908433e-05
- I-Disease 0 0.0027002026326954365
deficient I-Disease 1 0.8843829035758972
patients O 0 7.787355571053922e-05
who O 0 6.586491707594178e-08
had O 0 8.506150379616884e-07
suffered O 0 0.015779756009578705
from O 0 1.8601993190259236e-07
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 1.407969847377899e-07

Direct O 0 7.929081391466752e-08
sequencing O 0 1.0816932416446434e-07
of O 0 1.4046619423169204e-10
amplified O 0 3.0225294267438585e-08
C9 O 0 1.0171669373448822e-07
cDNA O 0 5.4325921539088995e-09
and O 0 6.195318702495456e-10
DNA O 0 6.309975653095989e-09
revealed O 0 3.746653209901751e-09
a O 0 2.344169858226053e-10
nonsense O 0 3.961628891602231e-08
substitution O 0 1.1774714536727515e-09
( O 0 2.2637634822242347e-10
CGA O 0 1.0884187986448524e-06
- O 0 1.31415703208404e-07
- O 0 1.7015914011153654e-07
> O 0 5.762418098242961e-09
TGA O 0 1.0753551293873898e-07
) O 0 1.1078687446597346e-11
at O 0 3.2943515970718096e-11
codon O 0 4.672424669394104e-10
95 O 0 6.843986488647147e-11
in O 0 3.2785052450634566e-11
exon O 0 2.733722137548966e-09
4 O 0 3.2660116278115936e-10
in O 0 1.700636576007497e-10
the O 0 1.3374878982119753e-10
four O 0 5.976262151818901e-09
C9 B-Disease 0 0.000378007855033502
- I-Disease 0 0.0019497806206345558
deficient I-Disease 0 0.00013368552026804537
individuals O 0 1.3239955798383107e-09
. O 0 3.608526810694457e-09

An O 0 7.387641165479408e-09
allele O 0 2.023905608439236e-06
- O 0 1.6852335704697907e-07
specific O 0 7.381975031250931e-10
polymerase O 0 1.9432905062899408e-08
chain O 0 6.578842803861562e-09
reaction O 0 3.8994915629864124e-10
system O 0 1.0468389349815865e-10
designed O 0 5.622748378009135e-10
to O 0 3.9726326395150835e-11
detect O 0 1.6272383440707472e-09
exclusively O 0 6.88070087018211e-11
only O 0 2.7903125990325073e-11
one O 0 2.178728551738285e-12
of O 0 4.460142108073106e-14
the O 0 7.2611708312742e-13
normal O 0 8.359574837912831e-11
and O 0 1.4760760322363176e-11
mutant O 0 6.095966509356288e-10
alleles O 0 6.836319288439086e-10
indicated O 0 2.0126018185351313e-08
that O 0 2.7780402978017094e-11
all O 0 1.4713642630670432e-12
the O 0 1.4743111245718588e-12
four O 0 6.139531157772771e-12
patients O 0 1.455085964913172e-11
were O 0 1.2680088749827956e-11
homozygous O 0 5.619486820318542e-11
for O 0 9.121143510620877e-13
the O 0 5.6553971575223905e-12
mutation O 0 1.950931499683506e-10
in O 0 9.318666671642717e-11
exon O 0 6.262972807036249e-09
4 O 0 6.359098247976647e-10
and O 0 1.180788106180941e-10
that O 0 6.558523689415008e-12
the O 0 3.029618569905246e-11
parents O 0 7.33502758532012e-10
of O 0 5.088587971130432e-12
patient O 0 6.8772965100549754e-09
2 O 0 1.302290358884406e-10
were O 0 8.266478168650337e-09
heterozygous O 0 2.5148366944449663e-07
. O 0 2.3121544678872397e-09

The O 0 2.528674825086341e-09
common O 0 6.517631323532669e-09
mutation O 0 1.1064132721116948e-08
at O 0 1.8581164384912086e-09
codon O 0 5.247402068420115e-09
95 O 0 3.173180052051805e-10
in O 0 1.1820906753445826e-10
exon O 0 8.763173298120819e-09
4 O 0 8.389255956586794e-10
might O 0 1.5243230677697284e-08
be O 0 1.3462941698960673e-11
responsible O 0 4.9161187273827345e-12
for O 0 8.463430694119478e-13
most O 0 5.669029135013659e-11
Japanese O 0 5.071187203498084e-08
C9 B-Disease 0 1.72445743373828e-05
deficiency I-Disease 0 9.569491339789238e-06
. O 0 1.1513075909297399e-10
. O 0 1.0416032480975446e-09

BRCA1 O 0 1.5675297618145123e-05
required O 0 1.0798024696612174e-08
for O 0 9.985902382769751e-11
transcription O 0 3.0106573944976844e-07
- O 0 5.594070898951031e-06
coupled O 0 2.7701852900463564e-07
repair O 0 4.7208206524373963e-05
of O 0 6.384835715689263e-11
oxidative O 0 5.425757620969307e-09
DNA O 0 1.1041201020134395e-07
damage O 0 1.6039074068885384e-07
. O 0 6.1274909590736115e-09

The O 0 1.195848540191946e-07
breast B-Disease 1 0.9999865293502808
and I-Disease 1 0.9979248046875
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
susceptibility O 0 7.049849273244035e-07
gene O 0 3.0831552066956647e-07
BRCA1 O 0 3.066027602471877e-06
encodes O 0 4.314076562650371e-08
a O 0 5.9418909792441355e-09
zinc O 0 0.00010946307156700641
finger O 0 0.00016909102851059288
protein O 0 2.0747583207025855e-08
of O 0 2.0241013726218782e-11
unknown O 0 4.2051055970659945e-09
function O 0 2.3731243636859745e-09
. O 0 4.6044994483906976e-09

Association O 0 7.844208838037048e-09
of O 0 7.628887105370907e-12
the O 0 4.6034035958153474e-12
BRCA1 O 0 7.241628630083596e-09
protein O 0 1.954160305794872e-10
with O 0 9.332015412158445e-13
the O 0 8.037464790944249e-12
DNA O 0 1.6044513273527627e-08
repair O 0 2.379925803097649e-07
protein O 0 1.0021459218023665e-08
Rad51 O 0 3.113316893177398e-07
and O 0 1.663622711811641e-10
changes O 0 3.378874957604694e-11
in O 0 5.869946455988595e-12
the O 0 7.28797827208999e-13
phosphorylation O 0 4.2665104088568384e-11
and O 0 1.8346357419374293e-11
cellular O 0 7.930712087045322e-09
localization O 0 1.3364429563011981e-09
of O 0 2.85619157448444e-13
the O 0 7.559299865754487e-13
protein O 0 4.335830999790957e-11
after O 0 1.2684975465859782e-11
exposure O 0 3.6099914724196935e-10
to O 0 5.209220641649859e-12
DNA O 0 1.8708771420961057e-08
- O 0 8.59843396483484e-09
damaging O 0 9.904307596286799e-09
agents O 0 1.886254485938821e-09
are O 0 1.797497393984937e-11
consistent O 0 1.3886149174968665e-10
with O 0 5.171737062041604e-13
a O 0 5.2967469819920066e-12
role O 0 5.398726257710429e-11
for O 0 2.5286229273641103e-12
BRCA1 O 0 2.9155890146626007e-08
in O 0 1.09401920855845e-09
DNA O 0 3.066195404244354e-07
repair O 0 5.032206900068559e-05
. O 0 2.7397993207500804e-08

Here O 0 3.916670152648294e-07
, O 0 1.777224478693995e-10
it O 0 4.382405462827199e-12
is O 0 1.0860132237944242e-12
shown O 0 9.8849487623065e-12
that O 0 5.1081144522568955e-12
mouse O 0 8.847955257351714e-09
embryonic O 0 7.69297248126577e-09
stem O 0 1.9758440217287898e-08
cells O 0 1.0388642124325997e-07
deficient B-Disease 0 8.789457751845475e-06
in I-Disease 0 2.288740447164983e-10
BRCA1 I-Disease 0 2.616143888189981e-07
are O 0 2.5298121930639184e-10
defective O 0 8.99403289622569e-08
in O 0 5.426624150040027e-10
the O 0 1.2982670494210424e-11
ability O 0 1.258672333026567e-10
to O 0 6.493003617408233e-12
carry O 0 1.5447039480864788e-10
out O 0 3.341531218392646e-10
transcription O 0 9.816557877684318e-08
- O 0 1.3952647748283198e-07
coupled O 0 4.99029972900189e-08
repair O 0 1.5112809705897234e-05
of O 0 8.065937674717194e-12
oxidative O 0 5.42289935179241e-10
DNA O 0 3.582735530471837e-08
damage O 0 2.313060605274586e-07
, O 0 1.0873781736142618e-10
and O 0 1.1967823954073253e-10
are O 0 5.02323876938604e-11
hypersensitive O 0 2.0058421057456144e-07
to O 0 6.736942947949132e-11
ionizing O 0 1.4164338146827049e-08
radiation O 0 1.0352700741123044e-07
and O 0 9.91388637849866e-10
hydrogen O 0 8.081483260369282e-10
peroxide O 0 1.7648295624894672e-06
. O 0 7.233566634567978e-09

These O 0 1.7568718702065667e-09
results O 0 2.9506308507620815e-09
suggest O 0 2.659957809569846e-10
that O 0 1.5678678841335447e-11
BRCA1 O 0 1.2703546303782787e-07
participates O 0 9.616838575476905e-11
, O 0 2.658752992074076e-12
directly O 0 6.361348513922449e-12
or O 0 1.0671439426568341e-10
indirectly O 0 1.9998343259164386e-10
, O 0 9.059285439871889e-12
in O 0 2.453737213414797e-10
transcription O 0 5.401952307693136e-07
- O 0 2.273580150813359e-07
coupled O 0 3.467780373966889e-08
repair O 0 1.0123094398295507e-05
of O 0 9.825212692049501e-12
oxidative O 0 9.774120401928599e-10
DNA O 0 1.9996761579932354e-08
damage O 0 1.969466545403975e-08
. O 0 3.3437819180193173e-10
. O 0 1.969319152195226e-09

Truncation O 0 2.9191418434493244e-05
mutations O 0 3.1533388664684026e-06
in O 0 8.907627524479267e-09
the O 0 2.327489173614694e-10
transactivation O 0 3.1991453397495206e-07
region O 0 5.431348704121319e-09
of O 0 2.075891368524818e-11
PAX6 O 0 8.603864785072801e-07
result O 0 2.705132118308029e-09
in O 0 5.702759930947821e-10
dominant O 0 1.8482716086509754e-06
- O 0 1.762496594892582e-06
negative O 0 5.088287480248255e-08
mutants O 0 3.077996382216952e-07
. O 0 4.0068730555731236e-09

PAX6 O 0 0.0004306403861846775
is O 0 2.156325606961218e-08
a O 0 6.436364774486947e-10
transcription O 0 1.347197819967505e-08
factor O 0 2.9587784999840494e-10
with O 0 2.9566319011131714e-12
two O 0 3.7271272873562467e-11
DNA O 0 1.6999734953060397e-08
- O 0 4.943359144249371e-08
binding O 0 9.007781187619912e-09
domains O 0 1.9268441064923536e-08
( O 0 7.891606812471252e-11
paired O 0 1.863770693333322e-09
box O 0 1.8061641071653867e-08
and O 0 1.2576242269801696e-09
homeobox O 0 9.348818963417216e-08
) O 0 2.046016654710936e-11
and O 0 3.851898661144659e-11
a O 0 3.438402340627533e-10
proline O 0 8.854507314026705e-07
- O 0 9.442148751759305e-08
serine O 0 5.739693278883351e-06
- O 0 1.166643187389127e-06
threonine O 0 4.5787419367115945e-06
( O 0 1.19136700504896e-09
PST O 0 7.935387884572265e-07
) O 0 3.388324620878791e-10
- O 0 3.677495419296406e-09
rich O 0 1.9526300576444555e-09
transactivation O 0 1.4532294017044478e-06
domain O 0 6.623529458238409e-08
. O 0 4.233166706058e-09

PAX6 O 0 0.0060515073128044605
regulates O 0 0.00012725642591249198
eye O 0 0.28296563029289246
development O 0 9.34380661732348e-09
in O 0 3.11311726397534e-10
animals O 0 3.163388995197636e-11
ranging O 0 7.828223486106012e-11
from O 0 1.178627508091612e-11
jellyfish O 0 1.0634580716040176e-10
to O 0 1.0904347737261677e-11
Drosophila O 0 2.3113332081603488e-10
to O 0 1.4141722515237376e-11
humans O 0 1.124968562749018e-09
. O 0 1.0948917328335028e-09

Heterozygous O 0 3.9432015910279006e-05
mutations O 0 2.0098837012483273e-06
in O 0 3.190709030320704e-09
the O 0 4.0106921256333194e-11
human O 0 1.0129604099962108e-10
PAX6 O 0 7.465394560313143e-07
gene O 0 7.572811000500224e-08
result O 0 1.11530740198873e-09
in O 0 6.304627653275219e-11
various O 0 2.965670070631532e-11
phenotypes O 0 5.9365889981677356e-09
, O 0 2.453473882391144e-11
including O 0 3.8145109293452606e-10
aniridia B-Disease 1 1.0
, O 0 3.087129471168737e-06
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 1.1608260308548779e-07
autosomal B-Disease 1 0.919634997844696
dominant I-Disease 1 0.6827964782714844
keratitis I-Disease 1 0.9999946355819702
, O 0 1.2908594726468436e-07
and O 0 7.948963798298792e-08
familial B-Disease 1 0.9780844449996948
foveal I-Disease 1 0.9998034834861755
dysplasia I-Disease 1 0.9999998807907104
. O 0 3.39437036700474e-07

It O 0 1.925131387636725e-09
is O 0 1.9435173956305896e-11
believed O 0 4.850864848693348e-11
that O 0 1.2589663469717016e-12
the O 0 2.7486448447161527e-12
mutated O 0 2.945431099021789e-08
allele O 0 1.4831647021651406e-08
of O 0 1.6863878349315797e-11
PAX6 O 0 2.2494552354146435e-07
produces O 0 1.113186431922486e-09
an O 0 8.64705668179866e-11
inactive O 0 3.757073940846567e-08
protein O 0 1.074315392202152e-08
and O 0 2.8626343961946077e-08
aniridia B-Disease 1 1.0
is O 0 1.1403442634616567e-08
caused O 0 3.2352363010801355e-09
due O 0 6.339624381013209e-10
to O 0 2.608235849521634e-10
genetic O 0 2.2354646489475272e-07
haploinsufficiency O 0 4.826728400075808e-06
. O 0 1.518276171452726e-08

However O 0 1.960329498729152e-08
, O 0 2.7786231648896376e-11
several O 0 2.608203583664981e-12
truncation O 0 4.648142759577922e-09
mutations O 0 2.997805337301429e-09
have O 0 2.2181118053410387e-10
been O 0 7.34623820108915e-11
found O 0 3.7386968521069264e-11
to O 0 1.2821430115522725e-12
occur O 0 9.231271129450658e-12
in O 0 3.823833263916221e-11
the O 0 3.404531517814391e-11
C O 0 4.9397208385926206e-06
- O 0 1.5045884538267273e-08
terminal O 0 9.026459579786206e-09
half O 0 4.984235246752178e-10
of O 0 7.987048522561935e-12
PAX6 O 0 1.0820171780778765e-07
in O 0 6.212358405477403e-10
patients O 0 4.012593812774412e-09
with O 0 1.240215291575808e-10
Aniridia B-Disease 1 1.0
resulting O 0 4.495955552297204e-10
in O 0 9.989083171735302e-11
mutant O 0 6.547044018034853e-10
proteins O 0 8.45579162245258e-11
that O 0 4.149265132868951e-12
retain O 0 5.2640475312060175e-11
the O 0 4.9606907123744826e-12
DNA O 0 2.020978939754059e-09
- O 0 8.368543635839387e-10
binding O 0 3.302834394869336e-10
domains O 0 1.2226754053656919e-09
but O 0 2.506976848337672e-10
have O 0 6.466311514019552e-11
lost O 0 1.780387504091152e-09
most O 0 1.766273650775918e-12
of O 0 2.654328308798054e-13
the O 0 1.9691817620959284e-11
transactivation O 0 1.213329312577116e-07
domain O 0 2.192033932146842e-08
. O 0 1.7646599737020097e-09

It O 0 1.4915706003648666e-08
is O 0 1.0701320385386737e-10
not O 0 2.0588255059128535e-11
clear O 0 1.2980467395395934e-11
whether O 0 1.6754445053557276e-12
such O 0 1.7590253255719834e-12
mutants O 0 1.2159530626831838e-07
really O 0 1.0327282325306442e-05
behave O 0 9.29470778121555e-10
as O 0 1.4968234984813478e-11
loss O 0 1.8253973332882367e-10
- O 0 5.023691462824331e-10
of O 0 1.5399258257442483e-11
- O 0 1.0013644136108724e-08
function O 0 1.60832264173294e-10
mutants O 0 1.1316880765832593e-08
as O 0 5.783380441215513e-10
predicted O 0 4.849704193787829e-09
by O 0 8.963298159248012e-11
haploinsufficiency O 0 9.779944321053335e-07
. O 0 3.6132101755015356e-09

Contrary O 0 4.781517759511189e-08
to O 0 8.404658913274687e-11
this O 0 1.8608339695525e-12
theory O 0 1.9444145946123648e-11
, O 0 1.32675402782223e-12
our O 0 1.5687106561662612e-12
data O 0 1.572450919473667e-10
showed O 0 2.512181129787905e-09
that O 0 6.032687370483014e-13
these O 0 4.938502948595436e-13
mutants O 0 1.9319869315470584e-10
are O 0 2.887353767536127e-12
dominant O 0 5.190869512006202e-09
- O 0 4.253319474400996e-09
negative O 0 7.167886284520364e-10
in O 0 1.1072819050550464e-10
transient O 0 1.157045126376488e-09
transfection O 0 6.996134516157326e-08
assays O 0 3.8448579431360486e-08
when O 0 1.8883991592666405e-10
they O 0 9.349425747484652e-12
are O 0 2.055944173587343e-12
coexpressed O 0 9.46123068779059e-10
with O 0 4.193525734996761e-12
wild O 0 8.214766644698557e-09
- O 0 1.3207019264882547e-06
type O 0 3.7839606648049084e-06
PAX6 O 0 2.964442865049932e-05
. O 0 2.031712931227503e-08

We O 0 7.234436605330075e-09
found O 0 8.245101129622512e-11
that O 0 1.1019419968519295e-12
the O 0 1.4442271163706e-12
dominant O 0 6.346139258539552e-08
- O 0 1.5136329523102177e-07
negative O 0 3.6307918893641045e-09
effects O 0 4.864527003434205e-09
result O 0 7.185897710204614e-11
from O 0 5.239143754248721e-12
the O 0 1.1867839610352204e-12
enhanced O 0 2.1949476958216252e-10
DNA O 0 4.4904793772282403e-10
binding O 0 5.00103049250189e-11
ability O 0 1.7543161368038795e-10
of O 0 2.0316118579111198e-12
these O 0 2.23054560932745e-11
mutants O 0 3.3682368894005776e-08
. O 0 2.13528772441407e-09

Kinetic O 0 6.574091315769692e-08
studies O 0 1.957874395941417e-08
of O 0 1.2737197581380588e-11
binding O 0 4.285452437358117e-09
and O 0 1.190447185273058e-09
dissociation O 0 1.2723322395657988e-09
revealed O 0 1.0511450598826855e-09
that O 0 1.970751470001253e-12
various O 0 6.541757153338823e-12
truncation O 0 8.01826374186021e-08
mutants O 0 3.251440148233087e-07
have O 0 1.5421904864254543e-09
3 O 0 2.737362558846712e-10
- O 0 3.620696986672556e-08
5 O 0 1.5206806924794591e-09
- O 0 3.570742279634942e-08
fold O 0 2.2152295553468093e-09
higher O 0 2.9956892522164935e-10
affinity O 0 3.958646951907063e-11
to O 0 6.662640274560094e-13
various O 0 2.020975834599037e-12
DNA O 0 4.1304845654899225e-10
- O 0 1.0896141627858569e-10
binding O 0 1.1630267929274574e-11
sites O 0 8.447698790492453e-11
when O 0 8.621629105087791e-11
compared O 0 1.6199476482459119e-10
with O 0 6.557019467320901e-13
the O 0 8.151836844438876e-12
wild O 0 5.163950600461931e-09
- O 0 3.236762893266132e-07
type O 0 1.1086725635323091e-06
PAX6 O 0 1.2114752280467656e-05
. O 0 1.700887963806963e-08

These O 0 3.2370635061340636e-09
results O 0 5.000823644074615e-10
provide O 0 1.4170207542074653e-11
a O 0 5.635995142805328e-11
new O 0 8.42572178694212e-10
insight O 0 3.3306137847688433e-09
into O 0 1.9407465218224118e-11
the O 0 3.786071716554984e-12
role O 0 2.0206220377461115e-11
of O 0 7.794290928821168e-13
mutant O 0 6.300991284291513e-09
PAX6 O 0 4.567209828110208e-07
in O 0 6.452962608705093e-09
causing O 0 1.2818905759104382e-07
aniridia B-Disease 1 1.0
. O 0 8.051731725799982e-09
. O 0 4.433867939468428e-09

Reversal O 0 3.82771177100949e-05
of O 0 2.2222597095833407e-08
severe O 1 0.6344795823097229
hypertrophic B-Disease 1 0.9999996423721313
cardiomyopathy I-Disease 1 1.0
and O 0 1.6654568071317044e-06
excellent O 0 1.297325889026979e-05
neuropsychologic O 0 0.00027198990574106574
outcome O 0 6.697682692902163e-07
in O 0 1.4290469252387084e-08
very B-Disease 0 2.076605142065091e-06
- I-Disease 0 2.0195508909637283e-07
long I-Disease 0 7.062834761484282e-09
- I-Disease 0 8.256645145365837e-09
chain I-Disease 0 5.7506184703015606e-08
acyl I-Disease 0 1.821332489271299e-07
- I-Disease 0 3.122045910686211e-08
coenzyme I-Disease 0 2.2363552787396657e-08
A I-Disease 0 8.238491666645587e-09
dehydrogenase I-Disease 0 9.75148068391718e-05
deficiency I-Disease 0 0.0005089789046905935
. O 0 1.4619343069455226e-08

Very B-Disease 0 2.9373268262133934e-05
- I-Disease 0 1.3672094610228669e-05
long I-Disease 0 7.65741674513265e-08
- I-Disease 0 1.048147026949664e-07
chain I-Disease 0 2.1539828765071434e-07
acyl I-Disease 0 7.427323680531117e-07
- I-Disease 0 1.1727198057087662e-07
coenzyme I-Disease 0 1.4596440500724839e-08
A I-Disease 0 6.011344200196334e-10
dehydrogenase I-Disease 0 6.475293616858835e-07
( I-Disease 0 1.981761199587595e-09
VLCAD I-Disease 0 8.67430935613811e-06
) I-Disease 0 3.4087974665197862e-09
deficiency I-Disease 0 2.2603353500016965e-05
is O 0 7.6018448480486e-11
a O 0 2.5635524814049404e-09
disorder O 0 4.459525371203199e-05
of O 0 1.8437952553629344e-11
fatty O 0 1.6262401203448462e-08
acid O 0 7.870761820072403e-10
beta O 0 2.416225552970275e-10
oxidation O 0 1.4780883461629202e-10
that O 0 3.262423664551761e-11
reportedly O 0 7.724495709737766e-09
has O 0 3.1300384506494083e-10
high O 0 3.4929723113918953e-08
rates O 0 3.817612196144182e-06
of O 0 4.7676411429886656e-11
morbidity O 0 1.4401870430447161e-05
and O 0 1.785741332582802e-08
mortality O 0 1.3576222102074098e-07
. O 0 2.7915769695852077e-09

We O 0 5.012705805995665e-09
describe O 0 5.488748344717465e-10
the O 0 8.659844542846518e-12
outcome O 0 1.0095001917731494e-10
of O 0 7.406447417174222e-13
a O 0 5.515327777816381e-11
5 O 0 1.8301037074675008e-10
- O 0 3.225952127650089e-08
year O 0 3.725581176894366e-09
- O 0 6.386793671708801e-08
old O 0 3.021295924554579e-06
girl O 0 1.4650546518168994e-06
with O 0 8.262170392292489e-10
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 1.203935369176179e-07
was O 0 5.5769309170727865e-09
first O 0 5.813614867289374e-11
seen O 0 6.1950742313854334e-09
at O 0 5.482282405822048e-10
5 O 0 2.1590096030421613e-11
months O 0 8.306377807798526e-11
of O 0 1.0482885176230083e-12
age O 0 2.6182658263707026e-09
with O 0 1.8892565289974073e-10
severe O 1 0.9961572289466858
hypertrophic B-Disease 1 0.9999998807907104
cardiomyopathy I-Disease 1 1.0
, O 0 0.02266835980117321
hepatomegaly B-Disease 1 1.0
, O 0 7.349454790528398e-06
encephalopathy B-Disease 1 0.939306914806366
, O 0 7.516613997893273e-09
and O 0 1.7012515840519882e-08
hypotonia B-Disease 0 0.006515988614410162
. O 0 3.5978828805127705e-08

Biochemical O 0 2.3119380784919485e-05
studies O 0 1.0325923540221993e-05
indicated O 1 0.9998158812522888
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 1.765308041967728e-07
by O 0 9.481495449881194e-11
a O 0 2.2127211174449712e-09
stable O 0 6.2165404415281955e-06
yet O 0 2.905618501358731e-08
inactive O 0 3.022598704660595e-08
enzyme O 0 1.4654352398224546e-08
. O 0 6.482813175168189e-10

Molecular O 0 2.5169504169753054e-07
genetic O 0 1.8455911288128846e-07
analysis O 0 1.3750377725330054e-08
of O 0 7.691702830214808e-11
her O 0 1.3517640340410253e-08
VLCAD O 0 2.1204310542088933e-05
gene O 0 1.642583526972885e-07
revealed O 0 4.47961127747476e-07
a O 0 2.8935716045452864e-09
T1372C O 0 6.010977244841342e-07
( O 0 2.4138082643787584e-09
F458L O 0 9.587036231550883e-08
) O 0 3.814380200584111e-10
missense O 0 1.5775796100570005e-06
mutation O 0 1.7498840065854893e-07
and O 0 2.036596447041461e-09
a O 0 7.377319644064073e-09
1668 O 0 0.005069756414741278
ACAG O 0 0.000195393935428001
1669 O 0 1.4550997548212763e-05
splice O 0 3.7261252145981416e-05
site O 0 2.889481720558251e-07
mutation O 0 1.1970710147579666e-06
. O 0 2.266215126667248e-08

After O 0 2.5688693838787913e-08
initial O 0 1.9575225884693737e-09
treatment O 0 1.0004227446458458e-09
with O 0 2.0214045715061246e-11
intravenous O 0 2.328144255159259e-08
glucose O 0 6.351543106575264e-06
and O 0 1.3788135078129926e-09
carnitine O 0 4.163035072224375e-08
, O 0 1.914364153310366e-11
the O 0 1.351241254304858e-11
patient O 0 7.889734199295617e-09
has O 0 6.527053897364965e-11
thrived O 0 3.1341397033202156e-08
on O 0 2.5481272647454034e-10
a O 0 1.3187482217347224e-09
low O 0 0.023855894804000854
- O 0 3.3976616578001995e-06
fat O 0 2.7219597242833515e-08
diet O 0 6.305424515851143e-10
supplemented O 0 1.543519895230716e-10
with O 0 9.814761850468479e-12
medium O 0 5.259580007077602e-07
- O 0 5.4953325445694645e-08
chain O 0 5.471277830793042e-08
triglyceride O 0 5.6695565575637374e-08
oil O 0 1.0841113784465506e-08
and O 0 1.363664459130831e-10
carnitine O 0 9.574332437978228e-09
and O 0 8.896819392312239e-11
avoidance O 0 3.6204399478378946e-09
of O 0 9.418047071385605e-12
fasting O 0 3.0875742851321775e-08
. O 0 7.653583877775816e-10

Her O 0 0.00023112820053938776
ventricular O 0 0.3115372359752655
hypertrophy O 0 0.0012912601232528687
resolved O 0 6.515025233966298e-06
significantly O 0 1.6098348964987963e-07
over O 0 2.3618521027835016e-10
1 O 0 1.680519057245533e-10
year O 0 1.5831129462906546e-10
, O 0 8.381170757409961e-12
and O 0 1.9951176821741967e-10
cognitively O 0 2.655459638845059e-07
, O 0 6.160449234071663e-11
she O 0 2.1710822029064047e-09
is O 0 1.9321105045738696e-12
in O 0 1.854184687732907e-11
the O 0 3.4633843102455097e-12
superior O 0 1.5730028390947837e-10
range O 0 4.447366364068728e-10
for O 0 2.0900162156500812e-10
age O 0 4.47686687721216e-09
. O 0 5.350241916168841e-10

Clinical O 0 1.3561692639996181e-06
recognition O 0 1.92936688847567e-08
of O 0 1.585517566127237e-07
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 2.2095918428277628e-09
important O 0 5.012798509618221e-10
because O 0 4.298564837412755e-10
it O 0 4.063374983709345e-11
is O 0 4.3164877054635564e-12
one O 0 8.186490547956726e-12
of O 0 1.8927054205603727e-13
the O 0 9.260898471696866e-12
few O 0 1.0556698848418478e-09
directly O 0 5.162874017194952e-10
treatable O 0 1.0886045629376895e-06
causes O 0 2.8021396314414915e-09
of O 0 3.237773382736009e-09
cardiomyopathy B-Disease 1 1.0
in O 0 3.8153888226588606e-07
children O 0 7.010719560440748e-09
. O 0 1.3918127761414212e-10
. O 0 1.2629991497092874e-09

Cloning O 0 7.083006181574092e-08
of O 0 2.3111733013503333e-11
a O 0 2.7125487619961142e-11
novel O 0 1.0850949999641202e-10
member O 0 2.278142778588954e-11
of O 0 4.4264396835413944e-13
the O 0 2.789477156206477e-11
low O 0 2.2167746465129312e-06
- O 0 1.3651965957706125e-07
density O 0 9.401616152260317e-10
lipoprotein O 0 4.860096396441804e-07
receptor O 0 2.5455648255956476e-08
family O 0 2.4148688382297223e-08
. O 0 6.641858174560866e-09

A O 0 2.0995955196667637e-08
gene O 0 3.2063347532584885e-08
encoding O 0 8.956026142925566e-09
a O 0 3.0003666218192393e-10
novel O 0 1.2530462223381278e-09
transmembrane O 0 6.50136655622191e-09
protein O 0 1.945653060886343e-08
was O 0 1.6307406980331507e-08
identified O 0 1.5116805029968816e-10
by O 0 1.8405476795435582e-12
DNA O 0 3.5795896802248706e-10
sequence O 0 2.9078597169052145e-11
analysis O 0 2.727635825539032e-11
within O 0 2.4122778427559943e-11
the O 0 5.4742055333179e-10
insulin B-Disease 1 0.9987121820449829
- I-Disease 1 0.9999997615814209
dependent I-Disease 1 0.9999998807907104
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 1.1430929447442395e-07
IDDM B-Disease 0 1.4458018085861113e-05
) O 0 5.569550376449683e-10
locus O 0 2.6100401839812548e-08
IDDM4 O 0 6.427123480534647e-06
on O 0 5.983792306096802e-08
chromosome O 0 3.552171619958244e-05
11q13 O 0 7.468501735274913e-06
. O 0 2.8613788671805196e-08

Based O 0 2.2648583453133142e-08
on O 0 2.6364164185110894e-09
its O 0 1.4403442327726168e-10
chromosomal O 0 8.655136412016873e-07
position O 0 2.1171170772049663e-07
, O 0 2.855202879681329e-11
this O 0 1.0905694750040773e-12
gene O 0 4.0939110435012083e-10
is O 0 8.642089648069895e-12
a O 0 7.251043949302316e-12
candidate O 0 6.354112375150933e-11
for O 0 5.4565098099590426e-12
conferring O 0 2.6212338966047355e-09
susceptibility O 0 1.544158294564113e-07
to O 0 2.84969061681295e-08
diabetes B-Disease 0 0.07529602944850922
. O 0 6.672955965569827e-09

The O 0 9.284359947514531e-10
gene O 0 2.191218761993241e-08
, O 0 8.082527008790308e-11
termed O 0 1.198268240187872e-08
low O 0 2.3939026505104266e-05
- O 0 2.6301956950192107e-06
density O 0 9.096729480795318e-10
lipoprotein O 0 1.2236726831815758e-07
receptor O 0 1.1012839529200846e-09
related O 0 3.127139658332112e-09
protein O 0 3.93046750701842e-09
5 O 0 2.325306197592525e-10
( O 0 9.077936319323854e-11
LRP5 O 0 8.717549349057663e-08
) O 0 6.853598417955187e-12
, O 0 1.0262887545006705e-12
encodes O 0 2.5763925715072133e-11
a O 0 4.1130354330731755e-12
protein O 0 3.2389144144495674e-10
of O 0 1.830298239358097e-11
1615 O 0 1.581363449076889e-07
amino O 0 1.507994423777248e-10
acids O 0 2.5536921535729284e-11
that O 0 2.6088289514780705e-13
contains O 0 1.8331543965091623e-13
conserved O 0 2.3978600355301083e-11
modules O 0 4.253236374207603e-10
which O 0 5.5729028163031824e-12
are O 0 9.79545546238303e-13
characteristic O 0 3.524185804293367e-11
of O 0 1.6407930786624392e-12
the O 0 1.3863707404304648e-10
low O 0 0.0005687300581485033
- O 0 3.703765287355054e-06
density O 0 1.5443364365097523e-09
lipoprotein O 0 3.902698153979145e-06
( O 0 9.040411197425158e-10
LDL O 0 6.41138797163876e-07
) O 0 2.295114098771478e-10
receptor O 0 4.342158188563872e-09
family O 0 7.044753225216027e-09
. O 0 3.8626288834109346e-09

These O 0 5.940301583962082e-10
modules O 0 1.0187135579542428e-09
include O 0 7.772560373098258e-12
a O 0 4.507106840523356e-11
putative O 0 6.88086565503454e-09
signal O 0 6.5933516424365735e-09
peptide O 0 1.2302141250142284e-10
for O 0 1.9445879368557017e-12
protein O 0 4.3882796701977256e-11
export O 0 6.136730235084542e-09
, O 0 1.0039470643707915e-10
four O 0 4.4765722378992123e-11
epidermal O 0 2.4808647580698562e-08
growth O 0 1.813146788265385e-08
factor O 0 1.053071518875015e-09
( O 0 1.5749360149364122e-10
EGF O 0 3.196997511167865e-08
) O 0 4.1626164321018067e-11
repeats O 0 1.147955508429277e-09
with O 0 8.487618594066326e-12
associated O 0 1.5708208067621854e-09
spacer O 0 9.19015656108968e-06
domains O 0 4.55561668388782e-08
, O 0 3.6194141433965044e-11
three O 0 6.052263551437065e-11
LDL O 0 2.6210361170342367e-07
- O 0 6.51131859541465e-09
receptor O 0 8.4045670423194e-10
( O 0 9.238426690316714e-11
LDLR O 0 3.3707186730680405e-07
) O 0 7.624439274378503e-11
repeats O 0 2.0444115289564024e-09
, O 0 1.6200520092102266e-11
a O 0 1.6357788387710848e-11
single O 0 1.4706530437891274e-10
transmembrane O 0 1.6811226855040218e-09
spanning O 0 2.3833306439513535e-09
domain O 0 4.277058263113531e-09
, O 0 3.693526040571271e-11
and O 0 1.1822749376722008e-11
a O 0 9.405520806637924e-11
cytoplasmic O 0 5.100998023976899e-08
domain O 0 6.387268314256289e-08
. O 0 5.164826788472965e-09

The O 0 6.604902735851681e-10
encoded O 0 1.858073805927063e-09
protein O 0 5.006494774306702e-09
has O 0 5.911453965223856e-11
a O 0 4.885012099692387e-12
unique O 0 1.1958416895607726e-11
organization O 0 6.954774950385101e-11
of O 0 1.5820317278425478e-11
EGF O 0 1.4248138313632808e-07
and O 0 1.3387135844311615e-09
LDLR O 0 2.1002017547289142e-06
repeats O 0 9.429331093713245e-09
; O 0 1.003303343183326e-11
therefore O 0 3.713233540092453e-11
, O 0 1.6758800944205454e-11
LRP5 O 0 3.539368549354549e-07
likely O 0 2.8583664324344227e-09
represents O 0 2.6859727983441495e-11
a O 0 7.694828108029128e-11
new O 0 1.2576721886148334e-09
category O 0 3.9098551951610716e-08
of O 0 1.4071980559970942e-11
the O 0 8.82445727601322e-10
LDLR O 0 1.5008850823505782e-05
family O 0 9.718467808284004e-09
. O 0 1.281924788543165e-09

Both O 0 8.191231026799528e-10
human O 0 2.6262869656790144e-10
and O 0 3.337423115645777e-10
mouse O 0 6.142986990198551e-07
LRP5 O 0 2.0993344151065685e-05
cDNAs O 0 3.800411718657415e-08
have O 0 1.7220655457172995e-10
been O 0 6.198507679355814e-11
isolated O 0 3.3111477448777293e-10
and O 0 5.022038340740664e-12
the O 0 3.274414973105516e-13
encoded O 0 3.1684731227610285e-11
mature O 0 2.65263540299987e-11
proteins O 0 1.3188896589438892e-12
are O 0 2.360767831222077e-13
95 O 0 2.382737410155933e-11
% O 0 5.575199590185376e-12
identical O 0 3.7447650536037713e-10
, O 0 5.048990739386916e-11
indicating O 0 3.748692023464173e-08
a O 0 2.9619307007067164e-09
high O 0 7.627016316291702e-07
degree O 0 9.824649538359154e-08
of O 0 6.365620704162911e-12
evolutionary O 0 1.0686919404978568e-10
conservation O 0 3.063828357685594e-11
. O 0 1.2883365207994046e-10
. O 0 1.92615234873017e-09

The O 0 7.125565026910863e-09
APC B-Disease 0 1.0328618316179927e-07
variants O 0 7.205148477851253e-08
I1307K O 0 8.133790174724709e-08
and O 0 1.6756668275164088e-10
E1317Q O 0 1.591005438505988e-09
are O 0 2.5837582941223847e-12
associated O 0 6.569024879610197e-09
with O 1 0.9774109721183777
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 5.309522776997255e-08
but O 0 5.846532702413754e-10
not O 0 1.1313027598047753e-10
always O 0 1.128656057503008e-10
with O 0 5.071464624119282e-13
a O 0 4.2589023974137774e-10
family O 0 9.471251560810856e-10
history O 0 1.9074628543336303e-09
. O 0 2.039632684969206e-09

Classical O 0 0.12022385001182556
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 0.00011218262807233259
FAP B-Disease 0 5.093763320473954e-06
) O 0 1.080345812809469e-09
is O 0 2.6426767024689823e-11
a O 0 9.148983237672326e-10
high O 1 0.8477955460548401
- O 1 0.9999998807907104
penetrance O 1 0.9999911785125732
autosomal B-Disease 1 0.9999994039535522
dominant I-Disease 1 0.9999550580978394
disease I-Disease 1 0.9985742568969727
that O 0 7.680726055170339e-10
predisposes O 0 2.9439540583098278e-08
to O 0 3.615515872801289e-11
hundreds O 0 3.72025188433156e-11
or O 0 1.4951521964956527e-10
thousands O 0 9.725022176443332e-11
of O 0 2.3256593806308956e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9830973148345947
carcinoma I-Disease 1 1.0
and O 0 2.1812847084135e-09
that O 0 2.5705026648892293e-11
results O 0 1.1857217985244972e-10
from O 0 8.105772997257787e-12
truncating O 0 1.316160780362452e-08
mutations O 0 8.787644389940397e-09
in O 0 4.5712272855880087e-10
the O 0 1.1401799643318e-10
APC B-Disease 0 1.1710731939729158e-08
gene O 0 3.011406235486902e-08
. O 0 6.308194411275281e-09

A O 0 1.8623649111759732e-07
variant O 0 1.2239765965205152e-05
of O 0 1.1863512394683084e-09
FAP B-Disease 0 2.599171239126008e-06
is O 0 1.0351851642553811e-07
attenuated B-Disease 1 0.9995653033256531
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 0.9999998807907104
coli I-Disease 1 1.0
, O 0 3.03132239309889e-08
which O 0 5.69606029010572e-11
results O 0 1.225205353838632e-10
from O 0 1.1025185972513007e-11
germ O 0 0.00012175126903457567
- O 0 7.109600574040087e-06
line O 0 2.5842226136774116e-07
mutations O 0 4.365418249108188e-09
in O 0 4.311275503265932e-10
the O 0 3.046800658990101e-11
5 O 0 2.7738629101992096e-11
and O 0 2.7598305585296856e-11
3 O 0 4.279417965824539e-12
regions O 0 1.8873467025337654e-11
of O 0 3.1550957593079465e-12
the O 0 1.8635031018288117e-10
APC B-Disease 0 1.8135963841814373e-08
gene O 0 3.8827224102533364e-08
. O 0 6.3694192142804695e-09

Attenuated B-Disease 1 0.9999957084655762
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 1 0.9999982118606567
have O 0 5.0343150093112854e-08
" O 0 1.6380126144355245e-09
multiple O 0 1.991029208170403e-08
" O 1 0.9999524354934692
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 1.2813094585339968e-08
typically O 0 4.58604043629407e-09
fewer O 0 3.325045794255743e-10
than O 0 1.9110589846715875e-11
100 O 0 2.3072004376456512e-11
) O 0 3.812907021366607e-12
without O 0 3.106827989318717e-11
the O 0 4.866155048355303e-11
florid O 0 2.07021275855368e-06
phenotype O 0 7.182276107187135e-08
of O 0 5.838216715625677e-11
classical O 0 6.818263642571765e-08
FAP B-Disease 0 9.340439532934397e-07
. O 0 7.323302408934751e-09

Another O 0 2.0511111031851215e-08
group O 0 2.581304281434882e-09
of O 0 4.540219328968975e-12
patients O 0 5.185474272195734e-10
with O 0 1.9414118750116227e-12
multiple O 0 2.3826944861582433e-09
adenomas B-Disease 0 0.013135677203536034
has O 0 5.242320355591801e-09
no O 0 3.6466973885040943e-10
mutations O 0 1.4181659180323436e-09
in O 0 6.8217924364955e-11
the O 0 1.1740951960659274e-11
APC B-Disease 0 4.089875937918208e-10
gene O 0 4.861055447058504e-10
, O 0 2.745874361220757e-11
and O 0 1.578182896866398e-11
their O 0 3.409561175060638e-11
phenotype O 0 2.249780628460485e-08
probably O 0 1.096445458870221e-07
results O 0 2.281670685722048e-10
from O 0 8.05048996216362e-12
variation O 0 1.4144433402307754e-09
at O 0 1.9901853498538458e-09
a O 0 2.8691512707346156e-11
locus O 0 5.971040328844879e-10
, O 0 4.565404304601728e-11
or O 0 9.305061582365326e-11
loci O 0 2.0738899486616447e-10
, O 0 1.5749323720171127e-11
elsewhere O 0 1.0588075971540434e-09
in O 0 2.43402936694892e-10
the O 0 1.194483678634839e-10
genome O 0 4.663060604315206e-09
. O 0 3.6546232706768933e-09

Recently O 0 1.7802850607040455e-06
, O 0 3.1293159730161335e-10
however O 0 5.0888432356899216e-11
, O 0 8.102662421224927e-13
a O 0 5.482287800812058e-12
missense O 0 9.611056839275989e-08
variant O 0 6.920597570569953e-06
of O 0 2.6509067163615896e-10
APC B-Disease 0 1.6401337177285313e-07
( O 0 2.2375562513943237e-10
I1307K O 0 3.2525129256555374e-08
) O 0 8.026560666118954e-11
was O 0 8.693485931132727e-09
described O 0 1.7211131131400492e-10
that O 0 1.693100304053785e-12
confers O 0 5.669472530334119e-11
an O 0 1.0697126778119737e-12
increased O 0 1.5706598688325357e-08
risk O 0 0.0007610338507220149
of O 0 0.038071293383836746
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 4.187950819467545e-10
including O 0 1.2362610934957274e-11
multiple O 0 2.7914919265015214e-09
adenomas B-Disease 0 0.0006907145143486559
, O 0 5.41099920425836e-09
in O 0 2.5531114999921556e-08
Ashkenazim O 0 0.0005725700175389647
. O 0 1.6122125856554703e-08

We O 0 1.6731901197886145e-08
have O 0 1.1666154153822106e-10
studied O 0 3.500365275410644e-10
a O 0 7.020664431756085e-12
set O 0 9.067623041314476e-11
of O 0 1.448364973961891e-12
164 O 0 8.205778279091192e-09
patients O 0 1.5099674399721152e-08
with O 0 2.253987552158776e-10
multiple O 1 0.9999982118606567
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.0008320044726133347
/ I-Disease 1 0.999313473701477
or I-Disease 1 0.7061325907707214
carcinoma I-Disease 1 1.0
and O 0 2.3925277758962693e-08
analyzed O 0 1.1564371504846349e-07
codons O 0 2.6070580361192697e-07
1263 O 0 2.126596427842742e-06
- O 0 1.1337662044752506e-06
1377 O 0 2.1744665446021827e-06
( O 0 2.8972828580720034e-09
exon O 0 1.3277370669584343e-07
15G O 0 2.7908978950108576e-07
) O 0 4.3963138685043646e-11
of O 0 7.761535012786036e-13
the O 0 7.13797380577641e-12
APC B-Disease 0 2.1058188526268395e-09
gene O 0 8.796746109318576e-10
for O 0 3.043884588826984e-11
germ O 0 3.7836391129530966e-05
- O 0 4.605380581779173e-06
line O 0 3.21231595989957e-07
variants O 0 6.456128858189913e-07
. O 0 8.45534753324273e-09

Three O 0 2.0836695924231208e-08
patients O 0 2.4150255129029574e-08
with O 0 1.4306619257331565e-11
the O 0 3.402758977366638e-11
I1307K O 0 3.8830037851766974e-08
allele O 0 2.525938391784166e-08
were O 0 4.517300755679798e-09
detected O 0 3.1863926608366455e-08
, O 0 6.180819311224495e-12
each O 0 1.5200259670736238e-12
of O 0 1.3892288361350147e-11
Ashkenazi O 0 5.943576297795516e-07
descent O 0 1.5263589148162282e-07
. O 0 5.277091208455431e-09

Four O 0 8.398694006928054e-08
patients O 0 2.5763532107703213e-07
had O 0 2.482236194367715e-09
a O 0 2.6381505313644027e-10
germ O 0 0.000741854659281671
- O 0 3.640909926616587e-05
line O 0 3.193956672475906e-07
E1317Q O 0 8.8619273697077e-08
missense O 0 1.7389723439009686e-07
variant O 0 1.9827155028906418e-07
of O 0 7.986073607968436e-12
APC O 0 2.282316113877414e-09
that O 0 9.232363137878785e-12
was O 0 1.8660579748086548e-09
not O 0 7.839709784129845e-12
present O 0 9.308921905884504e-13
in O 0 1.977380204021273e-10
controls O 0 1.1479296517791227e-06
; O 0 1.0927333690680108e-11
one O 0 5.600918166759339e-12
of O 0 5.882807804259704e-14
these O 0 8.292074709162489e-13
individuals O 0 1.512642333438563e-12
had O 0 3.4513103486233376e-08
an O 0 2.843245821074203e-12
unusually O 0 2.534908116746948e-10
large O 0 1.564659339592378e-11
number O 0 1.440932234642034e-10
of O 0 3.399249631774737e-11
metaplastic B-Disease 0 1.168716153188143e-05
polyps I-Disease 0 1.1798330490364606e-07
of I-Disease 0 1.4131099068670494e-11
the I-Disease 0 2.2083687656326845e-10
colorectum I-Disease 0 5.041704298491823e-07
. O 0 3.0785227700391715e-09

There O 0 9.760413810511182e-09
is O 0 2.1083405854493975e-11
increasing O 0 5.386792140821273e-12
evidence O 0 4.358608265975228e-11
that O 0 2.203843010861739e-12
there O 0 2.4082725830903984e-12
exist O 0 3.197199796578509e-11
germ O 0 5.613666758108593e-07
- O 0 7.03203983931644e-09
line O 0 7.576127503128305e-10
variants O 0 3.1993244165029466e-10
of O 0 1.104578668115197e-12
the O 0 6.528320852655645e-12
APC B-Disease 0 3.4545472038516323e-10
gene O 0 2.8241911587123525e-10
that O 0 6.631366896575619e-12
predispose O 0 7.414825975438077e-10
to O 0 2.394508636510695e-12
the O 0 2.5548209381387466e-12
development O 0 2.5803172098992633e-11
of O 0 1.0232484304317779e-10
multiple O 1 0.9887409806251526
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9998785257339478
carcinoma I-Disease 1 1.0
, O 0 4.682401133493386e-09
but O 0 4.5734860343316086e-10
without O 0 1.875075442137053e-11
the O 0 2.4195217010469783e-11
florid O 0 6.793761713197455e-06
phenotype O 0 2.489770452029916e-07
of O 0 1.617350524341088e-11
classical O 0 1.603772048497376e-08
FAP B-Disease 0 2.52105767373223e-08
, O 0 6.252845463627921e-11
and O 0 6.781041873848981e-12
possibly O 0 3.547547325344347e-11
with O 0 1.2616827070946468e-12
importance O 0 1.6024565008265768e-09
for O 0 0.0030319662764668465
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 1.4061156434763689e-06
in O 0 1.5167925249137681e-10
the O 0 5.341518893864361e-12
general O 0 6.458481319193687e-12
population O 0 3.84090675931148e-12
. O 0 2.7779450614828782e-11
. O 0 7.243062261075295e-10

Genomic O 0 8.602224284004478e-07
structure O 0 3.918223967502854e-08
of O 0 3.629168146557227e-11
the O 0 2.2771359797779667e-10
human O 0 3.76754414332936e-08
congenital B-Disease 1 1.0
chloride I-Disease 1 0.9999980926513672
diarrhea I-Disease 1 1.0
( O 0 7.111309514584718e-06
CLD B-Disease 0 0.19786269962787628
) O 0 4.346865090099072e-09
gene O 0 3.882434214119712e-07
. O 0 2.773967722191628e-08

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 0.0005584288737736642
CLD B-Disease 1 0.9976468682289124
) O 0 2.7554780679395208e-09
is O 0 1.1931175492030377e-10
caused O 0 6.489540155252271e-11
by O 0 1.0691074761592922e-11
mutations O 0 4.782847007334112e-09
in O 0 1.0235724767770904e-10
a O 0 8.228981385194345e-11
gene O 0 8.03571342800069e-09
which O 0 3.5432617950803547e-10
encodes O 0 7.910830213120335e-09
an O 0 6.84436896047913e-10
intestinal O 0 5.632904503727332e-06
anion O 0 8.435512199866935e-07
transporter O 0 4.439866461325437e-05
. O 0 4.7305732664426614e-08

We O 0 9.750164764454894e-08
report O 0 8.132142959027533e-09
here O 0 7.083239550453868e-11
the O 0 1.0830759032687265e-12
complete O 0 1.7318399318788646e-12
genomic O 0 1.2706727336997403e-10
organization O 0 3.587427577222968e-11
of O 0 1.0801154892367548e-12
the O 0 2.70692530890404e-11
human O 0 9.655307109390776e-11
CLD B-Disease 0 8.603077503721579e-07
gene O 0 4.271457409998902e-09
which O 0 7.390114215022336e-11
spans O 0 4.970184819264034e-10
approximately O 0 3.823424563065281e-11
39kb O 0 1.8271568933414528e-06
, O 0 4.505870954130131e-10
and O 0 3.1651647969255237e-10
comprises O 0 9.584317367528072e-11
21 O 0 1.4378306323337142e-09
exons O 0 4.439150558255278e-08
. O 0 4.013588572604476e-09

All O 0 1.596462517738928e-08
exon O 0 7.625845341863169e-07
/ O 0 2.633574069932365e-07
intron O 0 6.873810889373999e-07
boundaries O 0 3.3833423174201016e-08
conform O 0 1.6921602252750745e-07
to O 0 1.447107156327121e-10
the O 0 3.961262429186263e-10
GT O 0 3.789763923123246e-06
/ O 0 5.817533292429289e-06
AG O 1 0.9974343180656433
rule O 0 1.1103920449784255e-08
. O 0 2.8880686731014293e-09

An O 0 1.4391037250760519e-09
analysis O 0 1.3877736737555324e-09
of O 0 2.8956763202525604e-12
the O 0 1.6826543630665824e-11
putative O 0 5.108628631234069e-09
promoter O 0 2.2205183469736767e-08
region O 0 3.5187219804555525e-09
sequence O 0 1.681517147744671e-09
shows O 0 1.749331790534825e-09
a O 0 5.317625229039891e-10
putative O 0 1.3548904576055065e-07
TATA O 0 9.060976481123362e-06
box O 0 4.469395165074275e-08
and O 0 1.2501290003186227e-09
predicts O 0 1.626779777552656e-08
multiple O 0 5.250633261510984e-10
transcription O 0 2.6021565346923126e-08
factor O 0 1.7690476861176307e-09
binding O 0 1.1866906346469364e-09
sites O 0 1.8550080582713235e-08
. O 0 5.486469500937119e-09

The O 0 8.907350967923833e-10
genomic O 0 1.0213677903436746e-08
structure O 0 1.1527501619923441e-08
was O 0 3.012674332225629e-09
determined O 0 1.4308591811396099e-10
using O 0 9.723723909393911e-11
DNA O 0 4.440587453302669e-09
from O 0 7.105481567709626e-12
several O 0 1.2801294312775324e-12
sources O 0 1.962848286685137e-11
including O 0 6.674494941114051e-13
multiple O 0 2.545803845510619e-11
large O 0 1.2592852316473113e-09
- O 0 0.01064684335142374
insert O 0 1.276388684345875e-05
libaries O 0 1.0176331670663785e-06
and O 0 2.2371637875551187e-10
genomic O 0 3.2995617349484974e-09
DNA O 0 1.3571012758006873e-08
from O 0 8.390663719382019e-10
Finnish O 0 1.9306314698042115e-06
CLD B-Disease 0 0.0019070038106292486
patients O 0 1.8420303149468964e-06
and O 0 1.5999216396167526e-09
controls O 0 3.2149253001989564e-06
. O 0 9.739028250521642e-09

Exon O 0 3.930495495296782e-06
- O 0 5.521703769773012e-07
specific O 0 3.044102303562113e-09
primers O 0 5.068571908850572e-07
developed O 0 1.7049904599275578e-08
in O 0 6.444570432861951e-10
this O 0 2.0105258603797527e-12
study O 0 2.6895085551009723e-12
will O 0 8.290588267984011e-13
facilitate O 0 8.697884426589475e-12
mutation O 0 1.0703116171129068e-10
screening O 0 6.173567212997e-10
studies O 0 4.980396095533024e-10
of O 0 4.620909557773167e-12
patients O 0 7.574451066361121e-10
with O 0 1.4584229657277348e-11
the O 0 2.0348025486782717e-09
disease O 0 3.4474401218176354e-06
. O 0 6.317369738439993e-09

Genomic O 0 5.354627319320571e-07
sequencing O 0 3.229553513506289e-08
of O 0 6.095661475580272e-11
a O 0 2.1462387422843676e-09
BAC O 0 9.465748007642105e-05
clone O 0 4.474748948268825e-06
H O 1 1.0
_ O 0 1.7430336063384289e-09
RG364P16 O 0 2.2884721673221975e-08
revealed O 0 1.739509869480571e-09
the O 0 1.7410738649414892e-12
presence O 0 6.266260947629387e-12
of O 0 3.234347468669685e-13
another O 0 2.1300950586722323e-11
, O 0 2.091381972116335e-12
highly O 0 1.1255640516849574e-11
homologous O 0 8.357342595743944e-11
gene O 0 2.4799930997687625e-09
3 O 0 1.9083280788922963e-10
of O 0 3.246444562829409e-12
the O 0 2.353277295252809e-10
CLD B-Disease 0 5.836527179781115e-06
gene O 0 1.204668720333757e-08
, O 0 1.2030532126061644e-10
with O 0 5.6672097570320545e-12
a O 0 6.91318113865691e-11
similar O 0 1.488201645249987e-10
genomic O 0 6.515343820012731e-09
structure O 0 3.583706131848885e-08
, O 0 6.596086871146767e-11
recently O 0 1.7075507674491064e-09
identified O 0 1.7442207678186605e-09
as O 0 5.741614406140627e-10
the O 0 3.9083712266574366e-08
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 2.745067604337237e-06
( O 0 9.076283724596124e-09
PDS B-Disease 0 7.525003638875205e-06
) O 0 2.335208970638547e-10
. O 0 9.305967108019786e-11
. O 0 4.927971919421736e-10

The O 0 1.2967297458033045e-08
APCI1307K O 0 3.0363764381036162e-05
allele O 0 2.068065805360675e-05
and O 0 2.8678405783466587e-07
cancer B-Disease 0 7.020542398095131e-06
risk O 0 4.274189535635742e-08
in O 0 3.665889536375033e-10
a O 0 1.4099069134410058e-10
community O 0 7.361780629544512e-11
- O 0 9.385316523946585e-09
based O 0 3.6598180042091144e-10
study O 0 2.525011033593927e-10
of O 0 2.8521114289747906e-11
Ashkenazi O 0 9.628341501866089e-08
Jews O 0 9.664155031785526e-10
. O 0 1.1435651314783968e-09

Mutations O 0 1.3615755051432643e-05
in O 0 1.8527593681483268e-08
APC O 0 2.068143345468343e-07
are O 0 1.5732098956888763e-10
classically O 0 8.000784873729572e-06
associated O 0 9.740256956547455e-08
with O 0 3.2212351470661815e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 3.3178363082697615e-05
FAP B-Disease 0 1.3598236364487093e-05
) O 0 2.1434691799271377e-09
, O 0 6.322269097136513e-11
a O 0 9.532381550769742e-10
highly O 0 0.0002276913437526673
penetrant O 1 0.9999997615814209
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 1.777122997737024e-05
by O 0 1.711502717327562e-09
multiple O 0 1.5617778217347222e-06
intestinal O 0 0.4094025492668152
polyps B-Disease 0 0.00013555982150137424
and O 0 7.485449482480533e-10
, O 0 6.664703077613465e-12
without O 0 2.310380012304769e-11
surgical O 0 3.329536468754668e-07
intervention O 0 2.2788199771639484e-08
, O 0 2.6674299921647382e-11
the O 0 3.460756204179405e-12
development O 0 8.482064828285729e-09
of O 0 0.0006510323146358132
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 5.6679780868762464e-08
CRC B-Disease 0 5.857638825546019e-06
) O 0 1.6127529312015554e-09
. O 0 2.9255475819667254e-09

APC B-Disease 0 8.306994459417183e-06
is O 0 5.190503138408076e-09
a O 0 2.3896955525515295e-08
tumour O 1 1.0
- O 0 6.629357812926173e-05
suppressor O 0 4.110401334855851e-07
gene O 0 1.337849369065225e-07
, O 0 2.418000522030894e-10
and O 0 8.443832438809196e-11
somatic O 0 4.171460687985018e-08
loss O 0 7.067702512131291e-08
occurs O 0 6.6445320356933735e-09
in O 0 3.458451089954906e-07
tumours B-Disease 1 1.0
. O 0 1.0434575159479209e-07

The O 0 1.2807475080478525e-08
germline O 0 4.15040813095402e-06
T O 0 7.038858257146785e-06
- O 0 9.623237673395124e-08
to O 0 2.183206809780458e-10
- O 0 2.214634875485899e-08
A O 0 3.520881919349961e-10
transversion O 0 1.840635555083736e-08
responsible O 0 7.139352303786595e-11
for O 0 1.320115349499884e-12
the O 0 8.328789914691104e-12
APC O 0 4.769182826436236e-09
I1307K O 0 1.1220419260382641e-08
allele O 0 1.6414068326753295e-08
converts O 0 3.803441117611328e-09
the O 0 2.6973496353166482e-11
wild O 0 3.721148111868189e-10
- O 0 2.404334686900711e-08
type O 0 1.521865478082418e-08
sequence O 0 2.5940663506140993e-10
to O 0 5.390381890846285e-11
a O 0 2.055108305754061e-09
homopolymer O 0 0.00014920167450327426
tract O 0 0.0012182019418105483
( O 0 5.227024146847725e-09
A8 O 0 2.924224281741772e-05
) O 0 1.7497203338989742e-11
that O 0 8.35937916110474e-12
is O 0 8.251944960679936e-11
genetically O 0 8.836120457544894e-08
unstable O 0 0.17421574890613556
and O 0 4.058793301453534e-09
prone O 0 4.473762160728256e-08
to O 0 8.310260118937762e-11
somatic O 0 1.1129347399219114e-07
mutation O 0 2.3582765606988687e-07
. O 0 1.0358582436253982e-08

The O 0 7.623065734208012e-09
I1307K O 0 3.274388973295572e-07
allele O 0 3.251793714298401e-07
was O 0 1.6682277248492028e-07
found O 0 1.4997685315876197e-09
in O 0 7.310277938543663e-10
6 O 0 1.3724482661459092e-09
. O 0 1.6726404705735831e-09

1 O 0 8.495587877632715e-08
% O 0 1.6887069520521436e-09
of O 0 4.021968522116559e-11
unselected O 0 2.066240085696336e-05
Ashkenazi O 0 4.218164576741401e-06
Jews O 0 2.08281836222568e-09
and O 0 2.1278383222078645e-10
higher O 0 1.6145010883761302e-09
proportions O 0 1.4225763900199695e-09
of O 0 2.026040446523325e-11
Ashkenazim O 0 1.2266934390936513e-05
with O 0 1.081821646153891e-10
family O 0 4.994207825070873e-10
or O 0 4.3738590527198085e-10
personal O 0 4.885252202768697e-09
histories O 0 2.505333327462722e-07
of O 0 1.4735282438671504e-10
CRC B-Disease 0 1.0356327948102262e-05
( O 0 1.7568418941849018e-09
ref O 0 1.0937746992567554e-05
. O 0 4.407194401090386e-11
2 O 0 1.541848593245021e-10
) O 0 9.179304538697863e-11
. O 0 8.107575721894023e-10

To O 0 2.8268709595380415e-09
evaluate O 0 3.982917107236972e-09
the O 0 1.3402758070046872e-11
role O 0 7.551165248642633e-11
of O 0 2.6473773260399236e-12
I1307K O 0 8.503430848350035e-09
in O 0 2.8788620376474228e-09
cancer B-Disease 0 3.5162077693939864e-08
, O 0 2.005013377548437e-10
we O 0 5.491261334533704e-10
genotyped O 0 1.0389533855459376e-07
5 O 0 1.2801136539675184e-10
, O 0 2.0207811812777976e-10
081 O 0 5.27638974290312e-07
Ashkenazi O 0 1.5662777741454192e-07
volunteers O 0 2.7659344259411967e-10
in O 0 1.3119136332839787e-10
a O 0 1.8909437904390813e-10
community O 0 2.714382330015752e-10
survey O 0 3.756938227184037e-08
. O 0 1.4535090908651682e-09

Risk O 0 7.847600500099361e-06
of O 0 3.0809296780454076e-10
developing O 0 0.00017176682013086975
colorectal B-Disease 1 1.0
, I-Disease 0 2.148719659089693e-06
breast I-Disease 0 5.496679659700021e-05
and I-Disease 0 1.05217274892766e-08
other I-Disease 0 9.411483814503185e-10
cancers I-Disease 0 1.6811255818538484e-06
were O 0 1.1380426601093063e-09
compared O 0 2.833941692426123e-10
between O 0 5.3784070946916174e-11
genotyped O 0 2.1325683974282583e-07
I1307K O 0 1.9117544880487003e-08
carriers O 0 2.1236226110943335e-09
and O 0 1.557947174046781e-11
non O 0 2.3169784146848116e-10
- O 0 7.417117475760904e-10
carriers O 0 1.2250984671169363e-09
and O 0 1.5257402979917956e-11
their O 0 3.022627287352364e-12
first O 0 1.7286273801264684e-10
- O 0 3.9797427575649635e-09
degree O 0 7.702765536521383e-09
relatives O 0 2.2213983985608365e-09
. O 0 2.404901000563342e-10

Sperm O 0 4.7045242013155075e-07
DNA O 0 8.290561481771874e-08
analysis O 0 2.257353193257927e-09
in O 0 9.312132731587042e-10
a O 0 1.1960397117150023e-08
Friedreich B-Disease 0 0.01025520171970129
ataxia I-Disease 1 0.9997761845588684
premutation O 0 0.018627388402819633
carrier O 0 2.2045718651497737e-05
suggests O 0 9.73899432210601e-08
both O 0 9.476708306976889e-10
meiotic O 0 2.3121782533053192e-07
and O 0 2.969101353667014e-10
mitotic O 0 9.419462543291957e-09
expansion O 0 1.7953919462243562e-09
in O 0 2.432729850898596e-10
the O 0 1.6200588093262525e-10
FRDA B-Disease 0 3.165379780512012e-07
gene O 0 1.0791152504907586e-07
. O 0 6.818234865590966e-09

Friedreich B-Disease 1 0.99978107213974
ataxia I-Disease 1 0.9999997615814209
is O 0 3.6912177165504545e-05
usually O 0 2.3831915996197495e-07
caused O 0 1.8806216584010826e-09
by O 0 3.5966407803400546e-12
an O 0 1.781091225026843e-12
expansion O 0 2.3117520397963887e-10
of O 0 1.0534642602699762e-11
a O 0 4.5399231041187704e-09
GAA O 0 2.347908889532846e-07
trinucleotide O 0 5.710438699679798e-07
repeat O 0 3.8495468146493295e-08
in O 0 2.3212913535797242e-10
intron O 0 1.1111107056649416e-07
1 O 0 1.7777702920884764e-10
of O 0 3.5993033640352445e-12
the O 0 9.630844038932551e-11
FRDA B-Disease 0 7.170107210185961e-07
gene O 0 1.44270529744972e-07
. O 0 7.2068502277033986e-09

Occasionally O 0 2.8189901968289632e-06
, O 0 1.0515180948189595e-09
a O 0 7.870908091955897e-11
fully O 0 8.233675546920338e-11
expanded O 0 6.090992155094455e-10
allele O 0 1.8640026411276267e-08
has O 0 1.8387039113498815e-10
been O 0 6.563382476398871e-11
found O 0 4.6942089104717866e-11
to O 0 1.9933887440010123e-12
arise O 0 1.098425690682081e-11
from O 0 3.1050786941655417e-12
a O 0 2.664165589527645e-11
premutation O 0 1.0248979442906148e-08
of O 0 1.1878618748351055e-12
100 O 0 4.654205840171066e-11
or O 0 3.5074163018400384e-10
less O 0 5.15026776781724e-09
triplet O 0 4.887388513452606e-06
repeats O 0 3.714826846135111e-07
. O 0 1.1820557865860337e-08

We O 0 2.049761604894229e-08
have O 0 6.269444685624848e-11
examined O 0 3.7529668261981897e-10
the O 0 2.9069431323885953e-12
sperm O 0 2.486954808755826e-10
DNA O 0 8.091802228271661e-10
of O 0 2.110580807346274e-12
a O 0 4.160538857878038e-10
premutation O 0 3.7447732665896183e-06
carrier O 0 1.3293869187691598e-06
. O 0 1.0462850141834679e-08

This O 0 3.3918958752821027e-09
mans O 0 1.4505027934319514e-07
leucocyte O 0 2.9406746193672006e-07
DNA O 0 1.1989615700258582e-07
showed O 0 2.5834136607727487e-08
one O 0 7.854651651317823e-11
normal O 0 1.4962998617917833e-09
allele O 0 2.2816120548441177e-08
and O 0 4.1353562241219777e-10
one O 0 6.99363067457881e-11
allele O 0 1.6444675621229976e-09
of O 0 2.673438944181261e-12
approximately O 0 1.2278629502038285e-10
100 O 0 1.0885615742139976e-09
repeats O 0 7.777811106279842e-08
. O 0 8.734605039251164e-09

His O 0 1.5949469300835517e-08
sperm O 0 4.2172846548282905e-08
showed O 0 1.8731265427618382e-08
an O 0 4.358464544135243e-12
expanded O 0 5.250583301474876e-10
allele O 0 5.537598468663418e-08
in O 0 2.2636317709157083e-08
a O 0 1.6181212814103674e-08
tight O 0 4.527224064077018e-06
range O 0 4.117994834018646e-09
centering O 0 3.418394456389251e-09
on O 0 4.93719420902039e-09
a O 0 1.0539793343644632e-10
size O 0 3.129304315674375e-10
of O 0 3.942941025764091e-12
approximately O 0 1.826630235957083e-10
320 O 0 2.2068466165592326e-08
trinucleotide O 0 5.555515599553473e-06
repeats O 0 1.2636065775950556e-06
. O 0 1.5516476992161188e-08

His O 0 2.2384170961231575e-07
affected O 0 3.5846497326019744e-07
son O 0 7.742338539173943e-07
has O 0 2.984727187627101e-10
repeat O 0 1.1432597091243224e-09
sizes O 0 4.153650312588297e-09
of O 0 6.128209051325939e-11
1040 O 0 4.406789244626452e-08
and O 0 8.667503936798937e-10
540 O 0 5.9522957229773965e-08
. O 0 2.3035355845024696e-09

These O 0 1.024498819113262e-09
data O 0 1.2603207366623792e-09
suggest O 0 1.5548308474055972e-10
that O 0 1.2477972214514077e-12
expansion O 0 6.392195800453138e-11
occurs O 0 1.1164215385495169e-11
in O 0 2.0887437612859827e-11
two O 0 1.228883748233267e-11
stages O 0 2.2169359403800826e-10
, O 0 7.614815028533783e-12
the O 0 2.3980875878820695e-12
first O 0 4.647552828696e-11
during O 0 5.7841054862395325e-11
meiosis O 0 4.833114464197763e-11
followed O 0 1.2345833556859365e-11
by O 0 1.1605753250792938e-12
a O 0 2.933635973034754e-11
second O 0 1.1145461220607444e-09
mitotic O 0 1.3970164580712208e-08
expansion O 0 1.2263803306211685e-08
. O 0 5.204660258328886e-09

We O 0 1.800983362443276e-08
also O 0 8.964682468581842e-11
show O 0 2.3158254480737384e-10
that O 0 3.3082909241949343e-12
in O 0 1.6110387329737463e-11
all O 0 1.0890000923594045e-12
informative O 0 1.0332643074484338e-10
carrier O 0 5.584623874455019e-10
father O 0 6.605441194018624e-11
to O 0 3.0049339752591386e-12
affected O 0 2.4683591282048667e-10
child O 0 1.5047197932105405e-09
transmissions O 0 3.423884891162743e-07
, O 0 1.9165233636209145e-11
with O 0 3.8790262777040063e-13
the O 0 1.1518336198029777e-12
notable O 0 1.3325777113715187e-11
exception O 0 9.157375552293345e-11
of O 0 3.2842597998822276e-13
the O 0 9.265580490358527e-12
premutation O 0 4.685566068474145e-08
carrier O 0 9.649720134063955e-09
, O 0 7.660908366013963e-12
the O 0 1.5200406038029524e-12
expansion O 0 2.3112008140646623e-10
size O 0 7.774050847508818e-10
decreases O 0 4.8921053874551035e-09
. O 0 1.4203634102205598e-10
. O 0 6.380675432460237e-10

The O 0 7.281212521803582e-09
R496H O 0 4.5213243993202923e-07
mutation O 0 2.42373783265748e-08
of O 0 5.020968363300682e-11
arylsulfatase O 0 1.0559482461758307e-06
A O 0 2.6285146503823853e-08
does O 0 2.324678760601273e-08
not O 0 5.868523000884807e-09
cause O 0 4.347373305790825e-07
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 0.9999998807907104
. O 0 2.8452947731238964e-07

Deficiency B-Disease 1 0.9999978542327881
of I-Disease 0 1.529068871519712e-09
arylsulfatase I-Disease 0 1.6587770005571656e-05
A I-Disease 0 6.924790341145126e-08
( O 0 6.422240961256875e-09
ARSA O 0 5.438632069854066e-05
) O 0 9.740696027549234e-10
enzyme O 0 1.1624722873193605e-07
activity O 0 6.582842502211861e-07
causes O 0 1.2052361171299708e-06
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 7.53916465328075e-05
MLD B-Disease 1 1.0
) O 0 2.4192484460172636e-08
. O 0 8.258661310378557e-09

A O 0 6.933142771003986e-08
number O 0 3.724904551472008e-10
of O 0 3.446279719931944e-11
ARSA O 0 5.4804277169751e-05
gene O 0 3.3758527706595487e-07
mutations O 0 1.8355841291395336e-07
responsible O 0 5.061453478560907e-09
for O 0 1.69102776226282e-09
MLD B-Disease 1 1.0
have O 0 1.0001827810413033e-08
been O 0 2.64170174624212e-09
identified O 0 1.0379882731115231e-08
. O 0 9.178154347644352e-10

Recently O 0 1.1978669363088557e-06
, O 0 6.647076777888117e-10
the O 0 4.038102491277229e-11
R496H O 0 1.6669403635205526e-08
mutation O 0 4.716111057234684e-09
of O 0 3.578352544830743e-11
ARSA O 0 4.3384152377257124e-05
was O 0 4.522810126417198e-09
proposed O 0 5.160695829009576e-11
to O 0 9.708559477183965e-12
be O 0 1.0272924871879141e-10
a O 0 1.72088343575183e-10
cause O 0 3.645454604850329e-09
of O 0 2.4697119904715237e-09
MLD B-Disease 1 1.0
( O 0 1.310074049243326e-09
Draghia O 0 1.6138915270857979e-07
et O 0 1.3524892494842788e-07
al O 0 2.3326172140514245e-06
. O 0 1.3191507886034515e-09
, O 0 8.312098925822298e-11
1997 O 0 1.4412730731105938e-10
) O 0 6.787864714752345e-11
. O 0 7.928832035375422e-10

We O 0 9.030075354132805e-09
have O 0 4.1263877731401166e-11
investigated O 0 9.138392126351036e-11
the O 0 2.9727192929485113e-12
R496H O 0 2.3121016212712675e-09
mutation O 0 3.423384353773429e-10
and O 0 7.1762786685303226e-12
found O 0 1.671006215342441e-11
this O 0 2.618010788626307e-13
mutation O 0 2.058927507653241e-11
at O 0 5.30626514949617e-11
a O 0 1.9691481084604945e-11
relatively O 0 5.668181035645148e-09
high O 0 7.327913387200624e-09
frequency O 0 4.065774827921587e-09
in O 0 2.341738469802124e-10
an O 0 3.399766579370578e-12
African O 0 5.200762129980996e-12
American O 0 3.636193776634933e-11
population O 0 1.897437719097783e-12
( O 0 1.8102136109532374e-11
f O 0 5.112423551167922e-08
= O 0 1.407494787386554e-09
0 O 0 3.9474751245549555e-10
. O 0 1.855197523381591e-10
09 O 0 6.901686333549151e-09
, O 0 3.317423072357606e-11
n O 0 7.831979509376197e-09
= O 0 1.2829772799705097e-08
61 O 0 9.89811432816623e-09
subjects O 0 3.554786687232081e-08
) O 0 3.166227557915846e-10
. O 0 1.3065130088918409e-09

The O 0 8.259575245972428e-09
ARSA O 0 2.185839730373118e-05
enzyme O 0 6.943266583903096e-08
activity O 0 2.022152045810799e-08
in O 0 2.405506627223275e-10
subjects O 0 1.6846534167669347e-09
with O 0 4.00729492991414e-12
and O 0 3.083115013291504e-11
without O 0 5.158252731202184e-12
the O 0 2.970457864057141e-12
R496H O 0 1.6702845773153285e-09
mutation O 0 4.3840153729490794e-10
was O 0 4.044681922721338e-09
determined O 0 7.352465858367907e-10
and O 0 2.8957935008233626e-11
found O 0 6.427626486615878e-11
to O 0 5.226537952429666e-12
be O 0 1.113502207106265e-10
normal O 0 3.746289056749674e-09
. O 0 9.04444685811967e-10

It O 0 6.401829288904537e-09
is O 0 6.886372722059164e-11
therefore O 0 2.935740539555809e-11
concluded O 0 4.305021894523975e-10
that O 0 1.7292785042463676e-12
the O 0 2.8090437961814096e-12
R496H O 0 4.24753121563981e-09
mutation O 0 9.900827935283019e-10
of O 0 1.0743773058707884e-11
ARSA O 0 1.3578995776697411e-06
does O 0 1.993223502916308e-10
not O 0 2.28991842848858e-11
negatively O 0 4.026450700633788e-11
influence O 0 2.7718901826623288e-11
the O 0 3.5358317836131636e-12
activity O 0 2.219975092643267e-09
of O 0 2.2065938486137693e-12
ARSA O 0 1.2305215477681486e-06
and O 0 7.103561489030241e-11
is O 0 1.0301840977500198e-11
not O 0 3.88613932700288e-11
a O 0 1.6381868084280882e-10
cause O 0 2.197115556157314e-08
of O 0 1.9158356678872224e-08
MLD B-Disease 1 0.9999998807907104

Down O 0 2.170037623727694e-05
- O 0 8.521909649061854e-07
regulation O 0 5.217146181735188e-08
of O 0 3.486743532787884e-11
transmembrane O 0 4.1875715339756425e-08
carbonic O 0 8.426017075180425e-07
anhydrases O 0 3.079939460803871e-06
in O 0 3.455598971413565e-07
renal B-Disease 1 0.9999887943267822
cell I-Disease 1 0.9999996423721313
carcinoma I-Disease 1 1.0
cell O 0 0.0006826521712355316
lines O 0 1.3191645109600358e-07
by O 0 5.548937975774493e-10
wild O 0 9.10882178573047e-08
- O 0 8.662279287818819e-05
type O 1 0.7153760194778442
von B-Disease 1 0.9999961853027344
Hippel I-Disease 1 0.9993671774864197
- I-Disease 1 0.7876963019371033
Lindau I-Disease 0 0.47791361808776855
transgenes O 0 0.001026685000397265
. O 0 1.9520209093570884e-07

To O 0 3.457937269857325e-09
discover O 0 7.251995448598336e-09
genes O 0 2.5065094444443048e-09
involved O 0 1.2071914579081522e-09
in O 0 1.2104798940981709e-08
von B-Disease 1 0.9999843835830688
Hippel I-Disease 1 0.9998881816864014
- I-Disease 1 0.9999175071716309
Lindau I-Disease 1 0.9998601675033569
( O 0 1.244033711600423e-07
VHL B-Disease 0 3.897207716363482e-05
) O 0 4.564712607901811e-09
- O 0 1.2374823654681677e-06
mediated O 0 1.553162837808486e-05
carcinogenesis O 0 4.756166526931338e-05
, O 0 2.4236521123377486e-10
we O 0 9.497966996230289e-11
used O 0 1.4694320427111052e-08
renal B-Disease 1 0.9975758194923401
cell I-Disease 1 0.9999998807907104
carcinoma I-Disease 1 1.0
cell O 0 0.36036527156829834
lines O 0 1.7035856217262335e-05
stably O 0 3.7869092921027914e-05
transfected O 0 1.575126248098968e-06
with O 0 1.0438845343685443e-09
wild O 0 5.146696224755942e-08
- O 0 6.477275746874511e-05
type O 0 0.10221897065639496
VHL O 0 0.2711097002029419
- O 0 5.726904873881722e-06
expressing O 0 3.350923094558311e-08
transgenes O 0 1.5944038750603795e-05
. O 0 2.2698014134903133e-08

Large O 0 2.5762297184428462e-08
- O 0 5.763645845036081e-07
scale O 0 2.102079754706665e-08
RNA O 0 7.513807531722705e-08
differential O 0 1.0856965104721894e-08
display O 0 2.0576182979681334e-09
technology O 0 2.331687483092537e-06
applied O 0 2.2798272159008093e-09
to O 0 1.9664945019592928e-11
these O 0 8.441186985508331e-12
cell O 0 7.1131944778812795e-09
lines O 0 1.7564598664421283e-09
identified O 0 5.196315044919686e-10
several O 0 3.259374541098037e-12
differentially O 0 3.526231528994117e-10
expressed O 0 9.448417742641269e-12
genes O 0 9.366922515408049e-11
, O 0 8.458815245471207e-13
including O 0 4.574779140578689e-13
an O 0 3.653816398746512e-12
alpha O 0 2.800055964868875e-09
carbonic O 0 1.1495900054114827e-07
anhydrase O 0 4.54466032806522e-07
gene O 0 7.779888022696468e-08
, O 0 4.599730873966479e-10
termed O 0 7.229652254636676e-08
CA12 O 0 5.4952382924966514e-05
. O 0 1.8754858999159296e-08

The O 0 3.749417720744219e-10
deduced O 0 2.4958708433331367e-09
protein O 0 7.938334989354701e-10
sequence O 0 2.3747082078529047e-10
was O 0 8.414833274628108e-10
classified O 0 4.4539366639284594e-10
as O 0 1.7909713642683123e-11
a O 0 5.254297344436942e-11
one O 0 2.198937920638855e-09
- O 0 5.32618798843032e-07
pass O 0 1.9964140562933608e-08
transmembrane O 0 1.994796328119719e-08
CA O 0 1.2127611626056023e-07
possessing O 0 1.2182570507945911e-09
an O 0 1.3578293003857489e-11
apparently O 0 1.4768329670289404e-08
intact O 0 5.754795751045094e-09
catalytic O 0 2.8441884403207496e-09
domain O 0 9.051712157592817e-10
in O 0 3.273108450940754e-10
the O 0 1.791245485271986e-10
extracellular O 0 4.468346759267661e-08
CA O 0 2.268788193759974e-05
module O 0 1.6236620581366878e-07
. O 0 5.7394822228218345e-09

Reintroduced O 0 2.418663825665135e-06
wild O 0 5.291830120768282e-07
- O 0 7.045453821774572e-05
type O 0 5.850230991200078e-06
VHL B-Disease 0 1.2996613804716617e-05
strongly O 0 1.0949340989441225e-08
inhibited O 0 2.9662064804369948e-08
the O 0 4.2902244257181366e-11
overexpression O 0 9.507251652607351e-10
of O 0 1.0014903403104958e-12
the O 0 6.281554703474468e-12
CA12 O 0 9.683681412298029e-09
gene O 0 1.8293646597555835e-09
in O 0 3.274632232042052e-10
the O 0 8.869139311862284e-10
parental O 0 3.0005072403582744e-05
renal B-Disease 1 0.9876755475997925
cell I-Disease 1 0.9999985694885254
carcinoma I-Disease 1 1.0
cell O 0 0.09086424857378006
lines O 0 5.132412115926854e-05
. O 0 8.996143918693633e-08

Similar O 0 1.1915039621612777e-08
results O 0 5.738168606939098e-09
were O 0 5.457647181406067e-11
obtained O 0 4.1370108727623034e-11
with O 0 8.070754134448244e-12
CA9 O 0 1.1343328878865577e-05
, O 0 1.2972769559971287e-11
encoding O 0 5.423095861267768e-10
another O 0 8.401757761733464e-11
transmembrane O 0 4.9573305460626216e-09
CA O 0 5.249389687378425e-06
with O 0 9.227328102989762e-12
an O 0 9.172824826098047e-12
intact O 0 2.0995315708205453e-08
catalytic O 0 3.32847527317881e-08
domain O 0 3.17226955814931e-08
. O 0 2.967964984890159e-09

Although O 0 9.551623492143335e-09
both O 0 1.0372847025763576e-10
domains O 0 8.719935884471397e-10
of O 0 1.7048341904857267e-12
the O 0 7.718814303003807e-12
VHL B-Disease 0 2.3761330680827086e-08
protein O 0 3.888921962236225e-10
contribute O 0 2.5988888124883758e-11
to O 0 3.071141951860312e-11
regulation O 0 2.5817965543240007e-09
of O 0 5.4019167611274455e-12
CA12 O 0 6.413943509642195e-08
expression O 0 1.6105634881302677e-10
, O 0 2.8267967393941218e-12
the O 0 1.993738507621856e-12
elongin O 0 6.1940226281365085e-09
binding O 0 4.308882972647865e-10
domain O 0 1.652069259172606e-09
alone O 0 5.031717820180859e-10
could O 0 1.0998203736622969e-10
effectively O 0 8.229598669196037e-10
regulate O 0 3.8351458897523116e-08
CA9 O 0 2.2364365577232093e-05
expression O 0 6.84846312992704e-08
. O 0 1.3061126402647005e-08

We O 0 1.3369999862788973e-07
mapped O 0 4.981361030331755e-07
CA12 O 0 6.658732218056684e-06
and O 0 9.321888816415935e-10
CA9 O 0 6.602266239497112e-06
loci O 0 8.29807245139591e-09
to O 0 2.9182900540547507e-10
chromosome O 0 2.737332067681564e-07
bands O 0 1.0055563137711943e-07
15q22 O 0 9.547017043587402e-07
and O 0 5.10036324286034e-09
17q21 O 0 9.192315246764338e-07
. O 0 7.2718298049778696e-09

2 O 0 5.148915249719721e-08
respectively O 0 3.5305671719498832e-09
, O 0 8.43806899353261e-11
regions O 0 1.0865307542573532e-09
prone O 0 1.170616314993822e-06
to O 0 2.9656035960279326e-10
amplification O 0 1.3759822614645145e-08
in O 0 2.55466758858347e-10
some O 0 2.7549391587444738e-11
human O 0 5.947602410572017e-10
cancers B-Disease 0 9.125990800384898e-06
. O 0 3.722583796772483e-09

Additional O 0 1.4012294657916868e-09
experiments O 0 1.4204182274824007e-09
are O 0 1.592849983855782e-11
needed O 0 9.958645713625813e-11
to O 0 9.823820359619595e-13
define O 0 3.035165174747334e-11
the O 0 8.05101211392989e-12
role O 0 2.3575313923274166e-10
of O 0 9.614174907579542e-12
CA O 0 1.63356321536412e-06
IX O 0 1.9157795350110973e-07
and O 0 8.937098283645639e-10
CA O 0 2.2480996619833604e-07
XII O 0 1.0088814228481624e-08
enzymes O 0 3.6360014998848555e-10
in O 0 7.078778969243915e-12
the O 0 8.306579382666435e-12
regulation O 0 1.0569372044244574e-09
of O 0 3.300400100783585e-12
pH O 0 3.121113645310203e-10
in O 0 1.1939772955049666e-11
the O 0 3.4877064344213116e-12
extracellular O 0 1.6523268864254703e-10
microenvironment O 0 7.931710399589065e-09
and O 0 2.9973336312938414e-11
its O 0 2.104779675202173e-12
potential O 0 3.7185778761772426e-11
impact O 0 5.936880986823212e-10
on O 0 8.171167742432317e-09
cancer B-Disease 0 6.839103150468873e-08
cell O 0 2.0294876321713673e-06
growth O 0 3.6625320376515447e-07
. O 0 2.6718423029592486e-09

A O 0 2.5741961451331008e-08
gene O 0 7.443782834570811e-08
encoding O 0 1.5609746384370737e-08
a O 0 2.2537555155466293e-10
transmembrane O 0 5.19801313103585e-09
protein O 0 8.128142603425204e-09
is O 0 1.8361595577331968e-10
mutated O 0 2.0294709202062222e-07
in O 0 3.587166119700669e-08
patients O 0 8.661403990117833e-05
with O 0 5.723426511394791e-06
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.5675931572914124
optic B-Disease 1 1.0
atrophy I-Disease 1 0.9999982118606567
( O 0 0.0490659661591053
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 3.662189129727267e-08
. O 0 2.299296397723083e-08

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 5.09512574353721e-05
WFS B-Disease 0 0.32439956068992615
; O 0 2.9751701546842924e-08
OMIM O 0 0.0002353639283683151
222300 O 0 2.9157070002838736e-07
) O 0 3.4670163961969536e-10
is O 0 2.2667230592521292e-10
an O 0 8.887241498278797e-10
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 0.9999938011169434
defined O 0 9.368915421248403e-09
by O 0 7.904069621034182e-10
young O 0 3.8179584294084634e-07
- O 0 2.032958946074359e-06
onset O 0 2.3460427200916456e-06
non O 0 6.122049285295361e-07
- O 0 1.1266158253420144e-05
immune O 0 6.519941962324083e-05
insulin B-Disease 1 0.9999648332595825
- I-Disease 1 0.9999905824661255
dependent I-Disease 1 0.9999977350234985
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 1.2406587757141097e-06
progressive O 0 3.7279687603586353e-06
optic B-Disease 1 0.9999630451202393
atrophy I-Disease 0 0.0024583942722529173
. O 0 1.1077419515004294e-07

Linkage O 0 2.9677200927835656e-06
to O 0 2.075180915994679e-09
markers O 0 5.2654112181471646e-08
on O 0 1.1459980520100999e-08
chromosome O 0 3.528807428665459e-05
4p O 0 0.00025602985988371074
was O 0 7.675737947465677e-07
confirmed O 0 5.522041135463951e-08
in O 0 3.745929677556603e-10
five O 0 8.710372700893032e-11
families O 0 5.992155382994468e-11
. O 0 4.4245049291014027e-10

On O 0 8.508411752927714e-09
the O 0 2.0510412812591028e-11
basis O 0 6.332080693116637e-11
of O 0 1.0470901055936732e-11
meiotic O 0 5.245143483989523e-07
recombinants O 0 4.156442082603462e-05
and O 0 9.668621459013593e-09
disease O 0 1.4119152638158994e-06
- O 0 1.4310140272755234e-07
associated O 0 4.629297389868725e-09
haplotypes O 0 9.109288612307864e-07
, O 0 6.51454168387744e-11
the O 0 1.9683895138844498e-11
WFS B-Disease 0 9.930944315783563e-07
gene O 0 5.167132499650506e-09
was O 0 1.3260047504459749e-09
localized O 0 1.6860099982807242e-09
to O 0 6.818617892534462e-11
a O 0 4.7643822220777565e-09
BAC O 0 0.12244167178869247
/ O 0 1.3016571756452322e-05
P1 O 0 0.00024295147159136832
contig O 0 4.949586127622752e-07
of O 0 1.4529200759172411e-11
less O 0 1.9029486320043532e-10
than O 0 3.0932579414555406e-11
250 O 0 1.2617176747831138e-10
kb O 0 1.7099937110742758e-07
. O 0 2.576287183586601e-09

Mutations O 0 3.3281946798524586e-06
in O 0 1.818309502965576e-09
a O 0 1.7779906713588645e-10
novel O 0 8.042670973651411e-10
gene O 0 2.7675625347001187e-08
( O 0 1.406410543580705e-09
WFS1 O 0 1.9781749927005876e-07
) O 0 2.737225376914232e-11
encoding O 0 5.637298960969872e-10
a O 0 7.179472294449596e-11
putative O 0 2.316294711590672e-09
transmembrane O 0 6.476559288870476e-10
protein O 0 1.2358520873334555e-09
were O 0 1.2605925192588074e-09
found O 0 3.6382213908225935e-10
in O 0 2.1556643622910876e-11
all O 0 7.439889633184538e-13
affected O 0 1.0452224155632628e-11
individuals O 0 6.632211056387116e-13
in O 0 6.621397874440049e-11
six O 0 4.315407586830133e-09
WFS B-Disease 0 2.1205907614785247e-05
families O 0 5.652606854811282e-11
, O 0 6.061224439024571e-12
and O 0 1.4801809083975215e-11
these O 0 2.563626828183674e-12
mutations O 0 1.9907805959284985e-10
were O 0 1.250211878467411e-10
associated O 0 3.6535600933529366e-11
with O 0 5.4312370573184054e-12
the O 0 1.8142010116406482e-09
disease O 0 6.339379979181103e-06
phenotype O 0 3.1776583000464598e-06
. O 0 7.912490218586754e-09

WFS1 O 0 0.0001664020528551191
appears O 0 9.614760898557506e-08
to O 0 5.707229133733449e-11
function O 0 5.510942743813807e-11
in O 0 2.9368957266129314e-10
survival O 0 2.193493564561777e-08
of O 0 5.027424657133572e-12
islet O 0 9.053273686276953e-08
beta O 0 1.1144849487720876e-08
- O 0 1.217117926444189e-07
cells O 0 6.0537472812427495e-09
and O 0 6.198345170460584e-10
neurons O 0 2.5852262552916727e-09
. O 0 1.002877156319748e-10
. O 0 5.109454526142088e-10

Stable O 0 4.492129846767057e-06
interaction O 0 4.076684767539973e-09
between O 0 7.79584452548221e-11
the O 0 9.271679778100061e-12
products O 0 8.723595734672074e-10
of O 0 4.4394948329508355e-13
the O 0 1.8422555148056574e-11
BRCA1 O 0 2.5330601260975527e-07
and O 0 1.257736914617169e-09
BRCA2 O 0 1.4889235444570659e-06
tumor B-Disease 0 2.4163435341506556e-07
suppressor O 0 3.697927581924887e-07
genes O 0 6.150771270085897e-08
in O 0 3.576165585883473e-09
mitotic O 0 2.709549278279155e-07
and O 0 1.0039360454072721e-09
meiotic O 0 7.90191904798121e-07
cells O 0 1.7881211533676833e-07
. O 0 8.504322579483414e-09

BRCA1 O 0 0.0021024062298238277
and O 0 2.6119124640899827e-08
BRCA2 O 0 1.2626501302293036e-06
account O 0 1.364659163449744e-09
for O 0 4.306110155949394e-12
most O 0 5.027846628619104e-12
cases O 0 1.1077419363736407e-11
of O 0 1.3211128154985707e-12
familial O 0 2.75718917919221e-07
, O 0 2.375632468520905e-10
early O 0 2.3584841528645484e-06
onset O 0 0.00022423116024583578
breast B-Disease 0 0.0015428558690473437
and I-Disease 0 2.3186858015833423e-05
/ I-Disease 1 0.9999998807907104
or I-Disease 1 0.9999997615814209
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.636213248223939e-10
encode O 0 2.9124180844775083e-10
products O 0 3.553395133693016e-09
that O 0 7.869763000989405e-12
each O 0 7.561116446494487e-13
interact O 0 5.360453747549343e-11
with O 0 7.337654095440627e-11
hRAD51 O 0 6.338033813335642e-07
. O 0 6.340075131561207e-09

Results O 0 8.510492932600755e-08
presented O 0 1.3093095496685692e-09
here O 0 1.8228574205636505e-10
show O 0 2.4728877279223127e-10
that O 0 1.3374182837588844e-11
BRCA1 O 0 1.509671534449808e-07
and O 0 1.0072710721065192e-10
BRCA2 O 0 8.867151990443745e-08
coexist O 0 1.6443357786499746e-09
in O 0 9.400320105656945e-11
a O 0 1.7627550807919334e-10
biochemical O 0 2.2236207541936892e-08
complex O 0 5.362299937416992e-09
and O 0 8.313117971781026e-10
colocalize O 0 1.899446431252727e-07
in O 0 1.0898433266959273e-09
subnuclear O 0 1.529802489130816e-07
foci O 0 1.0911900716337186e-07
in O 0 4.82998363526832e-10
somatic O 0 5.473185016313664e-09
cells O 0 2.154737499537873e-09
and O 0 1.6001770741791432e-10
on O 0 1.2068683552524107e-10
the O 0 2.184549850042794e-12
axial O 0 2.3727419334873545e-11
elements O 0 8.62793031464193e-11
of O 0 1.0474955972061828e-11
developing O 0 6.388692241898752e-09
synaptonemal O 0 7.47010858503927e-07
complexes O 0 1.3442542012853664e-07
. O 0 4.864359581802091e-09

Like O 0 4.828477813134668e-07
BRCA1 O 0 5.7952056522481143e-05
and O 0 8.684536645375829e-09
RAD51 O 0 2.4966420824057423e-05
, O 0 1.0997348587338251e-09
BRCA2 O 0 1.2186130788904848e-06
relocates O 0 1.307224550828323e-07
to O 0 1.508323133059264e-09
PCNA O 0 5.421205969469156e-06
+ O 0 8.369920756479132e-09
replication O 0 3.8297200966042055e-09
sites O 0 8.055844324950101e-10
following O 0 8.660096251222882e-11
exposure O 0 4.4894710171661245e-09
of O 0 1.1957960663333544e-11
S O 0 4.262116704012442e-08
phase O 0 5.4051579878589e-10
cells O 0 2.791123165923892e-10
to O 0 1.5512763296143817e-10
hydroxyurea O 0 2.3685183236921148e-07
or O 0 2.6853608225962944e-09
UV O 0 4.997872338208253e-07
irradiation O 0 8.478443760395749e-07
. O 0 6.064784230375153e-09

Thus O 0 1.131502447293542e-08
, O 0 8.423118313949374e-10
BRCA1 O 0 7.52223854760814e-07
and O 0 5.164548788627599e-10
BRCA2 O 0 9.983554605241807e-08
participate O 0 1.0592070276427279e-10
, O 0 1.564707217960315e-11
together O 0 1.0976465396328461e-11
, O 0 6.1408898799353295e-12
in O 0 4.317757609784145e-11
a O 0 4.956383081733406e-10
pathway O 0 5.92523186071503e-09
( O 0 2.370784402128123e-10
s O 0 5.226665322766166e-09
) O 0 1.9107773089471758e-12
associated O 0 1.9373476781159304e-11
with O 0 1.7478148919489178e-12
the O 0 8.273847752759966e-12
activation O 0 6.005233116335162e-11
of O 0 2.848309912581448e-12
double O 0 9.060477879074824e-08
- O 0 0.0008981177234090865
strand O 0 0.06534271687269211
break O 0 0.005015002563595772
repair O 1 0.8431882262229919
and O 0 9.006028811597844e-09
/ O 0 3.6133290137740914e-08
or O 0 4.050670909805376e-10
homologous O 0 1.5214446591471642e-08
recombination O 0 2.383341666245542e-07
. O 0 1.8225048137310296e-08

Dysfunction O 0 4.727402483695187e-05
of O 0 4.311289519831618e-11
this O 0 1.883642547495512e-11
pathway O 0 1.2406559113387061e-09
may O 0 1.6256384682833414e-08
be O 0 7.0735960491785654e-12
a O 0 8.208020201017074e-12
general O 0 8.390159227100735e-12
phenomenon O 0 8.365639292406968e-10
in O 0 2.4367513562495446e-10
the O 0 4.998606129708039e-12
majority O 0 5.959406145644719e-12
of O 0 4.910840072265554e-13
cases O 0 9.49438028197136e-11
of O 0 1.3021488054487662e-10
hereditary B-Disease 1 0.9998527765274048
breast I-Disease 1 0.9919397234916687
and I-Disease 0 0.0075244419276714325
/ I-Disease 1 1.0
or I-Disease 1 0.9999997615814209
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.728445247512923e-09
. O 0 3.2117866144432128e-09

A O 0 2.7684599501753837e-08
novel O 0 2.3006125005053946e-08
Arg362Ser O 0 5.741356403632381e-07
mutation O 0 1.1169046132408766e-08
in O 0 2.877038329796022e-10
the O 0 5.096293526074547e-11
sterol O 0 4.110340796614764e-06
27 O 0 6.040693278919207e-07
- O 0 2.4457135623379145e-06
hydroxylase O 0 6.2591452660853975e-06
gene O 0 1.6690950133124716e-07
( O 0 1.32558253262971e-09
CYP27 O 0 6.422146157092357e-07
) O 0 1.7415463168801715e-11
: O 0 5.359875954527582e-13
its O 0 1.3542877756733684e-12
effects O 0 3.3801528243060375e-10
on O 0 5.988307627546874e-10
pre O 0 6.899293225615111e-08
- O 0 1.5156568222707278e-09
mRNA O 0 2.3788243597167025e-10
splicing O 0 3.625560296427466e-09
and O 0 4.358184299557699e-11
enzyme O 0 9.329306216443456e-10
activity O 0 2.9178350846592593e-09
. O 0 6.123223039722347e-10

A O 0 3.642877643983411e-08
novel O 0 5.729430263556878e-09
C O 0 7.925722798063362e-07
to O 0 2.603572565873513e-11
A O 0 3.417486571510864e-10
mutation O 0 3.148438176836521e-10
in O 0 2.7491653051270326e-11
the O 0 3.632055767255338e-11
sterol O 0 5.596151822828688e-06
27 O 0 4.851029302699317e-07
- O 0 1.2876606660938705e-06
hydroxylase O 0 5.48361322216806e-06
gene O 0 1.1937520127958123e-07
( O 0 2.411001620572506e-09
CYP27 O 0 2.1256435047689592e-06
) O 0 9.517987786811233e-11
was O 0 7.623134901102446e-10
identified O 0 5.950356873896112e-11
by O 0 7.244514775399391e-13
sequencing O 0 3.643290669153032e-10
amplified O 0 7.527518164351932e-09
CYP27 O 0 4.264157738020913e-08
gene O 0 3.1392350940961933e-09
products O 0 4.100047412691765e-09
from O 0 5.980851230935613e-11
a O 0 2.3815858174458526e-09
patient O 0 3.891051164828241e-06
with O 0 7.626512754654868e-09
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 8.821739072573109e-08
CTX B-Disease 0 0.00019740946299862117
) O 0 2.676902477460885e-09
. O 0 2.4327400094392715e-09

The O 0 6.114088346720337e-09
mutation O 0 4.42999841254732e-08
changed O 0 1.3145474930809087e-08
the O 0 4.703144124151848e-11
adrenodoxin O 0 5.260572777388006e-08
cofactor O 0 7.94682577520689e-08
binding O 0 7.924633393940894e-09
residue O 0 1.2593872611432744e-07
362Arg O 0 3.967118544778714e-08
to O 0 1.5039787470971788e-10
362Ser O 0 6.697555221535367e-08
( O 0 1.7621500092435127e-10
CGT O 0 1.0734800781619924e-07
362Arg O 0 5.1444388304844324e-08
to O 0 4.0474890106168004e-10
AGT O 0 1.3222469306128914e-06
362Ser O 0 1.6954627923837506e-08
) O 0 2.365868265186144e-11
, O 0 3.499841041976204e-12
and O 0 4.938617657185285e-12
was O 0 1.7313132871787928e-10
responsible O 0 5.5852496239072735e-11
for O 0 5.384801632368763e-11
deficiency O 0 9.039867165938631e-08
in O 0 2.53238419817281e-11
the O 0 6.646045519476118e-11
sterol O 0 3.8616776691924315e-06
27 O 0 2.355900647899034e-07
- O 0 4.685950329985644e-07
hydroxylase O 0 1.2601432217707043e-06
activity O 0 1.7662038942489744e-07
, O 0 1.1342232708599909e-11
as O 0 9.737675943366497e-12
confirmed O 0 2.3975580201729407e-11
by O 0 2.93912165655677e-13
expression O 0 1.1815807013371149e-11
of O 0 5.488383727526858e-13
mutant O 0 3.1186978000086185e-10
cDNA O 0 1.9379076121595062e-09
into O 0 9.600367167905688e-10
COS O 0 4.404929859447293e-05
- O 0 6.069485181114942e-08
1 O 0 6.294465504375069e-10
cells O 0 9.118483745851336e-09
. O 0 1.8118874178796318e-09

Quantitative O 0 5.204107651479717e-07
analysis O 0 9.769576259088808e-09
showed O 0 9.626170971444026e-09
that O 0 1.9639220805167668e-12
the O 0 8.040971859711588e-13
expression O 0 1.8301936355324955e-11
of O 0 8.479944719509691e-13
CYP27 O 0 5.693155280539486e-09
gene O 0 7.164360216194154e-10
mRNA O 0 4.5523984582018784e-10
in O 0 6.078756942251573e-11
the O 0 3.3969813073575494e-11
patient O 0 9.59334300887349e-09
represented O 0 6.569397248412656e-10
52 O 0 5.033575334323359e-08
. O 0 4.832538369470285e-09

5 O 0 9.730527494866692e-08
% O 0 6.605936353487607e-10
of O 0 4.0271249876489e-12
the O 0 8.399674705783511e-11
normal O 0 7.311720651159703e-08
level O 0 1.697272296041774e-07
. O 0 1.3137222421022443e-09

As O 0 6.096736893113075e-09
the O 0 8.078519797560801e-11
mutation O 0 1.056667087162566e-09
occurred O 0 2.1311699072157353e-09
at O 0 5.736094585429008e-11
the O 0 2.8044452610870296e-12
penultimate O 0 3.1438309733289316e-09
nucleotide O 0 1.9360298086912309e-10
of O 0 3.0725112124679876e-12
exon O 0 1.0901765712389988e-08
6 O 0 2.6123396779098584e-09
( O 0 5.40326172693284e-10
- O 0 7.77273854168925e-08
2 O 0 3.8146419356621664e-10
position O 0 3.763972689085904e-09
of O 0 1.0501501578052963e-11
exon O 0 8.987444566344038e-09
6 O 0 2.8557070042012356e-09
- O 0 6.321229051309274e-08
intron O 0 1.7743255966706784e-06
6 O 0 3.607625309598461e-09
splice O 0 1.8940902180020203e-07
site O 0 9.221495789191181e-10
) O 0 5.567781912602099e-12
of O 0 1.14581168988645e-13
the O 0 9.943489174407683e-13
gene O 0 8.15217227057019e-10
, O 0 2.0313804457994245e-11
we O 0 1.3594489249590946e-11
hypothesized O 0 3.041597876340951e-11
that O 0 1.2053672946918392e-12
the O 0 5.066062586794873e-12
mutation O 0 2.148237365773298e-09
may O 0 3.041276119830627e-09
partially O 0 1.3908210139135235e-09
affect O 0 2.6562110844174924e-10
the O 0 7.838005418314697e-12
normal O 0 7.285931857836658e-10
splicing O 0 7.585225780815108e-09
efficiency O 0 6.190735701849803e-10
in O 0 2.4244195540035207e-10
exon O 0 2.4549661858941363e-08
6 O 0 1.6026338034436094e-09
and O 0 9.998193939431133e-11
cause O 0 5.6199364606435154e-11
alternative O 0 3.9303604815188464e-10
splicing O 0 9.390186406221801e-09
elsewhere O 0 4.274328091469215e-08
, O 0 3.989207922328042e-11
which O 0 3.733058567129133e-12
resulted O 0 3.099630621616889e-11
in O 0 1.7355585024692033e-10
decreased O 0 5.72601379644766e-08
transcript O 0 4.2657518406485906e-08
in O 0 3.1476454775969387e-10
the O 0 1.594978732422092e-10
patient O 0 4.94189791311328e-08
. O 0 1.3901791939829877e-09

Transfection O 0 1.9193585103494115e-05
of O 0 7.406967261758268e-10
constructed O 0 1.6701866556445566e-08
minigenes O 0 3.332336291350657e-06
, O 0 7.343829017125714e-11
with O 0 2.006714022381728e-12
or O 0 2.4999860515073635e-10
without O 0 5.977852240990345e-11
the O 0 1.2410475425106426e-11
mutation O 0 1.9114537730402503e-10
, O 0 3.152930173888624e-12
into O 0 7.218013686749458e-11
COS O 0 5.116091051604599e-05
- O 0 1.8556761682830825e-09
1 O 0 2.074885922798142e-11
cells O 0 1.3563856982035105e-10
confirmed O 0 7.729576978476871e-10
that O 0 1.9174987118952824e-12
the O 0 1.7123426157908406e-12
mutant O 0 2.7839841543197963e-09
minigene O 0 1.255501871355591e-07
was O 0 4.147696852641047e-09
responsible O 0 1.2520080458489069e-11
for O 0 6.207610922688567e-13
a O 0 8.4124495564053e-12
mRNA O 0 1.8609884466780358e-10
species O 0 7.78600361267534e-12
alternatively O 0 1.0463723221221244e-09
spliced O 0 2.6340162548876833e-06
at O 0 3.3508339214449734e-08
an O 0 3.0560326491624323e-10
activated O 0 1.9359032421562006e-07
cryptic O 0 3.1306450409829267e-07
5 O 0 1.8607763108136055e-09
splice O 0 1.1136539797007572e-06
site O 0 1.336499710902217e-08
88 O 0 8.933694672919046e-09
bp O 0 5.5681436350596414e-08
upstream O 0 1.187836495830652e-09
from O 0 4.7713069606381e-11
the O 0 2.69343713998893e-11
3 O 0 7.254533779255112e-11
end O 0 4.542432818777087e-10
of O 0 3.526241364876226e-12
exon O 0 1.6094627852680787e-08
6 O 0 3.426710915022113e-09
. O 0 2.090312145597295e-09

Our O 0 7.847890337586705e-09
data O 0 1.2108603009153285e-09
suggest O 0 1.7454379608317083e-10
that O 0 2.0597434348401666e-12
the O 0 4.0110115749614206e-12
C O 0 2.127637621640588e-08
to O 0 2.301670139204237e-12
A O 0 3.1256117138944717e-10
mutation O 0 3.411683713316904e-10
at O 0 1.0322262489204093e-10
the O 0 3.241470026421611e-12
penultimate O 0 2.3631963053105665e-09
nucleotide O 0 2.1302382080534699e-10
of O 0 5.477719840218942e-12
exon O 0 6.074925895660499e-09
6 O 0 3.090493694291041e-10
of O 0 2.6904630866936285e-12
the O 0 4.2103827369022184e-11
CYP27 O 0 1.288531166210305e-07
gene O 0 1.7894297155152117e-09
not O 0 9.307475623554495e-11
only O 0 2.307024536685187e-11
causes O 0 2.5652827084776675e-10
the O 0 2.2504058616590328e-09
deficiency B-Disease 0 1.2866410543210804e-05
in I-Disease 0 9.466497724597289e-11
the I-Disease 0 1.101182617313512e-10
sterol I-Disease 0 1.291068474529311e-05
27 I-Disease 0 2.763960083029815e-07
- I-Disease 0 3.268810644385667e-07
hydroxylase I-Disease 0 2.19977346205269e-06
activity I-Disease 0 2.519006329748663e-06
, O 0 2.36903496819707e-10
but O 0 5.089370036515106e-10
also O 0 6.919895906287721e-11
partially O 0 9.135224798839658e-10
leads O 0 7.745659669211591e-11
to O 0 8.803501330700847e-12
alternative O 0 3.597996067750131e-10
pre O 0 7.300378257468765e-08
- O 0 2.244952890251284e-09
mRNA O 0 3.456353259156941e-10
splicing O 0 4.607644488174856e-09
of O 0 7.057181661968004e-12
the O 0 7.231269749663483e-11
gene O 0 3.010183391438659e-08
. O 0 2.223585759963953e-09

To O 0 9.502247877435366e-10
our O 0 4.966316247134728e-11
knowledge O 0 1.230751611736025e-10
, O 0 2.6294320453618125e-12
this O 0 6.22375848774448e-13
is O 0 1.3926611600045824e-12
the O 0 6.797808301504948e-13
first O 0 7.478310332098559e-11
report O 0 1.334297811128593e-10
regarding O 0 6.460218644754878e-12
effects O 0 8.55517254261251e-11
on O 0 1.1711390190960458e-10
pre O 0 8.358657765938915e-09
- O 0 5.742555875265509e-10
mRNA O 0 7.426782799857534e-11
splicing O 0 3.844091156501861e-10
of O 0 4.1156306336033455e-13
a O 0 1.558699176673617e-11
mutation O 0 2.437634261109878e-10
at O 0 3.4790459402245233e-10
the O 0 2.4287087965757514e-11
- O 0 7.286634229330957e-08
2 O 0 4.031663336512281e-10
position O 0 7.227113130170437e-09
of O 0 1.7565275406070113e-12
a O 0 3.4796499015499194e-10
5 O 0 6.642045247140516e-10
splice O 0 1.0892204045376275e-06
site O 0 7.435367876951204e-08
. O 0 9.303295911422538e-09

ATM O 0 8.639560110168532e-05
germline O 0 3.267290230724029e-05
mutations O 0 1.7163538359454833e-06
in O 0 1.9044792409772526e-08
classical O 0 0.13080905377864838
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999994039535522
in O 0 9.487695962206999e-08
the O 0 2.273980725941982e-10
Dutch O 0 1.7752181236119213e-07
population O 0 8.15582254509728e-11
. O 0 6.437764210609487e-10

Germline O 0 0.00012654851889237761
mutations O 0 5.475387752085226e-06
in O 0 5.279265913316067e-09
the O 0 1.8071228541360895e-11
ATM O 0 7.041891514347753e-09
gene O 0 2.768478502002125e-10
are O 0 1.886050343680168e-12
responsible O 0 2.543377140840075e-11
for O 0 3.1058860344712613e-11
the O 0 6.744190613972023e-06
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9819583296775818
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.246821750873096e-08
. O 0 9.18626774648601e-09

In O 0 1.1498099361517689e-08
our O 0 1.1489910411999205e-10
study O 0 1.7471491267628814e-11
, O 0 2.317449183941722e-12
we O 0 2.0991147188509363e-12
have O 0 8.600482522339026e-13
determined O 0 1.678845951147423e-11
the O 0 4.6748264981300025e-12
ATM O 0 3.5558588251660694e-07
mutation O 0 7.809182744900056e-10
spectrum O 0 4.724535762612447e-10
in O 0 7.444585503613155e-10
19 O 0 1.4225656208566306e-09
classical O 0 1.4787813995553734e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 2.3649714421480894e-05
, O 0 1.9480478428285375e-12
including O 0 2.528178133422848e-13
some O 0 2.2619267570078705e-12
immigrant O 0 3.31936811370781e-10
populations O 0 8.639222150164105e-12
, O 0 6.186951992392942e-12
as O 0 1.5578045797770557e-11
well O 0 6.028069710062312e-11
as O 0 1.1774281549747911e-10
12 O 0 1.1905298795411579e-11
of O 0 4.3217165957010195e-13
Dutch O 0 8.50240855498896e-09
ethnic O 0 3.0284514479506086e-11
origin O 0 1.2832996887368608e-09
. O 0 1.2304283147912543e-09

Both O 0 1.1573496605521427e-09
the O 0 1.6832329974292293e-10
protein O 0 1.5072618708700247e-09
truncation O 0 5.88307251803144e-08
test O 0 8.71666827606532e-08
( O 0 3.822041294565537e-10
PTT O 0 2.9760782283005938e-08
) O 0 3.5223156856500903e-12
and O 0 1.3316877982283426e-12
the O 0 1.4823726014051575e-12
restriction O 0 2.1451664888871846e-09
endonuclease O 0 1.0846946452147677e-06
fingerprinting O 0 2.389951418990677e-07
( O 0 9.111623955337933e-11
REF O 0 3.6243108070266317e-08
) O 0 1.2974148665134688e-12
method O 0 1.1319885133420637e-11
were O 0 5.6695911854198755e-11
used O 0 8.432180648165755e-11
and O 0 4.0412385243771e-11
compared O 0 2.4038404947135383e-11
for O 0 1.4372959203021174e-13
their O 0 6.366224279512334e-13
detection O 0 4.7755861765086394e-11
efficiency O 0 1.1196116950218382e-11
, O 0 1.2369161684483432e-12
identifying O 0 3.758552497012957e-11
76 O 0 1.2838236029821815e-09
% O 0 4.211426693490061e-11
and O 0 3.745899077034487e-11
60 O 0 7.905286147913415e-11
% O 0 9.79028750430766e-12
of O 0 8.309142219761756e-13
the O 0 1.058471921222548e-10
mutations O 0 8.382766480963255e-09
, O 0 1.4210081722421108e-10
respectively O 0 3.6242051582036083e-09
. O 0 2.121298914303793e-09

Most O 0 5.002180891722219e-09
patients O 0 2.7324773554937565e-08
were O 0 2.46962617023172e-10
found O 0 2.440405690029568e-11
to O 0 1.967558928284152e-12
be O 0 1.9494241290662906e-11
compound O 0 1.4429323291764717e-09
heterozygote O 0 1.7297810472882702e-07
. O 0 7.855438077797317e-09

Seventeen O 0 3.6823655591433635e-07
mutations O 0 5.9601799051733906e-08
were O 0 1.0949732232035103e-09
distinct O 0 1.3548033528376635e-10
, O 0 2.743131242988195e-11
of O 0 1.384846420480687e-13
which O 0 3.1484728019171015e-11
10 O 0 1.1200388706777975e-11
were O 0 8.60522153534049e-10
not O 0 6.478842462520618e-11
reported O 0 7.189647543981437e-09
previously O 0 1.8243819788210658e-09
. O 0 6.927465823203249e-10

Mutations O 0 4.382014594739303e-06
are O 0 1.6341307196299226e-09
small O 0 7.90928766924992e-10
deletions O 0 1.8500513476737979e-07
or O 0 4.331068481633338e-08
point O 0 4.859882807295435e-08
mutations O 0 9.218619823059271e-08
frequently O 0 3.350443833483041e-08
affecting O 0 1.81874746374433e-08
splice O 0 4.48169748779037e-06
sites O 0 1.3315512603639945e-07
. O 0 2.8028466658724938e-08

Moreover O 0 1.5488823237319593e-06
, O 0 2.877528215705638e-09
a O 0 7.817155811551402e-10
16 O 0 4.599356007162214e-09
. O 0 9.847322957057258e-10

7 O 0 8.003279958757048e-07
- O 0 3.015050538124342e-07
kb O 0 6.0798086565228e-08
genomic O 0 1.3189048964079575e-08
deletion O 0 1.0600043509612078e-08
of O 0 4.670209965279559e-12
the O 0 1.4969149184085317e-11
3 O 0 7.978100124983456e-11
end O 0 2.5663887681659503e-10
of O 0 1.2896868089532637e-13
the O 0 8.901122026949704e-13
gene O 0 3.864631670236207e-10
, O 0 1.4004986406690456e-11
most O 0 3.881369184388639e-11
likely O 0 3.2252307491376087e-09
a O 0 4.449604226741677e-11
result O 0 1.0485134982474165e-10
of O 0 1.3176073730344906e-12
recombination O 0 1.0381338150233788e-10
between O 0 2.213082911373121e-10
two O 0 2.0889281970859486e-10
LINE O 0 6.926032369847235e-08
elements O 0 1.2600877008495104e-09
, O 0 3.7813771558425913e-10
was O 0 2.1265664784664295e-08
identified O 0 2.5163783945458817e-08
. O 0 8.84238349208033e-10

The O 0 7.893704023764769e-10
most O 0 4.499960126747027e-11
frequently O 0 4.1281530971382097e-10
found O 0 3.5331118586334753e-10
mutation O 0 2.71675459906362e-10
, O 0 1.0747749044914823e-11
identified O 0 1.0154039831178352e-09
in O 0 8.324283623517559e-11
three O 0 6.700084931310357e-12
unrelated O 0 6.206768432548415e-10
Turkish O 0 5.42612248466412e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
individuals O 0 3.1189968385803013e-09
, O 0 5.649408718610971e-10
was O 0 2.1559470653187418e-08
previously O 0 1.505660734979486e-10
described O 0 2.085607936352929e-10
to O 0 7.356049797069275e-12
be O 0 1.4096023827347981e-11
a O 0 7.278160712997916e-12
Turkish O 0 7.3569590419708675e-09
A B-Disease 1 1.0
- I-Disease 1 0.9999970197677612
T I-Disease 1 1.0
founder O 0 2.1816943274188816e-07
mutation O 0 3.0035306508580106e-07
. O 0 2.0232244324347448e-08

The O 0 3.635876599794585e-10
presence O 0 2.4640270379627793e-10
of O 0 1.4408758474554473e-12
a O 0 3.522512143083745e-11
founder O 0 2.33587815756664e-09
mutation O 0 2.4024815470369276e-09
among O 0 4.91025484161689e-11
relatively O 0 8.652831229305491e-11
small O 0 2.1117736032083556e-11
ethnic O 0 1.1545043566985047e-11
population O 0 1.1294561206437459e-12
groups O 0 5.24506002866354e-13
in O 0 3.373766327072203e-12
Western O 0 1.2877909849606795e-10
Europe O 0 5.256450776869315e-07
could O 0 5.04755170993576e-09
indicate O 0 1.7465037749353485e-10
a O 0 2.4941552295709712e-11
high O 0 1.2883567546140284e-09
carrier O 0 2.1838157948650405e-09
frequency O 0 1.6670413938157935e-09
in O 0 8.731648737381192e-11
such O 0 1.0155831037250707e-11
communities O 0 2.1900967150934036e-10
. O 0 9.191117311679875e-10

In O 0 3.329681774744131e-08
patients O 0 1.920474623773316e-08
of O 0 2.244136083559556e-12
Dutch O 0 2.5488978039334143e-08
ethnic O 0 1.609871611019109e-11
origin O 0 1.808058008867519e-10
, O 0 6.021588783156062e-11
however O 0 1.0910116560181038e-10
, O 0 4.595236517690449e-12
no O 0 8.44569726654587e-12
significant O 0 1.6640914340948498e-11
founder O 0 1.7338752655859935e-09
effect O 0 7.13934600327093e-09
could O 0 1.6825797644060003e-08
be O 0 1.8998043416207366e-10
identified O 0 8.071320500846468e-09
. O 0 3.5349451144028876e-10

The O 0 1.052850695515417e-09
observed O 0 9.114340393523435e-10
genetic O 0 1.7601958779422944e-09
heterogeneity O 0 5.454954266070899e-10
including O 0 1.4885008373446973e-12
the O 0 6.126803491629529e-12
relative O 0 2.602492665815248e-09
high O 0 2.354824601979999e-07
percentage O 0 1.4033966877491366e-08
of O 0 6.9722504679459174e-12
splice O 0 4.6860866859788075e-05
- O 0 9.066836810234236e-07
site O 0 5.9133093976981854e-09
mutations O 0 2.3455099551483727e-07
had O 0 6.376757824000379e-07
no O 0 4.777264694943995e-10
reflection O 0 1.7939123797550138e-10
on O 0 7.85483456056113e-10
the O 0 2.4923019203981767e-10
phenotype O 0 5.813601333670704e-08
. O 0 9.721595750633583e-10

All O 0 5.185377460747986e-09
patients O 0 4.731692015980116e-08
manifested O 0 8.890992830856703e-09
classical O 0 5.447480816656025e-06
A B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
and O 0 9.680574120096708e-10
increased O 0 5.146406079070687e-10
cellular O 0 5.11323321461532e-08
radioresistant O 0 3.0437032449981416e-08
DNA O 0 1.2406684568588844e-08
synthesis O 0 2.4793793684807497e-08
. O 0 4.124943941974379e-09

Determination O 0 2.425393219596117e-08
of O 0 6.158953989171545e-12
the O 0 8.019563312033906e-12
genomic O 0 3.7570418998100763e-10
structure O 0 4.187016289236567e-10
of O 0 2.2340655801006415e-12
the O 0 3.285992658530468e-11
COL4A4 O 0 9.805909684246217e-08
gene O 0 1.8015390290671007e-09
and O 0 1.1728148834044827e-11
of O 0 7.614142606346408e-13
novel O 0 5.86869086660613e-09
mutations O 0 2.0924784621456638e-05
causing O 0 1.8159720639232546e-05
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.2304839174248627e-06

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 4.977723051524663e-07
a O 0 8.47621421939948e-08
progressive O 0 9.869211498880759e-05
hematuric B-Disease 1 0.9999538660049438
glomerulonephritis I-Disease 1 1.0
characterized O 0 7.94810512161348e-06
by O 0 2.1402746241960813e-09
glomerular B-Disease 0 0.00021533276594709605
basement I-Disease 1 0.9411939978599548
membrane I-Disease 0 0.0037934896536171436
abnormalities I-Disease 1 0.9999624490737915
and O 0 8.491946729138888e-11
associated O 0 2.7786550838015955e-11
with O 0 1.072383241235153e-11
mutations O 0 4.604411518727147e-09
in O 0 4.006626419528203e-10
either O 0 4.766325112370851e-10
the O 0 1.2476414346096476e-10
COL4A3 O 0 1.0125230573976296e-06
or O 0 2.4068924631137634e-10
the O 0 1.8190570577614196e-11
COL4A4 O 0 3.878074394947362e-08
gene O 0 1.0234245673146347e-09
, O 0 3.4037375782475232e-12
which O 0 5.933000401733834e-13
encode O 0 1.3294253198292694e-10
the O 0 9.477914980626778e-11
alpha3 O 0 6.781467618566239e-07
and O 0 9.729888006404508e-10
alpha4 O 0 7.316701271520287e-07
type O 0 3.0739956855541095e-05
IV O 0 6.074013072066009e-05
collagen O 0 3.1975346814760996e-07
chains O 0 4.4538225552059885e-07
, O 0 1.8393703227204128e-10
respectively O 0 7.765470488863002e-10
. O 0 8.544119856068733e-10

To O 0 6.096175786396429e-10
date O 0 9.063758632521512e-09
, O 0 1.6544578207433602e-11
mutation O 0 8.128691469933003e-11
screening O 0 6.171483324379778e-10
in O 0 4.7918731482798904e-11
the O 0 2.1465221093641684e-12
two O 0 6.8605689705625306e-12
genes O 0 5.126977731251259e-10
has O 0 5.021966731355576e-10
been O 0 4.838985656618888e-09
hampered O 0 4.7152948923212534e-07
by O 0 6.028216120723684e-12
the O 0 1.001808011547034e-11
lack O 0 5.654773871377472e-11
of O 0 6.498501281364255e-13
genomic O 0 4.994856195317254e-10
structure O 0 9.015098667575216e-10
information O 0 1.4411968285443777e-09
. O 0 1.9648767057844907e-09

We O 0 4.775265338707868e-08
report O 0 2.4158626210635248e-09
here O 0 3.879096696635109e-11
the O 0 6.047687307539351e-13
complete O 0 6.7928865657429505e-12
characterization O 0 2.048083092009989e-10
of O 0 2.4025958089354815e-13
the O 0 3.5793538272210768e-12
48 O 0 6.08532252366345e-11
exons O 0 9.287046826012002e-11
of O 0 1.287639916566774e-12
the O 0 2.3349938302330564e-11
COL4A4 O 0 1.0855167431600421e-07
gene O 0 2.6141140363478144e-09
, O 0 1.896259364808639e-11
a O 0 1.2440953649217601e-11
comprehensive O 0 6.661685092446135e-10
gene O 0 1.5483101023505697e-08
screen O 0 3.777571691898629e-06
, O 0 1.1795012744286737e-09
and O 0 6.322523060653396e-11
the O 0 3.500448845714099e-12
subsequent O 0 1.8808279586557397e-11
detection O 0 4.5226092315608923e-10
of O 0 1.7105537906264567e-12
10 O 0 7.360232215369855e-12
novel O 0 3.484456473357156e-11
mutations O 0 1.947051631034924e-09
in O 0 4.810730702686783e-10
eight O 0 5.665640401275596e-09
patients O 0 3.8943408071645536e-06
diagnosed O 0 0.003377616638317704
with O 0 7.574154636813546e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 4.703582817455754e-06

Furthermore O 0 2.0404903011694842e-07
, O 0 5.389778068298767e-10
we O 0 2.249004975307667e-11
identified O 0 3.5304693196680503e-11
a O 0 5.983735208714425e-12
glycine O 0 1.2203222876649988e-09
to O 0 1.133963669491811e-11
alanine O 0 1.4859190544669332e-09
substitution O 0 1.0659843840965522e-10
in O 0 5.0306502019648036e-11
the O 0 1.2560168183295417e-11
collagenous O 0 1.2255712000808217e-08
domain O 0 1.8385144795463049e-10
that O 0 8.417713574793151e-12
is O 0 4.762848535705411e-12
apparently O 0 1.3723855385450179e-09
silent O 0 5.10356201743889e-10
in O 0 3.493826755684992e-11
the O 0 3.470274415051655e-12
heterozygous O 0 4.4505232832392494e-10
carriers O 0 1.3924933428555164e-09
, O 0 2.1957590259913395e-11
in O 0 8.895262859631714e-10
11 O 0 3.909010448666095e-09
. O 0 1.2423040374187622e-09

5 O 0 6.741257863041028e-08
% O 0 5.151346016418756e-10
of O 0 1.103157495907503e-12
all O 0 2.3290768185607602e-12
control O 0 3.598044084895946e-10
individuals O 0 5.8064859344286734e-12
, O 0 2.221819776770939e-11
and O 0 7.839699028844294e-11
in O 0 4.731993685780367e-10
one O 0 5.45925075978726e-11
control O 0 5.520982560014431e-10
individual O 0 2.3613094986274508e-12
homozygous O 0 3.141228110958849e-10
for O 0 4.051918522929299e-12
this O 0 2.644144105057311e-11
glycine O 0 1.3587744263077184e-08
substitution O 0 4.3497347945731235e-09
. O 0 1.591254128463504e-09

There O 0 9.246862830991631e-09
has O 0 2.87054824354982e-10
been O 0 6.780941780304417e-11
no O 0 5.495132994470797e-12
previous O 0 4.76183112038675e-12
finding O 0 3.734490147677683e-12
of O 0 6.1881259122952e-14
a O 0 3.7669615690627545e-12
glycine O 0 4.965106659149399e-10
substitution O 0 5.886049286862871e-11
that O 0 7.997689316363576e-12
is O 0 2.5285166755512067e-12
not O 0 1.1278328531511006e-12
associated O 0 1.9370622727360454e-12
with O 0 7.523426326372373e-13
any O 0 1.2487223755019983e-10
obvious O 0 2.5896792266166813e-08
phenotype O 0 9.438889492230373e-08
in O 0 9.297296266197463e-10
homozygous O 0 4.560485677984616e-08
individuals O 0 4.350745042014381e-10
. O 0 2.269423537981652e-09

Founder O 0 8.95669472811278e-06
BRCA1 O 0 0.000603197724558413
and O 0 3.318510266581143e-08
BRCA2 O 0 7.788209586578887e-06
mutations O 0 6.146151321217985e-08
in O 0 9.066692951975597e-10
French O 0 1.4465341564573464e-06
Canadian O 0 7.22069526091218e-05
breast B-Disease 1 0.9999996423721313
and I-Disease 1 0.999997615814209
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.8673860558446904e-08
. O 0 8.475466550805777e-09

We O 0 1.0365005742585254e-08
have O 0 2.9443031346332305e-11
identified O 0 9.709045373229586e-11
four O 0 2.9436338349481117e-12
mutations O 0 6.63803942368979e-11
in O 0 7.553077954747245e-12
each O 0 8.245423115983697e-13
of O 0 4.8164185313670504e-12
the O 0 3.420846717006043e-09
breast B-Disease 0 0.0006088561494834721
cancer I-Disease 0 1.0849194950424135e-05
- O 0 2.599894969534944e-06
susceptibility O 0 2.854813203612139e-07
genes O 0 3.749686925402784e-07
, O 0 1.280602623943139e-09
BRCA1 O 0 2.9911473120591836e-06
and O 0 1.7177983480110015e-09
BRCA2 O 0 1.2283359183129505e-06
, O 0 5.4911544061786444e-11
in O 0 1.228593893287666e-10
French O 0 4.762704065797152e-06
Canadian O 0 1.0379901141277514e-05
breast B-Disease 1 0.9988541603088379
cancer I-Disease 1 0.9609009623527527
and O 1 0.9406905770301819
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.1944393918383867e-08
from O 0 5.980934081328826e-10
Quebec O 0 4.0874621021202984e-08
. O 0 7.1083663399917896e-09

To O 0 2.4645641083509418e-09
identify O 0 7.94908139312156e-09
founder O 0 7.573457416754081e-09
effects O 0 1.0798873262274356e-07
, O 0 9.908743825448596e-10
we O 0 1.6676160452533395e-10
examined O 0 3.23178706018723e-10
independently O 0 2.1101682901036867e-10
ascertained O 0 5.521680446207711e-09
French O 0 1.5996661772987864e-08
Canadian O 0 9.583321691764013e-09
cancer B-Disease 0 2.6704068289973293e-08
families O 0 1.540342853267873e-11
for O 0 1.9993890169791445e-13
the O 0 2.5978752569294494e-13
distribution O 0 5.306515643566101e-12
of O 0 1.5707406078938058e-12
these O 0 3.110391458283068e-11
eight O 0 1.908903174419052e-10
mutations O 0 7.915146760240077e-09
. O 0 9.37071642503895e-10

Mutations O 0 6.373468863785092e-07
were O 0 1.0689418239451243e-08
found O 0 1.3318575131648913e-09
in O 0 1.157923132377725e-10
41 O 0 2.613893546055124e-10
of O 0 2.8593815683264356e-12
97 O 0 8.340056645295135e-09
families O 0 6.205004288162286e-10
. O 0 1.059417664706075e-09

Six O 0 3.088475608592489e-08
of O 0 1.1306032499103225e-11
eight O 0 1.0830521202098708e-10
mutations O 0 1.3754829497614196e-09
were O 0 9.285032742667454e-10
observed O 0 6.882670128272039e-11
at O 0 1.04500165465371e-10
least O 0 7.91003720856942e-11
twice O 0 2.8730693379941386e-09
. O 0 1.9015056196280966e-09

The O 0 7.533765611356102e-09
BRCA1 O 0 3.8366360968211666e-05
C4446T O 0 2.0540824152703863e-06
mutation O 0 8.345661939301863e-08
was O 0 3.572838691567881e-09
the O 0 2.1780305423796387e-12
most O 0 2.0133424007834355e-12
common O 0 2.6113519679960007e-10
mutation O 0 7.613471519896109e-10
found O 0 6.893608350821978e-09
, O 0 3.058596778626743e-11
followed O 0 2.5324322500130947e-11
by O 0 6.2699910367836065e-12
the O 0 2.2325515047771916e-10
BRCA2 O 0 6.439774551836308e-06
8765delAG O 0 1.3734907042817213e-06
mutation O 0 6.090219812904252e-07
. O 0 1.957799788954162e-08

Together O 0 1.0557348772977093e-08
, O 0 5.0540495399875596e-11
these O 0 1.4115360356253825e-12
mutations O 0 1.512398678515936e-10
were O 0 2.5473689824195844e-10
found O 0 1.032637864106789e-10
in O 0 4.180909438100677e-11
28 O 0 6.40310443555947e-11
of O 0 2.533758522004631e-13
41 O 0 1.1105391606314186e-10
families O 0 1.29838772112284e-12
identified O 0 7.998456064139958e-11
to O 0 1.4951336609753119e-12
have O 0 5.794200119701998e-10
a O 0 1.6681100944992977e-09
mutation O 0 7.220171482913429e-08
. O 0 4.148551280280799e-09

The O 0 1.3209787708134968e-09
odds O 0 3.2254416026944455e-08
of O 0 4.9316804980048534e-12
detection O 0 3.3975725011181623e-10
of O 0 3.076039585808016e-13
any O 0 4.1876111953054185e-12
of O 0 1.5314708052063808e-13
the O 0 9.172964471337863e-12
four O 0 1.2669192084313607e-10
BRCA1 O 0 7.663128940293973e-07
mutations O 0 2.524397757497354e-07
was O 0 3.5172251955373213e-06
18 O 0 5.541695102806443e-09
. O 0 1.5770049710539524e-09

7x O 0 0.003971408121287823
greater O 0 5.066295472033744e-08
if O 0 2.990798053659205e-09
one O 0 8.36047897578851e-12
or O 0 8.305280074782928e-12
more O 0 2.3838270767073677e-12
cases O 0 3.4969419027142123e-10
of O 0 1.2510949431998597e-07
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 1.7104790472899367e-08
also O 0 1.854220076091817e-11
present O 0 2.807592266312886e-12
in O 0 2.363898521373642e-10
the O 0 1.0326083044187584e-10
family O 0 1.283745221236643e-09
. O 0 7.397733536862461e-10

The O 0 2.3021564654612803e-09
odds O 0 4.276383336332401e-08
of O 0 5.159019912659435e-12
detection O 0 2.977506297074939e-10
of O 0 6.317826036633667e-13
any O 0 1.097043809961118e-11
of O 0 6.93373418576837e-13
the O 0 1.3909257426392152e-11
four O 0 3.202102194510559e-10
BRCA2 O 0 2.1925750388618326e-06
mutations O 0 2.9961725545035733e-07
was O 0 1.0662049589882372e-06
5 O 0 2.3973045770731005e-09
. O 0 4.245052309670427e-09

3x O 0 0.0003455541154835373
greater O 0 1.749692835062433e-08
if O 0 2.3032631357722266e-09
there O 0 4.608290485319522e-11
were O 0 1.316533410067322e-10
at O 0 1.4023323301193269e-11
least O 0 1.4658515287008234e-12
five O 0 1.697235559559862e-12
cases O 0 2.1642665090637614e-11
of O 0 1.997744157600234e-11
breast B-Disease 0 7.779324369039387e-05
cancer I-Disease 0 1.782673848538252e-06
in O 0 1.0605423206300202e-08
the O 0 7.856422734597857e-10
family O 0 4.103998474391801e-09
. O 0 1.9388393113217717e-09

Interestingly O 0 3.603828645282192e-06
, O 0 2.1732231292315163e-10
the O 0 1.7284343444348704e-12
presence O 0 1.258450722102511e-11
of O 0 1.120076796069791e-12
a O 0 7.882874797360273e-09
breast B-Disease 0 0.00012616225285455585
cancer I-Disease 0 1.5613206016951153e-07
case O 0 3.880085142071721e-09
< O 0 2.2061733773171e-08
36 O 0 5.377086553792765e-10
years O 0 2.3681482122506203e-11
of O 0 1.4786818687897996e-12
age O 0 5.800149249779452e-10
was O 0 1.1333804728064223e-10
strongly O 0 1.493196365165428e-11
predictive O 0 6.794137474841477e-10
of O 0 7.806744074974337e-13
the O 0 1.106575660096698e-12
presence O 0 1.0646814159465112e-11
of O 0 1.5220648092589828e-13
any O 0 9.036918782734382e-12
of O 0 7.187041218235934e-13
the O 0 1.191625010471542e-11
eight O 0 1.5254471297243555e-10
mutations O 0 2.0480568352354567e-09
screened O 0 1.0212279022425719e-07
. O 0 8.728809675062621e-09

Carriers O 0 9.549422941290686e-08
of O 0 8.840553289424236e-12
the O 0 3.429923229117393e-12
same O 0 2.5236326917088547e-11
mutation O 0 8.552986097143389e-11
, O 0 4.568224704765145e-12
from O 0 2.1938739887261693e-12
different O 0 6.222408005518432e-12
families O 0 8.156005384951648e-12
, O 0 1.8353794504176457e-13
shared O 0 1.4211124681542953e-12
similar O 0 6.470012720027896e-11
haplotypes O 0 2.9677568846864233e-08
, O 0 4.5612961324659196e-11
indicating O 0 2.1290815777064154e-09
that O 0 5.7481831794437e-12
the O 0 1.1687724356043705e-12
mutant O 0 5.364609312330515e-10
alleles O 0 3.065677156577351e-10
were O 0 2.563699252888796e-09
likely O 0 1.5096586203355855e-09
to O 0 1.1832511966763937e-12
be O 0 3.964621599766849e-12
identical O 0 1.3842879099945637e-11
by O 0 1.0381842954765297e-12
descent O 0 1.0221935520249303e-09
for O 0 6.324035262475491e-13
a O 0 5.137939032562322e-11
mutation O 0 5.590666818378054e-10
in O 0 3.276168780708133e-10
the O 0 2.123721858093841e-11
founder O 0 1.857421882967003e-09
population O 0 1.0568822206291628e-10
. O 0 3.2862215171292064e-09

The O 0 1.0360533542197459e-09
identification O 0 1.7539188990056687e-09
of O 0 5.567696911151776e-12
common O 0 5.3995146132024274e-09
BRCA1 O 0 7.832219125702977e-05
and O 0 2.0298340785984692e-08
BRCA2 O 0 1.9571598386391997e-05
mutations O 0 7.323752271304329e-08
will O 0 9.452261889864033e-11
facilitate O 0 7.877339891493307e-10
carrier O 0 1.0288072616049249e-08
detection O 0 3.9336773838272165e-09
in O 0 6.457810397542119e-10
French O 0 2.2719098069501342e-06
Canadian O 0 4.16832199334749e-06
breast B-Disease 1 0.9588260650634766
cancer I-Disease 1 0.5259406566619873
and O 1 0.9361820816993713
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 7.249204969639322e-08
. O 0 5.004366254723891e-09

Are O 0 4.639818840246335e-08
Dp71 O 0 3.559648803275195e-06
and O 0 4.572729750407234e-09
Dp140 O 0 8.02251406639698e-07
brain O 0 6.434443662328704e-07
dystrophin O 0 3.417647178594052e-07
isoforms O 0 1.3063019999037806e-08
related O 0 3.2842037978042526e-09
to O 0 4.3170103602996335e-10
cognitive B-Disease 0 4.004056677331391e-07
impairment I-Disease 0 9.718258297652937e-06
in O 0 5.902055733031375e-08
Duchenne B-Disease 1 0.9997430443763733
muscular I-Disease 1 0.9999226331710815
dystrophy I-Disease 1 0.9999903440475464
? O 0 6.28675552434288e-05

Molecular O 0 2.4797725473035825e-07
study O 0 2.3131436321932597e-08
and O 0 1.476877398154386e-09
neuropsychological O 0 2.158292389253802e-08
analysis O 0 2.1439136577150464e-10
were O 0 4.989323953985547e-10
performed O 0 1.3836921886056786e-10
concurrently O 0 2.3317448666348994e-11
on O 0 5.89524318250767e-10
49 O 0 1.033862773169858e-08
patients O 0 6.665450857923361e-09
with O 0 1.1015359735466745e-09
Duchenne B-Disease 1 0.9999747276306152
muscular I-Disease 1 0.9999982118606567
dystrophy I-Disease 1 0.9999997615814209
( O 0 6.757685241609579e-06
DMD B-Disease 1 1.0
) O 0 3.4671767679128607e-09
in O 0 1.6967356686325985e-10
order O 0 1.4884194571296305e-11
to O 0 4.251755631595744e-12
find O 0 4.841965162150075e-10
a O 0 1.8132995105446525e-11
molecular O 0 2.5224886068819785e-10
explanation O 0 3.2139543804099446e-10
for O 0 7.291958703525836e-12
the O 0 1.1142096967287074e-10
cognitive B-Disease 0 6.871766800031764e-08
impairment I-Disease 0 1.7878518576708302e-07
observed O 0 1.3354586880787167e-10
in O 0 1.2899451506953596e-09
most O 0 5.3972723179640525e-08
DMD B-Disease 1 1.0
patients O 0 0.0003023377212230116
. O 0 1.0386220772318211e-08

Complete O 0 3.3585376257860844e-08
analysis O 0 3.7052994006359086e-09
of O 0 8.218217772970604e-12
the O 0 1.1876834585256013e-11
dystrophin O 0 3.071093956918958e-08
gene O 0 4.8380933037606155e-08
was O 0 6.55334631005644e-08
performed O 0 3.350114630151779e-10
to O 0 3.723387483750562e-12
define O 0 3.641469070725378e-11
the O 0 2.908558463521338e-11
localization O 0 5.959347237904922e-09
of O 0 1.0186401418546542e-12
deletions O 0 4.107185702650895e-09
and O 0 2.848840052749324e-10
duplications O 0 7.067295637597226e-09
in O 0 2.3728607967399284e-10
relation O 0 2.465108117633008e-10
to O 0 1.7942673388726682e-11
the O 0 6.959419152074986e-11
different O 0 5.299645167156086e-09
DMD B-Disease 1 1.0
promoters O 0 5.379572030506097e-06
. O 0 1.5914615403289645e-08

Qualitative O 0 1.9663085026877525e-07
analysis O 0 4.931810515529378e-09
of O 0 7.918094131753595e-12
the O 0 3.3122702497445644e-11
Dp71 O 0 5.145459169852984e-08
transcript O 0 1.1701737889779906e-07
and O 0 1.6301637817406345e-10
testing O 0 9.734375805425799e-11
for O 0 3.02996776974096e-13
the O 0 4.1710442066390796e-13
specific O 0 1.0889419791229593e-12
first O 0 6.091756266091153e-11
exon O 0 1.0906356928686023e-09
of O 0 8.558039693573605e-12
Dp140 O 0 1.1833913404757368e-08
were O 0 2.7739782026969806e-08
also O 0 1.7188758749675515e-10
carried O 0 1.0431401298305332e-09
out O 0 4.221392957415304e-10
. O 0 6.142242825468713e-10

Neuropsychological O 0 0.00014864049444440752
analysis O 0 3.193116242528049e-07
assessed O 0 2.6344608272665937e-07
verbal O 0 3.528338083924609e-07
and O 0 1.4059384767506344e-09
visuospatial O 0 9.79457922767324e-07
intelligence O 0 7.281034442030432e-08
, O 0 9.82622871958938e-11
verbal O 0 4.599305469810133e-08
memory O 0 4.1705295217298044e-08
, O 0 5.02833108484424e-10
and O 0 1.95168436967208e-09
reading O 0 4.436577114574902e-07
skills O 0 3.7005838748882525e-07
. O 0 1.4905943146459322e-09

Comparison O 0 7.925603995317942e-08
of O 0 1.0660698018805093e-10
molecular O 0 7.25484228247808e-10
and O 0 5.064074853899925e-11
psychometric O 0 3.7181152379162086e-08
findings O 0 4.115118801273354e-10
demonstrated O 0 1.7570420118850905e-10
that O 0 1.6266097843664618e-11
deletions O 0 7.733385487540545e-09
and O 0 1.1863031390557666e-10
duplications O 0 4.4637533669344975e-09
that O 0 8.031917145268075e-12
were O 0 8.226266889899136e-11
localized O 0 2.932490639206975e-10
in O 0 6.878211333827267e-10
the O 0 3.248663490995618e-11
distal O 0 1.6503686195434852e-09
part O 0 6.290189896729359e-11
of O 0 2.098550500040375e-12
the O 0 1.3718161155640285e-11
gene O 0 2.3113961855614207e-09
seemed O 0 1.6397584090555029e-07
to O 0 5.5122434394760944e-12
be O 0 4.005055835587523e-12
preferentially O 0 2.982870200840537e-11
associated O 0 4.6106115453303786e-11
with O 0 2.6423441559786376e-11
cognitive B-Disease 0 2.0777332565558027e-07
impairment I-Disease 0 2.740317313509877e-06
. O 0 1.2096413870565925e-09

Two O 0 1.5029019806434007e-08
altered O 0 3.3530304222040286e-07
Dp71 O 0 5.195468588681251e-07
transcripts O 0 7.508879207307473e-08
and O 0 1.372636032614949e-10
two O 0 1.0856078189180884e-11
deleted O 0 1.705757313175127e-09
Dp140 O 0 1.9703860765218906e-09
DNA O 0 2.6627700044912217e-10
sequences O 0 2.2292228826770177e-11
were O 0 2.518266498108268e-11
found O 0 1.6161941576720018e-11
in O 0 1.0386185834987405e-11
four O 0 1.5741965023186033e-11
patients O 0 1.3068039705910195e-10
with O 0 5.261427404867902e-11
severe O 0 0.06355191022157669
cerebral B-Disease 1 0.9995517134666443
dysfunction I-Disease 0 0.06107785925269127
. O 0 2.6526496554879486e-08

These O 0 3.9208367108578557e-10
findings O 0 4.0470413131821203e-10
suggest O 0 2.0285240154294115e-10
that O 0 1.350060688243282e-12
some O 0 3.9313894479274525e-13
sequences O 0 8.205765927860043e-12
located O 0 1.590560842756883e-11
in O 0 4.188508220814846e-11
the O 0 6.314830169190655e-12
distal O 0 5.675978020924788e-10
part O 0 4.013462132079759e-11
of O 0 3.975145137103536e-13
the O 0 3.086049211314945e-12
gene O 0 4.174074974550024e-10
and O 0 2.140334437461533e-10
, O 0 2.6640118062914997e-12
in O 0 5.040616795487507e-12
particular O 0 5.162162364236167e-11
, O 0 9.002717842043761e-12
some O 0 6.573103866758245e-11
DMD B-Disease 1 1.0
isoforms O 0 2.644151564368258e-09
expressed O 0 3.121344502310386e-11
in O 0 3.9605671520170915e-10
the O 0 2.0323193128390926e-10
brain O 0 8.084271030384116e-06
may O 0 1.085191314587064e-08
be O 0 5.068527195173367e-12
related O 0 1.6588121501404096e-11
to O 0 2.0536473997051496e-12
the O 0 6.963641469015514e-11
cognitive B-Disease 0 2.4062524417445275e-08
impairment I-Disease 0 6.827607990089746e-08
associated O 0 6.498002691479599e-10
with O 0 8.730241418675178e-09
DMD B-Disease 1 1.0
. O 0 2.585207958816227e-08
. O 0 4.773132555868642e-09

I1307K O 0 5.7366371038369834e-05
APC O 0 3.366068312971038e-06
and O 0 1.1273699751512822e-09
hMLH1 O 0 5.249757251135634e-08
mutations O 0 2.013577038439962e-08
in O 0 2.5714749773975143e-10
a O 0 1.2901266166487346e-10
non O 0 8.207300083995506e-08
- O 0 4.245070783781557e-08
Jewish O 0 6.436143284993534e-10
family O 0 3.5202102344200625e-10
with O 0 7.655054368171932e-11
hereditary B-Disease 1 0.9981525540351868
non I-Disease 1 0.9999991655349731
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.187247549860331e-07

We O 0 1.1652267595252397e-08
describe O 0 2.8004512042656415e-09
a O 0 1.833520696381541e-10
French O 0 8.003290474789537e-08
Canadian O 0 3.4793521308529307e-07
hereditary B-Disease 1 0.9999872446060181
non I-Disease 1 0.9999995231628418
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 3.155074637106736e-06
HNPCC B-Disease 0 0.0030836935620754957
) O 0 3.2573164165938806e-09
kindred O 0 1.8767691472021397e-06
which O 0 3.1596394944877204e-10
carries O 0 1.2922993786190773e-09
a O 0 2.468439341818396e-10
novel O 0 5.16780263026817e-09
truncating O 0 9.485303849032789e-07
mutation O 0 4.159416846505337e-07
in O 0 1.1913972919330718e-08
hMLH1 O 0 1.4803180192757281e-06
. O 0 8.969908371625479e-09

Interestingly O 0 7.191088116087485e-06
, O 0 1.2848329067338682e-09
the O 0 8.832838627181872e-11
I1307K O 0 4.533790232130741e-08
APC O 0 2.4266334719413862e-08
polymorphism O 0 5.617030396365408e-08
, O 0 4.390052123909305e-12
associated O 0 1.0129173541595371e-11
with O 0 1.051829521918346e-12
an O 0 1.685939907646039e-12
increased O 0 9.003933598705771e-09
risk O 0 1.4905182069924194e-05
of O 0 2.150907675968483e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 2.956455968927685e-09
is O 0 1.1947889899666109e-10
also O 0 6.134009272740215e-11
present O 0 1.3895256473217543e-11
in O 0 3.331668718686842e-09
this O 0 3.3941202626230904e-10
family O 0 1.8404943125105433e-09
. O 0 1.0531439054162206e-09

The O 0 6.646749817207365e-09
I1307K O 0 5.270425162962056e-07
polymorphism O 0 2.3419120225298684e-06
has O 0 3.9135145124546966e-10
previously O 0 5.977555256331257e-11
only O 0 5.767269474488135e-12
been O 0 3.155952235656123e-11
identified O 0 9.119795890688565e-11
in O 0 3.106920970497029e-12
individuals O 0 2.3852176744137976e-13
of O 0 6.795189953258396e-13
self O 0 3.485398991642796e-08
- O 0 7.573756306555879e-07
reported O 0 2.678722694327007e-06
Ashkenazi O 0 7.065398222039221e-08
Jewish O 0 5.34966071441545e-10
origins O 0 1.9468815892764724e-08
. O 0 2.3145814154190703e-09

In O 0 1.5427260580125335e-09
addition O 0 2.8065123142129167e-11
, O 0 1.171381915077152e-11
in O 0 5.268798591862023e-11
this O 0 1.041604302809418e-11
family O 0 8.588360578265508e-11
, O 0 2.9581773228898323e-12
there O 0 3.4324640352245694e-11
appears O 0 7.30965066253475e-10
to O 0 1.3770907157650836e-11
be O 0 2.4517116115063686e-10
no O 0 7.839893317873603e-11
relationship O 0 6.873539237783888e-11
between O 0 1.0582695310346057e-11
the O 0 1.5111262935407765e-11
I1307K O 0 2.282908084794144e-09
polymorphism O 0 5.217203113971891e-09
and O 0 1.516097664078231e-11
the O 0 1.3726766034602433e-12
presence O 0 2.0543105411219287e-11
or O 0 2.41479253260124e-10
absence O 0 5.076165598971727e-10
of O 0 7.894448983414293e-12
cancer B-Disease 0 1.3804299925368468e-08
. O 0 1.8651104272127128e-10
. O 0 1.463920318300893e-09

Identification O 0 1.42068230957193e-07
of O 0 3.7607323505328694e-11
a O 0 6.268822960731057e-11
novel O 0 5.726892848834098e-10
mutation O 0 2.2125099530256875e-09
of O 0 6.106923126913966e-12
the O 0 2.995356393475923e-11
CPO O 0 4.0394951383859734e-08
gene O 0 7.45886907793647e-10
in O 0 9.41327432668615e-11
a O 0 5.152564486188282e-10
Japanese O 0 2.909162901687523e-07
hereditary B-Disease 0 0.00015359357348643243
coproporphyria I-Disease 0 7.232886127894744e-05
family O 0 6.974072164211975e-08
. O 0 1.0859325882961457e-08

Hereditary B-Disease 1 0.9999731779098511
coproporphyria I-Disease 0 0.23237423598766327
( O 0 4.033886966681166e-07
HCP B-Disease 0 5.294253787724301e-05
) O 0 5.842118455667844e-10
is O 0 8.444187016287685e-11
an O 0 1.2245418568035404e-10
autosomal B-Disease 1 0.9999849796295166
dominant I-Disease 1 0.9999984502792358
disease I-Disease 1 0.9999078512191772
characterized O 0 6.928033258191135e-07
by O 0 8.653709970829482e-10
a O 0 7.097624461493979e-07
deficiency B-Disease 0 0.0811094343662262
of I-Disease 0 3.747456858715914e-11
coproporphyrinogen I-Disease 0 1.3501170315066702e-06
oxidase I-Disease 0 1.1510369546385846e-07
( O 0 4.302223022278895e-10
CPO O 0 2.3210132837903075e-07
) O 0 3.6439146838818104e-11
caused O 0 8.874549706217039e-11
by O 0 1.904653518236543e-12
a O 0 1.9025857278531788e-10
mutation O 0 1.1733396476643065e-09
in O 0 7.378259114787511e-10
the O 0 1.670016208654701e-10
CPO O 0 3.953820453261869e-07
gene O 0 4.239374717940336e-08
. O 0 3.243169288680292e-09

Only O 0 3.213583710248713e-08
11 O 0 1.7962621390310574e-09
mutations O 0 1.0081057100208568e-09
of O 0 8.985113000847811e-13
the O 0 2.5341994128180723e-12
gene O 0 5.171073569343321e-10
have O 0 9.783739096658195e-11
been O 0 2.5909513423627573e-10
reported O 0 2.454170378030085e-08
in O 0 4.618255999844223e-09
HCP B-Disease 0 3.920711242244579e-05
patients O 0 3.2538284244765237e-07
. O 0 4.5233190526516864e-09

We O 0 3.1979855208419394e-08
report O 0 1.286475925788011e-09
another O 0 4.2226631913333534e-11
mutation O 0 4.3968609308997486e-10
in O 0 1.6241738509670256e-10
a O 0 4.974045064720656e-10
Japanese O 0 6.074522929111481e-08
family O 0 1.6248253853490269e-09
. O 0 8.620630875810775e-10

Polymerase O 0 1.7232193840754917e-06
chain O 0 2.1590587095943192e-07
reaction O 0 2.6859000357148943e-08
- O 0 4.6802959730030125e-08
single O 0 6.956874520902545e-10
strand O 0 1.345169948763214e-07
conformational O 0 3.6998757391160098e-09
polymorphism O 0 4.109726603473973e-08
and O 0 1.864568915932452e-11
direct O 0 5.829293298065252e-11
sequence O 0 1.860441800616286e-10
analyses O 0 9.867440198263466e-10
demonstrated O 0 6.259491536209083e-11
a O 0 5.2543774886615324e-11
C O 0 2.6144844511577503e-08
to O 0 2.080037184160055e-11
T O 0 7.411648184074693e-09
substitution O 0 1.8837262305559932e-10
in O 0 9.274691431526705e-11
exon O 0 1.4200687292742487e-09
1 O 0 3.2569523467085304e-11
of O 0 2.0162671445639324e-12
the O 0 1.2535899401866502e-11
CPO O 0 6.40389297146271e-09
gene O 0 2.3997323572721996e-10
at O 0 3.5952709559472495e-11
nucleotide O 0 3.144355609219218e-11
position O 0 2.9633517861782366e-11
85 O 0 1.7124808515678325e-11
, O 0 3.8059316982697045e-12
which O 0 1.144170522215937e-11
lies O 0 1.4818625493351334e-10
in O 0 8.377515348101383e-11
the O 0 9.874999255810035e-12
putative O 0 8.531580442117104e-10
presequence O 0 1.5844883183291358e-09
for O 0 1.3895753037812542e-12
targeting O 0 4.5841058726736605e-10
to O 0 6.396488894111485e-11
mitochondria O 0 4.273146103628278e-08
. O 0 2.723749892297178e-09

This O 0 1.970311025445426e-09
mutation O 0 4.570758882493919e-09
changes O 0 9.080534241201477e-11
the O 0 8.273185088392143e-12
codon O 0 6.290601373137861e-10
for O 0 5.539010547971068e-13
glutamine O 0 2.8718846745157123e-10
to O 0 3.608941270827337e-12
a O 0 7.567414750386803e-11
termination O 0 9.044761384302547e-09
codon O 0 7.834773718684573e-09
at O 0 2.009899052746178e-10
amino O 0 3.4243835544955914e-10
acid O 0 3.9846700938817037e-10
position O 0 2.8729270074023816e-09
29 O 0 5.431307403824803e-09
. O 0 5.273355641044475e-10

MaeI O 0 8.562956281821243e-06
restriction O 0 4.195958425157187e-08
analysis O 0 4.274798737213814e-09
showed O 0 3.5338010295760114e-09
two O 0 1.8849713456781103e-12
other O 0 5.49343177284195e-13
carriers O 0 3.309152674102478e-10
in O 0 9.247418109037397e-11
the O 0 1.2878793864690152e-10
family O 0 1.4873027254225235e-09
. O 0 1.0281280271584592e-09

The O 0 1.639276270282153e-08
C O 0 0.010843265801668167
- O 0 0.02070119045674801
T O 0 0.0001248596381628886
mutation O 0 2.8203935187320894e-08
is O 0 5.781380929548163e-11
located O 0 6.301489885451872e-11
within O 0 1.522379965146481e-11
a O 0 1.422830742114911e-10
recently O 0 4.3536028115909176e-09
proposed O 0 1.6218489051755824e-10
putative O 0 2.035610124906384e-09
alternative O 0 1.5411321108160791e-09
translation O 0 3.121009584106105e-08
initiation O 0 2.9500795140080527e-09
codon O 0 2.4612770488374736e-08
( O 0 3.9543776586548063e-10
TIC O 0 3.3070532481360715e-06
- O 0 1.7649504968630936e-08
1 O 0 4.332995767741821e-11
) O 0 2.182538438172399e-12
, O 0 4.571316740940856e-13
supporting O 0 2.6845680626413904e-12
that O 0 5.3357269991227696e-11
TIC O 0 2.133068483090028e-05
- O 0 1.0237959813252928e-08
1 O 0 4.1182734306088875e-11
is O 0 4.124567874741469e-12
the O 0 6.095518621102025e-12
real O 0 1.3125657893908738e-08
TIC O 0 3.4895572298410116e-07
rather O 0 2.995756073764788e-11
than O 0 3.458402314526765e-11
TIC O 0 1.4348487411552924e-06
- O 0 3.813858562295991e-09
2 O 0 9.622434793410406e-11
. O 0 4.108638776423312e-11
. O 0 2.371078333673893e-10

Human B-Disease 0 1.1631837715242455e-08
complement I-Disease 0 2.1421362816909095e-07
factor I-Disease 0 3.6569581425283104e-06
H I-Disease 1 1.0
deficiency I-Disease 1 0.9985561966896057
associated O 0 6.335435500659514e-07
with O 0 3.3698811421345454e-06
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 2.752081854850985e-06

This O 0 1.4757874922111114e-09
study O 0 2.3762666834237223e-10
reports O 0 7.541813284994703e-10
on O 0 6.561292481555014e-11
six O 0 1.687314350740099e-11
cases O 0 7.82085091133311e-11
of O 0 4.2252899096206775e-11
deficiency B-Disease 0 5.320031959854532e-06
in I-Disease 0 3.5850950680371696e-11
the I-Disease 0 3.103154668990249e-12
human I-Disease 0 8.223658733153005e-12
complement I-Disease 0 3.8097050514274144e-10
regulatory I-Disease 0 1.4041972917766543e-08
protein I-Disease 0 4.778306195163395e-09
Factor I-Disease 0 6.3672689343263755e-09
H I-Disease 1 0.9999998807907104
( O 0 2.4441908497152554e-09
FH O 0 4.983450708095916e-06
) O 0 6.699049735076068e-12
in O 0 5.505477150558047e-12
the O 0 1.692651444354376e-12
context O 0 1.091425907984167e-10
of O 0 5.885866447008503e-12
an O 0 8.112123195402887e-10
acute B-Disease 1 0.9996477365493774
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 3.441847979956947e-07

Five O 0 5.1654969190906286e-09
of O 0 1.889752026737468e-12
the O 0 4.465603234415916e-12
cases O 0 1.7024954362954148e-11
were O 0 1.0339997608133089e-10
observed O 0 2.2052696474483824e-11
in O 0 2.226902516555551e-11
children O 0 6.162223509242892e-11
presenting O 0 6.232178106913011e-10
with O 0 2.1138683692356608e-08
idiopathic O 1 0.9999998807907104
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.0010431250557303429
HUS B-Disease 1 1.0
) O 0 2.0557997970627184e-07
. O 0 2.4717113689121106e-08

Two O 0 9.418810176242687e-10
of O 0 5.782756652000787e-12
the O 0 8.313045564423138e-12
children O 0 2.306778032479251e-11
exhibited O 0 1.1539595945464498e-09
a O 0 5.182866136266284e-09
homozygous O 1 0.5496935248374939
deficiency O 0 0.2809019982814789
characterized O 0 3.832804296166614e-09
by O 0 2.4155837052841633e-11
the O 0 5.270718583805234e-11
absence O 0 2.5497218225645213e-10
of O 0 1.9077647176856533e-13
the O 0 1.603181671618048e-12
150 O 0 1.4779889118132772e-11
- O 0 7.845820659824199e-10
kD O 0 3.3905376284337763e-09
form O 0 7.970556159531128e-11
of O 0 7.4820731207903e-12
Factor O 0 2.054645786842002e-09
H O 1 1.0
and O 0 6.051571049825455e-11
the O 0 7.198757649012899e-13
presence O 0 7.779946825658968e-12
, O 0 6.15858655305529e-13
upon O 0 6.818117034498861e-13
immunoblotting O 0 2.3755790667934207e-09
, O 0 1.3085586217029266e-12
of O 0 6.969796376328496e-14
the O 0 7.446906806485298e-12
42 O 0 1.0558228735746411e-09
- O 0 1.3006724586261953e-09
kD O 0 3.077620291946914e-08
Factor O 0 3.2773204150515767e-09
H O 1 1.0
- O 0 4.128960640059631e-08
like O 0 4.137659936898075e-10
protein O 0 1.8068592178011045e-09
1 O 0 3.173537266309978e-10
( O 0 1.6352461051916123e-10
FHL O 0 1.238878098774876e-06
- O 0 2.008207466985823e-08
1 O 0 1.1184553977416911e-10
) O 0 4.8087081191972025e-12
and O 0 1.5324708732902814e-12
other O 0 9.975254997018901e-12
FH O 0 5.591408262262121e-05
- O 0 3.1090421348523023e-09
related O 0 2.9420439418004207e-09
protein O 0 5.309722883595214e-09
( O 0 2.607753180061678e-10
FHR O 0 1.975011940658078e-07
) O 0 3.464079717518942e-11
bands O 0 2.125896347848766e-09
. O 0 1.7372551175398598e-09

Southern O 0 3.119683071872714e-07
blot O 0 4.559592707664706e-05
and O 0 1.4491243760517136e-09
PCR O 0 2.3646494540230378e-08
analysis O 0 3.7391745949522104e-11
of O 0 2.323175018244944e-13
DNA O 0 1.3741238702458247e-10
of O 0 4.672631097150937e-13
one O 0 3.632339914960703e-11
patient O 0 2.1385972992504776e-09
with O 0 4.550937404701472e-11
homozygous O 0 0.00017101800767704844
deficiency O 1 0.5834178924560547
ruled O 0 5.913177147931492e-08
out O 0 3.0448962795581735e-10
the O 0 4.0276758165626314e-13
presence O 0 4.6820815453874065e-12
of O 0 1.790962668966889e-13
a O 0 1.4606603686989628e-12
large O 0 5.191852590208379e-12
deletion O 0 1.1028689073100395e-09
of O 0 1.2716726543321455e-12
the O 0 4.081644397468942e-11
FH O 0 2.0537495402095374e-06
gene O 0 1.1449095005389154e-09
as O 0 5.4477977684541656e-11
the O 0 8.179654002737902e-12
underlying O 0 5.776779499200302e-09
defect O 0 2.3437427998374005e-08
for O 0 3.378539809029135e-11
the O 0 1.68676272949142e-09
deficiency O 0 0.00010623672278597951
. O 0 6.109507566520733e-09

The O 0 2.1980815778643858e-10
other O 0 1.7074449493170718e-11
four O 0 8.88809772309207e-12
children O 0 3.399649702376384e-12
presented O 0 1.1721261981845199e-11
with O 0 1.0490656260353504e-10
heterozygous O 0 0.23936040699481964
deficiency O 0 0.3675975501537323
and O 0 2.49627901682814e-10
exhibited O 0 1.5118262197688637e-08
a O 0 1.3207570592754792e-09
normal O 0 1.1456521775699002e-07
immunoblotting O 0 5.988656539557269e-07
pattern O 0 1.0537773320606902e-08
of O 0 6.371569396222687e-13
proteins O 0 5.854918546516208e-12
of O 0 1.0750859837788118e-12
the O 0 3.834169093330786e-10
FH O 0 0.06862649321556091
family O 0 3.178803220649229e-09
. O 0 1.8484943575813872e-09

Factor B-Disease 0 0.005911287385970354
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999690055847168
is O 0 1.7445658806458653e-10
the O 0 2.1411093384382518e-11
only O 0 1.1624673668109153e-08
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 2.238104812590791e-08
with O 0 3.8176861671956885e-09
HUS B-Disease 1 0.9999990463256836
. O 0 9.655927613039239e-08

These O 0 2.1680448547556352e-09
observations O 0 4.920967189292469e-09
suggest O 0 1.9818897634138466e-09
a O 0 8.525753020238724e-11
role O 0 3.480897792229598e-10
for O 0 2.2972327165526885e-11
FH O 0 0.00010419543832540512
and O 0 6.176606448526911e-10
/ O 0 1.5062860825310054e-07
or O 0 1.333115506874094e-09
FH O 0 5.187564511288656e-06
receptors O 0 3.8072422992030397e-10
in O 0 5.2056678412348845e-11
the O 0 1.3585235367208348e-11
pathogenesis O 0 5.382055690006382e-09
of O 0 7.693683190534983e-11
idiopathic O 0 4.511058432399295e-05
HUS B-Disease 1 0.9999963045120239
. O 0 1.1310578251766401e-08
. O 0 1.123540993575034e-08

Further O 0 9.370148212894946e-09
evidence O 0 8.618690761075243e-10
for O 0 4.169908775913944e-12
a O 0 6.251506257104467e-12
major O 0 2.555036737739158e-11
ancient O 0 6.365107996231245e-09
mutation O 0 1.1539794286363758e-05
underlying O 0 0.0005105140735395253
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 1.4268407788620152e-08
linkage O 0 2.549146984165418e-06
disequilibrium O 0 1.2363910173007753e-05
studies O 0 3.9193597700659666e-08
in O 0 3.5942512854880704e-10
the O 0 1.5284490686995333e-11
Japanese O 0 1.1287298873341456e-09
population O 0 1.4812089055293853e-11
. O 0 4.1484624069276776e-10

The O 0 9.97159986582119e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.6899365186691284
DM B-Disease 1 1.0
) O 0 1.8411341784485558e-08
mutation O 0 3.935855730219373e-08
is O 0 6.816606168413841e-10
an O 0 2.3595828069211677e-10
unstable O 0 0.0006777975359000266
( O 0 8.261334949466459e-10
CTG O 0 1.860887692828328e-07
) O 0 1.0703933572830948e-10
n O 0 8.822980568368166e-09
repeat O 0 4.0529005929101913e-08
, O 0 3.9343490271237513e-11
present O 0 8.734492296103014e-12
at O 0 1.5964914112931439e-10
a O 0 1.1242338657235784e-11
copy O 0 6.8260419539001305e-09
number O 0 5.2465760902453695e-11
of O 0 3.162771910689144e-12
5 O 0 8.792535588497685e-10
- O 0 2.4361733608202485e-07
37 O 0 5.068679698183587e-09
repeats O 0 2.299461954180515e-09
on O 0 1.8284926905920429e-09
normal O 0 1.8703980586565194e-09
chromosomes O 0 2.1329999988495274e-09
but O 0 3.751349231251311e-10
amplified O 0 8.756386171704378e-10
to O 0 3.384570054776326e-11
50 O 0 3.633020828619493e-10
- O 0 1.3421291855664208e-09
3000 O 0 1.2446140784660997e-09
copies O 0 2.1378928849458134e-08
on O 0 2.0217989913362544e-06
DM B-Disease 1 1.0
chromosomes O 0 3.3917396535798616e-07
. O 0 3.777039569996532e-09

Previous O 0 2.0841393677528686e-07
findings O 0 2.6603562020000027e-08
in O 0 7.970195614603881e-10
Caucasian O 0 5.930107604967816e-08
populations O 0 1.8119902800428633e-10
of O 0 1.511679670329613e-11
a O 0 1.8273070168106642e-07
DM B-Disease 1 1.0
founder O 0 6.302496302623695e-08
chromosome O 0 2.447486622259021e-06
raise O 0 6.631086346686743e-09
a O 0 6.215131742592916e-10
question O 0 2.2802797428056465e-09
about O 0 1.774452980385366e-11
the O 0 2.278567525632047e-12
molecular O 0 4.476418541399241e-11
events O 0 7.301868311382353e-12
involved O 0 3.493553363265178e-11
in O 0 9.508806242397583e-11
the O 0 3.3695237572350933e-11
expansion O 0 2.2358253026766306e-09
mutation O 0 2.5971484518549914e-08
. O 0 2.032405577168106e-09

To O 0 2.9593558714680057e-09
investigate O 0 1.3770106166433038e-09
whether O 0 2.3323865061541937e-10
a O 0 4.254791657887225e-11
founder O 0 1.2295040541232538e-09
chromosome O 0 2.584636149549624e-08
for O 0 3.020519251384357e-11
the O 0 4.122827856889444e-09
DM B-Disease 1 1.0
mutation O 0 2.442438473693187e-09
exists O 0 5.487793205971592e-11
in O 0 1.500505275586761e-11
the O 0 2.8085346548412105e-12
Japanese O 0 4.838355827097018e-10
population O 0 5.334724632530263e-13
, O 0 2.6859612624330342e-12
we O 0 5.992715351732514e-11
genotyped O 0 2.1156580931602775e-09
families O 0 4.5657770099405415e-12
using O 0 7.539004837076035e-11
polymorphic O 0 1.613279998480266e-08
markers O 0 2.5437934425553976e-08
near O 0 3.131313164317362e-08
the O 0 2.1585085108188906e-10
( O 0 3.2679806083457663e-10
CTG O 0 9.88836248438929e-08
) O 0 1.9448162524859924e-10
n O 0 2.6739849445789332e-08
repeat O 0 5.632522359633185e-08
region O 0 1.1239653652239667e-08
and O 0 4.5653719693561357e-10
constructed O 0 2.3356298228804917e-08
haplotypes O 0 2.4339167339348933e-06
. O 0 1.983902642166413e-08

Six O 0 7.2381212135042006e-09
different O 0 1.8132037538087786e-10
haplotypes O 0 1.9255436356502287e-08
were O 0 2.0615154028291727e-09
found O 0 1.9472743417736638e-09
and O 0 7.0603700663696145e-09
DM B-Disease 1 1.0
alleles O 0 1.6735922869770548e-08
were O 0 1.0794770410882393e-08
always O 0 5.865266938798186e-09
haplotype O 0 3.3659642895145225e-07
A O 0 1.1444559966378165e-08
. O 0 9.79809122725328e-09

To O 0 2.2356121398559026e-09
find O 0 6.064156399254728e-10
an O 0 1.8564485886052307e-12
origin O 0 1.149424479207628e-11
of O 0 4.991876595243638e-13
the O 0 1.710042350777652e-11
( O 0 7.280344382909476e-11
CTG O 0 4.2151615531338393e-08
) O 0 4.436079281688876e-11
n O 0 2.9164775039447477e-09
repeat O 0 1.4008267434917343e-08
mutation O 0 6.138741182049046e-10
and O 0 1.7739792274040767e-11
to O 0 1.1013957757974313e-12
investigate O 0 1.3701975318247683e-11
the O 0 5.1191165022224094e-12
mechanism O 0 4.283928073389731e-11
of O 0 1.0907998815182576e-13
the O 0 6.011438092104471e-13
expansion O 0 5.405980524342269e-11
mutation O 0 2.9188901295995606e-11
in O 0 1.147111659133282e-11
the O 0 1.867799751670285e-12
Japanese O 0 2.731208592621215e-10
population O 0 2.0029385593665905e-13
we O 0 2.7060775495413303e-12
have O 0 1.261333810835541e-12
studied O 0 1.4871942566330176e-10
90 O 0 1.0017740803558439e-10
Japanese O 0 2.9113667210367566e-07
DM B-Disease 1 1.0
families O 0 8.037453341769307e-11
comprising O 0 2.6912392453448675e-11
190 O 0 4.864644798097117e-10
affected O 0 8.9396212654691e-10
and O 0 9.21421272614964e-11
130 O 0 9.862360927925806e-10
unaffected O 0 3.648590620741743e-07
members O 0 5.609230302461299e-10
. O 0 1.2267680205013676e-09

The O 0 1.79811299183541e-09
results O 0 1.990477782598532e-09
suggest O 0 2.782220287489423e-10
that O 0 2.5839161539586986e-12
a O 0 4.218909509939861e-12
few O 0 6.432949312129566e-11
common O 0 2.6741235961691423e-11
ancestral O 0 4.3276041084006067e-10
mutations O 0 2.4859792002729364e-09
in O 0 4.5298090278755865e-10
both O 0 2.4338620008279577e-10
Caucasian O 0 7.294921289258127e-08
and O 0 7.859236872409525e-11
Japanese O 0 5.170146533117759e-10
populations O 0 3.2534493762254035e-12
have O 0 2.1534278266815976e-12
originated O 0 4.508017917292939e-11
by O 0 2.956709313148287e-13
expansion O 0 2.4802175938032356e-11
of O 0 2.749110075868366e-13
an O 0 1.2118820487058701e-12
ancestral O 0 5.557877491568775e-10
n O 0 1.7148661157762035e-08
= O 0 8.191704203852623e-09
5 O 0 5.839912442517914e-10
repeat O 0 1.496968593528436e-08
to O 0 1.1587803633306137e-10
n O 0 2.305510271582989e-08
= O 0 1.7686168973796157e-08
19 O 0 7.523429701450368e-08
- O 0 8.135202023140664e-08
37 O 0 4.6047543555971515e-09
copies O 0 5.133167135795702e-08
. O 0 2.6554021204105993e-09

These O 0 6.769986238275294e-10
data O 0 4.5667478132394024e-10
support O 0 1.628348150761738e-11
multistep O 0 1.7776331517893595e-08
models O 0 1.8253157207936965e-08
of O 0 4.730096869742795e-11
triplet O 0 2.9278555757628055e-07
repeat O 0 3.762953060260088e-09
expansion O 0 1.0915320730608968e-10
that O 0 7.1428488124247735e-12
have O 0 1.6552208822323555e-12
been O 0 1.7730953424249796e-12
proposed O 0 7.548695284305407e-13
for O 0 1.6938270447700021e-12
both O 0 2.1985533393831247e-08
DM B-Disease 1 1.0
and O 0 7.836985282949627e-09
Friedreichs B-Disease 0 2.2154326870804653e-06
ataxia I-Disease 0 0.0002542638103477657
. O 0 3.913725343807073e-09
. O 0 2.8252484796098543e-09

The O 0 4.209822768164173e-10
molecular O 0 1.7489013570681777e-09
basis O 0 2.0916641751966836e-09
of O 0 1.5095982064394775e-07
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.6348976616953337e-09
the O 0 5.3672856090147825e-12
western O 0 4.626293792497904e-10
Cape O 0 4.93455765138151e-09
, O 0 3.358263320207833e-11
South O 0 4.0271441736905444e-10
Africa O 0 2.7660200796475465e-09
. O 0 8.903275339200434e-10

Deficiency B-Disease 1 0.9999853372573853
of I-Disease 0 6.652416395525051e-10
the I-Disease 0 1.5691342669654773e-10
sixth I-Disease 0 3.5646365859065554e-09
component I-Disease 0 3.1368335706716266e-10
of I-Disease 0 6.27941925887554e-13
human I-Disease 0 1.1306032499103225e-11
complement I-Disease 0 2.516338915015126e-09
( O 0 1.2128411608358647e-09
C6 O 0 6.828811933701218e-07
) O 0 2.342818647416145e-11
has O 0 2.60945865609985e-11
been O 0 1.845844033177002e-10
reported O 0 1.2239640412303743e-08
in O 0 4.9179219724360124e-11
a O 0 1.3581556018715801e-11
number O 0 6.786929525326446e-12
of O 0 4.835046208892524e-13
families O 0 1.0899976667783084e-12
from O 0 7.158694210335215e-13
the O 0 1.2510334565160597e-12
western O 0 5.024860527669262e-10
Cape O 0 4.798764940971978e-09
, O 0 3.6087639820880923e-11
South O 0 1.681461775371318e-10
Africa O 0 2.0612793694141374e-09
. O 0 4.886153703864693e-10

Meningococcal B-Disease 1 0.9997631907463074
disease I-Disease 1 0.995292067527771
is O 0 9.484507401680276e-09
endemic O 0 1.160951779155539e-08
in O 0 2.1195800670170684e-09
the O 0 1.0152659962736621e-10
Cape O 0 6.8610241932276494e-09
and O 0 1.6697263016673958e-10
almost O 0 2.6537941982818225e-11
all O 0 1.9786685311051766e-12
pedigrees O 0 2.7512139233465405e-09
of O 0 2.4359030417753225e-12
total O 0 1.4456057328970928e-07
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 3.1865370342387678e-09
C6Q0 O 0 8.17261877728015e-07
) O 0 1.1237621944104603e-11
have O 0 2.764920063735854e-11
been O 0 1.3278896038304566e-10
ascertained O 0 1.1714880177038367e-09
because O 0 4.7737463287900184e-11
of O 0 3.1334056876941574e-11
recurrent O 0 1.7749447579262778e-05
disease O 0 0.00011394165630917996
. O 0 2.635402118755792e-08

We O 0 1.0194603383695267e-08
have O 0 3.1479562012659557e-11
sequenced O 0 3.2090050061661657e-10
the O 0 2.4885039775351947e-12
expressed O 0 2.9364839553014388e-12
exons O 0 2.960336697999111e-10
of O 0 1.0396189117911625e-12
the O 0 2.761568057563224e-11
C6 O 0 3.582202268148649e-08
gene O 0 9.85483916693397e-10
from O 0 4.427018474029154e-11
selected O 0 2.629393404396385e-11
cases O 0 7.383210709477339e-11
and O 0 1.53345999093224e-11
have O 0 3.043733667884574e-11
found O 0 1.4274789683632605e-10
three O 0 1.7677441108143732e-11
molecular O 0 1.5369995054470564e-08
defects O 0 3.2235091111942893e-06
leading O 0 1.2512113567453298e-10
to O 0 2.591419440145515e-11
total O 0 2.8635065429938322e-09
deficiency O 0 0.032030362635850906
879delG O 0 4.907678317067621e-07
, O 0 6.693548493252877e-11
which O 0 9.598526834464494e-12
is O 0 3.0131411688644194e-12
the O 0 4.827454842121215e-12
common O 0 4.482728854782181e-09
defect O 0 3.2411364259132824e-08
in O 0 1.279042149970877e-10
the O 0 6.042667061167961e-11
Cape O 0 1.4188099584089287e-09
and O 0 1.475665839523188e-10
hitherto O 0 1.3843296287063822e-08
unreported O 0 6.9491594700821224e-09
, O 0 1.7194651952268103e-11
and O 0 4.188715693742573e-11
1195delC O 0 1.1799316190774789e-08
and O 0 1.8797170764361937e-10
1936delG O 0 6.05658856400737e-09
, O 0 3.391347315820359e-12
which O 0 1.1245979191290556e-12
have O 0 1.4089786629090106e-11
been O 0 2.504270402159392e-11
previously O 0 2.00702492819671e-11
reported O 0 7.971016069419079e-10
in O 0 3.374701212921494e-11
African O 0 6.358415877150136e-11
- O 0 8.615276492207613e-09
Americans O 0 1.09306386164576e-09
. O 0 4.809667109029192e-10

We O 0 4.044822432547335e-08
also O 0 2.1000499950130092e-10
show O 0 9.238285830770465e-11
that O 0 2.7045709422024444e-12
the O 0 9.128527794777241e-12
879delG O 0 2.7618673570373176e-08
and O 0 2.4688124877769724e-09
1195delC O 0 4.125869509152835e-06
defects O 0 2.749349550867919e-05
are O 0 1.4040070104789915e-12
associated O 0 4.177115250914021e-11
with O 0 3.619241711882992e-11
characteristic O 0 6.747562110831495e-06
C6 O 1 0.9913017749786377
/ O 0 7.828096568118781e-05
C7 O 0 1.5965897546266206e-06
region O 0 1.8046591776510468e-08
DNA O 0 2.281912969692712e-07
marker O 0 9.658212007934708e-08
haplotypes O 0 5.777156388830917e-07
, O 0 1.9205825818602307e-10
although O 0 4.8790829015876724e-11
small O 0 1.0025214686182338e-10
variations O 0 8.712442323144387e-09
were O 0 3.87291478887164e-08
observed O 0 2.8346835989623287e-09
. O 0 1.5489354243669595e-09

The O 0 5.833881377981243e-09
1936delG O 0 1.126005940932373e-06
defect O 0 2.549664714024402e-06
was O 0 4.920084784032497e-09
observed O 0 3.403778300881122e-11
only O 0 1.263038892224122e-11
once O 0 7.621618614006564e-11
in O 0 1.9201383538725025e-11
the O 0 9.341707095378293e-12
Cape O 0 1.6644488010086889e-09
, O 0 1.1486267666172001e-11
but O 0 6.533727118368526e-12
its O 0 1.2302341220390978e-12
associated O 0 3.549992799722901e-10
haplotype O 0 6.624343882322137e-07
could O 0 1.9860342703736933e-08
be O 0 2.0299019409808494e-10
deduced O 0 5.683434167735868e-09
. O 0 6.42147834906126e-10

The O 0 6.732938095943553e-10
data O 0 1.4322196761895611e-09
from O 0 1.1001239849650624e-11
the O 0 3.867016949710145e-12
haplotypes O 0 5.993921803337798e-09
indicate O 0 4.940340136982968e-09
that O 0 4.90044723550076e-12
these O 0 2.457073823916578e-12
three O 0 6.0656423460370146e-12
molecular O 0 7.613620844892921e-09
defects O 0 5.576262651629804e-07
account O 0 3.183447949695051e-11
for O 0 5.645988017388692e-12
the O 0 4.629659322574753e-09
defects O 0 0.27439916133880615
in O 0 5.302099870263532e-10
all O 0 1.9007857787745053e-11
the O 0 1.330865799509251e-11
38 O 0 6.096547711109679e-10
unrelated O 0 1.0714233944497664e-09
C6Q0 O 0 7.69384129739592e-08
individuals O 0 7.587066391812058e-12
we O 0 9.9879784998258e-11
have O 0 9.490265344413995e-12
studied O 0 4.169905531981044e-10
from O 0 1.2088168140078626e-11
the O 0 2.7317124257075776e-11
Cape O 0 5.549321446807198e-09
. O 0 9.333346318030067e-10

We O 0 1.9293448616508613e-08
have O 0 4.487266114239219e-11
also O 0 5.32609590112032e-12
observed O 0 8.469410936462474e-12
the O 0 4.081525915855533e-12
879delG O 0 2.585903224883168e-08
defect O 0 2.1531608496161425e-08
in O 0 4.047131726969688e-11
two O 0 4.969796796316928e-10
Dutch O 1 0.9999597072601318
C6 B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
deficient I-Disease 1 1.0
kindreds O 0 3.6228371754987165e-05
, O 0 5.6607524223650785e-11
but O 0 1.0326472316135593e-11
the O 0 2.018025286806835e-12
879delG O 0 9.617563634378712e-09
defect O 0 4.2621062235070895e-09
in O 0 2.5576452414299844e-11
the O 0 1.0793025327637817e-11
Cape O 0 1.1479532879832277e-09
probably O 0 3.2484308576385956e-07
did O 0 1.346005418234597e-09
not O 0 5.2441024613048e-12
come O 0 1.5590937828963147e-12
from O 0 1.344386949854448e-12
The O 0 9.95009630244681e-12
Netherlands O 0 5.933148194969817e-09
. O 0 1.9768322395696813e-11
. O 0 5.430680211082617e-11

Complement B-Disease 1 0.99967360496521
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 5.4634750057402925e-09
seven O 0 1.306572211534629e-10
further O 0 6.611101249776041e-11
molecular O 0 2.0694058378012414e-07
defects O 0 0.4946708381175995
and O 0 1.0159983271362805e-10
their O 0 2.622651575079349e-11
associated O 0 2.004685528689265e-09
marker O 0 1.1006507349975436e-07
haplotypes O 0 6.941994797671214e-06
. O 0 2.390789610728916e-08

Seven O 0 1.7760097392738317e-08
further O 0 4.058497149461715e-10
molecular O 0 1.2113707814620511e-09
bases O 0 1.6867561791755747e-09
of O 0 2.100628826440243e-08
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 9.819344448658285e-09
described O 0 4.879751003272759e-08
. O 0 3.5797009800830892e-09

All O 0 2.8853805456030557e-10
these O 0 3.4740029863228328e-12
new O 0 1.1438262836893642e-10
molecular O 0 1.8649629396350065e-08
defects O 0 4.9935039214688e-07
involve O 0 6.728775175934842e-11
single O 0 2.0625376961902475e-09
- O 0 6.40868549339757e-08
nucleotide O 0 1.540127025911886e-09
events O 0 7.095192489092739e-11
, O 0 2.379177063693838e-11
deletions O 0 2.12554351897154e-09
and O 0 5.213756162913974e-11
substitutions O 0 1.313100322919425e-10
, O 0 7.95900238076408e-13
some O 0 1.3500343150254362e-13
of O 0 1.270934854753769e-13
which O 0 6.828245434353786e-12
alter O 0 4.041088796924441e-09
splice O 0 1.1301644775585373e-07
sites O 0 1.4406012383005873e-08
, O 0 6.276507091840244e-10
and O 0 1.111946507093009e-10
others O 0 3.564654960097613e-10
codons O 0 2.386989628178071e-08
. O 0 3.870813669593076e-10

They O 0 2.3849040520218523e-09
are O 0 4.416238208460044e-12
distributed O 0 1.8279843784496652e-12
along O 0 8.361819049673702e-12
the O 0 1.4130775542742224e-11
C7 O 0 4.473762160728256e-08
gene O 0 3.898288802872685e-09
, O 0 5.331719094003873e-11
but O 0 2.4809036769379844e-11
predominantly O 0 1.741124432130814e-11
towards O 0 2.8160780998764956e-11
the O 0 1.501542501447517e-10
3 O 0 2.536881260617463e-10
end O 0 9.775336984318983e-09
. O 0 7.044762551089434e-10

All O 0 3.573927265243526e-10
were O 0 2.5674365411454403e-10
found O 0 2.92111786148741e-11
in O 0 1.2236399393739106e-11
compound O 0 1.2654924885779906e-09
heterozygous O 0 1.2062805865298287e-08
individuals O 0 1.1196144011904607e-10
. O 0 9.61708157554142e-10

The O 0 7.485698461096035e-07
C6 O 1 0.8733055591583252
/ O 0 0.0015378965763375163
C7 O 0 2.2263626306084916e-05
marker O 0 5.13429370130325e-07
haplotypes O 0 1.4033533943802468e-06
associated O 0 1.9195079303813145e-08
with O 0 5.861550689267858e-10
most O 0 4.366436883174174e-07
C7 B-Disease 1 0.9996603727340698
defects I-Disease 1 0.950619637966156
are O 0 3.867765829834724e-10
tabulated O 0 4.205501014098445e-08
. O 0 1.137855365485052e-10
. O 0 8.353967517749084e-10

A O 0 1.3304646984124702e-07
genome O 0 3.4712879681819686e-08
- O 0 2.4015969302126905e-07
wide O 0 9.991640848028283e-10
search O 0 2.0900092767561773e-09
for O 0 2.6604283012710006e-11
chromosomal O 0 7.615220170009707e-07
loci O 0 1.1205875338760052e-08
linked O 0 3.3045330383174587e-07
to O 0 3.3526217357859878e-09
mental O 0 8.36960862216074e-06
health O 0 2.1803623795335625e-08
wellness O 0 6.067667612796868e-08
in O 0 4.2363149099777786e-10
relatives O 0 2.4292625688815406e-09
at O 0 1.0612701828449644e-09
high O 0 6.810735975193438e-09
risk O 0 3.0574405229799595e-08
for O 0 1.417976625006645e-09
bipolar B-Disease 1 0.9998884201049805
affective I-Disease 0 0.07354509085416794
disorder I-Disease 1 0.7410180568695068
among O 0 7.1980271743044e-10
the O 0 3.387536362531307e-10
Old O 0 1.4914786561348592e-06
Order O 0 1.062102517046526e-09
Amish O 0 4.483920292841503e-06
. O 0 4.193564162591201e-09

Bipolar B-Disease 1 0.9999997615814209
affective I-Disease 1 0.999985933303833
disorder I-Disease 1 0.9999995231628418
( O 0 3.928881778847426e-05
BPAD B-Disease 1 1.0
; O 0 0.00015973970585037023
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 0.9999996423721313
) O 0 5.421950000084053e-09
is O 0 8.129342338181189e-11
characterized O 0 2.1120928617168744e-10
by O 0 1.7418452097350823e-11
episodes O 0 1.1672153021891063e-08
of O 0 1.4943254966759412e-10
mania B-Disease 0 0.00010178190132137388
and O 0 4.393124530821524e-09
/ O 0 3.944276159018045e-06
or O 0 2.3181613073575136e-08
hypomania B-Disease 0 2.9080223612254485e-05
interspersed O 0 7.922762534917638e-08
with O 0 7.64036542366675e-11
periods O 0 2.0849734383432406e-08
of O 0 1.298708501851209e-10
depression B-Disease 0 2.4582936930528376e-07
. O 0 3.5371575113352094e-10

Compelling O 0 1.6294838189878647e-07
evidence O 0 2.3108099878044186e-09
supports O 0 1.5208541370714812e-10
a O 0 2.74675438644012e-11
significant O 0 4.1678677870082836e-11
genetic O 0 6.325882040414399e-09
component O 0 3.9681533614555065e-09
in O 0 4.0199765738435644e-10
the O 0 3.016328159466397e-11
susceptibility O 0 5.317171591912029e-09
to O 0 3.5238847950758156e-10
develop O 0 1.4679749256174546e-06
BPAD B-Disease 1 1.0
. O 0 1.305179182509164e-07

To O 0 1.206677979759263e-09
date O 0 1.5540319253659618e-08
, O 0 2.767769347045146e-11
however O 0 1.8526787742834117e-11
, O 0 1.8747095889559695e-12
linkage O 0 1.4938018599863767e-09
studies O 0 2.493091011412929e-10
have O 0 1.5591481231091997e-11
attempted O 0 6.679570785372846e-11
only O 0 4.5368257761690955e-12
to O 0 1.4654154625870497e-12
identify O 0 7.605909790875387e-10
chromosomal O 0 3.5585250657277356e-07
loci O 0 2.6156752319650423e-09
that O 0 9.499923764311191e-11
cause O 0 4.729810432202441e-10
or O 0 6.32750740692245e-10
increase O 0 6.104216021540765e-10
the O 0 3.31425636934668e-10
risk O 0 9.229277786459988e-09
of O 0 1.9249421501221775e-11
developing O 0 2.4708731416467344e-07
BPAD B-Disease 1 1.0
. O 0 2.0195001226852582e-08

To O 0 1.3970476997471337e-09
determine O 0 8.398605699788675e-10
whether O 0 5.520979853845809e-11
there O 0 6.241310940291456e-11
could O 0 5.639113828670439e-11
be O 0 3.237342468750959e-12
protective O 0 7.532451051783795e-11
alleles O 0 1.1514283970726069e-10
that O 0 6.607139314829258e-12
prevent O 0 7.831942039349116e-11
or O 0 5.415932147201374e-10
reduce O 0 2.8566371490512665e-10
the O 0 4.6128986047611065e-11
risk O 0 7.133652557556047e-10
of O 0 2.6145691514600777e-12
developing O 0 7.220474884661598e-08
BPAD B-Disease 1 1.0
, O 0 1.1229785851218921e-10
similar O 0 1.115712643801059e-11
to O 0 6.271665912299662e-12
what O 0 4.663696512308135e-11
is O 0 3.1276420255771376e-12
observed O 0 4.062008975708187e-12
in O 0 6.037044475437625e-11
other O 0 2.512316576996909e-08
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 5.7376263462582955e-11
we O 0 7.33084148940577e-11
used O 0 1.6502867961065704e-09
mental O 0 3.7839822653040756e-06
health O 0 2.0542158196690252e-08
wellness O 0 1.2201068955164374e-07
( O 0 2.120488784562724e-10
absence O 0 3.1779181508539978e-09
of O 0 8.507944349034346e-12
any O 0 2.729211701080203e-08
psychiatric B-Disease 1 0.7689536213874817
disorder I-Disease 0 1.9584069377742708e-05
) O 0 1.743234549766992e-11
as O 0 3.5425318234416636e-10
the O 0 6.258981111173512e-10
phenotype O 0 1.0463019179951516e-06
in O 0 4.757680471811909e-09
our O 0 3.5371575113352094e-10
genome O 0 9.76834280130845e-10
- O 0 1.6738117381009943e-07
wide O 0 1.3221691297360394e-08
linkage O 0 1.3455048247124068e-05
scan O 0 0.0001455273450119421
of O 0 1.1114625712849158e-11
several O 0 5.232662393661602e-12
large O 0 3.431096032291414e-11
multigeneration O 0 7.488311553061067e-07
Old O 0 3.8971162297229966e-08
Order O 0 5.921486218030125e-11
Amish O 0 8.616858337973099e-08
pedigrees O 0 1.6589925166954345e-07
exhibiting O 0 3.074240950695639e-08
an O 0 9.700124037337332e-11
extremely O 0 7.170011713242275e-07
high O 0 5.370756639422325e-07
incidence O 0 3.904541244992288e-06
of O 0 6.437939514825075e-09
BPAD B-Disease 1 1.0
. O 0 2.831021816973589e-08

We O 0 5.161143956655678e-09
have O 0 5.925293589115199e-11
found O 0 3.062694889366391e-11
strong O 0 3.5938446663053014e-11
evidence O 0 6.1991540373229626e-12
for O 0 3.4592890617995975e-13
a O 0 1.3866954459706982e-11
locus O 0 1.9270782747327075e-09
on O 0 1.2965521989372064e-07
chromosome O 0 0.00032583504798822105
4p O 0 3.436392216826789e-05
at O 0 1.2623785572429824e-08
D4S2949 O 0 2.895969153371425e-08
( O 0 1.0545424256047653e-10
maximum O 0 6.599538693308205e-10
GENEHUNTER O 0 1.887668304334511e-06
- O 0 3.800730752345771e-08
PLUS O 0 8.165730314146913e-09
nonparametric O 0 2.988593053032673e-07
linkage O 0 1.3716085049964022e-06
score O 0 1.1693258983314081e-07
= O 0 6.533724672408425e-09
4 O 0 2.0983924320372438e-10
. O 0 2.1644562878120333e-11
05 O 0 2.158765788351502e-08
, O 0 5.1852539623142846e-11
P O 0 6.868765467515914e-06
= O 0 1.3369478857327977e-09
5 O 0 2.0376135501098958e-10
. O 0 5.713382891792129e-11
22 O 0 3.203678156094014e-10
x O 0 4.624657776730601e-07
10 O 0 4.822640065071937e-09
( O 0 1.4558062533254201e-09
- O 0 1.524639287708851e-06
4 O 0 7.167476612224277e-10
) O 0 1.953760764283885e-11
; O 0 1.7738978688730533e-11
SIBPAL O 0 2.494530804142414e-07
Pempirical O 0 3.7254693552313256e-08
value O 0 1.1182383907737403e-09
< O 0 6.6056875525077885e-09
3 O 0 3.563891889935e-11
x O 0 1.0526985505521225e-08
10 O 0 1.298297913621127e-09
( O 0 7.351961262003215e-10
- O 0 3.0843551712678163e-07
5 O 0 3.1708810577235624e-10
) O 0 7.127715518501221e-12
) O 0 2.661208493154321e-12
and O 0 1.0385651540156804e-11
suggestive O 0 6.942614927396562e-09
evidence O 0 6.941733993182098e-11
for O 0 8.53329288740684e-13
a O 0 4.000843406570809e-11
locus O 0 6.67137767251802e-09
on O 0 1.5709616718595498e-07
chromosome O 0 0.0078339958563447
4q O 0 0.19166606664657593
at O 0 3.444891660819849e-08
D4S397 O 0 6.757993986639121e-08
( O 0 3.467816589441952e-10
maximum O 0 7.355734354952403e-10
GENEHUNTER O 0 1.5489266615986708e-06
- O 0 8.55880841754697e-08
PLUS O 0 1.8486929320715717e-08
nonparametric O 0 5.158194653631654e-07
linkage O 0 2.0426136870810296e-06
score O 0 2.1246940207220177e-07
= O 0 6.993064349813949e-09
3 O 0 1.7465569268626524e-10
. O 0 5.0508403015570025e-11
29 O 0 6.000075547518691e-09
, O 0 9.695093339256999e-11
P O 0 1.4697154256282374e-05
= O 0 1.106324143407278e-09
2 O 0 7.236195670445866e-11
. O 0 2.252576770944703e-11
57 O 0 4.572101808264506e-09
x O 0 4.926087626699882e-07
10 O 0 6.458011014842668e-09
( O 0 2.2907593599796883e-09
- O 0 6.469497293437598e-07
3 O 0 4.1893011282212456e-10
) O 0 1.1966700200205516e-11
; O 0 1.078070098470274e-11
SIBPAL O 0 1.6202204733417602e-07
Pempirical O 0 4.48793251450752e-08
value O 0 1.3993678438239954e-09
< O 0 4.951037357869836e-09
1 O 0 2.18779924732182e-11
x O 0 1.1489746043480409e-08
10 O 0 8.856544941870936e-10
( O 0 1.714106412364913e-09
- O 0 1.6811271734695765e-06
3 O 0 3.6151109883419963e-10
) O 0 7.296563526992816e-12
) O 0 8.902853497819163e-13
that O 0 1.1251728715411247e-12
are O 0 1.3966833332240691e-12
linked O 0 6.9900503163466965e-09
to O 0 3.4333039189426984e-10
mental O 0 7.328160904762626e-07
health O 0 1.774892233186165e-08
wellness O 0 1.5182665435986564e-07
. O 0 3.071853882374853e-09

These O 0 3.1036384573468467e-09
findings O 0 1.3261894915572725e-09
are O 0 8.068783488579534e-12
consistent O 0 1.7799180185296137e-10
with O 0 5.547161579903814e-13
the O 0 1.9359468455409923e-12
hypothesis O 0 5.569101776958796e-11
that O 0 7.295543834849594e-13
certain O 0 1.4863285949240357e-11
alleles O 0 5.180135764781824e-10
could O 0 9.99206051233159e-10
prevent O 0 1.1592093257517533e-10
or O 0 5.450856432887008e-10
modify O 0 1.4454584196244014e-09
the O 0 1.1491526480389425e-11
clinical O 0 1.1370836494606351e-09
manifestations O 0 7.20549953037164e-10
of O 0 2.3118268410726728e-10
BPAD B-Disease 1 1.0
and O 0 1.8525604383867744e-09
perhaps O 0 6.825726650561137e-10
other O 0 1.0195255056855146e-10
related O 0 1.704539300817487e-07
affective B-Disease 0 3.4692828194238245e-05
disorders I-Disease 0 0.13735641539096832
. O 0 2.049065805920236e-08

Segregation O 0 0.00019319163402542472
distortion O 0 0.0003271514142397791
in O 0 5.302567842591088e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 1.25138433304528e-06

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.99993896484375
DM B-Disease 1 1.0
) O 0 1.8203717644382778e-08
is O 0 1.790668169299181e-10
an O 0 6.777813033043145e-11
autosomal B-Disease 1 0.9608731269836426
dominant I-Disease 1 0.9999724626541138
disease I-Disease 1 0.9994646906852722
which O 0 3.057569131215132e-08
, O 0 1.0993400634262684e-10
in O 0 1.023584134118849e-10
the O 0 2.9565995485203445e-11
typical O 0 9.61143875599646e-09
pedigree O 0 6.716692837471783e-07
, O 0 3.381053770290521e-11
shows O 0 2.1740648170620602e-10
a O 0 1.062087778835874e-10
three O 0 1.8658684319827756e-10
generation O 0 9.104927478631453e-09
anticipation O 0 1.7975994026642184e-08
cascade O 0 1.4177372520407516e-07
. O 0 8.11695599622908e-09

This O 0 2.8626438997036985e-09
results O 0 1.6308558059563438e-08
in O 0 2.371315943605623e-08
infertility B-Disease 1 0.9926487803459167
and O 0 0.000150687774294056
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 4.979926870873896e-07
CDM B-Disease 0 1.0240850315312855e-05
) O 0 1.072334651630591e-10
with O 0 4.512162345149395e-12
the O 0 1.9483199775738314e-11
disappearance O 0 1.1514580400273644e-08
of O 0 3.026697503738518e-10
DM B-Disease 1 1.0
in O 0 4.513339479927936e-09
that O 0 8.324144706861603e-10
pedigree O 0 3.559380559181591e-07
. O 0 2.318805591983164e-09

The O 0 3.4787872582597856e-10
concept O 0 5.887254017622467e-10
of O 0 2.0352391646993873e-11
segregation O 0 6.881994529805979e-09
distortion O 0 7.022470160933381e-09
, O 0 6.417945602049668e-12
where O 0 1.0087870209313232e-12
there O 0 1.7322429298263775e-12
is O 0 8.309474527727623e-13
preferential O 0 4.766524952515283e-10
transmission O 0 1.4564736972033643e-08
of O 0 6.229886940524454e-13
the O 0 9.693863550416792e-13
larger O 0 3.948933541275679e-11
allele O 0 1.0465704747275595e-08
at O 0 2.656425301950094e-09
the O 0 1.2974389340669745e-09
DM B-Disease 1 1.0
locus O 0 5.113113044075135e-09
, O 0 4.887160121036516e-10
has O 0 1.654780756865648e-10
been O 0 8.588201261261474e-10
put O 0 3.8337596985904554e-10
forward O 0 1.9420953734083923e-10
to O 0 2.4356521573926093e-12
explain O 0 8.049419464306595e-11
partially O 0 4.3865247545404884e-10
the O 0 2.7087795548275118e-11
maintenance O 0 4.093860539455818e-08
of O 0 2.8791791173432557e-10
DM B-Disease 1 1.0
in O 0 4.867218184045896e-09
the O 0 3.668559553360318e-11
population O 0 2.80000519298218e-11
. O 0 5.845629535983221e-10

In O 0 9.817808788170623e-09
a O 0 9.69613389578683e-10
survey O 0 2.3804970439300632e-08
of O 0 2.2556735645995474e-10
DM B-Disease 1 1.0
in O 0 7.443524019379311e-09
Northern O 0 2.6870015545910064e-08
Ireland O 0 2.456812808304676e-06
, O 0 1.016285111621329e-10
59 O 0 9.73497504830334e-10
pedigrees O 0 3.840899864826497e-08
were O 0 1.9230321779417636e-09
ascertained O 0 1.8995924833120625e-08
. O 0 6.367302796128627e-10

Sibships O 0 4.3057511902588885e-06
where O 0 4.86346685146799e-10
the O 0 1.973592470005947e-11
status O 0 8.448117899684249e-11
of O 0 3.2907560682492176e-13
all O 0 1.6980387365292393e-12
the O 0 1.3793428205177705e-12
members O 0 1.2103527815415793e-12
had O 0 2.8863714196525336e-10
been O 0 2.2869064281172413e-11
identified O 0 3.741057810757731e-11
were O 0 2.098791453131188e-11
examined O 0 9.816487900327076e-11
to O 0 7.528880947502148e-13
determine O 0 1.141003957982889e-11
the O 0 6.694566342252406e-12
transmission O 0 3.4087195288634575e-09
of O 0 4.1194651856368836e-12
the O 0 2.2646411412807765e-09
DM B-Disease 1 1.0
expansion O 0 2.649122587961017e-10
from O 0 8.01797656047043e-11
affected O 0 3.1225427798986516e-10
parents O 0 5.3517294762439604e-11
to O 0 2.441801318434078e-12
their O 0 4.04605134118885e-11
offspring O 0 7.741424723484158e-10
. O 0 6.073799241335109e-10

Where O 0 3.1221216723054113e-09
the O 0 9.766251002352178e-11
transmitting O 0 4.6151671995176e-07
parent O 0 2.616498022689484e-07
was O 0 1.5957888876982906e-07
male O 0 3.379097224254224e-09
, O 0 1.4503734324655682e-10
58 O 0 3.5368894479859136e-09
. O 0 1.4180632224025658e-09

3 O 0 4.7927120050417216e-08
% O 0 2.3467375265262547e-10
of O 0 1.2988261724813932e-12
the O 0 4.365236904585457e-12
offspring O 0 5.180449472175219e-11
were O 0 6.256355433720273e-10
affected O 0 4.532676317614559e-11
, O 0 2.788337486250847e-12
and O 0 6.417871876301939e-12
in O 0 2.849425383144588e-11
the O 0 5.4307808250442235e-12
case O 0 3.9240666271922464e-11
of O 0 1.3938457050881314e-13
a O 0 6.860075701942137e-11
female O 0 1.9323711519803055e-09
transmitting O 0 3.964335633099836e-07
parent O 0 2.4470497805850755e-07
, O 0 1.8163788251257529e-09
68 O 0 1.2198987064948597e-07
. O 0 3.4764804368592195e-09

7 O 0 8.004310529940994e-07
% O 0 4.829921351756639e-09
were O 0 1.6197446717214348e-09
affected O 0 3.725453723291139e-09
. O 0 9.261084676914777e-10

Studies O 0 1.6046158179960912e-07
on O 0 6.837561628003641e-09
meiotic O 0 3.3855894798762165e-07
drive O 0 2.566097734302275e-08
in O 0 3.291957568762882e-07
DM B-Disease 1 1.0
have O 0 1.4537522574631367e-10
shown O 0 3.536737569476145e-11
increased O 0 6.100708827005974e-11
transmission O 0 1.464456556021787e-09
of O 0 4.3143451051302906e-13
the O 0 1.2642553020095204e-12
larger O 0 6.530192359077702e-11
allele O 0 3.302169915286868e-08
at O 0 8.391084271863747e-09
the O 0 6.836074817329063e-09
DM B-Disease 1 1.0
locus O 0 5.786097379001376e-09
in O 0 2.7247111233918986e-09
non O 0 0.0003016625705640763
- O 1 0.9995977282524109
DM O 1 1.0
heterozygotes O 0 9.96943185782584e-07
for O 0 4.347791571213122e-10
CTGn O 0 2.723666341353237e-07
. O 0 2.1485406787036254e-09

This O 0 1.2037126850827917e-09
study O 0 1.2111900371536422e-10
provides O 0 1.2734330950836537e-11
further O 0 1.4022574768013385e-11
evidence O 0 5.473628841845546e-11
that O 0 4.228821112728376e-11
the O 0 2.8764250981083705e-09
DM B-Disease 1 1.0
expansion O 0 6.444426325913355e-09
tends O 0 5.1906519082933755e-09
to O 0 1.53622635445938e-11
be O 0 1.7213921954528644e-10
transmitted O 0 2.208750160548334e-08
preferentially O 0 3.089665767674887e-08
. O 0 3.923097402491749e-09

Diagnosis O 1 0.9998588562011719
of O 0 1.956225332833128e-07
hemochromatosis B-Disease 1 1.0
. O 0 4.188790114767471e-07

If O 0 1.5027508197817951e-06
untreated O 0 0.00038607700844295323
, O 0 3.739137710567775e-08
hemochromatosis B-Disease 1 1.0
can O 0 2.4723343017285515e-07
cause O 0 3.050771226753568e-07
serious O 0 0.3637669086456299
illness O 0 0.035001229494810104
and O 0 1.326053489236756e-08
early B-Disease 0 2.3090118702384643e-05
death I-Disease 0 6.584077283378065e-09
, O 0 2.274595442552929e-11
but O 0 1.5837471611934717e-10
the O 0 3.317087923782047e-11
disease O 0 1.7349124448173825e-07
is O 0 2.3491200651371e-10
still O 0 2.3283085681669036e-08
substantially O 0 2.372108127701722e-07
under O 0 2.287556242208666e-07
- O 1 0.9973570704460144
diagnosed O 0 0.08711770176887512
. O 0 7.505096100146602e-09

The O 0 1.1738612304412754e-09
cornerstone O 0 7.641684618420186e-09
of O 0 3.2321968452403427e-12
screening O 0 4.4769843388081654e-10
and O 0 1.1637191210667197e-11
case O 0 1.2283119833755851e-11
detection O 0 5.918459472509241e-11
is O 0 1.233335265513058e-12
the O 0 8.096282433540936e-13
measurement O 0 6.375274197445435e-10
of O 0 9.842989054029139e-13
serum O 0 3.540687742997761e-10
transferrin O 0 3.102064383142533e-09
saturation O 0 3.3412523858800114e-09
and O 0 3.2018318552040625e-11
the O 0 1.9553301686126012e-11
serum O 0 3.852813179605619e-09
ferritin O 0 2.2267705901413137e-07
level O 0 3.6945184689329835e-08
. O 0 1.5846152168208505e-09

Once O 0 1.5803277619852452e-07
the O 0 1.731776499980242e-09
diagnosis O 0 4.7075809561647475e-06
is O 0 5.6703267081736897e-11
suspected O 0 8.345025293010622e-08
, O 0 2.6315708293034312e-11
physicians O 0 2.934577580937514e-10
must O 0 1.1194921725743434e-11
use O 0 1.6630960497643343e-10
serum O 0 2.571968060749441e-08
ferritin O 0 3.327496642668848e-06
levels O 0 1.6457634899325058e-07
and O 0 2.478999672206328e-09
hepatic O 0 9.548327852826333e-07
iron O 0 9.667953236203175e-06
stores O 0 4.0853146856534295e-06
on O 0 6.764622639821027e-08
liver O 0 2.566167154327559e-07
biopsy O 0 3.790226628552773e-06
specimens O 0 5.371633138295806e-10
to O 0 2.580051276790396e-11
assess O 0 1.4729079067521411e-09
patients O 0 6.926976769960902e-10
for O 0 4.607863569872084e-13
the O 0 1.2340647167347063e-12
presence O 0 1.0433506142382143e-10
of O 0 3.5101515444280196e-11
iron B-Disease 0 0.00032072729663923383
overload I-Disease 0 1.3718622540181968e-06
. O 0 4.2945349498779706e-09

Liver O 1 0.9998433589935303
biopsy O 1 0.999925971031189
is O 0 3.407568671676131e-09
also O 0 1.9322734384763507e-11
used O 0 1.3788463426589459e-11
to O 0 2.3273893662995038e-12
establish O 0 5.5485432221002995e-11
the O 0 6.7828659355839704e-12
presence O 0 5.727861934756717e-11
or O 0 3.1496694141708304e-10
absence O 0 4.89975116035879e-10
of O 0 7.611881611135907e-12
cirrhosis B-Disease 0 3.841207529831081e-08
, O 0 1.1971835849056145e-11
which O 0 5.5347282312823154e-11
can O 0 3.4978910878891156e-09
affect O 0 6.482467256319069e-07
prognosis O 0 0.00011305828957119957
and O 0 3.055754316250159e-09
management O 0 1.291390994140329e-08
. O 0 8.376400684184659e-10

A O 0 2.4442712742711592e-08
DNA O 0 3.7879498648862864e-08
- O 0 1.2774149737992957e-08
based O 0 1.3305313795175522e-10
test O 0 2.8695246179211154e-10
for O 0 4.364502194983272e-13
the O 0 3.841111890362514e-12
HFE O 0 4.092142802392118e-08
gene O 0 7.025600656795916e-10
is O 0 7.69407627887464e-12
commercially O 0 8.284720132145651e-10
available O 0 3.958731953357386e-10
, O 0 1.9136085077642306e-11
but O 0 1.5663852159786273e-11
its O 0 3.600331567165521e-13
place O 0 4.646648690820321e-11
in O 0 3.2218762380242794e-11
the O 0 6.319664930254376e-11
diagnosis O 0 7.1340787144436035e-06
of O 0 2.060020626304393e-10
hemochromatosis B-Disease 1 1.0
is O 0 6.2138787448873245e-09
still O 0 6.8921885976180874e-09
being O 0 4.933520258987301e-10
evaluated O 0 2.6874871217330565e-09
. O 0 2.974038237901766e-10

Currently O 0 2.2582756997735487e-08
, O 0 3.769249148910525e-11
the O 0 7.652579199664278e-13
most O 0 1.3171199157377411e-12
useful O 0 9.33999665803098e-12
role O 0 6.298206314120369e-12
for O 0 2.082027448667076e-13
this O 0 1.0303546210677084e-12
test O 0 1.1038026742626883e-10
is O 0 8.479589101197116e-13
in O 0 4.1256065404227105e-12
the O 0 2.2944027320420668e-12
detection O 0 7.064354101693482e-10
of O 0 3.0440369669371137e-10
hemochromatosis B-Disease 1 1.0
in O 0 1.658348680599886e-09
the O 0 1.7165553700682068e-11
family O 0 1.3071572470269022e-11
members O 0 2.1538947383471785e-13
of O 0 5.091964176695551e-13
patients O 0 1.7729787082920723e-10
with O 0 9.03686251264163e-13
a O 0 1.2721228237477789e-10
proven O 0 6.011498498992296e-08
case O 0 5.206367781340759e-09
of O 0 8.836710009563209e-12
the O 0 1.7203493074546827e-09
disease O 0 1.0566000128164887e-06
. O 0 6.262256491140761e-09

It O 0 1.2050249686978987e-08
is O 0 2.3923885095200603e-10
crucial O 0 4.5792054592652676e-09
to O 0 9.406588397098403e-09
diagnose O 1 0.9999983310699463
hemochromatosis B-Disease 1 1.0
before O 0 0.0003305179998278618
hepatic B-Disease 1 0.9996066689491272
cirrhosis I-Disease 1 0.8855270147323608
develops O 0 1.2712996976915747e-05
because O 0 6.909828442758226e-08
phlebotomy O 0 0.0003557872259989381
therapy O 0 0.00022105651441961527
can O 0 7.544625901800828e-08
avert O 0 0.00010120827209902927
serious O 1 0.9977374076843262
chronic O 1 0.9999997615814209
disease O 1 0.7709344029426575
and O 0 1.4030247186269662e-08
can O 0 2.3207169519423587e-09
even O 0 2.8152109532442182e-09
lead O 0 6.808744679176471e-10
to O 0 6.131436330880646e-11
normal O 0 2.069407223359576e-08
life O 0 2.6019466581317374e-09
expectancy O 0 3.9686152142337505e-09
. O 0 2.447720151566024e-11
. O 0 1.87821896924234e-10

Prevalence O 0 9.416151442565024e-05
of O 0 2.0443792492219615e-10
the O 0 3.4540450360998065e-11
I1307K O 0 2.241137764258383e-08
APC B-Disease 0 1.0311175913102488e-08
gene O 0 7.799749290882119e-09
variant O 0 5.997595167173131e-07
in O 0 1.2297620699541767e-09
Israeli O 0 1.093389734307948e-08
Jews O 0 4.08712889921059e-11
of O 0 2.4533169549686984e-13
differing O 0 1.2272629093534881e-11
ethnic O 0 1.558898322928659e-11
origin O 0 5.143393488893366e-10
and O 0 2.3666786308496057e-09
risk O 0 2.022445784177762e-07
for O 0 6.189649752741389e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.591452196223145e-08

BACKGROUND O 0 0.02355428785085678
& O 0 8.743892976781353e-06
AIMS O 0 1.9604454948307648e-08
Israeli O 0 4.410873888360811e-09
Jews O 0 8.025290154645148e-11
of O 0 2.881351841149682e-12
European O 0 1.1812527844767828e-07
birth O 0 2.5678211557078612e-08
, O 0 2.2765106466593465e-10
i O 0 9.622227281624873e-08
. O 0 8.827861401952686e-13
e O 0 1.368777174937108e-10
. O 0 5.355587067573664e-12
, O 0 5.435537870496221e-12
Ashkenazim O 0 2.2283972000991525e-08
, O 0 1.2565552981805284e-12
have O 0 1.0854111880120865e-11
the O 0 1.8308508875630736e-10
highest O 1 0.9991756081581116
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 9.563068488205317e-06
of O 0 4.844223546601745e-12
any O 0 2.1007952322182888e-10
Israeli O 0 3.4497112721965095e-08
ethnic O 0 6.921879180943336e-10
group O 0 4.284308463553543e-09
. O 0 2.513048658059347e-09

The O 0 2.013680777679383e-08
I1307K O 0 4.813829264094238e-07
APC B-Disease 0 9.891625296631901e-08
gene O 0 3.5664402986412824e-08
variant O 0 1.33409239424509e-05
was O 0 6.179679985507391e-06
found O 0 1.2280141348242068e-08
in O 0 3.6413057014073047e-09
6 O 0 9.914495890939179e-09
. O 0 3.5188965075150236e-09

1 O 0 2.4080614835497727e-08
% O 0 1.568957741504562e-10
of O 0 1.8453766075995914e-13
American O 0 7.904905896527481e-12
Jews O 0 2.244650819382965e-11
, O 0 2.6543650090415927e-12
28 O 0 2.8763455159341866e-11
% O 0 1.252867384490819e-12
of O 0 1.4565040796707396e-12
their O 0 6.056104950857844e-08
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 1.800181962607894e-06
, O 0 2.464468629170824e-10
but O 0 6.93067769841349e-10
not O 0 2.584756575441105e-10
in O 0 3.456933350687308e-10
non O 0 1.8762038678232784e-07
- O 0 1.3584924829501688e-07
Jews O 0 1.2463530207895701e-09
. O 0 1.6919083911659527e-09

We O 0 1.0792136073689562e-08
assessed O 0 2.671719956381935e-09
the O 0 1.591680606760626e-11
I1307K O 0 1.6465932617393264e-08
prevalence O 0 1.723125286900995e-08
in O 0 3.243660895435596e-11
Israeli O 0 1.0449443532678515e-09
Jews O 0 1.1087565761347395e-11
of O 0 1.1116818864108716e-13
differing O 0 2.0449232585040278e-12
ethnic O 0 3.023030827400963e-12
origin O 0 1.487988759985015e-10
and O 0 1.6177623685109666e-09
risk O 0 2.5975751327678154e-07
for O 0 2.039264614950298e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.4770228413426594e-08

METHODS O 0 1.218585225615243e-06
DNA O 0 1.405092575623712e-07
samples O 0 4.157407307303629e-09
from O 0 4.4967165407916454e-11
500 O 0 3.498301301418927e-11
unrelated O 0 9.183193094841613e-11
Jews O 0 6.02423042006528e-11
of O 0 8.209111558923898e-13
European O 0 2.7259432489046276e-09
or O 0 3.252378921736465e-10
non O 0 8.07587863249637e-09
- O 0 1.0704169106645622e-08
European O 0 1.6969793348309281e-09
origin O 0 8.037851634279392e-11
, O 0 2.8379468913763972e-12
with O 0 4.141190699819691e-13
or O 0 9.042200321829341e-11
without O 0 2.8020565034925227e-11
a O 0 3.923639885217156e-11
personal O 0 5.702752048364346e-09
and O 0 1.592303249253746e-07
/ O 0 0.0004773997061420232
or O 0 1.6685085313383752e-08
family O 0 1.8622382802480075e-10
history O 0 7.417538111509359e-11
of O 0 3.150134883847522e-12
neoplasia B-Disease 0 1.4615224586123077e-07
, O 0 4.668644984495707e-11
were O 0 1.1724514692446064e-09
examined O 0 1.5791028484812841e-09
for O 0 1.1479888220589096e-12
the O 0 2.4224110131004783e-12
I1307K O 0 1.415922601388786e-09
variant O 0 1.7208719782502158e-08
by O 0 2.5209192372477318e-11
the O 0 1.3061661474633723e-10
allele O 0 4.981436418916019e-08
- O 0 5.5313808644541496e-08
specific O 0 4.511798490369756e-09
oligonucleotide O 0 6.8297308644105215e-06
( O 0 4.677939813291232e-08
ASO O 0 9.98323957901448e-05
) O 0 1.968950003039538e-10
method O 0 5.170810002397275e-09
. O 0 2.0954817880891596e-09

RESULTS O 0 7.249397526720713e-07
In O 0 2.938038701216783e-10
persons O 0 6.088584497687677e-11
at O 0 9.916055476733021e-11
average O 0 7.895093467880088e-09
risk O 0 7.503524557250785e-08
for O 0 2.411123887213762e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 2.7367896837660055e-09
I1307K O 0 1.489558343337194e-07
was O 0 8.440962062650215e-08
found O 0 1.1649017306325504e-09
in O 0 6.854428691305259e-10
5 O 0 1.1139212885424854e-09
. O 0 2.513326657904713e-09

0 O 0 1.0665675631571503e-07
% O 0 1.4275886028869422e-09
of O 0 6.4103843760987544e-12
120 O 0 3.2398597693550357e-10
European O 0 9.196018169177478e-08
and O 0 3.939398585117715e-09
1 O 0 5.1825377322956e-10
. O 0 1.0285908791374254e-09

6 O 0 4.6148767296472215e-07
% O 0 1.603190136201249e-09
of O 0 3.892755041923213e-12
188 O 0 1.5090713123555588e-09
non O 0 9.715729021309016e-08
- O 0 1.6666756437189179e-06
European O 0 1.5283406540334e-08
Jews O 0 9.0915258654789e-10
( O 0 1.3504200535585653e-10
P O 0 2.1025013552389282e-07
= O 0 8.340116930405372e-10
0 O 0 2.959495148946445e-10
. O 0 6.685816483775753e-11
08 O 0 2.5694513183793788e-09
) O 0 4.228538699746487e-11
. O 0 4.031494305056782e-10

It O 0 1.4084944766068475e-08
occurred O 0 3.782809088193062e-08
in O 0 1.6734127417095124e-09
15 O 0 2.1990722576248345e-09
. O 0 1.1188356907609887e-09

4 O 0 7.597347462251491e-08
% O 0 8.286269448376515e-10
of O 0 1.0542763710652547e-11
52 O 0 2.5596696318075374e-08
Ashkenazi O 0 3.1280356779461727e-05
Israelis O 0 5.811350547446636e-07
with O 0 1.3639460672010273e-09
familial O 0 0.34620365500450134
cancer B-Disease 0 0.004102203994989395
( O 0 2.4008109278383927e-08
P O 0 0.02285357378423214
= O 0 2.758424422211192e-08
0 O 0 1.6852191864202837e-09
. O 0 5.153134585711427e-10
02 O 0 1.6043655293174197e-08
) O 0 6.322253918306098e-12
and O 0 2.8902701412758525e-11
was O 0 1.737815935598519e-08
not O 0 2.467549498064159e-10
detected O 0 3.018577388047561e-08
in O 0 5.880677056424588e-10
51 O 0 2.83407275425418e-09
non O 0 7.933587120589891e-09
- O 0 1.5008911447011997e-08
European O 0 8.393881700818895e-10
Jews O 0 6.971881405526403e-11
at O 0 5.249672363483171e-10
increased O 0 1.0219304291680942e-09
cancer B-Disease 0 2.1101220326613657e-08
risk O 0 8.897948156061375e-09
. O 0 8.935802653375902e-10

Colorectal B-Disease 1 0.9997668862342834
neoplasia I-Disease 0 0.01741418056190014
occurred O 0 2.187420250265859e-06
personally O 0 2.533310805574729e-08
or O 0 8.54702142394359e-10
in O 0 1.5307459466651352e-10
the O 0 1.5391210875237427e-11
families O 0 4.421674398152886e-12
of O 0 9.365912993081205e-13
13 O 0 3.0452782656675836e-11
of O 0 1.1531437697082092e-12
20 O 0 1.3775984519792672e-10
Ashkenazi O 0 1.6930487234390057e-08
I1307K O 0 1.9593529021477707e-09
carriers O 0 1.7839533184016432e-09
, O 0 1.4118060019663314e-11
8 O 0 2.4941361476127355e-11
of O 0 8.121461944794739e-13
whom O 0 3.2822251583297657e-09
also O 0 2.5179136553532544e-09
had O 0 3.5581916080218434e-08
a O 0 7.164192156183802e-11
personal O 0 6.51463594181223e-09
or O 0 3.039943763383235e-08
family O 0 4.488715510397867e-10
history O 0 2.5676716308709047e-10
of O 0 8.130986162147025e-11
noncolonic O 0 4.59879765912774e-06
neoplasia B-Disease 0 5.6757733545964584e-05
. O 0 5.2488459800770215e-08

CONCLUSIONS O 0 2.1002017547289142e-06
The O 0 1.0319689547344524e-09
I1307K O 0 1.721575273450071e-07
APC O 0 5.4519020409316e-08
variant O 0 1.6723514590921695e-06
may O 0 8.555343988803088e-09
represent O 0 1.9289077279882605e-11
a O 0 6.802874236155887e-11
susceptibility O 0 4.7186397011955705e-09
gene O 0 7.35732612611173e-08
for O 0 1.9228167502660654e-08
colorectal B-Disease 1 1.0
, I-Disease 0 2.837159673862999e-10
or I-Disease 0 2.7114122058691237e-10
other I-Disease 0 4.841235745622896e-10
, I-Disease 0 6.084237558212635e-09
cancers I-Disease 0 4.809319580090232e-05
in O 0 9.936229616869241e-09
Ashkenazi O 0 9.0786045348068e-07
Jews O 0 1.1352843665157764e-10
, O 0 1.1122260230866932e-11
and O 0 2.3455459796650757e-11
partially O 0 1.8546889579695858e-09
explains O 0 1.361996404547483e-09
the O 0 1.8327924247718563e-11
higher O 0 1.0824857099578367e-07
incidence O 0 0.001945544732734561
of O 0 0.005438279360532761
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 2.5597723052328547e-08
European O 0 1.3797382791835844e-07
Israelis O 0 1.813799030969676e-06
. O 0 5.038644612653798e-09

Systematic O 0 4.794778263317312e-08
analysis O 0 5.142081871412074e-09
of O 0 8.743597512683721e-11
coproporphyrinogen O 0 9.028853469317255e-07
oxidase O 0 3.760096205951413e-06
gene O 0 6.819077680120245e-05
defects O 1 0.5929757952690125
in O 0 7.491824050021023e-09
hereditary B-Disease 1 0.5364775657653809
coproporphyria I-Disease 0 0.00220959959551692
and O 0 2.6939087405253304e-08
mutation O 0 5.375583782551985e-07
update O 0 2.6311640795029234e-06
. O 0 5.752425202842915e-09

Hereditary B-Disease 1 0.9999402761459351
coproporphyria I-Disease 0 0.3869485855102539
( O 0 3.149589247186668e-07
HC B-Disease 0 0.0016122166998684406
) O 0 4.649062523842673e-10
is O 0 6.843321048721762e-11
an O 0 1.7199612567520006e-10
acute O 0 0.45174312591552734
hepatic B-Disease 1 0.9999996423721313
porphyria I-Disease 1 1.0
with O 0 5.753542609454598e-06
autosomal O 1 0.9999990463256836
dominant O 1 0.9916931986808777
inheritance O 0 0.01554830465465784
caused O 0 7.172965865720471e-07
by O 0 8.471954804356585e-10
deficient B-Disease 0 0.002369901165366173
activity I-Disease 0 5.2322533861115517e-08
of I-Disease 0 4.139346851395054e-11
coproporphyrinogen I-Disease 0 2.8429778922145488e-06
III I-Disease 0 3.0863444067108503e-07
oxidase I-Disease 0 1.3799962061966653e-07
( O 0 1.2914714853096143e-09
CPO O 0 3.7180589629315364e-07
) O 0 8.485717684081351e-10
. O 0 1.6716422690521426e-09

Clinical O 0 4.344283752288902e-06
manifestations O 0 1.3937287235421536e-07
of O 0 9.847581083910484e-11
the O 0 4.801454234204527e-10
disease O 0 1.4073390275370912e-07
are O 0 8.185292721396564e-11
characterized O 0 8.529855710648349e-10
by O 0 1.079175498963636e-10
acute O 0 3.4371321362414164e-06
attacks O 0 7.428436106238223e-07
of O 0 9.835121606016628e-10
neurological B-Disease 0 0.009910615161061287
dysfunction I-Disease 0 4.703111699200235e-06
often O 0 2.5740967135590154e-09
precipitated O 0 1.7592393097842773e-09
by O 0 4.686861575925461e-12
drugs O 0 3.994816033525694e-09
, O 0 7.57238161064322e-11
fasting O 0 1.2450492192783713e-08
, O 0 3.489990588190217e-11
cyclical O 0 4.1837876096906257e-07
hormonal O 0 2.4788786845419963e-07
changes O 0 1.2114076408664687e-09
, O 0 1.2543367733375277e-10
or O 0 1.6398077562485014e-08
infectious B-Disease 0 5.864174090675078e-05
diseases I-Disease 0 0.0002750797721091658
. O 0 1.3414542365808302e-08

Skin O 1 1.0
photosensitivity O 1 0.9999372959136963
may O 0 0.004135652910917997
also O 0 6.481267744717911e-10
be O 0 1.2958475438529238e-11
present O 0 2.7101387106709396e-11
. O 0 4.486164772998791e-10

The O 0 3.612569354771722e-09
seven O 0 5.753717502443578e-10
exons O 0 2.4889588168264254e-09
, O 0 7.28417413192739e-12
the O 0 7.0358931354708165e-12
exon O 0 2.6393662366785975e-08
/ O 0 4.435105083189228e-08
intron O 0 1.6617650544503704e-07
boundaries O 0 1.0494669133720436e-08
and O 0 1.58971835695354e-10
part O 0 3.1521559668012955e-11
of O 0 1.9181169239740337e-12
3 O 0 1.6492843549209546e-11
noncoding O 0 9.088492181064112e-10
sequence O 0 3.8430925108912106e-11
of O 0 1.1768253472405066e-12
the O 0 6.906257683791939e-12
CPO O 0 4.111512463822464e-09
gene O 0 3.0223420988129135e-10
were O 0 8.697557257741906e-11
systematically O 0 1.5388518237458015e-10
analyzed O 0 3.621479158222307e-11
by O 0 8.072258139701916e-13
an O 0 3.8130375593081745e-12
exon O 0 3.2295766061452014e-09
- O 0 1.8882342356363324e-09
by O 0 4.543273257606728e-10
- O 0 2.6027652211269015e-07
exon O 0 1.3295923508849228e-06
denaturing O 0 3.5444769309833646e-05
gradient O 0 1.5731251323813922e-06
gel O 0 7.859936886234209e-06
electrophoresis O 0 3.674546178444871e-07
( O 0 3.791489788795843e-09
DGGE O 0 6.429929158002778e-07
) O 0 6.823627080043693e-11
strategy O 0 1.213780742581605e-09
followed O 0 1.5552661589146588e-11
by O 0 4.172858618974734e-13
direct O 0 1.6279507256133918e-11
sequencing O 0 5.054938689852406e-10
in O 0 2.9258978573309946e-10
seven O 0 1.3980172575145389e-10
unrelated O 0 7.323358364175192e-09
heterozygous O 0 1.5137065929593518e-06
HC B-Disease 0 0.0009017697884701192
patients O 0 1.204682234856591e-06
from O 0 1.8670156531896964e-09
France O 0 0.0002447031729388982
, O 0 3.03986102956344e-09
Holland O 0 3.738663963304134e-06
, O 0 1.7086838888236144e-10
and O 0 1.4933794478810825e-10
Czech O 0 1.6403021163569065e-08
Republic O 0 2.7222435416973667e-09
. O 0 1.112911007794537e-08

Seven O 0 2.3539753257750817e-08
novel O 0 9.685270363490872e-09
mutations O 0 2.5242718137974407e-08
and O 0 1.243147251805965e-10
two O 0 7.206014864674648e-12
new O 0 1.0477178846723945e-10
polymorphisms O 0 8.632617465309522e-08
were O 0 4.0622264663170427e-08
detected O 0 1.4368823713084566e-06
. O 0 2.9276912005826716e-09

Among O 0 1.961283224716226e-08
these O 0 1.5313329770894057e-10
mutations O 0 1.9296750863873058e-09
two O 0 1.291524439478442e-11
are O 0 2.4642277801634194e-11
missense O 0 3.300162063624157e-07
( O 0 5.782034850909668e-10
G197W O 0 6.602969193636454e-08
, O 0 1.21129634100825e-10
W427R O 0 5.38632738411593e-09
) O 0 7.2585579040385095e-12
, O 0 1.7669610349532738e-12
two O 0 3.615127945263974e-12
are O 0 7.541895580276403e-11
nonsense O 0 6.063456794436206e-07
( O 0 5.547156831098299e-11
Q306X O 0 1.0442693820778004e-08
, O 0 5.757842466702634e-11
Q385X O 0 4.999376468362016e-09
) O 0 6.9802471094893015e-12
, O 0 4.599927643650359e-12
two O 0 8.7240647648687e-13
are O 0 7.774157294478112e-13
small O 0 1.7579392802558047e-11
deletions O 0 1.3559989575639975e-08
( O 0 1.0114892257107044e-10
662de14bp O 0 6.1511915561140995e-09
; O 0 8.666222253705946e-12
1168del3bp O 0 9.185934679578622e-09
removing O 0 5.19315479508009e-10
a O 0 1.5713774725867324e-10
glycine O 0 2.0791675936493448e-08
at O 0 7.51689654965304e-10
position O 0 2.8926153139430255e-10
390 O 0 1.3086372263604318e-10
) O 0 4.113011580625381e-12
, O 0 3.6558867912150905e-12
and O 0 8.547436196326696e-12
one O 0 8.03165606938494e-12
is O 0 8.902365823681979e-12
a O 0 2.384357156159922e-10
splicing O 0 1.1517885241119075e-06
mutation O 0 2.7019725123977878e-08
( O 0 3.974885420809926e-10
IVS1 O 0 3.4181464343419066e-06
- O 0 1.6350861642422387e-07
15c O 0 1.310524112341227e-06
- O 0 8.312903077012379e-08
- O 0 2.2354389273004927e-07
> O 0 3.1241649267599314e-09
g O 0 1.1939740307553848e-09
) O 0 1.832274349605756e-12
which O 0 4.074331150238919e-12
creates O 0 2.3270708277012275e-11
a O 0 2.2991712700370925e-10
new O 0 2.325617698417659e-09
acceptor O 0 2.718996583439548e-08
splice O 0 2.1826192551088752e-06
site O 0 1.2077208566552144e-07
. O 0 1.661078208314848e-08

The O 0 1.0188708765568322e-09
pathological O 0 3.784180435673079e-08
significance O 0 5.112057444023321e-10
of O 0 2.214279757814519e-12
the O 0 5.6265942426081406e-12
point O 0 1.8026596881881574e-09
mutations O 0 2.4624495775782407e-09
G197W O 0 9.37102395681677e-09
, O 0 3.20215555460468e-11
W427R O 0 8.104394488839262e-09
, O 0 3.04196910716481e-11
and O 0 7.1786058000733455e-12
the O 0 8.168288094523302e-12
in O 0 3.856298391724522e-09
- O 0 1.1449600378909963e-06
frame O 0 1.8972173165821005e-06
deletion O 0 1.204473960569885e-07
390delGly O 0 4.153604749035367e-08
were O 0 8.688077479668266e-10
assessed O 0 1.9156946862164403e-10
by O 0 5.988036130312457e-13
their O 0 1.2920018787471177e-12
respective O 0 5.890763137700317e-12
expression O 0 9.262170024004757e-12
in O 0 5.022366550422319e-11
a O 0 2.2112082997960414e-11
prokaryotic O 0 3.758022018574003e-11
system O 0 1.5801528488457173e-11
using O 0 1.432530344347427e-10
site O 0 1.6014245929341087e-08
- O 0 2.140255084270848e-08
directed O 0 1.128256377214143e-09
mutagenesis O 0 1.9406408569011546e-07
. O 0 1.3054825664937653e-08

These O 0 3.0030131714653407e-09
mutations O 0 1.1629664342649448e-08
resulted O 0 4.05942612857757e-10
in O 0 1.1721514037166259e-10
the O 0 1.6939538313720526e-11
absence O 0 6.041320776972725e-10
or O 0 5.224267893289003e-11
a O 0 2.771012586055832e-11
dramatic O 0 1.6836136040865313e-08
decrease O 0 1.871722865587344e-08
of O 0 9.99758470454637e-11
CPO O 0 1.2743481647703447e-06
activity O 0 6.449815259657043e-08
. O 0 1.1855006976091431e-09

The O 0 1.1229448482197313e-09
two O 0 2.3981858165988967e-10
polymorphisms O 0 4.133546482876227e-08
were O 0 8.14430856088677e-10
localized O 0 3.030806494663807e-09
in O 0 1.0032928932091068e-09
noncoding O 0 1.7641090366282697e-08
part O 0 1.5086330795721636e-10
of O 0 1.8945448508611573e-12
the O 0 4.2601651373264104e-12
gene O 0 1.1080552447806369e-10
1 O 0 6.549473203359968e-12
) O 0 9.881626766850005e-13
a O 0 4.2012938267221855e-11
C O 0 5.517796671483666e-05
/ O 0 1.151818082689715e-06
G O 0 3.3482785966043593e-07
polymorphism O 0 9.138664154306753e-07
in O 0 2.6099142846902623e-09
the O 0 3.449069641003888e-10
promotor O 0 4.11621499551984e-07
region O 0 8.967701248252524e-09
, O 0 1.685880463009326e-10
142 O 0 1.2673259108808566e-09
bp O 0 1.8702849047258496e-08
upstream O 0 7.595066242593873e-10
from O 0 7.74366161471196e-12
the O 0 3.0185136074695196e-12
transcriptional O 0 6.233651927978201e-10
initiation O 0 3.123280106764881e-11
site O 0 6.505812555346324e-11
( O 0 7.539522478561267e-11
- O 0 3.9453560418678535e-08
142C O 0 1.0282068387823529e-06
/ O 0 3.440532054810319e-07
G O 0 4.460529723360196e-08
) O 0 2.986366015589326e-11
, O 0 2.752701712405159e-11
and O 0 4.5439291218585254e-11
2 O 0 1.0853386765707906e-11
) O 0 1.3953387056897526e-12
a O 0 1.3688234573594471e-11
6 O 0 3.019691441341621e-10
bp O 0 8.440238019602475e-08
deletion O 0 3.175663954024799e-09
polymorphism O 0 1.399053672912487e-08
in O 0 1.3962478395690425e-10
the O 0 1.7398631146914312e-11
3 O 0 2.816497035595944e-11
noncoding O 0 2.466012061219658e-09
part O 0 5.047344486808214e-11
of O 0 2.2845076524946606e-12
the O 0 8.235588426497298e-12
CPO O 0 9.121023047953258e-09
gene O 0 1.4417357308005307e-09
, O 0 3.104109330687166e-11
574 O 0 2.2895407791878597e-09
bp O 0 1.8900189857617988e-08
downstream O 0 3.962743466701113e-10
of O 0 5.288466604740083e-13
the O 0 2.812780607389098e-12
last O 0 7.975574367602434e-11
base O 0 3.884107011714599e-12
of O 0 1.9319435103342525e-13
the O 0 5.390327940946182e-12
normal O 0 3.8609351271645664e-09
termination O 0 6.3865357446957205e-09
codon O 0 1.5288129873169964e-08
( O 0 1.8513797439556612e-10
+ O 0 1.32197754965091e-08
574 O 0 2.447728419952e-08
delATTCTT O 0 1.4145309989999078e-07
) O 0 1.6655252732533654e-09
. O 0 2.799489973170921e-09

Five O 0 5.524517021626707e-08
intragenic O 0 7.701959248151979e-07
dimorphisms O 0 1.7342534874842386e-06
are O 0 3.3003152988264617e-10
now O 0 2.1025428620369269e-10
well O 0 2.3442487534497403e-11
characterized O 0 9.152870822370929e-11
and O 0 1.4360977684813037e-10
the O 0 2.507205033863702e-11
high O 0 1.9746224655392552e-09
degree O 0 1.4796460723331961e-09
of O 0 5.406803043478403e-12
allelic O 0 2.882549088312203e-09
heterogeneity O 0 5.345879294793576e-09
in O 0 5.3064121985357815e-09
HC B-Disease 0 0.05530150607228279
is O 0 5.084906384844601e-10
demonstrated O 0 1.843950964142138e-10
with O 0 2.063628564905051e-12
seven O 0 4.687203403186402e-11
new O 0 2.512164087864477e-11
different O 0 9.194720505811826e-12
mutations O 0 7.264894796854549e-10
making O 0 6.136551822244485e-10
a O 0 1.4045970116172146e-11
total O 0 6.2478464242510245e-12
of O 0 1.0760671000087374e-11
nineteen O 0 3.1184097082359585e-08
CPO O 0 2.5012820970005123e-06
gene B-Disease 0 7.1478693826065864e-06
defects I-Disease 0 0.005157151259481907
reported O 0 1.5111407947188127e-07
so O 0 1.4056356079095167e-09
far O 0 9.989259419640462e-10
. O 0 7.752206515609927e-11
. O 0 3.554891381263303e-10

Coincidence O 0 4.180963628641621e-07
of O 0 3.22693816112718e-11
two O 0 1.2544724807550534e-11
novel O 0 2.1426013740999394e-10
arylsulfatase O 0 4.390689056776864e-08
A O 0 1.0533849348348667e-09
alleles O 0 1.2552787254094255e-08
and O 0 2.966300982620851e-09
mutation O 0 4.540098430538819e-08
459 O 0 5.581626538742057e-08
+ O 0 6.104838234932686e-08
1G O 0 6.737363378306327e-07
> O 0 1.2727890741359715e-08
A O 0 3.1674537992465446e-10
within O 0 6.311726835628306e-11
a O 0 2.57581556084574e-09
family O 0 4.3079730893680335e-09
with O 0 2.6054824964205636e-09
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 1.153334025505437e-10
molecular O 0 1.1087063211956405e-10
basis O 0 2.2665155863244024e-10
of O 0 1.7589188786026888e-11
phenotypic O 0 8.694451736346309e-08
heterogeneity O 0 2.9728280992458167e-07
. O 0 2.1601291422257418e-08

In O 0 3.825414651714709e-08
a O 0 2.7759243792502275e-09
family O 0 6.702801647051615e-10
with O 0 1.4089759740876229e-11
three O 0 6.367666949280704e-10
siblings O 0 1.0708253839197823e-08
, O 0 5.434469714515888e-12
one O 0 1.2140434491048069e-11
developed O 0 2.8419813169477948e-09
classical O 0 3.193352313246578e-06
late O 1 0.9942542910575867
infantile O 1 0.9999934434890747
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 5.448550837172661e-06
MLD B-Disease 1 1.0
) O 0 1.1617109496597777e-09
, O 0 6.836902571860648e-11
fatal O 0 5.2882679568710955e-08
at O 0 1.510633609314027e-07
age O 0 1.038967241129285e-07
5 O 0 7.969339771429773e-11
years O 0 1.1239342789792772e-10
, O 0 6.375122218321705e-12
with O 0 2.2705210975249024e-11
deficient O 0 0.25049281120300293
arylsulfatase O 0 2.679198132682359e-06
A O 0 1.2645135605282576e-08
( O 0 8.418300501134013e-10
ARSA O 0 2.529034190956736e-06
) O 0 4.0738048351363076e-11
activity O 0 2.980416802245145e-09
and O 0 2.9392255990190463e-11
increased O 0 5.984996387375929e-10
galactosylsulfatide O 0 4.237153461872367e-06
( O 0 6.537140162521382e-09
GS O 1 1.0
) O 0 6.283418230168536e-10
excretion O 0 8.82424266990256e-09
. O 0 1.0311208553659412e-09

The O 0 6.704335975271647e-10
two O 0 2.32711974690325e-11
other O 0 1.5502224504082562e-11
siblings O 0 3.5696237077331716e-09
, O 0 4.2379291048666445e-11
apparently O 0 2.5793401619012e-06
healthy O 0 5.222841537033673e-07
at O 0 9.160267211427708e-09
12 O 0 9.351962954040616e-11
( O 0 1.5705077863192862e-11
1 O 0 7.583876859840188e-10
/ O 0 6.498739821836352e-07
2 O 0 1.464709881160431e-10
) O 0 2.1951390358210254e-11
and O 0 3.7754532833389476e-10
15 O 0 1.5555576271530924e-10
years O 0 5.4445156716376175e-11
, O 0 1.0053966123177438e-12
respectively O 0 7.710224819712508e-11
, O 0 7.05798960942694e-12
and O 0 1.214360730028563e-11
their O 0 6.106526742599705e-12
father O 0 1.6125253354815072e-09
, O 0 4.5954728737640504e-12
apparently O 0 1.147546679902689e-08
healthy O 0 3.04254088590028e-09
as O 0 3.1882725626264374e-11
well O 0 6.106203737088478e-11
, O 0 4.14458311420729e-12
presented O 0 3.25898003028513e-10
ARSA O 0 0.0011472961632534862
and O 0 2.3447964281331224e-07
GS O 1 1.0
values O 0 1.0735748401380363e-10
within O 0 1.181391356269712e-11
the O 0 1.2560790949023293e-11
range O 0 2.028416545840628e-09
of O 0 7.011745628560107e-10
MLD B-Disease 1 0.9999998807907104
patients O 0 5.959815894129861e-07
. O 0 3.021991989982098e-09

Mutation O 0 1.565595425745414e-06
screening O 0 2.21193360516736e-07
and O 0 1.8285685465802004e-10
sequence O 0 5.6006751320003545e-11
analysis O 0 1.0362267988117679e-10
disclosed O 0 6.10042460991167e-09
the O 0 7.189540195823296e-12
involvement O 0 8.46444025981441e-11
of O 0 5.283637568263833e-13
three O 0 7.129782007841978e-12
different O 0 3.687571081822938e-11
ARSA O 0 4.23589290221571e-06
mutations O 0 4.686922405738869e-09
being O 0 4.200045866653568e-10
the O 0 2.707337175625324e-12
molecular O 0 1.9070717227620548e-11
basis O 0 1.011836586739534e-10
of O 0 1.5975231554277158e-11
intrafamilial O 0 1.5187546864581236e-07
phenotypic O 0 2.8948906560799514e-07
heterogeneity O 0 1.3187813010517857e-06
. O 0 6.180995626436925e-08

The O 0 1.841260655055521e-08
late O 0 2.2012404770066496e-06
infantile O 0 0.03923720866441727
patient O 0 0.0003324295685160905
inherited O 0 0.00022251032351050526
from O 0 2.8685043673704058e-08
his O 0 6.405737718040427e-09
mother O 0 1.253778414422868e-08
the O 0 3.3864152801377223e-12
frequent O 0 7.337336294099828e-10
0 O 0 2.5305952888743377e-09
- O 0 7.108232580321783e-07
type O 0 5.279189281282015e-05
mutation O 0 1.095124162020511e-06
459 O 0 1.6359066989934945e-07
+ O 0 3.02225267034828e-08
1G O 0 2.250787787261288e-07
> O 0 5.979614137174849e-09
A O 0 1.4326677622022999e-09
, O 0 4.195896408099031e-11
and O 0 6.552162978845644e-11
from O 0 3.952251304006893e-10
his O 0 8.89022577776899e-10
father O 0 8.493036829371192e-10
a O 0 6.425172026369719e-12
novel O 0 1.061597684759441e-10
, O 0 2.1679517556161265e-11
single O 0 1.45862405487307e-10
basepair O 0 4.7843002448644256e-08
microdeletion O 0 1.6265410351934406e-08
of O 0 5.73073316231798e-12
guanine O 0 1.3672749599180634e-09
at O 0 1.525371495780803e-10
nucleotide O 0 4.1943218342943567e-10
7 O 0 1.6553551585030135e-10
in O 0 7.983184252546849e-11
exon O 0 2.4338365989251542e-08
1 O 0 1.4950959359438798e-09
( O 0 5.33203703412255e-10
7delG O 0 5.991181240005972e-08
) O 0 3.648687185719979e-10
. O 0 9.449833138219788e-10

The O 0 4.683580190345538e-09
two O 0 1.980283714786424e-09
clinically O 0 0.00011880880629178137
unaffected O 0 4.859465661866125e-06
siblings O 0 6.358591875255115e-09
carried O 0 1.5303285028078761e-10
the O 0 4.990549293260038e-11
maternal O 0 5.9118463013874134e-08
mutation O 0 2.053855219230627e-08
459 O 0 4.153462285216847e-08
+ O 0 8.922152261447991e-08
1G O 0 7.908228667474759e-07
> O 0 3.683000571186312e-08
A O 0 6.064148294626648e-09
and O 0 6.615127889908479e-10
, O 0 1.472499205901201e-11
on O 0 9.526378991209228e-11
their O 0 2.603741180995378e-11
paternal O 0 2.1891759516279308e-08
allele O 0 7.692898762456934e-09
, O 0 1.6692541446317044e-11
a O 0 2.3649885869114762e-11
novel O 0 3.129244363631045e-10
cytosine O 0 3.7595602186968335e-09
to O 0 3.5591366659426527e-11
thymidine O 0 4.516769180895608e-08
transition O 0 1.4901906375541785e-09
at O 0 4.1072931167285276e-10
nucleotide O 0 3.413937355034591e-09
2435 O 0 5.456354301713873e-08
in O 0 1.915409775232746e-10
exon O 0 1.4056872998935432e-08
8 O 0 1.4404658577049645e-09
, O 0 1.3597004598631113e-11
resulting O 0 1.0160403768333381e-11
in O 0 3.0870046102693394e-11
substitution O 0 1.7139650809738782e-10
of O 0 1.0696621539907358e-11
alanine O 0 4.21773549419413e-08
464 O 0 8.555311126201559e-09
by O 0 4.177380386050089e-10
valine O 0 2.4570737878093496e-05
( O 0 1.143720007590332e-09
A464V O 0 1.5219096383134456e-07
) O 0 6.727136625528374e-10
. O 0 1.8939441126519796e-09

The O 0 1.5548383913710495e-08
fathers O 0 6.146209585722318e-08
genotype O 0 6.842926154604356e-07
thus O 0 7.920160527419284e-09
was O 0 2.762421331681253e-07
7delG O 0 3.1151216717262287e-06
/ O 0 6.31686316410196e-06
A464V O 0 2.364068905080785e-06
. O 0 8.303802978559816e-09

Mutation O 0 9.482750101597048e-06
A464V O 0 5.274596333038062e-06
was O 0 1.1132637922628419e-07
not O 0 1.2453447995053324e-10
found O 0 1.6240436773173883e-10
in O 0 3.8820965886365855e-10
18 O 0 1.719591580240376e-09
unrelated O 0 3.536746646659594e-07
MLD B-Disease 1 1.0
patients O 0 0.00012274572509340942
and O 0 1.0658588456280427e-09
50 O 0 4.679880927227487e-10
controls O 0 6.966440082578629e-07
. O 0 1.3267189125087953e-08

A464V O 0 2.7509391657076776e-05
, O 0 2.925927278241147e-09
although O 0 9.272484446931628e-10
clearly O 0 4.102894912705324e-09
modifying O 0 6.925266404778085e-08
ARSA O 0 8.381745283259079e-05
and O 0 1.565529714753211e-07
GS O 1 1.0
levels O 0 2.01786001241544e-08
, O 0 4.800004838045879e-11
apparently O 0 1.1849626835314098e-09
bears O 0 3.764351330648452e-10
little O 0 5.090437515953283e-10
significance O 0 9.595053918065588e-11
for O 0 6.620460690082153e-12
clinical O 0 4.461487013163179e-10
manifestation O 0 3.5922176344627132e-09
of O 0 1.0120977389505015e-09
MLD B-Disease 1 1.0
, O 0 1.2097083335049774e-09
mimicking O 0 4.2876788342027794e-08
the O 0 5.112593681744215e-10
frequent O 0 4.343200430412253e-07
ARSA O 0 0.02508818916976452
pseudodeficiency O 0 0.00011151826765853912
allele O 0 3.529945024638437e-05
. O 0 4.0917058186096256e-08

Our O 0 1.0481066681222728e-08
results O 0 1.1184410064757344e-09
demonstrate O 0 1.538417587765295e-10
that O 0 1.7313906384985867e-12
in O 0 8.772692641767499e-12
certain O 0 8.218958152950151e-11
genetic O 0 3.098619174579653e-07
conditions O 0 0.0002637940924614668
MLD B-Disease 1 1.0
- O 0 1.0435323929414153e-05
like O 0 4.9242558475270926e-08
ARSA O 0 0.0016053399303928018
and O 0 6.16224369309748e-08
GS O 1 0.9999998807907104
values O 0 6.925784945543967e-11
need O 0 2.2356781356758226e-11
not O 0 7.223945833884082e-12
be O 0 5.875835842189536e-13
paralleled O 0 7.088267472976639e-11
by O 0 7.135509197397916e-12
clinical O 0 5.472216813018349e-08
disease O 0 7.375859922831296e-08
, O 0 5.253463029181171e-12
a O 0 4.465827013744317e-11
finding O 0 7.624734177369419e-10
with O 0 5.7339504672127006e-11
serious O 0 1.5412832965466805e-07
diagnostic O 0 1.3718133232032415e-05
and O 0 1.3025053036130885e-08
prognostic O 0 4.381739472592017e-06
implications O 0 1.9875088241860794e-07
. O 0 1.5540290831950188e-08

Moreover O 0 9.776791785043315e-07
, O 0 2.2467689930749657e-09
further O 0 2.3447117580843724e-09
ARSA O 0 5.0366666982881725e-05
alleles O 0 1.187568017257945e-07
functionally O 0 1.202362227559206e-07
similar O 0 1.6942431901867394e-09
to O 0 2.1410694051038348e-10
A464V O 0 5.231275679307146e-08
might O 0 1.2577657804158093e-09
exist O 0 1.3367533469033077e-10
which O 0 5.6049498375898565e-11
, O 0 3.811118087782006e-12
together O 0 8.627295926266765e-13
with O 0 1.7537656439928218e-12
0 O 0 7.973768312297125e-10
- O 0 1.6881801911949879e-06
type O 0 5.501314808498137e-05
mutations O 0 2.8762622150679817e-06
, O 0 6.849854017332291e-10
may O 0 1.2032610463563742e-08
cause O 0 2.81459877626844e-09
pathological O 0 1.5232268196996301e-05
ARSA O 1 0.5047556161880493
and O 0 2.7312432848702883e-06
GS O 1 1.0
levels O 0 1.0104142411648809e-08
, O 0 1.2369025942371437e-11
but O 0 1.4841671294729686e-11
not O 0 9.598966586865654e-12
clinical O 0 3.3185071357522133e-10
outbreak O 0 9.83592873815553e-10
of O 0 4.170450009638449e-12
the O 0 4.167289291423515e-10
disease O 0 4.975141010277184e-08
. O 0 3.2774941094437793e-10
. O 0 9.485768837080855e-10

Human O 0 8.050265023484826e-06
MLH1 O 1 0.9994623064994812
deficiency O 1 0.9999529123306274
predisposes O 0 0.00015621572674717754
to O 0 5.6481212595826946e-08
hematological B-Disease 1 0.985233724117279
malignancy I-Disease 1 0.9936694502830505
and O 0 2.2104322283666988e-07
neurofibromatosis B-Disease 1 0.5284121036529541
type I-Disease 0 0.18422533571720123
1 I-Disease 0 2.0254105947969947e-07
. O 0 2.205012172851184e-08

Heterozygous O 0 2.715275695663877e-05
germ O 0 0.002504959236830473
- O 0 0.001979557564482093
line O 0 8.985545463247036e-08
mutations O 0 1.0666871830267155e-08
in O 0 1.019432177562507e-10
the O 0 1.4839717996095736e-11
DNA O 0 3.160450745554044e-08
mismatch O 0 2.8246033707546303e-06
repair O 0 6.636518719460582e-06
genes O 0 4.276783016621266e-08
lead O 0 1.0156040453068726e-08
to O 0 1.5546723020065656e-08
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.5736519521378796e-07

The O 0 1.4064650777356746e-08
disease O 0 8.036236636144167e-07
susceptibility O 0 9.302799419685925e-09
of O 0 1.1184847319156699e-11
individuals O 0 2.647854713266895e-10
who O 0 2.4229475314996307e-08
constitutionally O 0 1.0708726705388472e-07
lack O 0 4.941961062598921e-09
both O 0 3.8353029085946844e-10
wild O 0 8.684701846561893e-09
- O 0 1.463303647142311e-06
type O 0 5.249196988188487e-07
alleles O 0 1.0065710931428384e-08
is O 0 6.296447252474024e-10
unknown O 0 4.1992649357780465e-08
. O 0 4.826928190482249e-09

We O 0 1.7238351190940193e-08
have O 0 1.1023656293351891e-10
identified O 0 1.553828871125873e-10
three O 0 1.446316590797414e-12
offspring O 0 1.3204887704121315e-11
in O 0 4.4594258841179624e-11
a O 0 5.405122749380098e-08
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 1.9963802344591386e-07
who O 0 1.4889547372831657e-09
developed O 0 3.958637861956049e-08
hematological B-Disease 0 0.3602902889251709
malignancy I-Disease 1 0.7420549988746643
at O 0 3.8914414801638486e-08
a O 0 5.960572035945688e-10
very O 0 1.2877154631496524e-07
early O 0 3.927868874598062e-06
age O 0 2.6669356500974573e-08
, O 0 9.151347214741978e-12
and O 0 3.741485940511602e-11
at O 0 2.908210339214179e-10
least O 0 6.288747300686737e-12
two O 0 2.7202569623935302e-12
of O 0 2.8368846442979045e-13
them O 0 2.610010081324776e-12
displayed O 0 9.405490830616259e-10
signs O 0 1.6551381065710302e-07
of O 0 7.088347964145925e-11
neurofibromatosis B-Disease 0 0.000456706911791116
type I-Disease 0 0.0014354931190609932
1 I-Disease 0 6.65958168610814e-08
( O 0 9.693882141448285e-09
NF1 B-Disease 0 1.569469714013394e-05
) O 0 2.004425514456898e-09
. O 0 2.6204540759522388e-09

DNA O 0 3.754864792426815e-07
sequence O 0 7.278962765866481e-09
analysis O 0 2.8243971605945717e-09
and O 0 7.891863551545697e-11
allele O 0 2.918253905193069e-08
- O 0 3.773110179849937e-08
specific O 0 7.592169115611114e-10
amplification O 0 6.257327811454161e-08
in O 0 4.225261918122669e-09
two O 0 2.0763597785578014e-10
siblings O 0 6.003624708483812e-09
revealed O 0 1.8045825944668081e-09
a O 0 2.3701829388045326e-10
homozygous O 0 2.4445942017337075e-06
MLH1 O 0 0.00034809482167474926
mutation O 0 7.04048318311834e-07
( O 0 5.562037497242045e-09
C676T O 0 1.5376937199107488e-06
- O 0 3.8268139178398997e-05
- O 0 4.4452506699599326e-05
> O 0 9.995576988330868e-08
Arg226Stop O 0 1.9982317667199823e-07
) O 0 9.130696199122212e-10
. O 0 1.1960026302659799e-09

Thus O 0 1.8756576736222996e-08
, O 0 1.8304109616895659e-10
a O 0 1.6265050417629823e-10
homozygous O 0 1.443503521159073e-07
germ O 0 0.15046097338199615
- O 0 0.005076522007584572
line O 0 2.704844746403978e-06
MLH1 O 0 0.0003840935823973268
mutation O 0 4.6767624439780775e-07
and O 0 1.5405177133942516e-09
consequent O 0 3.256607215007534e-07
mismatch O 1 0.8597615957260132
repair O 1 0.9999908208847046
deficiency O 1 0.9999682903289795
results O 0 6.424374987545889e-08
in O 0 1.0052830790030498e-09
a O 0 2.957331624031667e-08
mutator O 1 0.9563756585121155
phenotype O 0 0.0014543563593178988
characterized O 0 8.403980018556467e-07
by O 0 1.3937801135455175e-08
leukemia B-Disease 1 0.9999982118606567
and O 0 8.79254803294316e-05
/ O 1 0.9999995231628418
or O 1 0.9998946189880371
lymphoma B-Disease 1 1.0
associated O 0 2.066408342216164e-07
with O 0 7.303365134880835e-10
neurofibromatosis B-Disease 1 0.8378714323043823
type I-Disease 1 0.5393512845039368
1 I-Disease 0 6.768133431478418e-08
. O 0 1.6589529749921894e-09
. O 0 3.965944017636502e-09

Missense O 0 0.0001695901300990954
mutations O 0 3.7256086216075346e-06
in O 0 3.2906872782234586e-09
the O 0 1.2670248530910477e-11
most O 0 1.82508912496826e-12
ancient O 0 1.0565067917744919e-11
residues O 0 4.463955316502677e-10
of O 0 2.860105544327113e-13
the O 0 7.75931836144439e-12
PAX6 O 0 1.601096926151513e-07
paired O 0 1.5115810825250264e-08
domain O 0 7.648173649954515e-09
underlie O 0 1.5391909968798245e-08
a O 0 2.7999053076044333e-10
spectrum O 0 7.857655859311308e-09
of O 0 1.4277486137803663e-10
human O 0 2.3036032814616192e-07
congenital B-Disease 1 1.0
eye I-Disease 1 0.9999991655349731
malformations I-Disease 1 0.9999194145202637
. O 0 2.0170948289433e-07

Mutations O 0 2.236766249552602e-06
of O 0 2.3336324539435793e-10
the O 0 3.042479809756138e-11
human O 0 2.520161024310852e-10
PAX6 O 0 1.09869151856401e-05
gene O 0 2.3875327315181494e-05
underlie O 0 0.0019504571100696921
aniridia B-Disease 1 1.0
( O 0 0.001977989450097084
congenital B-Disease 1 0.9999998807907104
absence I-Disease 0 4.0210315432887e-07
of I-Disease 0 2.4927379604910982e-11
the I-Disease 0 1.0554981888510895e-10
iris I-Disease 0 1.7835373000707477e-05
) O 0 1.3110532104398942e-10
, O 0 2.7146293893332007e-11
a O 0 1.4241666179692913e-10
rare O 0 5.636121613861178e-07
dominant O 1 0.9999707937240601
malformation B-Disease 1 0.9999357461929321
of I-Disease 0 4.208417503370754e-10
the I-Disease 0 8.960794772860936e-09
eye I-Disease 0 0.34051206707954407
. O 0 1.2093056511730538e-07

The O 0 2.206887561584381e-09
spectrum O 0 8.748544111369938e-09
of O 0 7.455693701308164e-11
PAX6 O 0 1.578049023009953e-06
mutations O 0 1.9468191680971358e-07
in O 0 6.777550964898182e-08
aniridia B-Disease 1 1.0
patients O 0 3.3647363579802914e-06
is O 0 2.0029788591613418e-11
highly O 0 1.2427631146394447e-10
biased O 0 8.37048332869017e-08
, O 0 5.826944395742606e-12
with O 0 8.460396554339777e-13
92 O 0 1.975014152222343e-09
% O 0 1.2734526107227584e-11
of O 0 4.37268466877902e-13
all O 0 6.610870271345215e-12
reported O 0 9.79981074067382e-09
mutations O 0 1.9746901891437574e-09
leading O 0 7.158513781746478e-10
to O 0 2.5016747007278184e-10
premature O 0 4.19161283460312e-09
truncation O 0 1.214774281166342e-09
of O 0 1.5345241353645345e-12
the O 0 8.49615430092987e-12
protein O 0 3.905744061505345e-10
( O 0 1.0000673900112389e-10
nonsense O 0 2.4668796072546684e-07
, O 0 1.9016777735858525e-11
splicing O 0 7.228546650139833e-09
, O 0 2.724027774181348e-11
insertions O 0 8.009440222167541e-09
and O 0 1.8135011548015e-10
deletions O 0 7.637925847348015e-09
) O 0 4.99780772322822e-11
and O 0 1.78044759491236e-10
just O 0 4.643304407636606e-09
2 O 0 3.704772946755419e-11
% O 0 3.677475858554491e-12
leading O 0 2.2431187116089824e-11
to O 0 1.1342010230314115e-12
substitution O 0 2.5121736288435947e-11
of O 0 6.171262502754904e-13
one O 0 4.522072299950608e-11
amino O 0 1.5966885799634234e-11
acid O 0 1.0388543324191257e-11
by O 0 6.020330718323197e-13
another O 0 1.5206626235997334e-10
( O 0 2.9813135293821347e-10
missense O 0 7.653670195395534e-07
) O 0 1.935384741358348e-09
. O 0 4.19786161387492e-09

The O 0 2.309668456490499e-09
extraordinary O 0 1.554238737710989e-09
conservation O 0 3.33017224907195e-11
of O 0 1.4913569511276759e-12
the O 0 6.483808715623818e-12
PAX6 O 0 4.968180888909046e-08
protein O 0 1.3075227567327374e-09
at O 0 1.5394213681574342e-10
the O 0 7.709765117991374e-12
amino O 0 1.3822069877544862e-10
acid O 0 2.3219377809358122e-10
level O 0 8.28715082668019e-11
amongst O 0 1.3833165515841905e-11
vertebrates O 0 5.672904368481113e-10
predicts O 0 5.373962164156865e-09
that O 0 5.301439842675393e-11
pathological O 0 3.4573000107229745e-07
missense O 0 3.835677489405498e-05
mutations O 0 9.335132062915363e-07
should O 0 5.422912341401798e-09
in O 0 1.2072529087525652e-10
fact O 0 1.0606161088277943e-10
be O 0 5.4742339133939666e-11
common O 0 1.3932975606589793e-10
even O 0 1.4707660644930343e-09
though O 0 7.404565849356004e-10
they O 0 4.456874799774191e-11
are O 0 3.2226983668476317e-12
hardly O 0 1.0509767500721523e-09
ever O 0 6.314450629041346e-10
seen O 0 1.20443441886664e-08
in O 0 1.3651752617249713e-08
aniridia B-Disease 1 1.0
patients O 0 4.1337364109494956e-07
. O 0 1.3984446933790196e-09

This O 0 1.854667641687513e-09
indicates O 0 4.716020907125085e-09
that O 0 5.18210734740121e-12
there O 0 1.2803645296766142e-11
is O 0 9.847139379945413e-13
a O 0 3.0341697904168186e-11
heavy O 0 4.631093361240346e-06
ascertainment O 0 3.7774923384858994e-06
bias O 0 6.133877832326107e-07
in O 0 4.177579393527253e-10
the O 0 6.565407505848553e-12
selection O 0 1.4222738438374183e-11
of O 0 1.2035158026418857e-12
patients O 0 5.4706017493799663e-11
for O 0 1.6035730686023153e-12
PAX6 O 0 1.8998721884599945e-07
mutation O 0 4.766600003591748e-09
analysis O 0 1.8071969476451955e-09
and O 0 1.6915494005509402e-10
that O 0 1.9186374711210874e-11
the O 0 6.099522276148406e-11
missing O 0 1.5165156241891964e-07
PAX6 O 0 1.2149184840382077e-05
missense O 0 2.4480690626660362e-05
mutations O 0 5.033354227634845e-06
frequently O 0 1.2900349588562676e-07
may O 0 1.7350116365832946e-07
underlie O 0 1.8735451590146113e-07
phenotypes O 0 9.217001917249945e-08
distinct O 0 1.000207650037055e-08
from O 0 2.0796832700398227e-08
textbook O 0 0.20496754348278046
aniridia B-Disease 1 1.0
. O 0 1.0150291984700743e-07

Here O 0 2.697256604733411e-07
we O 0 4.680353882235977e-10
present O 0 8.89335393522428e-12
four O 0 1.1517418962991854e-11
novel O 0 4.0198616657605157e-10
PAX6 O 0 1.8159694263886195e-06
missense O 0 8.943481589085422e-06
mutations O 0 8.452649353785091e-07
, O 0 3.2430066965183357e-10
two O 0 2.1575276287766343e-11
in O 0 9.990683974558934e-11
association O 0 1.4209269871834351e-10
with O 0 2.4293851652590348e-11
atypical O 0 1.7299906176049262e-05
phenotypes O 0 5.714040526072495e-06
ectopia B-Disease 0 0.0002839545195456594
pupillae I-Disease 0 0.0001480743521824479
( O 0 1.5816863374595869e-09
displaced B-Disease 0 4.47239489886897e-09
pupils I-Disease 0 1.3494472739239427e-07
) O 0 6.369343386047888e-10
and O 0 1.3526077680126036e-07
congenital B-Disease 1 0.9999998807907104
nystagmus I-Disease 0 5.883290941710584e-05
( O 0 3.049186902970291e-09
searching B-Disease 0 2.1100782987559796e-07
gaze I-Disease 0 1.3589321952167666e-06
) O 0 5.685163104174329e-11
, O 0 2.424353599816964e-11
and O 0 7.804533408428682e-11
two O 0 2.1759554227895883e-11
in O 0 6.18761930581968e-10
association O 0 5.7814360937546994e-11
with O 0 2.3078156139583195e-12
more O 0 6.946979103084061e-11
recognizable O 0 8.938357609622472e-07
aniridia B-Disease 1 1.0
phenotypes O 0 1.91712615560391e-06
. O 0 1.2936910209759844e-08

Strikingly O 0 0.0018416519742459059
, O 0 8.019667596670388e-09
all O 0 3.347596505554051e-11
four O 0 3.80041874706305e-12
mutations O 0 1.559415790941543e-11
are O 0 7.784781933667384e-13
located O 0 8.433752828052032e-12
within O 0 2.2095968717911196e-12
the O 0 1.8897600498335443e-11
PAX6 O 0 3.578309915042155e-08
paired O 0 1.5197006986156225e-09
domain O 0 5.476273323701264e-10
and O 0 3.1191899757532227e-11
affect O 0 9.380975857231633e-11
amino O 0 1.8275807950329792e-11
acids O 0 4.8297299319599585e-12
which O 0 4.933249446968657e-13
are O 0 3.6042203293076835e-13
highly O 0 2.43555913284621e-12
conserved O 0 2.1886256695857753e-11
in O 0 1.547174749427782e-10
all O 0 4.11062763688852e-12
known O 0 2.9157960768078084e-11
paired O 0 4.706843803603533e-10
domain O 0 1.3080015959232583e-09
proteins O 0 8.963011999263415e-10
. O 0 2.672066568010223e-09

Our O 0 3.461500641677162e-09
results O 0 3.351661170825082e-10
support O 0 2.0437768231268416e-12
the O 0 1.0387666204633716e-12
hypothesis O 0 3.0264304951010956e-11
that O 0 6.046257244873843e-13
the O 0 9.357984222593818e-13
under O 0 2.7811471875471838e-11
- O 0 5.102890332508991e-10
representation O 0 4.5640113216505185e-11
of O 0 1.4008620652372628e-11
missense O 0 2.219016778326477e-06
mutations O 0 1.0404723838064456e-07
is O 0 2.0768983755026227e-10
caused O 0 3.8605427188365127e-10
by O 0 8.486911173832823e-11
ascertainment O 0 1.0008346862377948e-06
bias O 0 1.69077577538701e-06
and O 0 4.5709833140783473e-10
suggest O 0 9.995224647951773e-10
that O 0 1.2447314880204008e-11
a O 0 2.2029489343822206e-11
substantial O 0 1.8859378503321977e-09
burden O 0 5.2642263881352847e-08
of O 0 3.54353005271868e-11
PAX6 B-Disease 0 0.0030261629726737738
- I-Disease 0 0.04800296947360039
related I-Disease 0 6.217849295353517e-05
disease I-Disease 0 0.2508014440536499
remains O 0 1.8556718259787885e-06
to O 0 7.494389137052693e-11
be O 0 1.1412852607417534e-10
uncovered O 0 3.8948719804920984e-08
. O 0 1.2514930758378284e-10
. O 0 7.00722646573837e-10

The O 0 4.7267465497213834e-09
chromosomal O 0 7.000513164712174e-07
order O 0 3.9952025021605664e-10
of O 0 5.255677837379125e-12
genes O 0 2.549635613746659e-09
controlling O 0 8.61445492716939e-09
the O 0 7.256276829403774e-11
major O 0 4.016718901933558e-10
histocompatibility O 0 2.1767140978568023e-08
complex O 0 4.982146695198253e-09
, O 0 4.593258412510792e-11
properdin O 0 2.0670363198860287e-08
factor O 0 8.759226122201369e-10
B O 0 1.139770006375329e-06
, O 0 6.06216465914855e-11
and O 0 2.4032528855855162e-08
deficiency B-Disease 0 1.1704890994224115e-06
of I-Disease 0 7.807294849677959e-13
the I-Disease 0 4.1990026039551154e-11
second I-Disease 0 6.013695097450977e-10
component I-Disease 0 3.9097688975253675e-10
of I-Disease 0 8.703559574441133e-12
complement I-Disease 0 9.296378777889913e-09
. O 0 5.361481925092448e-09

The O 0 1.6414654080421087e-09
relationship O 0 7.773610199990344e-09
of O 0 1.7135319855740572e-12
the O 0 4.942048072859029e-12
genes O 0 9.055666772006532e-10
coding O 0 1.1416696032995333e-08
for O 0 3.793395805806732e-11
HLA O 0 2.3261822690301415e-08
to O 0 1.1341021004251939e-11
those O 0 3.82058169823285e-11
coding O 0 6.0201248430757914e-09
for O 0 1.3079952919381466e-11
properdin O 0 8.889398550593341e-09
Factor O 0 7.397281676091438e-10
B O 0 1.3678526045168837e-07
allotypes O 0 3.2187919885018346e-08
and O 0 6.204090019501507e-11
for O 0 7.018752939957906e-11
deficiency B-Disease 0 4.21365086822334e-07
of I-Disease 0 2.9002570744313116e-13
the I-Disease 0 1.1114498210673673e-11
second I-Disease 0 2.8801128149069655e-10
component I-Disease 0 1.9483507862627647e-10
of I-Disease 0 6.834209305243977e-13
complement I-Disease 0 7.709258231791694e-10
( O 0 6.53176457365845e-10
C2 O 0 6.950461539645403e-08
) O 0 9.265739217556579e-12
was O 0 1.174022434824451e-09
studied O 0 1.6639218891612018e-09
in O 0 3.628545380829351e-11
families O 0 5.953293847477115e-12
of O 0 7.299552672382359e-13
patients O 0 1.1249814413361037e-09
with O 0 1.8627177578167675e-10
connective O 1 0.8731269240379333
tissue O 1 0.9999804496765137
disorders O 1 0.998833954334259
. O 0 2.4588182157003757e-08

Patients O 0 0.00015155135770328343
were O 0 2.5599564690281795e-09
selected O 0 1.3035869259048205e-11
because O 0 7.707250636312946e-12
they O 0 3.0324208855764256e-12
were O 0 3.369735740443858e-11
heterozygous O 0 7.208523777890719e-10
or O 0 3.7009024317358197e-11
homozygous O 0 7.38911012376775e-08
for O 0 1.3969649614864466e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.8144753255455726e-08

12 O 0 6.484476671175798e-07
families O 0 6.303596533641098e-10
with O 0 1.0613197820585896e-11
15 O 0 2.5947791137959086e-10
matings O 0 2.3740409460515366e-07
informative O 0 2.732845587161137e-06
for O 0 1.0164741297558066e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 8.130312423304531e-09
found O 0 3.046838337183999e-09
. O 0 5.42898448419038e-10

Of O 0 2.956467071157931e-09
57 O 0 5.024290672395182e-08
informative O 0 5.955055115691721e-08
meioses O 0 1.9995025013486156e-06
, O 0 2.7681390166178765e-11
two O 0 2.2203614814808592e-12
crossovers O 0 9.475245033030433e-10
were O 0 1.1304399083478245e-10
noted O 0 4.1493784103119324e-11
between O 0 6.56563622913886e-11
the O 0 2.5707574877742445e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
gene O 0 1.934126414582238e-09
and O 0 2.2963827020494598e-11
the O 0 1.395248847013697e-11
HLA O 0 5.7588611213077456e-08
- O 0 2.6568003352878122e-09
B O 0 4.868462522011896e-09
gene O 0 3.4440997276341534e-10
, O 0 2.9698856221505032e-12
with O 0 2.255127914919594e-13
a O 0 2.376889700686502e-12
recombinant O 0 8.766742193300203e-11
fraction O 0 3.4016250927138003e-10
of O 0 3.216393471006107e-11
0 O 0 2.2276269717735886e-09
. O 0 1.8120221989548213e-09

035 O 0 0.00711657851934433
. O 0 1.6312374100380111e-06

A O 0 7.77122465933644e-07
lod O 0 0.0003233942261431366
score O 0 3.052365826761161e-08
of O 0 1.268700769441189e-11
13 O 0 1.5167665734505675e-10
was O 0 1.1587936860069092e-10
calculated O 0 9.390106053830394e-11
for O 0 8.19280147196233e-12
linkage O 0 8.966557288658805e-06
between O 0 0.07725435495376587
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 4.207384218801735e-09
HLA O 0 3.34571581106502e-07
- O 0 1.0016567131287957e-08
B O 0 8.436500387176693e-09
at O 0 1.2648300809492419e-11
a O 0 2.1489142930375404e-12
maximum O 0 4.443741381809918e-12
likelihood O 0 2.4308544760431872e-11
value O 0 6.862532677537336e-12
of O 0 1.4877479131460147e-13
the O 0 7.57638960249829e-13
recombinant O 0 3.256846875521191e-11
fraction O 0 1.1206505862171312e-10
of O 0 1.5729299807087926e-11
0 O 0 3.109896118402844e-09
. O 0 2.9652771349475415e-09

04 O 0 0.0010800553718581796
. O 0 4.363148491393076e-07

18 O 0 1.3981928077555494e-06
families O 0 8.593510347765232e-10
with O 0 1.687906758807145e-11
21 O 0 5.124123347854947e-10
informative O 0 3.908503742877656e-09
matings O 0 4.323351632251615e-08
for O 0 3.051121161279369e-11
both O 0 7.39056524312609e-11
properdin O 0 4.5984808849652836e-08
Factor O 0 5.726696339358739e-10
B O 0 7.259416889837667e-08
allotype O 0 4.2325229543394016e-08
and O 0 1.0697774888157596e-09
HLA O 0 4.1596547362132696e-07
- O 0 4.7861163920970284e-08
B O 0 6.881498393340735e-08
were O 0 5.290149429626467e-10
found O 0 4.735036807090864e-10
. O 0 1.531964000101027e-10

Of O 0 3.944232940256143e-09
72 O 0 4.3224531509622466e-08
informative O 0 7.609776986328143e-08
meioses O 0 2.5853935312625254e-06
, O 0 1.5336186487413528e-10
three O 0 5.030465193706091e-12
recombinants O 0 4.9592410178433965e-09
were O 0 2.3090021561422702e-10
found O 0 5.5801707005143086e-11
, O 0 2.233715057538277e-13
giving O 0 1.9804648101594963e-13
a O 0 2.7476751342930816e-12
recombinant O 0 9.393258393330939e-11
fraction O 0 4.5198497722331865e-10
of O 0 5.331901933858241e-11
0 O 0 4.101580408644168e-09
. O 0 2.077247929221926e-09

042 O 0 0.0004121100646443665
. O 0 1.0675511248336989e-06

A O 0 7.336866474361159e-07
lod O 0 0.0001482257794123143
score O 0 1.4775261014676744e-08
of O 0 4.386436092823631e-12
16 O 0 2.393510042941749e-11
between O 0 4.74215632040309e-11
HLA O 0 3.8975738902990997e-07
- O 0 1.5117915808104954e-08
B O 0 1.108705394159415e-08
and O 0 1.3345618013471672e-11
Factor O 0 8.261362427486318e-11
B O 0 1.9786195792903527e-08
allotypes O 0 1.1649199826990753e-08
was O 0 5.436341377063059e-10
calculated O 0 6.569669808165202e-11
at O 0 8.855810182395452e-12
a O 0 5.291735474290127e-13
maximum O 0 6.324372991452221e-13
likelihood O 0 1.4518000517049767e-12
value O 0 1.2416602034742708e-12
of O 0 1.7289897405502533e-14
the O 0 1.7351221913257386e-13
recombinant O 0 1.2860133097314375e-11
fraction O 0 1.62677815662704e-10
of O 0 1.9492567282508588e-11
0 O 0 2.4885884464254104e-09
. O 0 2.5096382749723034e-09

04 O 0 0.0008130112546496093
. O 0 7.285813126145513e-07

A O 0 9.08553587919414e-08
crossover O 0 4.033928746594029e-08
was O 0 2.651739094972072e-08
shown O 0 2.219000261316495e-10
to O 0 1.0832375794966875e-11
have O 0 3.208856444447683e-11
occurred O 0 1.1565767094046109e-10
between O 0 7.58604930175405e-13
genes O 0 1.1746932419842704e-11
for O 0 8.611512653140807e-13
Factor O 0 1.920427879220643e-11
B O 0 7.032495918934956e-09
and O 0 1.903663893187968e-10
HLA O 0 1.861136240677297e-07
- O 0 2.9126654865763157e-08
D O 0 6.116120232491085e-08
, O 0 4.86073551200783e-12
in O 0 1.2156584766609413e-11
which O 0 1.8182946814881973e-10
HLA O 0 2.4789096642052755e-07
- O 0 1.6926613000123325e-08
D O 0 9.413970047944531e-08
segregared O 0 4.0976178894425175e-08
with O 0 4.825524702045669e-11
HLA O 0 1.7008743213864363e-07
- O 0 7.520629452528738e-09
A O 0 2.9115196920059816e-09
and O 0 1.6793888502064647e-09
B O 0 1.645997400601118e-07
. O 0 4.563978917015987e-10

These O 0 6.221085313562469e-10
studies O 0 6.509576766511316e-10
suggest O 0 2.1472530697952408e-10
that O 0 1.8715443691336153e-12
the O 0 3.5069893495297266e-13
genes O 0 6.80084634441247e-12
for O 0 6.057222865646361e-13
Factor O 0 7.086431996761178e-10
B O 0 0.42960524559020996
and O 1 0.774284839630127
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 5.547175566111839e-12
located O 0 7.283340597297183e-12
outside O 0 2.9576598115088615e-11
those O 0 2.9157722243600137e-12
for O 0 1.510318671342492e-12
HLA O 0 2.4821698030308426e-09
, O 0 9.295721744434493e-13
that O 0 5.226804232483229e-13
the O 0 6.443479105312788e-13
order O 0 2.459352600042708e-12
of O 0 1.1091325340800706e-12
genese O 0 2.8756588221767743e-08
is O 0 9.806756795516236e-11
HLA O 0 2.195791637404909e-08
- O 0 4.124422747775469e-10
A O 0 6.860680912268435e-10
, O 0 5.054646978752686e-11
- O 0 1.2759044931698327e-09
B O 0 9.26271415124802e-09
, O 0 4.141777198984897e-12
- O 0 1.8727970285681295e-09
D O 0 6.396641882844278e-09
, O 0 2.658519671766557e-12
Factor O 0 6.735118018852404e-11
B O 0 1.0771390890340626e-07
allotype O 0 5.838286597281694e-06
, O 0 7.1892641244630795e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 3.600704153242096e-12
that O 0 3.6875816527941196e-13
the O 0 9.829444116288277e-13
genes O 0 5.532517555195682e-09
coding O 0 3.1237248094839742e-06
for O 0 9.94584297586698e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 5.521382795414809e-10
Factor O 0 1.3271611587484244e-09
B O 0 4.883135602540278e-07
allotypes O 0 2.2287967027523337e-08
are O 0 6.518553492124157e-12
approximately O 0 2.4549343460855688e-11
3 O 0 2.3171774221619756e-10
- O 0 8.272364482309058e-08
- O 0 3.543522097970708e-08
5 O 0 1.5487219839904753e-10
centimorgans O 0 1.811701721976533e-08
from O 0 3.297947331892814e-11
the O 0 3.0981824744591435e-11
HLA O 0 1.0335945432871085e-08
- O 0 1.2673083416014919e-10
A O 0 9.629026048729727e-11
and O 0 1.213988631842966e-10
HLA O 0 2.87714012614515e-08
- O 0 1.5003006614833225e-09
B O 0 9.830358749240986e-10
loci O 0 4.2686593842988785e-11
, O 0 8.370318869445337e-13
and O 0 5.888356750978485e-13
that O 0 2.003599516115992e-13
the O 0 8.107965796151639e-13
apparent O 0 2.596115544761801e-10
lack O 0 2.0447225856923268e-10
of O 0 2.2900349151699917e-12
recombinants O 0 2.516348462933138e-09
between O 0 1.3033930705563801e-11
the O 0 2.599551867168981e-12
Factor O 0 7.77158615239415e-11
B O 0 3.9954276331855e-08
gene O 0 6.766693445570127e-07
and O 0 0.005431412719190121
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 4.3484430278795116e-08
suggests O 0 1.9486230407039784e-09
that O 0 5.3528496739285725e-12
these O 0 1.5800736370349955e-12
two O 0 3.570217472353976e-12
genes O 0 1.8423899905695151e-10
lie O 0 2.7918380940405996e-09
in O 0 1.280924533109129e-10
close O 0 1.4046894758479311e-09
proximity O 0 9.044257009982459e-10
to O 0 4.4031722712389865e-10
one O 0 1.7756194292672944e-09
another O 0 1.7647677763577008e-09
. O 0 3.024142714025402e-09

Distribution O 0 2.0740303696697993e-08
of O 0 5.827205940001079e-10
emerin O 0 3.613947228586767e-06
and O 0 8.1780243688101e-10
lamins O 0 1.3327446595212677e-06
in O 0 6.740599634014188e-09
the O 0 4.773766937304913e-10
heart O 0 6.91146340159321e-08
and O 0 1.9881658819276282e-10
implications O 0 4.701756206593188e-10
for O 0 1.1259854854062112e-10
Emery B-Disease 1 0.9800577163696289
- I-Disease 1 0.9955962300300598
Dreifuss I-Disease 1 0.8056858777999878
muscular I-Disease 1 0.9733592867851257
dystrophy I-Disease 1 0.9920444488525391
. O 0 7.031948712210578e-08

Emerin O 0 7.155890489229932e-05
is O 0 2.224323614186119e-09
a O 0 1.233802365829817e-10
nuclear O 0 1.6823544779498434e-09
membrane O 0 1.1322488502329975e-09
protein O 0 1.1193779236862156e-09
which O 0 3.1530760641329536e-11
is O 0 3.5365484846172635e-11
missing O 0 2.8972384491510184e-09
or O 0 3.0036076403838763e-10
defective O 0 3.094307601259061e-07
in O 0 6.13077801858708e-08
Emery B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999979734420776
Dreifuss I-Disease 1 0.9998464584350586
muscular I-Disease 1 0.9999834299087524
dystrophy I-Disease 1 0.9999971389770508
( O 0 5.842993004989694e-07
EDMD B-Disease 1 1.0
) O 0 9.074414109022655e-09
. O 0 2.3874620058705887e-09

It O 0 1.3173361068652412e-08
is O 0 1.1405063005121008e-10
one O 0 6.8216070812920915e-12
member O 0 3.3708331265147606e-12
of O 0 2.867260736564431e-13
a O 0 1.611552974400965e-10
family O 0 4.267163289384257e-10
of O 0 1.1344742853469647e-11
lamina O 0 1.0889010582104675e-07
- O 0 4.3700442375893545e-08
associated O 0 7.226971798779402e-10
proteins O 0 9.945851087156399e-11
which O 0 1.9963766750841216e-11
includes O 0 3.145177521202136e-11
LAP1 O 0 2.4398850655416027e-06
, O 0 1.9250422089722719e-10
LAP2 O 0 9.929958650900517e-07
and O 0 6.761043946923451e-10
lamin O 0 1.7199159856318147e-06
B O 0 1.4110548818280222e-07
receptor O 0 1.5339129078029146e-08
( O 0 1.481524125601652e-09
LBR O 0 3.60908052243758e-06
) O 0 8.858775379927408e-10
. O 0 2.7092628140934494e-09

A O 0 8.955925636655593e-07
panel O 0 3.181850161126931e-08
of O 0 7.303093893518131e-12
16 O 0 9.394333227996654e-11
monoclonal O 0 1.0581292508859974e-09
antibodies O 0 1.0047488174791397e-08
( O 0 5.056028928862588e-10
mAbs O 0 5.255698454220692e-08
) O 0 1.1347561085228719e-10
has O 0 1.5113922613441133e-10
been O 0 1.8173862414982977e-10
mapped O 0 9.250668564497744e-10
to O 0 8.974669098160692e-12
six O 0 1.9679494579066814e-12
specific O 0 1.800690401908972e-13
sites O 0 1.0330687694182217e-11
throughout O 0 9.751597099261211e-12
the O 0 4.316816869243123e-12
emerin O 0 1.1981898806467939e-09
molecule O 0 4.6057595237680715e-11
using O 0 5.258157104170991e-11
phage O 0 2.6347375392532513e-09
- O 0 1.0353975454790998e-09
displayed O 0 2.9827907505053375e-11
peptide O 0 1.8668462609117142e-11
libraries O 0 9.122631122737701e-11
and O 0 1.7531478005428092e-11
has O 0 1.2884555618611349e-12
been O 0 1.4717234592467876e-12
used O 0 1.999103790492618e-12
to O 0 5.203372021450603e-12
localize O 0 3.8214476916209605e-08
emerin O 0 1.5483446702546644e-07
in O 0 2.0051357796369018e-10
human O 0 8.050003025283914e-11
and O 0 1.8084796993278474e-09
rabbit O 0 1.0501243195903953e-05
heart O 0 7.1503645813209005e-06
. O 0 1.4236059442396254e-08

Several O 0 2.184821035200457e-08
mAbs O 0 8.694764233041496e-07
against O 0 7.084648423472117e-10
different O 0 3.0262992112284337e-10
emerin O 0 7.95439376588547e-08
epitopes O 0 1.3024879841339043e-08
did O 0 9.591183847135198e-09
not O 0 1.8519474148659398e-11
recognize O 0 2.7375648622984805e-11
intercalated O 0 1.3528826947606376e-09
discs O 0 4.195830740627571e-07
in O 0 2.100732032772612e-09
the O 0 6.828405202385923e-11
heart O 0 6.14744095628339e-08
, O 0 1.4104575146722809e-11
though O 0 5.381926848624374e-11
they O 0 1.1966082638648068e-11
recognized O 0 2.152783853959228e-11
cardiomyocyte O 0 1.7254931705679155e-08
nuclei O 0 1.5741673242697374e-10
strongly O 0 5.114729750843594e-10
, O 0 2.8717190084237565e-11
both O 0 1.4899843511773092e-11
at O 0 3.009583138258165e-10
the O 0 1.0473377373698689e-11
rim O 0 3.651475921628844e-08
and O 0 1.2655841929998246e-09
in O 0 1.801917171029288e-09
intranuclear O 0 6.054754635442805e-07
spots O 0 4.681028187292213e-08
or O 0 1.9809447415752857e-09
channels O 0 6.595165302769601e-08
. O 0 7.365818621707376e-09

A O 0 4.2366102093183144e-07
polyclonal O 0 2.5763440135051496e-05
rabbit O 0 4.223198629915714e-05
antiserum O 0 2.1410083718365058e-05
against O 0 3.7779059880449495e-08
emerin O 0 2.520844873288297e-06
did O 0 2.670120347048055e-09
recognize O 0 4.309028828197725e-11
both O 0 8.8736318640259e-12
nuclear O 0 5.459138696650712e-10
membrane O 0 4.5463502407194767e-10
and O 0 3.146227375849797e-11
intercalated O 0 1.2100545010440555e-09
discs O 0 1.0226488456055449e-07
but O 0 6.734556801113456e-10
, O 0 5.594925022410491e-13
after O 0 1.9329655064070916e-12
affinity O 0 7.518222155944443e-12
purification O 0 1.0452303085550785e-11
against O 0 6.181243451114371e-12
a O 0 6.097301136209765e-11
pure O 0 9.329097494514826e-09
- O 0 9.782456800166983e-06
emerin O 0 2.129616404999979e-06
band O 0 2.938847165623315e-09
on O 0 2.313604724468732e-10
a O 0 2.43557899543001e-11
western O 0 7.865838536069703e-10
blot O 0 0.0005489447503350675
, O 0 3.2201596944503308e-09
it O 0 5.544494308118431e-10
stained O 0 3.947354343836196e-06
only O 0 2.524673803350197e-10
the O 0 1.7674472996276336e-11
nuclear O 0 8.318323807543493e-09
membrane O 0 2.4519149377510985e-08
. O 0 1.907306534931763e-09

These O 0 3.4070164467436825e-09
results O 0 3.4144780336475833e-09
would O 0 3.5243603174750504e-11
not O 0 1.1417158017612561e-11
be O 0 4.2399642824486605e-12
expected O 0 6.715927813871758e-11
if O 0 6.164665566216199e-12
immunostaining O 0 1.908103453018839e-09
at O 0 1.0632431740598136e-10
intercalated O 0 4.673904041574417e-10
discs O 0 3.733707387709728e-08
were O 0 4.34266983484477e-10
due O 0 1.2012824762708263e-11
to O 0 7.051110455062737e-13
a O 0 5.586099291465807e-12
product O 0 6.424195203580396e-11
of O 0 3.2331632488467876e-13
the O 0 6.225518364710858e-12
emerin O 0 8.435518061844505e-09
gene O 0 1.979924890704865e-09
and O 0 4.64073474093496e-10
, O 0 1.2765117088364697e-11
therefore O 0 2.2820741824025603e-11
, O 0 4.69671437158814e-12
cast O 0 5.5279340133163046e-11
some O 0 1.7813028829749555e-11
doubt O 0 1.8374697596801326e-10
upon O 0 3.725559628593028e-13
the O 0 9.287374471908527e-13
hypothesis O 0 1.7693371767713018e-10
that O 0 1.9042847854144895e-10
cardiac B-Disease 0 0.0022138613276183605
defects I-Disease 0 0.33486711978912354
in O 0 1.0034276698434041e-07
EDMD B-Disease 1 1.0
are O 0 7.76808217750613e-09
caused O 0 1.8318577765796817e-09
by O 0 1.048961091598688e-11
absence O 0 1.0332885658215218e-09
of O 0 8.581086362313695e-12
emerin O 0 7.50962385609455e-08
from O 0 4.839020295577257e-10
intercalated O 0 7.102703847294833e-08
discs O 0 7.933050255815033e-06
. O 0 1.1703005675656186e-08

Although O 0 4.509796269758226e-08
emerin O 0 1.1522597560542636e-06
was O 0 5.055182494828614e-09
abundant O 0 5.091891838726603e-11
in O 0 7.169400489948075e-11
the O 0 7.533337668952367e-12
membranes O 0 2.348707894839208e-10
of O 0 1.3715591162810625e-12
cardiomyocyte O 0 1.0079312495747672e-08
nuclei O 0 1.2799793169815388e-10
, O 0 6.022254916970837e-11
it O 0 1.2529953463680243e-10
was O 0 1.1391252030534815e-07
absent O 0 7.574118554565246e-10
from O 0 7.174690962868935e-12
many O 0 3.457991488639567e-12
non O 0 1.840690821985902e-09
- O 0 1.8853203442859012e-08
myocyte O 0 3.0337346856867953e-07
cells O 0 4.650110962955978e-09
in O 0 9.59776813580504e-10
the O 0 3.239890578043969e-10
heart O 0 1.8221976461063605e-07
. O 0 6.225528093040111e-09

This O 0 3.122090364016117e-10
distribution O 0 4.987190521665852e-11
of O 0 2.4512742096555185e-12
emerin O 0 5.10888014559896e-07
was O 0 8.490093073021399e-09
similar O 0 3.331949516641175e-12
to O 0 1.2634213336984446e-12
that O 0 1.4522653912774075e-12
of O 0 5.680973269930889e-13
lamin O 0 4.774427964093775e-08
A O 0 4.5695186523531106e-10
, O 0 5.9470974152209255e-12
a O 0 1.1684877024298324e-11
candidate O 0 1.0754644397259483e-10
gene O 0 2.2363029206218243e-09
for O 0 2.7817095848980955e-11
an O 0 1.7201352842111106e-10
autosomal O 0 3.3882718071254203e-06
form O 0 1.8410170810057025e-07
of O 0 6.795698936912231e-08
EDMD B-Disease 1 1.0
. O 0 3.096220382303727e-07

In O 0 6.814009800848453e-09
contrast O 0 1.8657029698943006e-08
, O 0 9.911030884879324e-10
lamin O 0 3.18265228997916e-05
B1 O 0 0.000444683333626017
was O 0 1.861377185718993e-08
absent O 0 5.4766728929678266e-09
from O 0 4.935946443240802e-11
cardiomyocyte O 0 1.433034668707478e-08
nuclei O 0 1.8928490719272162e-10
, O 0 8.8243301554769e-12
showing O 0 4.119471874730607e-09
that O 0 3.299138462420359e-10
lamin O 0 7.38003518563346e-06
B1 O 0 7.816013749106787e-06
is O 0 9.160149201659085e-12
not O 0 3.5091658311808827e-12
essential O 0 8.205030405106228e-12
for O 0 1.444359280615426e-12
localization O 0 1.4716050600327435e-09
of O 0 1.7565711255343452e-12
emerin O 0 1.7639239402456042e-08
to O 0 2.3310554875255463e-11
the O 0 9.686036001044229e-11
nuclear O 0 1.7042125932675845e-07
lamina O 0 3.7433341049109004e-07
. O 0 3.275720583673092e-09

Lamin O 1 0.9896361231803894
B1 O 1 0.9998290538787842
is O 0 1.1627849971773685e-07
also O 0 1.2368566171261364e-09
almost O 0 9.786693677682479e-10
completely O 0 5.4502176993764806e-08
absent O 0 5.404462655178577e-08
from O 0 8.151799235633916e-10
skeletal O 0 3.521480721246917e-06
muscle O 0 4.0466139239470067e-07
nuclei O 0 4.409160325735684e-08
. O 0 4.270927611571551e-09

In O 0 8.361673735635122e-07
EDMD B-Disease 1 1.0
, O 0 2.1527399307608164e-10
the O 0 2.1032626595224313e-12
additional O 0 4.1985356163953824e-12
absence O 0 1.3070433624307043e-10
of O 0 9.603031911331605e-12
lamin O 0 3.332123378640972e-05
B1 O 0 3.369652040419169e-05
from O 0 6.440564193077591e-10
heart O 0 4.637067263502104e-07
and O 0 1.8295505554988267e-08
skeletal O 0 5.632792817777954e-05
muscle O 0 1.8587682859561028e-07
nuclei O 0 1.6920344014792477e-09
which O 0 2.1978301123493083e-10
already O 0 4.1723420274308864e-09
lack O 0 1.2881159472399872e-09
emerin O 0 2.2914086912351195e-06
may O 0 4.829820099416793e-09
offer O 0 3.2784178150002674e-11
an O 0 2.6079136137939496e-13
alternative O 0 5.6137549470092196e-11
explanation O 0 1.7890329495617863e-10
of O 0 2.742789719303862e-12
why O 0 2.557153933047118e-10
these O 0 3.520763975500829e-12
tissues O 0 4.265875500064631e-11
are O 0 4.6465578780463535e-12
particularly O 0 2.694543477232969e-10
affected O 0 3.410564330952326e-10
. O 0 3.537736076308917e-11
. O 0 4.3442105468471937e-10

Genetic O 0 3.3369219636369962e-06
mapping O 0 1.690242470431258e-07
of O 0 2.1059624877306504e-10
the O 0 3.3529656828790166e-10
copper B-Disease 0 5.009482606510574e-07
toxicosis I-Disease 0 5.744233021687251e-06
locus O 0 3.345207488791857e-08
in O 0 6.616456271757443e-09
Bedlington O 0 0.00018597663438413292
terriers O 0 0.00011661581083899364
to O 0 9.939787881663165e-10
dog O 0 2.847034750175226e-07
chromosome O 0 2.6415225420350907e-06
10 O 0 9.678913226451868e-10
, O 0 3.3025932683061754e-11
in O 0 1.655247883203259e-10
a O 0 3.422959971022266e-10
region O 0 1.5439102440950592e-08
syntenic O 0 2.9417703899525804e-06
to O 0 8.486845948230126e-11
human O 0 2.0263429822975354e-10
chromosome O 0 3.6382465395945474e-07
region O 0 6.028572840932611e-08
2p13 O 0 1.4160553291731048e-05
- O 0 2.508400712031289e-06
p16 O 0 3.7314048313419335e-06
. O 0 1.3870651294212166e-08

Abnormal O 1 0.9989644289016724
hepatic B-Disease 1 0.991926908493042
copper I-Disease 0 0.00019700742268469185
accumulation I-Disease 0 1.0291723029354216e-08
is O 0 1.2194740009463523e-11
recognized O 0 9.517148354121208e-12
as O 0 5.22401177871501e-10
an O 0 4.9773407617692556e-09
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 1.099886830502328e-07
man O 0 4.8896545195020735e-06
, O 0 3.673953086202886e-10
mouse O 0 2.042418827841175e-06
, O 0 5.815727899260992e-09
rat O 0 3.0807754228590056e-05
and O 0 1.236069646637361e-08
dog O 0 1.0608967386360746e-05
. O 0 1.2388500003623903e-08

The O 0 1.5700480915370463e-09
major O 0 1.0899909863582025e-09
cause O 0 2.0183170690302177e-09
of O 0 1.2389055059625065e-10
hepatic B-Disease 0 0.00016623472038190812
copper I-Disease 0 0.0022096328902989626
accumulation I-Disease 0 1.1096217633621563e-07
in O 0 1.9481817048472294e-08
man O 0 2.7401736133469967e-06
is O 0 7.83303283347081e-11
a O 0 7.839492943695348e-10
dysfunctional O 0 1.0694291177060222e-06
ATP7B O 0 6.168327672639862e-06
gene O 0 3.637962038283149e-07
, O 0 2.0872923389703146e-09
causing O 0 8.25548340799287e-08
Wilson B-Disease 0 1.9115734176011756e-05
disease I-Disease 0 0.014798271469771862
( O 0 7.427345138921737e-08
WD B-Disease 1 0.9866349101066589
) O 0 1.9916218008120268e-08
. O 0 1.1236996222407925e-08

Mutations O 0 2.7823136861115927e-06
in O 0 3.05894998220424e-09
the O 0 1.994379522640699e-10
ATP7B O 0 1.1064601324051182e-07
genes O 0 2.4014921162773817e-09
have O 0 2.10256284605137e-10
also O 0 5.3215390427574505e-11
been O 0 4.4706675861316825e-11
demonstrated O 0 4.178438151036801e-11
in O 0 1.9996208855399544e-10
mouse O 0 5.521197863345151e-07
and O 0 3.165916950820247e-08
rat O 0 5.015959231968736e-06
. O 0 1.0458360399923095e-08

The O 0 4.117115093293933e-09
ATP7B O 0 6.344450866890838e-07
gene O 0 3.1190698024374797e-08
has O 0 3.107991364270646e-10
been O 0 8.343215007755589e-11
excluded O 0 1.352951778388345e-10
in O 0 1.2664619353230933e-11
the O 0 2.710313093748362e-12
much O 0 8.779375837431047e-11
rarer O 0 5.820546888912759e-08
human O 0 1.365720869728193e-10
copper B-Disease 0 6.271741312957602e-06
overload I-Disease 0 2.13498287848779e-06
disease O 0 2.4860523240022303e-07
non B-Disease 0 8.804290985153784e-08
- I-Disease 0 4.458276237073733e-07
Indian I-Disease 0 1.4552074212303978e-08
childhood I-Disease 0 5.2342279559525196e-06
cirrhosis I-Disease 0 9.499730367679149e-06
, O 0 1.173934560672052e-10
indicating O 0 4.758036808993893e-08
genetic O 0 1.802857099164612e-07
heterogeneity O 0 3.905406060766836e-07
. O 0 1.4812790105622753e-08

By O 0 1.327553511565327e-09
investigating O 0 1.1737857796845219e-08
the O 0 1.1417991552242768e-10
common O 0 6.942233454765301e-08
autosomal O 1 0.9375686049461365
recessive O 1 0.9995830655097961
copper B-Disease 0 0.0018578901654109359
toxicosis I-Disease 0 0.0035183276049792767
( O 0 1.7300507693107647e-08
CT B-Disease 1 0.9999735355377197
) O 0 1.5512149342811199e-09
in O 0 2.4441162427280005e-09
Bedlington O 0 0.09076588600873947
terriers O 0 0.25879329442977905
, O 0 4.0278508306457184e-10
we O 0 1.5817751622404508e-11
have O 0 1.138462154409714e-12
identified O 0 1.241165937387878e-11
a O 0 6.007635361404695e-12
new O 0 2.0737149844518576e-11
locus O 0 8.026824760420936e-10
involved O 0 4.512272333556666e-09
in O 0 1.1656889000732917e-06
progressive O 1 0.9832995533943176
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.0415764961635432e-07

We O 0 1.1520907783335588e-08
examined O 0 5.6260769376592634e-09
whether O 0 5.6988209290453895e-11
the O 0 4.2106956810172846e-11
WD B-Disease 0 7.936879228509497e-06
gene O 0 2.1569040598024003e-07
ATP7B O 0 1.5806752344360575e-05
was O 0 4.857109381362079e-09
also O 0 4.345534695970876e-11
causative O 0 9.568777992186028e-10
for O 0 3.859022476571106e-12
CT B-Disease 0 5.2050552767468616e-05
by O 0 1.3701609291594252e-11
investigating O 0 5.360457078218417e-10
the O 0 5.281073495178035e-11
chromosomal O 0 1.2895765166831552e-06
co O 0 4.70170732569386e-07
- O 0 2.71343310487282e-07
localization O 0 9.150893731657561e-08
of O 0 1.90138044198207e-11
ATP7B O 0 5.418509658738913e-07
and O 0 1.7798468254781596e-10
C04107 O 0 1.6710142158871122e-09
, O 0 1.8167468397722875e-12
using O 0 9.893211250222578e-12
fluorescence O 0 5.664838043095699e-10
in O 0 8.801764317389882e-10
situ O 0 5.775754541303968e-09
hybridization O 0 3.350020483239291e-09
( O 0 2.276914629062432e-10
FISH O 0 3.4386664626850916e-09
) O 0 5.4156817919093214e-11
. O 0 1.893686873977174e-10

C04107 O 0 3.149927215417847e-05
is O 0 2.997965653506185e-09
an O 0 3.4110179958357634e-11
anonymous O 0 5.466904262618755e-09
microsatellite O 0 5.0002751095235e-07
marker O 0 4.273839238067012e-07
closely O 0 3.407915016850893e-08
linked O 0 3.666655743472802e-07
to O 0 9.237837161890639e-09
CT B-Disease 1 0.9999666213989258
. O 0 5.180259776693674e-08

However O 0 5.738357700124652e-08
, O 0 8.286142882951708e-10
BAC O 0 4.695528161846596e-07
clones O 0 1.6051034279485066e-08
containing O 0 1.460687681920092e-09
ATP7B O 0 4.960283149557654e-06
and O 0 4.674920450753461e-10
C04107 O 0 1.0000073658034125e-08
mapped O 0 3.4349432187497086e-09
to O 0 1.2828847359425133e-11
the O 0 2.529762684055914e-11
canine O 0 4.6589470059643645e-08
chromosome O 0 2.615390428672981e-07
regions O 0 1.593095255714161e-08
CFA22q11 O 0 1.4920476587576559e-06
and O 0 1.843171171245217e-09
CFA10q26 O 0 8.334654211239467e-08
, O 0 6.09011799324044e-11
respectively O 0 1.0004508332883688e-10
, O 0 1.053029950563722e-12
demonstrating O 0 2.6153782264892733e-11
that O 0 1.0865027627593449e-11
WD B-Disease 0 3.031623521110305e-07
cannot O 0 9.617925345040135e-10
be O 0 1.8135279736264387e-11
homologous O 0 5.114885737178554e-10
to O 0 7.300537951948627e-10
CT B-Disease 1 0.9931929707527161
. O 0 8.542135887523727e-09

The O 0 4.6673140907671495e-09
copper O 0 5.198056030053522e-08
transport O 0 6.525467721729683e-09
genes O 0 2.757020034493962e-08
CTR1 O 0 4.389878540678183e-06
and O 0 5.467079011722831e-10
CTR2 O 0 3.7947623354739335e-07
were O 0 7.564849857644163e-10
also O 0 1.079771948936381e-11
excluded O 0 2.669547222167168e-11
as O 0 1.896026955230945e-12
candidate O 0 1.5315717444286392e-11
genes O 0 2.3147389560662646e-10
for O 0 3.0018019320232625e-11
CT B-Disease 1 0.9999899864196777
since O 0 5.130149638432613e-09
they O 0 4.1442922010803684e-11
both O 0 4.586558563501875e-12
mapped O 0 4.4889378325585483e-10
to O 0 8.101078835531794e-11
canine O 0 2.38648283357179e-07
chromosome O 0 1.1534120858414099e-06
region O 0 6.2963685820705e-08
CFA11q22 O 0 1.4386866496352013e-05
. O 0 1.5518638818434738e-08

2 O 0 8.366719157493208e-06
- O 0 0.00014083419227972627
22 O 0 1.6503402378020837e-07
. O 0 6.811813779705744e-09

5 O 0 2.7095022687717574e-06
. O 0 7.898515264059824e-08

A O 0 1.1090040175076865e-07
transcribed O 0 1.975270009779706e-07
sequence O 0 1.5880281534208507e-09
identified O 0 1.284455541927798e-09
from O 0 1.2427529491598754e-11
the O 0 6.612232462954726e-12
C04107 O 0 3.2557261331334075e-09
- O 0 9.098673481311437e-10
containing O 0 2.0412584122997401e-10
BAC O 0 2.176288262489834e-06
was O 0 2.3145814154190703e-09
found O 0 5.025672586422836e-11
to O 0 8.380670831788228e-13
be O 0 1.719989168452729e-12
homologous O 0 1.1291335054453011e-11
to O 0 3.4078428013534223e-12
a O 0 2.090433902368627e-11
gene O 0 1.5991407087412313e-09
expressed O 0 2.190663622725353e-11
from O 0 1.685744772939035e-11
human O 0 3.564462960903292e-11
chromosome O 0 2.68303324446606e-07
2p13 O 0 2.724544287957542e-07
- O 0 3.515437470014149e-07
p16 O 0 1.0280367490622666e-07
, O 0 4.957231153346342e-11
a O 0 2.595332282417928e-11
region O 0 1.0520296855887068e-09
devoid O 0 2.262827702992354e-09
of O 0 2.53768208703653e-12
any O 0 7.344724828328708e-11
positional O 0 1.896463430739459e-07
candidate O 0 2.379757191306453e-08
genes O 0 1.3103061746733147e-07
. O 0 9.103434450707937e-09

Molecular O 0 5.780419343182075e-08
analysis O 0 3.5893135130748988e-09
of O 0 5.132667294655002e-12
the O 0 2.612700680804103e-11
APC B-Disease 0 3.5997551606214984e-09
gene O 0 3.5685481236669148e-09
in O 0 5.745514064514623e-10
205 O 0 3.799612624533211e-09
families O 0 4.56523013836474e-11
: O 0 6.7699925526687466e-12
extended O 0 2.024752365770155e-09
genotype O 0 0.0008039881940931082
- O 0 0.0010859278263524175
phenotype O 0 5.435596904135309e-06
correlations O 0 1.2835228062613169e-06
in O 0 1.4899944611457272e-09
FAP B-Disease 0 3.4106573121306383e-09
and O 0 5.707171714386394e-12
evidence O 0 7.622981239296944e-12
for O 0 1.7526678350830716e-13
the O 0 3.2788957096338556e-13
role O 0 3.5525443697892456e-11
of O 0 1.7442247732951666e-12
APC B-Disease 0 6.03113226027574e-10
amino O 0 1.0414775986067326e-10
acid O 0 3.517230673377725e-10
changes O 0 7.258634249218687e-10
in O 0 0.0017557890387251973
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 0 0.0007941289222799242
. O 0 5.486849019575857e-08

BACKGROUND O 0 0.0011686650104820728
/ O 0 3.4422000680933706e-06
AIMS O 0 3.6996217200879755e-09
The O 0 3.5078960569645545e-11
development O 0 9.435838776994387e-10
of O 0 3.1901499824016355e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 9.123419242307307e-10
a O 0 4.642290371559277e-11
variable O 0 5.110945555664159e-10
range O 0 3.5794756048090903e-09
of O 0 9.639334469513372e-11
extracolonic O 0 2.9263303531479323e-06
manifestations O 0 1.210094183079491e-06
in O 0 5.1916009397245944e-05
familial B-Disease 1 1.0
adenomatous I-Disease 1 0.9999995231628418
polyposis I-Disease 1 1.0
( O 0 1.5273855069608544e-06
FAP B-Disease 0 6.9696699256383e-07
) O 0 3.9011430197355423e-10
is O 0 3.837086551272684e-11
the O 0 6.883795616863253e-12
result O 0 1.5860840418824296e-10
of O 0 1.4403207359431347e-12
the O 0 4.848330070750251e-11
dominant O 0 4.6308889523061225e-07
inheritance O 0 2.2171509499457898e-06
of O 0 5.124245561205498e-08
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 0.9999990463256836
coli I-Disease 1 1.0
( O 0 3.176059806264675e-07
APC B-Disease 0 1.7750217295997572e-07
) O 0 6.301301147537686e-10
gene O 0 1.1919886588884765e-07
mutations O 0 1.0296905657014577e-06
. O 0 1.1216054751628235e-08

In O 0 8.936488882227422e-09
this O 0 4.023387872864603e-11
study O 0 8.227784772940616e-12
, O 0 4.679525538765772e-13
direct O 0 1.7428556861598388e-11
mutation O 0 2.864619375042565e-10
analysis O 0 1.1827581969381384e-10
of O 0 9.863399159926178e-13
the O 0 1.316831713116251e-11
APC B-Disease 0 1.088794054915354e-09
gene O 0 1.0612701828449644e-09
was O 0 1.8971078041829514e-09
performed O 0 4.264866931835698e-11
to O 0 4.325850441744272e-12
determine O 0 1.015388551017793e-09
genotype O 0 5.9735637478297576e-05
- O 0 0.00012533656263258308
phenotype O 0 8.487132276968623e-07
correlations O 0 2.415362132524024e-07
for O 0 1.5650541973499799e-10
nine O 0 1.5841257194892933e-09
extracolonic O 0 5.979547523793372e-08
manifestations O 0 3.6299747652179803e-09
and O 0 4.171048575973835e-11
to O 0 3.158792888716122e-12
investigate O 0 5.034643188461807e-11
the O 0 3.213670649038214e-11
incidence O 0 1.952675710015228e-08
of O 0 1.8663549872233176e-11
APC B-Disease 0 1.3170798673911577e-08
mutations O 0 3.523759062318277e-09
in O 0 1.3251856278984064e-09
non O 0 0.08726675063371658
- O 1 0.9999995231628418
FAP O 1 0.9999810457229614
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.8938716550565005e-07

METHODS O 0 8.46226328121702e-07
The O 0 3.533174197656308e-09
APC B-Disease 0 4.3064389387836854e-08
gene O 0 1.5552181764633133e-08
was O 0 7.398752721599067e-09
analysed O 0 3.764920375459724e-09
in O 0 2.1289466023421966e-10
190 O 0 2.8442481703194744e-09
unrelated O 0 1.5139558939836206e-08
FAP B-Disease 0 7.497087750607534e-08
and O 0 4.6388054508739174e-10
15 O 0 2.2006707567356898e-09
non O 0 0.0013898183824494481
- O 1 0.9999997615814209
FAP O 1 0.9999675750732422
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 1.3691176263819216e-06
using O 0 2.3734969545330387e-08
denaturing O 0 3.7023193726781756e-05
gradient O 0 6.145741622276546e-07
gel O 0 2.837162810465088e-06
electrophoresis O 0 1.5812382514468482e-07
, O 0 6.138199670768785e-11
the O 0 8.990226098293252e-12
protein O 0 4.6392303887365927e-10
truncation O 0 3.391548020204027e-08
test O 0 1.4869480935431056e-07
, O 0 1.3952727861976655e-11
and O 0 3.2841990845605684e-12
direct O 0 2.1345616940671164e-10
sequencing O 0 1.5432211952770558e-08
. O 0 3.98991195638132e-09

RESULTS O 0 3.4297281104045396e-07
Chain O 0 3.247838264996972e-08
terminating O 0 3.1305727787867e-08
signals O 0 2.7751424269695235e-08
were O 0 1.2833749341023548e-10
only O 0 2.087715200368989e-12
identified O 0 8.77899072881938e-11
in O 0 1.1109284499266625e-11
patients O 0 2.5174310552822377e-11
belonging O 0 1.4054980790323413e-10
to O 0 5.642510764181097e-12
the O 0 4.97532362531139e-11
FAP B-Disease 0 3.776059909199603e-09
group O 0 5.760261712062231e-10
( O 0 1.1393995469344276e-10
105 O 0 5.839603023360951e-09
patients O 0 4.6126150010650235e-08
) O 0 2.063181986367013e-10
. O 0 1.5589415314209987e-09

Amino O 0 1.9405391071813938e-07
acid O 0 1.1147890610629929e-08
changes O 0 6.381280920342292e-11
were O 0 5.58318322130269e-11
identified O 0 8.089497821606173e-11
in O 0 1.89529746064121e-11
four O 0 4.681717513665973e-11
patients O 0 1.8108604893374292e-10
, O 0 1.5553929672007527e-12
three O 0 4.338376879964301e-12
of O 0 1.0855949385962793e-12
whom O 0 1.185403442072186e-09
belonged O 0 1.9354040148300555e-08
to O 0 2.3464766588099373e-11
the O 0 2.6892432725134086e-11
non O 0 3.241884627414038e-08
- O 0 2.175984121777219e-07
FAP O 0 1.8934791512492666e-08
group O 0 1.785380376873036e-08
of O 0 7.538525892414327e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 4.989629815099761e-05
. O 0 5.129503932721491e-09

Genotype O 1 0.9996168613433838
- O 1 0.9999228715896606
phenotype O 0 0.00010015890438808128
correlations O 0 6.57146028970601e-06
identified O 0 5.6499960265909976e-08
significant O 0 8.979901267025525e-10
differences O 0 8.690356168017388e-08
in O 0 5.8174585149117775e-09
the O 0 1.986637417072945e-11
nature O 0 1.0172853011358729e-11
of O 0 7.68810091544142e-13
certain O 0 5.0885323732430265e-11
extracolonic O 0 3.8318116679647574e-08
manifestations O 0 3.2328431043282535e-09
in O 0 7.072740171309988e-10
FAP B-Disease 0 2.1037806163803907e-08
patients O 0 4.503415862444626e-09
belonging O 0 1.2813038408054922e-09
to O 0 7.92925169967873e-11
three O 0 1.8960361058972808e-10
mutation O 0 1.2489380196711863e-08
subgroups O 0 7.425023085261273e-08
. O 0 5.415521808771473e-09

CONCLUSIONS O 0 2.7599510303844e-06
Extended O 0 9.379986920521333e-08
genotype O 0 0.0007318553980439901
- O 0 0.025747470557689667
phenotype O 0 3.6320591334515484e-06
correlations O 0 1.6696982356734225e-06
made O 0 8.445821819691446e-09
in O 0 1.8514997868201988e-10
this O 0 3.022062418020499e-12
study O 0 9.928749662713177e-12
may O 0 7.686646874560665e-10
have O 0 3.5164757390682144e-12
the O 0 2.6602225739087715e-13
potential O 0 1.8054027240213544e-12
to O 0 7.068926065161019e-13
determine O 0 1.7393090440132042e-11
the O 0 1.4987196596608077e-12
most O 0 2.62936200590147e-12
appropriate O 0 3.703741133231908e-11
surveillance O 0 4.725701163721396e-09
and O 0 2.430381590423636e-11
prophylactic O 0 1.3789037467404341e-08
treatment O 0 2.383012454032496e-09
regimens O 0 3.024367645210191e-09
for O 0 9.32833129317634e-13
those O 0 3.675624908605624e-12
patients O 0 1.025589127512383e-10
with O 0 2.0322164090424977e-12
mutations O 0 3.838261708466462e-09
associated O 0 6.05575312118134e-10
with O 0 2.2591178927555688e-10
life O 0 1.0707988273850333e-08
threatening O 0 4.30113004767918e-06
conditions O 0 7.0544087975576986e-06
. O 0 1.0082773727049243e-08

This O 0 9.708162052035618e-10
study O 0 5.272679168277783e-11
also O 0 2.802627270884206e-12
provided O 0 1.4939050430734513e-12
evidence O 0 6.282980212490852e-12
for O 0 3.8369944699821745e-13
the O 0 1.844575056933473e-12
pathological O 0 1.0288773166777787e-09
nature O 0 2.5562114924770896e-11
of O 0 1.8240591329043987e-12
amino O 0 6.854111722631728e-11
acid O 0 8.767244569218846e-11
changes O 0 2.593075927592725e-11
in O 0 1.8829610093362703e-10
APC O 0 2.6527291474565118e-09
associated O 0 9.45538161656323e-11
with O 0 8.160408980495415e-12
both O 0 2.816111788206399e-10
FAP B-Disease 0 1.3266150844515323e-08
and O 0 5.538311476094293e-10
non O 0 0.07475297152996063
- O 1 0.9999998807907104
FAP O 1 0.9999836683273315
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 8.772256114752963e-05
. O 0 2.8050470279872286e-10
. O 0 6.687911335845342e-10

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 0.999997615814209
and O 0 1.882926699181553e-05
cancer B-Disease 0 8.224941120715812e-05
risk O 0 1.2774982849350636e-07
of O 0 2.19095627057575e-11
the O 0 2.200552240427811e-10
APC O 0 1.0120136550995085e-07
I1307K O 0 3.4565221085358644e-07
polymorphism O 0 4.561904916045023e-06
. O 0 1.6884758480273376e-08

Germ O 0 0.0023066061548888683
- O 0 0.0035729221999645233
line O 0 2.7711232064575597e-07
and O 0 5.935827940284355e-10
somatic O 0 9.730969807719703e-09
truncating O 0 1.294619256242413e-08
mutations O 0 6.143640263189809e-09
of O 0 2.8906768471947952e-12
the O 0 4.718740589243486e-12
APC B-Disease 0 5.678468806280534e-10
gene O 0 3.367829071176942e-10
are O 0 1.4174506186848124e-11
thought O 0 1.148132922068612e-09
to O 0 9.45646408401224e-11
initiate O 0 1.0259599321216228e-06
colorectal B-Disease 1 1.0
tumor I-Disease 0 4.7327477659564465e-05
formation O 0 3.8817450587202984e-08
in O 0 2.0269073957024375e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 1.1501954759296495e-05
sporadic O 1 0.9999977350234985
colorectal O 1 1.0
carcinogenesis O 1 0.5315103530883789
, O 0 2.5764753885937353e-08
respectively O 0 2.6882576165121463e-08
. O 0 1.9905954662391423e-09

Recently O 0 3.9604586277164344e-07
, O 0 4.78477923948617e-10
an O 0 7.373725241510698e-11
isoleucine O 0 1.1684474884532392e-05
- O 0 6.729773076585843e-07
- O 0 8.722703341845772e-07
> O 0 4.200178338464866e-08
lysine O 0 3.4103018720088585e-07
polymorphism O 0 1.1079949899794883e-06
at O 0 7.841815197195956e-09
codon O 0 7.875409124835642e-08
1307 O 0 2.741572302511486e-07
( O 0 5.1426285452294e-10
I1307K O 0 3.4194833631318033e-09
) O 0 5.836521370372605e-12
of O 0 2.41677961280648e-13
the O 0 5.255707761359085e-12
APC B-Disease 0 5.161200355985329e-10
gene O 0 2.8212729374921253e-10
has O 0 1.5348469023512834e-11
been O 0 4.9477096031314005e-11
identified O 0 2.0654185306501205e-10
in O 0 9.734259405480561e-12
6 O 0 6.722528089753155e-11
% O 0 7.987372568907247e-11
- O 0 2.189714720657321e-08
7 O 0 1.3942500487473808e-09
% O 0 3.15359335867349e-11
of O 0 1.6931615614765305e-12
the O 0 4.001026593369872e-11
Ashkenazi O 0 5.121077339964586e-09
Jewish O 0 1.0024392427254725e-10
population O 0 1.954763260980652e-11
. O 0 4.45759984479821e-10

To O 0 2.117753528096955e-09
assess O 0 1.0916122228366021e-08
the O 0 3.257729155881073e-11
risk O 0 1.1057750548548739e-10
of O 0 1.0119045223055609e-13
this O 0 2.8523056312679262e-12
common O 0 2.6459159863101434e-10
APC B-Disease 0 1.4851207374988462e-08
allelic O 0 3.4301393725399976e-08
variant O 0 0.00011821258522104472
in O 0 0.002797365188598633
colorectal O 1 1.0
carcinogenesis O 0 0.0012055982369929552
, O 0 9.217807850347981e-09
we O 0 1.8671500456868273e-10
have O 0 7.911059828058509e-12
analyzed O 0 7.61335161580945e-11
a O 0 1.0913170540860495e-11
large O 0 6.129658586262465e-11
cohort O 0 2.3471248056239347e-08
of O 0 2.3879877242283243e-11
unselected O 0 5.917197995586321e-06
Ashkenazi O 0 5.993604190734914e-07
Jewish O 0 2.1944213113300748e-09
subjects O 0 2.0927627630840107e-08
with O 0 5.11376385681217e-10
adenomatous B-Disease 0 2.4637092792545445e-05
polyps I-Disease 0 1.9295755919301882e-05
and O 0 2.671281862376418e-09
. O 0 1.86570203730696e-09
or O 1 0.9999560117721558
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 3.4664937587081113e-10
for O 0 8.95176120729868e-12
the O 0 8.048744309929745e-11
APC O 0 9.600742600923695e-08
I1307K O 0 1.3304799040270154e-07
polymorphism O 0 3.910320629074704e-06
. O 0 2.0297568070759553e-08

The O 0 1.5210760651029887e-08
APC O 0 7.120106033653428e-07
I1307K O 0 2.4225158767876565e-07
allele O 0 2.3184027497791249e-07
was O 0 1.2619691958093426e-08
identified O 0 1.4399081926796953e-09
in O 0 1.7953021014260884e-10
48 O 0 9.65752144921339e-10
( O 0 4.332226938297268e-11
10 O 0 1.1201584798614661e-11
. O 0 8.96778636592932e-13
1 O 0 9.667611329533532e-12
% O 0 1.6768041816161983e-11
) O 0 2.6504189468146144e-12
of O 0 5.297020200939473e-12
476 O 0 2.7539979186030905e-08
patients O 0 1.0955570672877002e-07
. O 0 2.0340034101451465e-09

Compared O 0 1.1360159390960689e-07
with O 0 4.9747636565733444e-11
the O 0 1.721637589435776e-11
frequency O 0 1.4808319015457982e-09
in O 0 1.1918664666321632e-10
two O 0 2.6227602988732057e-12
separate O 0 1.4043391016044238e-12
population O 0 3.7044014231969735e-13
control O 0 9.030617920124939e-11
groups O 0 2.407248228877834e-12
, O 0 3.812994191221275e-12
the O 0 7.740058594052357e-12
APC O 0 1.0938381755920545e-08
I1307K O 0 5.468186792256802e-09
allele O 0 6.5659429004938374e-09
is O 0 1.0968093620833397e-11
associated O 0 9.328264723162949e-12
with O 0 5.721839560317299e-13
an O 0 1.2763212795668943e-12
estimated O 0 2.066142396062176e-11
relative O 0 5.724023477426954e-09
risk O 0 2.392395437311734e-08
of O 0 1.9304904896877417e-11
1 O 0 2.6642192896275674e-09
. O 0 3.347293109356997e-09

5 O 0 2.686879270186182e-06
- O 0 1.7543285139254294e-05
1 O 0 1.0774407144253928e-08
. O 0 2.1851156439822716e-09

7 O 0 3.803947492997395e-06
for O 0 5.0186969247079105e-08
colorectal B-Disease 1 1.0
neoplasia I-Disease 0 0.0869465246796608
( O 0 2.931928477778456e-08
both O 0 1.504548308162157e-08
P O 0 0.19710256159305573
= O 0 8.902943449129452e-08
. O 0 1.531915039265641e-09
01 O 0 3.398266983367648e-07
) O 0 1.3012606547846417e-09
. O 0 4.152327370832154e-09

Furthermore O 0 8.943722917820196e-08
, O 0 2.795513265319016e-10
compared O 0 4.033909595246854e-10
with O 0 1.9440882931265335e-11
noncarriers O 0 1.650152853471809e-06
, O 0 1.7045920230884803e-10
APC O 0 4.617163540387992e-09
I1307K O 0 4.014415466713217e-09
carriers O 0 5.477310160983961e-09
had O 0 1.1970706648156693e-09
increased O 0 8.336741019743243e-11
numbers O 0 7.009709479532944e-11
of O 0 5.711658576657008e-12
adenomas B-Disease 0 0.08056531101465225
and O 0 0.47800183296203613
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9666306972503662
per O 0 9.431672509663258e-08
patient O 0 2.2022561097401194e-05
( O 0 9.549018464838355e-09
P O 0 0.027257701382040977
= O 0 4.521371721466494e-08
. O 0 4.197787395465724e-10
03 O 0 1.0717878140553694e-08
) O 0 4.566639167508102e-12
, O 0 1.93777177463772e-12
as O 0 4.65955095688142e-12
well O 0 1.2503709873046276e-11
as O 0 3.777799600923615e-11
a O 0 4.5842196705336846e-10
younger O 0 9.035488091058141e-08
age O 0 2.383326203059255e-09
at O 0 1.9150234731313276e-09
diagnosis O 0 3.968572173107532e-07
. O 0 2.461059800396015e-09

We O 0 4.312529711114621e-08
conclude O 0 1.8247657607162182e-08
that O 0 1.9492938513332447e-11
the O 0 7.959613003427624e-12
APC O 0 2.6893947069339674e-09
I1307K O 0 3.7128409235975823e-09
variant O 0 1.1564625879145751e-07
leads O 0 3.143290072671334e-10
to O 0 1.7660868600888335e-10
increased O 0 2.8855960408691317e-05
adenoma B-Disease 1 1.0
formation O 0 5.241520106835651e-09
and O 0 6.348261499811159e-11
directly O 0 1.6178287876034148e-11
contributes O 0 4.341160417253853e-11
to O 0 5.498970202799658e-12
3 O 0 6.450137646218934e-11
% O 0 1.6813654635239317e-10
- O 0 8.291047848274502e-09
4 O 0 1.4868935249712223e-10
% O 0 3.4223967410040856e-11
of O 0 3.401297255997693e-12
all O 0 4.567427547286229e-10
Ashkenazi O 0 0.0001601742405910045
Jewish O 0 0.0072938683442771435
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.5936444930939615e-08

The O 0 2.550281097413176e-10
estimated O 0 4.190225944000758e-11
relative O 0 4.663734398668851e-10
risk O 0 3.7938607810872327e-10
for O 0 2.041415864476037e-12
carriers O 0 3.3143845445948728e-09
may O 0 5.19953746724866e-10
justify O 0 7.12669923075282e-11
specific O 0 1.8317266106682162e-11
clinical O 0 8.184999900073819e-10
screening O 0 3.3730104820328677e-10
for O 0 1.893150566867341e-12
the O 0 1.7544582323406055e-12
360 O 0 1.5241065354221206e-10
, O 0 1.349193109664859e-12
000 O 0 3.7505085842548525e-12
Americans O 0 1.2432272225582075e-11
expected O 0 4.4348105049385467e-11
to O 0 1.3233396583406387e-12
harbor O 0 2.321344505507028e-10
this O 0 1.1713857965209296e-12
allele O 0 4.0860242966900273e-10
, O 0 3.132800442673389e-12
and O 0 5.781003280247443e-12
genetic O 0 3.3932659460056414e-10
testing O 0 2.4391144659574593e-09
in O 0 2.1375522185618223e-10
the O 0 1.511474972959448e-11
setting O 0 1.3912024310336335e-10
of O 0 3.941361993720083e-12
long O 0 5.595598207008834e-09
- O 0 3.490279425477638e-07
term O 0 7.13465269086555e-08
- O 0 2.1481401546452616e-08
outcome O 0 1.0157237273489272e-09
studies O 0 2.654509390076498e-10
may O 0 1.9391194205908846e-10
impact O 0 2.0186893823215257e-10
significantly O 0 9.695769449535874e-07
on O 1 0.9998114705085754
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 3.841808293714166e-08
in O 0 1.2807314930807223e-10
this O 0 7.71210352523699e-12
population O 0 2.7414157749428014e-11
. O 0 1.2747928268552755e-09

Localization O 0 1.1090331781815621e-06
of O 0 5.20188579711256e-11
human O 0 3.7815195419454994e-11
BRCA1 O 0 3.1382316478811845e-07
and O 0 3.716126295572053e-10
its O 0 2.718925085076762e-11
loss O 0 1.2204293131645727e-09
in O 0 2.1207204881079633e-09
high O 0 1.0508797458896879e-05
- O 0 2.5420689780730754e-05
grade O 0 9.272966053686105e-06
, O 0 1.984869490989638e-10
non B-Disease 0 0.000808735319878906
- I-Disease 1 0.9999399185180664
inherited I-Disease 1 0.9999970197677612
breast I-Disease 1 0.999998927116394
carcinomas I-Disease 1 1.0
. O 0 3.4695176509558223e-07

Although O 0 3.181593655199322e-09
the O 0 1.3173190836768267e-11
link O 0 6.293241483490419e-10
between O 0 7.788666239738617e-11
the O 0 4.5452666630474425e-10
BRCA1 O 1 0.974922776222229
tumour B-Disease 1 1.0
- O 0 2.2312503915600246e-06
suppressor O 0 5.966867320239544e-07
gene O 0 1.208832259180781e-06
and O 0 7.477371468667116e-07
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 1.0994070931413802e-10
established O 0 5.271995340283553e-11
, O 0 4.216576740545541e-12
the O 0 1.291479401720197e-12
role O 0 1.2047249309254937e-10
, O 0 1.4689702579340214e-11
if O 0 2.9989389877665973e-12
any O 0 6.559724551741253e-12
, O 0 3.139039158814305e-12
of O 0 7.395577748293969e-13
BRCA1 O 0 3.371618007008692e-08
in O 0 1.965986484719906e-09
non B-Disease 0 0.029518723487854004
- I-Disease 1 0.9969354867935181
familial I-Disease 1 0.8253863453865051
cancers I-Disease 1 0.9840324521064758
is O 0 7.070908747408566e-09
unclear O 0 1.23703117083096e-07
. O 0 4.947431353485854e-09

BRCA1 O 0 0.0012307943543419242
mutations O 0 1.4480717709375313e-06
are O 0 5.865520846803918e-10
rare O 0 1.6696187765674608e-09
in O 0 2.8499282933580616e-09
sporadic B-Disease 1 0.9280920028686523
cancers I-Disease 1 0.9996814727783203
, O 0 8.377359361766423e-10
but O 0 9.207295481594713e-10
loss O 0 5.015266535401963e-10
of O 0 2.8235096552475802e-12
BRCA1 O 0 1.22774764577116e-07
resulting O 0 1.7048651379525381e-10
from O 0 8.373648996418126e-11
reduced O 0 2.962093070824068e-10
expression O 0 2.7994992435331767e-10
or O 0 8.56660631320949e-10
incorrect O 0 3.1177851411712254e-08
subcellular O 0 5.645244982588338e-07
localization O 0 3.326831858885271e-07
is O 0 3.9938368584513384e-11
postulated O 0 1.0110191572820781e-09
to O 0 8.488493762059957e-12
be O 0 4.956699547337129e-12
important O 0 7.296466382478162e-12
in O 0 8.845112142719103e-11
non B-Disease 0 1.915939719765447e-06
- I-Disease 0 0.02038273587822914
familial I-Disease 1 0.9990842342376709
breast I-Disease 1 0.9999996423721313
and I-Disease 1 0.9999856948852539
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 4.17576728750646e-08

Epigenetic O 0 6.639645289396867e-05
loss O 0 6.876131465105573e-06
, O 0 9.184002447426565e-10
however O 0 2.1820868723043674e-10
, O 0 1.5033986208723427e-11
has O 0 7.068686348060682e-12
not O 0 3.798259016335459e-12
received O 0 3.6451917873048245e-12
general O 0 2.4073679247976765e-12
acceptance O 0 1.6336905439562344e-10
due O 0 1.290786366681118e-10
to O 0 5.472905548892237e-12
controversy O 0 2.9181775051956294e-11
regarding O 0 2.2454302306407214e-11
the O 0 5.486147126865237e-12
subcellular O 0 4.9507349331179284e-09
localization O 0 4.305607426147162e-09
of O 0 1.4746908121726632e-12
BRCA1 O 0 3.885824995109033e-09
proteins O 0 7.735383861229295e-11
, O 0 1.2144139860392755e-11
reports O 0 6.587361905951994e-11
of O 0 1.3146319970125386e-13
which O 0 7.29660516035624e-12
have O 0 7.832404863572506e-11
ranged O 0 2.4547108790073935e-10
from O 0 2.9997627645772518e-12
exclusively O 0 1.996864132380871e-11
nuclear O 0 4.161111899492198e-09
, O 0 1.1185060690144244e-11
to O 0 2.3311834233818995e-12
conditionally O 0 3.8201028451645413e-10
nuclear O 0 5.385256685030981e-10
, O 0 1.1989334221598758e-12
to O 0 2.884022502151057e-13
the O 0 1.0037283504349404e-11
ER O 0 7.904888548182498e-07
/ O 0 9.26380927523951e-09
golgi O 0 3.400428383315557e-08
, O 0 2.909873557388476e-11
to O 0 1.0877053598090658e-11
cytoplasmic O 0 6.538586116988654e-09
invaginations O 0 7.083384900852252e-08
into O 0 1.4352598276534678e-10
the O 0 8.3496626279711e-11
nucleus O 0 2.292157796901506e-09
. O 0 1.4992823649251363e-09

In O 0 1.2042116637189793e-08
an O 0 3.524709690783112e-11
attempt O 0 1.388038350924603e-09
to O 0 1.2199632970499863e-10
resolve O 0 1.1199679406104224e-08
this O 0 3.143252672033192e-11
issue O 0 1.0092003899231372e-09
, O 0 2.1631026830837286e-11
we O 0 2.4119420002910452e-11
have O 0 1.0713609686907599e-11
comprehensively O 0 6.742962854744405e-10
characterized O 0 8.791139344266341e-11
19 O 0 2.239913254875603e-10
anti O 0 2.2889173223461512e-08
- O 0 6.317649337006515e-08
BRCA1 O 0 3.288688219527103e-07
antibodies O 0 5.133460945216939e-08
. O 0 1.0949633200141307e-08

These O 0 3.3973603930093077e-09
reagents O 0 3.367119560948595e-08
detect O 0 2.427582401764994e-08
a O 0 4.020474786425865e-10
220 O 0 1.035684338290821e-08
- O 0 7.362577036928997e-08
kD O 0 2.3352740186055598e-07
protein O 0 9.253690258503866e-09
localized O 0 1.4414477611524035e-08
in O 0 8.284672947667104e-10
discrete O 0 6.655338502525865e-09
nuclear O 0 1.0853966614376986e-07
foci O 0 8.846829047115534e-08
in O 0 7.914116029184015e-10
all O 0 3.1081259094234426e-11
epithelial O 0 7.578352945181166e-10
cell O 0 1.1468557659100043e-07
lines O 0 1.8249814104365214e-08
, O 0 3.2062117717723826e-12
including O 0 4.1698353212167583e-13
those O 0 1.879503714122266e-12
derived O 0 1.0260744337520222e-10
from O 0 2.5139115233940856e-09
breast B-Disease 0 1.1996470448139007e-06
malignancies I-Disease 0 4.373890533315716e-06
. O 0 1.5797454011590162e-08

Immunohistochemical O 0 0.00017159852723125368
staining O 0 2.2532010916620493e-05
of O 0 5.70918090581074e-10
human O 0 1.0389742399752322e-09
breast O 0 7.345590233853727e-07
specimens O 0 6.9108807565498864e-09
also O 0 2.545068378267956e-09
revealed O 0 5.432833205532006e-08
BRCA1 O 0 4.075053311680676e-06
nuclear O 0 3.040828744360624e-07
foci O 0 4.59032298749662e-06
in O 0 1.9182053279109823e-07
benign O 1 0.999750554561615
breast O 1 0.6886522173881531
, O 0 6.696392773619664e-08
invasive B-Disease 1 0.6768845915794373
lobular I-Disease 1 0.9999994039535522
cancers I-Disease 1 0.999998927116394
and O 0 5.943491032667225e-06
low B-Disease 1 0.99986732006073
- I-Disease 1 0.9999505281448364
grade I-Disease 1 0.8743742108345032
ductal I-Disease 1 0.9998799562454224
carcinomas I-Disease 1 1.0
. O 0 4.62134210010845e-07

Conversely O 0 2.5048270799743477e-06
, O 0 4.739113546037288e-09
BRCA1 O 0 2.775143173039396e-07
expression O 0 3.6579428375205225e-09
was O 0 1.6939532443416283e-08
reduced O 0 1.7264460694388362e-10
or O 0 8.887949404234874e-11
undetectable O 0 3.584579300053292e-09
in O 0 1.2464473897466632e-10
the O 0 3.423909593347485e-12
majority O 0 1.1724615202324262e-11
of O 0 4.385482862273582e-12
high O 0 3.3010101105901413e-06
- O 0 0.006303680129349232
grade O 0 0.0006489920197054744
, O 0 1.4343218834866889e-09
ductal B-Disease 0 0.14180009067058563
carcinomas I-Disease 1 1.0
, O 0 3.705241113927116e-10
suggesting O 0 1.9808541473764762e-09
that O 0 1.694978532529312e-11
absence O 0 6.779558164859978e-11
of O 0 1.6485823123302268e-12
BRCA1 O 0 1.3554772237966972e-07
may O 0 1.3874613680187053e-09
contribute O 0 4.032620591620795e-12
to O 0 2.0871817729001263e-12
the O 0 4.427168267401305e-12
pathogenesis O 0 3.372920553967873e-10
of O 0 3.9825594536600784e-13
a O 0 1.838976540491366e-11
significant O 0 7.660564960154659e-10
percentage O 0 8.700887832446824e-08
of O 0 3.45928147238439e-10
sporadic B-Disease 1 0.9993703961372375
breast I-Disease 1 0.9995275735855103
cancers I-Disease 0 0.16093800961971283
. O 0 6.3698930574673795e-09
. O 0 4.902978911758282e-09

